Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ABCA7	ABCX	ENSG00000064687	"ATP binding cassette subfamily A member 7"	Q8IZY2	19	1040101-1065572	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Phagocytosis, Transport"	Translocase	"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 35.2"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 68.5;Bipolar cells: 64.0;Cone photoreceptor cells: 164.9;Extravillous trophoblasts: 217.5;Rod photoreceptor cells: 151.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 26.7;HMC-1: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041564	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cell Junctions"		NA	NA			"Golgi apparatus, Plasma membrane"	"Cell Junctions"	"HPA041564: AB_2677550"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (7.26e-4)"	"prognostic favorable (1.12e-4)"	"unprognostic (8.88e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.68e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.08e-2)"	"unprognostic (3.66e-1)"	"unprognostic (7.88e-2)"	"unprognostic (7.85e-2)"	6.0	3.5	6.2	20.2	4.8	35.2	7.6	13.6	11.1	5.0	5.8	1.9	4.7	4.9	2.1	3.9	7.5	2.8	5.5	2.3	5.3	6.5	5.3	3.6	9.5	17.7	5.2	5.1	1.0	7.0	5.6	34.5	3.1	7.7	4.9	4.2	34.7	9.9	6.5	5.5	11.1	11.1	1.8	6.7	26.6	7.9	1.6	4.3	19.8	7.0	3.9	14.5	5.1	4.9	1.5	9.9	10.8	2.5	1.9	2.6	1.2	5.7	5.4	1.1	3.4	6.7	3.0	5.6	0.8	0.8	0.3	0.6	4.1	2.2	11.2	3.8	0.8	0.4	5.7	2.3	5.1	0.3	7.4	2.1	8.6	26.7	4.1	2.6	3.2	32.2	2.8	1.8	1.5	2.9	5.5	1.9	6.1	8.7	7.0	1.0	1.4	3.1	2.3	0.6	4.2	2.5	2.9	0.6	8.0	2.8	10.8	0.7	2.2	6.3	1.9	0.6	2.5	3.7	5.2	2.8	0.6	1.4	2.9	0.8	8.1	7.9	6.1	1.4	7.7	1.3	4.3	2.5	7.0	2.6	1.7	1.6	1.0	1.5	1.8	2.8	1.5	1.4	2.1	10.8	1.9	1.6	9.9	0.6	1.2	6.2	4.8	13.6	11.1	5.3	6.5	5.2	5.1	7.7	4.3	68.5	31.1	10.2	0.6	3.0	64.0	5.6	2.5	5.3	9.1	5.2	164.9	2.4	1.7	2.7	6.0	2.9	9.0	0.0	2.1	217.5	2.8	1.4	9.3	3.2	6.9	14.3	3.4	3.1	14.8	2.9	0.0	7.0	0.0	10.0	3.8	13.0	5.9	10.5	0.0	1.3	151.3	0.0	3.1	0.7	1.9	3.0	21.5	10.2	2.9	1.7
ABCB4	"GBD1, MDR2, MDR3, PFIC-3, PGY3"	ENSG00000005471	"ATP binding cassette subfamily B member 4"	P21439	7	87401697-87480435	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 93.2"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 235.3"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 16.3"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"memory B-cell: 4.9;naive B-cell: 11.4"	"Lineage enriched"	"Detected in many"	8	"B-cells: 11.4"	"Group enriched"	"Detected in some"	5	"SH-SY5Y: 12.0;WM-115: 22.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA049395, HPA053288"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Nucleoplasm, Plasma membrane, Actin filaments"	"Focal adhesion sites"	"HPA049395: AB_2680745, HPA053288: AB_2682102"	"unprognostic (7.92e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.35e-3)"	"unprognostic (9.91e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.44e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.01e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.47e-1)"	0.5	4.1	0.2	4.3	0.2	0.2	0.3	0.1	1.1	0.2	0.6	0.4	0.0	0.0	0.1	0.2	0.6	0.1	0.3	4.0	0.3	0.2	0.4	93.2	0.1	4.1	0.3	0.2	0.3	0.1	0.0	0.5	0.0	0.3	0.3	0.4	0.8	0.4	0.1	2.9	0.6	1.2	1.6	0.5	5.2	0.2	0.5	0.4	0.1	0.4	4.2	3.2	0.6	0.5	11.4	1.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.3	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	12.0	0.0	0.6	2.2	0.5	0.2	0.5	0.0	0.2	1.6	0.1	0.0	0.0	0.0	2.8	0.2	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.0	0.1	1.4	11.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.2	0.1	1.1	0.3	0.2	0.3	0.2	0.3	0.4	0.0	0.3	23.1	0.0	0.9	0.0	9.3	0.0	0.0	0.0	1.8	0.0	0.9	0.0	0.1	0.6	0.8	0.1	0.0	0.0	0.2	1.5	0.0	0.0	235.3	0.5	36.5	0.0	5.5	5.4	0.2	0.0	0.0	10.1	0.0	0.0	0.0	0.1	0.0	0.4	0.5	0.0	0.0	0.9	0.5	0.1	0.4	0.1	0.0	0.0	0.0
ABCB6	"EST45597, MTABC3, umat"	ENSG00000115657	"ATP binding cassette subfamily B member 6 (Langereis blood group)"	Q9NP58	2	219209766-219219017	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Dyskeratosis congenita, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	14	"Ciliated cells: 4.0;Club cells: 2.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 27.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046723, HPA058011"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Mitochondria,Cytosol"		NA	NA		22000	"Golgi apparatus"	"Nucleoplasm, Plasma membrane, Mitochondria, Cytosol"	"HPA046723: AB_10960288, HPA058011: AB_2683578"	"unprognostic (8.04e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.11e-2)"	"prognostic unfavorable (9.45e-7)"	"unprognostic (2.26e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.18e-4)"	"unprognostic (3.02e-3)"	"prognostic unfavorable (1.52e-7)"	"unprognostic (1.51e-1)"	"unprognostic (9.55e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.30e-1)"	10.1	8.4	8.2	3.9	13.5	10.2	9.2	7.6	9.1	6.9	7.6	5.4	8.3	8.1	7.1	10.1	9.0	8.4	8.5	9.5	5.6	8.2	6.9	16.2	7.2	4.9	9.8	7.6	13.1	7.1	8.0	6.0	3.7	9.2	9.2	4.2	6.0	5.6	11.3	24.0	5.5	8.0	9.5	9.2	3.2	6.8	19.5	7.7	0.8	9.9	11.3	4.7	14.8	6.0	2.8	5.6	1.3	1.1	1.2	3.2	2.4	0.1	9.9	2.0	12.5	14.0	5.0	12.3	3.7	3.4	4.1	4.1	15.2	2.1	0.1	19.1	3.6	2.2	21.4	0.2	1.5	1.3	6.3	2.2	15.5	10.9	27.9	16.9	0.0	5.2	7.3	1.8	2.7	0.0	6.1	7.1	2.1	13.1	1.9	2.7	5.1	1.0	0.1	3.1	23.0	4.1	5.2	6.3	0.6	2.2	0.2	7.4	7.9	7.7	18.3	8.1	8.0	5.5	0.3	3.2	5.5	0.2	7.4	4.3	5.0	4.0	0.0	6.2	0.1	7.3	1.3	1.1	0.0	1.7	0.9	0.5	2.8	1.3	0.7	0.9	2.3	3.2	2.1	0.0	1.2	0.8	5.6	1.1	2.4	8.2	13.5	7.6	9.1	5.6	8.2	9.8	7.6	9.2	7.7	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	4.0	2.3	0.0	0.0	0.2	0.0	0.6	1.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.4	0.0	0.7	0.0	0.2	0.9	0.2	0.3	0.2	0.0	0.0	0.0
ABCC1	"GS-X, MRP, MRP1"	ENSG00000103222	"ATP binding cassette subfamily C member 1"	P33527	16	15949577-16143074	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	"Hydrolase, Translocase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 7.5;eosinophil: 3.1;T-reg: 2.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 7.5;T-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 39.0"	"Low region specificity"	"Detected in all"							"HPA002380, HPA076011"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Cell Junctions"	"HPA002380: AB_1844432, HPA076011: "	"unprognostic (9.97e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.94e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (5.42e-5)"	"unprognostic (3.42e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.07e-2)"	"unprognostic (9.78e-3)"	"unprognostic (7.19e-2)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (1.84e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.80e-2)"	8.9	8.2	2.4	8.3	3.1	8.4	9.6	4.4	5.0	8.3	10.7	2.6	15.5	3.5	10.5	12.7	14.7	5.6	9.6	8.0	2.1	2.4	4.5	1.6	10.9	12.2	3.0	2.1	6.8	5.8	18.4	4.2	5.2	4.1	9.6	4.1	12.0	16.9	10.9	20.8	6.6	8.2	16.4	4.0	9.2	10.9	15.1	2.3	26.8	15.7	12.6	15.6	15.3	11.8	0.7	0.5	7.5	0.5	0.4	2.1	0.2	2.3	24.7	0.1	6.5	5.7	3.5	1.3	7.3	8.9	6.3	6.6	3.9	17.8	6.7	39.0	14.0	5.9	6.7	2.0	7.1	4.8	11.8	2.3	8.3	14.4	14.3	17.1	3.0	21.5	7.5	4.8	1.8	1.0	5.4	6.9	12.9	8.4	3.4	1.9	4.6	5.3	2.8	3.9	3.3	3.6	18.9	3.7	3.3	2.3	8.3	3.6	5.9	9.2	10.0	2.4	6.6	3.5	1.6	0.7	0.4	1.5	5.2	5.8	6.4	3.2	2.3	3.3	3.1	0.7	7.5	0.1	3.1	0.6	0.4	0.6	0.7	0.5	0.6	0.5	0.3	0.6	0.6	0.0	0.4	0.5	0.3	2.1	0.2	2.4	3.1	4.4	5.0	2.1	2.4	3.0	2.1	4.1	2.3	23.8	6.4	10.4	6.8	7.8	3.1	5.3	5.1	2.7	12.5	5.2	21.6	0.6	3.3	8.7	7.2	6.2	1.1	0.0	5.5	2.2	3.3	13.8	20.9	0.2	7.2	4.8	17.9	8.6	15.5	11.0	6.9	10.2	3.3	6.4	7.2	1.2	8.5	3.5	6.3	1.4	8.3	0.0	3.1	2.4	5.9	4.4	0.5	9.6	3.1	8.4
ABCC3	"cMOAT2, EST90757, MLP2, MOAT-D, MRP3"	ENSG00000108846	"ATP binding cassette subfamily C member 3"	O15438	17	50634777-50692252	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 53.5;liver: 66.2"	"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 262.4;Enterocytes: 161.4;Hepatocytes: 155.5;Paneth cells: 153.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 6.2;non-classical monocyte: 7.6"	"Lineage enriched"	"Detected in many"	5	"monocytes: 7.6"	"Cell line enhanced"	"Detected in many"		"A549: 31.4;CAPAN-2: 24.0;OE19: 34.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB037136, HPA048483"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB037136: AB_477165, HPA048483: AB_2680414"	"unprognostic (1.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.67e-3)"	"unprognostic (6.19e-3)"	"unprognostic (7.44e-3)"	"unprognostic (8.20e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (1.60e-3)"	"prognostic unfavorable (4.68e-6)"	"unprognostic (3.42e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.57e-3)"	3.5	36.0	0.4	17.0	0.4	0.5	7.7	0.3	0.4	1.9	23.9	0.8	14.1	10.3	1.6	4.6	5.3	1.0	53.5	0.8	0.4	0.4	13.5	66.2	9.0	10.3	0.6	0.0	1.0	22.2	1.7	0.8	3.5	1.5	5.4	7.7	0.8	4.7	23.6	0.4	4.8	37.0	2.5	4.6	4.9	12.8	1.0	0.0	0.8	4.5	7.0	7.9	7.1	3.5	0.0	1.6	1.3	7.6	0.3	0.5	7.4	2.2	31.4	0.0	0.1	1.8	2.8	0.0	4.2	5.2	0.3	0.3	1.7	24.0	0.0	3.3	8.2	5.9	5.7	0.0	0.4	0.4	0.0	0.0	0.6	13.2	9.5	7.1	0.0	0.0	3.1	2.3	1.2	2.5	3.5	0.5	0.0	0.0	0.0	3.3	7.3	0.0	0.0	0.0	34.9	4.1	0.0	0.0	0.1	13.7	13.6	0.0	0.2	7.6	1.3	0.0	0.0	1.0	0.0	6.9	0.2	1.4	0.1	3.3	0.0	0.0	0.0	3.4	0.0	0.3	0.3	2.8	0.0	0.0	6.2	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	1.3	0.3	7.6	0.2	0.5	7.4	0.4	0.4	0.3	0.4	0.4	0.4	0.6	0.0	1.5	0.0	17.9	5.6	2.4	103.4	8.4	1.2	2.5	262.4	0.0	23.9	14.0	0.0	0.3	5.0	84.3	55.0	1.4	161.4	0.0	92.3	3.0	3.5	62.4	0.0	155.5	27.5	1.6	22.7	4.9	18.2	59.8	8.3	13.8	3.3	4.6	85.5	3.7	82.4	153.0	2.8	7.9	0.1	0.0	5.2	0.7	0.6	9.3	0.8	2.5	66.2	81.6
ABCC6	"ARA, EST349056, MLP1, MRP6, PXE, URG7"	ENSG00000091262	"ATP binding cassette subfamily C member 6"	O95255	16	16148928-16223522	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Transport, Vision"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 27.4"	"Cell type enhanced"	"Detected in many"	14	"Distal tubular cells: 38.1;Hepatocytes: 56.7;Proximal tubular cells: 117.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 16.7"					"Cell type enriched"	"Detected in some"	5	"classical monocyte: 7.3"	"Lineage enriched"	"Detected in many"	5	"monocytes: 7.3"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 38.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA038105			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA038105: AB_2675835"	"unprognostic (1.32e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.09e-1)"	"prognostic favorable (3.82e-4)"	"unprognostic (6.54e-3)"	"unprognostic (3.64e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.41e-1)"	2.3	1.4	0.2	0.0	0.2	0.0	1.1	0.0	0.0	0.1	1.5			7.0	0.0	0.0	0.0	0.3	1.2	0.8	0.1	0.1	9.0	27.4	2.8	0.0	0.2		0.1	6.7	0.5	0.1	0.0		0.7	1.2		6.7	0.2	1.7	0.0	3.7	0.0	0.2	0.1	2.2	0.0			2.2		0.0	0.0	0.0	0.2	0.9	1.3	7.3	0.6	0.1	1.2	0.0	0.9	0.4	0.0	0.0	0.5	1.1	0.0	0.2	0.6	0.9	3.8	1.5	0.0	0.5	0.0	0.1	0.0	0.4	0.0	0.3	0.0	0.4	1.1	0.1	38.6	0.2	0.0	0.2	1.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.2	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.6	0.1	0.5	0.1	0.2	4.9	3.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	7.3	0.3	0.0	1.0	0.0	0.0	0.1	0.0	0.9	0.2	0.1	0.1	1.3	0.6	0.1	0.1	0.0	1.2											26.8	26.9	3.6	0.7	0.1	0.3	2.4	20.4	18.7	9.1	8.7	0.0	0.0	38.1	1.6	0.2	0.6	19.1	0.0	7.1	0.0	1.0	1.6	1.1	56.7	1.1	0.0	2.9	1.8	4.1	0.4	1.4	1.5	1.7	1.0	13.4	1.3	2.9	3.5	5.3	117.8	0.7	0.0	0.5	0.1	0.2	0.6	0.0	0.0	13.3	0.4
ACKR3	"CMKOR1, CXCR7, GPR159, RDC1"	ENSG00000144476	"Atypical chemokine receptor 3"	P25106	2	236567787-236582358	"Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Basal keratinocytes: 19.6;Club cells: 21.6;Endothelial cells: 44.5;Fibroblasts: 27.8;Ito cells: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"NK-cells: 6.1;T-cells: 6.1"	"Cell line enhanced"	"Detected in some"		"HeLa: 23.4;MCF7: 17.2;RT4: 68.3;SiHa: 20.9;U-2197: 71.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032003, HPA049718"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA032003: AB_2674107, HPA049718: AB_2680859"	"unprognostic (1.65e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (2.50e-1)"	"unprognostic (1.92e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.70e-3)"	"unprognostic (6.69e-2)"	"prognostic unfavorable (1.76e-6)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (9.71e-2)"	"unprognostic (8.57e-3)"	"prognostic unfavorable (2.93e-4)"	56.1	2.9	5.4	6.9	5.6	1.7	28.5	2.2	6.4	10.7	15.2	8.9	9.1	5.7	9.9	20.4	23.6	14.6	15.3	30.2	8.4	3.0	3.8	29.6	10.9	7.2	3.8	6.5	19.3	25.7	2.2	10.7	59.6	8.4	14.2	12.8	25.2	8.9	8.9	36.4	16.0	15.7	32.6	7.2	70.9	12.6	9.4	5.5	0.2	34.3	22.3	8.6	59.2	17.8	1.0	0.2	0.1	0.5	6.1	6.1	0.6	0.0	0.0	1.4	0.0	2.4	0.0	10.0	0.5	0.3	0.5	1.0	0.1	0.0	0.0	1.1	0.0	3.8	14.7	0.0	5.2	0.0	0.0	0.0	0.0	23.4	0.0	0.0	0.0	0.0	0.6	13.4	0.0	0.0	3.3	2.4	0.0	0.2	0.0	0.0	17.2	0.0	0.0	2.3	0.0	0.1	0.0	1.6	0.1	0.0	68.3	0.0	0.0	20.9	0.1	0.0	5.5	0.0	0.0	0.0	0.1	5.4	71.8	0.0	0.3	0.0	0.0	0.2	1.4	0.1	0.0	0.1	0.0	4.1	0.3	6.1	0.6	2.1	5.0	0.2	1.0	1.8	2.3	0.1	6.1	0.5	0.0	3.1	0.6	5.4	5.6	2.2	6.4	8.4	3.0	3.8	6.5	8.4	5.5	8.9	4.5	0.5	0.1	19.6	1.3	6.9	0.0	6.7	21.6	0.0	0.0	0.0	0.0	0.2	1.0	44.5	0.7	0.0	9.3	0.2	27.8	0.2	5.8	0.9	0.8	0.0	0.0	17.8	2.5	0.2	1.4	4.0	1.7	1.0	0.0	0.0	0.9	0.8	1.1	0.6	0.0	0.0	15.0	0.3	0.4	13.9	0.2	0.0	0.0	0.9
ACLY	"ACL, ATPCL, CLATP"	ENSG00000131473	"ATP citrate lyase"	P53396	17	41866908-41930542	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007783, HPA022434, HPA022953, HPA022959, HPA028758"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		2100000	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB007783: AB_562242, HPA022434: AB_1844513, HPA022953: AB_1844514, HPA022959: AB_1844515, HPA028758: AB_10603575"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.94e-3)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (3.38e-3)"	"unprognostic (4.11e-2)"	"unprognostic (5.94e-3)"	"unprognostic (2.13e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.90e-2)"	"unprognostic (4.67e-3)"	38.3	24.0	16.7	26.2	22.9	19.1	35.7	21.5	29.1	22.9	22.2	25.1	18.0	30.7	27.0	24.9	23.2	23.7	28.2	18.4	18.3	33.7	37.8	22.2	23.3	27.4	23.1	17.9	19.0	30.6	27.1	19.5	26.7	49.0	41.3	23.2	15.6	25.4	19.6	10.9	19.6	29.6	27.2	26.2	24.5	24.6	20.7	21.4	32.0	21.3	18.2	24.6	20.3	21.3	16.1	23.9	25.2	26.3	16.0	23.9	21.4	23.4	80.1	37.8	32.6	58.5	54.9	34.8	33.1	36.2	41.7	52.4	40.6	27.1	38.2	21.3	46.4	39.2	37.4	48.7	56.7	34.9	34.4	46.6	21.8	46.1	42.2	27.2	35.3	28.6	43.6	17.1	73.2	14.8	27.4	43.9	29.6	26.9	30.5	34.5	23.9	58.1	19.8	24.6	15.8	14.5	38.1	45.7	49.0	42.7	41.9	71.2	39.1	23.6	73.9	25.3	34.1	44.1	33.8	47.2	32.6	26.8	32.7	54.3	17.9	22.7	36.3	55.0	27.4	26.4	18.9	20.7	25.2	23.8	22.1	22.5	16.1	19.0	21.3	23.9	13.8	14.6	16.1	10.7	16.0	26.3	13.9	23.9	21.4	16.7	22.9	21.5	27.7	18.3	33.7	23.1	17.9	49.0	21.4	26.8	22.1	18.5	8.0	22.1	9.0	9.6	40.8	18.7	15.9	22.7	3.9	19.9	10.0	29.9	66.2	28.7	23.4	0.0	29.7	39.3	29.9	33.0	14.0	24.6	27.1	17.5	63.4	40.5	40.5	11.4	57.2	21.6	30.4	31.5	46.6	7.0	34.4	17.3	48.1	71.1	6.5	12.9	16.5	21.4	33.8	28.9	18.5	21.3	19.8	12.0
ADA		ENSG00000196839	"Adenosine deaminase"	P00813	20	44619522-44652233	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Nucleotide metabolism"	Hydrolase	"Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 64.0;intestine: 142.2;lymphoid tissue: 99.0"	"Cell type enhanced"	"Detected in many"	10	"Extravillous trophoblasts: 90.2;Leydig cells: 39.1;monocytes: 49.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 64.0"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"JURKAT: 61.5;MOLT-4: 198.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001399, CAB004307, HPA023884"	Enhanced		Supported	"Plasma membrane,Cytosol"		No	No		650000	"Plasma membrane"	Cytosol	"CAB004307: AB_626634, HPA001399: AB_1078099, HPA023884: AB_1844573"	"unprognostic (4.30e-2)"	"unprognostic (6.89e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (1.23e-7)"	"unprognostic (9.33e-2)"	"unprognostic (9.07e-3)"	"prognostic unfavorable (6.77e-5)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (2.94e-14)"	"unprognostic (2.29e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.82e-1)"	8.1	3.2	2.5	5.4	6.5	5.3	5.1	0.9	5.0	2.8	7.4	5.0	1.8	142.2	1.7	3.4	4.6	2.4	3.0	9.2	2.7	0.8	1.3	2.1	2.8	8.9	3.6	2.3	1.2	2.4	0.8	0.3	1.8	3.9	1.8	1.5	0.7	2.6	1.3	2.0	2.8	5.0	2.1	1.3	9.5	19.7	1.6	6.1	99.0	2.8	2.1	7.6	3.6	2.6	1.3	41.6	0.5	64.0	16.9	10.3	9.6	1.4	4.0	2.0	1.4	3.9	5.5	3.3	1.4	0.8	1.4	1.0	1.8	1.5	4.0	1.7	1.9	2.7	0.2	1.4	5.9	0.8	0.3	1.8	0.8	0.7	1.4	1.6	0.6	2.2	26.2	2.5	0.5	0.9	1.3	5.4	61.5	2.0	3.3	0.6	3.4	198.0	2.9	0.5	1.8	1.4	10.7	2.8	9.9	0.2	0.0	0.0	0.9	2.1	0.4	2.5	2.7	0.4	1.9	1.7	1.0	2.0	2.2	0.2	4.3	2.7	8.3	0.3	3.3	0.9	0.0	1.8	0.2	8.7	30.7	5.7	1.3	7.3	10.3	6.8	1.0	5.7	8.1	0.5	16.9	64.0	41.6	5.3	9.6	2.5	6.5	0.9	5.0	2.7	0.8	3.6	2.3	3.9	6.1	0.0	3.4	12.7	3.0	11.4	0.0	1.9	0.0	2.7	0.0	1.8	0.0	2.3	0.0	3.7	0.1	16.2	0.5	0.0	17.9	90.2	16.7	0.9	0.0	2.9	27.6	0.0	0.0	6.7	13.4	1.5	39.1	14.4	8.5	49.5	1.4	2.9	8.2	0.0	2.5	2.1	0.0	12.9	16.1	0.4	1.3	12.2	3.1	30.5	3.3	2.4
ADAM10	"CD156c, HsT18717, kuz, MADM"	ENSG00000137845	"ADAM metallopeptidase domain 10"	O14672	15	58588807-58749978	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Metalloprotease, Protease"	"Alzheimer disease, Amyloidosis, Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 77.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001709, HPA050670"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		8200000	"Plasma membrane"	"Nucleoplasm, Vesicles"	"CAB001709: , HPA050670: "	"unprognostic (1.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.70e-3)"	"unprognostic (7.48e-2)"	"prognostic unfavorable (8.46e-5)"	"unprognostic (3.99e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (6.69e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.57e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.60e-2)"	25.9	11.1	15.5	17.1	17.7	15.6	20.0	25.2	17.6	18.6	20.1	15.7	12.7	13.9	19.9	11.8	17.1	13.8	18.0	18.8	17.6	13.7	20.8	14.8	25.0	26.1	23.1	12.4	13.9	13.1	10.9	11.6	36.1	14.5	23.6	16.7	14.6	12.4	19.1	8.9	15.4	15.6	12.8	30.4	40.4	18.4	8.5	18.9	38.5	27.3	9.2	14.9	30.0	19.1	6.2	12.7	26.9	23.7	9.8	12.2	12.8	12.1	27.4	7.5	8.1	9.6	13.9	18.9	10.4	31.0	7.7	10.7	12.6	16.1	5.6	32.2	9.3	13.5	24.8	4.5	11.0	10.2	8.4	5.8	9.6	10.0	11.7	10.7	6.8	27.7	12.1	8.1	5.4	7.9	11.2	14.9	12.2	6.0	15.3	13.5	4.5	22.4	7.7	10.2	4.0	3.9	9.3	24.5	14.4	17.9	32.7	8.1	5.3	11.3	13.2	18.0	17.1	7.8	13.6	10.5	10.1	11.3	77.5	10.0	8.6	18.5	6.1	14.1	13.1	17.6	12.9	18.8	10.4	8.1	21.5	12.2	5.3	8.0	7.1	12.7	6.2	8.4	7.0	26.9	9.8	23.7	5.8	10.3	12.8	15.5	17.7	25.2	16.9	17.6	13.7	23.1	12.4	14.5	18.9	77.4	49.8	30.6	25.8	23.7	20.2	29.7	30.6	30.8	35.2	76.8	25.5	27.4	1.7	45.7	21.6	61.6	39.3	0.0	27.7	46.7	28.8	75.5	27.9	30.4	56.9	42.9	34.7	76.1	87.0	16.2	16.7	64.0	43.9	13.6	45.8	27.0	37.3	43.2	15.9	20.3	32.7	12.9	28.3	13.6	16.2	19.4	22.2	43.6	33.7	59.6
ADAM12	"MCMPMltna, MLTN"	ENSG00000148848	"ADAM metallopeptidase domain 12"	O43184	10	126012381-126388455	"Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	50	"placenta: 487.4"	"Cell type enhanced"	"Detected in many"	24	"Cone photoreceptor cells: 96.2;Extravillous trophoblasts: 348.4;Syncytiotrophoblasts: 108.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in some"	5	"MAIT T-cell: 9.8"	"Lineage enriched"	"Detected in single"	98	"T-cells: 9.8"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 47.3;hTEC/SVTERT24-B: 29.7;U-2197: 29.3;U-251 MG: 26.2;U-87 MG: 22.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA030866, HPA030867, HPA030868"	Enhanced		Supported	"Plasma membrane"	"Secreted in female reproductive system"	NA	NA			"Plasma membrane"		"HPA030866: AB_2673636, HPA030867: AB_10602428, HPA030868: AB_2673638"	"unprognostic (3.35e-1)"	"unprognostic (1.05e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.91e-6)"	"unprognostic (2.17e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.39e-14)"	"unprognostic (3.11e-3)"	"unprognostic (9.06e-3)"	"unprognostic (4.70e-3)"	"unprognostic (3.47e-3)"	6.0	0.0	0.6	2.1	2.8	0.0	5.9	0.6	0.6	8.0	0.5	0.5	0.4	0.0	2.6	0.5	0.5	0.1	4.6	0.7	0.6	0.7	1.0	0.4	1.1	1.0	0.8	0.5	8.2	0.6	0.0	1.1	487.4	0.8	0.7	0.1	0.9	1.1	0.4	0.5	0.3	0.4	1.5	0.7	0.5	0.1	0.7	0.6	0.5	0.4	0.5	1.2	4.5	0.8	0.0	0.0	0.0	0.0	0.0	9.8	0.1	5.0	0.7	2.0	0.0	6.0	12.4	0.0	13.2	1.1	4.5	11.3	0.0	0.0	0.0	0.0	47.3	9.5	0.0	0.0	0.4	4.9	0.5	0.1	0.0	8.0	0.0	0.9	0.0	10.5	15.2	0.0	29.7	0.9	8.6	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.5	1.3	0.1	13.5	0.1	9.0	1.5	0.0	0.2	0.8	0.0	0.0	0.0	16.3	5.4	29.3	26.2	0.0	0.1	0.0	22.5	0.0	10.0	0.0	0.0	0.0	0.5	0.0	9.8	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.6	2.8	0.6	0.6	0.6	0.7	0.8	0.5	0.8	0.6	0.0	3.4	0.0	0.4	1.3	0.8	1.4	0.0	1.4	0.0	0.0	96.2	12.1	0.0	7.6	6.3	1.1	0.4	0.0	1.0	348.4	2.0	0.6	49.5	0.0	14.2	6.4	0.0	2.5	0.3	1.1	15.5	0.7	1.7	15.4	0.2	5.5	1.9	0.0	0.7	0.0	31.5	0.0	1.2	5.1	5.5	0.5	108.0	3.1	0.7	0.5
ADAM28	"ADAM23, eMDCII, MDC-Lm, MDC-Ls"	ENSG00000042980	"ADAM metallopeptidase domain 28"	Q9UKQ2	8	24294040-24359018	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 133.1"	"Cell type enhanced"	"Detected in many"	15	"B-cells: 115.5;Club cells: 62.6;Macrophages: 32.1;Pancreatic endocrine cells: 32.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 24.9;naive B-cell: 32.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 24.8;OE19: 7.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA074034	Enhanced		Approved	"Plasma membrane,Mitochondria"	"Secreted to blood"	NA	NA			"Plasma membrane"	Mitochondria	"HPA074034: AB_2686654"	"unprognostic (4.23e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.06e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (2.89e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.77e-3)"	"unprognostic (7.77e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.62e-1)"	2.0	1.7	7.7	17.4	8.8	3.5	2.1	0.9	5.8	6.7	5.8	12.7	2.0	3.7	3.1	133.1	2.7	5.1	16.7	1.1	8.9	5.0	3.1	1.1	3.1	10.1	12.4	3.7	1.8	2.7	1.0	22.5	1.9	10.8	3.3	5.0	1.9	12.6	5.1	0.7	1.8	17.9	1.7	26.0	15.5	38.7	0.9	12.1	0.8	1.8	0.4	19.9	7.4	1.6	32.2	7.5	12.5	0.9	0.9	0.0	0.9	0.0	0.4	0.1	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.0	1.0	24.8	0.2	0.8	0.0	0.8	0.1	0.0	0.8	0.1	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	3.2	0.6	7.6	0.1	0.1	0.0	0.3	0.6	0.7	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.3	0.1	0.1	1.1	2.1	0.1	1.9	0.9	0.2	12.5	0.9	6.4	0.0	0.2	0.0	24.9	0.0	0.0	7.5	32.2	0.0	0.0	1.6	0.9	0.0	0.4	0.0	0.9	7.7	8.8	0.9	5.8	8.9	5.0	12.4	3.7	10.8	12.1	3.0	5.9	115.5	2.2	0.8	0.0	0.9	25.5	17.4	62.6	3.5	0.0	0.3	0.0	7.1	0.9	0.7	0.5	0.0	3.1	8.1	1.1	2.0	2.3	0.0	9.0	0.0	0.0	0.0	12.3	1.8	0.6	32.1	5.0	5.4	0.1	0.0	32.8	0.0	0.4	3.6	0.0	6.5	0.3	0.2	0.1	0.5	0.5	6.9	0.9	6.3
ADD2	ADDB	ENSG00000075340	"Adducin 2"	P35612	2	70607618-70768225	"Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"bone marrow: 53.6;brain: 35.0"	"Cell type enhanced"	"Detected in some"	22	"Early spermatids: 28.5;Erythroid cells: 70.0;Horizontal cells: 131.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 4.7;non-classical monocyte: 4.4"	"Group enriched"	"Detected in many"	20	"B-cells: 4.7;monocytes: 4.4;T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"HAP1: 14.3;JURKAT: 13.9;K-562: 18.7;NTERA-2: 36.9;RPMI-8226: 17.6;SCLC-21H: 18.4;U-251 MG: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009796, HPA034509, HPA034510"	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		66000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009796: AB_2223572, HPA034509: AB_2674201, HPA034510: AB_2674202"	"unprognostic (3.58e-2)"	"unprognostic (2.68e-4)"	"unprognostic (3.83e-2)"	"unprognostic (3.01e-4)"	"unprognostic (1.94e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.47e-7)"	"unprognostic (2.81e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.71e-3)"	"unprognostic (1.31e-3)"	1.9	2.6	14.0	2.6	17.9	53.6	1.5	29.7	35.0	1.3	1.3	1.2	0.0	1.0	1.3	1.2	2.3	1.4	1.2	1.5	14.1	10.7	0.9	0.9	1.8	3.1	6.0	19.7	1.0	2.1	1.3	2.8	1.6	14.0	1.3	1.2	1.7	1.1	1.1	1.6	1.2	1.2	1.9	6.0	1.9	1.1	2.9	2.7	0.0	2.3	0.0	2.9	1.5	0.5	4.7	0.1	0.1	4.4	0.0	1.9	0.6	7.1	8.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	1.1	5.3	0.0	14.3	0.0	0.0	0.0	8.4	0.7	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	3.4	0.0	13.9	18.7	0.0	0.0	0.0	0.1	0.6	36.9	0.0	0.2	0.0	0.2	17.6	2.4	0.0	18.4	8.3	9.1	0.0	0.0	4.2	0.0	4.4	0.3	0.0	0.4	0.0	19.4	6.0	7.0	0.0	0.3	2.9	3.3	0.1	0.1	0.0	0.0	2.4	0.1	4.7	0.0	0.0	0.1	4.0	1.9	1.0	0.1	0.0	4.4	0.0	0.0	0.6	14.0	17.9	29.7	35.0	14.1	10.7	6.0	19.7	14.0	2.7	0.0	0.3	3.4	0.1	0.1	19.8	2.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	28.5	2.9	0.0	70.0	0.9	0.2	1.0	0.7	0.0	0.0	0.2	131.9	0.0	1.3	0.3	24.0	0.9	0.0	1.7	1.0	0.0	0.5	0.5	0.0	0.7	0.0	9.4	0.0	0.0	0.7	3.2	0.1	0.2	0.0	0.0	0.6
ADGRB2	BAI2	ENSG00000121753	"Adhesion G protein-coupled receptor B2"	O60241	1	31727117-31764893	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 52.0"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 18.3;Horizontal cells: 7.9;Late spermatids: 10.3;Muller glia cells: 10.1"	"Cancer enhanced"	"Detected in many"		"glioma: 20.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 20.7;SH-SY5Y: 15.2;T-47d: 17.5;U-2 OS: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069175			Supported	"Plasma membrane"		NA	NA		49000	"Plasma membrane"		"HPA069175: "	"prognostic favorable (6.46e-4)"	"unprognostic (1.74e-1)"	"unprognostic (7.98e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.17e-4)"	"prognostic unfavorable (4.02e-5)"	"unprognostic (2.31e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.75e-3)"	"unprognostic (7.98e-2)"	2.2	5.4	15.9	1.3	26.8	1.1	1.4	7.9	52.0	2.4	1.4	7.3	0.0	5.2	2.4	1.2	1.6	2.2	2.1	2.8	18.9	8.0	1.4	0.9	1.3	1.3	7.4	16.5	1.8	1.4	1.3	2.7	3.8	8.4	2.4	1.1	1.3	1.4	3.1	1.1	1.5	5.0	2.4	2.9	1.8	1.8	3.2	6.3	1.5	3.2	0.0	1.1	2.0	0.5	0.4	0.0	0.0	0.0	0.0	0.9	0.3	0.6	4.4	4.2	12.0	1.2	0.7	2.0	2.8	4.5	2.8	4.9	0.2	1.3	0.0	2.8	1.2	4.6	0.4	1.8	0.2	0.4	3.1	1.9	0.0	20.7	0.0	0.1	0.0	1.6	0.7	0.3	3.8	0.0	8.8	0.4	8.8	0.4	0.1	3.1	0.4	7.9	0.1	5.2	0.1	1.3	12.1	0.4	0.4	0.0	5.7	3.2	15.2	6.5	0.4	0.5	1.5	17.5	0.0	0.1	2.1	17.0	0.3	0.7	0.0	0.0	0.4	6.7	0.0	5.1	0.0	0.0	0.0	0.9	0.0	0.6	0.4	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	15.9	26.8	7.9	37.6	18.9	8.0	7.4	16.5	8.4	6.3	0.0	0.0	0.0	0.5	0.0	18.3	4.1	0.0	0.0	0.0	0.0	5.9	0.7	0.0	0.1	2.9	0.0	0.0	0.0	0.0	1.1	0.4	0.5	0.0	0.0	0.4	7.9	1.2	0.0	0.0	10.3	1.1	0.0	0.0	0.0	0.0	10.1	0.1	0.0	1.8	1.9	4.1	0.0	0.3	0.7	4.5	0.0	0.2	0.0	0.1	0.9
ADGRD1	"DKFZp434B1272, GPR133, PGR25"	ENSG00000111452	"Adhesion G protein-coupled receptor D1"	Q6QNK2	12	130953907-131141469	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 66.1"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 20.8;Alveolar cells type 2: 29.1;Cardiomyocytes: 39.1;Fibroblasts: 20.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 4.1;intermediate monocyte: 4.9;myeloid DC: 2.4;non-classical monocyte: 3.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.4;monocytes: 4.9"	"Cell line enhanced"	"Detected in some"		"BJ: 5.1;fHDF/TERT166: 5.8;HeLa: 10.5;HHSteC: 6.7;HMC-1: 14.5;U-2 OS: 7.1"	"Region enhanced"	"Detected in some"		"basal ganglia: 5.3"	"Low region specificity"	"Detected in all"			"HPA042395, HPA076279"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		600000	"Plasma membrane"	Nucleoplasm	"HPA042395: AB_10796906, HPA076279: "	"unprognostic (3.21e-1)"	"unprognostic (1.49e-4)"	"unprognostic (1.32e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (9.27e-4)"	"unprognostic (2.55e-3)"	"unprognostic (1.63e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.79e-5)"	"unprognostic (1.31e-3)"	"unprognostic (4.58e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.77e-3)"	12.7	2.1	2.0	3.2	3.1	0.5	8.9	1.1	3.9	11.2	5.5	2.2	3.9	2.2	13.3	14.0	6.8	8.8	45.6	34.8	1.9	1.5	1.6	5.2	18.6	0.6	4.2	2.2	12.5	11.8	0.3	3.5	26.6	2.4	13.3	2.4	13.0	1.6	2.3	11.6	3.8	6.4	66.1	6.4	1.9	10.2	3.8	2.6	0.0	6.3	7.1	2.1	29.5	30.8	0.2	2.4	0.0	4.9	0.5	0.0	1.2	0.0	0.7	0.0	2.6	0.1	0.0	0.1	5.1	0.0	0.0	0.4	0.0	0.0	0.3	0.0	5.8	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.5	0.0	6.7	0.0	14.5	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.9	0.0	0.1	0.2	2.2	0.5	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	3.3	0.0	0.4	0.0	0.5	7.1	1.9	0.1	0.1	1.8	0.9	0.1	0.0	0.0	0.0	4.1	0.0	0.0	4.9	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.0	0.0	0.5	3.6	0.0	0.0	1.2	2.0	3.1	1.1	3.9	1.9	1.5	4.2	2.2	2.4	2.6	20.8	29.1	0.0	0.0	0.0	0.0	39.1	0.0	4.0	9.1	1.8	0.0	0.9	0.0	0.0	14.7	1.0	0.0	0.0	0.3	0.6	20.1	0.1	1.1	2.6	2.3	0.0	0.0	3.1	2.4	14.7	12.7	0.7	0.0	1.8	0.0	0.0	0.5	0.0	14.9	0.0	0.7	6.5	0.9	2.6	5.7	0.0	0.8	0.0	0.0	0.3
ADGRG2	"EDDM6, GPR64, HE6, TM7LN2"	ENSG00000173698	"Adhesion G protein-coupled receptor G2"	Q8IZP9	X	18989309-19122637	"Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"epididymis: 202.4"	"Cell type enhanced"	"Detected in some"	9	"Cholangiocytes: 5.1;Ciliated cells: 4.0;Glandular cells: 3.0;Horizontal cells: 3.2;Muller glia cells: 4.5"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.3;BEWO: 7.9;HeLa: 6.5;NTERA-2: 6.8;SH-SY5Y: 7.1;U-2197: 15.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA001478, HPA050029"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		7900000	"Plasma membrane, Cytosol"		"HPA001478: AB_1078923, HPA050029: AB_2680996"	"unprognostic (3.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.43e-3)"	"unprognostic (2.63e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.54e-7)"	"unprognostic (6.37e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.35e-1)"	4.4	0.3	0.4	0.9	0.2	0.2	2.8	0.1	0.2	0.8	1.0	0.1	6.6	0.2	0.5	202.4	0.9	6.9	1.4	1.8	0.6	0.6	0.7	0.9	1.7	3.1	0.2	0.2	0.9	0.9	24.8	1.9	0.6	0.3	3.2	0.2	1.6	9.6	0.8	0.6	0.3	1.4	0.6	0.2	1.2	3.5	4.7	0.2	2.7	1.8	0.6	1.9	1.1	1.5	0.1	0.2	0.9	0.6	0.0	0.2	0.0	0.2	6.3	0.0	0.0	0.1	1.0	7.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	2.5	0.0	6.5	0.3	0.9	0.0	0.0	0.1	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	2.3	6.8	0.0	2.1	0.0	0.1	4.5	0.0	1.3	2.4	7.1	1.6	0.1	0.0	1.2	0.1	0.1	0.1	0.2	0.4	15.7	2.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.9	0.1	0.4	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.0	0.7	0.0	0.6	0.1	0.0	0.0	0.4	0.2	0.1	0.2	0.6	0.6	0.2	0.2	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.8	5.1	4.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	3.0	0.0	0.4	0.0	3.2	0.0	1.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	4.5	1.8	0.0	1.4	0.0	0.7	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1
ADH1C	ADH3	ENSG00000248144	"Alcohol dehydrogenase 1C (class I), gamma polypeptide"	P00326	4	99336492-99353027	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 47.1;liver: 149.4;stomach 1: 43.1"	"Cell type enhanced"	"Detected in many"	15	"Exocrine glandular cells: 606.8;Hepatocytes: 378.8;Undifferentiated cells: 355.3"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 238.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC TERT1: 5.2;HSkMC: 15.4"									"HPA047814, HPA060902"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		9700000	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (3.98e-2)"	"unprognostic (9.88e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (4.55e-4)"	"prognostic favorable (2.99e-4)"	"unprognostic (8.25e-2)"	"unprognostic (8.89e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.37e-2)"	4.7	0.0	0.0	18.5	0.0	0.0	1.1	0.0	0.0	1.1	37.9	0.0	1.1	43.4	0.3	1.2	1.7	0.0	12.0	2.0	0.0		8.3	149.4	1.1	0.0	0.2	0.0	1.1	11.4	0.0	0.0	0.0	0.0	2.5	13.6	0.0	1.1	0.8	6.0	0.0	47.1	0.9	0.5	0.0	43.1	1.6	0.0	0.0	0.5	2.0	0.2	1.3	0.7	0.2	0.2	0.3	0.1	0.1	0.3	0.1	0.0	2.3	0.0	0.1	1.8	5.2	1.1	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.3	0.1	0.5	1.4	0.3	15.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.4	1.0	0.4	0.0	0.1	0.1	0.9	2.2	0.9	0.0	0.4	1.6	0.7	0.8	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.3	0.2	0.1	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.3	0.1	0.0	0.2	0.0	0.1											3.0	5.3	1.5	3.6	0.0	0.0	0.8	50.9	80.3	45.5	27.9	0.0	0.0	0.0	141.2	2.4	0.0	51.2	23.3	606.8	0.0	0.0	1.2	0.0	378.8	0.0	0.0	20.7	12.9	12.9	0.6	9.8	0.0	0.0	3.6	36.7	0.0	99.5	63.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	355.3	2.0
ADORA1	RDC7	ENSG00000163485	"Adenosine A1 receptor"	P30542	1	203090654-203167405	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 38.7"	"Group enriched"	"Detected in some"	4	"granulocytes: 23.0;Muller glia cells: 40.0"	"Cancer enhanced"	"Detected in many"		"glioma: 24.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 19.7;MCF7: 11.9;RH-30: 32.7;RPTEC TERT1: 15.9;SK-BR-3: 17.7;U-138 MG: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044383			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA044383: AB_2678921"	"unprognostic (3.93e-3)"	"unprognostic (8.16e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.38e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.64e-2)"	"unprognostic (4.17e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.13e-2)"	"unprognostic (5.76e-4)"	4.5	1.0	19.7	2.6	21.7	0.8	6.1	9.7	38.7	1.1	1.6	27.4	0.0	2.0	2.0	1.6	1.6	2.0	1.8	13.8	19.8	12.1	4.2	1.0	2.8	1.4	22.8	13.4	0.8	15.5	15.5	0.9	8.9	25.0	1.2	1.6	1.8	8.9	1.3	2.0	1.9	1.8	1.3	20.7	7.4	1.6	16.3	15.9	0.0	3.2	0.0	1.4	3.4	0.3	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.1	1.4	0.3	0.1	0.1	0.8	0.1	1.0	1.5	0.4	0.2	19.7	0.3	0.0	4.5	3.6	2.4	0.0	0.3	0.0	0.1	0.0	0.5	0.0	0.2	0.0	0.3	0.0	0.0	0.4	0.0	0.4	0.0	3.2	0.0	3.2	0.0	0.0	3.1	11.9	0.0	0.0	5.1	0.0	0.0	0.0	32.7	1.0	15.9	0.0	0.3	0.4	2.1	17.7	0.2	1.9	1.0	0.4	0.0	10.6	5.4	0.0	5.7	0.0	0.1	0.0	5.3	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	19.7	21.7	9.7	25.7	19.8	12.1	22.8	13.4	25.0	15.9	0.0	0.0	0.0	0.0	0.0	0.5	2.5	5.1	0.0	0.0	3.5	0.0	0.0	0.0	7.2	0.1	0.0	0.0	0.0	3.0	1.0	0.7	0.0	23.0	0.0	0.9	0.0	0.0	0.0	1.3	0.0	0.0	0.4	1.7	0.0	0.0	40.0	0.5	0.0	0.7	1.0	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
ADRA1B		ENSG00000170214	"Adrenoceptor alpha 1B"	P35368	5	159865080-159972544	"Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.6;liver: 20.3;lymphoid tissue: 17.4"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 13.2;HaCaT: 6.7;TIME: 11.1;U-2 OS: 9.3;U-251 MG: 7.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA074416			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA074416: AB_2686688"	"unprognostic (4.93e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (6.00e-5)"	"prognostic unfavorable (6.98e-4)"	"unprognostic (4.08e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.68e-1)"	"unprognostic (6.12e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (2.28e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (1.40e-6)"	"unprognostic (5.24e-4)"	"unprognostic (2.54e-1)"	"prognostic favorable (3.19e-5)"	"unprognostic (1.59e-2)"	5.3	2.9	5.3	0.9	9.0	0.4	2.3	1.3	21.6	0.9	1.2	0.7	0.8	1.2	1.5	3.6	1.1	3.6	1.3	3.3	6.2	5.8	7.4	20.3	4.7	2.3	1.2	13.9	6.2	0.8	1.0	0.8	1.1	5.2	1.6	1.1	0.9	1.0	1.9	1.6	1.3	1.7	1.2	0.9	17.4	0.9	0.8	0.5	0.0	2.0	0.0	1.1	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.7	0.3	0.0	2.4	0.9	0.1	0.5	0.2	0.6	0.3	0.0	4.3	0.0	13.2	3.9	5.2	6.7	0.0	0.6	0.3	0.0	0.3	0.0	1.7	0.0	5.1	0.0	0.0	2.8	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.7	0.0	4.5	0.0	0.4	0.0	0.0	0.3	0.4	2.3	0.1	0.0	11.1	0.1	9.3	0.0	7.1	0.0	0.0	0.0	3.4	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	9.0	1.3	21.6	6.2	5.8	1.2	13.9	5.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AGER	"RAGE, SCARJ1"	ENSG00000204305	"Advanced glycosylation end-product specific receptor"	Q15109	6	32180968-32184324	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Inflammatory response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"lung: 178.6"	"Cell type enriched"	"Detected in many"	18	"Alveolar cells type 1: 2224.3"	"Cancer enhanced"	"Detected in all"		"lung cancer: 27.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEK 293: 4.9;JURKAT: 8.1;MCF7: 4.2;RPTEC TERT1: 5.1;U-266/70: 6.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB011682, HPA064436, HPA069474"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane,Cell Junctions"	"Secreted in other tissues"	NA	NA	5360000	140000	"Plasma membrane, Cell Junctions"	"Nucleoli fibrillar center"	"CAB011682: AB_2258049, HPA064436: AB_2685264, HPA069474: "	"unprognostic (9.37e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.59e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.01e-7)"	"unprognostic (3.57e-1)"	"unprognostic (3.70e-2)"	"unprognostic (4.44e-2)"	"prognostic favorable (2.74e-6)"	0.2	0.3	0.2	0.3	0.2	0.2	0.2	0.9	0.2	0.3	0.3	0.2	0.2	0.2	0.3	0.6	0.4	0.4	0.2	0.2	0.2	0.0	0.5	0.2	178.6	0.2	0.2	0.2	0.5	0.3	0.1	0.7	0.4	0.4	0.5	0.3	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	1.0	0.2	0.2	0.2	0.2	22.6	0.2	0.2	0.2	0.3	0.7	0.7	1.0	0.3	0.1	0.5	0.1	0.2	0.2	0.0	0.6	0.2	1.9	2.7	0.1	0.2	0.1	0.2	0.1	0.4	0.2	2.1	0.5	0.0	2.2	0.2	1.1	0.3	0.4	4.9	1.3	0.1	0.0	0.0	0.6	2.2	0.3	0.3	0.1	0.2	0.3	0.3	8.1	0.0	0.8	0.2	4.2	0.3	1.5	0.0	0.2	0.0	0.1	0.2	0.3	5.1	0.1	0.1	0.5	0.1	0.0	1.9	0.1	1.2	0.1	0.2	0.0	1.5	1.5	0.1	6.1	3.2	2.2	2.2	0.5	0.5	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.3	0.2	0.0	0.7	0.4	0.3	1.0	0.1	0.2	0.7	0.0	0.1	0.2	0.2	0.9	0.2	0.2	0.0	0.2	0.2	0.4	0.2	2224.3	120.3	1.7	1.1	0.8	4.8	3.4	5.1	8.1	37.5	1.8	0.0	0.9	0.0	1.5	0.0	2.6	0.5	0.0	0.8	0.8	1.6	2.3	16.3	1.8	1.2	6.4	0.0	2.5	9.0	0.2	1.7	4.9	1.7	2.8	1.4	7.4	0.8	2.9	1.1	0.2	4.1	6.5	1.7	0.0	0.7	1.6	1.8	5.0	0.9	0.8
AKR1B10	"AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI"	ENSG00000198074	"Aldo-keto reductase family 1 member B10"	O60218	7	134527592-134541408	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 41.5;intestine: 99.7;stomach 1: 68.6"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 275.2;Enterocytes: 221.4;Pancreatic endocrine cells: 89.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 353.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	99	"A549: 217.4;Hep G2: 60.3;OE19: 227.4"									"HPA020280, CAB070163, HPA073633"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA		68000000	Cytosol	"Plasma membrane"	"CAB070163: AB_10008614, HPA020280: AB_10602228, HPA073633: AB_2686620"	"unprognostic (1.29e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.91e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (4.80e-9)"	"unprognostic (2.12e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-1)"	0.6	0.8	0.6	2.2	0.6	0.0	0.6	0.6	0.6	13.1	11.5	0.6	0.6	99.7	0.6	0.9	41.5	0.0	28.9	0.6	0.6	0.0	4.0	6.3	2.0	0.6	0.6	0.6	0.6	0.6	0.0	2.5	0.6	0.6	2.0	7.3	1.3	6.1	0.6	0.6	1.0	54.1	7.1	0.6	0.6	68.6	0.8	0.6	0.9	0.7	28.6	3.6	16.3	22.9	0.4	0.1	1.8	0.2	0.4	0.2	0.1	0.0	217.4	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	60.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	227.4	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.2	1.8	0.4	0.1	0.1	0.1	0.1	0.6	0.6	0.6	0.6	0.6	0.0	0.6	0.6	0.6	0.6	0.0	0.0	0.5	1.9	2.5	0.0	0.4	275.2	5.3	1.2	0.0	0.0	0.2	0.0	21.5	0.3	0.0	221.4	23.3	23.1	0.1	0.1	0.3	0.0	31.6	0.0	0.0	3.4	3.7	1.6	0.4	3.1	0.0	0.0	1.0	11.7	0.0	89.4	24.6	1.8	1.4	0.0	0.0	0.9	0.0	0.0	9.2	0.2	0.0	41.3	5.2
AKR1B15		ENSG00000227471	"Aldo-keto reductase family 1 member B15"	C9JRZ8	7	134549136-134579875	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"breast: 61.7;placenta: 31.8"	"Cell type enhanced"	"Detected in some"	27	"Early spermatids: 2.3;Late spermatids: 2.7;Syncytiotrophoblasts: 8.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.8"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"A549: 15.5;HDLM-2: 12.3;Hep G2: 10.8;SK-BR-3: 5.2;U-87 MG: 6.6"									"HPA020280, HPA073633"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA020280: AB_10602228, HPA073633: AB_2686620"	"unprognostic (2.35e-1)"	"unprognostic (3.85e-2)"	"unprognostic (9.74e-3)"	"unprognostic (2.74e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (8.36e-4)"	"prognostic unfavorable (1.80e-5)"	"unprognostic (5.04e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.22e-7)"	"unprognostic (6.88e-2)"	"unprognostic (4.29e-1)"	"unprognostic (2.99e-3)"	"prognostic unfavorable (1.90e-5)"	2.7	0.1	0.1	0.1	0.1	0.0	61.7	0.1	0.2	1.6	0.6	0.2	0.1	5.6	0.1	1.5	3.8	0.0	2.2	0.1	0.1	0.0	0.1	0.8	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	31.8	0.2	0.8	0.2	0.5	2.9	0.1	11.6	1.9	1.7	0.8	0.4	0.1	5.0	0.6	0.1	0.3	0.4	16.1	1.8	1.5	3.0	0.1	0.0	1.8	0.1	0.4	0.0	0.3	0.0	15.5	0.2	0.0	0.6	0.5	1.0	0.0	0.4	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.7	0.1	0.0	0.1	0.0	12.3	0.1	0.1	0.2	10.8	0.0	0.2	0.5	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.6	0.0	0.0	0.2	0.2	3.2	0.3	0.0	0.1	0.2	0.3	0.1	0.1	0.1	0.1	0.6	5.2	0.0	0.1	0.1	0.3	0.0	0.1	0.7	0.4	0.0	0.2	0.2	0.2	6.6	0.2	0.2	1.8	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	8.7	0.0	0.0	0.1
ALK	CD246	ENSG00000171094	"ALK receptor tyrosine kinase"	Q9UM73	2	29192774-29921566	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.1;pituitary gland: 17.9"	"Group enriched"	"Detected in some"	12	"Early spermatids: 36.6;Late spermatids: 30.9"	"Group enriched"	"Detected in some"	5	"glioma: 1.0;melanoma: 1.5;ovarian cancer: 0.7;thyroid cancer: 1.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SH-SY5Y: 27.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010694	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA010694: AB_1078133"	"unprognostic (4.96e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.56e-7)"	"unprognostic (7.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.07e-3)"	"unprognostic (6.29e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-4)"	"unprognostic (3.70e-2)"	"unprognostic (2.06e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.61e-2)"	1.8	3.1	3.6	1.2	4.4	0.3	1.1	0.5	8.1	0.7	2.1	2.0	0.0	0.7	0.5	0.5	0.6	0.5	1.2	0.4	3.4	4.9	0.4	0.5	1.1	0.5	2.7	4.2	0.6	0.4	0.4	17.9	0.5	5.5	0.5	1.2	2.4	0.9	0.8	0.3	0.9	1.5	0.9	2.1	0.5	0.8	4.9	0.9	0.0	1.6	0.0	0.3	0.6	1.2	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	3.6	0.0	0.0	0.1	0.3	27.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	3.2	0.0	4.1	0.0	0.1	0.0	0.7	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.6	4.4	0.5	5.9	3.4	4.9	2.7	4.2	5.5	0.9	0.0	0.0	0.0	0.0	0.0	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	30.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0
ALOX15B	15-LOX-2	ENSG00000179593	"Arachidonate 15-lipoxygenase, type B"	O15296	17	8039017-8049134	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 57.4;esophagus: 30.6;lung: 44.0;prostate: 35.9"	"Cell type enhanced"	"Detected in many"	26	"Alveolar cells type 2: 58.0;Kupffer cells: 33.3;monocytes: 149.7"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 91.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"classical monocyte: 6.1;myeloid DC: 6.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 6.8;monocytes: 6.1"	"Cell line enhanced"	"Detected in some"		"HHSteC: 6.1;HSkMC: 13.0;hTCEpi: 26.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA010562	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA010562: AB_2668305"	"unprognostic (1.76e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	"unprognostic (9.49e-2)"	8.9	0.6	0.4	0.7	0.6	0.3	57.4	0.1	0.4	7.6	4.6	0.1	0.0	0.2	0.3	0.7	30.6	0.8	0.5	0.2	1.3	0.0	2.9	0.7	44.0	7.1	1.8	0.3	0.8	0.8	0.2	0.9	0.7	1.3	35.9	0.3	0.1	3.6	0.2	0.3	15.4	1.9	0.2	4.1	3.1	1.6	1.0	2.0	0.5	0.8	6.6	4.1	1.1	12.9	0.0	6.8	0.2	6.1	0.7	0.0	1.7	0.0	0.0	0.0	0.0	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	13.0	26.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.2	0.7	0.0	0.2	0.0	1.7	0.4	0.6	0.1	0.4	1.3	0.0	1.8	0.3	1.3	2.0	0.0	58.0	0.0	0.5	2.7	0.0	0.3	2.5	2.7	2.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.1	16.8	1.1	0.0	4.1	0.0	0.0	1.3	33.3	0.0	0.0	1.9	5.0	149.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.7	1.0	0.7	0.0	0.0	1.8
AMER1	"FAM123B, FLJ39827, RP11-403E24.2, WTX"	ENSG00000184675	"APC membrane recruitment protein 1"	Q5JTC6	X	64185117-64205744	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 4.5;Cholangiocytes: 5.1;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065214, HPA065265"	Approved		Supported	"Nuclear bodies,Vesicles,Plasma membrane"		NA	NA			"Nuclear bodies"	"Vesicles, Plasma membrane"	"HPA065214: AB_2685435, HPA065265: AB_2685450"	"unprognostic (1.56e-2)"	"unprognostic (8.85e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.69e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-2)"	"unprognostic (2.89e-1)"	3.0	3.4	3.0	2.8	5.6	2.3	3.0	8.8	4.9	6.8	4.7	3.1	7.8	3.3	9.8	11.3	6.9	5.2	2.4	3.5	3.0	3.4	4.2	7.1	2.8	2.6	4.5	1.6	15.5	8.1	5.1	3.9	2.0	6.3	4.5	3.2	6.8	7.0	5.3	9.0	4.8	3.7	6.6	2.9	3.7	5.1	1.4	4.3	2.4	3.4	6.5	3.4	4.3	5.7	0.4	0.2	0.0	0.3	2.0	1.0	0.1	3.0	2.2	5.8	4.6	2.2	2.2	4.6	1.4	1.2	2.1	1.3	7.2	1.0	5.7	1.9	2.9	1.6	4.2	12.2	4.0	2.0	2.6	2.4	3.5	4.5	4.6	1.6	7.4	0.9	3.0	5.3	1.6	3.2	1.7	1.2	4.5	5.3	5.8	1.1	3.5	4.8	4.0	15.4	3.8	4.3	11.5	9.4	4.1	1.0	0.9	2.6	3.9	3.6	4.9	1.9	5.0	1.6	2.1	0.8	2.6	5.9	6.6	1.9	3.0	2.0	4.4	1.2	8.4	0.0	0.0	0.3	0.0	0.4	0.1	0.0	0.4	0.0	0.4	0.0	0.3	1.0	0.0	0.0	2.0	0.0	0.2	0.9	0.1	3.0	5.6	8.8	4.9	3.0	3.4	4.5	1.6	6.3	4.3	0.0	0.0	0.0	0.6	1.9	4.5	2.3	5.1	0.0	0.0	0.0	2.0	0.8	0.0	1.0	0.0	1.0	0.5	0.0	1.4	0.6	0.8	0.4	0.0	1.9	0.3	0.0	1.2	2.5	1.5	0.0	2.3	0.1	1.7	0.0	0.9	0.2	0.5	0.0	3.9	0.6	0.7	6.5	1.2	0.0	0.2	2.3	0.6	0.5	1.3	0.7
AMER2	"FAM123A, FLJ25477"	ENSG00000165566	"APC membrane recruitment protein 2"	Q8N7J2	13	25161684-25172288	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	26	"brain: 57.0"	"Cell type enhanced"	"Detected in some"	24	"Bipolar cells: 86.8;Cone photoreceptor cells: 76.6;Horizontal cells: 144.6;Muller glia cells: 354.7;Rod photoreceptor cells: 96.7"	"Cancer enriched"	"Detected in single"	24	"glioma: 4.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"AF22: 5.9;SCLC-21H: 5.0;SuSa: 4.3;U-266/70: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039458	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA039458: AB_10795677"	"unprognostic (1.69e-2)"	"unprognostic (4.13e-2)"		"unprognostic (7.43e-3)"	"unprognostic (2.32e-1)"	"unprognostic (3.00e-3)"		"unprognostic (5.00e-3)"	"unprognostic (7.28e-2)"	"unprognostic (2.34e-2)"	"unprognostic (5.90e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.34e-1)"		1.2	1.4	15.5	1.2	33.5	1.2	1.2	11.7	57.0	1.2	1.2	24.7	0.0	1.2	1.2	1.2	1.2	2.2	1.2	1.2	19.9	9.7	1.2	1.2	1.2	1.2	41.9	9.2	1.2	1.2	1.1	1.6	1.2	15.8	1.4	1.2	0.0	1.2	1.5	1.4	1.3	1.2	1.2	15.9	1.2	1.2	2.0	47.8	0.0	1.2	0.0	1.2	1.2	0.0	0.4	0.4	1.1	0.4	0.7	0.3	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.1	0.0	0.0	0.0	4.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.4	0.0	0.2	0.0	0.1	1.1	0.3	0.2	0.2	0.3	0.3	0.3	0.2	0.2	0.1	0.4	0.3	0.3	0.9	0.7	0.4	0.4	0.3	0.0	15.5	33.5	11.7	20.9	19.9	9.7	41.9	9.2	15.8	47.8	0.0	0.0	0.0	0.0	0.1	86.8	0.8	0.0	0.0	0.0	0.0	76.6	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	144.6	0.0	0.0	0.0	1.0	0.0	0.0	1.7	0.0	0.0	354.7	0.0	0.0	0.0	0.0	96.7	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.1
ANK2	LQT4	ENSG00000145362	"Ankyrin 2"	Q01484	4	112818109-113383740	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"		"Disease mutation, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.5;heart muscle: 56.7;kidney: 59.8;skeletal muscle: 66.9"	"Cell type enhanced"	"Detected in many"	21	"Bipolar cells: 313.8;Cone photoreceptor cells: 451.6;Horizontal cells: 1352.3;Rod photoreceptor cells: 483.8"	"Cancer enhanced"	"Detected in many"		"glioma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 16.5;ASC TERT1: 22.9;RH-30: 31.5;SH-SY5Y: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008007, CAB015178, HPA035970"	Enhanced	Approved	Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB015178: AB_2242828, HPA008007: AB_2667965, HPA035970: AB_2674893"	"unprognostic (8.33e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (2.41e-6)"	"unprognostic (1.18e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.04e-3)"	17.3	8.7	34.0	6.3	42.1	0.8	10.7	43.7	58.5	20.9	9.5	24.5	0.6	4.3	10.5	4.3	8.3	5.8	13.0	56.7	29.4	30.3	59.8	2.0	4.6	5.1	28.7	38.7	19.0	2.4	1.6	8.6	2.0	42.1	5.4	7.2	7.8	2.6	8.7	66.9	3.5	4.7	15.2	19.0	15.1	3.8	5.8	24.2	0.0	5.6	4.4	4.5	4.5	4.8	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	10.4	4.2	16.5	22.9	0.0	1.1	1.9	0.7	2.1	4.1	0.0	4.3	1.4	3.7	2.5	0.0	7.6	0.4	0.6	1.9	6.3	2.5	0.0	1.7	1.0	1.0	0.7	9.8	1.7	0.9	4.0	2.7	0.0	0.2	0.0	7.0	3.5	0.1	0.2	0.0	5.4	0.0	1.8	0.5	31.5	0.0	0.1	0.0	8.4	15.8	0.1	0.3	5.4	7.4	0.1	0.6	0.0	3.2	1.8	0.2	1.9	4.2	1.2	0.6	12.9	0.4	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.0	42.1	43.7	54.3	29.4	30.3	28.7	38.7	42.1	24.2	0.0	3.8	0.0	0.0	9.3	313.8	152.3	0.0	1.4	2.3	19.2	451.6	0.1	13.3	0.0	92.0	11.6	0.0	0.0	1.5	0.1	44.2	0.4	1.1	0.4	0.8	1352.3	63.4	0.0	0.0	26.4	33.6	1.0	16.9	1.0	0.0	40.0	0.1	0.0	28.3	129.2	483.8	6.5	20.5	1.1	1.5	8.3	0.0	0.0	0.1	0.1
ANK3		ENSG00000151150	"Ankyrin 3"	Q12955	10	60026298-60733490	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Autism spectrum disorder, Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 95.4;parathyroid gland: 74.4"	"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 464.8;Cone photoreceptor cells: 212.1;Rod photoreceptor cells: 219.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 24.0;SK-BR-3: 24.1"									"CAB013249, CAB015179, HPA038455"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB013249: AB_2533145, CAB015179: AB_633909, HPA038455: AB_2676020"	"unprognostic (1.91e-1)"	"unprognostic (5.33e-3)"	"unprognostic (6.76e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.70e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.28e-2)"	"prognostic favorable (8.88e-16)"	"unprognostic (5.75e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.83e-2)"	2.7	3.1	21.1	3.1	24.8	1.1	9.1	95.4	29.1	5.5	10.5	21.5	19.4	15.7	9.7	52.9	7.1	8.2	8.9	31.2	24.4	16.4	38.9	6.6	10.1	2.5	26.8	19.8	5.2	5.0	74.4	10.5	31.9	31.9	8.6	8.8	6.5	16.1	19.4	29.2	16.0	10.6	5.9	16.5	5.9	6.3	3.4	30.0	0.6	17.2	4.6	3.4	5.6	6.6	6.2	3.5	1.7	0.4	2.1	7.7	1.3	4.1	2.3	14.8	0.2	0.0	0.9	11.4	0.3	0.2	0.0	0.2	10.6	8.0	0.2	4.8	0.3	0.4	5.8	7.9	7.1	0.2	0.2	5.3	0.1	4.5	0.0	3.1	0.0	0.2	7.3	4.6	3.8	0.2	12.9	1.7	0.0	2.0	10.0	3.3	13.6	0.0	0.4	6.7	11.0	12.8	0.0	10.6	2.0	2.6	24.0	7.7	1.4	0.3	24.1	0.0	17.3	14.0	0.0	4.8	0.4	1.5	6.5	0.7	0.4	0.0	0.0	2.7	0.1	9.1	1.7	0.4	0.6	4.1	0.3	3.7	6.2	7.0	2.2	0.2	1.9	7.7	1.9	1.1	2.1	0.4	3.5	1.0	1.3	21.1	24.8	95.4	29.1	24.4	16.4	26.8	19.8	31.9	30.0	41.7	132.9	8.9	17.9	16.9	464.8	156.4	15.3	72.3	58.0	50.6	212.1	34.4	16.6	7.2	18.5	2.1	50.2	0.0	7.4	8.8	4.0	13.1	11.6	0.8	3.9	41.3	29.4	12.9	3.2	8.5	25.9	2.9	8.5	7.2	10.6	35.7	5.0	39.0	5.3	48.8	219.9	0.0	0.4	1.1	0.6	15.8	20.9	5.3	16.0	19.2
ANKIB1	"DKFZP434A0225, KIAA1386"	ENSG00000001629	"Ankyrin repeat and IBR domain containing 1"	Q9P2G1	7	92246234-92401384	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019358, HPA021780"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA019358: AB_1844831, HPA021780: AB_2670819"	"unprognostic (1.77e-1)"	"unprognostic (5.96e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.97e-3)"	"unprognostic (2.75e-1)"	"unprognostic (7.67e-2)"	"unprognostic (4.88e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.52e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.06e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.20e-1)"	11.9	11.8	21.4	9.2	29.2	5.8	12.3	15.0	25.5	13.6	12.1	34.9	16.0	10.7	12.6	16.4	11.8	10.0	14.7	9.7	22.7	20.0	25.3	10.1	10.6	11.5	31.1	18.4	13.1	12.7	28.5	10.9	12.2	23.4	10.2	12.6	8.4	12.7	18.4	8.6	14.0	11.3	13.4	23.8	11.4	10.9	19.4	35.0	11.5	17.1	4.5	11.1	13.1	13.3	4.8	4.5	3.1	2.0	3.2	4.9	1.1	16.8	10.3	9.1	13.8	16.9	18.0	9.7	13.2	15.1	12.8	16.8	7.5	26.1	9.7	11.6	19.5	33.1	8.1	8.4	13.8	19.6	16.4	6.9	6.1	11.9	6.0	11.5	8.7	13.6	12.2	11.7	15.1	20.0	18.0	14.5	8.8	7.8	21.0	15.1	13.6	18.5	8.2	9.9	11.8	11.6	7.0	11.2	10.4	13.6	14.6	12.7	14.9	18.9	21.3	11.1	18.9	8.8	5.0	12.9	24.8	20.1	28.0	13.4	13.2	23.5	12.2	14.4	10.6	28.3	2.8	1.3	3.1	2.7	2.0	2.2	3.9	2.6	3.8	1.1	4.8	2.2	2.8	0.8	3.2	1.6	4.5	4.9	1.1	21.4	29.2	15.0	25.5	22.7	20.0	31.1	18.4	23.4	35.0	23.8	25.4	15.9	15.3	16.6	20.1	32.3	17.8	14.7	23.9	26.2	17.7	11.3	1.7	18.0	40.4	15.7	15.3	0.0	16.6	22.9	19.1	16.9	26.5	12.9	11.8	28.6	40.3	28.3	21.1	45.0	30.8	16.4	16.9	6.4	23.5	26.9	26.0	7.0	38.2	30.1	15.7	19.4	18.1	58.5	57.5	19.8	11.7	17.5	19.2	21.8
ANKRD13A	"ANKRD13, NY-REN-25"	ENSG00000076513	"Ankyrin repeat domain 13A"	Q8IZ07	12	109999186-110039763	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 116.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 49.6;HBF TERT88: 50.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039488, HPA043218"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA039488: AB_10673612, HPA043218: AB_2678367"	"unprognostic (1.54e-1)"	"unprognostic (3.94e-3)"	"unprognostic (5.81e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (7.70e-6)"	"unprognostic (5.68e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (9.71e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.29e-2)"	11.1	12.3	7.0	19.8	12.6	18.3	10.2	6.8	12.8	10.6	13.8	23.3	8.6	7.9	12.0	6.9	19.9	9.8	13.1	9.1	9.2	6.4	12.8	14.0	15.1	28.7	13.1	8.3	11.1	10.6	6.5	5.3	39.4	9.5	12.6	13.0	17.1	21.7	15.1	6.2	21.1	16.8	31.0	12.3	24.2	12.7	45.8	13.8	13.3	19.1	8.0	36.5	21.5	13.0	3.9	2.5	8.9	4.2	1.4	2.9	1.3	38.1	1.7	4.2	3.8	6.5	6.4	5.1	38.4	36.8	37.2	19.9	5.1	2.5	25.4	3.0	49.6	4.7	4.6	5.3	5.8	50.2	28.4	4.3	9.4	3.9	4.2	5.7	10.9	11.3	5.6	6.2	15.8	9.2	9.4	5.6	6.2	7.2	4.2	16.5	1.3	9.6	4.8	2.2	2.8	7.9	8.3	11.7	10.1	5.4	5.0	8.7	4.1	7.1	14.2	4.9	3.0	6.4	9.3	7.0	27.9	4.9	15.3	20.6	9.0	5.3	34.0	13.7	7.7	4.0	2.6	1.9	8.9	0.9	4.2	2.9	3.9	2.4	1.1	2.5	1.9	1.4	1.8	6.0	1.4	2.0	1.9	1.0	1.3	7.0	12.6	6.8	12.8	9.2	6.4	13.1	8.3	9.5	13.8	44.7	33.3	22.3	16.2	26.1	20.0	11.7	25.5	25.4	31.8	54.1	13.7	13.2	18.3	25.5	73.7	14.6	14.0	0.0	15.1	17.2	15.3	13.6	12.7	14.9	13.2	23.8	18.0	15.4	34.8	116.0	10.9	19.7	13.5	19.8	10.0	10.5	21.6	8.6	20.5	6.8	13.3	32.3	15.0	43.4	13.5	33.1	31.5	17.8	14.4	20.1
ANO1	"DOG1, FLJ10261, ORAOV2, TAOS2, TMEM16A"	ENSG00000131620	"Anoctamin 1"	Q5XXA6	11	70078302-70189528	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Developmental protein, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"ductus deferens: 142.4;epididymis: 38.5;salivary gland: 122.9;seminal vesicle: 93.6"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 56.2;Hepatocytes: 117.3;Late spermatids: 50.1;Sertoli cells: 45.3;Smooth muscle cells: 42.3;Suprabasal keratinocytes: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A-431: 32.9;CAPAN-2: 50.5;HaCaT: 61.6;OE19: 43.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA032148, HPA057356"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA032148: AB_2674180, HPA057356: AB_2732610"	"unprognostic (2.73e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.66e-2)"	"prognostic favorable (4.58e-6)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (7.28e-5)"	"unprognostic (1.16e-3)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (2.13e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (4.09e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.81e-1)"	6.9	0.4	1.1	2.1	1.1	0.0	17.2	1.6	1.4	9.7	5.3	1.1	142.4	0.2	14.2	38.5	3.6	11.7	10.6	6.9	1.1	0.2	2.6	24.4	4.4	1.5	1.0	1.0	3.9	4.5	0.5	2.0	6.2	1.5	7.2	1.7	1.7	122.9	93.6	3.4	19.1	1.8	5.7	1.0	1.1	9.5	7.6	0.9	1.1	8.9	8.1	3.8	4.5	5.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	32.9	1.3	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	50.5	0.0	0.6	0.0	0.0	61.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	43.3	4.8	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	10.5	0.2	0.3	3.9	0.1	0.1	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.1	1.6	1.4	1.1	0.2	1.0	1.0	1.5	0.9	0.0	0.0	0.0	18.1	15.8	0.0	2.8	25.5	0.0	1.2	0.0	0.0	1.1	0.0	2.9	56.2	2.2	0.0	0.0	0.0	0.6	3.5	9.1	4.6	117.3	0.2	0.0	0.0	4.9	1.6	50.1	1.7	0.9	5.0	0.0	11.4	1.0	0.6	0.0	1.4	0.4	0.3	45.3	42.3	1.4	1.5	40.8	3.4	0.0	0.2	17.8
ANO10	"FLJ10375, MGC47890, SCAR10, TMEM16K"	ENSG00000160746	"Anoctamin 10"	Q9NW15	3	43354859-43691594	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 104.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 22.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016624, HPA051569"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA016624: , HPA051569: AB_2681537"	"unprognostic (1.51e-3)"	"unprognostic (1.38e-2)"	"prognostic favorable (6.70e-4)"	"prognostic favorable (1.11e-4)"	"unprognostic (4.23e-1)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (7.99e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (6.41e-6)"	"unprognostic (9.83e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.19e-3)"	"unprognostic (5.71e-2)"	21.6	12.7	11.8	12.6	13.2	20.6	22.0	18.2	14.1	17.5	27.4	14.3	13.2	42.0	17.9	12.4	19.8	10.4	16.7	10.5	12.3	15.2	22.2	10.5	13.6	10.7	17.3	12.3	12.7	14.4	18.6	14.4	17.5	19.4	10.7	24.4	18.6	23.1	19.5	11.3	24.6	52.9	19.9	23.6	9.4	11.1	9.1	8.8	5.5	17.7	15.8	13.9	13.7	17.0	2.0	8.5	22.4	12.5	6.3	4.6	4.3	9.0	7.2	8.0	8.4	32.6	17.6	9.8	26.5	44.2	13.6	17.3	4.8	8.4	1.0	8.5	34.9	13.4	4.9	6.3	14.5	16.5	10.0	4.5	11.8	9.7	5.2	14.3	2.1	9.6	16.3	11.6	16.7	22.8	24.9	31.7	5.7	8.8	7.7	30.0	6.4	2.3	1.5	9.6	7.0	8.4	1.8	5.7	3.1	26.7	9.5	2.0	5.9	10.5	8.6	6.1	14.8	18.4	4.3	25.8	20.7	7.7	21.7	12.1	5.0	6.5	0.3	18.9	4.5	13.6	4.4	12.5	0.9	4.6	7.1	2.7	1.9	3.2	3.1	8.5	2.0	2.8	4.3	22.4	6.3	7.7	1.5	3.5	4.3	11.8	13.2	18.2	14.1	12.3	15.2	17.3	12.3	19.4	8.8	6.0	2.7	2.2	5.2	4.9	7.1	4.5	10.2	4.0	7.9	14.0	0.0	12.0	104.5	19.0	2.7	14.0	47.9	23.3	15.4	15.5	7.8	5.5	2.3	6.8	10.4	9.5	9.2	19.0	9.2	3.1	5.2	8.2	13.5	1.8	19.1	20.3	11.8	16.5	9.6	14.9	3.6	6.5	12.3	14.7	22.6	5.4	14.3	3.9	24.3	4.6
ANO2	"C12orf3, TMEM16B"	ENSG00000047617	"Anoctamin 2"	Q9NQ90	12	5531869-5946232	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"placenta: 46.9;retina: 30.6;testis: 13.4"	"Group enriched"	"Detected in many"	12	"Cone photoreceptor cells: 76.6;Early spermatids: 58.6;Late spermatids: 219.4;Rod photoreceptor cells: 168.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"basophil: 5.1"	"Lineage enriched"	"Detected in single"	51	"granulocytes: 5.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.6;HUVEC TERT2: 8.5;U-2 OS: 22.5"	"Region enriched"	"Detected in some"	4	"basal ganglia: 20.0"					"HPA036276, HPA057499"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA036276: AB_10670713, HPA057499: AB_2732613"	"unprognostic (6.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.84e-3)"	"unprognostic (3.78e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.10e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.17e-1)"	5.8	0.1	1.0	1.3	2.3	0.0	4.3	1.2	1.3	3.3	1.0	1.6	0.9	0.8	1.8	2.1	0.9	1.9	1.5	3.9	1.9	0.9	1.2	0.9	4.7	0.9	1.6	2.0	0.9	0.9	1.4	0.9	46.9	1.2	1.4	0.7	30.6	0.9	1.6	2.3	0.6	0.9	2.1	1.1	1.9	1.0	13.4	0.9	0.9	1.6	1.3	0.9	1.3	2.3	0.0	0.0	5.1	0.0	0.0	0.0	0.2	2.2	0.0	4.0	0.0	0.0	0.2	1.9	0.0	8.6	0.4	0.9	0.0	0.1	0.1	0.2	0.0	0.1	0.3	0.0	0.1	0.6	0.2	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.5	0.0	0.0	1.7	0.0	0.8	0.0	0.0	4.1	2.0	0.0	1.7	0.0	0.9	0.1	0.1	0.0	0.0	2.1	1.4	0.0	3.7	1.2	0.0	0.2	0.0	22.5	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	1.0	2.3	1.2	1.3	1.9	0.9	1.6	2.0	1.2	0.9	0.0	0.0	0.0	0.0	0.0	7.4	1.1	0.0	0.0	0.0	0.0	76.6	1.1	0.0	0.0	58.6	3.6	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.2	9.5	0.0	1.8	0.0	219.4	0.3	0.0	0.0	0.0	0.0	10.6	0.0	0.0	1.4	0.0	168.7	0.0	0.4	1.5	1.3	0.1	2.1	0.0	0.0	0.0
ANO6	"DKFZp313M0720, TMEM16F"	ENSG00000177119	"Anoctamin 6"	Q4KMQ2	12	45215987-45440404	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Lipid transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 81.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038958	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		1500000	"Plasma membrane, Cytosol"		"HPA038958: AB_10672835"	"prognostic unfavorable (7.56e-5)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.82e-3)"	"unprognostic (7.43e-2)"	"unprognostic (3.01e-3)"	"unprognostic (7.55e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.41e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.28e-1)"	40.7	15.3	6.4	17.3	7.0	3.8	42.8	2.5	7.3	22.2	29.7	6.1	34.8	16.5	33.2	16.0	21.2	18.5	20.2	20.7	6.7	5.4	21.6	25.4	25.6	11.7	7.6	4.2	27.4	12.7	20.1	7.1	23.3	8.8	21.6	6.9	14.2	16.8	39.3	40.3	10.0	41.3	42.8	14.6	12.5	13.5	10.4	5.8	21.6	11.2	14.7	9.6	37.6	38.1	2.1	7.1	4.4	9.3	3.1	4.0	5.0	13.6	15.7	8.8	12.0	40.6	21.1	33.7	19.2	24.2	13.3	12.3	23.6	20.7	7.1	18.0	30.0	11.8	18.1	8.0	10.6	15.5	10.4	5.7	8.2	6.4	19.9	12.9	12.7	6.6	17.6	10.6	11.1	16.4	31.7	17.4	14.9	6.2	11.5	14.1	3.6	13.5	4.1	9.8	0.0	5.9	7.8	11.5	7.8	12.2	21.7	4.0	13.7	20.1	12.5	9.2	23.9	14.7	20.1	23.8	14.2	9.1	14.3	9.7	6.1	7.0	8.6	12.8	40.8	11.3	4.4	7.7	1.9	3.3	9.3	3.4	2.1	3.2	2.8	7.1	1.7	2.9	2.0	0.9	3.1	8.6	3.6	4.0	5.0	6.4	7.0	2.5	7.3	6.7	5.4	7.6	4.2	8.8	5.8	56.6	10.2	3.7	20.1	27.1	0.4	20.3	30.6	6.7	13.6	17.4	0.0	29.4	3.3	35.0	1.0	34.4	4.9	0.0	32.0	21.1	32.3	17.2	12.7	81.6	17.8	0.0	8.1	54.0	49.8	1.3	47.5	21.3	16.9	8.2	11.4	9.8	55.0	10.2	38.2	18.0	0.2	38.8	31.6	2.4	4.2	19.3	20.6	6.4	10.7	25.1
ANPEP	"CD13, gp150, LAP1, p150, PEPN"	ENSG00000166825	"Alanyl aminopeptidase, membrane"	P15144	15	89784889-89815401	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Differentiation, Host-virus interaction"	"Aminopeptidase, Developmental protein, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 195.3;kidney: 78.7;pancreas: 93.9"	"Cell type enhanced"	"Detected in many"	16	"Cholangiocytes: 372.0;Enterocytes: 993.7;Exocrine glandular cells: 328.5;Proximal tubular cells: 388.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 59.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 59.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 78.5;BJ: 78.2;BJ hTERT+: 111.8;fHDF/TERT166: 67.0;HMC-1: 71.1;HSkMC: 68.7;HUVEC TERT2: 87.5;TIME: 87.4;U-2197: 95.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB002417, HPA004625"	Enhanced		Supported	"Plasma membrane"		NA	NA		1500000000	"Plasma membrane"		"CAB002417: AB_563491, HPA004625: AB_2667199"	"unprognostic (6.31e-2)"	"unprognostic (7.94e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.73e-2)"	"unprognostic (5.28e-3)"	"unprognostic (3.96e-1)"	"unprognostic (4.04e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.99e-2)"	21.3	1.1	0.6	2.9	0.8	9.5	17.0	1.0	1.3	8.2	21.2	0.8	0.5	195.3	1.4	8.4	3.6	1.4	27.7	3.7	0.4	0.3	78.7	37.7	9.7	9.3	0.9	0.9	1.8	93.9	0.0	0.7	14.7	1.3	8.6	4.7	4.0	6.6	1.8	1.6	4.9	155.8	4.3	1.2	7.2	0.8	4.7	0.2	5.6	1.5	4.2	3.8	4.7	3.0	0.0	6.9	59.4	12.8	0.0	0.0	5.5	0.0	5.0	0.0	0.0	61.3	78.5	0.5	78.2	111.8	9.6	8.5	0.5	0.0	0.0	0.9	67.0	0.0	0.0	0.6	0.0	3.8	0.0	0.0	14.7	0.4	11.7	36.1	1.0	71.1	68.7	0.1	30.2	0.0	0.4	87.5	0.0	0.4	0.1	3.7	0.0	0.0	34.7	0.2	0.0	5.3	0.0	0.0	0.8	43.7	0.0	0.1	0.7	0.0	0.1	0.0	0.1	0.0	6.8	87.4	42.2	0.0	95.3	0.0	0.0	0.0	0.0	0.1	0.0	2.2	5.7	12.8	10.4	0.0	7.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	59.4	0.0	12.0	0.1	0.0	5.5	0.6	0.8	1.0	1.3	0.4	0.3	0.9	0.9	1.3	0.2	0.0	4.8	8.2	3.1	8.9	0.0	0.8	372.0	2.7	20.5	19.2	0.0	9.7	36.5	10.6	0.1	1.8	993.7	0.0	328.5	12.0	36.3	18.0	24.2	144.7	39.4	0.0	2.9	101.9	51.7	0.0	2.6	46.4	3.3	39.7	10.5	0.0	120.5	201.5	1.4	388.5	0.0	25.8	5.0	0.4	0.1	5.1	5.4	1.0	18.3	1.3
ANXA13	ANX13	ENSG00000104537	"Annexin A13"	P27216	8	123680794-123737407	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ductus deferens: 41.9;gallbladder: 38.7;intestine: 108.6"	"Cell type enhanced"	"Detected in some"	20	"Cholangiocytes: 180.9;Intestinal endocrine cells: 43.0;Mucus-secreting cells: 139.9"	"Group enriched"	"Detected in many"	13	"colorectal cancer: 7.8;liver cancer: 8.5;pancreatic cancer: 6.1;renal cancer: 7.0;stomach cancer: 7.3"	"Region enhanced"	"Detected in single"		"midbrain: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A549: 23.8;HDLM-2: 12.3"					"Low region specificity"	"Detected in all"			"HPA018535, HPA019569, HPA019650, CAB025135"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB025135: , HPA018535: AB_1844854, HPA019569: AB_1844855, HPA019650: AB_1844856"	"unprognostic (6.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.66e-2)"	"unprognostic (4.05e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.86e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.11e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.79e-2)"	"unprognostic (4.79e-2)"	0.2	0.1	0.3	0.7	0.5	0.0	0.4	0.1	0.4	0.2	30.3	0.4	41.9	66.5	1.1	2.6	0.2	13.3	38.7	0.1	0.5	0.6	2.1	4.3	0.1	0.1	3.0	0.1	0.9	0.3	0.0	0.1	0.1	0.7	1.1	8.1	0.2	0.2	20.7	0.1	0.1	108.6	0.4	8.0	0.1	0.7	2.3	0.3	0.1	0.1	0.1	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.5	0.0	0.0	0.0	1.4	1.4	0.0	0.1	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.1	0.4	0.5	0.6	3.0	0.1	0.7	0.3	0.0	0.0	0.0	0.2	0.9	0.0	0.3	180.9	5.3	0.0	0.0	0.0	0.0	3.3	0.0	0.9	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	43.0	0.0	0.0	1.0	1.1	0.0	0.0	0.0	139.9	0.0	0.1	18.7	0.0	18.5	9.5	0.0	0.0	0.0	0.1	0.5	0.0	0.0	20.0	0.0
AP2M1	"AP50, CLAPM1, mu2"	ENSG00000161203	"Adaptor related protein complex 2 mu 1 subunit"	Q96CW1	3	184174689-184184091	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036849, HPA069870"	Uncertain		Supported	"Plasma membrane"		NA	NA		340000	"Plasma membrane"		"HPA036849: AB_10672101, HPA069870: AB_2686217"	"unprognostic (1.16e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.28e-3)"	"unprognostic (4.96e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.88e-2)"	"prognostic unfavorable (9.12e-4)"	"unprognostic (3.80e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.11e-2)"	"unprognostic (9.18e-2)"	"prognostic unfavorable (7.45e-6)"	"unprognostic (2.61e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.28e-1)"	37.6	78.2	58.6	38.3	78.2	47.7	32.5	64.2	111.9	52.4	42.7	33.5	35.4	40.7	46.7	27.0	54.9	39.1	41.2	86.8	62.5	64.6	39.7	36.8	35.8	35.2	57.5	83.0	49.8	26.0	53.6	48.2	59.0	79.8	40.0	35.6	44.4	40.2	61.3	33.9	38.1	36.1	60.3	41.5	34.1	32.9	27.8	32.1	30.5	35.3	34.5	37.1	49.5	38.8	26.4	59.3	51.4	62.6	34.9	39.5	77.6	48.6	37.4	32.2	36.2	51.8	54.5	33.3	82.0	47.8	92.7	65.3	40.2	35.7	22.3	100.3	122.6	60.8	55.3	43.5	55.4	76.9	45.8	54.3	57.6	43.0	35.6	61.2	28.3	36.7	69.2	31.5	58.7	37.7	84.0	68.9	29.8	27.6	43.9	86.8	111.4	36.4	16.8	78.5	43.8	56.2	33.9	41.2	44.2	57.5	44.4	34.3	25.0	64.4	81.1	38.1	52.6	108.6	34.6	73.8	58.9	47.8	57.5	108.0	39.6	34.6	49.9	111.0	41.8	38.3	37.5	62.6	51.4	32.5	52.7	32.0	26.4	30.3	31.1	59.3	25.5	26.1	26.7	28.5	34.9	42.2	29.7	39.5	77.6	58.6	78.2	64.2	111.9	62.5	64.6	57.5	83.0	79.8	32.1	50.6	49.0	96.0	145.4	110.9	179.9	166.5	81.5	20.1	39.8	108.2	66.8	350.0	318.3	216.7	238.9	157.2	189.4	116.8	141.3	275.4	160.1	132.3	147.6	66.5	475.3	262.2	135.2	174.3	117.8	263.1	152.5	165.2	189.0	547.4	101.7	147.8	177.5	138.2	201.9	236.1	93.7	194.1	212.7	73.4	100.5	110.7	429.5	123.6	136.9	178.1
APBB1	"Fe65, RIR"	ENSG00000166313	"Amyloid beta precursor protein binding family B member 1"	O00213	11	6395124-6419414	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, DNA damage, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 84.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 34.4"	"Lineage enriched"	"Detected in many"	5	"T-cells: 34.4"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 28.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038521, HPA038522"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA038521: AB_2676058, HPA038522: AB_2676059"	"unprognostic (4.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.97e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (7.30e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.36e-1)"	"prognostic favorable (1.86e-5)"	"unprognostic (2.21e-1)"	"prognostic favorable (7.44e-13)"	"unprognostic (1.32e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.09e-2)"	7.9	14.0	26.0	6.9	26.0	1.9	5.5	54.3	84.6	11.5	9.6	31.1	3.7	4.5	15.7	3.2	9.2	19.7	7.0	21.8	29.5	23.9	9.2	2.3	9.4	7.5	27.0	30.7	21.3	9.5	14.8	15.7	5.4	25.8	10.9	3.3	5.5	8.0	16.5	21.5	4.6	5.2	19.5	36.4	5.9	5.7	7.2	24.7	6.0	7.7	2.5	6.6	7.7	5.8	6.3	0.6	3.0	0.6	5.5	34.4	11.3	0.0	5.9	20.7	9.2	11.2	11.6	0.0	9.7	16.9	16.9	21.3	10.7	4.1	0.0	1.5	17.7	15.2	0.2	18.0	3.0	8.1	10.8	13.6	0.1	3.8	0.3	8.1	0.0	4.1	10.4	0.7	7.9	1.2	14.5	20.9	0.5	0.4	0.3	6.2	0.2	0.2	0.0	7.4	0.3	6.4	0.1	0.8	0.0	0.7	0.0	28.5	16.1	1.4	1.2	6.4	6.6	0.8	1.3	9.2	1.7	10.5	11.2	2.0	5.6	2.6	0.8	8.7	0.0	5.8	3.0	0.6	0.1	9.1	0.5	9.8	2.6	12.7	11.7	0.6	6.3	34.4	20.0	0.5	5.5	0.2	0.1	17.0	11.3	26.0	26.0	54.3	49.3	29.5	23.9	27.0	30.7	25.8	24.7	17.9	4.8	3.2	10.7	4.4	36.4	40.0	10.2	26.8	9.1	5.2	21.6	0.4	21.6	14.5	4.3	13.7	0.5	0.0	3.6	0.6	12.5	8.9	1.1	3.0	1.1	38.1	18.6	19.0	2.8	9.2	8.9	0.8	8.5	3.6	0.7	23.8	7.3	1.1	18.0	19.2	16.8	6.5	18.7	4.2	6.6	2.5	0.7	21.7	0.8	4.4
AQP1	"CHIP28, CO"	ENSG00000240583	"Aquaporin 1 (Colton blood group)"	P29972	7	30911694-30925516	"Blood group antigen proteins, Predicted membrane proteins, Transporters"	Transport	"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 156.5"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 218.3;Cholangiocytes: 377.0;Endothelial cells: 221.7;Proximal tubular cells: 281.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 20.9;HeLa: 7.0;SH-SY5Y: 7.8;U-2 OS: 9.8;WM-115: 37.8"									"CAB001707, HPA019206"	Enhanced		Supported	"Plasma membrane"		NA	NA		250000	"Plasma membrane"		"CAB001707: , HPA019206: AB_1844965"	"unprognostic (4.18e-2)"	"unprognostic (7.82e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (6.52e-4)"	"unprognostic (1.95e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.80e-2)"	"unprognostic (4.16e-1)"	"unprognostic (2.05e-2)"	"prognostic favorable (1.32e-8)"	"unprognostic (3.43e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.09e-1)"	"unprognostic (7.21e-2)"	68.2	8.0	9.9	8.7	17.1	9.4	51.9	10.7	13.0	46.5	18.1	62.1	7.7	10.8	28.0	20.8	58.8	29.0	36.3	46.7	18.1	15.4	156.5	4.2	103.2	9.1	36.9	17.8	16.4	49.9	12.9	4.0	9.1	63.2	32.4	10.6	8.3	19.8	22.7	35.2	24.8	18.2	41.2	56.4	2.9	18.2	15.0	17.8	1.9	21.3	33.5	12.5	36.0	76.7	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.1	0.6	0.4	1.8	0.4	1.2	0.4	0.0	0.0	0.2	0.3	0.0	20.9	1.1	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.2	7.0	0.0	0.4	0.1	0.0	3.3	0.0	0.1	0.0	0.0	2.9	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.3	0.6	0.0	0.0	5.2	0.1	0.7	0.0	0.2	7.8	1.2	0.6	0.0	3.9	0.1	0.1	0.0	0.0	9.8	0.8	0.3	0.5	0.3	0.0	0.1	0.0	37.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	9.9	17.1	10.7	13.0	18.1	15.4	36.9	17.8	63.2	17.8	166.7	218.3	2.9	1.1	81.4	1.1	57.7	377.0	6.7	6.8	29.6	7.9	1.9	24.9	35.6	1.9	221.7	4.2	0.0	2.1	3.0	91.5	1.0	1.1	1.3	3.3	0.0	7.0	154.1	1.8	1.6	1.1	9.8	84.4	2.8	18.2	0.3	2.8	19.2	3.2	281.0	0.2	12.9	92.0	0.3	1.3	68.8	6.1	0.0	71.0	1.0
AQP10		ENSG00000143595	"Aquaporin 10"	Q96PS8	1	154321090-154325325	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	8	"intestine: 59.9"	"Group enriched"	"Detected in some"	7	"Cholangiocytes: 2.5;granulocytes: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 16.0;HMC-1: 6.7;K-562: 18.3;SH-SY5Y: 4.4"					"Low region specificity"	"Detected in many"			"HPA062621, HPA065947"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA062621: , HPA065947: AB_2685584"	"unprognostic (6.84e-2)"	"unprognostic (4.97e-2)"		"unprognostic (4.19e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.45e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.68e-1)"		"unprognostic (7.64e-3)"	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	36.0	0.0	0.0	37.2	0.2	0.3	0.1	4.3	0.5	0.7	0.4	0.0	0.0	0.1	2.2	0.4	0.1	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	59.9	0.0	0.0	2.7	0.3	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.9	0.1	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	6.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	7.6	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0
AQP3	GIL	ENSG00000165272	"Aquaporin 3 (Gill blood group)"	Q92482	9	33441154-33447633	"Blood group antigen proteins, Plasma proteins, Predicted membrane proteins"	Transport	"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 179.6;lymphoid tissue: 156.1;salivary gland: 194.2;tongue: 132.4"	"Group enriched"	"Detected in many"	6	"Basal glandular cells: 608.6;Basal keratinocytes: 1708.5;Collecting duct cells: 1526.7;Glandular cells: 959.6;Suprabasal keratinocytes: 2172.4;Urothelial cells: 2008.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"hippocampal formation: 2.1;pons and medulla: 6.7"	"Group enriched"	"Detected in many"	6	"MAIT T-cell: 41.1;memory CD4 T-cell: 39.2;memory CD8 T-cell: 12.0;naive CD4 T-cell: 22.7;naive CD8 T-cell: 10.8;T-reg: 42.1"	"Lineage enriched"	"Detected in many"	16	"T-cells: 42.1"	"Cell line enhanced"	"Detected in many"		"HaCaT: 28.1;HeLa: 51.2;JURKAT: 28.8;RT4: 47.6;SK-BR-3: 32.9;U-266/70: 34.1;U-266/84: 44.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA014924	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA014924: AB_2669120"	"unprognostic (4.29e-2)"	"prognostic favorable (5.31e-4)"	"unprognostic (1.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.51e-2)"	1.3	0.4	0.4	2.7	0.2	1.9	5.2	0.9	0.3	29.7	26.7	0.1	1.7	9.9	5.5	3.2	179.6	3.3	2.0	6.0	2.1	0.4	23.9	44.0	16.5	5.7	0.5	0.3	3.6	5.7	0.0	0.7	5.3	6.7	15.5	1.2	0.4	194.2	5.5	0.9	65.2	33.2	5.1	0.3	17.2	3.9	1.2	0.0	70.6	0.6	132.4	156.1	37.6	60.2	2.6	2.4	0.5	0.1	0.5	42.1	10.3	0.1	8.4	0.4	0.0	15.6	2.8	0.2	0.0	0.2	0.2	0.2	4.4	2.6	0.1	2.0	0.0	0.1	28.1	1.3	0.1	0.0	13.4	1.3	0.9	51.2	0.4	0.0	0.2	0.3	0.4	1.4	0.1	0.0	0.0	0.1	28.8	14.3	13.0	1.5	6.2	12.8	5.0	1.1	19.2	0.1	0.2	21.3	2.3	0.2	47.6	0.4	1.1	7.1	32.9	0.0	1.9	0.2	2.2	0.2	0.0	0.2	0.0	0.0	34.1	44.2	3.2	0.1	0.0	0.0	0.3	0.1	0.0	4.5	0.0	41.1	2.6	39.2	12.0	0.0	0.5	22.7	10.8	0.5	0.5	0.1	2.4	42.1	10.3	0.4	0.2	0.9	0.3	2.1	0.4	0.5	0.3	6.7	0.0	35.7	265.4	2.2	608.6	1708.5	1.4	2.1	104.4	136.5	215.0	1526.7	2.0	0.6	0.0	27.2	1.3	40.5	4.2	93.5	41.7	1.3	46.3	959.6	19.7	111.7	2.2	0.0	7.9	16.0	3.8	0.0	30.8	32.1	150.1	1.0	63.7	0.3	32.0	2.9	1.1	28.8	0.4	0.0	42.2	0.0	1.0	2172.4	42.0	43.3	3.5	2008.6
AQP4	MIWC	ENSG00000171885	"Aquaporin 4"	P55087	18	26852038-26865818	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 185.1;lung: 53.5"	"Cell type enriched"	"Detected in some"	4	"Alveolar cells type 1: 1024.3"	"Cancer enriched"	"Detected in some"	22	"glioma: 223.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.9;Karpas-707: 2.0;RPTEC TERT1: 3.9;SCLC-21H: 1.3;U-87 MG: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005079, HPA014784, CAB058689"	Enhanced	Supported	Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Cell Junctions"	"CAB005079: AB_2274338, CAB058689: AB_2665579, HPA014784: AB_1844967"	"unprognostic (7.23e-5)"	"unprognostic (1.55e-1)"		"unprognostic (3.19e-8)"	"unprognostic (3.68e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.64e-3)"	"unprognostic (8.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.10e-2)"		1.7	1.7	60.7	1.6	57.1	1.6	1.8	21.8	185.1	1.9	1.6	41.3	0.0	1.6	1.6	2.0	1.9	2.1	1.6	2.7	64.3	27.1	2.7	2.0	53.5	1.7	39.8	36.4	2.8	1.7	2.9	0.8	1.6	39.1	1.8	1.6	0.0	1.8	1.7	25.4	1.6	1.6	1.6	67.2	1.8	6.1	1.7	42.2	0.0	8.4	0.1	1.6	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.5	0.2	0.9	0.0	0.0	0.0	0.0	0.0	3.9	0.0	1.3	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.7	57.1	21.8	31.7	64.3	27.1	39.8	36.4	39.1	42.2	1024.3	245.1	0.0	0.6	0.0	2.1	8.5	0.0	37.5	138.8	3.5	5.9	0.0	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	3.5	0.5	0.0	1.6	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	224.7	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6
ARHGAP21	"ARHGAP10, KIAA1424"	ENSG00000107863	"Rho GTPase activating protein 21"	Q5T5U3	10	24583609-24723668	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 54.8"	"Cell type enhanced"	"Detected in all"	7	"Muller glia cells: 217.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036610, HPA057861"	Approved		Supported	"Plasma membrane,Cell Junctions,Actin filaments"		NA	NA			"Cell Junctions, Actin filaments"	"Plasma membrane"	"HPA036610: AB_10669910, HPA057861: AB_2683546"	"unprognostic (7.65e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.12e-3)"	"unprognostic (5.35e-2)"	"unprognostic (9.75e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.65e-3)"	"unprognostic (3.23e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.61e-2)"	19.6	13.6	34.5	7.1	38.5	4.7	15.6	37.9	39.3	16.2	12.0	39.1	4.4	9.4	14.8	6.0	8.4	14.0	13.5	15.0	43.1	25.2	8.5	9.8	15.7	3.5	42.3	24.0	25.5	11.0	12.4	9.7	12.1	27.3	8.2	14.1	6.7	16.0	9.1	10.9	4.7	11.5	13.7	54.8	6.0	19.5	10.4	43.7	2.7	9.8	3.7	4.2	9.2	9.3	0.2	1.6	3.6	1.9	1.0	2.0	1.0	23.0	10.2	25.1	21.3	17.7	25.6	8.6	16.6	11.0	10.2	14.4	7.4	14.7	4.3	5.7	26.3	15.8	15.3	13.2	16.6	15.0	14.1	8.4	25.3	22.0	5.3	10.6	0.0	3.9	10.4	18.2	13.3	14.5	15.2	17.5	6.5	10.7	38.8	20.0	4.5	12.0	0.8	3.8	8.3	5.5	2.6	8.9	2.4	6.9	4.1	4.3	4.4	11.3	6.3	13.5	7.7	6.6	3.6	19.3	14.7	9.4	16.0	11.9	4.3	7.6	3.0	15.1	4.4	9.8	3.6	0.8	1.6	0.5	1.9	0.4	0.2	0.6	1.6	1.3	0.0	2.0	1.2	0.1	1.0	0.9	1.6	1.0	1.0	34.5	38.5	37.9	36.1	43.1	25.2	42.3	24.0	27.3	43.7	80.4	22.0	5.2	10.4	26.3	127.8	32.7	20.4	34.8	61.4	5.2	64.8	19.4	1.7	18.9	4.3	25.3	34.0	23.3	23.9	15.9	47.4	17.6	16.2	18.7	12.1	125.5	15.5	20.9	25.3	5.3	86.0	24.4	18.6	7.2	26.8	217.5	27.9	26.0	55.9	5.7	53.2	25.8	19.4	25.1	33.0	17.7	10.5	10.0	23.4	24.0
ARHGAP22	RhoGAP2	ENSG00000128805	"Rho GTPase activating protein 22"	Q7Z5H3	10	48446034-48656265	"Predicted intracellular proteins"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Developmental protein, GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 32.3"	"Group enriched"	"Detected in many"	5	"Early spermatids: 51.6;Late spermatids: 92.5;monocytes: 23.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 3.2;myeloid DC: 2.9;naive B-cell: 2.6"	"Group enriched"	"Detected in many"	29	"B-cells: 2.6;dendritic cells: 2.9;monocytes: 3.2"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 28.1;LHCN-M2: 25.4;TIME: 26.9;U-87 MG: 33.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB020696, HPA040391, HPA064439"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB020696: , HPA040391: AB_2676957, HPA064439: AB_2685266"	"unprognostic (1.87e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.74e-3)"	"unprognostic (4.81e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (2.16e-8)"	"unprognostic (7.40e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.39e-2)"	"unprognostic (3.66e-2)"	2.6	3.1	10.2	6.7	12.5	3.0	2.0	7.3	12.2	1.8	2.7	32.3	1.0	1.7	2.1	1.9	1.6	2.2	4.4	3.3	12.5	9.6	1.2	0.8	2.9	6.0	18.3	6.6	7.7	1.5	2.7	1.8	2.2	24.6	3.2	2.8	1.6	3.4	3.2	3.9	3.4	2.5	3.4	27.3	6.2	2.3	4.6	18.4	2.0	6.0	0.4	5.4	3.1	1.9	2.6	2.9	0.0	3.2	0.0	0.0	0.9	2.4	0.5	0.1	0.0	2.1	8.6	1.7	13.1	6.0	1.2	1.7	2.7	0.3	0.0	0.5	5.1	0.9	4.8	0.1	4.4	2.1	0.2	4.5	6.9	0.0	0.0	1.1	0.7	0.8	2.0	4.5	15.0	1.2	28.1	8.2	0.0	6.5	1.2	25.4	0.1	0.1	0.0	2.8	0.0	0.2	0.0	0.0	3.1	2.5	0.2	0.4	2.6	0.6	0.0	0.2	0.2	0.1	0.1	26.9	12.3	0.1	1.6	9.1	0.0	0.0	0.0	33.5	0.1	1.9	0.0	3.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.9	2.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.9	10.2	12.5	7.3	9.2	12.5	9.6	18.3	6.6	24.6	18.4	0.0	1.7	1.3	4.2	3.1	1.0	2.4	0.0	6.7	4.5	0.0	2.0	9.2	0.0	2.5	51.6	1.4	0.0	0.0	3.9	0.2	2.6	1.0	0.0	0.0	10.4	0.0	0.0	2.5	9.5	92.5	2.6	11.0	1.7	23.4	0.0	1.5	2.0	0.0	5.6	0.0	1.4	0.0	0.5	1.4	4.2	0.5	0.8	0.0	0.0	0.5
ARHGAP40	"C20orf95, dJ1100H13.4"	ENSG00000124143	"Rho GTPase activating protein 40"	Q5TG30	20	38601934-38651035	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"breast: 18.6;epididymis: 38.0;skin 1: 26.7"	"Cell type enhanced"	"Detected in some"	12	"Collecting duct cells: 3.5;Early spermatids: 3.2;Late spermatids: 2.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.7;HBEC3-KT: 12.2;RPTEC TERT1: 10.8;SK-BR-3: 11.6;T-47d: 14.0"	"Not detected"	"Not detected"							"HPA042636, HPA042840"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		No	NA			"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA042636: AB_10962149, HPA042840: AB_10963929"	"unprognostic (9.89e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.24e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.35e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (2.89e-4)"	"unprognostic (2.24e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.54e-1)"	0.3	0.0	0.3	0.3	0.3	0.0	18.6	0.3	0.5	1.6	0.3	0.4	5.2	0.8	0.6	38.0	15.8	0.0	0.9	0.3	0.3	0.1	4.1	0.3	1.8	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.4	0.3	3.0	0.0	0.3	1.9	5.1	0.3	26.7	0.3	0.7	0.3	0.3	2.6	1.2	0.6	0.3	0.3	5.2	6.6	3.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	7.7	0.1	0.0	0.0	0.1	0.1	0.8	0.0	3.4	0.0	0.0	0.0	0.0	12.2	0.2	0.0	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	11.6	0.0	1.5	14.0	0.4	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.5	0.3	0.1	0.3	0.3	0.3	0.6	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.2	3.5	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.2
ARHGEF1	"LBCL2, P115-RHOGEF, SUB1.5"	ENSG00000076928	"Rho guanine nucleotide exchange factor 1"	Q92888	19	41883161-41930150	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 61.0"	"Cell type enhanced"	"Detected in many"	8	"T-cells: 145.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009502, HPA012924, HPA060784"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB009502: AB_667785, HPA012924: AB_1845000, HPA060784: AB_2684363"	"prognostic favorable (5.92e-4)"	"unprognostic (2.09e-1)"	"unprognostic (8.29e-3)"	"unprognostic (8.10e-3)"	"unprognostic (7.63e-2)"	"unprognostic (7.59e-3)"	"unprognostic (4.99e-2)"	"unprognostic (7.28e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.29e-3)"	"prognostic unfavorable (3.36e-8)"	"unprognostic (3.54e-1)"	"unprognostic (1.95e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.65e-2)"	15.5	8.4	10.7	40.1	16.5	50.0	13.8	8.7	13.8	11.7	14.1	23.3	9.7	13.7	12.7	9.6	12.2	13.0	14.1	9.3	10.6	6.2	12.4	10.4	23.7	57.8	18.1	8.5	12.5	10.8	7.0	11.8	9.6	11.8	11.4	5.8	12.1	13.1	9.2	5.2	12.9	29.3	9.0	12.2	61.0	17.0	3.7	15.6	43.6	13.4	8.6	40.8	12.4	11.7	11.1	10.8	13.7	26.9	15.4	26.3	14.3	20.0	24.4	5.6	7.0	8.0	8.4	6.6	10.6	16.3	13.5	11.9	7.4	17.3	26.9	19.6	9.7	7.1	11.8	7.2	16.4	4.3	25.2	8.3	21.7	10.5	9.7	11.7	23.1	35.9	10.2	10.9	13.0	8.5	7.2	12.8	24.0	8.5	16.6	7.7	13.8	16.2	18.0	6.4	16.0	19.0	24.5	10.5	15.9	8.3	11.1	3.7	15.7	14.8	6.6	12.1	3.0	7.8	39.6	17.3	17.9	12.1	9.5	16.4	22.6	14.3	23.2	14.6	36.9	28.3	5.1	9.4	13.7	25.1	19.8	20.3	10.8	19.1	26.3	10.8	11.1	20.0	20.4	13.7	15.4	26.9	5.8	19.4	14.3	10.7	16.5	8.7	13.8	10.6	6.2	18.1	8.5	11.8	15.6	6.0	19.5	51.4	11.9	12.9	17.4	2.8	7.6	1.4	2.3	7.0	25.5	11.4	3.3	21.3	1.1	20.3	9.5	0.0	21.5	19.5	14.6	12.3	31.1	9.5	33.0	11.1	20.8	18.4	49.7	0.0	17.8	29.5	18.6	25.2	27.7	10.8	38.4	20.1	15.6	5.8	20.1	25.8	9.8	4.8	8.6	12.9	8.5	145.4	26.3	10.1
ARHGEF11	"GTRAP48, KIAA0380, PDZ-RHOGEF"	ENSG00000132694	"Rho guanine nucleotide exchange factor 11"	O15085	1	156934840-157045370	"Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 47.5;Cone photoreceptor cells: 88.4;Rod photoreceptor cells: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"WM-115: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011026, HPA012037, HPA014658"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA011026: AB_1850426, HPA012037: AB_1850430, HPA014658: AB_1850428"	"unprognostic (2.19e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.94e-3)"	"unprognostic (3.30e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (3.38e-1)"	"unprognostic (2.41e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.73e-2)"	11.9	13.0	17.5	11.6	13.4	4.3	12.3	28.8	22.4	12.3	13.2	9.2	22.0	14.4	14.7	11.9	13.1	12.2	14.3	13.2	13.6	16.0	10.9	7.6	12.7	8.0	13.9	13.7	15.6	11.0	31.7	15.4	12.3	13.1	11.4	12.9	14.5	9.3	25.1	14.7	11.2	23.3	15.2	9.1	9.8	11.9	20.9	9.9	1.0	14.9	5.3	6.3	13.2	12.6	0.4	0.9	3.3	2.8	0.0	1.0	0.7	7.0	14.0	12.0	9.1	16.0	8.3	13.7	7.0	10.5	11.0	8.1	9.4	7.5	0.9	12.3	12.3	8.4	7.7	8.1	7.3	6.1	10.1	5.0	3.5	8.3	6.1	9.3	7.1	12.5	12.7	8.0	10.1	7.9	8.3	7.9	3.1	5.7	0.6	7.3	9.2	1.8	3.9	14.9	11.2	8.6	0.2	5.9	3.9	5.4	11.6	2.3	13.7	15.1	12.2	12.8	10.9	10.9	16.2	11.8	11.3	7.2	9.9	7.2	10.1	6.2	0.7	7.2	0.9	37.4	0.0	1.4	0.0	0.0	2.8	0.0	0.4	0.6	0.0	0.9	0.0	0.6	1.0	3.3	0.0	1.5	0.0	0.3	0.7	17.5	13.4	28.8	22.4	13.6	16.0	13.9	13.7	13.1	9.9	3.0	3.4	0.8	2.3	1.0	47.5	11.8	0.0	1.4	2.3	1.8	88.4	1.5	1.7	1.0	5.3	3.5	14.6	0.0	1.4	0.5	3.0	3.2	9.2	4.9	3.6	20.6	5.2	2.5	7.5	6.7	4.4	4.0	1.7	0.0	4.0	12.3	1.1	5.1	4.2	0.8	54.7	0.0	4.1	3.0	4.8	1.8	1.3	0.0	3.9	2.2
ARHGEF15	"ARGEF15, FLJ13791, KIAA0915, MGC44868, Vsm-RhoGEF"	ENSG00000198844	"Rho guanine nucleotide exchange factor 15"	O94989	17	8310241-8322516	"Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 47.3"	"Group enriched"	"Detected in some"	5	"Endothelial cells: 35.8;Ito cells: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	46	"HUVEC TERT2: 23.4;TIME: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA044443, HPA063495"			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA044443: AB_10960424, HPA063495: AB_2685023"	"unprognostic (3.02e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.18e-2)"	"unprognostic (7.09e-3)"	"unprognostic (3.82e-1)"	"unprognostic (7.29e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.23e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.89e-1)"	"unprognostic (9.56e-3)"	47.3	3.6	1.5	4.6	2.6	0.3	24.7	0.9	2.8	9.6	5.7	2.0	3.3	3.1	19.9	4.9	5.0	5.9	7.5	18.5	3.8	1.4	9.7	4.2	19.4	3.0	2.2	1.5	6.8	2.8	4.2	3.0	14.1	3.1	8.7	2.1	10.7	3.4	5.1	15.0	4.9	4.1	7.0	1.7	6.9	4.4	2.7	1.1	0.6	8.7	8.4	2.9	9.4	32.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.6	0.9	2.8	3.8	1.4	2.2	1.5	3.1	1.1	0.0	4.8	0.5	0.2	2.5	0.8	6.2	5.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	2.1	35.8	0.0	0.0	0.0	0.1	0.6	0.3	0.0	0.0	0.1	0.0	0.0	34.4	2.4	3.0	0.0	0.0	6.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.9	0.1	0.7	0.0	0.3
ARHGEF26	"DKFZP434D146, SGEF"	ENSG00000114790	"Rho guanine nucleotide exchange factor 26"	Q96DR7	3	154121003-154257827	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Alveolar cells type 1: 315.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 10.0;U-251 MG: 18.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017722, HPA049195"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA017722: AB_1856800, HPA049195: AB_2680671"	"unprognostic (1.41e-1)"	"unprognostic (1.43e-3)"	"unprognostic (3.55e-1)"	"unprognostic (7.99e-3)"	"unprognostic (2.82e-1)"	"unprognostic (9.42e-3)"	"prognostic favorable (9.74e-4)"	"unprognostic (7.06e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.01e-5)"	"unprognostic (1.44e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.53e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.24e-3)"	11.2	4.0	9.1	5.8	8.7	1.0	9.8	5.6	17.8	9.2	20.0	6.5	3.3	10.3	5.9	3.1	12.0	8.3	17.6	4.1	8.7	4.6	3.1	22.0	18.6	1.0	5.4	6.3	5.3	27.1	13.9	2.9	4.7	12.2	5.3	3.7	4.4	4.1	5.5	1.5	7.0	11.5	12.7	9.7	1.6	12.3	7.4	5.5	0.0	4.1	2.5	2.0	7.4	11.4	0.0	0.3	0.0	0.5	0.0	0.1	0.0	5.3	3.1	6.1	4.2	2.7	0.4	0.1	0.3	0.0	1.6	1.8	2.5	0.4	2.5	0.4	0.1	2.8	6.3	3.1	1.5	2.8	0.0	8.1	0.0	2.3	0.8	2.5	0.8	0.1	0.9	0.1	1.9	0.3	0.9	0.1	2.6	0.0	0.0	1.0	6.2	1.1	0.1	3.9	1.2	2.7	0.0	10.0	0.0	0.5	3.5	2.3	0.7	0.7	8.8	1.3	3.3	5.4	0.4	0.0	0.9	4.0	0.0	18.1	2.6	0.4	0.0	1.6	0.0	6.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.1	8.7	5.6	10.1	8.7	4.6	5.4	6.3	12.2	5.5	315.6	29.8	0.9	7.9	17.3	9.4	1.2	20.4	21.4	17.0	3.5	3.9	1.4	0.0	1.9	9.1	3.0	2.6	0.0	2.2	1.0	8.1	6.7	4.7	44.5	0.6	4.8	0.0	8.6	2.8	1.7	9.8	0.9	3.3	1.8	4.5	70.3	1.7	2.9	17.7	0.0	50.2	0.0	4.2	2.9	32.4	20.7	5.1	5.7	1.7	5.3
ARHGEF5	"GEF5, P60, TIM, TIM1"	ENSG00000050327	"Rho guanine nucleotide exchange factor 5"	Q12774	7	144355288-144380632	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 44.1;Paneth cells: 42.1;Urothelial cells: 36.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"B-cells: 3.1;granulocytes: 1.1;T-cells: 4.2"	"Cell line enhanced"	"Detected in many"		"A-431: 20.7;CAPAN-2: 14.1;hTCEpi: 15.6;WM-115: 15.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA020980, HPA029504, HPA044188, HPA045619, HPA045699"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA020980: AB_1845007, HPA029504: AB_10602231, HPA044188: AB_2678850, HPA045619: AB_2679393, HPA045699: AB_2679423"	"unprognostic (1.45e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.94e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.69e-2)"	"unprognostic (9.95e-3)"	"unprognostic (9.21e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (3.28e-7)"	"unprognostic (4.67e-2)"	"unprognostic (4.86e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.76e-2)"	2.3	1.0	1.2	5.2	1.8	0.9	7.6	1.2	1.2	4.6	7.7	1.2	7.4	8.5	3.4	7.8	16.6	2.5	8.4	1.3	1.2	0.4	9.0	6.7	4.8	3.2	1.2	1.2	3.0	8.8	7.7	4.3	14.3	2.6	6.6	4.6	4.0	17.7	9.4	1.2	21.1	16.7	2.2	1.7	2.4	6.5	1.4	1.2	1.5	11.6	10.0	4.5	3.4	6.9	3.1	0.2	1.1	0.1	0.0	4.2	0.4	20.7	2.0	0.0	0.0	0.0	0.0	7.1	2.2	1.5	1.0	1.3	7.0	14.1	0.0	6.8	0.9	1.7	9.7	0.8	9.6	1.0	0.0	2.9	0.0	3.2	1.1	2.3	0.0	0.0	3.6	15.6	0.7	7.2	3.2	0.2	0.0	0.0	0.0	0.9	8.6	0.0	0.0	4.5	9.3	3.8	0.8	0.0	0.2	11.5	7.1	0.0	0.0	8.8	8.6	3.7	2.6	5.3	1.3	0.2	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.7	0.0	15.3	0.0	0.0	0.0	0.8	0.1	1.3	1.8	2.7	2.1	0.1	3.1	2.7	0.7	1.1	0.0	0.0	0.2	4.2	0.4	1.2	1.8	1.2	1.2	1.2	0.4	1.2	1.2	2.6	1.2	6.0	15.0	0.8	31.5	16.5	0.0	1.1	7.6	18.7	12.5	21.0	3.9	9.2	5.0	12.2	1.3	0.8	44.1	0.0	14.5	11.9	2.3	16.5	0.0	5.9	1.5	0.0	9.2	1.3	0.0	0.4	1.4	0.0	5.0	0.0	15.4	3.4	19.5	42.1	1.4	3.4	2.4	0.0	1.6	0.4	0.9	14.6	11.9	0.5	15.6	36.6
ARL4C	"ARL7, LAK"	ENSG00000188042	"ADP ribosylation factor like GTPase 4C"	P56559	2	234493041-234497053	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 44.7"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 168.9;Kupffer cells: 128.2;T-cells: 193.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 38.6;RPTEC TERT1: 72.9;U-2197: 39.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028927	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA028927: AB_10602387"	"unprognostic (1.93e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.20e-3)"	"prognostic unfavorable (2.90e-7)"	"unprognostic (8.01e-3)"	"unprognostic (3.35e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (3.69e-8)"	"unprognostic (8.57e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (6.99e-5)"	9.3	6.8	11.1	17.7	9.6	30.3	12.8	19.2	21.2	6.4	6.2	4.9	3.1	3.9	3.6	9.4	13.9	7.6	19.2	3.6	9.1	16.5	8.5	7.9	9.9	28.9	9.4	11.8	2.6	3.6	0.8	5.4	16.8	23.9	6.7	7.4	5.9	14.2	3.6	1.7	15.1	8.1	3.6	5.3	28.0	7.9	1.9	1.8	44.7	2.5	4.4	20.1	14.0	10.8	5.9	17.8	18.7	0.5	18.2	29.7	8.7	7.2	22.5	2.9	0.3	2.6	0.8	7.5	0.7	3.4	0.9	1.6	10.4	14.3	0.0	1.9	1.9	27.4	5.5	2.9	15.6	1.0	6.7	1.0	0.0	0.1	0.1	2.7	0.0	0.6	1.6	10.4	8.8	5.4	38.6	1.5	19.2	0.0	24.2	4.1	1.0	21.0	0.0	3.0	5.4	5.1	0.0	13.0	4.1	72.9	8.1	10.6	1.9	0.2	1.7	1.1	4.8	0.2	0.4	3.3	14.6	5.6	39.9	14.0	12.1	4.4	0.3	25.1	0.0	7.6	18.7	0.4	8.4	29.7	0.5	29.2	5.9	20.7	23.5	3.2	5.7	18.7	20.9	0.7	18.2	0.2	17.8	25.8	8.7	11.1	9.6	19.2	21.2	9.1	16.5	9.4	11.8	23.9	1.8	68.5	22.3	38.9	97.5	110.8	168.9	8.1	50.9	6.7	44.3	14.0	7.9	25.6	0.0	15.7	7.5	16.9	0.2	0.0	4.9	3.3	28.8	51.3	25.6	3.0	29.0	101.7	1.7	9.8	128.2	4.2	0.3	83.9	40.5	43.3	0.0	30.9	11.5	0.0	0.0	1.0	10.8	0.0	16.0	0.4	0.8	37.5	12.2	193.9	0.4	46.5
ARRB2	"ARR2, BARR2, DKFZp686L0365"	ENSG00000141480	"Arrestin beta 2"	P32121	17	4710489-4721499	"Predicted intracellular proteins"	"Protein transport, Transport"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 102.8;lymphoid tissue: 66.6"	"Cell type enhanced"	"Detected in many"	11	"Hofbauer cells: 226.1;Kupffer cells: 213.1;Macrophages: 203.0;monocytes: 348.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 42.4;HMC-1: 71.5;NB-4: 43.0;U-937: 61.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075177			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA075177: "	"unprognostic (1.12e-1)"	"prognostic favorable (2.93e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.43e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.62e-3)"	"unprognostic (3.85e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.66e-3)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (1.32e-2)"	"unprognostic (8.61e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.88e-1)"	21.6	15.6	23.7	47.8	18.3	102.8	10.0	28.1	26.3	8.7	16.1	20.4	1.9	23.0	7.4	7.8	7.1	10.8	14.8	10.2	27.3	20.9	10.5	15.6	35.0	31.3	20.1	19.6	8.7	8.3	6.6	10.2	16.0	19.7	7.4	13.2	10.7	8.7	6.2	5.5	5.8	21.0	13.7	21.7	66.6	12.5	5.0	18.3	23.5	6.4	3.2	17.0	15.7	7.1	2.2	18.0	52.9	32.8	5.9	11.4	16.0	3.7	19.9	7.8	7.5	1.5	2.2	4.1	2.9	4.0	8.7	10.9	6.8	3.1	10.4	2.7	2.2	4.2	6.3	12.9	4.1	9.0	24.8	18.8	42.4	10.1	12.0	2.3	18.8	71.5	2.0	5.3	10.7	4.3	5.7	6.6	19.7	2.8	10.5	1.9	6.6	18.8	43.0	4.2	10.0	4.1	22.2	6.9	11.6	3.0	2.0	8.1	11.2	6.6	11.5	5.1	3.4	5.5	8.9	5.7	3.3	6.6	5.6	11.1	4.4	5.9	5.9	8.7	61.3	4.8	22.6	30.4	52.5	11.0	31.5	7.8	2.2	7.1	11.4	18.0	1.9	6.8	9.0	52.9	5.9	32.8	4.4	6.0	16.0	23.7	18.3	28.1	26.3	27.3	20.9	20.1	19.6	19.7	18.3	20.8	44.9	18.5	7.0	10.2	17.4	8.1	10.2	8.1	18.2	3.5	2.0	4.8	13.3	8.8	0.4	9.2	10.3	0.0	6.2	9.4	8.1	3.9	91.4	12.1	226.1	20.6	8.1	19.6	213.1	1.8	4.6	203.0	10.1	348.1	14.3	4.7	7.6	17.3	4.6	12.9	7.5	19.4	5.4	0.5	11.8	7.3	5.0	76.9	11.9	10.5
ARRDC4	FLJ36045	ENSG00000140450	"Arrestin domain containing 4"	Q8NCT1	15	97960698-97973838	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 67.3"	"Cell type enhanced"	"Detected in many"	4	"Paneth cells: 45.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 2.3;classical monocyte: 5.1;eosinophil: 3.1;intermediate monocyte: 3.6;myeloid DC: 2.4;neutrophil: 3.0"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.4;granulocytes: 3.1;monocytes: 5.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 19.1;BJ: 39.3;HSkMC: 22.2;hTCEpi: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039934, HPA042109"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA039934: , HPA042109: AB_10795606"	"unprognostic (2.13e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.32e-1)"	"unprognostic (5.60e-3)"	"unprognostic (4.49e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.78e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.02e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.77e-2)"	9.2	9.3	11.4	11.5	18.4	6.7	14.8	3.3	16.3	9.4	27.4	67.3	11.6	11.2	10.7	11.9	11.8	10.8	14.7	9.7	18.7	9.2	14.1	21.8	14.1	6.4	18.1	15.2	7.4	25.0	3.7	6.5	13.0	29.4	8.3	17.0	4.6	6.5	13.5	10.1	25.3	15.3	14.0	48.7	5.9	18.1	10.2	41.9	1.9	14.9	4.5	3.5	11.7	12.4	0.5	2.4	3.1	5.1	0.1	0.1	0.8	2.1	0.0	0.3	5.8	2.6	19.1	0.0	39.3	17.6	5.2	2.3	2.3	1.4	0.0	5.5	1.8	0.5	2.3	1.4	13.7	8.5	0.0	3.6	3.7	0.7	1.5	1.0	2.5	5.9	22.2	33.9	6.0	7.0	7.4	0.2	1.1	5.3	0.0	1.8	7.1	0.4	2.1	1.1	6.5	0.8	0.0	0.3	0.0	10.2	4.8	1.9	3.4	5.9	2.2	10.6	1.2	0.8	3.9	0.0	1.6	1.1	8.2	1.8	0.0	0.0	0.0	3.4	0.4	4.0	2.3	5.1	3.1	0.1	3.6	0.0	0.5	0.0	0.0	2.4	0.4	0.1	0.0	3.0	0.1	0.6	0.6	0.0	0.8	11.4	18.4	3.3	16.3	18.7	9.2	18.1	15.2	29.4	41.9	3.0	7.2	3.2	2.6	22.6	1.6	12.6	15.3	9.4	3.4	21.0	5.9	0.2	6.6	2.4	3.3	5.0	36.0	0.0	7.2	0.1	13.0	10.0	23.1	14.1	18.0	0.0	36.8	6.2	31.5	6.7	4.6	17.3	23.6	0.0	21.7	0.5	8.8	45.6	7.8	1.3	3.1	0.0	16.4	1.4	5.9	27.1	0.6	1.3	20.3	5.9
ASGR2	CLEC4H2	ENSG00000161944	"Asialoglycoprotein receptor 2"	P07307	17	7101322-7115700	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 154.1"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 660.0"	"Cancer enriched"	"Detected in many"	66	"liver cancer: 214.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"classical monocyte: 36.9;myeloid DC: 21.7"	"Group enriched"	"Detected in many"	52	"dendritic cells: 21.7;monocytes: 36.9"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 107.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014899, HPA015998"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA		4700000	"Endoplasmic reticulum, Plasma membrane"		"HPA014899: AB_1845085, HPA015998: AB_1845084"	"unprognostic (6.76e-2)"	"unprognostic (7.45e-7)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.35e-4)"	"unprognostic (1.54e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.31e-2)"	0.2	0.0	0.3	1.4	0.1	1.0	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.1	0.1	3.4	0.2	0.2	0.0	0.2	154.1	0.5	4.1	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.9	0.1	0.1	0.1	1.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.0	21.7	0.5	36.9	0.0	0.1	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	36.9	0.2	0.0	3.8	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.1	9.5	0.3	0.1	0.1	0.2	0.2	0.0	0.1	0.1	0.2	0.1	0.0	9.0	14.0	0.0	0.0	0.0	0.0	152.8	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.3	0.0	0.0	23.3	0.0	0.1	0.0	0.1	2.3	660.0	6.9	0.0	6.8	16.0	35.5	0.4	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.5	0.0	0.0
ASH2L	"ASH2, ASH2L1, ASH2L2, Bre2"	ENSG00000129691	"ASH2 like histone lysine methyltransferase complex subunit"	Q9UBL3	8	38105242-38144076	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 65.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042289	Approved		Supported	"Nucleoplasm,Plasma membrane"		Yes	No			Nucleoplasm	"Plasma membrane"	"HPA042289: AB_10795608"	"unprognostic (9.39e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.67e-3)"	"unprognostic (5.40e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.04e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.10e-2)"	"unprognostic (9.73e-3)"	"prognostic favorable (4.25e-4)"	"unprognostic (9.95e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.69e-3)"	"unprognostic (2.54e-1)"	22.3	17.0	24.2	16.7	26.7	24.0	19.7	26.1	28.2	20.9	20.0	21.9	14.7	14.5	20.8	16.1	21.6	18.2	19.6	20.6	21.0	23.4	21.0	20.6	16.0	21.4	20.3	26.8	24.1	30.1	28.3	13.9	24.3	23.1	19.4	20.9	16.0	18.1	20.0	31.8	18.8	23.0	21.8	20.1	20.3	18.8	41.7	16.0	36.2	19.5	15.3	24.1	20.1	17.4	12.6	17.0	33.9	16.6	16.6	13.2	11.4	14.1	7.5	12.6	12.6	9.1	11.4	16.2	14.4	15.2	18.2	16.1	8.0	6.4	16.0	12.3	12.1	9.1	8.5	16.2	8.1	17.3	6.2	7.3	65.0	8.0	16.9	13.2	10.5	13.2	9.8	7.7	8.4	9.4	9.2	14.2	15.0	43.5	12.4	17.7	8.2	27.7	13.1	16.4	12.6	4.8	11.5	14.0	6.9	9.4	10.7	5.8	10.4	10.7	7.0	11.6	13.1	8.5	12.3	11.1	11.3	11.4	16.0	11.4	11.8	14.8	14.2	11.5	13.7	15.5	18.2	13.9	33.9	11.1	16.6	11.8	12.5	12.5	13.1	17.0	12.6	13.2	12.1	11.8	16.6	15.0	9.7	13.0	11.4	24.2	26.7	26.1	28.2	21.0	23.4	20.3	26.8	23.1	16.0	11.9	18.6	12.7	7.9	6.2	12.1	15.3	10.2	25.4	17.0	12.2	9.8	31.2	6.6	17.1	6.6	11.3	10.6	0.0	25.1	31.4	12.7	5.3	18.5	10.2	20.4	6.4	10.4	13.5	18.9	11.2	21.6	14.8	21.9	29.7	10.5	14.8	16.9	7.0	19.4	13.2	14.9	12.9	9.5	30.1	32.2	5.9	25.9	15.0	11.4	6.5
ASIC1	"ACCN2, BNaC2, hBNaC2"	ENSG00000110881	"Acid sensing ion channel subunit 1"	P78348	12	50057548-50083611	"FDA approved drug targets, Predicted membrane proteins"	"Calcium transport, Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 43.7"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 3.1;Ciliated cells: 6.7;Club cells: 2.3;Horizontal cells: 3.2"	"Cancer enhanced"	"Detected in many"		"glioma: 12.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 23.0;SH-SY5Y: 17.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058870			Supported	"Golgi apparatus,Plasma membrane"		NA	NA			"Golgi apparatus, Plasma membrane"		"HPA058870: AB_2683841"	"unprognostic (5.32e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.48e-3)"	"unprognostic (2.92e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.86e-3)"	"unprognostic (6.97e-7)"	"unprognostic (7.19e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.78e-3)"	"unprognostic (8.27e-5)"	2.5	1.7	13.9	1.8	20.3	0.8	2.9	20.1	43.7	5.3	3.1	12.8	0.3	2.3	2.5	1.2	3.4	3.6	4.0	2.2	12.3	14.3	1.6	0.9	1.3	1.3	12.9	8.5	1.4	1.4	5.2	0.5	1.5	10.2	4.5	2.5	1.8	5.6	3.4	1.3	1.5	2.5	3.6	5.4	1.1	4.3	1.4	11.0	0.4	1.1	0.0	1.0	2.6	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	1.9	4.3	5.7	12.9	1.7	2.7	3.2	1.4	3.7	2.5	2.5	3.0	1.5	1.2	3.0	0.8	1.5	2.0	5.6	4.7	1.4	1.2	15.4	3.9	6.1	1.8	2.5	5.7	14.5	6.8	2.3	0.4	0.6	23.0	0.4	15.2	2.5	0.1	2.0	2.4	5.5	11.3	2.4	4.4	7.6	5.6	5.4	2.6	1.2	0.2	8.5	17.9	3.2	1.1	2.0	1.0	7.0	3.8	0.4	2.5	8.4	1.7	0.7	0.0	0.0	0.0	3.2	5.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.3	13.9	20.3	20.1	18.3	12.3	14.3	12.9	8.5	10.2	11.0	0.0	0.0	0.0	0.2	0.0	3.1	0.9	0.0	6.7	2.3	1.8	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.6	0.0	0.0	0.3	3.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.4	0.1	0.0	1.1	0.8	0.5	0.0	0.2	0.0	0.7	0.0	0.2	0.0	0.0	0.1
ATG3	"APG3L, DKFZp564M1178, FLJ22125, MGC15201, PC3-96"	ENSG00000144848	"Autophagy related 3"	Q9NT62	3	112532509-112562046	"Predicted intracellular proteins, Transporters"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Early spermatids: 501.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037260, HPA040471"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		26000	"Plasma membrane, Cytosol"		"CAB037260: AB_1078236, HPA040471: AB_2677000"	"unprognostic (2.77e-2)"	"prognostic favorable (6.82e-4)"	"unprognostic (4.90e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (9.35e-6)"	"unprognostic (6.79e-2)"	"unprognostic (6.67e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (7.52e-3)"	"unprognostic (4.66e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.25e-2)"	24.2	27.7	30.8	30.3	34.2	51.6	23.1	19.5	26.8	20.0	24.3	29.9	16.6	24.5	18.0	17.0	23.6	15.7	17.4	20.9	31.4	27.1	32.2	36.2	23.2	31.0	38.9	17.9	21.1	29.0	24.5	27.7	24.5	33.3	18.5	26.9	13.1	20.3	22.3	18.7	19.6	27.9	19.6	53.3	40.1	23.5	51.7	34.8	33.8	28.2	23.4	28.6	21.6	19.7	12.3	34.5	35.6	61.9	9.7	15.0	24.0	31.2	17.1	16.1	16.4	21.2	17.6	18.1	27.7	20.2	27.4	25.1	23.9	18.7	39.4	21.1	23.8	33.6	22.8	26.3	24.0	38.5	6.7	12.7	24.8	17.0	15.3	33.1	43.3	21.1	16.2	18.4	26.8	41.4	18.0	25.4	25.1	21.2	33.9	28.9	27.4	25.5	20.4	17.6	41.1	34.1	22.4	14.4	33.2	22.7	17.1	27.8	10.9	23.0	22.0	32.3	15.9	24.8	32.5	20.5	29.3	23.9	12.3	24.2	22.1	21.1	61.0	26.8	40.4	21.5	10.8	34.3	23.9	8.6	51.6	10.7	12.3	10.6	10.6	34.5	11.5	10.4	10.2	35.6	9.7	61.9	7.4	15.0	24.0	30.8	34.2	19.5	26.8	31.4	27.1	38.9	17.9	33.3	34.8	44.7	36.6	54.6	35.3	65.8	20.1	77.1	38.2	29.4	29.6	24.4	11.8	64.1	99.5	58.2	501.6	54.0	48.5	93.5	75.2	69.9	44.7	31.1	38.2	35.8	111.6	17.5	30.0	36.2	92.5	97.9	39.4	118.7	65.8	143.3	50.3	40.1	56.9	45.6	40.7	62.4	18.1	58.2	69.0	227.9	110.0	61.7	102.3	47.9	67.3	39.9
ATP10D	"ATPVD, KIAA1487"	ENSG00000145246	"ATPase phospholipid transporting 10D (putative)"	Q9P241	4	47485288-47593486	"Enzymes, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 55.7"	"Cell type enhanced"	"Detected in many"	11	"Leydig cells: 57.5;Syncytiotrophoblasts: 147.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"basophil: 31.5"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 31.5"	"Cell line enhanced"	"Detected in many"		"HAP1: 24.4"									HPA050808	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA050808: AB_2681242"	"unprognostic (1.62e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.05e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.43e-1)"	"prognostic favorable (5.00e-8)"	"unprognostic (3.97e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.37e-2)"	8.1	9.7	7.6	6.8	8.0	1.4	6.9	3.9	7.5	10.2	7.4	5.2	10.4	4.5	12.9	10.1	15.2	6.7	8.6	7.4	7.3	4.0	14.5	5.8	9.4	6.7	7.0	4.8	10.0	6.2	16.9	18.6	55.7	8.1	8.1	4.5	7.7	7.5	11.5	2.8	14.8	6.0	11.4	8.9	12.7	7.6	3.9	7.3	3.6	10.7	5.4	9.2	9.9	13.1	3.6	1.8	31.5	2.9	1.0	0.9	0.6	1.4	1.0	2.3	1.6	6.7	7.3	0.4	10.4	12.6	5.0	9.0	5.4	9.0	4.6	3.9	16.8	8.5	2.7	24.4	8.7	7.7	1.8	1.9	3.7	1.7	0.3	6.0	1.1	2.3	6.3	6.7	9.8	6.5	16.5	8.4	2.3	0.0	2.5	13.6	0.5	2.4	0.7	0.8	0.0	1.3	2.8	5.3	0.0	9.1	1.8	1.5	2.9	4.8	1.2	3.1	5.4	2.2	1.2	12.7	12.4	2.5	1.1	4.5	1.1	0.8	0.0	6.1	6.9	3.9	31.5	1.4	0.1	0.6	2.3	0.9	1.3	0.2	0.3	1.8	3.6	0.0	0.4	0.7	1.0	2.9	1.1	0.3	0.6	7.6	8.0	3.9	7.5	7.3	4.0	7.0	4.8	8.1	7.3	8.9	6.9	15.0	7.9	17.1	10.9	3.6	0.0	2.7	2.3	15.7	29.5	27.1	1.7	4.3	1.6	14.0	1.6	0.0	4.1	7.4	11.8	5.8	2.3	4.9	11.7	12.7	9.2	17.8	16.1	0.6	57.5	9.1	6.8	7.2	4.3	28.8	2.7	2.5	23.7	9.1	8.9	25.8	9.8	0.4	2.7	23.6	147.8	11.5	3.7	6.5
ATP1B3	"CD298, FLJ29027"	ENSG00000069849	"ATPase Na+/K+ transporting subunit beta 3"	P54709	3	141876124-141926514	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 712.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB020697, HPA048963"	Enhanced		Supported	"Plasma membrane"		NA	NA		100000	"Plasma membrane"		"CAB020697: , HPA048963: AB_2680574"	"unprognostic (2.31e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.75e-1)"	"prognostic favorable (5.19e-5)"	"unprognostic (2.60e-2)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (6.32e-6)"	"unprognostic (8.11e-3)"	"unprognostic (6.99e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.29e-5)"	"unprognostic (5.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.19e-3)"	"unprognostic (6.15e-2)"	50.5	79.9	12.7	26.3	23.3	17.5	105.9	25.7	35.1	17.7	48.2	9.1	16.8	37.3	17.9	14.6	36.9	20.0	47.8	44.0	16.0	18.9	24.9	7.7	44.9	43.4	21.3	12.8	34.7	11.5	6.3	33.8	32.6	43.3	20.5	58.1	23.9	18.4	24.8	7.4	85.4	57.3	24.3	28.4	16.5	13.5	21.1	13.6	14.5	15.6	41.4	18.4	21.9	31.5	10.4	26.8	13.6	60.9	7.8	20.0	22.5	46.4	28.9	27.2	25.5	73.0	21.3	62.3	54.5	49.6	39.7	45.0	44.9	23.4	37.9	49.3	41.4	57.5	102.0	26.9	26.0	45.2	20.6	34.2	33.1	32.5	29.1	28.9	27.2	26.0	22.5	62.3	31.1	30.1	28.4	42.3	26.6	22.7	33.7	40.6	21.1	27.6	45.6	37.8	64.7	13.9	38.0	20.4	38.6	33.3	35.9	22.4	15.3	71.2	33.1	73.1	49.4	25.2	33.2	29.4	34.9	13.4	52.1	31.7	25.1	32.3	61.1	45.5	29.6	28.6	13.6	27.1	8.9	19.2	44.5	14.1	10.4	15.6	20.0	26.8	7.5	9.2	16.7	1.9	7.8	60.9	16.4	16.9	22.5	12.7	23.3	25.7	35.1	16.0	18.9	21.3	12.8	43.3	13.6	53.6	46.5	109.5	333.7	437.8	35.4	16.7	20.4	10.7	43.3	209.3	23.6	255.9	34.9	71.5	391.5	178.3	384.3	140.2	52.8	199.5	109.5	121.1	129.2	6.0	276.1	23.8	53.9	79.8	137.2	712.2	78.6	209.3	210.9	518.4	67.0	42.5	54.6	123.0	64.3	29.8	25.4	122.9	189.2	42.4	191.3	362.3	327.4	66.0	109.6	362.4
ATP2B1	PMCA1	ENSG00000070961	"ATPase plasma membrane Ca2+ transporting 1"	P20020	12	89588049-89709300	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 53.8"	"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 311.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 59.7;LHCN-M2: 92.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005605, HPA011166, HPA012945"	Enhanced	Supported	Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB005605: AB_2061563, HPA011166: AB_1855484, HPA012945: AB_1855483"	"unprognostic (6.78e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.57e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (7.74e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.46e-2)"	"unprognostic (7.82e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-2)"	8.7	5.1	23.4	12.5	53.8	40.5	8.8	30.9	44.1	9.0	14.0	4.1	4.0	17.8	8.2	5.8	6.5	8.4	11.3	5.2	29.0	11.8	7.4	10.0	9.2	11.8	7.8	31.5	7.6	7.4	13.7	8.7	11.7	9.2	6.4	14.8	2.9	5.6	6.9	10.9	11.3	12.8	8.7	6.1	12.7	12.4	9.8	16.4	5.7	6.3	6.0	12.3	9.9	7.4	27.1	16.2	41.5	25.6	8.4	16.3	6.2	4.2	21.5	8.5	4.1	12.4	19.7	3.9	13.0	42.9	12.6	20.2	8.6	3.9	8.4	0.9	18.1	14.6	3.8	7.4	3.6	35.5	2.9	8.7	3.0	7.6	7.5	40.3	12.5	5.0	16.3	6.9	39.5	59.7	14.9	3.2	3.2	4.9	3.1	92.7	6.7	3.9	5.4	6.6	5.9	10.3	5.6	27.4	3.5	12.0	19.8	8.0	4.4	15.1	4.3	3.6	18.0	6.3	1.4	2.2	34.5	5.6	12.6	14.2	2.3	3.6	9.0	15.6	3.5	7.6	2.7	13.0	6.7	7.1	13.6	9.0	27.1	12.4	9.0	16.2	27.0	4.6	5.7	41.5	8.4	25.6	2.9	16.3	6.2	23.4	53.8	30.9	44.1	29.0	11.8	7.8	31.5	9.2	16.4	41.7	42.4	79.2	52.7	179.2	311.6	18.9	45.9	29.4	36.4	50.6	145.3	117.8	1.7	21.2	1.8	49.1	113.3	0.0	24.6	36.9	79.9	37.8	30.1	35.8	157.7	286.0	87.9	47.3	100.2	6.0	27.0	213.2	52.3	116.4	24.1	78.6	21.7	48.2	30.1	23.1	99.9	32.3	51.5	12.9	122.1	178.9	191.3	55.4	45.3	59.3
ATP2B4	"ATP2B2, MXRA1, PMCA4"	ENSG00000058668	"ATPase plasma membrane Ca2+ transporting 4"	P23634	1	203626561-203744081	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 153.7;Suprabasal keratinocytes: 132.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 59.5;fHDF/TERT166: 45.1;SuSa: 49.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016118, HPA040431"	Enhanced		Supported	"Plasma membrane"		NA	NA		21000	"Plasma membrane"		"CAB016118: AB_2061729, HPA040431: AB_2676980"	"unprognostic (7.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.23e-3)"	"unprognostic (8.68e-2)"	"unprognostic (3.81e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (3.52e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.56e-3)"	23.0	14.0	24.8	10.8	14.2	5.9	11.6	9.4	23.6	32.6	44.2	7.5	12.9	5.3	69.6	13.1	20.4	27.0	13.9	24.0	13.1	8.7	5.0	14.2	16.1	5.3	6.4	19.2	21.9	6.4	8.0	4.8	16.2	9.3	17.0	13.4	11.6	7.5	31.5	5.4	22.0	13.2	74.2	5.7	4.8	16.4	13.1	7.5	9.0	8.3	8.4	7.7	32.8	14.2	1.0	4.2	4.5	2.2	4.2	10.4	2.6	9.2	1.7	3.4	3.2	26.0	38.8	18.0	41.8	59.5	7.1	6.1	0.8	4.7	2.1	6.1	45.1	9.5	9.0	4.9	5.8	7.5	26.5	1.7	6.2	8.3	0.5	9.3	8.8	11.0	28.1	5.7	22.8	3.5	17.3	13.5	12.3	2.7	4.2	5.2	0.5	8.9	2.9	2.0	1.7	5.2	4.7	2.5	3.3	2.4	0.8	1.0	1.4	14.7	2.2	6.6	49.6	1.9	4.3	11.8	17.3	2.5	29.0	10.0	2.8	4.2	1.1	17.3	6.4	5.1	3.0	2.2	0.0	10.4	1.5	7.9	1.0	6.6	8.3	2.4	0.3	1.6	4.2	4.5	4.2	2.2	4.2	6.3	2.6	24.8	14.2	9.4	23.6	13.1	8.7	6.4	19.2	9.3	7.5	83.4	62.7	10.4	15.6	86.3	2.8	64.1	7.6	34.8	40.9	17.4	2.0	22.3	0.0	31.1	4.3	39.1	3.9	23.3	13.2	13.3	48.3	9.5	9.3	15.7	31.0	111.2	23.0	54.6	14.6	1.3	40.6	13.2	25.3	7.2	1.9	153.7	25.2	11.9	35.7	5.0	6.9	19.4	82.4	22.3	2.1	132.0	21.7	45.7	2.6	43.3
ATP8A2	"ATPIB, ML-1"	ENSG00000132932	"ATPase phospholipid transporting 8A2"	Q9NTI2	13	25372071-26025851	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 34.9;pituitary gland: 37.0;testis: 10.4"	"Cell type enhanced"	"Detected in many"	13	"Cone photoreceptor cells: 90.3;Early spermatids: 29.4;Rod photoreceptor cells: 86.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.3;naive CD8 T-cell: 3.3"	"Lineage enriched"	"Detected in single"	12	"T-cells: 3.3"	"Group enriched"	"Detected in some"	4	"HMC-1: 21.6;JURKAT: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039926, HPA040033"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA039926: AB_10794205, HPA040033: AB_2676809"	"unprognostic (3.79e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.95e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.66e-1)"	"unprognostic (4.96e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.20e-5)"	"unprognostic (9.10e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.22e-2)"	1.1	4.9	11.2	1.4	11.4	0.8	2.2	34.9	30.2	1.1	1.3	1.3	0.0	1.4	2.1	4.8	0.9	0.9	1.0	1.0	9.4	11.8	1.3	0.8	2.3	1.9	6.7	10.4	1.2	1.9	0.9	37.0	1.2	19.8	1.1	1.3	3.1	1.0	1.0	1.3	0.9	1.5	1.0	3.5	1.3	1.8	10.4	1.4	0.0	1.0	0.0	1.2	1.2	0.3	0.0	0.0	0.2	0.0	0.2	3.3	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	1.0	0.0	0.0	0.6	1.4	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	21.6	0.2	0.0	0.0	0.0	0.6	0.5	9.6	0.0	0.0	1.7	0.3	3.7	0.0	2.0	0.0	0.7	0.0	2.7	1.0	0.2	0.1	3.3	0.0	0.1	0.3	0.1	0.4	0.0	0.4	0.2	0.1	1.1	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.8	0.6	0.0	0.0	2.3	3.3	0.2	0.2	0.0	0.0	0.7	0.6	11.2	11.4	34.9	18.4	9.4	11.8	6.7	10.4	19.8	1.4	0.0	9.8	0.9	0.1	0.9	20.0	2.2	2.5	0.0	0.0	0.0	90.3	1.2	0.0	0.3	29.4	1.5	0.0	0.0	0.0	0.3	0.4	0.2	4.7	0.0	2.4	20.6	0.0	0.0	0.0	24.5	0.9	0.0	0.0	0.0	0.0	4.5	0.0	0.0	1.1	0.6	86.2	12.9	0.0	12.9	9.9	0.4	0.9	0.5	0.0	0.0
ATP8B1	"ATPIC, BRIC, FIC1, PFIC, PFIC1"	ENSG00000081923	"ATPase phospholipid transporting 8B1"	O43520	18	57646426-57803101	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hearing, Lipid transport, Transport"	Translocase	"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 21.3"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 198.4;Mucus-secreting cells: 179.9;Undifferentiated cells: 138.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 27.5;HBF TERT88: 24.7;RT4: 58.5"	"Low region specificity"	"Detected in many"							"HPA018673, HPA018674"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA018673: AB_1845207, HPA018674: AB_1845208"	"unprognostic (1.83e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (2.60e-4)"	"unprognostic (8.81e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.62e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.30e-3)"	"unprognostic (4.55e-3)"	"prognostic favorable (6.35e-4)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.60e-3)"	3.8	2.3	0.0	1.8	0.0	0.0	3.4	0.0	0.3	4.5	21.3			8.9	2.4	0.8	6.7	2.6	4.8	1.8	0.2	0.0	2.1	3.0	3.6	0.0	0.1		0.7	10.7	2.7	1.1	1.3		6.0	19.3		5.8	2.8	0.4	3.6	11.1	2.0	0.2	1.2	13.3	0.0			5.7		0.2	12.8	5.4	6.0	2.0	4.7	2.1	0.7	1.3	0.3	10.2	3.5	0.1	0.1	3.6	6.6	5.0	19.9	19.4	21.0	13.1	2.6	8.9	0.7	6.0	27.5	8.3	15.2	0.1	4.2	24.7	0.2	0.4	0.1	0.9	0.9	1.1	0.2	0.1	1.0	3.8	6.3	11.1	15.5	11.0	0.2	0.1	0.4	12.1	4.9	0.2	0.2	0.2	11.0	1.0	0.1	0.1	0.2	2.9	58.5	0.4	0.3	0.4	12.3	0.1	0.5	3.8	0.6	12.6	17.1	0.6	2.7	4.6	0.2	0.1	0.2	0.4	0.2	0.9	0.8	2.1	0.5	1.3	0.9	1.0	2.7	1.0	0.7	0.5	6.0	0.9	1.0	4.7	0.7	1.2	2.0	0.4	0.3											17.9	18.2	4.5	44.8	6.9	0.7	4.0	33.1	40.2	48.9	38.4	0.0	17.1	0.0	20.8	2.0	26.8	198.4	0.0	45.9	1.9	5.1	74.4	4.6	16.8	2.3	6.4	65.7	30.1	3.8	0.0	0.3	1.3	6.8	1.0	179.9	0.2	33.7	74.8	0.0	0.1	1.1	12.9	17.6	0.3	1.2	14.3	9.2	1.5	138.5	100.6
AXL	"ARK, JTK11, Tyro7, UFO"	ENSG00000167601	"AXL receptor tyrosine kinase"	P30530	19	41219203-41261766	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Differentiation, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Oncogene, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Kupffer cells: 104.4;Sertoli cells: 207.0;Smooth muscle cells: 341.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 8.8;plasmacytoid DC: 18.3"	"Group enriched"	"Detected in many"	14	"dendritic cells: 18.3;NK-cells: 8.8"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 67.0;U-251 MG: 71.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032501, HPA037422, HPA037423, HPA075217"	Uncertain		Supported	"Vesicles,Plasma membrane,Actin filaments"		NA	Yes	12100000	61000000	"Plasma membrane"	"Vesicles, Actin filaments"	"CAB032501: AB_2062572, HPA037422: AB_10672347, HPA037423: AB_2675470, HPA075217: "	"unprognostic (2.20e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.79e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.49e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.57e-3)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.53e-7)"	"unprognostic (1.16e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.83e-3)"	38.0	15.4	10.6	11.7	12.7	1.3	27.1	6.3	12.1	26.2	26.8	13.4	8.1	9.1	28.0	19.4	21.8	17.4	17.8	18.5	11.5	6.1	7.8	13.0	20.0	7.6	10.6	9.3	20.9	5.1	9.6	5.6	26.6	10.1	19.5	10.2	16.8	7.8	20.4	14.1	13.8	12.8	29.4	10.7	27.3	16.2	22.4	10.4	3.4	12.0	8.4	5.8	35.6	18.3	0.1	18.3	0.9	0.2	8.8	0.3	0.2	53.3	21.4	1.3	0.1	4.8	4.9	0.0	42.3	38.1	62.2	38.6	1.1	25.1	0.0	17.2	67.0	32.5	4.5	0.0	28.5	53.6	0.0	0.0	0.0	14.2	0.8	17.6	0.0	0.0	3.7	0.5	36.6	56.9	35.3	23.0	0.0	2.0	0.0	38.5	0.0	0.0	0.0	0.5	0.1	10.3	0.0	22.7	0.0	27.8	0.0	0.0	0.0	10.9	0.0	0.2	8.2	0.1	0.9	47.2	44.1	30.1	42.1	71.7	0.0	0.1	0.1	29.4	0.0	32.8	0.9	0.2	0.1	0.1	0.2	0.2	0.1	0.3	0.1	4.2	0.1	0.2	0.2	0.3	8.8	0.1	18.3	0.2	0.2	10.6	12.7	6.3	12.1	11.5	6.1	10.6	9.3	10.1	10.4	8.9	2.2	0.5	72.4	37.1	0.0	4.2	0.0	4.0	5.7	5.2	0.0	2.3	0.0	4.0	8.6	2.9	0.0	0.0	0.2	1.7	91.1	28.0	0.0	0.0	26.7	1.6	0.0	13.5	104.4	2.7	57.0	49.8	25.3	4.6	0.0	28.7	8.9	0.0	75.0	0.0	1.1	207.0	341.9	0.5	2.1	25.5	9.6	2.5	0.0	26.4
BACE1	BACE	ENSG00000186318	"Beta-secretase 1"	P56817	11	117285207-117316259	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"brain: 53.0;pancreas: 161.1"	"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 111.9;Early spermatids: 89.1;Late spermatids: 222.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB016358	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB016358: AB_626716"	"unprognostic (7.96e-3)"	"unprognostic (8.05e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.94e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.54e-2)"	"unprognostic (8.04e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (6.76e-4)"	6.5	7.1	12.1	3.8	18.8	2.2	5.5	9.6	22.4	9.8	4.6	42.5	2.7	3.4	9.3	5.6	7.6	8.6	9.1	5.9	16.9	12.4	6.8	12.1	7.3	2.8	28.8	15.0	11.4	161.1	12.8	4.2	6.3	26.4	6.5	4.7	6.9	5.3	9.9	6.2	7.2	3.6	11.7	53.0	5.7	4.9	4.1	21.4	0.0	6.3	2.3	2.8	6.7	5.5	4.0	2.2	0.7	3.2	2.2	6.7	1.1	3.9	4.7	9.7	14.8	32.2	34.7	0.4	21.3	18.6	10.4	8.5	3.6	6.3	0.8	5.2	38.6	7.8	6.9	10.3	6.1	8.5	2.3	5.5	2.4	7.9	4.3	15.9	0.8	0.5	30.0	9.6	13.2	12.9	25.7	8.9	1.4	0.8	0.4	19.0	14.3	0.6	1.9	6.3	4.1	10.4	1.8	4.4	0.8	4.4	2.2	12.6	14.1	7.9	1.0	2.3	8.9	10.2	2.7	12.2	18.7	2.0	19.5	6.8	0.3	0.3	0.4	8.8	1.2	13.0	0.6	2.0	0.7	2.0	3.2	5.2	4.0	6.7	5.3	2.2	1.8	3.1	2.7	0.0	2.2	1.3	1.3	6.3	1.1	12.1	18.8	9.6	21.7	16.9	12.4	28.8	15.0	26.4	21.4	17.9	8.5	0.0	3.8	4.1	53.4	8.1	17.8	4.0	20.5	5.2	111.9	0.8	5.0	4.7	89.1	5.2	1.5	0.0	17.3	0.9	11.5	2.8	2.3	31.6	7.9	54.0	20.8	6.7	12.6	222.6	17.8	5.8	3.3	1.8	2.4	16.6	5.8	4.0	20.8	5.4	48.1	6.5	6.6	3.2	1.7	3.0	0.7	1.0	2.7	2.5
BDKRB2	BK-2	ENSG00000168398	"Bradykinin receptor B2"	P30411	14	96204679-96244166	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 15.3;Ciliated cells: 13.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebellum: 13.5;pons and medulla: 5.7"	"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 22.8;BJ hTERT+: 41.8;U-87 MG: 18.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003551, HPA050841"	Approved		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	"Golgi apparatus, Vesicles"	"HPA003551: , HPA050841: AB_2681254"	"unprognostic (1.03e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.79e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.11e-2)"	"unprognostic (9.40e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.49e-2)"	9.0	1.2	1.5	3.7	1.0	0.0	4.7	13.5	1.1	12.2	9.0	1.3	4.4	5.6	8.5	12.7	14.9	5.1	21.1	4.3	0.8	0.7	12.1	0.7	2.2	0.4	0.9	0.3	4.7	6.8	0.9	1.1	2.9	5.7	6.9	9.2	0.9	3.1	11.3	2.7	4.0	10.3	11.3	1.3	0.4	4.2	3.2	0.0	0.6	3.6	13.9	4.4	16.7	13.5	0.0	0.9	0.0	0.0	0.0	1.2	0.0	0.7	2.7	0.0	4.9	7.4	22.8	0.0	2.4	41.8	1.4	1.7	0.1	4.6	0.0	0.1	3.8	1.6	6.5	0.0	1.0	1.2	0.5	0.0	0.0	0.5	0.0	3.6	0.0	0.0	6.9	3.3	4.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	8.8	0.0	0.0	1.0	0.0	1.4	0.0	1.5	0.5	0.8	6.9	0.0	1.0	0.4	0.0	0.0	0.1	0.1	1.4	0.0	0.1	0.0	0.0	18.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.5	1.0	13.5	1.1	0.8	0.7	0.9	0.3	5.7	0.0	3.0	1.9	0.0	0.5	8.1	0.0	0.5	15.3	13.4	9.1	8.7	0.0	0.5	6.6	10.2	0.0	4.2	8.9	0.0	3.5	1.9	6.1	0.8	0.0	0.0	0.2	0.0	6.8	3.1	0.0	0.0	0.9	0.6	5.0	0.0	5.0	0.0	4.5	4.5	1.1	0.0	0.0	0.0	2.0	0.0	0.0	5.1	3.3	0.0	0.7	2.4
BFSP1	"CP115, CP94, filensin, LIFL-H"	ENSG00000125864	"Beaded filament structural protein 1"	Q12934	20	17493905-17569220	"Disease related genes, Predicted intracellular proteins"		"Eye lens protein"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	6	"Ito cells: 3.7;Late spermatids: 4.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 6.1"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.5;T-cells: 6.1"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 10.0;RPTEC TERT1: 18.2;SK-BR-3: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA040748, HPA042038"	Enhanced		Supported	"Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"		"HPA040748: AB_10963786, HPA042038: AB_10964054"	"unprognostic (2.24e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.63e-1)"	"prognostic favorable (1.39e-4)"	"unprognostic (1.07e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.22e-6)"	"unprognostic (5.11e-2)"	"unprognostic (5.53e-1)"	"unprognostic (2.10e-4)"	"unprognostic (1.75e-1)"	"unprognostic (8.81e-2)"	"unprognostic (3.35e-4)"	"unprognostic (4.45e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.78e-2)"	"unprognostic (7.50e-2)"	2.5	1.8	3.5	2.5	5.6	0.8	2.6	2.8	4.4	3.5	1.8	0.9	5.5	0.8	10.7	5.4	5.1	2.2	4.8	2.4	3.2	3.7	6.1	1.1	4.1	0.6	3.3	1.7	5.3	2.7	4.8	1.3	4.5	3.0	3.3	1.2	2.3	2.0	4.0	3.0	1.8	0.9	2.7	6.9	0.8	1.1	8.0	0.7	0.6	5.3	2.3	1.5	5.1	1.1	0.0	0.0	0.7	0.0	1.5	6.1	0.5	0.7	7.4	2.4	0.3	0.6	2.5	0.4	1.8	8.7	1.2	1.1	3.3	6.4	0.0	1.5	1.0	4.7	1.1	2.6	1.4	1.0	1.6	2.0	0.5	1.0	1.0	1.4	0.4	0.8	2.9	4.6	0.7	2.1	10.0	5.2	0.5	0.2	0.4	3.9	1.4	0.0	1.0	5.6	4.7	2.0	0.0	1.7	0.4	18.2	1.3	2.5	0.3	2.1	9.8	3.8	1.2	4.7	1.6	5.9	0.3	0.6	0.6	1.7	0.0	0.1	0.0	1.3	0.0	1.5	0.1	0.0	0.0	6.1	0.0	0.2	0.0	1.7	1.0	0.0	0.0	0.1	0.5	0.7	1.5	0.0	0.0	0.0	0.5	3.5	5.6	2.8	4.4	3.2	3.7	3.3	1.7	3.0	0.7	3.0	1.7	0.0	0.4	0.8	0.2	1.1	2.5	1.4	0.0	0.0	0.0	0.8	1.7	0.7	0.7	2.1	0.0	0.0	0.8	1.5	0.6	0.3	0.0	0.0	0.4	0.0	0.0	3.7	0.0	4.7	1.7	0.0	1.7	0.0	0.0	1.0	0.7	0.0	0.0	0.2	0.0	0.0	0.9	0.7	1.6	0.6	0.3	0.0	0.2	0.5
BLNK	"BASH, bca, BLNK-s, Ly57, SLP-65, SLP65"	ENSG00000095585	"B cell linker"	Q8WV28	10	96191702-96271587	"Disease related genes, Predicted intracellular proteins"	"B-cell activation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 50.7;lymphoid tissue: 47.1"	"Cell type enhanced"	"Detected in many"	5	"B-cells: 42.3;Collecting duct cells: 38.4;Syncytiotrophoblasts: 34.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"memory B-cell: 35.9;naive B-cell: 31.0;plasmacytoid DC: 50.7"	"Group enriched"	"Detected in many"	117	"B-cells: 35.9;dendritic cells: 50.7"	"Group enriched"	"Detected in some"	6	"Daudi: 18.3;REH: 44.3;RPMI-8226: 24.4;U-698: 66.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009333, CAB016291, HPA038309, HPA038310"	Enhanced		Supported	"Plasma membrane,Cytoplasmic bodies"		NA	NA			"Plasma membrane, Cytoplasmic bodies"		"CAB009333: AB_2290422, CAB016291: AB_626752, HPA038309: AB_2675945, HPA038310: AB_2675946"	"unprognostic (4.86e-2)"	"unprognostic (6.05e-3)"	"unprognostic (1.00e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.08e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.23e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.46e-3)"	"prognostic favorable (2.67e-6)"	2.3	2.0	6.9	22.1	8.9	4.2	3.0	1.3	4.8	6.2	15.0	13.7	9.8	17.7	1.9	15.3	31.1	2.7	9.9	1.5	6.4	3.6	18.9	29.5	3.2	24.4	8.9	4.4	1.4	10.4	9.3	2.4	5.0	9.2	5.4	8.5	2.4	9.5	11.5	1.2	6.3	20.6	1.2	16.7	41.7	13.3	1.4	8.7	3.6	6.4	12.8	47.1	6.8	11.8	35.9	50.7	0.2	0.3	0.3	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.1	0.0	0.0	0.1	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	44.3	0.0	24.4	0.2	3.4	0.0	0.0	0.0	4.2	0.0	0.0	6.2	0.3	0.0	0.0	0.1	0.0	0.0	1.5	0.0	66.8	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	35.9	0.0	0.0	4.4	31.0	0.0	0.0	0.2	0.3	0.0	50.7	0.0	1.8	6.9	8.9	1.3	4.8	6.4	3.6	8.9	4.4	9.2	8.7	6.0	7.7	42.3	18.6	1.0	0.0	0.7	28.1	1.4	2.3	38.4	0.0	16.5	23.2	7.3	2.1	0.0	10.2	0.0	12.2	11.6	0.3	4.4	1.1	22.1	20.5	0.0	4.7	3.7	6.9	1.1	0.3	9.7	1.7	3.6	16.7	0.0	5.5	20.4	0.0	1.8	0.0	6.5	0.2	0.2	0.1	1.3	34.7	0.5	20.1	24.2
BMPR2	"BMPR-II, BMPR3, BRK-3, PPH1, T-ALK"	ENSG00000204217	"Bone morphogenetic protein receptor type 2"	Q13873	2	202376936-202567751	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017385, HPA049014"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA017385: AB_1845397, HPA049014: AB_2680599"	"unprognostic (2.17e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.21e-3)"	"unprognostic (9.20e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.40e-1)"	18.1	15.0	12.1	9.8	14.2	1.1	10.2	9.5	17.1	15.7	11.7	8.2	6.5	5.5	12.9	10.2	10.6	10.3	13.2	14.6	10.8	13.5	10.7	11.5	24.9	4.4	10.4	14.5	12.0	7.0	15.5	6.1	21.7	10.8	11.0	7.7	11.4	7.1	9.1	10.6	7.2	8.1	15.3	7.5	8.9	7.2	12.9	3.8	3.9	11.6	5.2	5.4	11.1	8.9	1.6	2.6	0.9	2.7	1.1	3.6	0.9	5.7	5.4	5.6	8.8	14.0	13.6	10.8	12.0	12.1	10.5	10.5	4.7	8.7	2.0	14.0	24.2	9.0	10.9	7.3	9.3	16.5	6.0	5.0	6.1	5.8	7.3	9.7	1.7	4.8	9.9	8.8	7.7	10.3	16.2	30.2	2.5	3.9	10.0	12.9	10.8	1.4	1.6	3.1	2.8	5.0	3.9	11.0	3.0	8.9	12.3	5.7	5.7	12.8	7.6	14.1	14.3	5.9	4.0	33.3	21.4	11.4	7.3	7.2	1.4	1.7	0.6	5.1	3.9	6.2	0.5	2.0	0.9	3.4	1.8	2.5	1.5	1.3	2.2	2.3	1.6	2.7	1.4	0.6	1.1	2.7	2.6	3.6	0.9	12.1	14.2	9.5	17.1	10.8	13.5	10.4	14.5	10.8	3.8	98.3	38.9	17.1	16.1	29.8	51.7	46.4	12.7	21.4	39.8	19.2	76.6	14.0	1.7	27.3	2.4	119.4	12.7	0.0	24.7	19.4	40.9	19.9	23.1	15.5	16.2	33.4	24.1	109.2	20.0	2.3	31.4	17.4	40.5	15.4	16.3	38.7	36.3	20.9	40.3	10.7	29.9	64.7	45.7	17.7	11.1	31.5	16.7	13.8	13.4	22.7
BMX	"ETK, PSCTK3"	ENSG00000102010	"BMX non-receptor tyrosine kinase"	P51813	X	15464246-15556529	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell adhesion, Stress response"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"epididymis: 57.1"	"Group enriched"	"Detected in some"	9	"Endothelial cells: 18.5;Ito cells: 51.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	17	"neutrophil: 10.5"	"Lineage enriched"	"Detected in single"	105	"granulocytes: 10.5"	"Cell line enriched"	"Detected in single"	121	"HUVEC TERT2: 90.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001048, CAB032495"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB032495: AB_2290760, HPA001048: AB_1078289"	"unprognostic (7.80e-2)"	"unprognostic (4.92e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.07e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.06e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.81e-2)"	8.2	0.3	0.1	1.0	0.7	3.6	5.4	0.1	0.3	2.2	5.5	0.1	4.6	2.4	2.6	57.1	1.5	2.5	2.6	10.5	0.5	0.0	0.2	0.9	3.7	6.5	0.4	0.0	1.4	0.9	0.2	0.6	2.6	0.7	2.2	1.4	0.5	1.5	0.6	4.2	1.6	5.5	2.2	0.4	2.4	1.5	1.9	0.1	0.2	2.2	1.1	0.8	2.8	2.4	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.1	0.3	0.5	0.0	0.4	0.0	0.7	0.1	0.0	1.4	0.0	0.5	0.3	0.0	1.2	0.0	1.4	0.0	1.8	0.0	0.0	0.0	0.0	0.0	18.5	0.0	0.0	0.2	0.0	0.5	0.4	0.0	0.2	0.1	0.0	4.1	51.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1
BOC	CDON2	ENSG00000144857	"BOC cell adhesion associated, oncogene regulated"	Q9BWV1	3	113211003-113287459	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	17	"Basal keratinocytes: 18.8;Leydig cells: 78.6;Peritubular cells: 44.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"memory B-cell: 1.3"	"Lineage enriched"	"Detected in single"	8	"B-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 31.2;ASC diff: 46.2;BJ hTERT+: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025806	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"	"Intracellular and membrane"	NA	No		4500000	"Nuclear bodies, Plasma membrane"	Nucleoplasm	"CAB025806: "	"unprognostic (6.89e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.03e-2)"	"unprognostic (5.03e-3)"	"prognostic favorable (4.89e-4)"	"unprognostic (8.66e-5)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.78e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.94e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.18e-5)"	19.4	4.8	5.3	10.4	8.1	0.4	21.6	4.2	6.0	26.6	23.8	5.4	10.6	3.9	25.8	25.3	19.6	33.2	14.5	20.3	13.3	2.9	4.7	1.0	3.6	3.6	5.5	2.2	26.1	12.0	1.9	12.5	1.9	26.2	21.2	3.9	45.6	17.9	17.4	4.6	25.7	9.6	35.2	36.7	3.5	11.8	9.2	7.6	1.2	13.4	12.9	4.9	28.4	25.0	1.3	0.1	0.0	0.0	0.0	0.1	0.3	0.0	2.9	11.0	31.2	46.2	2.4	0.3	5.0	16.5	1.2	1.1	0.0	0.0	0.0	3.1	8.4	0.7	0.0	2.2	1.0	0.4	0.0	1.3	0.0	1.0	0.0	0.2	0.1	0.1	8.0	0.7	0.7	0.1	10.3	0.0	0.0	0.0	0.0	0.2	0.8	0.1	0.5	2.8	0.0	2.7	0.0	4.9	0.0	0.3	0.0	3.3	4.7	0.0	0.2	0.1	3.4	1.3	0.1	0.0	1.8	2.9	0.0	1.6	0.0	0.0	0.0	3.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	5.3	8.1	4.2	6.0	13.3	2.9	5.5	2.2	26.2	7.6	0.0	0.3	0.0	2.3	18.8	0.4	0.8	0.0	0.0	1.2	5.2	0.0	4.4	0.0	0.0	1.3	3.3	0.0	0.0	0.0	4.0	12.4	2.8	0.0	0.0	0.7	0.0	1.7	2.5	0.0	1.1	78.6	0.9	10.1	0.0	0.0	14.1	0.5	0.0	44.9	0.0	0.5	0.0	8.3	1.1	3.0	9.7	1.6	0.0	0.0	0.3
BST2	"CD317, tetherin"	ENSG00000130303	"Bone marrow stromal cell antigen 2"	Q10589	19	17402939-17405648	"CD markers, Plasma proteins, Predicted membrane proteins"	"Antiviral defense, B-cell activation, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 101.0"	"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 338.9;Ito cells: 362.2;Leydig cells: 321.0;Peritubular cells: 394.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 79.0;Karpas-707: 76.6"									HPA017060	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Golgi apparatus, Plasma membrane, Cytosol"		"HPA017060: AB_1845467"	"prognostic favorable (6.69e-4)"	"unprognostic (1.75e-1)"	"unprognostic (8.42e-3)"	"unprognostic (8.93e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.25e-1)"	"unprognostic (6.46e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (3.56e-9)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.46e-2)"	29.6	72.2	8.4	31.1	9.8	13.6	27.9	2.5	7.6	14.4	12.0	5.6	24.8	6.9	13.4	36.7	8.6	26.8	30.1	13.9	7.9	4.9	24.7	30.8	44.9	16.6	10.0	5.2	101.0	6.9	0.3	8.6	31.5	8.8	15.6	4.8	8.4	11.4	17.5	6.0	3.2	14.0	11.3	9.0	32.9	12.3	8.5	9.4	10.3	10.3	5.9	12.3	14.0	42.4	26.2	74.1	35.8	66.4	57.9	32.6	54.5	39.6	0.0	0.1	18.3	0.0	0.1	6.3	0.1	3.1	58.6	79.0	18.6	35.8	30.8	43.3	24.4	1.8	0.1	26.7	2.9	1.8	33.9	0.2	0.4	64.3	18.1	33.6	14.5	39.0	0.1	0.0	19.4	0.0	0.5	14.9	0.7	17.5	76.6	0.0	10.9	6.9	25.4	20.1	0.0	51.4	12.9	0.1	64.2	13.9	0.1	0.0	0.1	40.5	1.5	48.8	1.6	30.7	20.5	0.1	0.2	1.4	0.0	0.4	39.6	51.6	20.4	0.1	57.4	0.2	35.8	61.6	21.0	32.6	66.4	30.8	21.0	27.5	30.2	50.7	26.2	22.5	25.6	20.3	57.9	59.3	74.1	24.8	54.5	8.4	9.8	2.5	7.6	7.9	4.9	10.0	5.2	8.8	9.4	53.6	16.5	81.0	13.1	29.5	0.0	4.5	50.9	14.7	38.7	47.1	0.0	7.1	31.5	19.8	9.9	239.7	1.6	0.0	1.0	55.9	84.0	7.2	225.9	155.9	338.9	0.0	1.2	362.2	153.7	4.5	321.0	191.2	70.9	239.0	1.4	1.3	2.2	3.5	394.2	0.7	1.9	161.7	150.2	1.4	1.2	22.8	11.0	126.9	2.6	30.3
BTK	"AGMX1, ATK, IMD1, PSCTK1, XLA"	ENSG00000010671	"Bruton tyrosine kinase"	Q06187	X	101349447-101390796	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Apoptosis, Immunity, Innate immunity, Transcription, Transcription regulation"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 77.5;lymphoid tissue: 37.0"	"Cell type enhanced"	"Detected in some"	19	"B-cells: 86.8;granulocytes: 203.6;Hofbauer cells: 50.3;Kupffer cells: 53.4;Macrophages: 53.0;monocytes: 52.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 77.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 29.5;HEL: 40.9;HMC-1: 147.5;U-937: 21.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001198, HPA002028, CAB016689"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		610000	"Plasma membrane, Cytosol"		"CAB016689: AB_1611894, HPA001198: AB_1078305, HPA002028: AB_1078306"	"unprognostic (3.19e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.06e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.76e-3)"	"unprognostic (6.55e-2)"	"unprognostic (3.58e-3)"	"unprognostic (6.02e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.08e-3)"	"unprognostic (7.80e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.14e-2)"	7.3	2.4	3.3	23.5	5.6	14.0	2.6	0.8	3.6	2.3	3.0	4.7	0.3	2.2	1.9	2.6	2.4	2.0	3.7	3.3	3.3	2.5	2.2	2.5	10.7	25.1	5.4	1.2	1.2	1.5	0.2	1.4	3.2	4.1	2.5	4.5	1.5	3.2	1.0	1.0	2.5	12.9	3.3	10.8	37.0	3.1	1.3	6.3	4.0	1.7	1.8	36.7	5.8	2.0	13.7	13.2	77.5	20.7	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.9	0.0	0.0	0.0	16.4	147.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.3	0.0	0.0	0.0	11.5	0.2	0.0	0.0	12.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.3	0.2	14.0	0.0	21.4	0.0	77.5	11.3	19.3	0.0	18.1	0.0	13.7	0.0	0.0	13.2	13.7	0.0	0.0	4.5	0.0	20.7	6.0	0.0	6.1	3.3	5.6	0.8	3.6	3.3	2.5	5.4	1.2	4.1	6.3	3.0	12.8	86.8	0.1	0.9	0.0	0.4	0.0	0.0	1.2	0.0	0.0	1.1	0.0	0.0	0.2	0.6	0.0	23.3	0.0	0.4	0.5	0.0	203.6	0.0	50.3	0.0	0.0	1.3	53.4	0.0	0.3	53.0	3.3	52.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.4	1.6	0.3	1.6	0.8	0.0	0.1
BVES	"HBVES, POP1, POPDC1"	ENSG00000112276	"Blood vessel epicardial substance"	Q8NE79	6	105096822-105137174	"Disease related genes, Predicted membrane proteins"	"Cell adhesion"	"Developmental protein"	"Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 29.3;skeletal muscle: 37.1"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 31.1;Early spermatids: 24.1;Late spermatids: 42.6;Sertoli cells: 12.9;Spermatocytes: 12.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.9"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.2;granulocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"RH-30: 18.7;WM-115: 18.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA014788, HPA018176"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		Yes	NA			"Plasma membrane, Cell Junctions"		"HPA014788: AB_1845504, HPA018176: AB_1845503"	"unprognostic (2.91e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.37e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.29e-2)"	"unprognostic (8.92e-2)"	"unprognostic (5.84e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.24e-4)"	2.9	1.0	2.3	2.4	7.6	0.6	8.9	0.7	4.1	2.6	11.5	6.7	6.7	1.7	5.3	2.8	5.3	2.5	2.1	29.3	2.8	2.5	1.5	0.7	2.3	0.9	10.4	1.3	1.2	1.0	0.8	3.5	3.5	6.1	5.4	3.5	3.6	1.6	10.0	37.1	0.8	2.7	19.4	10.7	0.7	5.9	10.0	6.3	0.0	1.6	8.6	0.8	10.3	8.6	0.5	1.2	2.9	0.3	0.4	0.4	0.1	0.8	1.2	4.8	0.8	7.0	9.7	2.1	3.6	2.5	5.6	7.4	0.3	0.0	0.0	0.0	6.7	9.3	0.0	2.0	1.2	5.2	0.0	1.7	0.0	0.6	0.2	1.5	0.0	0.4	5.6	4.3	8.6	0.7	4.2	2.4	2.0	0.1	12.1	12.2	0.1	0.1	0.6	1.0	0.0	0.0	3.4	18.7	0.0	0.0	0.0	6.2	10.8	2.3	0.0	4.8	3.6	0.0	12.2	5.5	8.9	0.0	0.0	9.3	1.1	0.5	0.0	5.3	0.0	18.8	2.9	0.3	0.3	0.2	0.1	0.2	0.3	0.2	0.4	0.0	0.5	0.3	0.3	1.7	0.4	0.1	1.2	0.1	0.1	2.3	7.6	0.7	4.1	2.8	2.5	10.4	1.3	6.1	6.3	0.0	0.0	0.0	0.2	0.2	0.0	31.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	1.9	0.0	0.0	0.0	0.1	1.5	0.6	0.0	0.0	1.7	0.0	0.0	2.5	0.0	42.6	1.1	0.5	0.0	1.8	0.0	0.0	0.2	0.0	3.2	0.0	0.0	12.9	3.9	12.5	5.1	0.6	0.1	0.0	0.0	0.1
CA9	"CAIX, MN"	ENSG00000107159	"Carbonic anhydrase 9"	Q16790	9	35673856-35681159	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"gallbladder: 70.4;pancreas: 47.4;stomach 1: 70.8"	"Cell type enhanced"	"Detected in some"	25	"Cholangiocytes: 53.5;Early spermatids: 178.0;Exocrine glandular cells: 46.4;Pancreatic endocrine cells: 33.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	10	"cerebellum: 7.3"	"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 40.0;HDLM-2: 20.8;hTERT-RPE1: 25.5;U-87 MG: 83.9"	"Region enriched"	"Detected in some"	4	"cerebellum: 13.8"	"Low region specificity"	"Detected in some"			"CAB005100, CAB017107, HPA055207"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"CAB005100: AB_2066539, CAB017107: , HPA055207: AB_2682738"	"unprognostic (8.01e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.71e-5)"	"unprognostic (1.47e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.22e-7)"	"unprognostic (7.29e-2)"	"prognostic favorable (9.50e-4)"	"unprognostic (2.97e-3)"	"unprognostic (8.67e-2)"	1.0	0.1	0.0	0.1	0.3	0.0	0.0	7.3	0.7	0.5	7.2	0.1	0.2	6.7	0.1	1.5	0.3	0.1	70.4	0.7	0.0	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.7	47.4	0.0	0.2	0.7	0.4	0.2	0.0	0.1	0.0	0.0	0.0	2.6	8.0	0.0	0.4	0.0	70.8	1.4	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	1.1	0.0	0.0	0.4	0.1	0.0	40.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.2	0.3	20.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	25.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.0	1.0	0.0	0.0	0.0	83.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.0	0.3	7.3	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	3.9	0.0	0.3	53.5	0.0	0.0	0.0	0.0	0.0	0.0	27.8	178.0	0.0	0.0	0.0	46.4	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	12.2	1.4	0.0	0.0	1.0	0.1	1.5	33.9	0.0	0.7	0.0	0.0	0.0	0.4	0.9	2.7	2.8	0.2	0.0	0.2	0.3
CALCRL	"CGRPR, CRLR"	ENSG00000064989	"Calcitonin receptor like receptor"	Q16602	2	187343129-187448460	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 91.0"	"Group enriched"	"Detected in many"	9	"Endothelial cells: 183.3;Ito cells: 192.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 3.3;myeloid DC: 11.2;plasmacytoid DC: 3.3"	"Group enriched"	"Detected in many"	6	"dendritic cells: 11.2;monocytes: 3.3"	"Cell line enriched"	"Detected in some"	4	"HUVEC TERT2: 62.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008070, HPA046515"	Uncertain		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA008070: AB_1845912, HPA046515: AB_2679681"	"unprognostic (7.06e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.44e-3)"	"unprognostic (7.60e-3)"	"unprognostic (9.25e-3)"	"unprognostic (4.14e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.32e-1)"	"unprognostic (3.77e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.50e-2)"	42.4	5.2	4.9	6.4	3.8	0.2	19.6	7.3	9.4	21.2	12.6	2.6	4.0	3.1	17.9	6.8	16.3	6.5	13.4	15.1	4.5	3.8	16.5	12.5	91.0	16.9	4.7	3.5	15.2	3.7	8.2	5.3	6.4	7.5	10.7	5.3	7.5	8.4	4.4	5.0	4.2	5.6	14.5	18.1	9.1	5.0	7.9	2.8	2.3	16.9	11.8	4.7	10.6	14.0	0.2	11.2	0.1	3.3	1.2	1.1	1.1	0.0	0.0	3.2	0.0	2.3	0.6	0.0	0.2	0.4	0.0	0.4	0.0	0.3	0.0	0.8	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.2	0.5	0.0	0.0	1.8	0.0	0.0	1.6	0.1	0.1	0.7	0.2	62.5	0.0	0.0	0.8	0.4	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.1	0.1	14.7	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	9.0	0.2	0.0	0.0	0.1	2.3	0.0	0.2	0.1	0.0	0.0	0.0	3.3	0.0	0.0	0.6	0.0	0.2	0.0	0.0	11.2	0.0	1.1	0.2	0.1	1.2	1.2	3.3	0.0	1.1	4.9	3.8	7.3	3.7	4.5	3.8	4.7	3.5	7.5	2.8	0.0	14.0	0.8	2.3	8.2	0.1	7.0	2.5	2.7	4.5	0.0	0.0	0.3	3.3	0.1	0.5	183.3	0.0	0.0	0.4	0.1	5.4	1.7	4.7	2.1	0.9	0.0	0.0	192.8	14.2	0.4	7.2	7.7	10.1	20.8	0.0	0.0	0.1	0.0	2.5	12.3	0.0	6.5	6.6	1.2	0.4	5.9	0.2	0.0	0.0	1.2
CAMK2B	"CAM2, CAMK2, CAMKB"	ENSG00000058404	"Calcium/calmodulin dependent protein kinase II beta"	Q13554	7	44217150-44334577	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.9;heart muscle: 39.2;skeletal muscle: 70.7"	"Cell type enriched"	"Detected in many"	11	"Bipolar cells: 838.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	8	"SCLC-21H: 42.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006849, HPA026307, HPA051783, HPA051785, HPA053973"	Enhanced	Supported	Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		680000	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB006849: , HPA026307: AB_1845941, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (1.88e-3)"	"unprognostic (4.49e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.23e-7)"	"unprognostic (7.04e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.95e-2)"	1.4	8.1	20.6	1.4	46.7	1.2	2.0	60.1	81.9	1.2	1.4	4.0	0.7	1.7	1.3	18.8	2.0	1.8	1.2	39.2	36.5	18.0	1.7	3.5	1.2	1.8	10.3	21.3	1.1	3.3	5.6	9.9	1.1	13.4	3.0	1.4	2.7	1.8	2.2	70.7	1.8	1.6	1.2	4.1	1.3	2.4	2.3	4.8	0.0	7.7	2.4	2.0	1.1	0.0	1.3	1.0	3.2	1.2	3.2	1.2	0.8	0.0	0.3	0.2	0.3	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.9	0.2	0.1	0.1	0.2	0.8	0.0	1.1	2.4	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.0	5.3	0.0	0.2	0.1	0.0	2.4	0.1	0.9	0.1	0.0	0.0	42.0	2.2	0.2	0.0	0.0	0.1	1.9	0.2	0.2	0.2	0.4	0.2	0.0	0.5	0.4	0.1	0.2	0.0	0.2	3.2	0.7	1.0	0.8	0.9	1.2	1.1	1.0	0.5	0.5	1.3	1.2	1.1	2.0	3.2	1.2	1.0	0.9	0.8	20.6	46.7	60.1	42.4	36.5	18.0	10.3	21.3	13.4	4.8	0.0	0.0	0.0	27.8	1.0	838.1	74.9	2.5	0.0	0.0	0.0	43.2	0.0	8.3	0.0	0.8	0.6	0.0	0.0	0.0	0.1	0.4	2.6	4.6	4.4	0.2	57.2	39.0	0.0	1.2	2.1	1.7	0.0	1.7	0.0	0.0	14.1	0.1	0.0	0.0	0.8	46.7	0.0	0.9	0.0	1.7	0.4	0.2	0.0	0.0	0.7
CASKIN2	"ANKS5B, FLJ21609, KIAA1139"	ENSG00000177303	"CASK interacting protein 2"	Q8WXE0	17	75500261-75515583	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Endothelial cells: 35.0;Ito cells: 55.9;Muller glia cells: 29.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071906, HPA075184"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA071906: AB_2732191, HPA075184: AB_2732281"	"unprognostic (1.60e-1)"	"unprognostic (4.54e-2)"	"unprognostic (9.12e-3)"	"unprognostic (5.27e-3)"	"unprognostic (9.32e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.10e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.47e-5)"	"unprognostic (1.82e-2)"	"prognostic favorable (4.83e-8)"	"unprognostic (1.43e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.95e-2)"	25.4	13.4	10.7	6.2	13.7	0.8	16.4	8.6	15.1	11.6	8.7	18.4	9.3	10.8	15.5	7.3	11.1	13.3	13.7	16.8	10.9	7.6	14.9	10.1	24.6	5.7	11.2	7.9	13.5	10.9	10.6	8.5	14.4	11.5	9.2	3.9	18.1	12.5	11.6	13.3	8.6	8.3	13.0	9.5	27.1	9.2	5.9	12.6	0.6	13.8	7.5	3.0	9.1	11.9	0.1	0.9	0.1	0.3	0.2	0.6	0.0	8.9	11.8	7.1	10.0	4.7	2.9	7.9	4.5	6.0	11.0	7.2	12.8	3.7	0.2	5.2	5.2	7.3	8.2	5.7	5.2	2.7	3.1	7.5	6.3	10.9	5.1	5.5	0.3	8.9	2.5	7.3	5.7	4.1	3.7	11.1	9.1	4.5	1.1	3.4	20.8	16.0	0.5	5.2	6.9	12.2	8.6	15.2	1.4	7.2	9.1	7.3	7.2	9.5	13.0	7.8	6.4	9.6	2.7	9.4	11.4	10.4	5.5	5.9	1.0	3.8	1.0	3.9	0.2	7.8	0.0	0.3	0.0	0.6	0.1	0.1	0.1	0.3	0.6	0.2	0.1	0.3	0.4	0.1	0.2	0.2	0.9	0.4	0.0	10.7	13.7	8.6	15.1	10.9	7.6	11.2	7.9	11.5	12.6	3.0	2.1	1.4	1.7	7.1	5.8	9.8	2.5	1.4	1.2	8.7	9.8	1.9	3.3	4.4	0.4	35.0	6.8	0.0	4.6	1.6	3.0	2.0	0.0	5.8	2.2	3.2	7.5	55.9	4.0	1.5	7.5	1.1	1.7	3.6	4.0	29.4	5.0	5.8	10.6	2.8	5.8	0.0	5.1	1.7	3.8	6.0	1.8	0.0	4.3	1.6
CAVIN1	"cavin-1, CGL4, PTRF"	ENSG00000177469	"Caveolae associated protein 1"	Q6NZI2	17	42402452-42423517	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transcription termination"	"RNA-binding, rRNA-binding"	"Congenital generalized lipodystrophy, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	20	"Alveolar cells type 1: 399.0;Alveolar cells type 2: 119.0;Club cells: 93.3;Cytotrophoblasts: 122.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 112.6;fHDF/TERT166: 80.4;TIME: 93.4;U-138 MG: 95.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049838, HPA074213"	Supported		Supported	"Vesicles,Plasma membrane"		NA	NA		29000	"Plasma membrane"	Vesicles	"HPA049838: AB_2680907, HPA074213: AB_2686674"	"unprognostic (1.59e-1)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (6.36e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.76e-3)"	"unprognostic (6.33e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (5.92e-4)"	"unprognostic (7.18e-3)"	"unprognostic (2.36e-1)"	"unprognostic (3.44e-3)"	"unprognostic (4.24e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.07e-3)"	"prognostic unfavorable (5.87e-4)"	105.6	12.7	4.7	26.4	5.4	0.7	111.2	4.5	7.6	68.6	52.0	15.3	31.9	7.1	65.6	45.6	60.3	37.1	74.0	37.3	6.4	4.6	12.1	6.6	47.0	15.6	7.7	6.1	57.8	6.8	7.5	6.9	47.7	13.6	51.8	12.4	34.0	17.4	53.8	45.4	28.6	18.6	115.4	14.7	23.9	27.0	24.3	5.2	3.3	30.4	47.9	12.6	80.6	57.9	0.9	0.6	2.7	0.5	0.7	1.2	0.2	31.2	26.8	0.5	7.1	36.3	43.8	0.7	112.6	49.0	45.0	35.7	13.5	2.0	0.0	22.6	80.4	18.5	51.8	4.8	33.7	36.9	0.1	0.9	13.7	16.4	6.5	23.0	0.0	0.1	30.0	12.5	35.4	12.1	24.1	60.7	0.0	9.3	0.1	19.2	0.5	0.7	0.1	2.6	4.8	0.1	0.0	18.0	0.0	19.2	0.1	0.0	0.2	37.8	0.6	9.0	15.8	3.1	0.2	93.4	95.7	45.0	34.2	40.8	0.0	0.0	0.1	28.4	0.0	10.7	2.7	0.5	0.3	0.5	0.4	0.3	0.3	1.2	0.3	0.2	0.9	0.6	0.3	2.3	0.7	0.4	0.6	0.3	0.2	4.7	5.4	4.5	7.6	6.4	4.6	7.7	6.1	13.6	5.2	399.0	119.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	93.3	22.7	0.0	122.7	3.3	43.9	0.0	0.0	0.0	0.0	3.9	8.9	0.0	0.0	58.1	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	65.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	64.5	0.0	0.0	0.0
CAVIN4	"cavin-4, MURC"	ENSG00000170681	"Caveolae associated protein 4"	Q5BKX8	9	100578079-100587906	"Predicted intracellular proteins"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skeletal muscle: 83.8;tongue: 52.4"	"Cell type enhanced"	"Detected in some"	13	"Cytotrophoblasts: 1.2;Pancreatic endocrine cells: 1.0"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 10.3;SCLC-21H: 15.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA020973, HPA020987, HPA021021"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Golgi apparatus, Plasma membrane"	Nucleoplasm	"HPA020973: AB_1853079, HPA020987: AB_1853080, HPA021021: AB_1853082"	"unprognostic (9.54e-5)"	"unprognostic (1.68e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.92e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.14e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.74e-8)"	"unprognostic (1.14e-1)"	"unprognostic (3.39e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.55e-3)"	3.5	0.0	0.3	0.1	0.6	0.0	0.0	0.5	0.3	0.1	0.1	0.0	0.0	0.0	0.2	2.7	1.9	0.0	0.1	16.4	0.5	0.3	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	2.8	0.0	83.8	0.1	0.0	0.1	0.7	0.0	0.1	1.4	0.0	0.1	0.2	52.4	1.6	0.0	0.0	0.4	0.3	1.4	0.4	0.7	0.7	0.0	0.5	0.4	7.4	2.7	1.6	2.4	5.3	1.3	1.0	1.0	1.2	0.0	0.5	0.3	0.3	0.6	2.6	0.3	3.5	0.1	2.1	1.7	2.5	0.0	1.2	0.0	0.5	0.3	0.4	5.9	0.3	1.0	0.6	1.8	1.3	1.8	0.2	0.3	4.6	0.1	2.0	0.3	10.3	1.1	0.8	3.0	6.9	0.0	0.8	0.4	15.8	4.2	0.2	0.3	1.4	5.0	0.2	0.2	1.3	1.8	1.5	1.3	1.1	0.4	1.3	0.7	2.0	0.1	1.3	0.6	0.3	0.2	0.5	0.4	0.2	0.2	0.7	0.5	0.1	0.4	0.5	0.5	1.4	0.7	0.3	0.3	0.2	0.0	0.3	0.6	0.5	0.3	0.5	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
CCBE1	"FLJ30681, KIAA1983"	ENSG00000183287	"Collagen and calcium binding EGF domains 1"	Q6UXH8	18	59430940-59697380	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis	"Developmental protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 28.0"	"Cell type enhanced"	"Detected in many"	15	"Horizontal cells: 14.3;Ito cells: 12.3;Rod photoreceptor cells: 42.0"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	4	"hippocampal formation: 10.0"	"Group enriched"	"Detected in some"	7	"basophil: 9.6;neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 9.6"	"Cell line enhanced"	"Detected in many"		"BJ: 26.8;BJ hTERT+: 27.5;BJ hTERT+ SV40 Large T+ RasG12V: 25.7;HBF TERT88: 30.8;hTERT-HME1: 41.8;LHCN-M2: 46.9;TIME: 25.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA041361, HPA041374"	Uncertain		Supported	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA			"Plasma membrane, Cytosol"		"HPA041361: AB_10796667, HPA041374: AB_10794515"	"unprognostic (3.09e-1)"	"unprognostic (5.01e-2)"	"unprognostic (9.54e-5)"	"unprognostic (1.66e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.68e-5)"	"unprognostic (2.31e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.62e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.02e-2)"	10.0	12.6	2.4	3.8	1.1	0.4	3.5	0.4	2.0	16.8	15.8	0.6	8.2	0.8	12.1	2.8	2.3	6.9	6.9	2.1	10.0	0.5	3.1	4.3	16.5	3.6	0.4	2.1	28.0	0.8	0.4	2.6	0.3	1.7	3.0	2.3	9.1	1.0	3.5	10.6	3.3	3.0	4.9	0.3	0.3	1.7	2.1	1.3	0.2	1.0	0.0	0.7	2.9	5.1	0.8	0.4	9.6	0.3	0.8	0.3	0.2	5.2	0.4	0.0	0.0	4.2	13.1	8.2	26.8	27.5	19.5	25.7	0.0	0.1	0.1	0.0	10.6	4.6	0.5	0.0	17.3	30.8	0.1	0.1	0.0	0.1	0.1	9.7	0.1	0.0	8.8	0.7	15.2	41.8	8.4	0.9	0.0	0.0	0.1	46.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.5	0.1	0.2	0.0	0.0	0.2	2.0	0.0	0.1	25.2	0.0	2.7	3.9	0.0	0.1	0.0	0.0	1.3	0.1	0.6	9.6	0.3	0.8	0.3	0.2	0.2	0.4	0.2	0.2	0.1	0.8	0.3	0.3	2.7	0.8	0.2	0.4	0.2	0.2	2.4	1.1	0.4	2.0	10.0	0.5	0.4	2.1	1.7	1.3	3.0	2.2	0.0	1.1	4.0	7.2	0.8	2.5	1.4	3.4	0.0	7.9	0.6	0.0	0.1	0.5	0.7	0.0	0.0	0.2	0.6	3.1	1.1	1.1	0.0	0.3	14.3	0.0	12.3	1.5	0.2	8.9	0.5	6.8	0.0	0.0	1.1	0.5	0.0	0.4	0.0	42.0	0.0	4.1	0.0	0.7	3.8	0.7	0.0	0.0	0.7
CCDC112	MGC39633	ENSG00000164221	"Coiled-coil domain containing 112"	Q8NEF3	5	115267188-115296831	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 40.4"	"Cell type enhanced"	"Detected in many"	12	"Spermatocytes: 227.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 50.4"	"Low region specificity"	"Detected in all"							"HPA045120, HPA050621"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted in male reproductive system"	NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA045120: AB_2679222, HPA050621: AB_2681191"	"unprognostic (1.88e-2)"	"unprognostic (5.10e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.60e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.32e-6)"	"unprognostic (4.30e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.41e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (1.51e-6)"	"unprognostic (7.00e-2)"	"unprognostic (2.79e-2)"	"unprognostic (8.61e-2)"	"unprognostic (4.10e-3)"	5.5	4.3	9.7	5.7	13.2	7.0	7.7	12.6	12.8	6.5	9.8	7.0	4.3	8.1	6.6	7.3	6.3	4.9	3.9	6.4	11.0	9.0	3.5	1.7	6.1	4.8	9.7	7.6	2.9	13.2	6.5	12.1	3.0	12.6	7.7	10.6	1.9	6.8	8.6	4.5	5.5	6.8	7.7	14.0	5.3	7.0	40.4	11.8	3.7	4.7	3.2	4.7	7.1	4.8	5.3	11.0	11.6	5.5	3.1	3.8	2.1	5.4	2.7	5.5	8.7	3.5	6.8	1.3	4.9	2.6	3.7	4.3	1.2	3.1	6.7	4.1	3.4	5.5	3.5	5.7	2.8	7.8	5.3	4.4	4.4	4.1	1.7	4.7	5.8	2.3	3.1	3.4	4.8	6.4	4.3	5.7	6.1	1.8	5.5	4.9	4.2	8.7	5.0	6.0	5.1	4.8	9.3	6.8	50.4	3.6	2.0	8.3	10.8	5.3	3.4	14.6	3.9	5.7	8.5	5.6	4.9	3.3	9.3	6.8	6.1	5.9	1.4	3.3	4.6	2.9	0.2	5.5	11.6	3.4	4.4	3.8	3.2	2.6	2.9	5.9	5.3	3.4	2.3	3.6	3.1	5.0	11.0	0.1	2.1	9.7	13.2	12.6	12.8	11.0	9.0	9.7	7.6	12.6	11.8	14.9	12.3	12.3	4.6	12.6	28.3	14.6	2.5	12.0	9.1	5.2	9.8	0.6	5.0	24.4	6.8	8.0	11.9	0.0	22.6	1.7	8.5	6.1	9.2	2.6	28.4	9.5	38.9	6.7	23.9	13.4	3.7	28.0	13.5	42.3	28.0	10.3	27.1	14.0	3.9	2.9	24.3	12.9	13.0	227.3	60.7	19.7	0.5	5.3	31.6	3.4
CCDC115	"ccp1, FLJ30131, MGC12981"	ENSG00000136710	"Coiled-coil domain containing 115"	Q96NT0	2	130338241-130342349	"Disease related genes, Predicted intracellular proteins"			"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034598	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA034598: AB_10601697"	"prognostic favorable (7.59e-4)"	"unprognostic (1.28e-2)"	"unprognostic (1.10e-3)"	"unprognostic (6.80e-3)"	"unprognostic (3.23e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.20e-2)"	"unprognostic (8.13e-3)"	"unprognostic (2.63e-1)"	"unprognostic (4.29e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.16e-2)"	18.7	18.4	25.1	14.7	25.9	17.2	21.5	23.4	39.8	27.1	22.3	24.6	17.9	18.1	22.3	28.9	24.2	25.6	19.9	15.0	25.2	24.1	24.9	14.9	21.8	22.6	26.1	22.5	36.1	24.0	25.3	17.1	23.2	28.1	21.3	17.2	19.1	23.8	25.4	9.4	26.5	19.1	17.7	24.1	19.5	16.9	13.0	16.8	17.1	25.3	14.2	28.4	20.3	20.1	34.0	32.8	51.5	56.2	26.7	34.4	38.7	12.7	6.8	8.3	5.3	16.9	17.9	10.5	6.6	16.1	13.3	15.4	15.0	28.4	16.8	22.7	10.2	7.7	13.4	7.0	11.0	10.5	20.1	12.7	12.2	3.8	18.6	14.3	13.9	24.3	15.3	26.1	8.3	4.8	13.7	13.7	14.9	12.0	14.1	15.9	12.2	21.3	23.0	11.4	7.2	17.3	17.1	9.4	14.1	11.6	12.3	9.4	14.5	8.6	15.2	14.7	6.3	15.1	15.0	11.0	7.5	8.1	12.0	5.0	7.7	8.1	15.9	13.9	13.5	8.8	36.8	33.1	51.5	29.7	45.3	26.6	33.8	32.1	31.7	32.8	34.0	30.9	28.8	11.4	26.7	56.2	25.8	34.4	38.7	25.1	25.9	23.4	39.8	25.2	24.1	26.1	22.5	28.1	16.8	17.9	21.2	46.9	40.9	46.0	24.7	9.8	25.5	21.4	25.0	73.3	9.8	63.5	89.5	38.6	1.0	26.9	31.9	0.0	37.4	30.0	32.8	14.5	53.0	17.4	55.9	22.3	26.6	25.8	41.5	3.0	39.4	47.9	50.6	125.4	31.4	38.4	24.8	48.7	49.1	53.6	21.3	45.3	33.9	5.8	20.6	61.2	22.1	52.4	39.6	21.0
CCR3	"CC-CKR-3, CD193, CKR3, CMKBR3"	ENSG00000183625	"C-C motif chemokine receptor 3"	P51677	3	46163604-46266706	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	25	"blood: 175.9"	"Cell type enhanced"	"Detected in some"	17	"granulocytes: 1.1;Melanocytes: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	22	"basophil: 175.9;eosinophil: 152.0"	"Lineage enriched"	"Detected in many"	92	"granulocytes: 175.9"	"Cell line enriched"	"Detected in some"	9	"RPMI-8226: 25.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB003795, HPA069514"	Uncertain		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB003795: AB_562259, HPA069514: "	"unprognostic (1.56e-2)"	"unprognostic (6.65e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.25e-3)"	"unprognostic (3.11e-7)"	"unprognostic (4.36e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.43e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.17e-6)"	"unprognostic (1.35e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.81e-2)"	0.6	0.2	0.3	2.9	1.1	0.4	0.3	0.2	0.8	0.3	1.3	0.2	0.2	2.9	0.8	0.2	0.4	0.5	1.3	0.3	0.2	0.2	0.5	1.2	5.8	0.6	0.3	0.2	0.2	0.3	0.0	0.3	7.0	0.7	1.0	1.4	0.9	2.4	0.2	3.2	3.6	5.1	1.6	0.5	2.7	2.2	0.4	0.2	0.6	1.8	2.8	0.6	4.0	0.3	0.0	0.2	175.9	0.0	0.0	1.9	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	2.3	0.0	0.7	0.0	0.8	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.1	0.3	0.1	0.0	0.0	0.2	0.0	25.5	0.0	2.1	0.1	0.0	0.0	0.7	0.0	0.8	0.0	0.6	0.0	0.1	0.2	0.0	0.1	2.8	2.2	0.0	0.0	0.5	0.0	175.9	0.0	152.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.2	1.9	0.3	0.3	1.1	0.2	0.8	0.2	0.2	0.3	0.2	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
CCR4	"CC-CKR-4, CD194, ChemR13, CKR4, CMKBR4, k5-5"	ENSG00000183813	"C-C motif chemokine receptor 4"	P51679	3	32951574-32956349	"CD markers, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"blood: 28.9;lymphoid tissue: 57.1"	"Cell type enhanced"	"Detected in some"	15	"Ciliated cells: 1.4;granulocytes: 2.3;Horizontal cells: 4.8;T-cells: 2.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"T-reg: 28.9"	"Lineage enriched"	"Detected in single"	48	"T-cells: 28.9"	"Cell line enriched"	"Detected in some"	17	"HDLM-2: 67.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA031613	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA031613: AB_10601096"	"unprognostic (4.63e-3)"	"unprognostic (8.70e-3)"	"unprognostic (2.82e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.18e-1)"	"unprognostic (4.59e-7)"	"unprognostic (3.02e-1)"	"unprognostic (5.05e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.88e-3)"	"unprognostic (2.04e-1)"	"unprognostic (5.53e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.40e-1)"	1.5	0.6	0.3	12.6	0.4	1.5	1.1	0.3	0.3	1.1	1.1	0.1	0.7	0.4	1.0	0.6	1.6	0.8	3.8	0.8	0.3	0.3	1.8	0.9	6.0	24.1	0.3	0.0	0.5	0.5	0.5	0.5	0.1	0.1	1.5	1.2	0.8	4.3	0.2	1.8	2.2	5.0	0.4	0.4	10.2	1.3	2.7	0.0	57.1	1.3	2.8	29.7	8.6	1.1	0.2	0.2	0.5	0.1	0.1	28.9	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	67.1	0.0	4.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.9	1.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.1	0.2	0.1	0.2	0.1	6.0	1.8	0.0	0.2	0.1	0.1	0.5	0.1	0.1	0.2	28.9	0.8	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.0	0.1	0.0	0.0	1.1	0.0	0.5	0.3	0.1	0.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.5	2.3	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	1.0	0.1	0.0	2.2	0.0	0.4
CD109	"CPAMD7, DKFZp762L1111, FLJ38569"	ENSG00000156535	"CD109 molecule"	Q6YHK3	6	73695785-73828316	"CD markers, Plasma proteins, Predicted membrane proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"parathyroid gland: 203.4"	"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 36.9;Endothelial cells: 28.0;Hofbauer cells: 36.5;Suprabasal keratinocytes: 38.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 62.8;BJ hTERT+: 38.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA008992, HPA015723"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		120000000	"Plasma membrane"	Cytosol	"HPA008992: , HPA015723: AB_2732415"	"unprognostic (2.28e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.17e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.23e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.15e-3)"	"unprognostic (8.81e-2)"	"prognostic unfavorable (2.65e-4)"	"prognostic unfavorable (7.96e-5)"	"unprognostic (9.50e-2)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (4.68e-4)"	27.4	1.5	1.6	1.9	2.2	1.9	6.5	0.4	1.9	15.0	7.1	3.4	2.0	1.5	22.5	8.5	22.4	3.4	2.4	8.2	1.8	1.4	3.5	1.4	14.5	1.4	1.7	1.4	2.8	1.2	203.4	0.6	5.0	3.0	7.1	2.1	0.6	4.2	2.2	4.1	12.4	2.4	12.6	4.5	1.7	1.5	3.3	2.8	6.3	1.7	16.8	4.7	8.7	8.0	0.3	2.6	1.4	0.4	0.6	0.4	0.3	9.4	8.5	0.5	0.0	12.9	62.8	0.0	8.6	38.5	2.8	6.2	0.0	5.5	0.0	5.3	17.7	6.2	26.6	0.9	17.2	3.8	2.6	1.5	3.3	6.9	1.4	2.7	0.0	0.0	17.3	13.7	5.3	21.5	9.9	20.3	1.0	0.0	0.0	12.9	0.2	0.2	0.0	0.6	0.0	5.5	0.7	2.4	11.6	1.2	1.1	0.0	0.0	19.5	0.1	8.4	0.4	0.2	1.5	18.8	26.9	3.7	4.8	7.4	0.1	5.3	0.0	10.8	0.0	23.8	0.6	0.4	0.3	0.2	0.2	0.1	0.2	0.3	0.2	2.6	0.3	0.4	0.2	1.4	0.6	0.2	1.4	0.1	0.3	1.6	2.2	0.4	1.9	1.8	1.4	1.7	1.4	3.0	2.8	3.0	1.7	0.8	6.2	36.9	0.3	11.1	0.0	2.7	12.5	0.0	0.0	0.3	1.7	0.1	18.2	28.0	0.0	0.0	0.0	0.4	7.8	5.8	2.3	0.4	36.5	0.0	0.0	19.0	2.8	17.2	0.6	15.3	21.9	4.6	0.0	0.0	0.3	0.0	0.0	15.9	0.1	0.0	14.6	0.7	3.2	38.1	1.1	2.2	0.0	6.4
CD163	"M130, MM130, SCARI1"	ENSG00000177575	"CD163 molecule"	Q86VB7	12	7470813-7503893	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Acute phase, Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 113.6"	"Cell type enriched"	"Detected in many"	7	"Kupffer cells: 1509.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"classical monocyte: 28.2;myeloid DC: 25.3"	"Group enriched"	"Detected in many"	40	"dendritic cells: 25.3;monocytes: 28.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.8;CACO-2: 1.7;GAMG: 5.4;HSkMC: 5.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"CAB002432, HPA046404, HPA051974"	Enhanced		Supported	"Plasma membrane"	"Secreted to blood"	NA	NA	903000000	1600000000	"Plasma membrane"		"CAB002432: AB_563510, HPA046404: AB_2679655, HPA051974: AB_2681678"	"unprognostic (1.13e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.72e-1)"	"unprognostic (6.17e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (1.04e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.20e-2)"	66.7	23.8	2.1	44.6	7.2	4.1	23.2	2.8	4.9	11.3	25.3	1.6	1.4	3.5	7.2	16.8	11.3	20.1	13.2	15.7	2.8	1.8	43.9	38.9	81.0	99.8	6.9	0.5	10.3	6.7	3.1	11.7	31.9	9.9	6.8	6.5	9.8	8.6	2.2	15.2	4.0	12.5	37.2	5.7	113.6	10.2	19.6	4.3	3.4	15.5	2.9	3.5	20.1	8.3	0.0	25.3	0.6	28.2	0.0	0.0	6.3	0.0	0.0	0.0	0.0	1.8	1.0	0.4	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	5.4	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.5	0.3	5.3	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.5	0.1	0.0	0.1	0.9	0.1	0.0	0.0	0.2	0.5	0.1	0.1	0.0	0.5	0.0	0.3	0.0	0.9	0.3	0.2	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.5	28.2	0.1	0.0	2.5	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	6.3	2.1	7.2	2.8	2.4	2.8	1.8	6.9	0.5	9.9	4.3	3.0	8.8	9.3	0.2	1.3	0.0	3.4	10.2	2.7	9.1	0.0	2.0	1.3	0.0	0.0	2.5	1.9	0.0	0.0	0.0	1.5	1.6	0.1	4.7	5.9	221.9	0.0	0.0	28.3	1509.4	3.9	4.6	104.2	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.0	0.1	116.4	0.3	3.9	1.7	0.9	2.5	5.0	0.0	0.0
CD200R1	"CD200R, HCRTR2, MOX2R, OX2R"	ENSG00000163606	"CD200 receptor 1"	Q8TD46	3	112921209-112975122	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 46.7;lymphoid tissue: 21.2"	"Cell type enhanced"	"Detected in some"	11	"Erythroid cells: 23.3;granulocytes: 14.0;Hofbauer cells: 24.1;Ito cells: 19.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 46.7;eosinophil: 12.7"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 46.7"	"Cell line enriched"	"Detected in some"	8	"HEL: 25.6"									HPA068512			Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		1500000	"Plasma membrane"		"HPA068512: AB_2732784"	"unprognostic (1.49e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.06e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.08e-5)"	"unprognostic (1.77e-1)"	"unprognostic (7.84e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.12e-3)"	3.6	1.6	1.0	9.5	1.4	1.8	3.8	0.8	1.4	5.0	3.5	0.3	1.5	2.0	3.9	5.4	7.5	1.3	2.7	5.8	1.0	1.2	1.4	3.4	4.3	9.0	1.0	0.0	1.0	1.1	0.5	1.0	7.8	0.4	4.2	3.5	2.4	2.5	1.6	0.9	3.4	3.3	1.7	0.9	21.2	1.7	2.5	0.5	15.8	2.0	3.9	17.0	3.8	2.0	2.3	5.8	46.7	0.8	0.6	3.7	1.3	0.6	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.2	25.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	1.2	0.0	46.7	0.8	12.7	1.0	0.4	1.8	2.3	3.7	2.1	5.8	1.2	3.6	1.7	0.2	0.6	0.1	0.1	1.0	1.3	1.0	1.4	0.8	1.4	1.0	1.2	1.0	0.0	0.4	0.5	0.0	1.4	2.9	0.1	1.6	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	23.3	0.0	0.1	1.3	0.0	14.0	0.0	24.1	0.0	0.0	19.6	4.7	0.0	0.0	3.6	5.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.2	0.6	0.6	7.5	0.0	0.1
CD226	"DNAM-1, DNAM1, PTA1, TLiSA1"	ENSG00000150637	"CD226 molecule"	Q15762	18	69831158-69961803	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 31.9;parathyroid gland: 82.5"	"Cell type enhanced"	"Detected in many"	10	"granulocytes: 12.8;Kupffer cells: 11.2;monocytes: 21.6;T-cells: 25.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"gdT-cell: 19.4;MAIT T-cell: 7.3;memory CD4 T-cell: 16.1;memory CD8 T-cell: 11.8;naive CD4 T-cell: 9.0;naive CD8 T-cell: 9.7;NK-cell: 14.0;T-reg: 5.5"	"Group enriched"	"Detected in many"	11	"NK-cells: 14.0;T-cells: 19.4"	"Group enriched"	"Detected in some"	6	"HEL: 45.3;HMC-1: 20.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA015715, HPA015865"	Supported		Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"		NA	No		27000000	"Plasma membrane"	"Nucleoplasm, Centriolar satellite"	"HPA015715: AB_1846278, HPA015865: "	"unprognostic (1.42e-4)"	"unprognostic (1.30e-3)"	"unprognostic (9.01e-3)"	"unprognostic (3.49e-5)"	"unprognostic (4.15e-1)"	"unprognostic (9.52e-4)"	"unprognostic (3.68e-3)"	"unprognostic (2.93e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.31e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.58e-2)"	1.2	0.6	1.0	7.5	2.0	1.7	0.8	0.7	0.9	1.5	2.9	0.3	0.1	1.1	1.0	1.4	0.8	0.8	1.4	0.9	1.9	1.3	1.3	3.1	5.2	14.0	1.7	0.0	1.0	0.6	82.5	2.4	0.6	1.3	0.9	1.2	2.4	5.4	0.6	1.1	0.4	6.0	1.3	4.2	31.9	1.4	1.8	0.5	6.4	1.8	2.6	10.1	2.0	1.6	0.4	1.5	0.9	0.6	14.0	19.4	6.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	2.4	0.0	45.3	0.1	0.0	0.0	0.3	20.2	0.0	0.5	0.1	0.3	0.0	0.0	0.4	0.1	4.7	0.2	0.0	0.3	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.0	0.1	5.5	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.5	19.4	0.4	7.3	0.4	16.1	11.8	1.5	0.1	9.0	9.7	0.9	14.0	0.6	0.1	5.5	6.6	1.0	2.0	0.7	0.9	1.9	1.3	1.7	0.0	1.3	0.5	3.0	5.1	0.8	0.3	0.0	2.4	1.6	0.0	2.7	1.2	0.0	0.0	0.1	0.0	0.0	6.6	0.1	0.0	0.0	0.3	0.0	0.4	0.2	12.8	0.5	1.4	0.0	0.0	2.5	11.2	7.5	0.9	7.8	0.0	21.6	0.0	1.4	0.2	0.0	0.7	0.0	3.7	0.0	0.3	0.3	0.5	0.4	0.0	25.4	0.0	0.1
CD274	"B7-H, B7-H1, B7H1, PD-L1, PDCD1LG1, PDL1"	ENSG00000120217	"CD274 molecule"	Q9NZQ7	9	5450503-5470566	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 23.9;placenta: 56.0"	"Cell type enhanced"	"Detected in many"	14	"granulocytes: 26.7;monocytes: 73.9;Syncytiotrophoblasts: 37.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 8.4"	"Group enriched"	"Detected in many"	6	"granulocytes: 8.4;T-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 34.2;HHSteC: 22.8;U-251 MG: 37.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003528, CAB076385"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA			"Plasma membrane, Actin filaments"	Nucleoplasm	"CAB076385: AB_2687655, HPA003528: "	"prognostic favorable (8.89e-4)"	"unprognostic (4.54e-2)"	"prognostic favorable (1.64e-5)"	"unprognostic (1.27e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.67e-4)"	"unprognostic (7.39e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.67e-1)"	"unprognostic (9.02e-2)"	3.4	2.1	1.7	10.8	3.2	1.4	2.2	2.5	3.3	2.0	2.3	2.5	2.8	2.6	1.7	2.4	3.0	1.9	4.3	9.5	1.4	3.7	3.0	3.6	23.9	6.4	2.3	0.7	1.7	2.7	3.8	7.4	56.0	3.2	2.9	2.2	3.3	1.7	1.6	4.3	1.3	2.7	2.3	2.4	12.8	1.9	1.2	1.0	11.6	3.7	2.1	5.8	3.1	1.9	0.9	0.0	8.4	0.1	0.4	2.4	0.7	5.9	0.1	0.0	0.2	0.0	0.0	0.0	11.9	10.1	3.0	4.2	0.0	1.9	0.0	0.2	0.3	1.5	0.2	0.0	5.2	9.9	34.2	0.0	3.4	0.1	0.0	22.8	0.0	0.0	0.2	0.0	6.3	9.3	3.1	5.9	0.3	0.0	1.1	9.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.7	0.3	0.6	0.1	0.0	0.1	0.1	0.9	0.7	0.9	0.0	0.1	10.9	6.5	2.0	0.2	37.9	0.2	0.1	0.1	2.1	0.1	0.0	8.4	0.1	0.3	1.2	0.1	2.1	0.9	2.4	1.8	0.0	0.2	1.3	0.7	5.7	0.4	0.0	0.0	1.1	0.7	1.7	3.2	2.5	3.3	1.4	3.7	2.3	0.7	3.2	1.0	11.9	10.7	0.5	1.2	4.0	1.4	6.5	0.0	4.0	3.4	0.0	0.0	4.9	0.0	6.4	0.2	6.3	0.8	0.0	3.7	20.2	1.9	0.9	26.7	1.0	4.9	0.0	0.0	10.4	1.9	0.0	0.3	7.7	3.3	73.9	0.1	0.6	12.0	0.0	0.4	0.4	0.1	0.0	0.9	0.5	0.7	2.3	37.2	1.3	0.2	2.2
CD2AP	CMS	ENSG00000198087	"CD2 associated protein"	Q9Y5K6	6	47477789-47627263	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 12.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003267, HPA003326, CAB004352"	Enhanced		Supported	"Plasma membrane,Centriolar satellite,Cytosol"		NA	NA		160000	"Plasma membrane"	"Centriolar satellite, Cytosol"	"CAB004352: AB_627009, HPA003267: AB_1078458, HPA003326: AB_1078457"	"unprognostic (5.98e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (5.53e-5)"	"unprognostic (2.21e-1)"	"unprognostic (3.09e-3)"	"unprognostic (6.12e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (7.57e-5)"	15.2	9.9	5.3	18.0	7.6	6.6	11.9	13.6	6.1	13.2	23.5	6.2	19.0	31.0	13.2	12.9	20.1	8.0	14.7	7.3	4.9	5.3	31.3	19.2	17.3	8.0	5.8	4.0	9.9	19.3	24.0	14.4	17.2	7.3	15.0	20.9	6.6	17.5	19.4	8.7	13.0	31.9	9.5	7.7	17.0	22.3	8.7	6.4	55.1	13.3	13.3	13.8	16.9	15.5	1.3	12.2	3.7	0.7	3.8	2.4	0.7	20.6	8.2	2.6	5.3	3.6	5.2	20.5	5.1	6.2	6.9	8.8	13.5	14.7	26.8	21.4	6.6	9.0	7.8	8.5	12.7	11.3	10.7	13.7	14.8	6.9	12.0	4.8	8.2	5.7	3.7	12.0	6.6	9.6	13.4	11.1	9.0	25.9	8.6	6.2	6.5	15.7	3.1	7.6	25.1	3.0	8.4	6.6	12.2	43.5	37.0	7.8	3.0	10.2	13.7	9.9	12.2	13.0	5.3	13.2	13.9	11.7	4.4	14.3	6.5	10.9	19.2	14.9	4.5	7.1	1.9	0.7	3.7	1.5	0.5	2.4	1.2	1.4	1.5	1.5	1.3	1.3	2.0	0.1	3.8	0.4	12.2	1.1	0.7	5.3	7.6	13.6	6.1	4.9	5.3	5.8	4.0	7.3	6.4	89.3	52.6	27.4	48.2	28.6	9.7	13.7	22.9	75.0	93.3	68.0	15.7	42.2	18.3	68.4	7.7	43.2	159.3	23.3	85.1	12.7	11.4	76.4	23.1	21.5	15.6	14.3	53.6	31.3	20.7	8.4	15.5	17.8	13.5	11.8	79.7	12.1	114.0	81.8	10.3	48.5	13.3	25.8	18.6	22.2	31.1	35.9	34.2	20.0	51.8	104.3
CD33	"FLJ00391, p67, SIGLEC-3, SIGLEC3"	ENSG00000105383	"CD33 molecule"	P20138	19	51225064-51243860	"CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 49.3;lymphoid tissue: 45.4"	"Group enriched"	"Detected in many"	7	"granulocytes: 73.9;Hofbauer cells: 67.4;Kupffer cells: 119.1;Macrophages: 56.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"classical monocyte: 37.6;intermediate monocyte: 27.3;myeloid DC: 49.3;non-classical monocyte: 12.6"	"Group enriched"	"Detected in many"	9	"dendritic cells: 49.3;monocytes: 37.6"	"Cell line enhanced"	"Detected in some"		"HEL: 28.5;HL-60: 37.9;HMC-1: 28.4;NB-4: 18.1;RPMI-8226: 20.5;THP-1: 22.2;U-937: 28.0"									"CAB011442, HPA035832, HPA064807"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		1400000	"Nucleoplasm, Plasma membrane"		"CAB011442: , HPA035832: AB_2674808, HPA064807: AB_2685356"	"unprognostic (1.18e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.80e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.59e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.28e-2)"	"unprognostic (6.88e-4)"	"unprognostic (7.79e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.67e-1)"	10.2	4.3	3.6	8.4	6.0	23.0	6.5	0.8	3.5	2.6	2.7	4.4	0.3	2.5	2.3	5.2	1.7	3.9	5.3	7.5	3.1	2.5	4.1	6.4	11.6	45.4	6.4	1.8	1.9	1.9	0.5	1.7	5.4	5.2	2.6	3.4	2.6	2.9	2.1	1.2	2.5	4.0	5.6	9.9	31.6	2.8	1.5	5.8	2.5	1.7	0.2	2.7	4.7	2.3	0.1	49.3	4.6	37.6	3.3	0.2	14.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	28.5	0.1	0.0	0.0	37.9	28.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.2	7.2	0.0	0.0	0.0	18.1	0.0	0.0	8.7	0.0	1.5	20.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	22.2	0.2	4.9	0.4	0.6	0.0	0.1	2.4	0.0	3.3	28.0	0.1	3.3	37.6	2.3	0.0	27.3	0.1	0.0	0.0	0.1	49.3	0.1	0.0	0.0	4.6	3.3	12.6	1.4	0.2	14.7	3.6	6.0	0.8	3.5	3.1	2.5	6.4	1.8	5.2	5.8	0.0	10.7	1.4	0.5	1.5	0.1	0.6	0.0	1.4	1.2	0.0	0.0	0.7	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.4	1.5	0.3	73.9	0.8	67.4	0.0	0.0	8.6	119.1	1.3	0.3	56.4	1.7	2.8	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.7	0.5	0.9	0.7	1.7	0.0	0.3
CD38		ENSG00000004468	"CD38 molecule"	P28907	4	15778275-15853230	"Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins"		"Hydrolase, Receptor, Transferase"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 94.9;seminal vesicle: 104.1"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 49.5;Erythroid cells: 46.7;granulocytes: 39.1;Kupffer cells: 31.1;T-cells: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 15.3"	"Group enriched"	"Detected in all"	4	"B-cells: 9.0;dendritic cells: 5.1;NK-cells: 15.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 50.8;Karpas-707: 14.2;MOLT-4: 12.8;REH: 10.3;U-266/70: 11.0;U-698: 9.6"	"Low region specificity"	"Detected in all"							"CAB002493, HPA022132, CAB025255, HPA052381"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB002493: AB_563556, CAB025255: , HPA022132: AB_1846300, HPA052381: AB_2681807"	"unprognostic (1.27e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.06e-2)"	"prognostic favorable (9.68e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.74e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.87e-2)"	"unprognostic (6.15e-6)"	"unprognostic (5.23e-1)"	"unprognostic (4.34e-1)"	"unprognostic (6.63e-6)"	"unprognostic (1.79e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.13e-1)"	4.1	3.3	3.8	17.6	8.5	9.3	2.6	0.7	12.0	1.0	3.2	10.4	14.6	4.3	0.7	0.9	2.3	2.4	1.5	5.0	4.0	4.2	1.2	5.4	4.7	16.1	4.9	3.1	0.6	0.7	0.0	2.5	0.6	3.1	10.8	2.7	4.4	2.8	104.1	14.2	0.5	6.2	0.9	1.8	20.6	2.0	0.7	2.5	94.9	2.8	2.0	13.2	7.6	0.9	9.0	5.1	1.3	2.2	15.3	2.3	3.7	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	50.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.1	14.2	0.0	0.0	12.8	3.1	0.0	0.0	0.0	10.3	0.0	8.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.0	2.2	0.2	0.0	0.0	0.0	0.0	11.0	0.1	9.6	0.1	2.4	0.1	0.0	1.7	0.0	1.1	2.2	0.3	9.0	1.4	1.2	4.1	6.6	2.3	1.8	1.3	15.3	1.4	5.1	2.1	3.7	3.8	8.5	0.7	6.2	4.0	4.2	4.9	3.1	3.1	2.5	3.0	10.8	23.4	0.4	0.0	0.0	0.8	0.0	49.5	18.2	0.0	9.8	0.2	0.0	0.0	1.6	0.1	0.0	46.7	0.0	0.0	0.5	10.7	39.1	1.3	4.6	0.0	0.0	3.1	31.1	0.0	0.0	10.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	2.2	1.4	0.0	0.5	30.5	0.7	0.1
CD3E		ENSG00000198851	"CD3e molecule"	P07766	11	118304545-118316175	"CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 294.2"	"Cell type enriched"	"Detected in some"	31	"T-cells: 377.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	36	"gdT-cell: 59.5;MAIT T-cell: 50.2;memory CD4 T-cell: 50.7;memory CD8 T-cell: 55.7;naive CD4 T-cell: 61.3;naive CD8 T-cell: 62.0;NK-cell: 21.8;T-reg: 46.8"	"Group enriched"	"Detected in many"	29	"NK-cells: 21.8;T-cells: 62.0"	"Group enriched"	"Detected in some"	67	"JURKAT: 80.1;MOLT-4: 108.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB000010, HPA040957, HPA043955, CAB072863, CAB072864"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA			"Endoplasmic reticulum, Plasma membrane"		"CAB000010: AB_2631163, CAB072863: AB_2665707, CAB072864: AB_2665708, HPA040957: AB_2677222, HPA043955: AB_2678747"	"prognostic favorable (1.72e-4)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.51e-2)"	"prognostic favorable (2.30e-6)"	"unprognostic (4.31e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (3.60e-3)"	"unprognostic (3.85e-2)"	"prognostic favorable (1.18e-4)"	"unprognostic (6.11e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (5.46e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.12e-2)"	3.9	1.0	0.5	16.7	0.7	6.8	1.9	0.5	0.7	2.1	4.7	0.9	0.7	4.4	2.0	1.4	3.3	3.0	4.0	1.4	0.5	0.5	3.3	2.6	7.3	40.9	1.3	0.6	1.5	1.3	0.0	0.9	1.2	0.9	2.6	3.9	1.9	6.4	1.1	0.8	1.3	21.1	1.1	1.9	34.5	4.6	1.2	0.5	294.2	3.4	2.1	37.8	6.3	3.0	0.2	0.9	1.4	0.2	21.8	62.0	32.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	80.1	0.1	0.3	0.0	0.0	108.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	1.4	0.0	0.1	0.0	1.3	0.2	0.2	59.5	0.1	50.2	0.1	50.7	55.7	0.1	0.2	61.3	62.0	1.4	21.8	0.2	0.9	46.8	32.9	0.5	0.7	0.5	0.7	0.5	0.5	1.3	0.6	0.9	0.5	0.0	11.3	4.5	0.3	4.6	0.0	0.2	0.0	0.0	1.2	1.8	0.0	0.0	0.0	0.1	6.5	0.2	0.0	0.0	0.0	0.0	1.0	0.1	7.0	0.8	0.3	0.0	0.0	12.3	7.3	0.0	0.0	2.5	11.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.5	0.0	0.0	4.6	0.2	377.3	0.2	0.3
CD3G		ENSG00000160654	"CD3g molecule"	P09693	11	118344344-118355161	"CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 187.6"	"Cell type enriched"	"Detected in some"	18	"T-cells: 153.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	30	"gdT-cell: 43.5;MAIT T-cell: 25.6;memory CD4 T-cell: 36.1;memory CD8 T-cell: 37.1;naive CD4 T-cell: 37.6;naive CD8 T-cell: 46.7;T-reg: 34.2"	"Lineage enriched"	"Detected in many"	37	"T-cells: 46.7"	"Group enriched"	"Detected in some"	53	"JURKAT: 24.1;MOLT-4: 64.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017520, HPA038494"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB017520: AB_831094, HPA038494: AB_2676044"	"prognostic favorable (6.33e-4)"	"prognostic favorable (2.61e-4)"	"unprognostic (4.58e-3)"	"unprognostic (3.12e-5)"	"unprognostic (6.30e-2)"	"prognostic favorable (3.00e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (9.33e-5)"	"unprognostic (1.60e-1)"	"unprognostic (2.37e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.10e-3)"	1.1	0.6	0.4	7.1	0.4	0.5	0.8	0.3	0.3	0.7	2.3	0.4	0.4	2.0	0.9	0.6	1.5	1.1	1.9	0.6	0.4	0.4	1.2	0.9	2.4	17.2	0.5	0.2	0.7	0.7	0.0	0.5	0.4	0.3	1.0	1.6	0.9	2.9	0.3	5.9	0.6	8.1	0.2	0.8	11.5	2.4	0.5	0.2	187.6	1.4	1.7	19.2	2.5	1.1	0.1	0.2	1.2	0.2	0.2	46.7	14.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	24.1	0.8	0.2	0.0	0.2	64.5	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.6	0.2	0.2	43.5	0.1	25.6	0.1	36.1	37.1	0.1	0.1	37.6	46.7	1.2	0.2	0.1	0.2	34.2	14.1	0.4	0.4	0.3	0.3	0.4	0.4	0.5	0.2	0.3	0.2	3.0	8.6	0.8	0.0	2.1	0.1	0.4	0.0	1.4	3.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	5.8	1.3	0.1	0.0	0.0	6.2	2.8	0.4	0.0	2.8	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.3	0.2	0.0	2.0	0.2	153.8	0.0	0.0
CD4		ENSG00000010610	"CD4 molecule"	P01730	12	6786858-6820808	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 111.5;parathyroid gland: 78.4"	"Cell type enhanced"	"Detected in many"	19	"Hofbauer cells: 121.3;Ito cells: 382.4;Kupffer cells: 192.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	17	"classical monocyte: 42.2;intermediate monocyte: 42.5;memory CD4 T-cell: 29.1;myeloid DC: 29.3;naive CD4 T-cell: 24.8;non-classical monocyte: 33.3;plasmacytoid DC: 46.7;T-reg: 26.4"	"Group enriched"	"Detected in many"	20	"dendritic cells: 46.7;monocytes: 42.5;T-cells: 29.1"	"Group enriched"	"Detected in some"	6	"HEL: 34.3;HL-60: 13.8;NB-4: 19.7;THP-1: 39.0;U-937: 36.7"	"Region enriched"	"Detected in single"	15	"basal ganglia: 41.4"	"Not detected"	"Not detected"			"CAB000011, HPA004252, HPA004472, CAB068180"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB000011: AB_442062, CAB068180: AB_2665653, HPA004252: AB_1078466, HPA004472: AB_1078465"	"unprognostic (1.39e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.75e-2)"	"prognostic favorable (2.16e-4)"	"unprognostic (7.76e-2)"	"unprognostic (4.82e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.74e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.65e-3)"	"unprognostic (9.08e-3)"	"unprognostic (2.95e-1)"	13.8	5.4	6.1	16.0	5.8	4.4	5.6	1.2	4.3	4.5	5.1	8.6	1.8	3.6	3.5	8.3	3.0	5.5	7.3	5.4	4.9	4.4	6.1	32.2	24.0	30.8	6.3	3.1	3.0	3.1	78.4	3.4	10.9	6.2	4.1	6.5	5.7	5.4	3.9	1.9	3.5	9.5	5.2	10.2	49.1	3.9	2.8	5.7	111.5	3.9	4.1	18.6	8.6	3.2	0.1	46.7	1.9	42.5	0.3	29.1	33.6	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	34.3	0.0	0.2	3.8	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	19.7	0.3	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	39.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.7	0.0	0.1	42.2	0.3	0.3	42.5	1.1	0.0	29.1	0.1	29.3	0.1	24.8	0.1	1.9	0.3	33.3	46.7	26.4	33.6	6.1	5.8	1.2	4.3	4.9	4.4	6.3	3.1	6.2	5.7	0.0	6.9	8.2	0.2	3.1	1.5	1.6	15.3	26.8	3.4	3.5	0.0	0.8	5.0	0.0	0.0	2.8	0.0	0.0	0.3	0.9	5.4	0.1	7.0	7.8	121.3	4.8	0.0	382.4	192.9	0.0	15.5	72.7	5.0	39.7	0.0	14.3	0.0	0.0	14.2	1.1	0.1	12.9	4.2	0.0	0.1	1.9	1.0	28.4	0.0	0.3
CD44	"CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1"	ENSG00000026508	"CD44 molecule (Indian blood group)"	P16070	11	35138870-35232402	"Blood group antigen proteins, Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Blood group antigen, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Basal keratinocytes: 888.0;Ductal cells: 858.7;Suprabasal keratinocytes: 895.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 139.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000112, CAB000316, HPA005785"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted - unknown location"	NA	NA		2400000000	"Plasma membrane"	"Golgi apparatus"	"CAB000112: , CAB000316: AB_2076596, HPA005785: AB_1078467"	"unprognostic (5.33e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.97e-2)"	"unprognostic (9.90e-3)"	"unprognostic (3.50e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.51e-3)"	"unprognostic (4.63e-2)"	"prognostic unfavorable (1.78e-8)"	"unprognostic (6.41e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.98e-2)"	45.5	9.0	10.5	42.5	21.7	53.0	35.6	4.7	13.4	43.2	19.5	26.3	8.3	10.6	80.5	20.3	66.5	18.6	48.0	11.7	14.9	9.3	12.4	9.1	43.4	48.4	31.5	6.1	12.8	83.9	0.8	3.8	19.4	40.7	30.1	24.5	30.2	148.2	22.4	15.9	107.7	18.9	44.5	100.5	30.9	19.9	7.2	20.3	17.9	20.6	53.9	53.7	55.0	54.2	22.7	41.0	19.1	65.2	54.6	53.1	59.9	39.7	35.9	0.3	0.0	21.7	60.0	0.1	77.9	60.9	43.4	24.2	2.4	12.5	0.0	10.4	110.3	89.3	68.5	0.8	84.7	59.6	8.5	0.4	1.4	17.7	0.0	21.4	20.2	93.5	27.0	66.8	58.3	47.4	139.4	15.1	0.0	0.3	13.0	41.6	0.2	1.8	13.3	0.7	0.7	10.6	0.1	7.4	0.6	63.6	11.5	0.1	0.1	14.7	0.4	35.2	3.4	2.1	1.2	43.5	54.1	9.8	66.3	80.0	22.5	24.3	0.2	82.1	11.4	78.6	19.1	65.2	6.0	26.2	45.7	37.0	22.7	39.8	34.9	41.0	16.2	34.5	28.7	16.4	54.6	59.3	14.2	53.1	59.9	10.5	21.7	4.7	13.4	14.9	9.3	31.5	6.1	40.7	20.3	89.3	339.9	168.9	263.7	888.0	0.0	4.0	25.5	18.7	135.4	19.2	2.0	4.0	1.7	858.7	30.1	53.0	5.0	23.3	741.5	3.7	143.9	293.1	733.4	2.5	234.7	0.0	96.2	20.3	427.0	13.8	20.8	611.7	573.6	514.0	84.8	26.6	787.6	8.6	0.4	0.6	1.6	155.2	254.2	0.4	0.4	895.8	15.0	244.8	66.1	304.0
CD47	"IAP, MER6, OA3"	ENSG00000196776	"CD47 molecule"	Q08722	3	108043094-108091862	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016055, HPA044659"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA		2000000	"Plasma membrane"	Vesicles	"CAB016055: AB_627086, HPA044659: AB_2679040"	"unprognostic (3.54e-2)"	"unprognostic (4.74e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (4.49e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.05e-3)"	"unprognostic (8.77e-3)"	"unprognostic (7.35e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (1.69e-4)"	"unprognostic (7.37e-2)"	"unprognostic (3.78e-1)"	"prognostic favorable (7.29e-5)"	"unprognostic (1.83e-1)"	16.2	24.3	23.0	28.8	46.5	58.0	29.0	44.0	55.5	20.5	25.7	42.5	13.4	19.8	16.2	30.4	46.7	31.7	26.0	26.7	24.1	24.4	19.1	22.1	49.6	35.1	27.4	28.8	16.2	25.7	11.5	34.8	23.3	43.6	40.2	29.0	15.7	43.8	18.9	18.1	19.3	21.2	21.0	37.7	29.0	33.4	20.6	25.0	34.4	30.1	22.0	42.5	25.1	29.1	40.1	35.6	44.1	64.4	45.1	65.3	51.7	45.7	8.2	16.6	9.4	23.8	25.6	21.9	17.3	27.1	13.5	23.1	0.4	25.9	21.0	28.1	16.6	31.0	31.4	9.2	17.5	17.6	12.4	6.3	53.5	7.7	0.7	13.8	38.1	72.3	16.4	10.7	12.9	10.4	21.0	13.3	21.8	12.6	50.0	20.0	23.5	46.3	14.3	6.9	42.7	21.0	24.6	12.2	29.7	34.2	18.3	12.6	7.8	10.3	20.5	17.5	8.8	37.1	12.5	12.8	35.0	6.4	19.6	11.7	19.4	13.1	29.5	25.5	19.1	9.6	31.7	24.7	44.1	40.2	48.1	35.0	40.1	47.0	42.0	35.6	39.2	35.4	38.3	30.1	45.1	64.4	27.7	65.3	51.7	23.0	46.5	44.0	55.5	24.1	24.4	27.4	28.8	43.6	25.0	342.4	135.6	141.2	259.6	146.8	90.6	37.8	109.5	58.9	102.4	89.0	90.3	137.8	13.3	418.5	33.5	71.3	35.8	23.3	357.7	75.9	79.2	245.6	56.6	30.2	163.7	116.0	61.4	82.9	78.2	40.6	31.7	105.3	111.3	90.2	60.0	47.2	337.0	107.2	45.6	11.9	214.8	64.7	72.9	25.2	13.2	122.5	101.4	137.1	79.7	264.1
CD48	"BCM1, BLAST, hCD48, mCD48, SLAMF2"	ENSG00000117091	"CD48 molecule"	P09326	1	160678746-160711851	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 81.3;lymphoid tissue: 86.3"	"Group enriched"	"Detected in many"	5	"B-cells: 233.4;granulocytes: 88.9;Hofbauer cells: 87.6;Kupffer cells: 195.5;Macrophages: 131.8;T-cells: 297.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 38.9;HMC-1: 43.5;U-266/70: 92.1;U-266/84: 61.5"									"CAB002497, HPA055146"	Enhanced		Supported	"Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		2600000	"Plasma membrane"	"Nucleoli fibrillar center, Cytosol"	"CAB002497: AB_563586, HPA055146: AB_2682716"	"prognostic favorable (3.91e-4)"	"unprognostic (1.72e-3)"	"prognostic favorable (4.17e-4)"	"unprognostic (1.58e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (3.21e-1)"	"unprognostic (4.69e-2)"	"unprognostic (9.38e-2)"	"unprognostic (8.51e-2)"	5.5	1.4	1.0	44.6	0.9	23.1	2.8	0.6	0.7	3.2	5.0	0.5	1.1	3.2	1.9	2.5	7.3	2.1	4.8	1.8	1.0	1.0	3.6	3.1	15.4	86.3	1.6	0.3	2.3	1.5	0.0	1.3	2.2	0.8	2.8	5.7	2.4	13.9	1.5	1.3	1.2	21.2	1.7	3.8	66.6	5.0	1.3	0.2	50.8	2.9	3.6	58.0	8.6	2.6	34.6	53.6	35.8	74.1	24.9	57.9	81.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	4.6	43.5	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	14.2	0.0	0.0	13.5	6.7	0.0	0.0	0.0	0.8	0.0	5.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	92.1	61.5	15.8	0.0	11.7	0.0	28.2	52.2	35.8	42.4	74.1	57.9	34.6	48.3	48.8	53.6	27.9	49.7	52.5	13.4	24.9	73.5	9.4	36.4	81.3	1.0	0.9	0.6	0.7	1.0	1.0	1.6	0.3	0.8	0.2	0.0	14.8	233.4	0.5	4.8	0.0	0.8	5.1	4.0	2.3	3.5	0.0	0.7	1.7	0.1	0.0	0.7	0.0	23.3	0.2	0.7	3.1	0.2	88.9	1.8	87.6	0.0	1.2	8.6	195.5	0.4	1.7	131.8	37.1	8.2	0.0	0.0	0.1	0.0	0.4	1.5	0.0	0.0	0.7	0.4	0.1	2.6	0.3	297.5	0.0	0.3
CD79B	"B29, IGB"	ENSG00000007312	"CD79b molecule"	P40259	17	63928740-63932354	"Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 138.8;lymphoid tissue: 56.6"	"Cell type enriched"	"Detected in many"	8	"B-cells: 486.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory B-cell: 100.6;naive B-cell: 138.8"	"Lineage enriched"	"Detected in many"	6	"B-cells: 138.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 117.7;REH: 38.7;U-698: 161.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009178, CAB009751, HPA044107"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"CAB009751: AB_2275844, HPA009178: AB_1078483, HPA044107: "	"unprognostic (3.90e-3)"	"unprognostic (1.61e-3)"	"unprognostic (5.21e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.22e-3)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.82e-1)"	"unprognostic (9.25e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.28e-2)"	"unprognostic (2.75e-1)"	1.7	0.7	0.4	50.6	0.4	11.1	1.2	0.3	0.4	0.6	1.7	0.3	0.3	0.7	0.6	0.5	2.6	0.6	1.4	3.4	0.4	0.2	2.3	1.7	1.3	56.6	0.4	0.3	0.6	1.6	0.0	9.0	0.5	0.3	1.0	1.3	0.8	8.9	0.9	1.2	0.9	22.4	0.5	0.4	56.0	1.8	0.6	0.3	3.7	1.4	1.7	46.6	4.5	0.9	138.8	4.2	0.5	25.0	3.4	9.2	9.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	117.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	6.5	0.0	0.0	0.0	2.5	0.0	0.0	0.0	38.7	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	1.8	0.1	0.0	0.4	0.0	0.0	5.9	5.7	161.1	0.0	0.2	0.0	0.5	1.1	0.0	4.2	16.5	4.8	100.6	5.4	2.8	4.2	138.8	3.7	2.2	0.5	3.4	25.0	0.6	9.2	9.0	0.4	0.4	0.3	0.4	0.4	0.2	0.4	0.3	0.3	0.3	0.0	2.2	486.9	0.3	3.9	0.0	0.8	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	7.1	0.0	23.3	0.0	0.4	4.3	0.3	15.0	0.5	4.7	0.0	1.2	62.0	14.1	1.1	1.1	3.5	20.3	1.0	0.0	0.0	0.0	0.0	1.8	0.8	0.0	0.0	3.3	0.7	0.1	2.8	0.3	34.6	0.0	0.1
CD81	"TAPA-1, TAPA1, TSPAN28"	ENSG00000110651	"CD81 molecule"	P60033	11	2376177-2397419	"CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Muller glia cells: 752.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 41.4;naive B-cell: 37.6"	"Lineage enriched"	"Detected in all"	4	"B-cells: 41.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 236.1;ASC TERT1: 134.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002507, HPA007234"	Supported		Supported	"Plasma membrane"		NA	NA		1900000	"Plasma membrane"		"CAB002507: AB_563639, HPA007234: AB_1846333"	"unprognostic (2.96e-1)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (7.56e-4)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (8.21e-5)"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (3.86e-4)"	"unprognostic (3.07e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.06e-1)"	102.5	43.7	52.8	40.1	57.0	9.6	79.3	31.7	63.2	124.7	88.9	75.8	261.4	21.1	143.5	141.5	56.8	123.1	86.8	101.2	46.6	52.8	65.5	123.9	107.4	82.4	70.4	51.3	77.9	62.4	41.4	42.9	61.2	63.0	89.3	34.0	46.6	59.7	263.3	22.6	59.6	39.7	138.9	59.3	64.5	52.1	57.6	53.3	25.3	66.3	38.5	37.9	93.5	80.2	41.4	2.1	5.7	1.8	3.5	9.9	2.7	25.0	26.1	20.9	31.9	236.1	134.3	17.5	47.4	105.1	38.4	38.8	24.4	0.1	21.4	17.1	132.9	24.5	33.0	12.9	33.7	15.8	10.1	39.7	3.2	9.9	0.0	78.1	13.9	28.2	97.5	48.3	15.6	23.8	59.6	36.7	15.6	14.6	37.6	53.6	19.2	11.7	17.7	25.1	22.9	21.1	24.2	10.5	13.6	41.2	16.9	22.6	25.0	15.1	39.8	28.6	17.5	13.2	25.4	48.8	19.6	14.4	36.6	16.2	27.9	6.3	39.1	28.4	8.3	33.4	0.2	0.9	5.7	6.0	1.4	9.9	41.4	4.3	9.4	0.6	37.6	2.6	5.0	0.3	3.5	1.8	2.1	3.0	2.7	52.8	57.0	31.7	63.2	46.6	52.8	70.4	51.3	63.0	53.3	226.3	220.8	55.9	245.9	159.7	80.4	246.3	147.7	72.3	130.8	197.1	25.5	19.0	29.9	103.9	13.1	213.4	6.4	46.7	46.5	23.9	217.2	129.6	79.7	450.6	229.2	139.8	69.1	262.8	169.7	26.3	360.5	166.2	143.4	23.4	40.0	752.2	58.2	11.5	236.2	26.2	63.6	116.4	236.9	12.0	13.4	144.2	16.8	56.5	36.6	204.6
CD86	"B7-2, B7.2, CD28LG2"	ENSG00000114013	"CD86 molecule"	P42081	3	122055366-122121139	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 27.0;brain: 26.1"	"Cell type enriched"	"Detected in many"	5	"monocytes: 760.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"classical monocyte: 25.6;intermediate monocyte: 26.4;memory B-cell: 13.6;myeloid DC: 25.9;naive B-cell: 8.0;non-classical monocyte: 27.0"	"Group enriched"	"Detected in many"	17	"B-cells: 13.6;dendritic cells: 25.9;monocytes: 27.0"	"Cell line enriched"	"Detected in some"	7	"HDLM-2: 80.7"					"Low region specificity"	"Detected in all"			"CAB004319, HPA026802"	Approved		Supported	"Plasma membrane"		NA	NA		220000	"Plasma membrane"		"CAB004319: AB_627200, HPA026802: "	"unprognostic (1.81e-1)"	"unprognostic (3.78e-3)"	"unprognostic (3.04e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.56e-2)"	"unprognostic (7.72e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (9.83e-5)"	"unprognostic (9.72e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.78e-2)"	"unprognostic (8.67e-2)"	10.5	4.7	7.1	23.6	9.5	6.0	3.6	1.5	6.3	2.9	4.3	9.8	0.6	2.5	2.6	5.2	2.8	3.3	10.4	3.5	7.3	6.0	4.0	7.8	13.0	17.8	11.7	3.0	2.5	2.3	2.1	2.6	10.3	8.1	3.1	5.6	3.0	3.6	1.8	1.3	2.4	6.9	5.1	26.1	22.5	3.4	2.4	10.3	7.7	2.3	2.1	15.0	9.2	2.2	13.6	25.9	0.3	27.0	1.2	0.4	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	80.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	4.3	0.1	9.6	0.0	0.2	0.0	0.0	25.6	0.2	0.0	26.4	0.0	13.6	0.1	0.1	25.9	8.0	0.0	0.0	0.3	1.2	27.0	2.6	0.4	9.3	7.1	9.5	1.5	6.3	7.3	6.0	11.7	3.0	8.1	10.3	0.0	10.6	25.1	0.0	3.2	0.0	0.2	0.0	0.0	4.5	1.8	0.0	1.6	0.0	0.2	3.0	0.2	0.0	0.0	2.9	0.5	1.7	0.3	2.3	0.8	106.9	0.0	0.0	1.8	111.1	1.3	0.0	155.5	6.8	760.2	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1	3.4	1.6	0.0	0.0	0.3
CD8A	CD8	ENSG00000153563	"CD8a molecule"	P01732	2	86784610-86808396	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	14	"blood: 82.2;lymphoid tissue: 262.3"	"Cell type enriched"	"Detected in some"	11	"T-cells: 65.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	13	"MAIT T-cell: 36.7;memory CD8 T-cell: 82.2;naive CD8 T-cell: 77.8"	"Lineage enriched"	"Detected in many"	20	"T-cells: 82.2"	"Cell line enhanced"	"Detected in some"		"JURKAT: 5.0;MOLT-4: 17.5;RPMI-8226: 4.0"					"Low region specificity"	"Detected in many"			"CAB000012, HPA037756, CAB075722"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		500000	"Plasma membrane"		"CAB000012: AB_2075537, CAB075722: AB_2665709, HPA037756: AB_2675648"	"unprognostic (1.29e-3)"	"prognostic favorable (4.54e-4)"	"unprognostic (9.26e-3)"	"prognostic favorable (6.15e-6)"	"unprognostic (7.28e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.56e-2)"	2.4	1.4	1.4	7.4	2.8	6.8	1.5	1.4	1.2	2.1	5.3	0.8	0.8	4.2	1.5	2.1	2.0	2.1	4.5	1.6	1.2	1.6	1.3	2.1	6.0	23.8	1.0	0.5	1.7	1.2	0.0	0.9	0.6	0.7	2.3	1.9	1.8	3.0	1.1	0.8	0.7	12.2	0.7	1.7	46.4	5.4	1.0	0.5	262.3	2.2	1.6	8.1	3.8	1.9	0.0	0.1	0.6	0.1	4.0	82.2	17.4	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.4	0.0	1.8	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.0	0.0	0.3	0.0	0.8	17.5	1.1	0.6	0.2	0.3	0.1	0.9	4.0	0.0	0.4	0.9	2.4	0.2	0.1	0.0	0.0	0.4	0.5	0.0	0.0	0.6	0.1	0.0	0.1	0.3	0.9	0.0	0.0	0.1	0.1	0.1	0.0	4.8	0.0	36.7	0.0	0.3	82.2	0.0	0.0	0.3	77.8	0.6	4.0	0.1	0.1	0.1	17.4	1.4	2.8	1.4	1.2	1.2	1.6	1.0	0.5	0.7	0.5	0.0	5.8	1.5	0.2	1.8	0.1	2.9	0.0	2.7	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.5	0.2	2.3	0.8	0.1	0.0	0.0	5.5	1.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.9	0.5	0.4	1.6	0.1	65.4	0.0	0.1
CD8B	CD8B1	ENSG00000172116	"CD8b molecule"	P10966	2	86815339-86861924	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 132.1;lymphoid tissue: 61.5"	"Cell type enriched"	"Detected in some"	7	"T-cells: 61.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"memory CD8 T-cell: 73.5;naive CD8 T-cell: 132.1"	"Lineage enriched"	"Detected in many"	40	"T-cells: 132.1"	"Cell line enriched"	"Detected in some"	55	"RPMI-8226: 158.6"									"CAB004353, HPA029164"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"CAB004353: AB_627211, HPA029164: AB_2672936"	"unprognostic (1.83e-3)"	"unprognostic (1.98e-3)"	"unprognostic (2.22e-2)"	"prognostic favorable (7.88e-7)"	"unprognostic (6.23e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.50e-3)"	"unprognostic (5.91e-2)"	"unprognostic (9.25e-2)"	"unprognostic (4.60e-1)"	"prognostic unfavorable (7.11e-6)"	"unprognostic (7.84e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.33e-2)"	1.2	0.7	1.0	5.3	1.0	3.9	1.0	1.3	1.3	21.2	1.1	1.0	1.0	2.5	1.2	1.0	1.0	1.1	1.8	1.0	1.0	1.8	1.0	1.0	2.7	14.4	1.7	1.0	1.3	1.0	6.4	7.4	1.0	2.2	1.3	1.3	1.0	1.0	1.0	1.0	0.9	11.4	1.0	1.5	12.7	2.3	1.0	1.0	61.5	1.5	1.0	8.1	1.8	1.3	0.1	0.1	3.2	0.1	0.1	132.1	36.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	158.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	3.2	0.1	0.0	2.0	0.1	10.0	0.0	0.2	73.5	0.0	0.1	0.5	132.1	0.7	0.1	0.1	0.1	0.2	36.3	1.0	1.0	1.3	1.3	1.0	1.8	1.7	1.0	2.2	1.0	6.0	8.5	0.8	1.7	3.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.6	0.0	0.2	0.1	0.0	0.0	0.6	1.0	0.0	0.0	1.3	5.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	2.5	0.0	61.8	1.2	0.1
CD9	"BA2, MIC3, MRP-1, P24, TSPAN29"	ENSG00000010278	"CD9 molecule"	P21926	12	6199715-6238271	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Fertilization"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Urothelial cells: 2399.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	21	"basophil: 137.8;eosinophil: 98.3"	"Lineage enriched"	"Detected in many"	24	"granulocytes: 137.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 129.4;RT4: 95.9;TIME: 191.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002490	Supported		Supported	"Plasma membrane"		NA	NA		68000000	"Plasma membrane"		"CAB002490: AB_563643"	"unprognostic (1.38e-1)"	"unprognostic (6.36e-3)"	"unprognostic (8.27e-3)"	"unprognostic (6.98e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.60e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.30e-1)"	"prognostic favorable (6.49e-5)"	"unprognostic (6.10e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (8.93e-5)"	"unprognostic (9.26e-2)"	38.1	44.5	20.0	24.1	36.2	3.1	48.2	6.8	29.6	55.0	68.3	63.1	151.6	19.5	36.2	43.4	139.8	38.4	23.2	39.2	30.3	15.6	39.9	12.2	61.1	8.2	43.3	23.3	14.1	23.3	89.5	15.2	13.0	28.7	77.9	73.5	25.5	91.6	180.4	11.3	60.1	29.6	62.2	48.9	12.2	27.7	10.4	47.7	6.0	63.6	112.3	85.8	54.5	76.0	1.9	0.9	137.8	5.6	0.2	1.1	5.6	34.3	15.1	0.3	9.3	14.8	15.3	13.1	20.4	40.7	7.0	10.7	11.1	129.4	0.1	5.1	4.3	20.8	75.4	7.9	40.7	5.4	1.7	5.5	0.1	11.5	2.4	6.4	0.1	43.3	0.0	30.3	12.8	11.0	19.7	83.6	2.5	1.6	0.1	4.4	49.2	0.1	3.7	11.7	41.8	15.2	0.3	24.9	43.8	68.4	95.9	0.0	2.9	20.3	16.8	17.5	71.5	7.8	3.5	191.3	0.7	19.1	0.7	2.4	0.1	0.1	5.2	11.9	0.0	18.8	137.8	5.6	98.3	0.1	1.8	0.2	0.5	0.1	0.1	0.9	1.9	0.4	1.1	2.6	0.2	0.0	0.3	0.0	5.6	20.0	36.2	6.8	29.6	30.3	15.6	43.3	23.3	28.7	47.7	738.4	321.6	28.1	1345.7	921.9	3.7	14.2	76.5	519.3	651.7	1020.6	0.0	8.4	116.0	478.4	2.3	477.7	411.2	0.0	155.9	225.1	473.0	1465.7	638.5	36.4	653.0	0.0	166.1	406.4	33.8	7.3	29.7	438.3	892.5	256.1	636.4	386.7	257.1	669.9	66.4	14.0	13.1	653.2	455.3	7.0	76.5	1118.7	45.2	23.0	620.5	2399.6
CD99L2	"CD99B, MIC2L1"	ENSG00000102181	"CD99 molecule like 2"	Q8TCZ2	X	150766337-150898816	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 72.2"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 49.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038782, HPA038783, HPA061400"	Enhanced		Supported	"Plasma membrane"		NA	NA		790000	"Plasma membrane"		"HPA038782: AB_10795139, HPA038783: AB_10794734, HPA061400: AB_2732660"	"unprognostic (2.10e-2)"	"unprognostic (2.62e-3)"	"unprognostic (3.12e-3)"	"unprognostic (6.03e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.66e-1)"	"unprognostic (5.56e-2)"	"prognostic favorable (4.96e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (2.74e-5)"	"unprognostic (5.50e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.74e-2)"	"unprognostic (9.23e-2)"	"prognostic unfavorable (8.74e-4)"	27.1	16.5	23.3	9.2	30.1	4.5	17.8	27.5	56.7	19.2	12.6	21.0	5.5	6.7	17.6	16.5	9.7	17.6	12.4	32.1	26.3	32.0	14.0	17.0	14.9	9.6	30.5	26.6	26.0	8.4	9.7	8.7	21.5	43.1	13.9	7.4	11.9	8.3	22.0	72.2	6.7	8.0	20.8	31.9	12.5	8.0	7.6	13.3	3.0	7.3	6.9	7.0	10.7	7.7	7.2	10.7	9.4	15.1	8.8	8.9	8.4	2.3	23.0	8.7	10.8	46.3	29.0	2.6	19.0	22.3	9.6	13.8	1.6	2.9	8.3	46.1	33.0	7.2	3.7	11.9	12.9	8.0	19.4	9.3	3.6	5.5	2.3	12.5	6.0	6.9	27.3	4.2	7.1	13.5	15.0	11.2	6.6	2.4	22.0	12.0	4.9	5.3	8.8	3.6	1.9	12.5	5.3	7.1	11.4	9.4	1.5	11.6	5.9	7.4	6.4	8.5	6.7	1.8	10.4	13.2	14.2	4.4	18.4	13.6	18.7	30.9	8.1	17.8	12.1	10.7	9.4	11.2	7.6	8.8	9.9	7.8	6.4	8.2	8.9	10.7	7.2	8.3	8.5	2.8	8.8	15.1	7.8	5.9	8.4	23.3	30.1	27.5	55.2	26.3	32.0	30.5	26.6	43.1	13.3	14.9	8.5	4.5	2.7	2.7	23.3	35.5	12.7	1.4	7.9	12.2	17.7	8.7	5.0	4.0	0.3	11.4	3.4	0.0	4.5	3.8	12.3	3.3	7.0	22.1	9.1	49.3	8.1	14.7	16.2	1.5	19.2	4.7	10.1	9.0	2.4	16.9	3.8	2.9	28.3	9.7	15.5	0.0	9.0	1.5	5.1	1.1	11.3	4.4	3.0	1.1
CDAN1	"CDA-I, CDAI"	ENSG00000140326	"Codanin 1"	Q8IWY9	15	42723544-42737128	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.7"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039404, HPA040787"	Supported		Enhanced	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA039404: AB_10673530, HPA040787: AB_2677137"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.71e-2)"	"prognostic unfavorable (1.07e-4)"	"unprognostic (7.17e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.20e-3)"	"unprognostic (2.04e-1)"	6.5	9.0	8.4	9.8	8.1	14.4	9.8	16.2	9.7	11.8	6.8	8.7	9.4	6.0	11.0	9.6	7.1	9.1	7.2	5.2	6.4	4.4	6.3	6.7	6.6	8.0	8.3	7.4	21.7	9.6	9.1	9.5	6.7	5.8	11.4	5.5	9.3	10.6	10.1	6.6	10.1	6.9	9.3	5.1	8.1	8.0	14.7	8.6	14.7	9.0	3.3	8.2	10.2	12.2	0.3	0.8	3.7	0.3	0.0	0.6	0.1	6.9	4.7	6.5	9.3	5.8	5.0	7.8	9.2	3.9	9.0	6.5	11.8	3.7	3.3	10.2	5.1	8.8	13.7	6.9	4.1	2.6	8.5	6.4	12.6	8.5	4.6	4.3	9.2	11.9	6.8	4.7	5.6	4.1	5.5	6.8	11.5	16.0	5.1	7.3	3.8	7.1	12.2	3.2	6.7	7.6	10.3	8.1	2.9	2.8	6.9	5.3	6.1	7.2	10.1	1.5	4.3	7.7	13.8	4.9	9.5	8.5	7.7	10.5	10.1	10.6	7.5	4.9	13.8	7.7	3.7	0.3	1.7	0.5	0.1	0.6	0.1	0.4	0.5	0.0	0.3	0.4	0.3	0.4	0.0	0.0	0.8	0.1	0.1	8.4	8.1	16.2	9.7	6.4	4.4	8.3	7.4	5.8	8.6	0.0	3.0	0.8	1.7	1.6	3.1	2.2	5.1	1.4	1.2	7.0	3.9	2.6	0.0	1.4	0.3	2.2	1.6	0.0	1.5	1.2	1.9	1.8	1.1	2.4	1.8	1.6	4.6	4.9	4.4	0.9	4.0	1.3	0.0	1.0	2.0	4.8	1.5	0.0	4.6	1.1	4.1	19.4	1.0	4.2	1.9	1.1	1.8	2.5	2.7	1.4
CDC42EP1	"Borg5, CEP1, MSE55"	ENSG00000128283	"CDC42 effector protein 1"	Q00587	22	37560447-37569405	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ductal cells: 199.1;Exocrine glandular cells: 194.9;Pancreatic endocrine cells: 199.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 9.4;intermediate monocyte: 2.9;myeloid DC: 3.5"	"Group enriched"	"Detected in many"	10	"dendritic cells: 3.5;monocytes: 9.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006379, HPA076536"	Approved		Supported	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA			"Plasma membrane"	"Nucleoplasm, Actin filaments"	"HPA006379: AB_1078486, HPA076536: "	"unprognostic (1.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.79e-3)"	"unprognostic (5.82e-2)"	"unprognostic (4.06e-2)"	"unprognostic (4.38e-2)"	"unprognostic (5.57e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.09e-3)"	19.1	26.2	12.1	10.6	29.4	1.9	21.9	2.9	27.3	17.2	13.0	68.7	7.2	19.7	21.0	6.2	25.0	20.4	31.9	12.2	18.3	10.1	14.6	57.4	18.6	6.9	41.4	13.1	31.7	80.8	7.4	5.7	24.9	28.7	11.5	9.9	12.0	36.5	16.9	7.2	22.4	13.8	13.2	34.5	9.7	69.5	8.8	34.2	0.4	9.7	14.2	14.2	10.3	19.2	0.6	3.5	0.4	9.4	0.6	0.3	3.5	30.5	8.9	3.9	17.3	6.2	10.6	18.8	17.6	10.4	20.3	14.1	21.8	4.0	0.0	6.2	20.3	6.5	23.9	4.5	8.8	6.8	3.8	15.3	0.1	8.6	13.1	44.4	0.0	0.1	19.7	13.4	16.7	16.0	16.4	15.1	0.0	19.1	0.1	8.3	10.5	0.0	0.1	3.4	23.9	20.1	0.1	7.0	0.6	7.1	0.4	0.1	0.7	12.9	28.7	27.5	5.6	12.8	2.7	23.0	42.7	25.5	20.5	24.3	0.0	0.1	0.0	16.9	0.1	34.4	0.4	9.4	0.0	0.2	2.9	0.2	0.0	0.1	0.1	3.5	0.6	0.1	0.3	0.3	0.6	0.2	0.4	0.0	3.5	12.1	29.4	2.9	27.3	18.3	10.1	41.4	13.1	28.7	34.2	6.0	24.5	3.4	55.6	41.7	0.0	1.6	91.7	1.4	12.5	12.2	0.0	83.5	1.7	199.1	3.2	31.5	19.5	0.0	194.9	83.2	32.7	99.5	2.3	31.4	11.9	1.6	11.1	61.4	2.9	1.2	36.5	3.9	20.3	10.0	60.1	9.5	199.6	49.1	33.2	4.4	0.0	38.8	53.1	2.4	0.2	45.5	93.8	2.6	57.5	135.8
CDC42EP3	"BORG2, CEP3, UB1"	ENSG00000163171	"CDC42 effector protein 3"	Q9UKI2	2	37641882-37738468	"Predicted intracellular proteins"	"Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 60.2"	"Cell type enhanced"	"Detected in many"	5	"Melanocytes: 190.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 107.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034986, HPA061792"	Approved		Supported	"Plasma membrane,Actin filaments"		NA	NA			"Plasma membrane, Actin filaments"		"HPA034986: AB_10602207, HPA061792: AB_2732670"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.92e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.38e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.14e-3)"	"unprognostic (7.30e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.53e-2)"	19.7	2.1	5.1	5.7	5.8	18.9	14.0	2.4	6.6	13.6	14.4	2.9	1.8	0.9	33.3	6.6	5.0	8.6	4.9	14.3	2.6	1.8	8.4	3.0	10.6	5.7	3.2	2.3	7.7	7.4	1.1	5.5	6.0	3.8	24.9	4.9	7.9	5.8	28.5	27.8	5.3	6.3	25.4	3.2	6.9	5.4	60.2	2.7	14.8	6.4	3.5	5.2	14.9	8.2	7.2	8.4	51.9	30.3	10.1	21.8	13.8	16.9	6.5	3.8	0.2	14.7	7.8	5.8	14.6	39.0	22.9	16.7	12.1	6.8	3.1	11.6	34.6	7.0	8.1	4.7	17.4	23.4	11.3	1.3	5.4	6.7	0.0	28.6	1.2	0.3	23.4	16.3	19.7	43.9	37.3	13.3	1.2	0.8	2.4	107.3	0.1	0.7	9.5	7.6	0.2	4.0	0.4	28.3	1.6	16.5	8.2	4.1	11.5	7.1	5.2	8.8	7.0	1.7	10.1	9.8	27.4	7.1	7.1	14.9	4.5	6.0	1.0	11.3	8.2	37.9	11.0	21.8	1.7	20.2	15.3	21.8	7.2	13.1	17.3	8.4	2.9	4.4	11.1	51.9	10.1	30.3	0.2	9.4	13.8	5.1	5.8	2.4	6.6	2.6	1.8	3.2	2.3	3.8	2.7	6.0	37.0	25.9	93.8	33.0	7.6	91.1	12.7	83.0	18.2	29.6	33.4	23.8	8.3	19.5	42.0	51.9	2.6	0.0	14.1	58.6	26.9	25.1	130.1	1.3	10.6	95.3	39.5	55.3	42.4	92.4	14.1	52.8	190.6	1.8	36.9	27.1	17.9	3.5	119.2	3.7	11.7	0.0	18.7	64.4	13.2	11.8	10.1	74.3	5.8	35.2
CDC42EP4	"BORG4, CEP4, KAIA1777, MGC17125, MGC3740"	ENSG00000179604	"CDC42 effector protein 4"	Q9H3Q1	17	73283624-73312175	"Predicted intracellular proteins"	"Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Horizontal cells: 711.9;Muller glia cells: 543.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 15.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023335, HPA024797"	Approved	Supported	Supported	"Plasma membrane,Actin filaments,Microtubules"		NA	NA			"Actin filaments, Microtubules"	"Plasma membrane"	"HPA023335: AB_10603783, HPA024797: AB_10600696"	"unprognostic (8.76e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.49e-2)"	"unprognostic (5.43e-3)"	"unprognostic (6.29e-2)"	"unprognostic (9.01e-3)"	"unprognostic (2.44e-3)"	"unprognostic (1.08e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.16e-2)"	"unprognostic (6.73e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-1)"	36.0	27.7	24.4	15.2	31.2	8.8	65.2	35.5	45.4	23.5	21.6	28.7	33.4	24.3	23.9	44.5	19.7	41.8	25.2	27.6	28.9	18.4	12.0	15.4	15.9	12.2	20.8	21.1	50.3	50.8	19.9	20.8	15.8	30.7	18.0	13.0	21.8	22.0	38.5	16.7	16.4	22.0	18.9	30.6	11.9	21.6	13.7	24.2	5.9	26.5	14.2	18.9	14.1	46.1	0.1	3.6	4.7	15.6	0.2	0.1	1.4	11.0	25.7	9.6	7.9	19.6	16.4	24.2	9.8	12.3	9.4	6.9	5.4	15.7	0.0	8.7	12.0	10.8	7.8	6.7	6.6	5.8	0.5	6.2	2.5	13.3	12.9	9.7	0.4	2.8	20.4	5.8	8.0	4.1	7.6	10.6	0.2	6.7	0.5	5.8	8.3	0.4	3.2	5.3	33.4	17.8	0.3	4.2	1.1	11.2	12.6	6.3	9.5	7.1	20.7	6.9	7.8	24.1	3.6	10.7	8.9	18.4	6.9	7.0	0.5	0.4	0.0	14.3	1.7	22.8	2.8	2.6	4.7	0.1	7.0	0.1	0.1	0.0	0.0	3.6	0.0	0.1	0.0	4.6	0.2	15.6	0.1	0.0	1.4	24.4	31.2	35.5	25.1	28.9	18.4	20.8	21.1	30.7	24.2	11.9	17.0	1.7	60.5	43.3	9.5	9.2	20.4	10.7	13.6	12.2	5.9	26.8	10.0	25.7	0.5	32.6	42.4	0.0	37.9	30.8	31.7	40.3	12.7	24.5	5.4	711.9	30.0	42.4	5.3	0.7	17.0	7.3	28.7	16.2	36.7	543.1	26.1	29.8	14.5	6.3	17.8	129.4	81.4	0.9	1.4	39.3	70.5	2.5	25.0	85.3
CDH1	"CD324, UVO, uvomorulin"	ENSG00000039068	"Cadherin 1"	P12830	16	68737225-68835548	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes, Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 125.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"myeloid DC: 2.8;plasmacytoid DC: 8.5"	"Lineage enriched"	"Detected in single"	18	"dendritic cells: 8.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 107.1;CACO-2: 36.0;CAPAN-2: 50.3;HaCaT: 48.6;hTCEpi: 34.3;MCF7: 29.7;OE19: 31.7;RT4: 37.0;T-47d: 32.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000087, HPA004812, CAB028364, CAB072855, CAB072856, CAB072857"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cell Junctions"		NA	NA		22000000	"Plasma membrane, Cell Junctions"	"Golgi apparatus"	"CAB000087: AB_2533003, CAB028364: AB_2076812, CAB072855: AB_2665698, CAB072856: AB_2665699, CAB072857: AB_2665700, HPA004812: AB_1078369"	"unprognostic (3.95e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.78e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.61e-1)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.92e-2)"	1.1	0.7	1.3	14.8	1.5	0.5	15.3	0.8	1.1	14.4	63.8	1.8	42.4	25.5	4.7	18.6	48.5	9.7	48.9	0.8	1.5	1.0	24.2	64.9	24.4	0.5	1.8	0.9	5.6	71.5	62.2	13.2	55.2	2.8	28.9	25.9	11.8	66.6	43.7	0.8	30.5	125.5	1.5	1.1	3.5	21.6	2.1	1.8	11.7	83.0	26.2	32.6	16.8	21.7	0.0	8.5	0.0	0.0	0.3	0.4	0.1	21.6	2.2	0.0	0.0	0.0	0.0	107.1	0.0	0.0	0.0	0.0	36.0	50.3	0.0	0.4	0.0	0.0	48.6	0.0	24.1	0.0	4.2	0.6	0.0	0.1	7.7	0.0	0.0	0.2	0.0	34.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.7	0.0	0.1	0.8	31.7	0.1	0.0	0.0	0.3	8.8	37.0	1.3	0.1	0.2	0.0	9.1	15.2	32.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	2.8	0.0	0.0	0.0	0.0	0.3	0.0	8.5	0.1	0.1	1.3	1.5	0.8	1.1	1.5	1.0	1.8	0.9	2.8	1.8	122.1	58.7	0.9	101.9	83.6	0.0	0.8	152.8	73.6	64.8	155.3	0.0	97.3	1.7	107.7	0.0	1.2	202.1	0.0	98.3	22.3	4.1	170.0	1.1	44.7	10.1	0.0	83.2	0.6	1.5	0.0	0.3	6.3	50.6	5.4	180.9	0.0	193.9	160.9	0.4	3.3	0.0	0.0	4.7	0.0	0.1	114.9	42.2	0.0	125.1	204.2
CDH13	CDHH	ENSG00000140945	"Cadherin 13"	P55290	16	82626803-83800640	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Basal keratinocytes: 62.8;Cardiomyocytes: 75.0;Early spermatids: 34.7;Endothelial cells: 34.3;Ito cells: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 7.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.9;monocytes: 7.2"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 48.1;U-138 MG: 62.1;U-87 MG: 54.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001380, CAB025863"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		230000000	"Plasma membrane"		"CAB025863: , HPA001380: AB_1078371"	"unprognostic (2.50e-2)"	"unprognostic (2.75e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.06e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.30e-3)"	"unprognostic (3.01e-1)"	"unprognostic (5.76e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (1.73e-6)"	"unprognostic (5.16e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.21e-1)"	14.0	2.3	13.9	2.7	14.8	0.7	7.6	0.6	32.5	32.7	3.6	2.0	2.8	1.3	36.1	8.9	6.4	6.1	3.6	34.6	5.2	9.9	3.7	1.4	10.8	1.2	4.2	13.3	3.2	0.8	1.1	0.7	4.0	3.8	2.8	4.2	0.9	4.0	5.0	37.2	14.3	1.8	19.5	3.4	1.6	1.7	3.6	1.6	0.0	4.1	21.3	2.7	4.6	14.6	1.0	0.9	2.9	7.2	0.1	0.1	0.3	2.2	0.0	0.8	0.1	14.2	13.7	0.0	10.1	11.2	11.8	5.1	0.0	0.0	0.0	1.9	29.5	5.7	19.1	0.2	15.1	17.7	0.0	0.1	0.0	7.5	0.0	8.2	0.1	0.1	1.7	13.1	23.6	28.9	18.5	5.8	0.0	0.0	0.1	48.1	0.1	0.0	0.1	2.3	0.0	4.2	0.0	12.7	0.1	10.1	0.1	0.0	0.0	18.1	0.1	0.0	23.9	0.2	0.0	9.3	62.1	5.1	0.4	9.2	0.0	0.0	0.0	54.1	0.1	15.2	2.9	1.0	2.4	0.1	3.8	0.1	0.9	0.1	0.0	0.9	1.0	0.1	0.1	2.0	0.1	7.2	0.6	0.1	0.3	13.9	14.8	0.6	32.5	5.2	9.9	4.2	13.3	3.8	1.6	0.0	0.3	0.0	24.0	62.8	1.5	75.0	0.0	0.0	3.4	3.5	0.0	0.1	6.6	0.3	34.7	34.3	0.0	0.0	0.0	0.1	8.9	3.6	0.0	0.0	0.5	4.8	1.7	41.1	1.3	31.3	0.3	1.0	8.5	0.0	1.3	0.3	0.1	0.8	0.0	0.0	0.3	0.0	31.6	0.5	0.2	16.4	0.1	0.7	0.0	4.8
CDH2	"CD325, CDHN, NCAD"	ENSG00000170558	"Cadherin 2"	P19022	18	27950966-28177446	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 77.6;parathyroid gland: 35.4"	"Cell type enhanced"	"Detected in many"	15	"Cardiomyocytes: 330.4;Cone photoreceptor cells: 141.4;Hepatocytes: 98.3;Muller glia cells: 175.2;Rod photoreceptor cells: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 4.4;neutrophil: 4.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.4"	"Cell line enhanced"	"Detected in many"		"AF22: 56.7;BJ: 40.9;fHDF/TERT166: 84.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000141, CAB018580, HPA058574, CAB078686"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA		160000000	"Plasma membrane, Cell Junctions"		"CAB000141: , CAB018580: AB_626778, CAB078686: AB_2665849, HPA058574: AB_2683760"	"unprognostic (9.42e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.07e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.53e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.00e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.93e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.59e-3)"	0.6	29.6	9.8	1.5	9.4	0.5	0.5	5.7	16.1	3.2	2.0	8.0	0.2	0.8	3.1	1.9	0.6	4.7	1.7	77.6	9.9	9.6	9.2	23.3	0.7	1.1	6.0	9.1	3.4	0.7	35.4	5.4	0.5	5.9	1.4	0.8	6.8	0.5	4.6	0.4	0.5	0.9	3.2	6.7	5.9	2.5	19.6	7.4	0.9	2.8	0.0	1.0	1.0	1.3	0.0	0.0	4.4	0.0	0.7	0.9	0.0	0.0	4.5	56.7	0.0	9.0	1.8	0.0	40.9	12.4	16.7	15.3	0.0	0.0	0.0	22.0	84.6	8.0	6.0	9.3	0.0	23.7	0.1	5.9	0.0	15.3	14.0	8.6	0.0	0.0	0.8	0.1	38.3	6.7	38.6	14.6	2.5	0.0	0.0	13.0	0.0	10.3	0.0	7.6	0.0	4.9	0.0	6.7	7.8	0.0	1.8	14.8	25.6	0.0	0.0	4.5	23.2	0.0	0.0	2.3	36.2	11.5	0.5	29.6	0.0	0.0	0.0	6.9	0.0	27.8	4.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.7	0.0	0.0	0.0	0.0	9.8	9.4	5.7	10.1	9.9	9.6	6.0	9.1	5.9	7.4	0.0	1.1	5.0	0.0	0.2	23.9	330.4	58.6	2.7	1.2	10.4	141.4	0.2	0.0	5.6	31.9	3.6	0.0	0.0	0.3	0.0	1.2	0.0	0.0	98.3	0.3	3.2	0.0	18.4	1.9	11.0	2.0	0.4	3.3	0.0	0.0	175.2	12.4	0.0	12.0	40.6	92.8	6.5	5.3	3.3	28.8	0.0	0.2	0.0	0.0	0.1
CDH26	VR20	ENSG00000124215	"Cadherin 26"	Q8IXH8	20	59958427-60034011	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.1;prostate: 15.3"	"Cell type enhanced"	"Detected in some"	19	"Ciliated cells: 45.5;Club cells: 18.2;Glandular cells: 12.1;Syncytiotrophoblasts: 12.5"	"Group enriched"	"Detected in some"	6	"cervical cancer: 1.5;head and neck cancer: 0.9;lung cancer: 2.3;prostate cancer: 3.6;urothelial cancer: 3.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.4;eosinophil: 1.6"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"RT4: 34.7"	"Low region specificity"	"Detected in single"							"HPA015722, HPA047578"	Uncertain		Supported	"Plasma membrane,Microtubules"		NA	NA			"Plasma membrane"	Microtubules	"HPA015722: AB_2077659, HPA047578: AB_2680091"	"unprognostic (2.42e-1)"	"prognostic favorable (7.62e-4)"	"unprognostic (4.71e-4)"	"unprognostic (8.17e-2)"	"unprognostic (9.40e-2)"	"unprognostic (9.95e-3)"	"unprognostic (6.65e-2)"	"prognostic favorable (3.75e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.26e-4)"	"unprognostic (8.24e-3)"	"unprognostic (9.96e-7)"	"unprognostic (1.85e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.04e-1)"	0.8	0.5	0.8	0.7	1.2	1.3	0.8	2.0	1.1	3.8	0.7	0.7	0.7	0.5	1.3	0.7	3.8	2.5	0.7	0.7	1.2	1.0	0.7	0.7	2.9	0.7	1.3	0.7	2.0	0.7	0.7	1.9	0.7	1.4	15.3	0.4	1.4	2.8	0.7	1.0	0.4	0.7	0.7	1.6	0.7	1.9	0.7	0.7	4.2	0.7	0.7	16.1	6.2	1.3	0.0	0.9	1.6	1.4	0.0	0.2	0.4	0.0	0.5	0.1	0.0	0.4	0.2	0.3	0.1	0.0	0.1	0.0	0.6	0.6	0.0	0.4	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	5.3	0.0	0.1	0.0	0.2	0.2	0.1	1.0	0.1	0.0	0.0	0.0	0.4	0.0	0.3	0.2	0.2	0.2	0.4	0.4	0.0	0.1	0.0	0.0	0.6	0.0	34.7	0.7	0.1	0.3	0.2	0.1	0.4	0.2	0.4	0.1	0.0	0.0	0.8	0.0	0.2	0.1	0.0	0.0	0.8	0.0	0.0	1.4	1.6	0.2	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.8	1.2	2.0	1.1	1.2	1.0	1.3	0.7	1.4	0.7	6.0	6.7	0.0	0.9	0.1	0.7	0.6	0.0	45.5	18.2	0.0	0.0	1.4	0.0	0.0	2.7	2.1	0.0	0.0	0.0	0.0	0.2	12.1	1.1	0.0	0.5	0.0	0.0	0.0	1.5	1.1	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.2	0.0	12.5	0.0	0.0	6.7
CDH3	"CDHP, PCAD"	ENSG00000062038	"Cadherin 3"	P22223	16	68636189-68722616	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Sensory transduction, Vision"		"Disease mutation, Ectodermal dysplasia, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 44.0;retina: 40.5"	"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 49.5;Basal keratinocytes: 54.0;Melanocytes: 57.3;Pancreatic endocrine cells: 60.0;Urothelial cells: 48.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	10	"pons and medulla: 16.0"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 24.9;HaCaT: 69.1;HBEC3-KT: 33.3;hTCEpi: 26.6;hTERT-HME1: 20.3;RPTEC TERT1: 29.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA001767, CAB002487"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Cell Junctions"	"CAB002487: AB_563446, HPA001767: AB_1078376"	"unprognostic (1.55e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.38e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (8.53e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.45e-2)"	"prognostic unfavorable (8.43e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.41e-5)"	"unprognostic (2.11e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.33e-3)"	"unprognostic (8.56e-2)"	2.2	0.1	1.0	2.5	1.2	0.0	8.7	1.5	1.1	10.5	1.0	2.2	3.0	0.3	9.4	10.3	23.5	8.9	1.4	0.4	1.1	0.8	8.3	0.2	3.6	2.1	0.6	0.4	32.6	0.4	0.5	3.6	6.4	16.0	11.7	0.5	40.5	9.3	4.4	0.1	21.2	0.4	4.1	1.5	10.0	0.7	2.2	0.1	44.0	2.0	26.1	20.1	2.5	6.7	0.9	0.6	1.4	0.5	0.6	0.8	0.2	24.9	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	14.9	9.3	0.0	0.1	0.0	0.0	69.1	0.6	33.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	26.6	0.0	20.3	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	1.3	0.2	2.1	0.0	0.0	0.0	29.9	11.3	0.1	0.0	0.2	0.0	11.8	12.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.5	0.2	0.4	0.2	0.3	0.6	0.5	0.4	0.1	0.9	0.6	0.8	1.4	0.6	0.2	0.6	0.2	0.2	1.0	1.2	1.5	1.1	1.1	0.8	0.6	0.4	16.0	0.1	14.9	2.9	0.0	49.5	54.0	0.8	1.2	0.0	4.0	13.6	14.0	2.0	21.3	0.0	31.6	0.2	0.5	0.0	0.0	28.5	1.2	3.3	13.1	1.1	0.0	2.5	0.0	1.2	0.0	0.0	0.0	0.6	1.2	57.3	1.8	1.4	0.2	60.0	0.0	8.9	0.0	0.4	0.0	1.9	0.2	0.7	26.8	5.3	0.0	0.4	48.9
CDH4		ENSG00000179242	"Cadherin 4"	P55283	20	61252426-61940617	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.4;lymphoid tissue: 10.2;skeletal muscle: 9.8"	"Group enriched"	"Detected in some"	6	"Horizontal cells: 15.9;Muller glia cells: 21.8"	"Group enriched"	"Detected in many"	6	"glioma: 6.9;renal cancer: 3.4;thyroid cancer: 2.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.4"	"Lineage enriched"	"Detected in single"	25	"T-cells: 2.4"	"Cell line enhanced"	"Detected in some"		"AF22: 8.1;hTERT-HME1: 10.7;U-2 OS: 14.5;U-251 MG: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015613			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA015613: AB_2732414"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.39e-4)"	"unprognostic (2.16e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.72e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.78e-2)"	1.0	1.2	17.4	0.7	15.8	0.9	0.9	1.3	13.6	0.9	0.7	4.0	0.0	0.8	0.9	0.7	1.4	2.6	0.9	1.0	10.2	6.9	0.8	0.9	1.0	0.9	2.8	11.8	6.2	2.0	0.7	0.5	0.9	3.3	0.8	0.7	0.6	1.5	3.6	9.8	2.7	0.8	0.7	1.6	10.2	0.8	1.9	3.1	0.0	1.7	0.0	0.7	0.8	0.3	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.9	8.1	0.0	0.1	0.6	0.1	2.2	0.0	4.1	0.4	0.2	0.0	0.0	0.2	2.7	2.6	2.9	0.0	4.4	1.7	0.2	0.0	0.0	0.1	0.1	5.6	0.0	0.1	0.8	1.1	0.8	10.7	2.2	0.8	0.3	0.0	0.0	1.6	0.3	0.1	0.0	0.9	0.0	0.0	0.0	0.0	1.1	2.6	0.0	0.8	1.9	0.0	0.1	0.1	1.3	0.0	0.0	0.0	0.0	14.5	0.1	25.3	4.7	0.1	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.4	0.0	17.4	15.8	1.3	13.6	10.2	6.9	2.8	11.8	3.3	3.1	3.0	0.0	0.0	0.5	0.2	1.2	1.2	0.0	0.0	1.2	0.0	2.0	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	21.8	0.2	0.0	0.4	0.0	1.8	0.0	0.5	0.1	1.7	0.3	0.0	0.0	0.0	0.1
CDH5	"7B4, CD144"	ENSG00000179776	"Cadherin 5"	P33151	16	66366622-66404786	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 96.6"	"Cell type enhanced"	"Detected in many"	15	"Endothelial cells: 155.1;Ito cells: 190.9;Syncytiotrophoblasts: 67.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 113.8;TIME: 97.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB028366, HPA075875"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane"		NA	NA		1000000000	"Plasma membrane"	"Nucleoplasm, Nuclear membrane"	"CAB028366: AB_2276033, HPA075875: "	"unprognostic (1.05e-1)"	"unprognostic (8.13e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.96e-2)"	"unprognostic (5.50e-3)"	"unprognostic (9.38e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (9.49e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.15e-2)"	48.7	5.6	4.0	6.2	5.8	0.6	28.1	2.6	4.8	11.1	6.6	3.4	5.5	3.7	18.7	11.2	8.4	7.2	12.6	21.7	4.5	4.3	7.8	12.7	43.7	9.7	6.5	2.8	7.7	3.6	5.0	3.5	96.6	7.6	9.0	4.8	8.5	5.2	4.4	19.0	7.0	6.8	12.1	5.4	10.8	5.7	6.7	3.3	1.2	16.6	15.7	4.5	11.7	11.3	0.0	0.6	0.4	0.8	0.1	0.1	1.1	0.0	0.0	0.7	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	113.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.3	0.0	0.0	97.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.4	0.1	0.0	0.6	0.1	1.1	4.0	5.8	2.6	4.8	4.5	4.3	6.5	2.8	7.6	3.3	0.0	10.4	0.0	0.0	3.7	0.0	14.6	7.6	0.0	1.2	1.8	0.0	3.3	0.0	0.1	33.0	155.1	0.0	0.0	0.0	40.7	3.1	0.1	3.5	1.5	2.1	0.0	0.0	190.9	29.5	47.7	5.8	2.3	11.8	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	3.1	13.4	0.2	2.6	67.5	0.0	0.0	0.0
CDH6		ENSG00000113361	"Cadherin 6"	P55285	5	31193750-31329146	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 73.8"	"Cell type enhanced"	"Detected in some"	14	"Ductal cells: 30.0;Pancreatic endocrine cells: 38.4;Proximal tubular cells: 100.9;Sertoli cells: 45.3;Smooth muscle cells: 69.4"	"Group enriched"	"Detected in many"	5	"ovarian cancer: 15.0;renal cancer: 28.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	8	"EFO-21: 106.5"	"Low region specificity"	"Detected in many"							"HPA007047, HPA007403, HPA007456, CAB025274"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA		1200000	"Plasma membrane, Cell Junctions"		"CAB025274: , HPA007047: AB_1078374, HPA007403: , HPA007456: AB_1078373"	"unprognostic (3.87e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.58e-2)"	"unprognostic (7.61e-3)"	"unprognostic (9.04e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.22e-3)"	"unprognostic (2.67e-1)"	"unprognostic (6.22e-2)"	"unprognostic (2.09e-2)"	6.7	1.9	3.4	2.2	7.5	0.6	3.9	1.1	8.4	7.0	2.1	2.4	1.0	2.1	4.5	8.4	3.8	10.0	13.4	3.0	3.3	4.3	73.8	1.4	6.5	1.1	5.0	4.8	3.5	1.3	2.5	2.1	5.3	5.6	2.4	1.7	20.4	1.4	2.9	1.9	1.8	2.0	4.0	6.3	1.4	1.8	0.9	5.5	0.0	3.5	3.3	1.3	4.4	3.4	0.6	0.5	1.7	0.5	0.7	0.4	0.3	0.0	0.4	13.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	106.5	0.0	0.0	0.0	10.6	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	2.4	0.0	3.1	0.0	0.3	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.4	1.3	0.3	0.0	0.0	0.2	0.0	0.0	0.3	1.5	0.4	0.4	0.4	0.3	0.3	0.4	0.3	0.3	0.2	0.6	0.3	0.4	1.7	0.7	0.5	0.5	0.3	0.3	3.4	7.5	1.1	6.7	3.3	4.3	5.0	4.8	5.6	5.5	0.0	0.3	0.0	0.0	0.8	7.9	1.7	25.5	0.0	3.4	10.4	0.0	0.0	23.2	30.0	0.2	1.4	0.0	0.0	2.5	0.0	0.9	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	1.8	0.0	0.3	38.4	0.0	0.4	100.9	0.7	45.3	69.4	0.0	0.2	0.9	0.0	0.0	0.0	0.0
CDK16	"FLJ16665, PCTAIRE, PCTAIRE1, PCTGAIRE, PCTK1"	ENSG00000102225	"Cyclin dependent kinase 16"	Q00536	X	47217860-47229997	"Enzymes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 91.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000974, HPA001366, CAB016535"	Approved		Approved	"Plasma membrane,Microtubules,Cytosol"		NA	NA			"Microtubules, Cytosol"	"Plasma membrane"	"CAB016535: AB_785112, HPA000974: AB_2666162, HPA001366: AB_1079584"	"unprognostic (2.37e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.16e-3)"	"unprognostic (8.80e-2)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (2.02e-6)"	"unprognostic (2.85e-1)"	"unprognostic (5.59e-2)"	"unprognostic (7.62e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.89e-3)"	"unprognostic (2.55e-1)"	22.0	20.1	32.3	13.9	25.0	26.6	17.6	51.5	49.0	17.2	19.3	15.5	17.0	16.4	14.8	12.8	23.8	18.8	14.1	47.3	29.2	18.0	19.9	12.7	14.0	10.8	22.0	21.1	16.7	18.6	22.8	14.9	18.6	28.5	12.7	14.7	13.7	20.1	16.1	91.2	17.0	15.3	18.2	14.8	12.0	14.7	28.7	12.1	10.4	20.9	36.3	12.6	12.9	12.1	8.5	13.5	8.5	10.7	6.3	7.7	5.7	40.6	31.2	30.0	44.3	22.0	18.9	30.0	19.4	23.9	29.5	22.0	35.1	19.8	9.8	12.4	34.7	54.7	23.1	31.9	41.3	19.9	11.7	50.6	10.6	43.9	27.3	28.6	11.1	24.9	23.6	26.4	41.8	50.5	24.7	26.4	10.3	15.7	16.7	25.8	35.4	9.7	25.6	23.5	15.4	33.8	10.3	23.7	17.1	22.2	32.3	25.4	19.2	52.6	40.7	20.0	36.5	36.3	13.7	26.5	19.8	32.4	30.1	23.1	13.2	12.8	9.5	17.4	52.0	22.1	3.1	8.8	8.5	4.8	10.7	6.2	3.8	6.2	7.7	11.6	8.5	5.6	5.8	4.2	6.3	9.6	13.5	6.0	5.7	32.3	25.0	51.5	49.0	29.2	18.0	22.0	21.1	28.5	12.1	0.0	6.7	15.3	27.9	28.8	24.3	37.2	15.3	4.0	4.5	29.6	3.9	23.1	46.4	30.2	25.1	15.7	50.5	0.0	32.2	31.3	23.1	37.6	5.7	14.8	21.7	28.6	26.9	20.3	19.6	46.6	15.8	10.3	32.1	12.6	30.7	16.0	41.5	33.6	12.4	28.2	12.9	0.0	19.8	18.1	16.8	30.4	21.7	10.2	41.6	53.3
CDK5	PSSALRE	ENSG00000164885	"Cyclin dependent kinase 5"	Q00535	7	151053812-151058530	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Lissencephaly, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 36.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008909, HPA064535"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Nucleoplasm, Plasma membrane"	"Cell Junctions"	"CAB008909: , HPA064535: AB_2685280"	"unprognostic (1.21e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.25e-3)"	"unprognostic (3.35e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.11e-1)"	4.5	11.3	24.4	6.9	30.4	6.1	5.3	13.6	36.1	5.3	6.1	6.7	4.5	7.9	4.5	17.4	6.5	5.0	6.2	5.8	25.0	19.7	9.0	7.7	5.3	6.0	15.4	15.4	3.2	5.8	8.9	7.9	5.3	20.8	5.8	6.3	3.2	6.0	6.3	5.7	6.5	6.2	6.0	8.6	5.2	5.7	3.1	7.7	6.8	6.0	3.6	6.9	6.7	3.1	6.6	21.5	9.0	21.7	9.5	14.9	10.6	11.7	14.1	13.2	21.5	14.6	10.7	6.6	7.8	12.8	15.3	12.6	10.0	11.0	11.6	27.9	9.6	22.8	8.4	21.2	11.8	7.0	9.1	12.6	12.7	12.4	9.9	9.6	10.2	23.9	11.6	8.9	12.6	3.9	21.4	10.3	18.2	12.9	8.5	15.3	22.7	27.6	21.0	14.5	18.9	22.3	13.5	5.4	12.9	13.3	8.9	8.4	35.9	11.2	13.8	14.7	12.6	6.4	9.0	8.7	15.1	3.9	11.3	14.5	19.7	21.5	4.5	23.7	14.8	27.0	7.8	19.0	9.0	6.9	21.7	5.4	6.6	6.8	6.8	21.5	5.9	5.1	6.2	2.8	9.5	16.4	12.8	14.9	10.6	24.4	30.4	13.6	36.1	25.0	19.7	15.4	15.4	20.8	7.7	0.0	5.9	11.5	6.4	3.2	11.5	3.2	7.6	8.1	7.9	10.4	2.0	20.0	33.2	19.0	0.6	6.3	7.1	0.0	16.6	10.2	6.6	5.0	31.0	9.6	37.8	0.0	8.6	6.2	21.6	0.9	4.4	14.3	10.1	20.8	9.1	11.5	18.7	14.4	10.6	24.0	4.7	6.5	5.0	2.6	9.7	5.5	7.6	8.5	9.6	7.6
CEACAM5	"CD66e, CEA"	ENSG00000105388	"Carcinoembryonic antigen related cell adhesion molecule 5"	P06731	19	41708585-41729798	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell adhesion"		"Cancer-related genes, Oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.5;intestine: 118.2;lymphoid tissue: 100.6"	"Cell type enhanced"	"Detected in some"	19	"Enterocytes: 233.4;Mucus-secreting cells: 290.9;Paneth cells: 482.9;Undifferentiated cells: 102.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 1007.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	4	"OE19: 35.9"									"CAB000021, CAB000022, HPA011041, HPA019758"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		19000000	"Plasma membrane"		"CAB000021: , CAB000022: AB_2335697, HPA011041: AB_1078481, HPA019758: AB_1846326"	"unprognostic (1.54e-2)"	"unprognostic (7.59e-2)"	"unprognostic (5.49e-3)"	"unprognostic (1.80e-1)"		"unprognostic (1.38e-2)"		"unprognostic (2.22e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.67e-9)"	"unprognostic (2.92e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.85e-1)"	0.1	0.1	0.1	78.8	0.1	0.0	0.1	0.1	0.2	12.5	117.1	0.2	0.1	2.5	0.9	0.1	103.5	0.3	1.2	0.1	0.1	0.1	0.1	0.1	3.3	0.1	0.1	0.1	0.2	0.2	0.0	0.2	0.5	0.1	0.3	118.2	0.2	6.8	0.1	0.1	0.6	12.8	3.3	0.1	0.1	20.1	0.2	0.1	0.6	0.2	29.4	100.6	2.0	14.1	0.6	0.6	1.8	0.7	0.6	0.5	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	35.9	0.7	0.1	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	1.2	0.3	0.8	0.3	0.2	0.1	0.5	0.2	0.3	0.6	0.6	0.4	0.5	1.8	0.6	0.7	0.5	0.3	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	29.8	2.6	0.0	0.6	0.0	0.0	0.3	0.0	1.4	5.7	0.0	0.0	0.0	0.0	0.3	0.3	0.0	233.4	0.0	0.8	0.0	0.0	7.8	4.6	0.0	0.0	0.0	63.1	0.0	0.0	0.0	0.0	0.0	5.0	0.0	290.9	0.0	12.4	482.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	102.6	36.7
CFLAR	"c-FLIP, CASH, CASP8AP1, Casper, CLARP, FLAME, FLIP, I-FLICE, MRIT"	ENSG00000003402	"CASP8 and FADD like apoptosis regulator"	O15519	2	201116104-201176687	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Urothelial cells: 475.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 79.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 79.2"	"Cell line enhanced"	"Detected in all"		"U-266/70: 55.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019044, CAB022157, CAB025216"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	Yes			"Nucleoplasm, Plasma membrane, Cytosol"	"Nuclear bodies"	"CAB022157: , CAB025216: , HPA019044: AB_10696204"	"unprognostic (4.61e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.95e-2)"	"prognostic favorable (2.79e-4)"	"unprognostic (7.46e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.12e-2)"	"unprognostic (3.08e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.83e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.24e-2)"	35.4	17.6	13.7	29.8	17.4	66.8	31.6	26.9	12.6	20.5	25.7	13.5	31.3	17.5	24.7	27.6	21.0	19.2	22.1	58.1	14.7	7.7	24.9	18.9	58.5	34.3	16.8	8.9	14.6	14.3	9.1	18.7	28.3	12.6	23.2	17.7	20.9	21.8	27.4	113.7	16.7	26.8	30.5	13.8	35.7	19.4	10.9	14.8	17.2	31.2	26.2	31.4	24.1	33.7	5.3	6.6	79.2	12.6	8.7	11.8	7.8	5.2	10.7	7.7	4.5	24.0	18.4	9.5	13.3	23.3	8.8	10.8	12.4	19.7	1.4	12.7	15.5	10.7	3.9	2.4	10.1	14.1	39.4	7.5	7.9	9.2	20.1	16.7	5.9	26.3	20.0	10.0	14.9	13.1	10.8	44.7	1.8	26.7	33.2	16.0	4.4	2.7	23.5	2.6	4.2	8.2	2.8	1.9	11.3	11.0	10.8	1.7	3.1	9.0	7.9	10.5	5.4	5.6	11.0	48.4	18.5	7.7	6.8	6.5	55.3	18.2	8.9	13.1	4.8	9.1	16.3	12.1	13.5	11.7	12.3	10.3	5.3	10.1	11.0	6.6	4.0	6.4	8.3	79.2	8.7	12.6	4.6	11.8	7.8	13.7	17.4	26.9	12.6	14.7	7.7	16.8	8.9	12.6	14.8	419.9	201.2	84.2	185.4	48.7	8.5	172.6	96.8	283.7	216.1	66.3	29.5	63.9	63.0	138.6	55.5	265.4	108.1	23.3	63.2	34.2	70.8	195.5	77.6	86.3	61.3	12.7	91.3	184.1	115.5	33.0	48.1	149.2	92.8	261.5	56.6	31.3	121.1	80.7	46.7	84.8	29.0	38.8	55.6	14.4	10.1	75.3	58.6	209.9	41.3	475.0
CGN	KIAA1319	ENSG00000143375	Cingulin	Q9P2M7	1	151510510-151538692	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 44.1"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 110.2;Ciliated cells: 50.9;Enterocytes: 85.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 36.9;CAPAN-2: 24.3;OE19: 23.6;RT4: 17.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB017193, HPA027586, HPA027587, HPA027657"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA		24000000	"Plasma membrane, Cell Junctions"		"CAB017193: , HPA027586: AB_10600208, HPA027587: AB_10601884, HPA027657: AB_10611527"	"unprognostic (1.57e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.98e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.61e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.96e-3)"	"unprognostic (7.10e-2)"	"prognostic favorable (5.84e-10)"	"unprognostic (2.66e-1)"	"unprognostic (3.00e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-2)"	3.9	0.3	2.1	8.5	5.1	0.0	4.1	11.9	3.5	2.2	18.0	3.7	15.5	23.9	1.0	3.5	5.9	6.1	11.9	0.5	1.4	1.4	10.7	15.0	12.4	0.2	5.0	1.0	1.4	25.3	22.1	4.7	1.9	4.8	4.6	11.6	1.8	19.8	14.4	0.2	11.6	44.1	1.8	1.9	0.2	13.6	6.4	4.3	0.9	3.6	2.3	4.3	6.9	3.8	1.2	0.9	2.6	1.0	1.6	2.4	0.1	11.5	1.3	1.1	1.9	0.0	0.0	14.8	0.0	0.0	0.3	0.4	36.9	24.3	0.5	4.0	0.0	2.0	11.1	3.6	2.0	0.2	6.9	2.4	1.0	0.5	0.7	0.0	0.2	1.6	0.0	0.4	0.5	0.3	0.0	0.1	3.3	0.5	3.5	0.0	10.7	2.0	0.2	9.5	23.6	1.0	2.2	1.2	1.7	7.8	17.9	3.7	1.9	0.7	11.3	0.4	4.5	13.9	0.1	0.2	0.1	3.6	0.2	0.5	3.3	3.2	2.0	0.1	1.3	0.9	1.1	1.0	0.4	2.4	0.4	0.7	0.7	0.7	0.5	0.1	1.2	0.8	1.4	2.6	1.6	0.5	0.9	0.7	0.1	2.1	5.1	11.9	3.5	1.4	1.4	5.0	1.0	4.8	4.3	110.2	25.7	0.0	3.7	0.2	2.7	0.4	15.3	50.9	26.1	3.5	0.0	2.1	0.0	19.2	0.0	0.0	85.9	0.0	22.2	0.2	0.3	9.6	0.0	25.2	0.2	0.0	9.9	0.0	0.0	0.5	0.6	0.7	3.3	3.6	26.7	16.6	34.9	40.1	0.7	2.6	1.4	0.0	0.3	0.7	7.1	1.6	0.3	0.0	21.4	13.9
CHRM3		ENSG00000133019	"Cholinergic receptor muscarinic 3"	P20309	1	239386565-239915452	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 39.8"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 17.2;Early spermatids: 14.2;Exocrine glandular cells: 14.9;Paneth cells: 23.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 8.7"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.3"	"Group enriched"	"Detected in many"	18	"monocytes: 1.2;T-cells: 2.3"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 10.2;SH-SY5Y: 32.5;U-266/70: 13.5;U-266/84: 9.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA024106, HPA048036"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA024106: AB_1854211, HPA048036: AB_2680238"	"unprognostic (1.63e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.11e-3)"	"unprognostic (3.48e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.30e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.29e-2)"	"unprognostic (6.44e-2)"	"unprognostic (5.34e-4)"	"unprognostic (3.04e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.88e-2)"	0.8	0.0	2.1	1.4	1.8	0.0	0.8	0.8	8.7	0.8	5.9	0.8	0.8	0.8	1.4	0.8	6.6	0.3	0.8	0.8	2.5	1.8	0.8	0.8	1.5	0.8	0.8	1.1	4.3	8.7	0.2	0.8	0.8	0.8	3.8	2.2	39.8	13.7	2.5	0.8	0.7	1.2	3.3	0.8	1.0	4.8	1.7	0.8	1.3	1.3	0.8	1.6	7.1	0.8	0.0	0.0	0.0	1.2	0.0	2.3	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.5	0.3	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	3.5	0.3	2.3	1.6	0.0	2.2	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.6	5.6	0.5	0.8	0.0	0.0	2.9	2.7	5.1	0.0	0.7	10.2	0.4	0.5	0.0	32.5	0.0	0.1	0.1	2.7	1.1	0.0	0.0	1.3	0.5	0.1	0.3	13.5	9.6	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	1.2	0.7	0.0	0.5	0.4	0.0	0.0	2.3	0.7	0.0	0.0	0.7	0.0	0.5	0.2	2.1	1.8	0.8	8.7	2.5	1.8	0.8	1.1	0.8	0.8	0.0	3.0	0.0	1.4	0.0	17.2	0.8	0.0	2.7	1.2	0.0	0.0	2.6	1.7	0.3	14.2	1.1	2.6	0.0	14.9	0.8	0.5	2.3	1.1	0.0	0.4	0.0	3.4	1.3	0.0	2.6	0.0	0.0	6.8	0.0	2.4	0.2	3.7	23.2	0.4	0.7	0.4	0.0	0.3	5.2	2.0	0.0	0.5	0.0	6.6	0.1
CHRNA1	CHRNA	ENSG00000138435	"Cholinergic receptor nicotinic alpha 1 subunit"	P02708	2	174747592-174787935	"Disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	8	"skeletal muscle: 96.7"	"Cell type enhanced"	"Detected in some"	11	"Early spermatids: 1.6;Melanocytes: 1.7;T-cells: 1.8"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Region enhanced"	"Detected in single"		"hippocampal formation: 2.0"	"Cell type enriched"	"Detected in single"	27	"plasmacytoid DC: 2.6"	"Lineage enriched"	"Detected in single"	27	"dendritic cells: 2.6"	"Group enriched"	"Detected in some"	18	"LHCN-M2: 89.4;RH-30: 73.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA071554	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA071554: AB_2686416"	"unprognostic (1.49e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.96e-1)"	"unprognostic (8.55e-3)"	"unprognostic (5.34e-2)"	"unprognostic (5.29e-3)"	"unprognostic (9.59e-2)"	"unprognostic (9.64e-2)"	"unprognostic (9.66e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.18e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.18e-2)"	4.5	0.0	0.5	0.5	0.1	0.0	0.6	0.0	0.4	0.7	1.7	0.0	0.1	0.2	0.0	4.6	1.2	0.0	0.0	0.3	2.0	0.1	0.0	0.2	0.7	0.9	0.1	0.0	0.0	0.0	0.0	12.1	0.2	0.0	2.4	1.0	0.0	1.5	0.0	96.7	0.0	0.0	0.0	0.8	0.1	0.0	0.3	0.0	0.5	0.0	4.5	1.3	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	89.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.5	0.1	0.0	0.4	2.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.9	0.3	0.0	1.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0
CHRNA5		ENSG00000169684	"Cholinergic receptor nicotinic alpha 5 subunit"	P30532	15	78565520-78595269	"Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"vagina: 33.9"	"Cell type enhanced"	"Detected in many"	16	"Extravillous trophoblasts: 9.6;Spermatogonia: 32.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054381	Approved		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Focal adhesion sites"	"Plasma membrane"	"HPA054381: AB_2682468"	"unprognostic (2.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.20e-3)"	"unprognostic (6.66e-2)"	"unprognostic (1.29e-3)"	"unprognostic (7.03e-5)"	"prognostic unfavorable (3.64e-5)"	"unprognostic (1.34e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.52e-2)"	"unprognostic (8.97e-2)"	"unprognostic (6.50e-11)"	"unprognostic (4.37e-1)"	"unprognostic (5.39e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.22e-1)"	2.9	3.3	1.7	4.4	1.7	0.6	4.9	1.8	1.7	2.7	6.4	0.4	1.6	7.8	4.7	1.9	4.0	1.1	16.3	2.4	1.7	1.8	0.9	1.8	1.4	2.0	1.9	0.3	1.7	11.8	0.0	0.7	2.1	1.2	3.6	7.1	3.5	1.7	0.7	5.8	1.0	6.8	6.1	1.3	1.9	5.3	9.8	0.6	4.5	1.6	2.9	4.4	5.7	33.9	0.9	1.1	3.4	1.6	1.6	1.4	0.7	6.7	17.4	9.5	5.2	1.1	0.8	3.8	4.9	2.4	5.5	10.0	6.6	32.1	4.0	12.2	1.0	14.8	6.0	18.1	7.3	5.6	8.1	21.7	7.4	13.6	6.6	0.6	5.0	10.5	0.3	1.3	1.5	2.0	2.0	10.2	5.6	7.2	5.2	3.5	14.7	6.3	1.7	7.7	13.3	4.8	8.1	10.9	4.0	6.6	16.1	16.0	23.5	11.9	11.6	5.5	5.6	25.8	1.3	2.2	7.5	9.0	5.5	15.5	6.1	25.0	4.5	4.5	8.1	6.9	3.0	1.6	2.5	0.8	1.6	0.4	0.3	0.8	0.5	0.9	0.9	1.4	1.4	3.4	1.6	1.3	1.1	0.3	0.7	1.7	1.7	1.8	1.7	1.7	1.8	1.9	0.3	1.2	0.6	0.0	0.0	0.0	7.8	2.9	1.9	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	1.0	1.0	0.0	0.0	1.8	9.6	0.4	5.2	0.0	0.0	0.9	4.8	3.4	0.0	0.0	1.2	0.3	0.8	1.7	0.0	6.3	0.2	0.7	0.0	0.4	0.2	0.5	0.0	2.1	3.2	32.1	1.4	0.8	1.3	1.5	2.7
CHRND	ACHRD	ENSG00000135902	"Cholinergic receptor nicotinic delta subunit"	Q07001	2	232525993-232536667	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"skeletal muscle: 49.1"	"Cell type enriched"	"Detected in single"	11	"Muller glia cells: 4.3"	"Cancer enriched"	"Detected in single"	7	"head and neck cancer: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	72	"RH-30: 43.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"olfactory region: 1.4"	"HPA056404, HPA065404"			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA056404: AB_2732603, HPA065404: AB_2732734"				"unprognostic (1.69e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.28e-3)"	"unprognostic (7.75e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.90e-1)"		"unprognostic (4.97e-8)"	"unprognostic (7.52e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.46e-1)"		2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	49.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	43.8	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CIB1	"CIB, KIP, SIP2-28"	ENSG00000185043	"Calcium and integrin binding 1"	Q99828	15	90229975-90234047	"Predicted intracellular proteins"	"Angiogenesis, Apoptosis, Cell adhesion, Cell cycle, Cell division, Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 1100.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012991, HPA042413, HPA048825"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"CAB012991: AB_2533205, HPA042413: AB_2732498, HPA048825: AB_2680533"	"unprognostic (1.20e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.73e-2)"	"prognostic favorable (2.26e-5)"	"unprognostic (7.56e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.77e-1)"	"unprognostic (4.09e-2)"	"unprognostic (5.25e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-2)"	16.5	40.1	15.0	31.1	14.7	42.5	21.8	4.1	13.8	24.1	51.6	15.4	31.0	31.6	12.2	37.2	39.9	37.2	43.3	47.7	14.8	14.0	49.8	74.5	27.9	27.6	17.5	13.8	17.8	67.8	20.2	24.0	20.6	18.3	30.3	34.0	16.7	40.4	44.5	21.2	10.0	67.5	13.9	13.6	29.3	23.8	25.7	11.0	21.5	37.8	27.8	44.3	38.0	16.3	87.9	43.0	49.4	45.4	35.9	55.2	64.9	24.5	55.6	4.9	17.8	21.8	22.9	8.2	26.1	22.8	21.6	19.3	21.8	43.9	7.1	28.2	30.6	27.9	25.6	10.5	30.1	11.7	16.9	23.9	15.9	38.3	36.1	21.5	31.9	15.6	16.2	18.1	20.1	13.9	24.3	27.5	17.8	21.4	11.3	16.4	48.2	24.0	37.2	7.9	47.2	28.6	13.7	13.5	28.9	55.0	42.0	4.1	4.9	35.6	28.9	27.8	9.3	22.5	19.3	17.3	23.9	17.0	28.8	31.9	15.4	24.1	8.3	38.5	36.5	10.2	25.3	39.3	49.4	46.0	45.4	37.7	87.9	55.2	50.2	43.0	70.7	46.0	45.5	22.8	35.9	41.0	28.5	44.3	64.9	15.0	14.7	4.1	13.8	14.8	14.0	17.5	13.8	18.3	11.0	83.4	104.1	147.3	209.7	76.1	10.0	74.5	152.8	653.1	152.4	174.5	9.8	90.9	384.7	302.9	295.2	73.0	544.4	0.0	585.6	97.5	113.1	427.5	136.2	209.7	199.6	3.2	93.2	65.1	107.8	1100.8	97.5	194.3	121.4	222.8	293.7	96.5	506.2	613.7	87.0	538.0	22.1	38.8	86.5	141.6	49.6	58.8	55.3	173.0	242.6	478.0
CLCA2	CLCRG2	ENSG00000137975	"Chloride channel accessory 2"	Q9UQC9	1	86424086-86456558	"Predicted membrane proteins"	"Cell adhesion, Ion transport, Transport"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 105.2;lymphoid tissue: 33.9;skin 1: 36.4;tongue: 42.1"	"Cell type enhanced"	"Detected in some"	13	"Basal keratinocytes: 42.1;Club cells: 22.7;Early spermatids: 20.6;Suprabasal keratinocytes: 47.9;Urothelial cells: 35.8"	"Group enriched"	"Detected in many"	6	"cervical cancer: 68.3;head and neck cancer: 146.1;lung cancer: 35.2;urothelial cancer: 31.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"hTCEpi: 68.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047192	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		66000	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA047192: AB_2679977"	"unprognostic (1.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.96e-3)"	"unprognostic (6.99e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.40e-1)"		"unprognostic (6.15e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.73e-1)"	"unprognostic (9.99e-3)"	"unprognostic (1.97e-8)"	"unprognostic (3.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.72e-1)"	0.4	0.0	0.1	0.1	0.1	0.0	2.0	0.1	0.1	27.7	0.2	0.1	0.4	0.1	1.1	0.7	105.2	0.1	0.2	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.2	0.1	1.4	0.3	0.1	5.1	0.1	0.1	36.4	0.3	0.1	0.2	0.1	0.0	0.2	0.1	0.7	0.1	42.1	33.9	6.1	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	12.6	0.5	0.8	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	10.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	68.6	0.3	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	6.0	42.1	0.0	0.3	0.0	10.7	22.7	0.0	0.0	0.2	0.0	0.0	20.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	47.9	0.1	0.0	0.0	35.8
CLCN5	"ClC-5, CLC5, DENTS, hCIC-K2, hClC-K2, NPHL1, NPHL2, XLRH, XRN"	ENSG00000171365	"Chloride voltage-gated channel 5"	P51795	X	49922615-50099235	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Antiport, Ion transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 46.1"	"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 32.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 6.6"	"Group enriched"	"Detected in many"	8	"dendritic cells: 6.6;monocytes: 1.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 25.4;RH-30: 39.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000401, HPA003213"	Uncertain		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Golgi apparatus, Plasma membrane"	Cytosol	"HPA000401: AB_1078531, HPA003213: AB_2666843"	"unprognostic (3.33e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.60e-1)"	"unprognostic (5.21e-2)"	"prognostic favorable (5.20e-4)"	"unprognostic (3.59e-2)"	"prognostic favorable (2.05e-8)"	"unprognostic (7.87e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.60e-2)"	4.4	4.1	2.5	2.4	2.9	2.1	3.4	9.4	3.4	2.3	3.1	2.6	4.7	5.0	9.8	26.7	3.7	4.6	7.6	2.2	3.1	2.8	46.1	15.8	4.7	3.0	2.6	2.5	10.8	6.7	2.6	8.3	7.3	5.9	2.7	3.7	7.6	4.0	3.5	5.6	6.2	6.4	3.8	4.3	3.0	4.0	5.9	2.3	1.2	3.6	4.0	2.3	2.4	3.1	0.2	6.6	0.5	1.8	0.3	0.4	0.5	1.8	2.8	2.2	3.3	8.4	5.3	4.7	1.5	0.8	1.0	1.2	25.4	1.7	1.8	0.8	1.7	5.6	1.5	6.8	0.8	1.6	0.7	4.6	1.8	1.4	6.6	4.0	2.3	3.4	3.1	1.1	2.6	3.8	0.8	3.6	2.4	2.7	2.7	2.9	1.8	0.8	0.7	3.2	4.2	1.4	1.1	39.3	2.8	3.8	2.9	3.8	2.7	2.2	2.2	3.1	8.7	1.9	1.1	1.8	1.0	2.1	7.8	0.9	2.3	6.9	4.1	1.7	3.8	5.1	0.1	1.8	0.0	0.2	1.5	0.3	0.2	0.4	0.4	3.8	0.2	0.1	0.1	0.5	0.3	0.3	6.6	0.0	0.5	2.5	2.9	9.4	3.4	3.1	2.8	2.6	2.5	5.9	2.3	8.9	5.9	1.5	1.6	6.4	19.5	1.6	5.1	5.3	0.0	12.2	2.0	5.2	10.0	3.7	1.1	3.8	10.9	0.0	2.9	2.2	5.7	3.1	2.3	21.7	8.9	7.9	0.0	0.6	9.5	0.0	4.9	8.9	3.3	5.4	5.7	2.8	5.8	6.2	12.4	32.4	4.3	0.0	3.3	1.0	0.7	8.3	4.2	0.0	6.4	4.6
CLDN4	"CPE-R, CPETR, CPETR1, hCPE-R, WBSCR8"	ENSG00000189143	"Claudin 4"	O14493	7	73799542-73832693	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 141.0"	"Cell type enhanced"	"Detected in many"	17	"Basal glandular cells: 2545.0;Glandular cells: 2415.4;Urothelial cells: 7943.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 43.3;BEWO: 51.0;CAPAN-2: 95.4;MCF7: 48.6;OE19: 49.3;PC-3: 62.1;RT4: 42.0;SK-BR-3: 80.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB002610	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB002610: "	"unprognostic (1.14e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.07e-1)"	"prognostic unfavorable (3.28e-4)"	"unprognostic (2.16e-3)"	"unprognostic (5.11e-1)"	"prognostic favorable (3.46e-10)"	"unprognostic (5.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.38e-2)"	"unprognostic (4.63e-2)"	0.7	0.2	0.4	17.1	0.4	0.0	17.1	0.4	0.5	17.5	53.7	0.7	23.2	25.0	5.1	15.9	62.3	15.4	15.4	0.5	0.4	0.3	30.2	2.0	28.8	0.4	0.4	0.4	5.5	32.4	2.7	3.5	78.1	1.3	31.8	24.7	0.7	52.0	25.7	0.6	35.3	93.3	2.7	0.4	0.4	2.7	2.5	0.4	3.8	141.0	60.9	55.7	38.5	21.0	0.1	0.1	0.2	0.1	0.1	0.6	0.0	43.3	0.5	0.0	0.2	0.0	0.0	51.0	0.4	0.0	0.0	0.0	22.7	95.4	0.0	3.5	0.0	0.3	24.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	15.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	48.6	0.0	0.2	0.0	49.3	62.1	0.0	0.8	1.0	11.6	42.0	10.1	0.2	0.0	80.9	0.1	2.9	31.6	0.1	0.0	0.1	1.8	0.4	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.6	0.2	0.1	0.0	0.1	0.0	0.0	0.4	0.4	0.4	0.5	0.4	0.3	0.4	0.4	1.3	0.4	256.1	182.2	2.2	2545.0	14.3	0.2	0.6	242.0	323.9	224.1	207.6	0.0	586.9	11.6	821.2	0.0	2.9	1686.2	0.0	388.8	629.5	21.8	2415.4	27.6	0.8	67.0	0.0	648.6	0.0	0.3	0.0	2.3	10.6	13.5	27.1	955.9	0.9	781.5	1557.1	0.0	10.2	0.0	0.0	2.1	0.0	0.2	47.2	799.6	1.7	627.6	7943.2
CLEC5A	"CLECSF5, MDL-1"	ENSG00000258227	"C-type lectin domain containing 5A"	Q9NY25	7	141927357-141947007	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 35.8"	"Group enriched"	"Detected in some"	4	"Hofbauer cells: 18.6;Macrophages: 57.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"classical monocyte: 11.5"	"Lineage enriched"	"Detected in many"	8	"monocytes: 11.5"	"Group enriched"	"Detected in some"	23	"HL-60: 15.2;U-937: 58.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA054137			Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA054137: AB_2732582"	"unprognostic (6.89e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.33e-5)"	"unprognostic (4.57e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (6.58e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.64e-1)"	1.4	3.2	1.8	7.3	2.4	35.8	0.8	0.8	2.5	1.7	0.4	1.9	0.6	0.4	0.8	0.5	1.4	1.2	2.0	3.8	7.6	3.1	2.9	2.1	13.9	0.3	2.4	0.5	2.7	2.6	1.4	1.1	2.7	8.2	0.9	0.5	0.8	2.7	0.8	0.3	2.7	0.3	1.5	4.8	2.1	0.4	0.9	4.8	1.1	1.4	4.9	1.4	1.9	1.1	0.0	0.5	1.4	11.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.7	0.0	0.0	11.5	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.0	1.9	1.8	2.4	0.8	2.5	7.6	3.1	2.4	0.5	8.2	4.8	0.0	7.4	0.0	0.0	1.6	0.0	0.3	2.5	5.3	9.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	2.3	0.0	18.6	0.0	0.0	0.0	3.8	0.2	0.0	57.4	1.7	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	1.3	0.2	0.0	0.0	0.0
CLECL1	DCAL1	ENSG00000184293	"C-type lectin like 1"	Q8IZS7	12	9715860-9733299	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	9	"blood: 42.4;intestine: 11.5;lymphoid tissue: 20.6"	"Group enriched"	"Detected in some"	4	"B-cells: 69.2;Hofbauer cells: 21.8;Kupffer cells: 84.7;Macrophages: 31.4;monocytes: 69.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 42.4"	"Lineage enriched"	"Detected in many"	5	"B-cells: 42.4"	"Group enriched"	"Detected in some"	5	"HEL: 16.0;Karpas-707: 22.2;U-698: 56.8;U-937: 31.2"									HPA063928			Supported	"Plasma membrane,Centriolar satellite"		NA	NA			"Plasma membrane, Centriolar satellite"		"HPA063928: "	"unprognostic (2.18e-2)"	"unprognostic (2.35e-3)"	"unprognostic (2.20e-3)"	"unprognostic (1.90e-3)"	"unprognostic (3.66e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.55e-4)"	"unprognostic (5.10e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.91e-5)"	"unprognostic (3.31e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.10e-2)"	"unprognostic (7.39e-2)"	2.7	1.0	0.8	9.8	1.1	0.9	1.1	0.3	0.9	0.6	1.7	1.3	0.1	1.6	0.7	1.3	2.6	0.9	1.5	2.7	1.0	0.9	1.6	1.4	1.9	15.5	1.3	0.7	0.5	1.7	0.0	0.9	0.5	0.9	0.8	2.8	0.8	1.5	0.1	0.5	0.5	11.5	0.9	2.5	20.5	2.6	0.6	0.3	2.2	0.9	0.5	20.6	2.8	2.4	42.4	8.6	0.7	4.6	0.0	3.5	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.2	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	56.8	0.0	31.2	0.0	0.7	2.6	0.1	1.7	4.6	0.0	42.4	1.4	3.5	6.1	14.5	0.0	0.5	0.1	0.0	4.6	8.6	0.1	2.1	0.8	1.1	0.3	0.9	1.0	0.9	1.3	0.7	0.9	0.3	0.0	0.0	69.2	0.1	1.8	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.4	0.0	4.7	0.2	21.8	0.0	0.0	0.6	84.7	1.1	0.3	31.4	11.8	69.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.5	0.2	0.0	0.0	1.6	0.2	12.5	0.0	0.1
CLIC2	XAP121	ENSG00000155962	"Chloride intracellular channel 2"	O15247	X	155276211-155334657	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 62.3;vagina: 66.1"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 83.4;Alveolar cells type 2: 48.6;Endothelial cells: 49.6;Kupffer cells: 47.8;monocytes: 118.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 9.5;myeloid DC: 24.5;non-classical monocyte: 6.5"	"Group enriched"	"Detected in many"	14	"dendritic cells: 24.5;monocytes: 9.5"	"Group enriched"	"Detected in some"	5	"HDLM-2: 37.3;K-562: 20.2;Karpas-707: 18.6;RPMI-8226: 31.8"					"Low region specificity"	"Detected in all"			"HPA047381, HPA060101"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		290000	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA047381: AB_2680022, HPA060101: AB_2684204"	"unprognostic (3.27e-2)"	"unprognostic (5.21e-3)"	"unprognostic (9.70e-2)"	"unprognostic (7.25e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (1.97e-2)"	"unprognostic (2.97e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.54e-1)"	26.5	3.7	3.8	7.5	6.1	3.4	24.1	2.6	4.8	15.5	6.8	0.6	3.3	4.0	11.3	10.5	10.4	6.5	9.8	9.4	3.7	3.4	5.4	6.3	31.0	15.6	7.5	1.4	12.5	2.6	2.0	7.8	4.5	6.8	9.1	6.9	3.0	5.4	3.2	10.3	5.2	7.3	10.2	5.2	32.1	4.7	5.6	4.3	6.9	62.3	8.7	12.4	14.0	66.1	0.0	24.5	0.6	9.5	1.1	0.1	1.0	0.2	0.0	0.4	0.3	0.3	2.1	0.0	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	37.3	0.2	5.2	0.1	0.0	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.2	0.0	0.2	20.2	18.6	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.0	31.8	0.1	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.0	0.4	0.0	1.7	0.6	0.7	0.3	1.2	1.6	0.0	0.9	1.1	0.6	0.0	1.8	0.1	0.0	9.5	0.1	0.0	0.0	0.1	24.5	0.0	0.0	0.0	0.6	1.1	6.5	2.5	0.0	1.0	3.8	6.1	2.6	4.8	3.7	3.4	7.5	1.4	6.8	4.3	83.4	48.6	0.8	0.7	11.7	1.1	2.8	0.0	2.7	10.3	0.0	0.0	0.0	0.0	0.0	0.1	49.6	0.0	23.3	0.2	0.1	22.3	0.4	3.5	1.0	4.8	0.0	1.2	19.0	47.8	0.4	12.7	29.8	16.9	118.2	0.0	0.0	0.1	0.0	8.9	0.2	0.3	6.5	4.8	0.0	0.0	12.0	0.0	2.2	0.0	1.4
CLIC5	DFNB102	ENSG00000112782	"Chloride intracellular channel 5"	Q9NZA1	6	45880827-46080348	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Hearing, Ion transport, Sensory transduction, Transport, Vision"	"Chloride channel, Ion channel, Voltage-gated channel"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 65.6;intestine: 46.2;skeletal muscle: 99.9"	"Cell type enhanced"	"Detected in many"	20	"Alveolar cells type 1: 473.4;Cardiomyocytes: 276.0;Enterocytes: 100.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 8.8"	"Lineage enriched"	"Detected in single"	23	"T-cells: 8.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.6;EFO-21: 9.6;HDLM-2: 5.0;REH: 11.7;U-266/70: 12.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA074371			Supported	"Nuclear speckles,Plasma membrane"		NA	NA		1000000	"Plasma membrane"	"Nuclear speckles"	"HPA074371: "	"unprognostic (4.95e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.73e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.46e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.65e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.01e-1)"	7.4	0.6	0.8	3.2	1.5	0.0	2.3	0.6	1.1	6.0	10.2	0.3	0.4	5.6	0.8	2.5	2.2	1.2	2.1	65.6	0.9	1.2	17.5	0.5	32.8	0.4	1.1	1.4	0.7	0.7	0.4	1.3	22.0	0.8	0.9	7.5	7.8	2.0	0.4	99.9	0.7	46.2	1.4	0.9	16.1	0.9	1.0	0.0	0.2	4.8	18.8	1.5	1.0	4.3	0.3	0.0	0.0	0.0	0.3	8.8	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	13.6	0.0	9.6	0.0	0.0	0.3	0.0	0.1	0.0	5.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.1	0.3	1.5	0.0	11.7	0.3	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.4	0.1	0.0	12.9	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	8.8	0.3	3.6	2.2	0.0	0.0	0.6	0.5	0.0	0.3	0.0	0.0	1.6	0.8	0.8	1.5	0.6	1.1	0.9	1.2	1.1	1.4	0.8	0.0	473.4	23.0	0.5	0.0	0.1	0.1	276.0	0.0	20.1	48.9	14.0	0.0	0.1	0.0	1.4	38.1	3.8	100.0	0.0	0.2	0.0	0.2	1.5	1.1	0.0	0.0	0.0	12.5	0.6	0.0	75.0	0.9	0.0	0.0	1.0	16.3	47.6	1.9	24.6	0.7	2.1	1.1	0.0	2.1	0.6	0.1	0.1	1.8	2.9	9.8	0.8
CLTB	Lcb	ENSG00000175416	"Clathrin light chain B"	P09497	5	176392455-176416569	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Pancreatic endocrine cells: 1144.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 105.2;MCF7: 93.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003692, HPA036458"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA		350000	Vesicles	"Plasma membrane, Cytosol"	"CAB003692: AB_425372, HPA036458: AB_2675136"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (7.89e-5)"	"unprognostic (3.55e-1)"	"unprognostic (7.50e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.60e-2)"	20.4	24.1	29.7	18.7	26.7	13.5	16.0	27.5	47.9	27.7	34.7	14.2	11.4	35.4	15.0	15.7	94.2	12.7	28.4	65.7	26.4	26.9	20.3	15.0	15.6	12.2	25.9	22.7	24.3	19.7	17.9	19.8	61.2	28.7	16.8	18.1	19.4	22.2	19.3	93.7	81.8	41.1	27.1	15.4	14.2	39.6	9.9	10.1	14.3	17.2	55.4	31.2	26.1	45.3	4.3	9.9	28.0	9.9	7.4	11.6	3.6	33.3	16.0	4.5	19.4	10.2	7.7	37.4	43.0	16.8	27.3	19.6	20.7	15.6	7.3	25.4	19.3	11.0	31.9	7.7	105.2	10.7	49.9	14.3	4.9	23.8	12.7	16.1	7.8	13.1	8.2	36.7	14.9	17.7	5.5	12.8	5.9	9.3	18.7	15.0	93.6	12.2	11.8	3.7	28.0	23.9	13.3	8.1	24.0	14.4	13.6	19.6	6.7	20.5	22.5	14.6	5.5	9.2	15.0	27.6	9.9	14.8	17.9	24.3	14.9	10.3	9.8	7.9	16.6	11.2	2.8	9.9	28.0	7.2	7.5	3.7	3.1	6.4	7.0	9.9	4.3	5.2	5.5	18.7	7.4	9.7	8.0	11.6	3.6	29.7	26.7	27.5	47.9	26.4	26.9	25.9	22.7	28.7	10.1	53.6	23.2	58.1	196.8	563.1	275.7	186.4	73.9	9.4	29.6	78.5	60.9	109.8	114.4	340.2	7.2	90.2	537.2	23.3	397.9	474.5	139.4	165.3	48.4	90.4	99.6	317.8	145.7	58.9	80.5	11.0	113.1	120.4	209.2	73.9	265.3	88.8	1144.6	526.1	122.0	193.6	54.8	77.6	222.4	15.8	14.4	701.9	323.2	77.3	199.5	331.8
CNNM4	"ACDP4, KIAA1592"	ENSG00000158158	"Cyclin and CBS domain divalent metal cation transport mediator 4"	Q6P4Q7	2	96760902-96811891	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Biomineralization, Ion transport, Sensory transduction, Transport, Vision"		"Amelogenesis imperfecta, Cone-rod dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 106.0;Enterocytes: 53.8;Rod photoreceptor cells: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 29.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017732	Enhanced		Uncertain	"Plasma membrane,Actin filaments"		NA	NA			"Actin filaments"	"Plasma membrane"	"HPA017732: AB_1847395"	"unprognostic (1.98e-3)"	"unprognostic (8.95e-3)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (9.14e-4)"	"unprognostic (3.42e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (8.75e-4)"	"unprognostic (4.75e-3)"	"unprognostic (3.72e-1)"	"unprognostic (8.14e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.06e-1)"	3.7	4.0	4.8	17.0	9.6	4.5	7.4	24.1	11.1	6.8	31.2	11.3	8.3	6.3	10.4	5.2	7.7	10.8	7.3	11.5	5.4	5.0	5.9	4.9	8.1	4.3	6.0	6.6	6.1	11.4	9.0	10.6	17.1	5.5	7.4	33.5	13.9	10.8	11.3	21.3	7.4	11.1	5.7	5.2	6.1	12.6	11.8	6.1	4.6	9.7	6.1	9.3	6.5	7.4	3.7	2.2	2.8	2.3	0.8	3.2	1.1	6.9	4.6	3.7	6.8	3.9	2.6	10.2	3.0	4.3	4.5	6.1	8.3	7.5	5.0	8.8	3.1	6.2	9.0	9.5	5.2	4.2	10.1	7.5	4.0	3.1	4.5	5.4	1.9	4.0	2.5	6.5	7.2	4.4	3.0	2.4	5.1	2.0	14.4	2.3	9.8	4.0	2.8	4.9	12.9	6.3	6.0	1.7	5.8	4.5	5.4	17.4	5.2	5.8	29.6	4.3	10.8	14.4	3.3	2.2	2.6	5.9	5.7	3.4	5.0	4.0	2.6	3.8	3.8	4.6	2.8	1.6	0.5	3.2	1.8	1.1	3.7	1.7	1.7	2.2	2.1	1.1	2.1	0.7	0.8	2.3	1.7	0.8	1.1	4.8	9.6	24.1	11.1	5.4	5.0	6.0	6.6	5.5	6.1	35.7	7.7	4.7	3.8	5.0	38.8	11.8	7.6	5.3	14.8	7.0	106.0	4.7	0.0	2.6	4.1	2.9	53.8	0.0	3.6	1.4	2.8	3.4	1.1	3.0	3.0	31.8	9.7	3.1	5.4	1.0	0.9	2.4	0.0	0.0	26.3	7.7	3.8	20.9	1.1	1.2	46.8	0.0	4.7	5.5	2.0	3.6	5.6	2.9	21.7	4.9
CNP		ENSG00000173786	"2',3'-cyclic nucleotide 3' phosphodiesterase"	P09543	17	41966741-41977731	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 211.7"	"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 49.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002672, HPA023266, HPA023278, HPA023280, HPA023338"	Enhanced	Supported	Supported	"Plasma membrane"		NA	NA		730000	"Plasma membrane"		"CAB002672: , HPA023266: AB_1847058, HPA023278: AB_1847060, HPA023280: AB_1847061, HPA023338: AB_1847062"	"unprognostic (2.17e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.09e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.10e-3)"	9.1	8.9	51.4	9.5	72.8	6.7	8.1	13.4	125.3	10.3	7.5	211.7	2.3	7.1	8.0	12.7	15.0	9.3	10.8	7.6	78.4	40.7	14.7	9.6	6.7	10.5	86.7	49.0	11.2	9.2	5.8	4.4	7.8	66.7	11.7	6.4	3.6	15.1	13.2	7.6	11.1	6.4	10.1	160.2	7.1	7.4	4.6	63.5	2.1	7.2	2.2	11.2	9.8	5.7	9.9	49.1	7.3	13.1	7.3	7.5	9.1	13.9	23.9	22.7	27.9	19.4	18.3	9.7	17.5	26.9	45.5	51.4	18.7	12.8	14.9	14.1	22.8	23.4	24.1	15.3	11.6	15.8	14.7	19.3	14.4	16.4	32.4	20.9	14.0	13.1	30.1	8.3	24.9	6.1	16.5	20.7	14.9	10.2	12.1	15.8	8.9	35.9	12.7	5.3	7.6	17.0	22.4	33.3	14.5	12.1	14.3	13.3	18.0	22.2	33.4	38.9	11.6	14.9	21.0	20.8	17.7	19.5	24.1	20.6	13.7	15.6	11.8	17.6	10.9	69.2	4.9	12.1	7.3	7.5	13.1	5.9	9.9	6.5	6.0	11.1	7.0	5.9	6.9	2.6	7.3	10.3	49.1	7.2	9.1	51.4	72.8	13.4	93.8	78.4	40.7	86.7	49.0	66.7	63.5	14.9	10.1	20.1	16.4	14.8	20.3	11.3	20.4	13.4	22.7	33.2	5.9	26.2	106.1	40.0	1.0	17.9	18.3	0.0	37.1	41.6	27.2	18.5	9.2	25.9	34.6	47.7	18.9	18.4	13.2	2.8	35.9	14.9	52.3	31.5	12.9	73.9	30.9	17.3	33.9	48.5	23.1	32.3	36.5	3.9	13.0	16.6	10.9	18.7	18.8	16.6
CNR1	"CANN6, CB-R, CB1, CB1A, CB1K5, CNR"	ENSG00000118432	"Cannabinoid receptor 1"	P21554	6	88139864-88166359	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.5"	"Cell type enriched"	"Detected in some"	14	"Sertoli cells: 97.0"	"Cancer enriched"	"Detected in many"	13	"glioma: 12.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 2.9;naive B-cell: 2.1"	"Lineage enriched"	"Detected in single"	6	"B-cells: 2.9"	"Group enriched"	"Detected in some"	7	"ASC diff: 40.3;HSkMC: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042256, HPA069945"	Enhanced	Supported	Supported	"Plasma membrane,Actin filaments"		NA	NA			"Plasma membrane"	"Actin filaments"	"HPA042256: AB_2677917, HPA069945: "	"unprognostic (1.28e-1)"	"unprognostic (7.04e-2)"	"unprognostic (4.61e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.68e-3)"	"unprognostic (5.88e-2)"	"unprognostic (7.00e-2)"	19.4	6.4	18.0	5.2	15.8	1.5	14.9	13.8	30.5	3.9	5.5	0.8	0.8	2.3	3.1	4.7	3.7	5.5	3.6	1.4	17.6	7.7	0.9	0.7	6.4	6.5	2.3	14.7	4.1	1.8	1.3	18.3	5.2	4.2	1.5	5.1	0.0	4.3	4.0	1.7	2.4	4.2	5.8	3.2	2.3	2.3	2.7	2.8	0.0	2.6	0.0	9.9	2.7	3.1	2.9	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	40.3	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.9	1.4	0.0	2.6	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.0	3.3	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.6	2.3	0.0	0.0	0.0	0.0	0.0	0.7	3.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	2.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	18.0	15.8	13.8	21.4	17.6	7.7	2.3	14.7	4.2	2.8	0.0	7.2	2.7	0.4	0.6	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	97.0	2.3	0.0	0.1	0.1	0.1	0.0	0.0	0.7
COG3	SEC34	ENSG00000136152	"Component of oligomeric golgi complex 3"	Q96JB2	13	45464898-45536630	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Hepatocytes: 73.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040353, HPA054470"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Golgi apparatus, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA040353: AB_10794027, HPA054470: AB_2732585"	"unprognostic (1.75e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.75e-1)"	"unprognostic (4.04e-3)"	"unprognostic (9.69e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavorable (9.53e-4)"	"unprognostic (5.82e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.71e-1)"	12.5	17.4	8.7	17.1	14.0	10.9	17.0	19.7	14.5	16.9	17.1	13.0	22.4	13.2	16.9	20.6	14.4	14.0	12.8	12.5	8.9	9.4	16.5	46.2	12.1	11.7	9.3	10.0	17.9	29.4	10.9	22.6	32.9	11.5	20.9	20.7	12.9	28.3	25.2	12.5	14.7	18.8	13.3	10.1	14.8	15.6	9.9	11.2	17.4	18.5	8.7	18.5	14.8	14.8	5.1	7.2	7.4	4.6	4.9	8.0	3.8	5.4	4.9	9.5	8.6	12.6	14.5	9.1	9.1	13.0	10.6	8.9	7.2	10.1	7.5	4.1	10.8	7.9	12.0	7.8	9.2	16.2	5.8	6.4	8.4	6.0	12.6	15.6	12.3	8.1	10.8	13.9	7.0	25.1	12.9	10.3	7.4	5.4	4.6	12.7	8.4	6.8	11.6	7.8	27.4	6.0	8.0	5.6	7.0	9.9	8.9	4.7	8.6	5.9	11.6	12.1	9.4	7.9	12.8	9.6	5.1	4.0	9.5	5.8	6.5	3.5	7.8	9.8	6.2	9.1	7.4	4.1	7.3	7.5	4.6	8.0	5.1	5.8	6.4	3.1	4.9	6.6	6.1	3.7	4.9	2.9	7.2	6.2	3.8	8.7	14.0	19.7	14.5	8.9	9.4	9.3	10.0	11.5	11.2	8.9	31.8	15.2	12.2	14.1	9.4	16.9	20.4	9.4	23.9	12.2	13.7	12.4	13.3	9.4	12.9	12.1	27.1	23.3	32.9	15.5	10.8	25.6	16.2	73.3	9.8	9.5	21.4	20.3	20.8	7.4	13.0	14.6	10.1	6.4	43.3	5.2	18.0	34.5	12.7	11.9	10.4	6.5	9.9	11.5	6.6	14.1	27.5	17.5	21.4	19.0
COL17A1	"BP180, BPAG2"	ENSG00000065618	"Collagen type XVII alpha 1 chain"	Q9UMD9	10	104031286-104086002	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 85.8;skin 1: 123.2;tongue: 64.0"	"Cell type enriched"	"Detected in many"	4	"Basal keratinocytes: 520.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 227.4"	"Region enriched"	"Detected in single"	4	"basal ganglia: 1.2"	"Cell type enriched"	"Detected in single"	15	"neutrophil: 3.7"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 3.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 24.8;HaCaT: 56.6;HBEC3-KT: 90.6;hTCEpi: 117.8;hTERT-HME1: 100.3"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.1"	"Not detected"	"Not detected"			"HPA043673, HPA052963"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA			"Plasma membrane"	"Golgi apparatus"	"HPA043673: AB_10960893, HPA052963: AB_2681999"	"prognostic favorable (1.38e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.63e-1)"	"unprognostic (7.85e-3)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.35e-2)"	0.2	0.0	0.2	4.4	1.2	7.5	8.1	0.2	0.2	15.2	9.3	0.2	0.9	2.0	0.6	2.6	31.5	0.1	1.2	0.2	0.2	0.1	0.4	0.2	0.7	0.2	0.2	0.2	0.2	0.2	0.0	0.6	85.8	0.2	5.0	5.4	0.2	15.5	7.3	0.5	123.2	23.2	0.8	0.2	0.3	3.9	4.0	0.2	18.1	2.0	64.0	24.7	3.0	17.3	0.0	0.0	3.7	0.2	0.0	0.0	0.8	3.1	0.0	0.1	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	24.8	0.0	0.7	0.0	0.5	56.6	0.1	90.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	117.8	0.0	100.3	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.0	0.0	0.0	5.1	3.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.2	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.2	0.0	0.0	0.8	0.2	1.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.6	0.0	12.4	520.3	0.6	0.8	0.0	2.7	20.5	0.0	0.0	3.5	0.0	0.7	8.5	1.0	105.8	0.0	0.8	8.3	2.1	0.6	0.0	0.0	1.2	0.0	2.4	0.0	0.0	2.6	0.3	1.0	32.1	0.0	5.9	0.4	45.8	16.1	0.7	0.0	0.4	0.0	1.7	8.3	1.1	121.8	4.7	0.0	14.5	8.0
CORO1B	coronin-2	ENSG00000172725	"Coronin 1B"	Q9BR76	11	67435510-67443821	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 281.3;Paneth cells: 280.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017616, HPA040113, HPA070456"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		200000000	"Plasma membrane, Cytosol"		"CAB017616: AB_2087018, HPA040113: AB_2676850, HPA070456: AB_2686268"	"unprognostic (1.94e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.02e-1)"	"unprognostic (8.23e-3)"	"unprognostic (1.49e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.64e-3)"	26.0	24.0	12.6	20.6	16.1	9.7	21.6	9.7	19.0	25.8	37.0	20.3	23.1	35.0	28.7	34.0	31.2	25.6	35.3	15.2	12.6	11.0	27.5	36.4	21.6	23.3	15.9	10.7	21.2	24.2	15.4	16.1	29.2	14.3	31.4	19.1	20.5	42.5	27.4	9.2	16.7	44.7	20.5	14.8	34.7	29.8	13.9	16.5	16.1	31.6	23.3	20.0	25.8	20.8	4.2	17.5	10.9	47.1	2.4	12.3	11.7	18.7	18.5	8.9	18.2	23.2	20.3	13.4	13.3	28.3	22.9	17.4	30.9	28.0	0.6	28.0	18.9	23.3	16.3	10.0	17.7	4.1	4.2	8.7	13.2	12.1	13.2	37.1	0.2	28.5	27.4	15.9	19.3	9.0	14.5	29.0	11.6	9.7	2.0	13.0	53.7	2.9	1.5	11.5	46.2	17.5	2.6	9.4	3.3	15.4	23.5	10.2	12.6	12.6	34.4	41.4	6.6	43.1	15.1	22.8	15.7	11.3	21.2	8.3	0.3	0.6	3.0	25.2	1.8	15.8	10.9	22.9	1.7	1.9	47.1	1.4	4.2	9.3	3.0	17.5	1.4	5.3	2.3	10.9	2.4	45.8	13.5	12.3	11.7	12.6	16.1	9.7	19.0	12.6	11.0	15.9	10.7	14.3	16.5	3.0	2.1	39.3	50.5	24.7	11.1	1.4	28.1	0.0	3.4	45.4	7.9	80.7	51.4	101.4	6.0	45.0	241.3	0.0	92.1	190.3	39.9	57.7	28.7	19.5	220.1	14.3	95.0	41.7	89.7	3.0	36.5	74.8	67.4	281.3	138.0	26.4	112.4	280.5	32.5	63.3	12.8	51.8	44.5	6.9	5.9	27.0	125.9	76.7	99.3	62.6
CPPED1	"CSTP1, FLJ11151"	ENSG00000103381	"Calcineurin like phosphoesterase domain containing 1"	Q9BRF8	16	12659799-12804017	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 93.6"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 85.5;Syncytiotrophoblasts: 110.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 93.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 45.3;HMC-1: 42.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040938, HPA041970"	Uncertain		Supported	"Plasma membrane,Cytosol"		No	No		380000	Cytosol	"Plasma membrane"	"HPA040938: AB_10673443, HPA041970: AB_2677774"	"prognostic unfavorable (9.72e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.04e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.13e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.64e-1)"	"prognostic favorable (1.62e-9)"	"unprognostic (5.05e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.40e-2)"	10.9	11.5	8.3	14.3	14.3	9.5	8.5	2.7	11.8	9.2	13.8	20.8	7.4	16.3	8.2	6.2	23.1	7.2	8.9	10.7	11.2	9.5	26.2	31.4	10.4	21.2	20.7	7.7	6.4	4.1	4.3	6.5	36.6	17.6	9.1	11.9	10.2	15.1	7.3	6.4	6.8	20.5	10.0	22.1	27.4	8.1	18.2	13.1	5.8	11.1	8.4	16.9	9.8	9.6	1.5	23.1	93.6	43.7	1.9	1.8	14.6	1.5	9.5	1.0	2.5	4.0	8.5	0.1	17.4	4.7	9.3	7.6	4.6	4.9	2.3	18.0	12.6	4.1	0.1	0.0	4.3	9.7	5.3	2.6	19.7	1.4	45.3	2.5	0.0	42.8	8.5	0.9	0.8	6.7	0.0	13.9	3.2	6.8	1.4	22.8	1.9	1.7	9.1	2.8	0.7	1.3	3.7	6.1	4.9	14.1	3.0	5.0	3.3	0.0	15.8	6.2	5.2	3.4	4.3	20.8	13.5	2.8	0.0	0.0	0.0	0.3	3.6	3.0	10.0	2.8	6.1	30.6	19.3	1.3	43.7	1.1	1.5	1.1	1.4	23.1	1.0	0.3	0.8	93.6	1.9	40.6	5.6	1.8	14.6	8.3	14.3	2.7	11.8	11.2	9.5	20.7	7.7	17.6	13.1	8.9	18.4	13.0	2.9	4.0	3.6	8.2	7.6	10.7	6.8	14.0	7.9	85.5	51.4	33.8	2.3	11.3	13.5	0.0	10.9	10.0	9.3	3.3	52.1	38.5	44.3	9.5	5.8	7.4	74.6	2.3	14.4	42.4	6.8	27.9	7.5	12.5	30.7	13.6	22.6	51.8	5.5	25.8	4.2	1.6	11.5	4.0	110.3	7.4	10.6	1.4
CSF1	"M-CSF, MCSF, MGC31930"	ENSG00000184371	"Colony stimulating factor 1"	P09603	1	109910242-109930992	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Immunity, Inflammatory response, Innate immunity"	"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 2: 47.6;granulocytes: 111.9;Ito cells: 54.0;Sertoli cells: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"basophil: 7.0;eosinophil: 16.5"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 16.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 46.5;ASC TERT1: 29.2;BJ hTERT+: 30.6;GAMG: 29.0;HHSteC: 70.7;HSkMC: 45.2;hTERT-RPE1: 32.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA076624			Supported	"Nuclear bodies,Plasma membrane"	"Secreted to blood"	NA	NA	270000	17000000	"Plasma membrane"	"Nuclear bodies"	"HPA076624: AB_2686810"	"unprognostic (2.35e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.19e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.10e-2)"	"prognostic unfavorable (1.00e-11)"	"unprognostic (2.03e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.01e-1)"	"unprognostic (3.16e-2)"	38.1	21.4	11.5	14.6	16.7	10.1	36.5	4.3	14.6	13.8	12.8	28.2	3.6	8.5	12.0	10.1	11.3	15.7	20.6	16.0	11.4	5.8	10.7	10.3	23.5	16.9	24.3	5.4	16.9	11.3	6.7	5.2	26.0	19.2	16.3	11.0	12.2	12.4	11.6	12.7	10.4	12.7	16.0	21.9	25.8	11.9	7.5	20.3	2.9	12.4	7.8	11.0	20.6	29.2	0.0	0.0	16.5	0.0	0.0	1.0	0.1	1.5	5.7	2.9	1.1	46.5	29.2	1.0	6.6	30.6	5.3	4.9	0.2	0.8	0.0	8.4	16.3	29.0	1.2	1.2	2.2	2.0	18.5	0.9	2.0	3.3	1.9	70.7	0.0	2.6	45.2	0.6	11.6	7.0	32.5	1.0	0.5	0.4	1.1	6.3	0.1	0.0	0.3	0.9	0.4	0.5	0.2	1.5	0.1	2.1	1.5	0.1	0.3	1.9	0.5	2.3	3.7	0.4	0.2	3.5	5.5	1.9	24.4	3.7	0.5	0.2	0.0	14.0	0.0	20.6	7.0	0.0	16.5	0.2	0.0	0.5	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.0	0.1	11.5	16.7	4.3	14.6	11.4	5.8	24.3	5.4	19.2	20.3	8.9	47.6	2.4	5.4	6.5	0.2	2.4	22.9	0.0	5.7	3.5	0.0	0.5	0.0	23.8	0.3	19.0	0.6	0.0	2.0	0.4	28.2	4.8	111.9	2.5	9.2	0.0	7.5	54.0	3.5	0.0	23.3	11.7	10.1	2.8	0.8	1.9	8.1	0.9	8.1	1.1	0.1	58.2	25.9	0.6	0.6	4.8	0.7	8.5	0.6	1.8
CSF1R	"C-FMS, CD115, CSFR, FMS"	ENSG00000182578	"Colony stimulating factor 1 receptor"	P07333	5	150053291-150113372	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Immunity, Inflammatory response, Innate immunity"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Neurodegeneration, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 82.5;lymphoid tissue: 82.6"	"Group enriched"	"Detected in many"	8	"Extravillous trophoblasts: 97.9;Hofbauer cells: 277.3;Kupffer cells: 200.7;Macrophages: 125.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 60.7;non-classical monocyte: 82.5"	"Lineage enriched"	"Detected in many"	4	"monocytes: 82.5"	"Group enriched"	"Detected in some"	5	"BEWO: 51.8;SK-BR-3: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008970, HPA012323"	Uncertain		Supported	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		1500000000	"Vesicles, Plasma membrane"		"CAB008970: , HPA012323: AB_1848977"	"unprognostic (3.82e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-3)"	"unprognostic (9.83e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (1.72e-2)"	"unprognostic (4.61e-2)"	20.9	12.4	18.2	28.1	18.9	1.8	7.7	2.8	13.5	9.3	8.3	25.4	1.1	9.2	5.9	13.1	8.4	7.9	16.1	8.7	16.4	13.7	7.8	15.1	13.7	25.4	21.3	6.0	5.3	5.2	5.9	6.4	52.1	17.1	8.5	8.4	16.8	8.0	8.7	3.0	5.8	14.5	16.2	25.8	82.6	9.0	4.9	23.0	3.1	4.2	2.9	8.2	16.4	4.7	0.0	19.1	2.9	82.5	0.0	0.1	13.9	1.7	0.0	0.0	0.0	0.8	0.2	51.8	0.1	0.0	0.0	0.0	1.5	0.0	2.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.1	0.0	19.8	0.0	0.8	0.0	7.4	0.0	0.3	0.0	0.0	1.3	0.0	0.1	0.0	2.6	0.9	0.0	0.4	18.1	0.5	0.1	60.7	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	2.9	0.0	82.5	1.4	0.0	13.9	18.2	18.9	2.8	13.4	16.4	13.7	21.3	6.0	17.1	23.0	0.0	6.7	0.5	0.0	2.5	0.0	2.8	5.1	1.4	0.0	0.0	0.0	2.9	0.0	0.0	3.7	2.2	0.0	0.0	0.0	97.9	3.3	0.0	2.3	0.8	277.3	0.0	0.0	4.9	200.7	3.5	1.7	125.7	3.3	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.4	12.9	1.3	0.5	0.2	1.1	22.1	2.2	0.0	0.0
CTTN	EMS1	ENSG00000085733	Cortactin	Q14247	11	70398404-70436584	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Endocytosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.6"	"Cell line enhanced"	"Detected in many"		"A-431: 129.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011235, HPA057242"	Supported		Supported	"Golgi apparatus,Vesicles,Plasma membrane,Cytosol"		NA	NA		34000000	"Plasma membrane, Cytosol"	"Golgi apparatus, Vesicles"	"CAB011235: , HPA057242: AB_2683379"	"unprognostic (6.34e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.13e-2)"	"unprognostic (5.81e-2)"	"prognostic unfavorable (2.19e-6)"	"prognostic unfavorable (4.45e-4)"	"unprognostic (6.10e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.50e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.94e-1)"	37.5	53.6	33.0	19.7	36.7	5.7	32.0	33.3	41.1	41.3	35.3	42.3	33.7	37.1	48.8	40.2	49.4	35.5	56.2	37.3	28.5	23.5	47.2	24.9	30.5	13.7	45.0	32.0	46.3	40.0	28.9	38.3	32.3	37.2	38.9	32.4	24.4	38.0	38.5	31.5	52.9	39.2	43.1	36.0	21.4	51.3	30.2	38.6	7.7	36.0	44.5	26.7	33.2	38.2	0.1	0.8	4.6	0.2	0.0	0.4	13.9	129.8	28.6	9.7	11.1	16.4	25.6	15.9	27.8	27.8	24.5	19.4	37.8	32.8	5.1	27.6	35.5	26.3	28.9	11.5	29.2	18.0	10.2	11.7	0.5	21.3	17.6	35.3	0.1	6.9	36.1	20.6	27.1	15.3	25.7	20.5	0.1	14.6	1.0	24.1	35.5	0.2	1.8	10.5	47.6	17.5	0.0	11.9	4.1	27.4	42.3	8.0	13.6	20.3	27.9	46.2	18.1	22.8	0.5	25.6	21.7	13.8	33.6	18.5	2.2	1.5	0.3	43.1	0.1	29.5	1.4	0.2	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.2	0.0	0.4	0.0	4.6	0.0	0.2	0.8	0.0	13.9	33.0	36.7	33.3	41.1	28.5	23.5	45.0	32.0	37.2	38.6	41.7	43.8	5.9	84.2	135.0	34.6	57.8	68.8	50.9	53.4	127.4	17.7	73.0	54.7	124.2	9.3	75.2	104.4	23.3	191.8	75.9	68.3	111.3	5.8	37.6	9.6	36.5	71.5	68.7	5.4	16.3	95.5	8.6	116.4	9.0	107.2	38.3	199.6	136.8	93.0	111.0	30.1	58.2	106.6	31.2	52.1	152.9	88.9	6.9	79.7	167.3
CX3CL1	"ABCD-3, C3Xkine, CXC3, CXC3C, fractalkine, neurotactin, NTN, SCYD1"	ENSG00000006210	"C-X3-C motif chemokine ligand 1"	P78423	16	57372458-57385048	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Chemotaxis"	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 39.3;Endothelial cells: 39.1;Glandular cells: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"EFO-21: 13.7;HDLM-2: 37.3;Hep G2: 27.8;RPTEC TERT1: 16.6;SK-BR-3: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026192, HPA040361"	Approved		Supported	"Plasma membrane"	"Secreted to blood"	NA	NA	1870000		"Plasma membrane"		"CAB026192: , HPA040361: AB_10796453"	"unprognostic (6.89e-3)"	"prognostic favorable (9.46e-4)"	"unprognostic (1.52e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.08e-3)"	"unprognostic (4.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.06e-2)"	"prognostic favorable (8.52e-7)"	"unprognostic (5.19e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.33e-2)"	24.3	3.6	13.4	4.7	26.6	0.7	42.5	3.8	45.1	12.4	5.9	6.9	8.7	4.2	12.1	7.0	10.7	11.7	14.9	12.0	16.4	13.8	14.5	11.2	35.3	6.0	9.2	18.0	5.2	9.6	3.8	4.5	3.4	11.7	22.3	4.5	12.2	39.9	34.4	9.2	9.9	5.0	21.7	6.6	1.5	5.0	3.8	3.9	0.8	12.0	5.7	4.9	19.7	6.7	1.0	0.8	2.1	0.7	0.8	0.6	0.2	0.0	0.3	3.6	3.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	13.7	0.0	1.9	0.1	0.0	0.0	0.0	37.3	0.2	0.0	0.0	27.8	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.5	0.0	16.6	0.1	0.1	3.2	0.0	9.7	0.8	2.4	0.0	0.1	0.0	0.1	2.2	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.6	1.4	0.7	0.5	0.6	0.4	0.3	0.6	0.4	0.3	0.2	1.0	0.4	0.6	2.1	0.8	0.4	0.8	0.2	0.2	13.4	26.6	3.8	37.3	16.4	13.8	9.2	18.0	11.7	3.9	3.0	5.8	0.0	39.3	3.9	5.4	7.0	25.5	10.7	25.0	3.5	3.9	0.0	0.0	25.9	0.3	39.1	0.2	0.0	1.6	0.0	3.3	28.6	1.1	10.0	0.0	4.8	1.7	3.1	0.6	0.0	4.4	0.0	0.0	1.0	0.0	0.8	6.6	0.0	26.2	10.2	1.7	12.9	14.4	0.1	0.1	2.3	0.2	0.0	0.7	24.6
CYBRD1	"CYB561A2, DCYTB, FLJ23462, FRRS3"	ENSG00000071967	"Cytochrome b reductase 1"	Q53TN4	2	171522247-171558133	"Predicted membrane proteins"	"Electron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 205.4;Leydig cells: 187.0;Peritubular cells: 208.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 12.0;intermediate monocyte: 12.4;myeloid DC: 11.7;neutrophil: 6.7;non-classical monocyte: 9.4"	"Group enriched"	"Detected in many"	4	"dendritic cells: 11.7;granulocytes: 6.7;monocytes: 12.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 144.2;ASC TERT1: 62.7;BJ hTERT+: 54.3;HSkMC: 44.4;hTERT-RPE1: 37.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014757	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA014757: AB_1847374"	"unprognostic (1.35e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.44e-3)"	"unprognostic (8.90e-3)"	"unprognostic (3.57e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.93e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.51e-2)"	75.2	26.0	10.1	9.3	13.2	4.0	78.9	6.1	8.0	44.5	56.3	14.7	16.3	49.5	44.3	28.5	29.6	26.1	38.8	43.1	12.1	5.5	8.6	6.2	35.6	10.6	11.0	11.2	49.5	5.4	2.0	9.5	9.5	11.4	41.7	10.2	32.0	21.5	21.1	17.5	26.7	111.3	41.1	12.8	7.3	18.1	20.1	11.7	2.1	103.8	23.9	10.0	43.8	56.0	0.0	11.7	6.7	12.4	2.5	1.2	4.4	3.2	2.4	1.3	2.6	144.2	62.7	0.2	11.8	54.3	6.2	7.8	0.1	4.5	0.0	2.0	27.7	6.3	1.6	1.1	0.9	7.3	2.4	0.3	2.7	3.7	0.0	30.3	2.8	0.2	44.4	9.2	9.6	1.8	37.0	3.9	1.6	0.9	0.0	16.9	0.0	0.9	2.6	0.7	0.0	0.6	0.3	17.0	0.1	0.9	0.1	0.1	0.6	13.7	0.0	7.3	0.5	4.8	1.7	7.8	13.9	2.0	12.9	5.0	0.0	0.0	0.0	6.6	2.4	7.4	0.0	12.0	0.5	1.2	12.4	0.2	0.0	0.2	0.1	11.7	0.0	0.0	0.0	6.7	2.5	9.4	0.5	0.0	4.4	10.1	13.2	6.1	8.0	12.1	5.5	11.0	11.2	11.4	11.7	205.4	82.9	0.0	33.8	107.6	0.0	17.1	28.1	8.1	48.9	24.4	0.0	1.6	0.0	1.0	0.9	40.3	13.6	46.7	5.8	1.3	122.8	21.6	2.3	2.1	39.6	0.0	0.0	57.7	57.5	2.1	187.0	28.5	42.2	12.6	3.8	29.3	1.3	8.6	208.2	0.3	1.8	19.4	57.5	0.9	1.3	52.6	1.1	2.5	4.8	13.8
CYFIP2	PIR121	ENSG00000055163	"Cytoplasmic FMR1 interacting protein 2"	Q96F07	5	157266079-157395595	"Predicted intracellular proteins"	"Apoptosis, Cell adhesion"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 42.8;brain: 44.2;kidney: 69.7"	"Cell type enhanced"	"Detected in many"	8	"Collecting duct cells: 150.1;Distal tubular cells: 147.6;Horizontal cells: 85.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 52.0;JURKAT: 35.9;MOLT-4: 49.3;U-266/70: 38.4;U-698: 36.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB055519, HPA068106, HPA071459"	Uncertain		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Endoplasmic reticulum"	"Plasma membrane, Cytosol"	"CAB055519: , HPA068106: AB_2685955, HPA071459: AB_2686400"	"unprognostic (1.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.07e-2)"	"prognostic unfavorable (2.42e-6)"	"unprognostic (3.76e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.97e-2)"	"unprognostic (5.25e-2)"	"prognostic favorable (1.18e-4)"	"unprognostic (3.81e-2)"	"prognostic favorable (3.21e-12)"	"unprognostic (2.90e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.49e-2)"	1.9	6.6	28.6	13.4	31.7	22.8	1.7	39.1	44.2	1.8	4.3	7.7	1.6	3.1	3.5	12.3	2.1	4.9	4.7	5.1	28.7	20.4	69.7	8.2	5.9	25.9	16.2	27.2	2.7	3.6	30.6	13.2	4.4	15.8	3.2	5.0	4.7	2.2	3.5	3.1	1.8	6.4	2.9	7.9	15.8	9.5	2.6	8.9	28.5	5.4	0.0	25.7	6.0	1.7	13.7	15.6	30.1	42.8	17.4	32.1	22.9	0.0	8.1	12.5	7.0	0.2	0.3	20.0	1.4	2.5	0.6	1.8	1.5	0.1	52.0	3.6	0.8	1.8	0.1	9.9	6.7	1.5	11.8	15.6	6.6	10.6	6.0	1.0	6.9	18.4	1.4	2.7	2.0	0.1	4.9	2.1	35.9	0.1	20.9	1.7	1.9	49.3	1.3	5.5	0.1	2.1	12.2	0.3	24.8	6.6	7.4	18.1	7.2	0.1	7.1	1.1	12.7	4.8	0.2	2.9	0.4	5.3	1.7	1.3	38.4	9.6	36.6	5.5	8.3	2.9	17.4	4.3	30.1	32.1	20.0	22.9	13.7	23.3	27.7	6.2	13.4	24.7	28.1	14.4	17.4	42.8	15.6	18.4	22.9	28.6	31.7	39.1	38.3	28.7	20.4	16.2	27.2	15.8	8.9	3.0	24.0	31.6	2.0	1.0	56.1	15.1	10.2	6.7	11.4	150.1	15.7	28.2	147.6	8.4	15.2	2.7	5.3	0.0	1.4	38.9	2.1	1.2	2.3	30.8	4.7	85.8	13.8	7.4	5.4	14.9	1.7	6.2	6.8	13.6	5.6	10.9	2.5	9.9	6.3	46.6	33.3	0.0	7.1	2.3	11.5	1.3	17.6	48.4	8.8	1.4
CYTH2	"ARNO, CTS18.1, cytohesin-2, PSCD2, PSCD2L, Sec7p-L, Sec7p-like"	ENSG00000105443	"Cytohesin 2"	Q99418	19	48469032-48482314	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 195.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB014872, HPA060662"	Uncertain		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		11000	Cytosol	"Golgi apparatus, Plasma membrane"	"CAB014872: , HPA060662: AB_2732652"	"unprognostic (2.28e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.97e-2)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (1.66e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.33e-2)"	"unprognostic (9.19e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (3.21e-4)"	13.5	14.2	12.7	14.1	13.6	8.0	19.5	11.4	24.4	21.9	11.7	12.9	14.8	23.2	15.4	15.9	18.8	15.0	25.5	8.3	12.4	7.4	19.2	8.9	15.2	10.0	13.2	18.9	14.4	17.3	35.1	21.0	21.1	12.4	18.0	9.7	13.5	24.2	14.4	7.4	19.9	23.0	12.2	8.7	13.0	19.2	42.0	13.5	18.4	46.2	15.1	10.6	15.6	15.9	4.1	5.6	11.1	4.0	1.8	6.1	3.2	9.0	13.7	41.7	9.4	6.3	5.5	7.6	7.1	6.5	7.6	7.2	7.5	12.3	5.9	7.5	6.2	6.3	11.4	8.0	8.7	4.9	9.0	10.9	8.4	17.2	8.0	5.7	5.1	11.5	7.0	14.9	9.5	6.1	35.0	9.8	8.8	8.3	20.9	10.1	7.3	8.5	37.3	4.5	8.1	5.7	10.9	6.3	4.1	13.0	19.7	12.2	12.0	7.8	21.9	6.0	13.5	10.3	6.9	10.6	16.5	8.4	3.9	10.1	20.8	11.0	3.9	6.0	10.2	11.5	4.1	4.0	3.3	4.1	3.0	2.7	4.1	5.3	6.1	3.3	2.7	4.9	3.4	11.1	1.8	3.9	5.6	5.3	3.2	12.7	13.6	11.4	24.4	12.4	7.4	13.2	18.9	12.4	13.5	26.8	33.9	13.7	98.2	40.8	35.5	10.1	58.6	50.9	33.0	38.4	23.6	40.9	29.9	73.0	195.8	42.1	25.3	0.0	81.0	38.9	34.0	62.5	16.3	7.8	38.3	20.6	25.0	36.8	22.1	127.7	34.5	34.4	33.7	73.1	30.9	37.8	102.2	41.6	34.6	39.6	55.8	51.8	45.9	70.2	46.4	41.5	119.3	32.0	31.1	126.1
CYTH4	"CYT4, cytohesin-4, PSCD4"	ENSG00000100055	"Cytohesin 4"	Q9UIA0	22	37282027-37315345	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 52.3;lymphoid tissue: 53.9"	"Cell type enhanced"	"Detected in some"	11	"granulocytes: 55.4;Hofbauer cells: 64.0;Kupffer cells: 57.8;Macrophages: 83.4;T-cells: 48.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HL-60: 12.1;HMC-1: 50.8;THP-1: 33.3;U-266/70: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004065, HPA071573"	Approved		Supported	"Plasma membrane,Cytokinetic bridge,Centriolar satellite,Cytosol"		NA	NA			"Plasma membrane"	"Cytokinetic bridge, Centriolar satellite, Cytosol"	"HPA004065: , HPA071573: AB_2686418"	"unprognostic (4.30e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.28e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.42e-2)"	"prognostic unfavorable (2.41e-8)"	"unprognostic (3.70e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.07e-1)"	13.6	6.6	7.0	32.0	9.2	24.2	7.6	1.5	4.2	2.9	5.0	7.0	0.9	4.1	3.9	6.5	3.2	5.5	8.3	9.2	4.7	3.7	5.1	4.5	14.8	27.4	10.3	2.6	2.5	3.1	1.1	3.7	13.5	6.9	4.0	4.8	4.6	10.3	2.1	2.1	3.0	13.2	6.0	9.9	53.9	5.4	2.3	7.5	12.9	3.6	2.9	22.9	12.0	3.2	8.0	27.2	52.3	31.4	11.4	15.1	16.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.2	0.1	0.0	0.8	0.0	0.0	0.2	0.0	1.8	0.0	3.5	0.0	0.0	0.0	12.1	50.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.1	4.5	0.0	0.0	0.3	0.4	0.1	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.3	0.1	0.0	0.0	0.0	0.0	10.3	1.3	1.6	6.9	4.1	0.1	3.7	15.6	21.6	15.1	26.4	10.6	7.8	8.3	11.9	12.4	8.0	8.0	10.6	52.3	11.4	31.4	27.2	7.5	16.1	7.0	9.2	1.5	4.2	4.7	3.7	10.3	2.6	6.9	7.5	3.0	12.5	18.1	0.7	2.2	0.0	1.6	0.0	0.0	3.4	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.6	2.1	0.3	55.4	0.8	64.0	0.0	0.0	2.5	57.8	0.0	0.6	83.4	6.8	1.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.8	0.0	0.1	1.9	0.8	48.9	0.0	0.6
DAG1	"156DAG, A3a, AGRNR, DAG"	ENSG00000173402	"Dystroglycan 1"	Q14118	3	49468703-49535618	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 62.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001960, CAB016353, HPA070563"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		70000000	"Vesicles, Plasma membrane"	Nucleoplasm	"CAB001960: , CAB016353: AB_627292, HPA070563: "	"unprognostic (1.58e-1)"	"unprognostic (5.14e-1)"	"unprognostic (6.71e-3)"	"unprognostic (3.32e-1)"	"unprognostic (7.39e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.27e-2)"	"unprognostic (8.18e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.10e-1)"	"prognostic favorable (2.59e-4)"	"unprognostic (9.22e-2)"	"unprognostic (1.99e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.57e-2)"	19.2	17.4	16.5	10.1	21.1	2.8	16.2	17.3	27.1	17.3	23.9	24.1	13.1	14.1	23.4	14.3	19.1	19.6	19.7	40.9	19.9	10.3	22.7	31.7	18.9	6.3	16.7	15.7	22.6	35.0	32.7	15.8	45.6	18.1	18.6	18.9	22.2	19.9	24.3	57.3	18.7	17.5	27.9	14.0	7.3	22.2	29.4	16.3	6.0	15.3	24.0	14.3	20.4	15.0	3.2	3.6	1.8	6.1	1.9	3.7	3.3	19.5	19.5	13.6	33.6	18.2	8.9	62.0	13.8	20.5	23.7	15.3	16.0	20.8	2.7	14.1	22.5	20.1	36.7	11.8	17.9	14.7	2.6	3.9	1.8	19.6	18.2	8.1	2.4	3.9	7.8	16.2	22.5	7.5	21.7	21.2	3.3	2.8	2.1	6.4	15.7	2.0	1.6	14.6	24.1	6.5	1.2	13.2	4.6	18.6	27.5	4.8	9.9	16.6	45.8	22.4	41.3	38.6	4.8	11.1	9.0	14.3	16.7	19.7	2.4	4.9	1.7	10.9	2.6	54.3	1.8	2.8	1.1	3.3	3.5	3.7	3.2	2.8	2.5	1.8	2.6	3.0	2.4	0.6	1.9	6.1	3.6	1.9	3.3	16.5	21.1	17.3	27.1	19.9	10.3	16.7	15.7	18.1	16.3	50.6	13.6	9.0	8.0	12.7	7.8	50.0	30.6	10.7	11.4	33.2	3.9	95.1	1.7	26.2	25.8	16.8	20.6	0.0	69.3	96.3	24.2	13.2	6.9	48.8	18.3	3.2	31.7	17.8	7.2	13.6	19.8	4.0	32.1	5.4	27.5	30.3	50.2	25.1	34.6	6.8	8.7	45.3	23.7	7.0	18.6	14.9	80.2	5.0	26.4	9.0
DAGLB	"DAGLBETA, KCCR13L"	ENSG00000164535	"Diacylglycerol lipase beta"	Q8NCG7	7	6409126-6484190	"Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069377			Supported	"Nucleoplasm,Plasma membrane"		No	No			"Plasma membrane"	Nucleoplasm	"HPA069377: AB_2686132"	"unprognostic (2.39e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.13e-3)"	"unprognostic (1.42e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (7.18e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-2)"	20.1	28.2	12.6	12.7	20.3	25.8	29.8	18.4	26.1	19.1	18.0	11.4	19.4	15.1	14.3	17.5	16.2	12.5	26.6	18.9	12.4	13.8	24.0	88.0	18.4	25.2	11.6	5.8	22.5	47.0	14.2	19.0	45.7	7.5	14.6	10.6	14.6	34.1	22.3	22.0	22.1	31.3	16.0	13.2	15.1	14.0	27.1	7.9	7.2	23.1	15.1	16.8	15.6	20.8	5.6	18.9	13.6	14.7	2.4	8.4	7.5	10.9	12.5	5.4	7.0	8.2	6.4	4.3	15.4	10.5	13.3	14.4	6.6	12.0	5.9	6.7	7.4	32.5	16.2	8.8	8.1	7.6	2.7	6.1	3.1	14.3	4.5	8.8	8.9	5.0	5.7	13.5	8.9	8.8	5.3	5.7	7.6	8.9	2.9	7.8	7.7	3.1	12.6	19.7	5.4	9.5	27.4	6.2	12.7	8.4	4.0	7.0	4.2	8.7	13.4	2.5	9.0	9.3	16.7	7.0	11.5	21.9	14.4	7.1	3.1	5.6	5.0	5.7	14.0	13.9	6.2	14.7	13.6	4.4	13.9	3.9	5.6	3.5	2.9	18.9	3.6	8.4	4.8	7.3	2.4	12.2	3.2	2.9	7.5	12.6	20.3	18.4	23.4	12.4	13.8	11.6	5.8	7.5	7.9	8.9	13.0	3.9	2.8	14.9	4.2	2.4	2.5	2.7	3.4	5.2	2.0	4.4	0.0	6.2	0.4	6.7	10.9	0.0	5.3	7.7	4.6	4.6	3.5	6.2	14.7	0.0	2.4	8.0	15.4	0.9	5.8	15.3	5.0	11.8	4.7	0.9	9.2	5.8	2.1	1.8	4.5	0.0	5.7	7.2	6.8	11.7	10.4	5.3	6.3	3.2
DCT	TYRP2	ENSG00000080166	"Dopachrome tautomerase"	P40126	13	94436808-94479682	"Enzymes, Predicted membrane proteins"	"Melanin biosynthesis"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	58	"retina: 151.5;skin 1: 54.2"	"Cell type enriched"	"Detected in some"	25	"Melanocytes: 3369.1"	"Cancer enriched"	"Detected in some"	215	"melanoma: 155.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	259	"SK-MEL-30: 76.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA010742, HPA010743, HPA010800, CAB017634"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"CAB017634: AB_1130818, HPA010742: , HPA010743: AB_1847519, HPA010800: AB_1847520"	"unprognostic (5.99e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.06e-2)"	"unprognostic (6.18e-5)"	"unprognostic (6.97e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.42e-1)"	0.2	0.2	0.5	0.1	1.5	0.1	1.7	0.2	0.6	0.2	0.1	0.3	0.1	0.0	0.2	0.5	0.1	0.8	0.1	0.1	0.4	0.5	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.1	1.4	0.1	0.3	0.2	0.0	151.5	1.4	0.2	0.2	54.2	0.2	0.1	0.8	0.1	0.0	0.3	0.4	0.1	0.1	0.3	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	76.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	1.5	0.2	0.6	0.4	0.5	0.3	0.1	0.3	0.4	0.0	0.0	0.0	0.1	135.3	0.7	0.8	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	12.6	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.9	0.0	3369.1	0.0	0.0	2.4	0.0	0.0	0.7	0.0	0.2	0.0	0.9	0.5	0.2	29.2	0.0	0.0	0.0	0.0
DCTN6	WS-3	ENSG00000104671	"Dynactin subunit 6"	O00399	8	30156297-30183640	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024049, HPA024558"	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Nucleoli, Cytosol"	"Plasma membrane"	"HPA024049: AB_1847524, HPA024558: AB_1847525"	"unprognostic (1.28e-1)"	"unprognostic (8.32e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.50e-2)"	"prognostic unfavorable (5.51e-4)"	"unprognostic (1.26e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.38e-2)"	"unprognostic (9.26e-2)"	"prognostic favorable (5.42e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.43e-1)"	29.5	34.6	41.4	15.6	39.4	23.3	32.6	23.6	43.6	21.0	20.6	27.4	15.4	14.2	24.1	27.2	24.1	18.0	20.0	44.5	37.7	35.2	32.8	27.5	20.3	15.3	42.3	36.3	26.3	19.5	31.0	27.7	32.7	41.4	21.9	22.5	16.5	20.3	23.7	20.4	17.5	15.6	26.0	46.2	16.8	19.3	13.9	30.3	15.4	33.7	18.2	17.9	25.7	18.8	7.4	19.8	9.5	15.9	10.2	11.2	6.9	19.1	18.3	23.3	12.2	21.1	29.2	14.9	26.1	30.1	25.4	26.7	11.9	12.8	14.2	28.0	27.2	23.8	14.2	16.1	22.0	30.0	11.4	12.5	20.4	15.8	18.6	16.3	11.5	17.4	24.6	31.4	18.2	19.5	22.1	22.7	20.5	22.8	15.7	27.0	14.5	21.3	16.6	18.9	32.2	11.7	11.4	17.5	12.4	36.1	18.8	38.1	21.6	15.2	18.6	25.8	12.3	18.0	16.3	21.8	13.8	48.3	11.3	18.5	6.7	7.4	18.4	25.5	13.2	24.0	9.5	14.1	4.9	8.6	15.9	9.8	7.4	7.8	10.1	16.8	5.5	9.0	11.2	4.5	10.2	15.1	19.8	8.7	6.9	41.4	39.4	23.6	43.6	37.7	35.2	42.3	36.3	41.4	30.3	23.8	31.2	37.4	81.1	50.8	33.7	73.4	45.9	57.6	37.5	41.8	13.7	76.0	104.5	78.2	11.6	53.1	26.3	0.0	74.2	71.3	55.9	41.2	46.1	41.8	61.9	25.4	39.2	44.2	46.4	7.3	74.8	51.6	65.8	65.9	27.4	43.3	77.1	38.6	70.7	114.8	36.3	51.8	70.0	42.8	48.2	55.6	170.3	40.5	29.2	81.2
DDR2	"NTRKR3, TKT, TYRO10"	ENSG00000162733	"Discoidin domain receptor tyrosine kinase 2"	Q16832	1	162631373-162787400	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Osteogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Fibroblasts: 84.7;Leydig cells: 58.4;Peritubular cells: 83.1;Smooth muscle cells: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.1;MAIT T-cell: 1.3"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 61.7;ASC TERT1: 61.0;BJ hTERT+: 45.1;fHDF/TERT166: 32.3;HSkMC: 43.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070112			Supported	"Plasma membrane,Actin filaments"		Yes	No		850000	"Plasma membrane, Actin filaments"		"HPA070112: AB_2686229"	"unprognostic (4.12e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.97e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.73e-7)"	"unprognostic (1.56e-3)"	"unprognostic (8.26e-3)"	"unprognostic (7.57e-2)"	"unprognostic (4.10e-3)"	42.1	43.5	4.7	10.9	6.9	0.2	15.6	7.9	7.1	30.3	30.4	9.0	18.6	3.3	24.2	17.7	25.0	13.4	16.6	15.4	7.9	4.7	4.0	3.3	8.9	5.1	12.9	3.4	26.4	2.2	2.1	4.0	6.6	12.7	21.8	9.1	30.7	6.4	19.3	5.2	6.1	10.1	34.3	19.7	3.4	14.1	8.3	7.5	0.0	8.6	12.8	4.1	29.0	18.3	0.1	0.2	0.0	0.0	0.2	1.3	0.0	0.1	0.0	0.0	16.3	61.7	61.0	0.2	24.0	45.1	10.5	15.1	0.0	0.0	0.0	0.0	32.3	2.1	0.0	0.0	0.1	14.4	12.9	0.1	0.0	0.1	0.0	26.8	0.0	0.0	43.3	0.1	18.5	0.5	17.0	12.1	0.1	0.1	5.1	9.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	6.9	0.1	0.0	0.0	0.0	9.9	0.0	0.0	0.8	0.9	0.0	0.0	0.6	16.8	3.7	8.5	3.3	0.7	1.3	0.0	15.2	0.0	17.0	0.0	0.0	0.0	1.1	0.0	1.3	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	4.7	6.9	7.9	7.1	7.9	4.7	12.9	3.4	12.7	7.5	3.0	2.9	0.0	2.4	11.2	3.1	23.3	2.5	4.0	1.2	0.0	0.0	0.5	0.0	0.5	6.9	21.3	2.0	0.0	1.5	0.4	84.7	4.1	1.1	3.0	1.1	0.0	1.2	24.5	2.1	4.0	58.4	1.5	21.9	0.0	0.7	19.0	1.5	1.7	83.1	0.9	2.9	38.8	68.4	0.9	0.9	7.5	0.8	1.3	0.6	3.3
DGKG	DAGK3	ENSG00000058866	"Diacylglycerol kinase gamma"	P49619	3	186105668-186362237	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.4"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 16.2;Ito cells: 27.6;Muller glia cells: 7.5;Sertoli cells: 12.9;Smooth muscle cells: 16.7"	"Cancer enhanced"	"Detected in some"		"glioma: 2.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 4.2;eosinophil: 2.4;intermediate monocyte: 2.4;myeloid DC: 2.9;neutrophil: 5.3;non-classical monocyte: 2.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.9;granulocytes: 5.3;monocytes: 4.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 20.2;HL-60: 6.4;U-266/84: 7.7;U-87 MG: 12.8;U-937: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036577	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA036577: AB_10672358"	"unprognostic (2.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.24e-5)"	"unprognostic (2.70e-1)"	"unprognostic (6.09e-4)"	"unprognostic (1.21e-3)"	"unprognostic (3.80e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.09e-2)"	"unprognostic (8.05e-7)"	"unprognostic (3.47e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.16e-3)"	3.1	6.9	13.4	3.1	7.1	14.5	1.9	53.4	23.1	2.7	3.5	6.2	1.1	3.0	1.9	14.6	8.5	7.7	2.2	15.0	15.3	7.4	3.1	2.1	4.3	2.1	7.4	11.3	2.0	1.6	4.7	7.5	13.5	25.2	3.1	2.1	7.8	1.9	4.0	2.4	1.4	2.7	5.3	5.6	2.0	3.3	1.2	7.1	0.0	2.5	0.0	2.1	4.8	2.4	0.6	2.9	5.3	4.2	0.0	0.0	1.3	2.7	4.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	2.4	0.0	2.9	0.2	0.0	0.0	0.0	20.2	0.0	2.7	0.0	2.9	0.0	6.4	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.5	0.0	0.4	0.3	0.1	0.1	2.2	0.4	0.0	1.2	1.4	0.0	2.3	0.0	0.0	0.5	0.0	0.8	0.0	1.7	0.0	0.1	4.2	0.0	0.0	0.7	2.1	2.4	0.0	7.7	0.0	12.8	6.0	2.3	0.0	4.2	2.4	0.0	2.4	0.0	0.6	0.0	0.0	2.9	0.3	0.0	0.0	5.3	0.0	2.8	0.5	0.0	1.3	13.4	7.1	53.4	14.7	15.3	7.4	7.4	11.3	25.2	7.1	0.0	1.7	1.5	0.1	0.3	0.0	16.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	1.2	2.4	0.0	0.0	0.0	1.1	0.0	0.2	0.1	0.0	0.0	1.9	1.6	0.0	27.6	2.7	2.0	1.7	2.3	0.0	1.0	0.0	7.5	0.7	0.0	0.4	0.8	0.0	12.9	16.7	0.0	0.0	0.4	0.1	0.0	0.0	0.4
DGKH	DGKeta	ENSG00000102780	"Diacylglycerol kinase eta"	Q86XP1	13	42040036-42256578	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Urothelial cells: 105.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039533, HPA040355, HPA061538"	Uncertain		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA039533: AB_10795145, HPA040355: AB_10796452, HPA061538: "	"unprognostic (2.80e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.55e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.60e-2)"	"unprognostic (7.00e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.43e-2)"	4.9	2.8	3.3	4.9	12.7	2.3	8.3	9.6	6.2	5.2	6.4	3.4	7.9	3.1	9.4	14.0	5.2	5.9	6.8	10.2	9.0	2.7	6.0	6.8	9.5	4.0	3.5	4.0	4.3	4.2	1.4	3.5	8.9	3.6	4.6	6.9	5.5	7.7	4.8	5.8	6.2	5.1	8.3	3.5	6.1	4.0	7.0	4.3	2.2	4.3	2.0	2.9	8.1	6.0	1.4	1.5	4.3	1.3	0.7	1.7	0.2	4.9	5.8	4.8	3.7	1.8	4.1	0.5	3.2	2.5	2.1	2.6	0.5	4.3	3.9	3.9	3.3	7.4	11.0	4.1	7.1	3.2	3.3	11.5	7.0	3.1	0.4	2.3	2.9	2.0	1.5	7.2	4.0	16.4	3.1	9.4	5.1	2.8	2.7	3.6	4.7	3.0	1.6	1.9	4.8	4.0	4.7	3.9	2.7	7.0	15.0	2.7	2.5	2.9	3.7	2.7	1.9	3.4	8.2	9.1	4.0	3.6	4.3	4.3	1.4	1.3	4.5	2.2	2.7	2.8	2.4	1.3	0.6	1.1	0.9	1.2	0.8	1.7	1.7	0.3	1.4	1.0	1.6	4.3	0.7	0.7	1.5	1.1	0.2	3.3	12.7	9.6	6.2	9.0	2.7	3.5	4.0	3.6	4.3	20.8	28.6	1.9	54.1	54.8	48.5	7.1	25.5	69.6	39.8	10.4	3.9	3.3	1.7	10.6	21.9	28.0	13.6	0.0	6.3	1.8	13.3	64.9	7.0	2.6	5.8	1.6	45.5	27.0	7.5	14.9	3.1	16.5	8.5	9.0	22.6	15.5	17.7	14.4	8.5	7.3	2.2	25.8	35.8	2.3	2.6	29.0	2.4	5.1	18.0	105.9
DIAPH3	"AN, AUNA1, DRF3, FLJ34705, NSDAN"	ENSG00000139734	"Diaphanous related formin 3"	Q9NSV4	13	59665583-60163987	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Deafness, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 35.2;testis: 19.6"	"Cell type enriched"	"Detected in many"	6	"Early spermatids: 290.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	4	"plasmacytoid DC: 2.0"	"Lineage enriched"	"Detected in single"	4	"dendritic cells: 2.0"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 39.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA032151			Supported	"Plasma membrane,Microtubules"		NA	Yes			"Plasma membrane, Microtubules"		"HPA032151: AB_2674181"	"unprognostic (3.78e-2)"	"unprognostic (1.28e-2)"	"prognostic favorable (9.04e-4)"	"prognostic unfavorable (4.18e-4)"	"unprognostic (2.78e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.27e-4)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.22e-5)"	"unprognostic (3.59e-3)"	"unprognostic (5.31e-5)"	"unprognostic (4.30e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.74e-3)"	1.8	0.4	1.7	11.5	1.8	6.7	1.6	0.1	1.4	0.9	4.7	0.2	0.4	2.0	1.4	1.1	7.1	0.3	2.5	1.1	1.0	1.6	1.7	0.4	4.1	2.9	1.0	0.0	0.4	0.4	0.5	0.2	9.4	0.2	0.4	2.3	0.0	1.6	0.0	0.1	1.8	4.3	2.7	0.3	2.5	3.1	19.6	0.0	35.2	0.2	5.3	5.9	0.8	1.5	0.4	2.0	0.4	0.2	0.0	0.5	0.2	18.3	6.1	6.4	3.6	1.1	2.9	10.8	25.7	11.4	26.0	22.7	16.2	12.5	6.1	2.1	13.1	6.8	12.6	10.3	10.1	39.7	6.9	7.1	8.8	15.7	3.6	1.7	11.9	7.0	1.1	0.2	15.8	10.7	6.6	11.6	5.6	6.7	8.8	24.7	2.6	10.6	5.1	5.9	8.7	3.5	7.2	15.7	5.0	8.5	3.8	3.3	5.8	13.1	9.1	3.9	14.3	6.6	6.5	11.5	16.5	10.6	5.5	21.2	5.9	6.5	9.6	4.4	5.9	12.4	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	2.0	0.5	0.2	1.7	1.8	0.1	1.4	1.0	1.6	1.0	0.0	0.2	0.0	50.6	4.3	0.8	0.3	3.3	0.0	0.4	2.5	0.0	2.3	0.0	0.0	8.7	5.0	0.6	290.3	0.7	1.3	23.3	3.7	26.7	3.3	0.3	0.0	0.4	5.2	0.0	0.0	2.5	0.6	34.3	0.6	1.2	0.0	0.0	1.1	2.3	1.3	0.0	0.0	3.1	0.0	0.0	0.0	34.2	17.3	1.0	6.1	0.9	1.7	0.6
DNAJC5	"CLN4, DNAJC5A, FLJ00118, FLJ13070"	ENSG00000101152	"DnaJ heat shock protein family (Hsp40) member C5"	Q9H3Z4	20	63895182-63936031	"Disease related genes, Predicted membrane proteins"		Chaperone	"Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012139, HPA012737, HPA013154"	Approved		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Golgi apparatus, Plasma membrane"	Vesicles	"HPA012139: , HPA012737: AB_1847293, HPA013154: AB_1847292"	"unprognostic (9.96e-3)"	"unprognostic (2.75e-1)"	"unprognostic (3.91e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (8.82e-6)"	"unprognostic (3.04e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.51e-1)"	"prognostic favorable (7.70e-6)"	"unprognostic (2.24e-2)"	"unprognostic (3.54e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.08e-2)"	13.0	14.2	30.5	12.1	36.6	16.4	8.5	38.0	48.6	7.3	12.3	11.2	9.6	14.2	7.2	7.8	29.9	10.8	8.7	22.6	28.1	31.6	9.3	9.6	12.3	14.5	23.8	26.7	5.9	23.7	20.7	15.1	10.7	23.4	11.2	8.9	12.8	14.9	14.3	10.2	16.5	14.7	9.9	12.8	11.7	11.4	8.2	9.2	8.1	14.7	8.4	10.1	11.8	8.2	3.2	9.0	7.5	7.6	2.6	6.7	4.5	11.9	11.3	9.6	9.2	9.7	7.6	7.0	13.3	12.7	23.4	11.3	26.3	14.3	4.8	14.7	13.0	11.3	16.9	7.7	25.1	8.8	3.6	6.1	9.1	8.5	14.6	9.0	8.9	20.7	8.8	19.2	10.8	5.8	9.5	11.7	8.0	8.9	4.2	10.7	8.6	9.5	15.1	3.5	10.4	13.6	9.5	5.4	4.9	8.6	11.6	10.5	6.7	14.4	24.3	8.2	6.3	11.4	36.1	20.5	20.9	6.8	9.8	10.1	4.9	2.4	6.5	20.9	12.0	12.4	2.2	7.5	4.8	6.7	7.6	4.4	3.2	4.4	6.1	5.2	2.9	5.2	5.6	7.5	2.6	5.7	9.0	5.9	4.5	30.5	36.6	38.0	43.5	28.1	31.6	23.8	26.7	23.4	9.2	6.0	16.2	5.3	10.4	18.4	55.1	25.2	15.3	6.7	14.8	22.7	58.9	15.2	11.6	18.8	39.2	18.0	53.6	23.3	32.2	14.9	9.5	25.8	1.1	24.1	37.2	74.7	31.2	26.4	43.4	86.4	6.6	20.5	13.5	20.8	27.7	20.9	42.5	35.1	11.7	19.2	43.4	12.9	10.8	12.0	13.8	19.9	25.3	10.2	23.4	59.6
DNAJC9	"JDD1, SB73"	ENSG00000213551	"DnaJ heat shock protein family (Hsp40) member C9"	Q8WXX5	10	73183362-73248862	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 24.2"	"Cell type enhanced"	"Detected in all"	5	"Erythroid cells: 140.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035215, HPA035216"	Supported		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA035215: AB_10603663, HPA035216: AB_2674522"	"unprognostic (4.18e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.67e-3)"	"unprognostic (3.45e-1)"	"unprognostic (6.83e-3)"	"unprognostic (2.43e-3)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (6.20e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.91e-1)"	"prognostic unfavorable (7.07e-5)"	"unprognostic (5.61e-2)"	"unprognostic (3.08e-3)"	"unprognostic (6.49e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.56e-1)"	3.1	4.0	4.0	5.0	4.3	24.2	4.6	12.9	5.8	3.0	4.6			4.2	4.0	3.9	6.8	2.9	1.7	2.7	4.2	5.2	2.8	3.5	2.9	7.7	3.5		5.2	2.6	3.6	4.3	5.4		3.6	5.8		3.6	3.9	3.4	5.3	4.1	3.8	3.1	5.9	3.4	4.3			2.9		9.9	3.1	4.4	15.6	9.4	13.2	4.9	10.6	16.5	8.8	26.5	16.4	21.3	17.6	5.1	5.0	9.4	21.6	12.8	21.7	22.7	28.1	18.7	18.4	7.1	9.5	9.3	18.1	21.3	14.3	24.6	21.3	14.7	39.1	16.8	18.6	3.5	34.3	15.8	4.0	7.9	22.8	20.0	10.6	14.3	23.4	34.9	21.4	17.1	24.6	33.2	26.0	7.8	12.6	46.0	24.7	18.6	10.1	10.8	12.9	10.2	17.2	15.8	26.0	11.3	10.2	13.6	16.1	10.4	14.5	25.7	15.5	32.9	10.0	15.1	29.6	14.6	34.2	9.3	7.3	1.8	13.2	13.0	4.9	14.4	15.6	15.9	14.1	3.0	12.7	15.6	13.8	2.1	10.6	4.7	9.4	16.5	8.8											8.9	10.5	40.2	29.5	42.4	24.8	2.4	25.5	29.4	27.3	8.7	7.9	69.3	18.3	29.2	74.3	18.0	13.1	140.2	27.2	89.2	17.4	20.5	39.5	8.2	51.9	14.3	11.5	9.8	11.3	30.7	13.0	16.8	30.4	31.5	17.2	26.4	30.7	17.3	19.1	11.3	38.3	25.8	22.7	21.1	59.5	38.0	48.5	45.3	32.2	33.3
DOCK4	"FLJ34238, KIAA0716"	ENSG00000128512	"Dedicator of cytokinesis 4"	Q8N1I0	7	111726110-112206411	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 44.7;Horizontal cells: 89.0;Ito cells: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 6.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.4"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 19.2;HUVEC TERT2: 36.4;TIME: 31.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071516			Approved	"Nucleoli,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Nucleoli, Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA071516: AB_2686407"	"unprognostic (1.37e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.48e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.78e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.48e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.39e-2)"	10.7	6.5	16.5	10.0	28.2	2.3	6.8	11.7	28.2	9.1	4.4	21.0	2.0	2.8	7.9	4.4	4.4	8.7	7.9	6.9	22.2	10.1	7.3	13.9	25.5	3.7	18.2	12.4	14.2	5.0	4.7	4.0	10.8	12.2	6.5	4.9	1.7	4.4	3.9	6.7	3.5	3.2	10.7	20.3	3.2	3.1	3.5	21.8	0.0	5.8	2.7	3.6	5.7	5.2	0.2	0.3	6.4	1.2	0.1	0.1	0.2	0.0	1.7	4.1	3.3	3.4	5.0	2.3	0.4	4.5	0.8	1.3	0.0	0.0	0.3	3.4	1.0	0.9	0.2	0.6	3.9	3.5	1.2	6.7	0.1	2.8	5.7	2.4	0.5	0.2	2.6	0.4	19.2	9.9	1.2	36.4	1.6	0.0	10.3	1.7	0.4	0.8	0.2	2.2	0.5	7.0	0.2	3.0	1.6	2.8	0.1	0.9	3.2	2.5	2.1	2.5	3.8	0.3	0.1	31.4	3.2	1.5	6.1	1.3	0.4	0.1	0.3	0.3	0.8	7.1	0.2	0.7	0.1	0.0	1.2	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.1	6.4	0.1	0.2	0.3	0.0	0.2	16.5	28.2	11.7	18.2	22.2	10.1	18.2	12.4	12.2	21.8	44.7	5.0	0.5	3.6	4.6	26.2	11.6	2.5	12.0	21.6	3.5	21.6	0.2	0.0	1.4	2.4	32.2	0.7	0.0	0.3	0.2	6.0	9.4	2.3	14.9	13.6	89.0	10.5	40.5	15.6	1.1	5.2	17.3	8.5	8.2	0.7	4.4	1.0	9.9	7.8	1.1	10.3	12.9	3.3	0.7	1.7	2.4	0.0	0.0	0.8	1.6
DOK3	FLJ22570	ENSG00000146094	"Docking protein 3"	Q7L591	5	177501907-177511274	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 47.5;bone marrow: 51.8;lymphoid tissue: 50.0"	"Cell type enhanced"	"Detected in some"	14	"granulocytes: 17.4;Hofbauer cells: 49.3;Kupffer cells: 45.9;Macrophages: 19.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 47.5"	"Group enriched"	"Detected in many"	6	"B-cells: 12.7;granulocytes: 47.5;monocytes: 23.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 41.4;HMC-1: 33.7;REH: 51.0;U-698: 40.9;U-937: 29.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA077312	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"		NA	NA		750000	"Plasma membrane"	"Nucleoplasm, Cytokinetic bridge, Cytosol"	"HPA077312: AB_2732339"	"unprognostic (2.21e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.17e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (3.82e-11)"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.78e-2)"	6.9	2.4	2.7	22.6	7.1	51.8	4.7	2.7	3.3	1.4	2.4	1.5	0.4	3.6	1.4	2.5	2.4	3.3	2.4	2.2	3.6	2.2	2.3	4.0	10.9	26.3	6.1	0.7	2.0	1.8	0.4	1.4	4.0	4.1	2.1	1.8	2.3	4.1	1.0	1.3	1.0	10.8	2.4	7.6	50.0	2.9	3.1	2.9	1.9	1.7	0.6	21.7	4.8	1.5	12.7	4.8	47.5	23.2	0.1	0.1	7.8	1.4	2.2	1.5	1.8	0.9	0.1	4.0	1.2	0.2	4.0	3.7	3.3	0.6	41.4	0.9	1.0	2.0	2.5	3.4	2.1	1.9	7.5	4.5	6.7	5.2	0.6	0.3	15.6	33.7	0.5	1.3	4.5	0.4	0.4	0.7	3.3	4.6	18.2	1.4	3.8	0.7	19.7	3.8	0.4	3.9	51.0	3.1	0.3	1.2	1.5	2.2	1.4	0.5	0.6	1.8	1.4	3.5	22.1	0.9	3.8	3.6	1.9	1.4	3.7	4.0	40.9	0.8	29.5	0.7	4.7	20.6	19.9	0.1	20.4	0.1	12.7	0.0	0.1	4.8	6.7	0.0	0.0	47.5	0.1	23.2	0.3	0.0	7.8	2.7	7.1	2.7	3.3	3.6	2.2	6.1	0.7	4.1	2.9	0.0	9.3	13.0	0.1	0.2	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.4	0.0	0.0	0.2	0.5	0.4	0.1	17.4	0.0	49.3	0.0	0.0	8.0	45.9	0.0	0.6	19.8	1.7	1.0	0.1	0.5	0.0	0.0	1.1	0.0	0.6	0.0	0.4	3.0	1.9	0.3	0.8	0.0	0.6	0.1
DYSF	"FER1L1, LGMD2B"	ENSG00000135636	Dysferlin	O75923	2	71453722-71686768	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 39.9;skeletal muscle: 53.3"	"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 20.1;Endothelial cells: 22.1;Ito cells: 34.4;Kupffer cells: 20.6;Syncytiotrophoblasts: 55.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 19.9"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 19.9"	"Group enriched"	"Detected in some"	5	"hTERT-RPE1: 12.8;HUVEC TERT2: 32.9;LHCN-M2: 29.9;RH-30: 31.6;TIME: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002510, HPA017071, HPA021945"	Enhanced		Supported	"Plasma membrane,Centriolar satellite"		Yes	No			"Plasma membrane, Centriolar satellite"		"CAB002510: AB_442097, HPA017071: AB_1847927, HPA021945: AB_1847928"	"unprognostic (1.04e-1)"	"unprognostic (7.66e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.43e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.97e-3)"	6.6	2.1	1.1	7.2	1.3	18.6	7.9	1.2	2.0	1.9	6.4	0.0	3.9	1.6	4.2	4.9	5.1	3.6	3.3	20.8	1.2	2.0	4.7	13.4	9.1	17.8	2.1	0.7	4.1	1.4	2.0	2.1	39.9	7.0	4.8	1.9	3.3	1.9	3.6	53.3	1.7	3.3	12.1	1.4	26.5	3.2	1.5	0.3	0.8	4.9	8.3	1.0	8.7	11.9	0.0	0.0	19.9	2.6	0.3	0.3	0.7	0.4	0.0	1.3	1.1	0.0	0.0	2.4	0.0	0.3	0.9	0.6	0.1	0.3	0.0	4.9	0.0	1.3	1.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.9	4.2	12.8	32.9	0.0	3.1	0.0	29.9	0.0	0.0	2.2	3.2	0.0	0.3	0.0	31.6	0.0	1.0	0.0	0.0	0.0	1.5	0.2	0.0	3.3	0.1	0.3	21.5	0.1	1.5	0.1	0.4	0.0	0.0	0.0	0.0	5.2	0.0	0.0	2.6	0.0	0.3	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	19.9	0.3	0.1	0.0	0.0	0.7	1.1	1.3	1.2	2.0	1.2	2.0	2.1	0.7	7.0	0.3	3.0	13.8	0.5	0.0	2.2	0.8	20.1	0.0	1.4	2.3	0.0	0.0	5.4	0.0	0.4	4.4	22.1	0.0	0.0	0.2	2.8	1.4	0.2	2.3	9.9	11.0	0.0	0.0	34.4	20.6	4.1	0.6	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	1.7	0.1	6.5	3.1	0.5	0.0	1.4	55.4	0.9	0.0	0.0
ECSCR	"ARIA, ECSM2"	ENSG00000249751	"Endothelial cell surface expressed chemotaxis and apoptosis regulator"	Q19T08	5	139448556-139462743	"Predicted membrane proteins"	"Angiogenesis, Apoptosis, Chemotaxis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	20	"Endothelial cells: 271.3"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.7"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.7"	"Group enriched"	"Detected in some"	121	"EFO-21: 49.7;HUVEC TERT2: 125.6;TIME: 92.7"									HPA063337			Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"	Nucleoplasm	"HPA063337: AB_2732701"	"unprognostic (5.91e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.83e-3)"	"unprognostic (2.41e-3)"	"unprognostic (1.36e-1)"	"unprognostic (9.90e-2)"	"unprognostic (2.91e-1)"	14.8	1.9	0.8	5.7	1.6	0.0	17.5	0.4	0.7	13.7	6.1	1.0	5.1	1.9	14.3	14.4	11.0	7.9	8.6	26.9	0.8		5.6	4.3	23.4	26.9	1.4	0.7	7.9	1.0	1.3	0.4	19.6	2.9	9.3	4.3	6.8	3.6	5.5	13.4	2.9	3.4	14.3	4.3	12.1	1.1	6.8	1.1	0.1	11.5	14.5	4.6	13.2	13.1	0.6	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	49.7	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	125.6	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	92.7	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.6	1.1	1.0	0.0	0.0	0.1	0.9	0.0	0.1	0.0	0.0	0.6	0.0											0.0	4.6	0.0	0.2	13.3	0.0	0.0	0.0	1.4	1.2	0.0	0.0	0.1	0.0	0.5	0.0	271.3	0.0	0.0	1.0	0.1	2.6	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	5.8	10.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	12.2	0.2	0.0	0.0	0.7
EDNRA		ENSG00000151617	"Endothelin receptor type A"	P25101	4	147480917-147544954	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 62.6;seminal vesicle: 52.3"	"Cell type enhanced"	"Detected in some"	14	"Leydig cells: 40.6;Peritubular cells: 64.0;Sertoli cells: 51.8;Smooth muscle cells: 84.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 7.3;ASC TERT1: 14.5;HHSteC: 7.4;LHCN-M2: 17.2;SH-SY5Y: 13.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013774, CAB018957"	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"CAB018957: AB_2039838, HPA013774: AB_1847994"	"unprognostic (3.08e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.20e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.75e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.34e-3)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (1.50e-7)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (6.20e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.53e-3)"	7.6	2.6	1.3	1.4	1.8	0.0	7.2	0.6	2.4	62.6	2.6	1.0	21.7	1.5	37.3	14.2	4.7	13.3	7.3	15.1	1.3	1.3	3.1	1.4	12.7	2.0	1.8	1.0	23.5	0.9	1.9	2.2	5.9	2.7	21.5	1.5	10.3	4.1	52.3	4.8	3.2	1.8	19.4	1.6	11.5	4.4	9.1	1.4	2.9	5.0	6.0	2.6	14.7	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	4.2	0.0	7.3	14.5	0.0	2.2	2.9	0.4	0.1	0.2	0.0	0.0	0.0	0.7	0.5	0.0	0.3	0.6	0.2	0.0	1.5	0.0	2.5	0.0	7.4	0.0	0.0	5.6	0.5	0.4	0.0	2.7	0.0	0.0	0.0	1.1	17.2	0.2	0.0	0.1	1.2	0.0	0.9	0.0	0.7	0.1	1.1	0.8	0.0	13.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	2.9	0.6	0.0	0.0	1.1	0.3	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.8	0.6	2.4	1.3	1.3	1.8	1.0	2.7	1.4	3.0	4.0	0.0	0.6	2.7	0.0	17.1	0.0	0.0	7.9	0.0	0.0	0.2	0.0	0.0	2.0	2.7	0.0	0.0	0.0	0.1	11.8	1.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.1	40.6	0.3	3.3	0.0	0.0	0.0	0.2	0.0	64.0	0.0	0.0	51.8	84.6	0.6	0.6	2.4	0.1	0.0	0.0	0.2
EDNRB	"ETB, HSCR, HSCR2"	ENSG00000136160	"Endothelin receptor type B"	P24530	13	77895481-77975529	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Albinism, Deafness, Disease mutation, FDA approved drug targets, Hirschsprung disease, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 67.5"	"Cell type enhanced"	"Detected in many"	10	"Endothelial cells: 97.7;Ito cells: 106.8;Melanocytes: 104.6;Muller glia cells: 142.7;Sertoli cells: 213.4;Smooth muscle cells: 110.2"	"Group enriched"	"Detected in all"	7	"glioma: 41.1;melanoma: 127.7;renal cancer: 28.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	21	"classical monocyte: 2.0;intermediate monocyte: 2.1"	"Lineage enriched"	"Detected in single"	21	"monocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"AF22: 25.2;ASC diff: 19.2;SK-MEL-30: 23.1;U-266/70: 15.1;WM-115: 48.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017842, HPA027546"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"CAB017842: , HPA027546: AB_2672327"	"unprognostic (7.75e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.59e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.45e-3)"	"unprognostic (4.17e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.01e-2)"	"prognostic favorable (7.20e-5)"	"unprognostic (1.59e-2)"	"unprognostic (3.86e-2)"	"unprognostic (4.58e-2)"	"unprognostic (6.77e-3)"	25.4	23.2	22.2	10.3	29.8	0.8	23.1	10.3	30.7	8.1	7.2	13.6	2.3	10.9	7.7	3.6	4.9	6.0	8.5	23.7	16.7	16.4	22.3	26.5	28.4	15.6	24.2	8.1	4.9	6.4	7.7	6.3	67.5	33.2	14.9	7.7	51.0	13.4	4.4	6.7	5.1	11.9	7.4	33.4	16.0	5.8	3.1	12.4	0.0	17.6	2.0	2.9	10.9	8.2	0.0	0.0	0.0	2.1	0.0	0.0	0.4	2.0	0.0	25.2	0.0	19.2	0.7	0.3	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	1.3	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	23.1	3.4	0.0	0.1	0.1	0.2	0.0	0.0	0.1	15.1	8.5	0.0	0.4	0.0	48.1	0.0	2.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	22.2	29.8	10.3	11.9	16.7	16.4	24.2	8.1	33.2	12.4	11.9	38.2	0.0	1.0	13.2	3.2	7.3	0.0	2.7	4.5	0.0	5.9	14.3	0.0	0.0	2.4	97.7	0.0	0.0	0.0	10.2	27.8	2.5	5.8	0.5	10.9	0.0	0.0	106.8	21.3	1.8	73.9	9.2	104.6	0.0	0.0	142.7	0.1	0.0	2.5	0.0	3.4	213.4	110.2	0.3	1.4	6.4	4.8	0.0	0.0	1.4
EFNB1	"CFNS, Elk-L, EPLG2, LERK2"	ENSG00000090776	"Ephrin B1"	P98172	X	68828997-68842147	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Cancer-related genes, Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 104.2;Ito cells: 108.6;Suprabasal keratinocytes: 105.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 7.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 35.3;hTCEpi: 27.6;PC-3: 26.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB031489, HPA067188"	Uncertain		Supported	"Plasma membrane"		NA	NA		790000	"Plasma membrane"		"CAB031489: AB_631414, HPA067188: AB_2685799"	"unprognostic (2.00e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (3.32e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.48e-2)"	"unprognostic (8.05e-3)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (4.29e-4)"	"unprognostic (1.29e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.76e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.86e-2)"	36.5	13.2	5.0	11.5	4.5	1.3	26.5	2.3	4.7	19.5	21.1	4.7	13.1	14.0	15.2	14.9	17.4	15.2	33.7	16.0	3.6	2.7	25.5	15.3	23.0	5.2	4.7	3.5	21.6	4.5	15.0	6.4	34.3	3.9	15.9	10.1	14.9	7.0	13.2	9.1	26.4	24.0	12.3	2.6	15.3	13.3	7.4	4.2	4.8	11.9	22.0	11.2	16.7	14.8	0.5	7.1	0.6	3.4	1.3	1.0	1.0	3.6	1.9	15.5	5.7	8.3	5.1	8.2	3.2	3.5	1.4	1.0	1.7	6.9	0.9	21.2	1.2	1.8	19.8	14.7	35.3	0.8	1.5	3.7	0.9	0.8	3.0	7.6	0.7	7.9	9.5	27.6	3.5	15.9	1.3	10.8	1.9	1.0	0.0	1.2	3.0	1.5	0.7	10.7	22.8	26.1	6.6	1.6	5.9	5.9	13.1	5.8	2.8	2.4	0.7	0.9	12.4	0.6	1.3	18.1	2.7	3.3	7.2	1.2	0.0	0.8	0.9	1.3	4.0	1.7	0.0	1.3	0.6	1.0	3.4	0.6	0.5	0.9	0.9	7.1	0.4	0.8	0.4	0.3	1.3	2.1	1.0	0.4	1.0	5.0	4.5	2.3	4.7	3.6	2.7	4.7	3.5	3.9	4.2	3.0	1.4	5.2	58.4	104.2	2.1	8.1	22.9	0.0	7.9	21.0	0.0	9.2	0.0	17.1	0.3	33.4	38.3	0.0	13.8	68.8	20.1	10.6	4.6	3.8	10.6	1.6	8.1	108.6	9.1	0.9	25.3	7.5	20.3	3.6	26.2	14.6	28.9	46.1	7.8	6.3	1.3	12.9	11.8	1.0	3.0	105.3	9.4	4.9	22.1	71.6
EFR3A	KIAA0143	ENSG00000132294	"EFR3 homolog A"	Q14156	8	131904088-132013642	"Predicted intracellular proteins"			"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 326.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022859, HPA023092, HPA023402"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA022859: AB_1848029, HPA023092: AB_2293240, HPA023402: AB_1848031"	"unprognostic (4.79e-2)"	"unprognostic (6.54e-2)"	"unprognostic (6.42e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.44e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.11e-2)"	"unprognostic (5.89e-3)"	"unprognostic (5.22e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.21e-3)"	14.7	16.0	21.6	13.6	21.4	8.0	46.8	48.6	52.2	20.4	19.2	7.1	15.0	15.0	18.0	26.5	18.6	16.5	14.6	22.7	28.2	18.5	20.2	28.9	18.8	22.4	20.7	24.4	13.6	13.8	29.2	12.9	13.3	63.3	18.7	12.5	13.9	14.6	20.8	37.1	13.8	15.2	28.1	11.9	14.5	14.8	13.8	7.6	18.7	25.4	9.8	17.7	18.1	14.1	9.5	12.0	11.8	25.8	10.0	12.1	9.5	21.1	19.2	6.0	4.9	24.6	28.5	12.0	15.2	21.3	12.7	16.8	4.2	15.9	13.0	14.4	34.2	16.9	7.0	9.5	20.8	15.6	30.0	5.2	13.0	9.5	8.5	23.7	4.9	13.7	24.0	11.9	12.5	19.9	21.1	15.9	6.5	7.1	17.7	22.4	13.9	13.8	4.5	3.4	18.3	12.1	5.6	11.8	6.1	15.3	13.3	4.0	14.0	30.2	4.3	11.7	16.5	13.7	8.5	22.1	22.6	20.8	11.0	15.8	12.6	10.8	8.2	16.7	12.1	11.5	5.4	11.7	11.8	12.1	16.4	10.8	9.5	9.8	9.8	12.0	8.3	9.0	9.1	7.2	10.0	25.8	2.8	7.7	9.5	21.6	21.4	48.6	52.2	28.2	18.5	20.7	24.4	63.3	7.6	38.7	39.7	28.4	22.3	18.8	326.9	47.0	20.4	14.7	37.5	48.8	86.4	19.7	18.3	23.5	2.9	20.4	30.0	0.0	26.8	17.3	31.0	39.8	24.4	65.5	40.6	25.4	10.9	26.4	46.6	6.5	18.4	36.1	8.5	35.1	17.5	38.4	22.9	31.7	41.8	40.4	105.3	19.4	32.3	32.9	29.7	27.5	31.0	18.4	14.7	27.8
EFR3B	"FLJ37871, KIAA0953"	ENSG00000084710	"EFR3 homolog B"	Q9Y2G0	2	25042130-25159137	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.5;retina: 21.1;skeletal muscle: 25.1"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 26.8;Cone photoreceptor cells: 21.6;Early spermatids: 15.3;Late spermatids: 37.7;Muller glia cells: 20.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 4.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 9.0;BEWO: 10.6;SH-SY5Y: 9.4;SK-BR-3: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038089, HPA071831"	Uncertain		Supported	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane"	"Actin filaments, Cytosol"	"HPA038089: AB_10672618, HPA071831: "	"unprognostic (9.31e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.24e-3)"	"unprognostic (3.82e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.32e-2)"	"unprognostic (4.49e-6)"	"unprognostic (4.83e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.55e-1)"	1.9	3.2	13.1	1.7	22.9	1.3	1.3	15.5	30.5	1.4	1.7	9.4	0.0	1.4	1.8	8.4	1.3	1.8	1.5	6.9	11.4	8.7	1.4	1.1	4.4	1.3	8.7	13.5	1.4	1.3	2.4	4.1	3.2	29.9	1.5	1.8	21.1	1.1	2.0	25.1	1.7	1.3	2.6	7.8	4.3	2.2	3.5	9.0	0.0	4.5	0.2	1.1	1.4	0.7	1.0	0.6	4.4	0.5	1.0	0.7	0.1	0.1	7.1	8.4	9.0	0.5	0.1	10.6	0.9	0.2	0.4	0.1	5.7	0.3	0.1	0.5	1.2	2.9	0.5	6.6	0.0	0.1	1.3	1.6	1.4	0.3	0.5	0.0	0.1	0.7	0.1	0.0	2.0	0.1	0.6	0.2	0.2	0.1	0.4	0.2	0.8	0.2	0.4	1.7	0.1	5.7	0.6	8.0	0.2	0.1	0.2	3.5	9.4	1.0	15.8	5.1	4.9	0.8	0.1	0.5	0.5	2.4	3.6	1.7	0.6	0.7	0.1	6.5	0.1	1.7	4.4	0.4	1.1	0.7	0.3	0.5	0.6	0.4	0.6	0.3	1.0	0.4	0.7	1.7	1.0	0.5	0.6	0.2	0.1	13.1	22.9	15.5	22.7	11.4	8.7	8.7	13.5	29.9	9.0	26.8	0.6	0.0	0.6	0.0	8.6	7.4	0.0	0.0	0.0	8.7	21.6	0.0	0.0	0.2	15.3	2.0	0.4	0.0	0.7	0.1	1.0	0.7	0.0	0.0	0.8	4.8	3.5	3.7	0.0	37.7	1.1	0.0	0.0	0.0	0.0	20.0	0.5	0.0	2.5	0.1	10.3	0.0	1.4	2.1	1.9	0.1	0.1	0.0	0.3	0.4
EHD1	"FLJ42622, FLJ44618, H-PAST, HPAST1, PAST1"	ENSG00000110047	"EH domain containing 1"	Q9H4M9	11	64851642-64888296	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"Early spermatids: 850.4;Late spermatids: 1539.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049890, HPA049986, HPA066751, HPA067747"	Approved		Supported	"Plasma membrane"		NA	NA		19000000	"Plasma membrane"		"HPA049890: AB_2680936, HPA049986: AB_2680983, HPA066751: AB_2685713, HPA067747: AB_2685896"	"unprognostic (1.51e-1)"	"unprognostic (3.21e-1)"	"unprognostic (6.35e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (2.81e-5)"	"unprognostic (1.46e-3)"	"unprognostic (9.10e-3)"	"unprognostic (9.44e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.37e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.59e-2)"	17.5	10.4	7.3	33.3	7.4	57.5	12.3	27.2	11.3	11.1	13.5	18.2	8.0	14.7	13.1	10.8	15.5	12.5	15.2	11.3	8.2	9.4	14.5	9.3	18.7	41.1	13.8	5.9	10.0	5.2	5.1	3.4	34.8	16.7	9.0	6.6	8.0	11.9	10.0	13.2	14.1	22.9	12.4	13.1	43.1	12.7	65.8	10.4	21.3	12.3	13.6	33.6	13.5	10.3	10.6	3.5	38.0	13.1	10.2	17.2	10.2	26.8	18.7	6.7	7.4	8.2	13.4	3.9	27.4	24.9	23.3	13.6	24.2	16.9	35.4	9.8	32.7	19.9	22.0	7.0	27.6	9.0	22.1	3.9	23.5	9.8	12.2	9.8	7.6	6.4	6.0	5.9	35.9	11.3	10.6	22.9	7.0	9.6	62.9	17.6	14.3	15.2	12.6	4.5	6.8	24.5	6.1	21.6	12.3	22.0	9.0	4.8	4.3	15.3	28.2	12.4	8.0	38.3	5.4	32.2	10.4	9.2	27.4	13.1	25.9	11.4	27.1	27.0	10.0	5.6	6.7	5.0	38.0	16.9	6.7	17.2	10.6	11.9	14.6	2.9	8.2	7.2	9.8	23.6	10.2	13.1	3.5	12.9	10.2	7.3	7.4	27.2	11.3	8.2	9.4	13.8	5.9	16.7	10.4	71.5	40.7	35.7	42.8	59.8	2.6	25.4	12.7	9.4	14.8	14.0	2.0	72.8	6.6	29.4	850.4	27.9	40.2	0.0	35.6	19.3	36.8	19.1	92.3	7.8	27.3	4.8	6.3	9.8	34.3	1539.3	27.9	44.1	25.3	33.3	22.2	4.8	64.9	24.6	25.5	32.3	2.8	77.6	60.8	21.2	24.7	43.0	114.5	67.3	18.3	38.9
EHD2	PAST2	ENSG00000024422	"EH domain containing 2"	Q9NZN4	19	47713343-47743134	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Leydig cells: 91.7;Peritubular cells: 100.8;Sertoli cells: 232.8;Smooth muscle cells: 117.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 59.6;ASC TERT1: 45.4;fHDF/TERT166: 46.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047394, HPA049890, HPA049986, HPA066751"	Approved		Supported	"Plasma membrane"		NA	NA		580000	"Plasma membrane"		"HPA047394: AB_2680026, HPA049890: AB_2680936, HPA049986: AB_2680983, HPA066751: AB_2685713"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.33e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.70e-3)"	"prognostic unfavorable (8.75e-4)"	"unprognostic (5.49e-3)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (6.59e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.06e-3)"	82.2	17.8	6.7	14.5	6.1	0.6	62.0	4.3	7.5	35.2	29.1	5.0	10.0	6.7	40.2	21.2	33.0	20.7	34.3	19.3	5.4	2.9	8.3	4.5	28.1	13.5	5.4	3.4	34.0	11.1	3.1	3.8	22.8	6.4	28.2	7.3	11.6	9.7	25.1	17.3	15.3	14.3	40.7	4.5	19.0	17.5	12.9	5.7	1.8	15.0	24.6	8.3	35.0	52.6	0.6	0.4	2.4	0.6	0.2	0.5	0.9	11.3	26.6	0.0	0.3	59.6	45.4	0.0	44.4	21.0	16.1	13.1	1.7	5.7	0.0	0.0	46.9	3.8	14.4	0.2	23.1	9.8	0.0	0.1	1.5	15.5	0.1	37.7	0.0	3.1	43.9	20.4	13.5	13.3	21.4	31.0	0.1	4.7	0.0	16.9	2.0	2.3	0.1	0.3	1.6	4.8	0.2	1.8	0.0	12.8	0.5	0.0	0.1	38.9	1.5	1.1	3.7	3.7	0.7	35.3	24.2	5.4	21.2	9.5	0.0	0.0	0.0	22.5	0.6	5.1	1.0	0.4	0.6	0.3	0.3	0.3	0.5	0.3	0.4	0.1	0.6	0.5	0.5	2.4	0.2	0.6	0.4	0.3	0.9	6.7	6.1	4.3	7.5	5.4	2.9	5.4	3.4	6.4	5.7	56.6	22.3	0.0	24.5	18.0	3.2	7.3	12.7	1.4	17.0	5.2	0.0	0.9	0.0	17.5	0.6	58.5	0.0	0.0	11.9	1.3	39.2	11.6	2.3	2.1	1.7	0.0	0.0	42.4	1.0	1.9	91.7	3.2	8.5	1.0	0.0	1.7	25.4	0.0	100.8	0.0	0.8	232.8	117.3	0.7	3.4	11.8	1.3	0.0	0.0	26.5
ENKD1	"C16orf48, DKFZP434A1319"	ENSG00000124074	"Enkurin domain containing 1"	Q9H0I2	16	67662945-67667265	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 36.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 4.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041163, HPA041478"	Approved		Supported	"Plasma membrane,Centrosome,Cytosol"		Yes	No			"Plasma membrane"	"Centrosome, Cytosol"	"HPA041163: AB_10794986, HPA041478: AB_10794668"	"unprognostic (6.02e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.59e-3)"	"prognostic favorable (1.68e-4)"	"unprognostic (4.41e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.69e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (9.60e-2)"	8.5	7.7	4.9	5.9	7.0	3.8	6.6	5.0	6.9	10.4	11.7	6.1	18.6	4.7	11.2	14.2	8.2	14.5	11.0	6.1	5.4	5.2	10.9	4.7	8.9	2.9	4.5	4.4	10.9	38.8	23.7	12.0	4.8	8.3	12.7	3.6	7.9	11.7	12.6	6.0	7.2	5.1	12.9	4.3	6.1	7.3	19.6	6.4	7.1	20.4	5.2	4.9	12.9	6.4	0.6	4.2	3.0	1.3	0.7	1.5	0.5	6.9	4.8	11.4	5.3	3.8	3.9	5.6	5.5	3.4	4.4	5.4	3.5	10.7	2.6	9.4	3.4	0.0	8.2	2.9	6.6	5.5	4.0	6.6	2.6	14.5	8.2	6.1	4.6	3.6	3.4	4.7	6.0	5.5	10.3	3.5	8.7	4.3	1.7	2.2	3.5	5.0	19.3	5.4	7.3	1.9	17.9	1.2	19.3	4.6	0.7	11.5	12.5	11.7	1.1	6.0	2.7	10.3	6.6	9.3	5.4	7.6	10.1	0.1	12.6	5.6	2.8	8.1	6.9	1.6	0.0	1.3	0.0	0.3	0.5	1.5	0.6	1.2	0.7	0.5	0.0	0.8	1.1	3.0	0.7	0.7	4.2	0.0	0.5	4.9	7.0	5.0	6.9	5.4	5.2	4.5	4.4	8.3	6.4	20.8	15.6	0.8	6.2	6.2	3.6	5.0	17.8	36.1	2.3	8.7	3.9	2.8	1.7	11.9	28.8	9.0	2.0	0.0	9.2	2.1	7.0	5.2	1.1	14.7	4.2	3.2	12.7	11.1	3.8	14.5	12.0	2.9	5.0	2.8	5.9	9.5	8.2	0.0	13.4	5.9	10.8	6.5	6.6	20.2	7.3	4.5	2.9	1.9	4.4	2.4
ENO2		ENSG00000111674	"Enolase 2"	P09104	12	6913745-6923698	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 119.2"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 242.1;Cone photoreceptor cells: 294.5;Horizontal cells: 405.2;Rod photoreceptor cells: 613.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 8.2;MAIT T-cell: 9.7;memory B-cell: 5.6;memory CD4 T-cell: 10.8;memory CD8 T-cell: 9.6;naive B-cell: 3.3;naive CD4 T-cell: 7.1;naive CD8 T-cell: 7.4;neutrophil: 6.2;T-reg: 5.5"	"Group enriched"	"Detected in many"	7	"B-cells: 5.6;granulocytes: 6.2;T-cells: 10.8"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 94.8;U-87 MG: 70.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000063, HPA068284, HPA068721, CAB073539, CAB079023"	Enhanced	Supported	Supported	"Plasma membrane,Cytosol"		NA	NA		89000000	"Plasma membrane, Cytosol"		"CAB000063: AB_2099322, CAB073539: , CAB079023: , HPA068284: , HPA068721: AB_2732119"	"unprognostic (8.96e-2)"	"unprognostic (8.28e-2)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (1.28e-1)"	"unprognostic (7.95e-3)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (1.48e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (7.89e-11)"	"unprognostic (7.61e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.24e-1)"	4.2	20.7	31.2	8.3	48.0	4.0	4.9	115.2	119.2	7.6	7.9	10.9	2.6	4.9	11.7	6.3	5.9	9.4	8.0	10.3	30.2	39.2	3.5	2.0	10.1	10.5	29.6	47.4	3.7	4.1	19.1	15.5	4.8	47.7	8.0	7.4	28.6	3.1	15.3	2.1	5.8	6.0	15.2	15.7	5.8	6.4	3.2	13.3	1.7	14.2	0.3	10.3	7.1	5.0	5.6	1.0	6.2	0.2	0.4	10.8	4.5	12.2	7.7	2.8	0.1	4.2	4.5	0.2	9.5	6.1	14.1	21.7	1.4	1.0	17.2	1.5	4.1	18.6	1.8	29.3	2.6	21.4	34.4	2.7	23.8	7.9	10.3	3.0	1.3	28.6	2.3	0.1	10.4	2.1	94.8	2.9	22.5	1.5	0.2	9.4	1.6	11.1	1.5	14.9	5.3	4.4	12.4	2.3	3.8	6.9	1.6	22.5	15.8	2.5	0.1	16.2	14.3	0.7	0.7	3.7	12.3	13.0	16.6	12.2	12.6	12.6	2.5	70.7	0.0	2.5	1.3	0.0	0.1	8.2	0.0	9.7	5.6	10.8	9.6	0.0	3.3	7.1	7.4	6.2	0.4	0.2	1.0	5.5	4.5	31.2	48.0	115.2	91.3	30.2	39.2	29.6	47.4	47.7	13.3	32.8	30.1	5.4	2.3	5.6	242.1	12.0	0.0	21.4	10.3	12.2	294.5	0.2	0.0	16.0	0.3	7.1	0.0	0.0	1.5	0.3	6.6	1.7	65.8	0.0	1.7	405.2	23.0	6.2	0.0	0.0	5.2	2.5	11.8	5.4	0.0	91.6	10.4	0.2	9.2	0.0	613.6	12.9	21.7	1.8	1.3	1.9	0.2	11.4	0.4	1.6
ENO3		ENSG00000108515	"Enolase 3"	P13929	17	4948092-4957131	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"skeletal muscle: 638.2;tongue: 320.3"	"Group enriched"	"Detected in many"	8	"Cardiomyocytes: 511.6;monocytes: 134.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"HDLM-2: 71.7;HeLa: 30.7;HMC-1: 30.3;RH-30: 49.3;RPMI-8226: 25.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA000793, HPA068284, HPA068721"	Enhanced		Supported	"Plasma membrane,Cytosol"		Yes	No		100000000	"Plasma membrane, Cytosol"		"HPA000793: AB_1078742, HPA068284: , HPA068721: AB_2732119"	"unprognostic (7.35e-2)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (7.33e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.50e-2)"	7.6	0.3	0.2	0.6	0.2	0.7	0.5	0.6	0.2	0.2	0.4	0.0	0.1	0.8	0.4	8.5	8.6	0.4	0.1	38.3	0.2	0.1	0.5	5.0	0.4	0.5	0.2	0.0	0.4	0.3	0.3	0.5	0.2	0.1	2.1	0.1	1.2	11.8	0.1	638.2	0.3	0.7	0.4	0.2	0.8	0.4	0.5	0.0	0.6	4.8	320.3	10.5	0.3	0.3	13.3	21.0	27.1	24.8	18.5	23.3	36.0	2.9	6.3	2.9	2.7	2.5	0.7	6.9	5.1	0.7	0.3	0.3	3.0	2.0	5.4	7.0	0.4	0.9	3.7	1.0	0.4	0.3	71.7	5.8	5.2	30.7	4.5	0.9	1.6	30.3	4.2	1.0	0.5	1.0	2.6	0.3	6.2	2.4	9.9	1.5	1.6	1.9	6.3	3.7	0.8	2.6	8.5	49.3	25.8	0.7	1.9	1.8	6.9	3.3	2.8	3.7	2.0	2.6	1.7	1.6	3.0	5.7	1.3	3.8	7.0	3.9	4.4	1.7	5.1	3.0	13.5	15.6	27.1	21.8	22.5	14.7	13.3	18.7	20.3	21.0	11.1	12.3	19.7	19.7	18.5	24.8	16.6	23.3	36.0	0.2	0.2	0.6	0.2	0.2	0.1	0.2	0.0	0.1	0.0	0.0	2.6	2.9	1.0	1.8	3.2	511.6	0.0	0.0	2.3	5.2	3.9	4.3	0.0	1.4	1.3	2.2	4.3	0.0	0.7	3.1	3.6	1.0	8.1	38.1	4.4	3.2	0.0	3.1	3.8	2.7	0.3	4.5	1.7	134.3	2.3	1.5	1.3	1.7	0.4	5.4	2.4	6.5	0.9	8.6	3.9	1.6	2.7	4.3	2.1	0.6
ENOX1	"cCNOX, CNOX, FLJ10094, PIG38"	ENSG00000120658	"Ecto-NOX disulfide-thiol exchanger 1"	Q8TC92	13	43213518-43786908	"Predicted intracellular proteins"	"Biological rhythms, Electron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	16	"Early spermatids: 179.3;Late spermatids: 183.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 12.8;RH-30: 17.8;TIME: 12.8;U-2197: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038355	Approved		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"HPA038355: AB_10673171"	"unprognostic (9.64e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.88e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.32e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.08e-3)"	"unprognostic (1.42e-2)"	5.7	2.2	10.7	4.5	14.8	0.8	2.8	2.1	17.0	5.2	8.5	15.0	0.2	1.3	7.2	2.0	2.1	4.7	3.1	8.3	10.3	6.0	6.1	1.0	1.9	3.5	9.4	10.6	11.2	2.5	0.7	2.3	7.8	15.6	5.6	3.1	3.2	1.3	6.9	11.0	1.4	2.2	8.8	7.7	1.5	3.5	14.5	15.0	0.1	1.4	0.3	2.6	4.8	3.7	0.2	2.3	0.9	0.3	0.3	0.2	0.1	0.1	0.2	2.5	0.0	2.6	10.0	0.5	1.2	2.8	4.2	4.0	1.7	0.3	0.0	0.1	3.6	0.4	0.1	0.5	0.3	1.8	2.9	4.1	0.5	2.9	0.0	1.6	0.1	0.6	9.6	0.9	12.8	6.5	0.7	0.3	2.0	0.0	0.6	2.6	0.2	4.1	0.1	2.8	0.0	1.1	0.0	17.8	0.0	2.2	0.5	8.7	3.4	1.5	2.6	0.6	2.0	0.5	0.0	12.8	1.4	0.4	13.2	1.4	0.0	0.0	0.1	6.2	0.0	9.3	0.9	0.1	0.3	0.1	0.1	0.2	0.2	0.1	0.1	2.3	0.1	0.2	0.1	0.3	0.3	0.3	0.3	0.2	0.1	10.7	14.8	2.1	17.0	10.3	6.0	9.4	10.6	15.6	15.0	3.0	0.0	0.0	1.3	0.6	3.6	1.4	0.0	9.4	4.5	0.0	0.0	0.1	5.0	0.5	179.3	0.0	0.0	0.0	0.3	0.0	1.9	1.6	0.0	0.0	0.2	1.6	0.0	0.0	0.0	183.1	11.2	0.6	0.0	0.0	0.0	0.1	0.1	0.0	4.2	0.1	0.4	6.5	1.2	3.0	7.6	0.3	0.2	0.0	0.0	0.5
ENOX2	"APK1, COVA1, tNOX"	ENSG00000165675	"Ecto-NOX disulfide-thiol exchanger 2"	Q16206	X	130623369-130903317	"Predicted intracellular proteins"	"Biological rhythms, Electron transport, Growth regulation, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000514, HPA003027"	Uncertain		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			Cytosol	"Plasma membrane"	"HPA000514: AB_1078558, HPA003027: "	"unprognostic (1.34e-2)"	"unprognostic (7.02e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.27e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.09e-5)"	"unprognostic (6.42e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.38e-1)"	13.1	14.6	13.5	14.8	17.6	4.7	11.4	7.6	11.0	13.2	11.6	13.9	10.7	8.0	15.6	12.9	13.3	13.2	11.2	18.9	14.6	13.1	10.4	23.6	8.8	16.0	14.7	8.8	14.6	7.4	12.5	12.3	11.7	12.2	12.9	9.3	8.5	10.3	15.1	11.2	8.6	11.1	14.5	13.4	17.7	9.2	9.7	17.7	17.4	11.0	11.7	15.9	14.2	9.7	12.8	11.9	15.0	16.7	11.3	13.3	9.7	12.3	9.1	14.0	5.8	12.0	11.4	5.6	10.5	12.1	7.1	4.4	4.3	10.7	8.7	25.4	8.8	9.5	8.7	9.1	9.7	8.8	11.5	10.0	20.2	6.2	5.7	9.3	14.7	14.3	9.0	16.6	7.7	9.6	3.0	10.6	7.8	12.4	7.1	5.5	17.2	9.2	3.2	7.3	17.3	12.7	6.6	8.7	9.6	8.2	8.7	4.2	8.5	9.1	6.0	14.7	5.2	3.9	8.1	8.6	6.8	4.1	10.9	21.3	7.4	3.6	5.7	19.9	15.4	11.5	8.0	12.0	15.0	10.4	16.7	11.1	12.8	12.2	10.8	11.9	11.6	13.3	11.7	2.1	11.3	7.8	5.7	13.2	9.7	13.5	17.6	7.6	11.0	14.6	13.1	14.7	8.8	12.2	17.7	3.0	6.1	1.5	5.8	3.8	4.3	10.1	5.1	20.1	10.3	3.5	0.0	4.9	6.6	7.0	0.8	7.1	4.0	0.0	8.2	4.4	5.6	5.8	5.8	10.6	6.0	3.2	4.6	6.2	17.7	0.9	5.2	14.4	8.5	19.0	4.2	4.9	8.9	3.5	6.0	6.7	6.4	6.5	8.4	6.5	10.6	4.3	6.1	8.2	5.0	4.7
EPB41	"4.1R, EL1"	ENSG00000159023	"Erythrocyte membrane protein band 4.1"	P11171	1	28887091-29120046	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Cell division, Mitosis, Transport"	"Actin-binding, Calmodulin-binding"	"Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 59.7"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 129.6;Erythroid cells: 116.8;Rod photoreceptor cells: 166.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 59.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 39.5"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	11	"cerebellum: 375.3"	"HPA028076, HPA028096, HPA028412, HPA028414"	Supported		Supported	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	No		3400000	"Plasma membrane, Cell Junctions"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA028076: AB_2672476, HPA028096: , HPA028412: AB_2672592, HPA028414: AB_10601366"	"unprognostic (2.16e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.92e-3)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (5.00e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (5.01e-3)"	"unprognostic (5.40e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (1.75e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.67e-2)"	9.2	9.6	3.3	19.4	10.2	28.0	9.6	59.7	11.6	8.2	12.4	2.0	9.8	9.3	10.5	5.7	10.8	5.5	7.9	7.5	3.3	4.8	10.0	13.2	11.0	25.4	3.9	3.0	12.3	10.4	9.1	9.0	8.7	10.3	8.3	12.5	14.6	10.1	10.8	15.0	8.9	14.6	9.2	5.8	13.5	14.0	7.9	6.9	42.2	8.1	8.8	19.8	11.3	12.4	9.9	3.0	30.1	2.1	5.7	15.9	7.7	7.4	1.8	18.6	8.8	1.5	0.2	6.2	1.9	2.8	2.3	2.9	4.9	9.0	13.8	5.0	2.5	3.8	3.4	23.2	1.8	2.5	24.8	7.1	39.5	5.6	8.0	2.9	13.4	26.4	0.5	5.4	2.2	4.0	5.7	4.1	22.1	37.2	11.0	0.0	2.5	21.7	8.8	19.5	12.3	2.9	33.4	8.2	19.8	2.2	9.5	25.1	18.6	5.8	5.5	12.6	6.6	4.2	5.2	0.4	0.1	3.9	3.6	3.8	16.5	21.4	24.7	3.5	13.8	2.1	17.2	2.1	12.6	8.5	0.7	9.6	9.9	12.4	9.3	2.4	9.3	14.8	8.9	30.1	5.7	0.8	3.0	15.9	7.7	3.3	10.2	59.7	11.6	3.3	4.8	3.9	3.0	10.3	6.9	17.9	64.9	30.6	6.3	9.3	105.3	20.1	30.6	22.7	21.6	15.7	129.6	2.3	14.9	15.8	13.9	14.5	25.2	116.8	16.1	3.2	3.3	11.2	23.1	28.8	6.5	20.6	40.0	20.3	22.1	13.3	2.0	11.5	0.0	11.8	25.9	13.2	25.6	22.4	2.1	10.5	166.4	12.9	4.7	8.6	53.0	14.6	3.4	42.8	28.3	11.5
EPB41L1	"4.1N, KIAA0338"	ENSG00000088367	"Erythrocyte membrane protein band 4.1 like 1"	Q9H4G0	20	36091504-36232799	"Disease related genes, Predicted intracellular proteins"		Actin-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 147.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	15	"plasmacytoid DC: 3.9"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 3.9"	"Cell line enhanced"	"Detected in many"		"A549: 39.5;HaCaT: 58.2;OE19: 45.7;SK-BR-3: 45.6"	"Low region specificity"	"Detected in all"							"HPA054104, HPA056817"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA054104: AB_2682380, HPA056817: AB_2683244"	"unprognostic (2.01e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (6.46e-5)"	"unprognostic (1.19e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.83e-3)"	"prognostic unfavorable (9.30e-4)"	"unprognostic (1.78e-1)"	"prognostic favorable (4.39e-10)"	"unprognostic (1.25e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.26e-2)"	23.1	57.8	36.0	3.5	39.5	0.3	10.9	21.5	56.8	18.4	14.0	28.8	7.3	6.2	13.1	14.7	21.5	21.4	18.3	9.4	31.2	34.6	30.5	3.9	13.5	1.9	35.2	39.4	20.2	13.2	16.8	8.7	9.8	45.2	12.9	9.8	9.4	23.9	20.8	4.8	6.5	7.4	12.7	22.3	3.6	27.9	8.2	23.7	0.0	11.4	4.6	6.1	14.9	11.1	0.2	3.9	0.0	0.0	0.0	0.2	0.0	12.6	39.5	14.2	5.2	9.2	5.8	13.3	4.1	9.1	8.6	6.9	26.1	22.8	0.7	6.8	12.6	17.7	58.2	6.5	4.7	6.5	0.1	3.7	0.1	13.2	25.4	2.8	0.0	4.8	5.0	2.3	8.0	0.6	11.1	2.1	3.1	0.6	10.1	7.4	8.1	0.4	0.2	5.4	45.7	12.3	0.6	3.9	15.6	7.4	20.4	5.0	6.1	18.2	45.6	1.6	11.3	11.2	0.5	1.7	10.3	11.2	5.2	0.9	13.3	4.5	0.1	17.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	36.0	39.5	21.5	56.8	31.2	34.6	35.2	39.4	45.2	23.7	14.9	16.6	0.0	5.2	2.6	31.6	7.9	28.1	26.8	17.0	45.4	147.3	1.3	16.6	19.2	2.3	6.8	8.8	0.0	9.5	0.4	6.4	3.9	49.8	0.4	5.7	30.2	14.9	9.2	1.6	2.0	14.7	1.8	3.3	0.0	5.5	22.2	22.2	16.5	39.6	24.9	8.0	32.3	7.5	4.1	3.6	1.5	0.9	0.0	10.6	14.4
EPCAM	"17-1A, 323/A3, CD326, CO-17A, EGP-2, EGP34, EGP40, Ep-CAM, ESA, GA733-2, HEA125, KS1/4, KSA, Ly74, M4S1, MH99, MIC18, MK-1, MOC31, TACST-1, TACSTD1, TROP1"	ENSG00000119888	"Epithelial cell adhesion molecule"	P16422	2	47345158-47387601	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Tumor antigen"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 303.2"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 1952.6;Mucus-secreting cells: 1256.8;Paneth cells: 2168.3;Undifferentiated cells: 1330.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.9"	"Cell line enhanced"	"Detected in many"		"A-431: 55.5;CACO-2: 71.9;CAPAN-2: 101.2;OE19: 96.3;RPTEC TERT1: 43.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB003809, HPA026761, CAB030012, CAB055098, HPA067463"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB003809: AB_562285, CAB030012: AB_756075, CAB055098: AB_2335685, HPA026761: AB_1848198, HPA067463: AB_2685846"	"unprognostic (6.79e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.61e-2)"	"unprognostic (3.40e-1)"	"prognostic favorable (3.30e-4)"	"unprognostic (5.27e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (1.04e-6)"	"unprognostic (6.38e-3)"	"unprognostic (1.28e-1)"	"unprognostic (6.45e-3)"	"unprognostic (6.08e-2)"	0.4	2.1	1.8	49.8	3.0	0.2	8.9	0.6	1.0	10.8	155.8	0.7	31.5	66.8	4.4	35.2	2.8	10.2	41.6	0.4	1.7	2.7	60.2	1.2	22.6	0.4	1.2	0.4	3.8	54.1	19.8	38.7	2.2	0.9	9.0	70.5	0.7	47.2	25.0	0.5	2.0	303.2	1.7	1.4	0.5	15.3	5.5	0.9	1.7	83.6	4.2	4.1	4.1	2.1	0.2	1.9	0.4	0.2	0.0	0.0	0.6	55.5	0.6	0.0	0.1	0.0	0.0	35.2	0.0	0.0	0.0	0.0	71.9	101.2	0.0	15.6	0.1	0.0	26.2	0.5	6.6	0.2	0.0	6.4	0.0	0.3	28.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	16.6	0.0	0.0	28.3	0.0	2.6	18.2	96.3	3.6	0.0	0.0	14.1	43.2	24.5	39.1	0.3	0.4	20.7	0.0	15.5	17.4	0.1	0.0	0.0	0.7	0.2	0.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.6	1.8	3.0	0.6	1.0	1.7	2.7	1.2	0.4	0.9	0.9	288.8	113.7	7.2	161.4	8.2	0.1	1.7	236.9	180.7	188.8	425.7	0.0	14.0	64.6	814.0	5.0	2.3	1952.6	0.0	356.0	2.6	1.9	182.8	33.3	0.4	2.4	0.0	478.4	0.0	0.0	3.2	19.0	5.0	33.7	19.8	1256.8	11.8	505.0	2168.3	17.7	160.0	0.7	12.9	0.4	67.3	135.0	9.2	5.0	2.5	1330.8	202.8
EPHA2	ECK	ENSG00000142627	"EPH receptor A2"	P29317	1	16124337-16156087	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Angiogenesis, Apoptosis, Cell adhesion, Differentiation, Host-virus interaction"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Cataract, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 51.2"	"Cell type enhanced"	"Detected in many"	8	"Basal keratinocytes: 179.7;Suprabasal keratinocytes: 217.2;Urothelial cells: 155.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	115	"plasmacytoid DC: 11.4"	"Lineage enriched"	"Detected in single"	115	"dendritic cells: 11.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 42.4;EFO-21: 40.9;PC-3: 48.6;U-251 MG: 49.8;WM-115: 54.6"					"Low region specificity"	"Detected in all"			CAB010464			Supported	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	"Nuclear speckles, Golgi apparatus"	"CAB010464: AB_631436"	"unprognostic (9.41e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.22e-2)"	"unprognostic (9.12e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.52e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.40e-2)"	6.7	3.4	1.3	3.1	2.6	0.0	5.2	0.5	2.1	12.1	4.9	1.6	1.9	4.3	7.8	3.8	51.2	4.6	16.7	6.4	1.1	0.8	5.7	8.2	6.6	4.7	2.7	1.3	4.5	10.2	2.2	2.8	8.9	3.4	5.8	2.6	5.4	31.0	2.8	3.4	12.7	13.1	2.7	3.0	2.8	6.8	2.4	1.2	1.2	5.7	21.8	25.5	15.2	18.5	0.0	11.4	0.0	0.0	0.0	0.0	0.0	15.6	31.7	8.8	4.2	0.6	0.7	5.2	9.5	13.4	17.2	10.9	13.2	42.4	0.0	40.9	5.4	21.3	6.4	2.1	21.9	6.0	0.0	1.4	0.0	9.2	8.4	11.3	0.0	0.0	1.0	8.2	9.3	20.7	27.0	18.3	0.0	0.0	0.0	10.9	5.0	0.0	0.0	4.2	11.8	48.6	0.0	8.0	0.0	18.2	8.1	0.0	1.3	18.4	4.5	1.2	4.8	0.6	0.1	22.6	6.1	16.5	0.4	49.8	0.0	0.1	0.1	4.7	0.0	54.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	1.3	2.6	0.5	2.1	1.1	0.8	2.7	1.3	3.4	1.2	50.6	28.9	0.5	100.5	179.7	0.6	5.8	40.8	37.5	33.0	8.7	3.9	8.1	0.0	31.3	5.4	17.5	57.1	0.0	12.5	0.9	7.0	56.8	5.7	19.8	1.6	0.0	2.9	32.5	2.8	0.0	3.1	4.6	25.3	1.8	19.6	5.8	62.9	20.1	0.0	1.4	2.0	32.3	17.6	0.0	0.7	217.2	6.3	0.0	17.7	155.0
EPHA3	"ETK, ETK1, HEK, HEK4, TYRO4"	ENSG00000044524	"EPH receptor A3"	P29320	3	89107524-89482134	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 39.0"	"Group enriched"	"Detected in some"	5	"Fibroblasts: 12.2;Horizontal cells: 19.1;Peritubular cells: 7.8;Rod photoreceptor cells: 16.9;Sertoli cells: 6.5;Smooth muscle cells: 20.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"AF22: 66.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010462, HPA069390"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"	NA	NA			"Nuclear membrane, Plasma membrane, Cytosol"	"Nucleoplasm, Actin filaments"	"CAB010462: AB_2099218, HPA069390: "	"unprognostic (1.48e-3)"	"unprognostic (2.30e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.24e-3)"	"unprognostic (7.43e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (3.28e-7)"	"unprognostic (3.63e-2)"	"unprognostic (1.88e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.20e-2)"	9.7	1.1	2.3	1.7	4.5	0.2	5.1	1.3	8.7	12.3	5.8	0.6	1.4	2.2	13.9	1.3	6.3	2.6	17.2	10.0	2.2	2.5	1.5	4.4	2.7	3.0	2.5	3.4	4.2	2.8	1.2	3.4	17.5	11.9	39.0	5.9	5.4	3.8	6.8	1.7	1.7	3.5	17.3	2.9	1.2	3.7	1.3	2.0	0.0	16.3	6.0	3.0	11.8	12.2	0.3	0.1	0.5	0.1	0.3	0.2	0.0	0.0	0.0	66.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	3.8	0.0	0.2	0.0	0.8	0.0	0.0	4.1	0.0	0.0	0.6	0.7	0.0	1.3	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.8	0.0	0.0	0.0	0.6	0.0	0.5	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.5	0.3	0.1	0.1	0.0	0.0	2.3	4.5	1.3	8.7	2.2	2.5	2.5	3.4	11.9	2.0	0.0	0.0	0.0	0.3	0.5	1.5	2.1	0.0	0.0	0.0	0.0	2.0	0.2	0.0	0.0	1.3	1.1	0.0	0.0	0.0	0.1	12.2	0.1	0.0	0.0	0.1	19.1	0.0	0.6	0.0	1.3	2.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	7.8	0.0	16.9	6.5	20.6	0.0	0.0	0.3	0.5	0.0	0.0	0.0
EPHB1	"EPHT2, Hek6"	ENSG00000154928	"EPH receptor B1"	P54762	3	134597801-135260467	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 74.7"	"Cell type enhanced"	"Detected in some"	14	"Cone photoreceptor cells: 9.8;Early spermatids: 30.2;Late spermatids: 26.8;Muller glia cells: 16.2"	"Cancer enriched"	"Detected in many"	6	"glioma: 7.0"	"Region enhanced"	"Detected in all"		"cerebellum: 74.7"	"Group enriched"	"Detected in some"	33	"neutrophil: 15.9;plasmacytoid DC: 15.4"	"Group enriched"	"Detected in many"	33	"dendritic cells: 15.4;granulocytes: 15.9"	"Group enriched"	"Detected in some"	4	"HDLM-2: 34.7;HMC-1: 20.6;RPTEC TERT1: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067740	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA			"Endoplasmic reticulum, Plasma membrane, Cytosol"		"HPA067740: AB_2685895"	"unprognostic (1.99e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.41e-6)"	"unprognostic (6.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.15e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.37e-3)"	"unprognostic (4.88e-4)"	2.0	1.5	9.0	1.8	16.6	1.5	5.5	74.7	23.6	3.6	3.4	3.4	3.1	2.8	4.1	2.0	3.8	2.8	3.3	1.1	9.4	5.3	2.3	2.9	1.0	3.3	2.8	7.0	1.7	1.1	0.6	3.8	0.9	7.1	3.3	1.4	1.9	3.9	5.1	7.4	6.0	1.7	1.7	6.0	3.4	1.3	16.7	6.0	0.0	11.6	2.9	3.3	4.5	2.6	0.0	15.4	15.9	0.0	0.0	0.4	0.1	0.0	0.0	4.8	0.0	0.1	0.0	0.1	3.6	0.0	0.2	0.0	0.0	0.0	0.6	1.0	1.9	0.3	0.0	3.2	0.0	0.7	34.7	0.4	2.6	0.0	0.0	0.0	0.0	20.6	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.2	2.6	0.1	0.1	0.1	1.4	0.6	0.0	0.0	0.5	0.1	9.4	0.0	0.6	0.1	0.0	0.0	0.0	0.7	0.1	0.4	0.2	0.6	2.0	0.3	4.3	0.1	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	15.4	0.0	0.1	9.0	16.6	74.7	19.0	9.4	5.3	2.8	7.0	7.1	6.0	0.0	0.0	0.9	0.0	3.3	1.2	1.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.8	30.2	0.6	0.0	0.0	0.3	0.0	0.2	0.1	0.0	5.8	0.4	0.0	0.0	0.0	0.0	26.8	0.6	0.0	1.7	0.0	0.0	16.2	0.6	0.0	0.0	0.0	0.9	0.0	0.8	0.4	0.9	5.1	0.0	0.0	0.0	0.1
EPHB2	"DRT, EPHT3, ERK, Hek5, Tyro5"	ENSG00000133216	"EPH receptor B2"	P29323	1	22710839-22921500	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.0"	"Cell type enhanced"	"Detected in many"	11	"Ductal cells: 42.3;Intestinal endocrine cells: 46.8;Mucus-secreting cells: 53.6;Pancreatic endocrine cells: 38.4;Undifferentiated cells: 82.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.5;intermediate monocyte: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"GAMG: 34.4;HUVEC TERT2: 29.7;TIME: 29.4;U-251 MG: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013647, HPA071200"	Approved		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	No	No		290000	"Plasma membrane"	Nucleoplasm	"CAB013647: , HPA071200: AB_2686360"	"unprognostic (2.47e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (4.98e-4)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (3.99e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.16e-4)"	"unprognostic (1.45e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.46e-2)"	3.7	2.9	3.4	15.4	5.4	0.9	2.5	1.9	8.2	3.8	23.9	16.2	4.6	21.6	2.5	3.2	1.1	5.4	4.4	5.4	5.6	6.5	3.5	1.1	3.0	5.5	12.7	3.8	17.9	5.4	6.1	5.4	12.0	8.2	3.3	25.0	2.2	6.6	4.0	0.7	1.8	22.6	4.0	12.1	3.3	2.3	2.9	9.3	0.1	8.4	1.0	2.1	5.3	3.3	0.1	0.6	0.3	2.5	0.1	0.1	0.4	15.9	6.7	6.5	10.4	0.6	0.6	0.0	3.7	0.2	11.3	2.4	2.3	6.4	0.2	8.0	1.6	34.4	15.1	4.4	21.7	3.0	0.0	1.6	0.0	0.7	0.0	6.8	0.0	1.6	2.2	7.0	20.2	0.1	10.0	29.7	0.9	0.6	0.0	2.2	2.3	0.3	0.1	1.5	17.8	4.4	1.9	6.7	0.3	5.5	1.5	7.1	7.4	6.5	0.2	0.0	0.6	0.4	0.2	29.4	4.5	11.8	11.4	25.5	0.0	0.1	0.0	8.4	0.3	0.1	0.3	2.5	0.1	0.1	2.1	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.4	3.4	5.4	1.9	8.2	5.6	6.5	12.7	3.8	8.2	9.3	3.0	0.0	0.0	1.5	0.7	11.6	1.2	12.7	1.4	3.4	0.0	0.0	0.4	0.0	42.3	2.3	0.5	6.8	0.0	6.8	2.2	1.5	1.4	0.0	0.5	9.1	6.4	46.8	0.6	7.5	0.4	0.9	3.7	0.0	0.0	53.6	20.9	38.4	3.5	0.7	0.0	1.7	0.0	1.7	0.5	2.6	0.4	0.9	0.0	82.9	1.0
EPN1		ENSG00000063245	"Epsin 1"	Q9Y6I3	19	55675226-55709858	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 273.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEK 293: 71.6"	"Low region specificity"	"Detected in all"							"CAB009729, HPA061136, HPA071503"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"	"Nucleoplasm, Vesicles"	"CAB009729: AB_2277865, HPA061136: AB_2684436, HPA071503: "	"unprognostic (6.93e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.94e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.16e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.78e-3)"	"unprognostic (7.92e-3)"	26.7	23.4	34.2	20.6	31.4	15.7	31.4	26.3	47.1	13.5	32.7	17.2	18.1	67.7	13.7	19.8	21.3	15.4	28.2	56.0	28.0	18.6	23.1	36.0	16.5	25.5	17.5	25.9	23.2	54.5	12.1	14.3	15.0	15.8	19.3	13.8	13.5	24.8	22.7	84.7	22.2	59.7	12.2	14.3	26.9	55.1	20.2	13.1	11.2	15.3	26.3	14.6	13.1	16.2	2.2	3.6	4.6	6.9	0.7	2.0	2.4	25.0	34.6	8.6	17.7	10.0	9.6	17.8	18.7	10.7	13.3	13.4	14.4	15.9	15.4	12.8	14.9	11.8	19.2	7.5	14.3	4.8	5.3	71.6	11.3	18.5	17.1	13.8	7.2	10.8	12.4	12.6	11.5	8.3	9.6	12.7	11.1	16.8	13.1	8.7	14.1	11.5	11.9	19.8	18.9	49.0	7.8	11.8	27.0	10.1	14.8	12.5	30.4	17.3	18.8	12.3	6.3	14.1	25.4	21.1	37.1	17.9	13.3	26.9	14.4	13.1	11.0	27.3	14.6	18.3	2.4	3.5	4.4	1.4	4.5	1.0	2.2	1.4	1.3	2.4	2.0	1.4	1.3	4.6	0.7	6.9	3.6	2.0	2.4	34.2	31.4	26.3	47.1	28.0	18.6	17.5	25.9	15.8	13.1	3.0	27.3	32.6	23.9	27.8	31.1	12.9	50.9	10.7	7.9	41.8	62.8	40.3	101.2	45.0	50.6	29.6	273.7	0.0	77.2	65.9	30.7	31.5	10.4	95.7	53.6	27.0	43.3	78.0	103.2	121.6	44.0	36.6	21.9	23.4	108.9	27.8	78.4	136.8	49.8	53.1	37.3	12.9	21.7	45.0	57.1	24.0	43.7	21.8	112.6	32.8
EPOR		ENSG00000187266	"Erythropoietin receptor"	P19235	19	11377205-11384342	"Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted membrane proteins"		Receptor	"Cancer-related genes, Congenital erythrocytosis, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Erythroid cells: 70.0;Ito cells: 78.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA077654			Supported	"Nuclear speckles,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"	"Nuclear speckles"	"HPA077654: "	"unprognostic (9.13e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.60e-2)"	"unprognostic (9.00e-2)"	"prognostic favorable (3.17e-5)"	"unprognostic (6.37e-3)"	"unprognostic (1.59e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.01e-3)"	5.5	8.6	2.1	1.1	2.9	14.7	2.6	1.3	1.7	3.9	3.3	2.8	13.3	1.0	3.6	11.6	2.4	3.2	1.8	11.2	1.9	1.4	12.1	8.4	8.5	6.9	1.9	1.6	1.9	9.2	28.1	5.2	12.7	2.3	3.1	1.4	3.3	8.7	18.3	2.0	1.1	1.7	1.5	4.0	8.0	3.7	2.2	1.0	1.6	21.5	1.0	1.5	1.9	2.1	2.6	2.5	12.2	7.7	0.9	4.8	2.9	3.5	1.2	3.5	4.1	5.4	3.4	2.1	2.2	6.8	3.6	4.6	1.2	1.3	2.4	3.9	4.0	5.0	0.9	2.7	1.4	4.2	2.0	1.6	13.1	1.1	2.0	3.8	2.7	5.5	2.5	0.5	4.8	3.3	8.4	8.3	5.1	11.6	11.7	4.0	3.1	2.5	3.3	1.9	1.9	9.4	6.7	6.0	5.3	3.3	1.8	1.4	11.0	1.4	2.0	6.1	3.9	3.6	4.7	3.4	1.9	2.7	6.5	2.0	6.0	4.3	2.6	10.5	2.7	2.0	8.1	4.2	3.3	2.1	5.1	4.5	2.6	4.2	3.1	2.5	1.6	4.8	2.8	12.2	0.9	7.7	0.1	3.7	2.9	2.1	2.9	1.3	1.7	1.9	1.4	1.9	1.6	2.3	1.0	17.9	16.8	5.3	3.5	2.1	2.5	5.1	7.6	2.7	4.5	19.2	0.0	1.8	3.3	2.0	0.7	6.5	0.3	70.0	2.9	11.5	7.6	2.4	26.5	1.9	32.5	1.6	8.1	78.5	15.6	0.0	2.6	3.1	8.5	1.0	2.3	11.1	3.8	0.0	3.9	0.8	2.2	19.4	20.8	3.3	6.4	0.9	2.5	8.7	1.4	1.1
EPS8L2	"FLJ21935, FLJ22171, MGC3088"	ENSG00000177106	"EPS8 like 2"	Q9H6S3	11	694438-727727	"Disease related genes, Predicted intracellular proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 73.3"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 131.0;Enterocytes: 200.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"plasmacytoid DC: 6.4"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 6.4"	"Cell line enhanced"	"Detected in many"		"A-431: 46.7;BEWO: 46.2;CAPAN-2: 44.0;SK-BR-3: 54.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	10	"cerebellum: 13.6"	HPA041143	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA041143: AB_10794985"	"unprognostic (1.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.40e-2)"	"prognostic unfavorable (2.31e-4)"	"unprognostic (6.87e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.79e-1)"	"unprognostic (5.03e-2)"	1.7	3.0	2.0	6.4	3.3	0.0	12.4	6.9	2.5	11.6	31.5	1.2	23.9	38.7	4.6	10.1	53.3	5.3	21.7	1.0	1.3	1.6	30.4	38.3	18.0	0.4	1.7	0.5	3.9	11.6	1.8	4.3	39.6	3.6	8.4	6.0	2.7	26.2	17.6	0.7	22.8	73.3	2.4	2.4	0.5	18.0	7.2	1.5	0.9	29.5	29.4	33.7	6.9	19.2	0.2	6.4	0.7	0.1	0.1	0.1	0.1	46.7	14.3	0.0	0.3	0.5	3.2	46.2	4.1	4.2	6.1	2.6	10.7	44.0	0.1	17.1	4.3	1.1	24.8	0.1	24.8	1.4	0.1	0.9	0.0	5.3	19.2	3.5	0.0	0.0	1.7	16.6	1.8	4.3	2.5	0.0	0.0	0.3	0.2	0.7	15.0	0.1	0.2	0.5	14.6	4.6	0.1	0.1	0.3	21.7	11.7	0.1	0.1	14.6	54.0	0.1	3.2	20.4	0.0	0.3	2.5	5.8	1.5	0.3	0.1	0.2	0.1	1.3	0.1	0.1	0.0	0.0	0.7	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	6.4	0.0	0.1	2.0	3.3	6.9	2.5	1.3	1.6	1.7	0.5	3.6	1.5	131.0	60.0	7.3	23.9	17.5	0.8	3.6	53.5	33.5	51.2	85.5	0.0	43.8	23.2	45.5	1.0	3.0	200.0	0.0	70.5	25.8	7.1	28.6	6.9	55.5	4.3	0.0	42.1	0.6	1.3	1.7	16.7	3.2	13.5	3.6	61.8	8.9	66.1	98.2	11.0	84.7	0.7	0.0	5.1	0.7	4.1	21.3	77.3	21.0	62.0	26.8
ERBB3	"HER3, LCCS2"	ENSG00000065361	"Erb-b2 receptor tyrosine kinase 3"	P21860	12	56076799-56103505	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 180.9;Enterocytes: 163.1;Paneth cells: 165.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.3"	"Cell line enhanced"	"Detected in many"		"Hep G2: 30.9;MCF7: 20.2;OE19: 31.8;RT4: 24.2;SK-BR-3: 28.4;SK-MEL-30: 37.9;T-47d: 31.5;WM-115: 40.2"	"Low region specificity"	"Detected in many"							"CAB025331, HPA045396"	Uncertain		Supported	"Plasma membrane,Actin filaments"	"Secreted - unknown location"	NA	NA		420000	"Plasma membrane"	"Actin filaments"	"CAB025331: , HPA045396: AB_2679312"	"unprognostic (2.97e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.31e-3)"	"unprognostic (2.66e-2)"	"unprognostic (9.89e-2)"	"unprognostic (4.30e-2)"	"unprognostic (4.76e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.07e-2)"	1.1	1.4	11.6	12.6	16.5	0.6	26.8	2.0	16.7	6.8	40.5	40.3	12.0	37.7	2.8	7.5	29.4	5.7	22.9	3.4	18.6	9.0	16.5	33.9	13.4	0.5	23.5	9.3	0.9	21.5	11.4	1.0	15.4	14.9	16.8	29.7	5.5	36.8	22.3	1.1	30.7	41.3	3.2	27.4	0.5	32.9	1.2	23.8	0.0	4.5	7.4	8.5	11.8	14.4	0.9	0.7	5.3	0.6	1.2	1.2	0.2	10.0	0.6	0.8	0.3	0.0	0.0	16.4	0.8	1.9	1.1	1.1	5.5	18.2	0.0	0.2	0.2	0.1	8.6	1.2	1.9	0.6	0.2	0.8	0.0	0.3	30.9	0.0	0.0	0.1	0.4	2.5	0.2	0.0	0.2	0.0	0.1	0.7	0.3	0.1	20.2	0.1	0.3	2.8	31.8	0.4	0.1	1.9	0.5	2.1	24.2	0.9	0.3	0.7	28.4	37.9	2.7	31.5	0.1	0.0	0.1	1.1	0.6	0.1	0.2	0.1	0.1	0.1	0.0	40.2	5.3	0.4	0.8	0.9	0.4	0.4	0.4	0.7	0.3	0.3	0.9	0.6	1.2	3.3	1.2	0.6	0.7	0.8	0.2	11.6	16.5	2.0	16.7	18.6	9.0	23.5	9.3	14.9	23.8	110.2	61.2	1.3	13.0	16.3	1.5	1.4	180.9	21.4	61.4	33.2	2.0	44.4	1.7	41.9	0.9	2.2	163.1	0.0	77.1	73.6	2.7	83.4	1.1	83.9	5.5	0.0	89.5	6.7	1.9	0.0	1.4	1.7	52.3	2.8	134.3	11.3	75.9	165.5	0.0	31.8	1.1	6.5	1.7	2.4	2.3	32.2	84.1	1.5	124.3	62.5
ERBIN	"ERBB2IP, LAP2"	ENSG00000112851	"Erbb2 interacting protein"	Q96RT1	5	65926475-66082549	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 65.5;Alveolar cells type 2: 48.1;Ciliated cells: 44.2;Club cells: 58.0;Collecting duct cells: 50.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048606, HPA059863"	Approved		Supported	"Nuclear speckles,Plasma membrane"		NA	NA		250000	"Nuclear speckles, Plasma membrane"		"HPA048606: AB_2680461, HPA059863: AB_2684146"	"unprognostic (4.34e-1)"	"unprognostic (5.56e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.52e-2)"	"unprognostic (5.45e-3)"	"unprognostic (7.98e-2)"	"unprognostic (5.62e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.08e-1)"	"unprognostic (6.86e-2)"	"unprognostic (7.81e-2)"	20.1	8.7	33.2	28.5	32.7	13.3	13.0	5.4	15.9	16.1	21.1	10.6	16.3	12.1	14.5	22.1	17.2	10.5	17.2	12.6	29.5	22.5	15.8	24.1	20.1	21.1	32.5	7.4	11.1	13.7	15.4	6.9	10.4	16.0	18.2	13.8	11.1	17.3	26.0	16.4	16.9	37.4	15.3	31.0	27.6	20.3	13.3	17.6	40.2	19.6	16.3	19.6	20.7	14.9	6.2	4.5	13.5	7.6	5.0	7.1	3.6	30.6	10.3	13.5	16.1	10.1	12.3	10.3	19.7	20.3	28.2	31.5	9.8	36.6	25.9	19.3	30.5	22.2	10.3	8.6	14.4	49.9	11.3	3.9	9.0	13.1	7.7	13.3	6.8	8.7	13.3	9.6	15.4	22.5	16.6	10.4	11.9	9.0	17.8	19.0	10.4	18.1	7.9	3.3	3.0	3.0	16.7	10.9	14.2	16.5	20.9	6.6	6.1	21.0	7.0	14.9	10.6	12.2	16.9	9.5	16.0	28.5	9.6	25.3	15.4	9.6	22.2	10.5	11.4	9.1	13.5	5.2	6.7	7.1	7.6	6.5	6.2	5.5	6.3	4.5	4.9	6.5	6.7	11.9	5.0	6.0	2.9	4.8	3.6	33.2	32.7	5.4	15.3	29.5	22.5	32.5	7.4	16.0	17.6	65.5	48.1	0.0	0.0	0.0	0.0	0.0	0.0	44.2	58.0	50.6	0.0	5.1	10.0	23.8	0.0	0.0	0.0	0.0	21.5	8.9	0.0	0.0	25.6	0.0	34.1	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	10.0	0.0	0.0	35.0	0.0	0.0	35.7	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0
ERC1	"CAST2, ELKS, KIAA1081, MGC12974, RAB6IP2"	ENSG00000082805	"ELKS/RAB6-interacting/CAST family member 1"	Q8IUD2	12	990509-1495933	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 174.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019513, HPA019523, HPA024130"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Vesicles, Plasma membrane"	"HPA019513: AB_1856012, HPA019523: AB_1856013, HPA024130: AB_1856014"	"unprognostic (2.41e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.50e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.75e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.01e-1)"	"unprognostic (7.37e-2)"	"prognostic unfavorable (7.01e-4)"	12.6	11.4	10.3	12.5	14.7	7.4	15.1	41.7	10.4	11.2	11.9	8.5	9.2	4.3	17.1	11.0	13.7	9.8	9.9	14.7	10.0	11.2	11.2	8.0	8.8	5.4	9.0	6.4	12.5	8.6	24.3	19.4	13.2	10.7	11.4	7.5	10.1	9.3	14.4	9.2	9.9	6.4	22.1	8.5	7.3	8.6	11.0	9.9	9.8	15.3	7.2	8.6	15.7	15.3	8.6	2.9	2.1	3.8	1.1	3.5	0.5	2.9	7.3	3.9	2.6	10.4	8.8	5.4	9.2	7.4	6.3	5.8	6.4	3.6	4.5	1.3	11.9	6.3	4.9	8.3	7.1	8.8	9.5	4.2	11.1	7.3	3.2	7.9	5.7	2.6	7.1	6.2	11.1	20.8	7.6	8.1	2.9	3.3	8.9	4.7	3.2	1.8	1.2	6.2	2.8	3.5	3.6	14.8	1.4	6.2	5.3	2.3	4.6	14.4	3.3	5.2	14.7	3.4	2.4	15.0	10.9	11.1	8.0	8.6	2.4	4.5	6.7	7.1	3.4	4.8	1.4	2.8	2.1	1.6	1.0	2.2	8.6	2.4	2.4	2.4	5.6	3.5	2.6	2.1	1.1	3.8	2.9	2.2	0.5	10.3	14.7	41.7	10.4	10.0	11.2	9.0	6.4	10.7	9.9	23.8	21.4	15.2	22.2	18.7	34.0	51.9	15.3	14.7	23.9	19.2	45.2	25.8	1.7	17.5	29.4	26.3	7.0	0.0	11.7	14.8	17.3	21.4	13.9	15.3	10.8	174.8	28.8	24.5	10.7	24.2	23.0	11.3	13.5	16.2	8.4	47.3	15.2	9.0	29.0	3.3	34.7	19.4	16.5	15.6	28.4	24.0	65.8	7.4	7.6	29.2
EVI2B	"CD361, D17S376, EVDB"	ENSG00000185862	"Ecotropic viral integration site 2B"	P34910	17	31303766-31314112	"CD markers, Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 133.6;lymphoid tissue: 72.8"	"Cell type enhanced"	"Detected in many"	16	"B-cells: 217.4;Kupffer cells: 447.5;Macrophages: 274.7;T-cells: 178.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 133.6"	"Group enriched"	"Detected in all"	4	"granulocytes: 133.6;monocytes: 34.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 24.2;HHSteC: 19.9;HL-60: 27.3;HMC-1: 38.5;Karpas-707: 27.3;NB-4: 21.6;RPMI-8226: 39.9;THP-1: 34.4"					"Low region specificity"	"Detected in all"			HPA007436	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA			Nucleoplasm	"Plasma membrane, Focal adhesion sites"	"HPA007436: AB_1848307"	"unprognostic (1.07e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (1.56e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.73e-2)"	15.0	3.6	4.4	37.7	5.8	44.0	4.2	1.7	4.4	3.7	10.7	6.5	0.3	6.0	2.8	4.8	7.1	4.7	8.1	6.7	6.4	4.4	7.8	7.1	38.5	37.5	10.2	2.6	3.8	2.7	0.4	2.1	4.8	7.8	5.3	8.1	2.5	6.6	1.5	2.3	2.4	23.3	4.2	22.0	72.8	8.0	3.7	6.7	26.1	4.0	3.0	43.0	13.0	7.6	18.6	14.6	133.6	34.3	4.1	16.4	19.8	0.1	0.1	0.0	0.0	1.9	2.5	0.0	0.2	1.7	2.0	3.7	0.0	0.9	24.2	0.0	1.5	7.5	0.1	0.0	0.3	2.2	0.0	0.0	0.5	0.0	0.0	19.9	27.3	38.5	4.6	0.0	1.1	1.5	0.6	1.9	2.0	0.3	27.3	5.7	0.0	7.9	21.6	0.0	0.0	0.0	13.9	0.1	39.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	34.4	2.1	0.5	0.0	0.2	1.9	5.3	0.2	5.3	2.5	9.4	0.6	78.9	30.5	74.5	8.2	23.2	7.9	18.6	12.6	10.6	14.6	14.3	9.7	9.1	133.6	4.1	34.3	8.4	16.4	19.8	4.4	5.8	1.7	4.4	6.4	4.4	10.2	2.6	7.8	6.7	0.0	17.9	217.4	0.6	4.7	0.2	0.4	2.5	4.0	11.4	1.8	0.0	0.5	0.0	0.0	5.3	2.7	0.2	0.0	0.0	0.5	2.8	0.3	78.7	1.7	88.8	0.0	0.0	9.8	447.5	4.7	0.0	274.7	35.4	10.8	0.0	0.0	0.7	0.0	0.4	0.7	0.8	19.4	4.1	0.3	0.5	3.1	0.2	178.5	0.0	1.1
F2RL3	PAR4	ENSG00000127533	"F2R like thrombin or trypsin receptor 3"	Q96RI0	19	16888860-16892606	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 69.4;breast: 30.7;lung: 33.0"	"Group enriched"	"Detected in some"	5	"Endothelial cells: 5.8;granulocytes: 6.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"HEL: 24.9;HMC-1: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031401, HPA042340"			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA031401: , HPA042340: "	"unprognostic (6.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.64e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.31e-3)"	"unprognostic (2.97e-1)"	"unprognostic (3.28e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.00e-3)"	"prognostic favorable (6.25e-4)"	"unprognostic (2.37e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.11e-2)"	69.4	3.3	0.2	2.6	0.4	1.3	30.7	0.2	0.6	1.3	16.9	0.4	0.5	1.9	1.3	1.9	4.3	1.0	4.5	9.7	0.5	0.2	5.0	0.8	33.0	2.6	0.2	0.3	3.9	12.3	0.5	2.3	1.1	1.4	1.4	1.5	1.3	1.0	0.8	6.5	2.2	4.4	1.1	0.2	3.0	5.4	2.5	0.2	0.3	27.1	2.3	1.5	3.4	1.9	5.3	4.3	5.8	2.5	3.9	3.3	3.2	0.2	0.2	0.7	0.3	0.1	0.2	0.7	0.4	0.1	0.2	0.1	0.4	0.7	0.5	0.5	0.2	0.3	0.7	0.1	0.2	0.2	0.3	0.4	24.9	0.9	0.4	0.2	0.3	10.0	0.0	0.1	0.3	0.2	0.3	0.8	0.5	2.0	1.0	0.1	0.3	0.3	2.4	0.3	0.3	0.2	0.2	0.2	0.8	0.2	0.5	0.4	0.2	0.2	0.2	0.1	0.6	0.5	1.7	1.0	0.6	0.5	0.3	0.3	0.5	0.3	0.5	0.2	0.4	0.4	5.8	2.5	1.6	2.2	1.4	2.1	3.9	2.4	1.9	0.8	5.3	3.3	3.1	5.3	3.9	1.8	4.3	1.7	3.2	0.2	0.4	0.2	0.6	0.5	0.2	0.2	0.3	1.4	0.2	0.0	0.6	0.0	0.2	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.5	0.0	0.5	0.3	6.9	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.5	0.0	0.0	0.3
FAM126A	"DRCTNNB1A, HCC, HYCC1, hyccin"	ENSG00000122591	"Family with sequence similarity 126 member A"	Q9BYI3	7	22889371-23014130	"Disease related genes, Predicted intracellular proteins"			"Cataract, Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042873	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA042873: AB_2678207"	"unprognostic (7.94e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.54e-4)"	"unprognostic (1.35e-1)"	"unprognostic (9.76e-3)"	"unprognostic (1.30e-2)"	"unprognostic (7.23e-2)"	"unprognostic (6.19e-2)"	"prognostic unfavorable (6.04e-7)"	"prognostic unfavorable (5.99e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (9.03e-4)"	15.6	6.1	12.4	13.6	16.9	4.6	14.3	1.7	10.2	10.5	10.5	9.3	1.5	9.6	10.9	4.7	16.1	7.3	12.3	12.2	11.9	6.4	6.1	8.6	15.0	16.8	12.0	5.2	8.6	7.9	1.5	13.2	16.6	10.0	9.7	5.2	11.3	8.4	6.0	28.4	6.0	10.7	13.1	8.6	14.7	6.0	22.3	11.4	12.8	8.1	10.3	14.3	10.6	15.0	9.5	5.9	16.3	12.1	3.6	5.3	3.3	9.6	4.0	19.6	7.9	18.7	29.7	3.0	29.0	29.4	12.8	19.3	6.3	3.6	8.8	5.2	23.6	28.4	3.7	19.8	6.5	21.1	4.2	7.0	7.5	6.7	4.4	16.1	12.9	8.8	12.9	4.8	26.3	25.9	25.0	14.9	5.8	16.1	26.4	23.1	2.7	7.9	10.2	19.3	0.0	8.5	8.6	19.5	4.5	3.7	3.4	6.5	0.0	11.8	0.3	12.0	17.3	5.7	9.3	14.7	44.1	5.9	22.7	15.6	36.2	14.0	30.4	28.5	6.9	38.5	3.9	4.6	16.3	2.3	9.5	1.8	7.6	3.3	2.1	5.9	9.5	1.8	2.4	0.9	3.6	12.1	2.2	5.3	3.3	12.4	16.9	1.7	9.4	11.9	6.4	12.0	5.2	10.0	11.4	3.0	13.7	13.1	5.2	22.7	39.4	18.9	2.5	1.4	4.5	3.5	2.0	9.7	0.0	6.4	27.6	31.7	1.3	0.0	4.2	11.0	31.5	4.2	8.1	17.4	12.5	15.9	7.5	24.5	27.1	16.2	18.7	26.2	33.7	12.6	1.3	7.0	3.5	0.3	18.4	4.8	4.0	19.4	33.0	40.9	9.1	21.0	5.0	13.8	1.3	6.0
FAS	"APO-1, APT1, CD95, FAS1, TNFRSF6"	ENSG00000026103	"Fas cell surface death receptor"	P25445	10	88990582-89015785	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	"Calmodulin-binding, Receptor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 100.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 40.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 40.1;T-cells: 30.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 28.0;Karpas-707: 44.7"					"Low region specificity"	"Detected in all"			HPA027444	Uncertain		Supported	"Nuclear bodies,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	11900000	450000	"Plasma membrane"	"Nuclear bodies, Cytosol"	"HPA027444: AB_10601378"	"unprognostic (6.84e-2)"	"unprognostic (2.88e-3)"	"unprognostic (8.38e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.35e-2)"	"unprognostic (9.56e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.01e-1)"	"unprognostic (7.70e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.65e-1)"	13.5	26.3	6.1	17.3	7.7	12.4	10.6	2.1	7.2	15.6	14.2	6.1	7.0	5.9	15.7	16.6	14.1	14.2	14.5	8.9	8.2	2.7	11.7	21.9	28.6	15.6	6.0	3.9	24.7	4.1	4.5	4.6	9.0	7.5	22.3	21.3	4.4	7.1	8.5	4.3	9.6	16.3	12.5	10.2	15.3	5.0	7.3	5.1	12.5	10.0	15.8	14.4	14.8	21.4	3.0	4.0	40.1	6.8	1.2	30.9	3.9	8.7	3.4	1.8	5.6	14.5	21.4	0.0	19.2	19.5	0.7	3.8	0.0	9.5	1.7	7.4	18.0	3.2	1.4	0.3	16.2	1.3	28.0	2.8	0.1	1.8	5.7	13.9	0.9	0.4	26.5	14.5	12.0	26.0	9.4	1.7	6.4	0.0	44.7	19.6	0.8	2.8	1.4	0.2	0.0	0.9	0.2	0.1	1.8	27.1	2.8	0.1	0.1	2.8	0.0	0.3	2.8	6.1	0.3	4.2	6.2	3.4	5.7	4.4	17.5	1.8	0.1	5.1	3.5	1.8	11.3	3.2	9.4	3.3	3.9	4.8	3.0	10.4	7.2	4.0	0.7	1.2	3.4	40.1	1.2	6.8	0.0	30.9	3.9	6.1	7.7	2.1	7.2	8.2	2.7	6.0	3.9	7.5	5.1	53.6	14.4	3.7	100.3	40.8	0.0	1.2	15.3	21.4	21.6	8.7	0.0	0.4	0.0	6.7	5.4	8.4	12.0	0.0	3.8	0.2	34.9	22.7	3.5	15.3	5.0	1.6	8.1	2.5	6.9	3.5	17.5	12.7	11.8	20.8	15.0	17.1	4.3	0.0	13.1	11.5	0.7	6.5	33.4	4.8	1.3	38.3	0.3	37.9	23.2	22.7
FBLN2		ENSG00000163520	"Fibulin 2"	P98095	3	13549131-13638422	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 80.5"	"Group enriched"	"Detected in many"	6	"Fibroblasts: 266.2;Leydig cells: 158.2;Peritubular cells: 213.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 9.2;naive CD8 T-cell: 5.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 75.4;fHDF/TERT166: 49.5;HMC-1: 60.2;HSkMC: 43.7;U-2197: 26.7"	"Region enriched"	"Detected in some"	7	"olfactory region: 15.4"	"Low region specificity"	"Detected in all"			"HPA001934, CAB018622"	Enhanced		Supported	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		28000000	"Plasma membrane"		"CAB018622: AB_2294196, HPA001934: AB_1078827"	"unprognostic (1.19e-1)"	"unprognostic (7.76e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (2.82e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (3.17e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-1)"	58.5	2.7	1.8	8.0	2.2	0.1	34.3	0.8	3.2	21.4	11.5	1.3	9.5	2.1	11.6	23.6	32.7	7.2	21.9	80.5	1.6	1.7	2.1	1.2	7.8	5.1	2.4	1.4	6.3	3.2	1.1	0.9	31.8	2.3	22.1	4.2	7.9	10.8	3.3	20.1	20.8	6.1	42.9	1.5	2.3	6.9	41.8	0.5	4.8	20.7	23.8	8.5	34.2	36.3	2.2	9.2	0.0	0.0	0.4	5.4	1.1	0.0	0.2	9.8	0.0	75.4	10.2	4.5	23.5	18.8	23.6	15.6	1.5	0.0	0.0	1.1	49.5	0.0	0.0	0.0	0.1	4.4	0.0	0.0	18.6	0.4	0.0	5.1	0.0	60.2	43.7	0.3	3.7	0.0	0.0	0.0	1.6	0.1	0.1	0.1	0.0	0.9	0.1	2.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.4	0.0	17.3	0.0	2.7	0.0	0.0	0.0	0.0	0.0	26.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	1.7	0.0	0.3	9.2	2.2	0.0	5.4	0.0	0.4	0.0	0.7	0.0	1.1	1.8	2.2	0.8	3.2	1.6	1.7	2.4	1.4	2.3	0.5	0.0	1.0	0.0	0.7	27.4	0.0	7.3	0.0	0.0	3.4	7.0	2.0	6.6	0.0	0.0	3.4	29.2	0.0	0.0	0.2	4.5	266.2	1.0	24.1	0.2	3.2	0.0	0.0	25.8	0.3	6.5	158.2	2.1	37.1	0.0	0.0	1.3	0.2	0.0	213.6	0.0	0.2	12.9	19.6	2.6	8.8	25.2	5.1	0.0	0.0	0.9
FBLN5	"ARMD3, DANCE, EVEC, UP50"	ENSG00000140092	"Fibulin 5"	Q9UBX5	14	91869412-91947987	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"		"Age-related macular degeneration, Charcot-Marie-Tooth disease, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Leydig cells: 580.2;Peritubular cells: 747.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.5"	"Group enriched"	"Detected in many"	19	"granulocytes: 8.5;T-cells: 2.8"	"Cell line enhanced"	"Detected in some"		"ASC diff: 87.8;ASC TERT1: 45.9;BJ: 41.1;BJ hTERT+: 38.5;fHDF/TERT166: 73.5;HSkMC: 42.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000848, HPA000868, CAB025843"	Supported		Supported	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		4500000	"Plasma membrane"		"CAB025843: , HPA000848: AB_1078620, HPA000868: AB_1078619"	"unprognostic (5.53e-3)"	"unprognostic (1.14e-1)"	"unprognostic (7.78e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.55e-3)"	"unprognostic (4.73e-2)"	"prognostic favorable (6.75e-4)"	"unprognostic (5.21e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.90e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.18e-2)"	"unprognostic (3.17e-3)"	48.3	23.5	3.4	11.5	9.5	1.8	49.5	2.2	5.6	52.4	26.6	5.3	20.3	6.0	51.7	36.0	22.6	32.2	97.4	54.5	2.5	2.6	38.9	12.1	50.5	8.6	7.0	4.1	36.5	14.6	7.6	3.9	21.0	9.4	41.2	6.4	40.6	18.3	23.8	24.7	17.5	12.8	51.8	6.8	48.2	18.8	43.9	2.1	1.2	30.3	15.1	9.4	56.4	51.1	0.2	0.1	8.5	0.3	0.0	2.8	0.6	0.0	0.2	0.0	0.0	87.8	45.9	4.6	41.1	38.5	1.1	0.8	0.7	0.0	0.0	0.8	73.5	0.1	0.0	1.8	0.1	0.2	0.0	0.4	0.0	0.8	0.0	14.6	0.0	0.0	42.1	0.0	0.7	2.7	0.5	1.9	0.0	0.0	0.0	4.7	0.1	0.0	0.1	0.1	0.0	0.1	0.0	5.8	0.0	0.2	0.0	0.0	0.0	2.3	0.1	0.5	1.3	0.5	0.0	0.3	0.6	1.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.2	3.5	1.2	0.2	0.7	0.1	0.5	0.1	0.0	0.2	1.7	2.8	4.1	0.0	0.3	0.1	0.1	0.6	3.4	9.5	2.2	5.6	2.5	2.6	7.0	4.1	9.4	2.1	77.4	13.3	0.0	2.5	8.1	0.0	4.5	0.0	17.4	12.5	5.2	0.0	1.9	5.0	3.7	4.7	9.2	0.0	0.0	4.3	1.4	129.7	1.2	2.3	0.5	7.7	0.0	0.0	46.6	1.9	12.1	580.2	2.5	20.3	1.0	0.0	0.0	2.7	0.0	747.1	24.2	0.0	6.5	15.0	2.1	2.0	7.5	3.1	6.9	0.0	0.7
FBXL2	"FBL2, FBL3"	ENSG00000153558	"F-box and leucine rich repeat protein 2"	Q9UKC9	3	33277025-33403662	"Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Calmodulin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 23.6;Early spermatids: 41.5;Late spermatids: 37.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 8.9;LHCN-M2: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061783			Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Plasma membrane"	"Nucleoplasm, Nucleoli"	"HPA061783: AB_2684605"	"unprognostic (5.73e-2)"	"unprognostic (4.47e-2)"	"unprognostic (7.92e-2)"	"unprognostic (7.21e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.35e-4)"	"unprognostic (3.30e-3)"	"unprognostic (9.72e-2)"	"unprognostic (4.28e-2)"	"unprognostic (5.90e-2)"	3.2	5.2	8.0	2.2	15.0	1.9	4.1	7.2	18.1	3.7	2.9	4.1	1.8	3.2	5.2	8.2	2.3	6.0	3.0	2.7	8.7	11.3	5.5	1.4	4.6	1.8	6.6	13.4	4.5	3.5	7.7	16.1	5.5	13.1	4.3	1.5	6.4	3.1	6.5	1.5	2.9	2.0	3.5	4.5	2.3	2.5	4.3	2.8	0.0	8.6	0.6	1.5	2.6	2.5	1.3	0.9	2.8	1.0	0.9	1.1	0.1	3.9	1.1	1.6	1.8	2.3	3.8	0.6	3.1	2.5	2.8	4.1	0.8	4.7	0.2	0.9	2.0	1.3	1.0	1.4	3.4	1.9	0.4	1.9	0.7	3.2	0.8	2.8	0.3	0.7	1.5	2.5	1.8	1.3	8.9	5.0	2.8	0.9	0.3	9.4	0.4	0.8	0.7	1.2	0.5	0.9	0.1	1.0	0.1	7.1	1.1	2.0	2.0	1.3	0.8	2.3	2.7	2.2	1.2	3.9	1.4	1.3	1.1	1.7	0.4	0.2	0.2	1.3	0.3	0.9	1.5	1.0	0.7	0.9	0.5	0.7	0.5	0.7	0.9	0.3	1.3	1.1	1.1	2.8	0.9	0.7	0.9	0.4	0.1	8.0	15.0	7.2	18.1	8.7	11.3	6.6	13.4	13.1	2.8	3.0	8.2	0.0	5.1	1.0	16.5	2.0	2.5	13.4	4.5	5.2	23.6	0.4	3.3	3.5	41.5	2.2	0.0	0.0	0.3	1.0	3.6	2.9	0.0	0.0	0.4	17.5	0.0	3.1	0.3	37.9	1.4	1.2	1.7	0.0	0.1	6.7	3.4	0.0	3.9	2.1	14.2	6.5	2.9	11.7	7.9	1.0	0.6	1.3	0.0	3.3
FBXO38	"Fbx38, FLJ13962, MOKA, SP329"	ENSG00000145868	"F-box protein 38"	Q6PIJ6	5	148383935-148442836	"Disease related genes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"		"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 2: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034821, HPA041444"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"		Yes	No			"Nucleoplasm, Plasma membrane"	"Cytokinetic bridge, Cytosol"	"HPA034821: AB_10669897, HPA041444: AB_2677484"	"unprognostic (7.72e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.70e-2)"	"unprognostic (7.06e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.03e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.70e-3)"	23.2	19.3	13.8	17.7	21.2	12.6	20.6	20.8	21.1	22.3	18.4	20.0	20.4	13.8	25.2	18.2	17.6	16.7	16.9	24.1	18.8	13.8	19.2	25.7	20.7	19.0	16.3	18.8	19.2	16.9	29.2	34.1	19.7	24.6	22.2	19.3	16.4	19.4	18.7	28.5	19.3	18.4	18.2	17.8	24.8	18.8	20.0	18.9	26.9	18.1	17.1	21.7	21.7	18.0	5.5	8.1	13.7	14.8	8.0	7.9	4.9	8.6	9.2	14.3	10.4	16.1	18.2	7.5	11.3	21.6	16.1	22.1	13.5	10.6	12.5	11.1	18.2	17.0	12.1	14.9	14.2	19.4	13.7	9.6	7.4	13.5	9.1	16.1	20.0	12.2	17.5	12.2	15.4	15.2	17.2	21.6	11.7	8.2	13.6	15.7	3.5	12.6	9.5	6.7	9.6	14.0	11.3	20.9	12.5	15.6	10.1	12.8	12.5	15.0	10.1	14.5	12.8	10.6	14.6	14.0	14.7	5.3	7.7	12.5	16.7	16.8	10.7	14.6	11.5	11.1	13.7	6.3	9.0	5.9	8.6	6.3	5.5	5.5	5.7	8.1	4.8	5.7	7.2	12.0	8.0	14.8	3.9	7.9	4.9	13.8	21.2	20.8	21.1	18.8	13.8	16.3	18.8	24.6	18.9	14.9	40.8	7.0	5.2	3.0	9.8	16.2	7.6	16.0	10.3	10.4	9.8	6.2	5.0	7.4	7.9	6.7	8.0	0.0	5.8	5.5	6.0	8.8	15.1	17.3	11.1	12.7	9.2	13.5	25.7	2.1	8.3	15.0	3.3	4.6	9.8	5.6	8.7	8.6	17.3	7.5	9.2	0.0	4.7	22.1	7.5	3.3	10.3	6.9	9.1	7.1
FCAR	CD89	ENSG00000186431	"Fc fragment of IgA receptor"	P24071	19	54874248-54890472	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"		"IgA-binding protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.1;lung: 19.5;lymphoid tissue: 15.9"	"Cell type enhanced"	"Detected in some"	15	"Alveolar cells type 2: 3.7;Cardiomyocytes: 1.4;Ciliated cells: 1.4;Kupffer cells: 5.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"classical monocyte: 2.6;neutrophil: 6.1"	"Group enriched"	"Detected in many"	44	"granulocytes: 6.1;monocytes: 2.6"	"Cell line enhanced"	"Detected in single"		"THP-1: 1.7"					"Low region specificity"	"Detected in all"			HPA014050	Approved		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"HPA014050: AB_1846338"	"unprognostic (1.46e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.71e-3)"	"unprognostic (3.46e-1)"	"unprognostic (2.02e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.19e-6)"	"unprognostic (9.23e-2)"	"unprognostic (8.10e-3)"	"unprognostic (8.04e-3)"	"unprognostic (9.81e-2)"	4.0	0.6	0.4	1.5	4.4	28.1	0.8	0.1	1.0	0.6	0.6	0.7	0.0	0.6	0.6	0.6	0.6	3.8	0.6	8.2	2.0	0.4	0.6	1.8	19.5	15.9	1.2	0.0	2.2	0.6	0.6	0.3	1.5	4.3	0.6	0.6	0.9	0.6	0.6	0.6	0.6	0.6	0.7	2.7	14.9	0.9	2.1	0.0	1.0	0.6	0.3	0.6	4.4	4.8	0.0	0.0	6.1	2.6	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.1	0.0	0.0	0.7	0.4	4.4	0.1	1.0	2.0	0.4	1.2	0.0	4.3	0.0	0.0	3.7	0.0	0.2	0.1	0.1	1.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.3	1.1	0.0	1.0	0.0	0.0	0.0	5.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.1
FCGR1A	"CD64, CD64A"	ENSG00000150337	"Fc fragment of IgG receptor Ia"	P12314	1	149782671-149792518	"CD markers, FDA approved drug targets, Predicted membrane proteins"	"Immunity, Innate immunity"	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 35.6;epididymis: 33.2"	"Cell type enhanced"	"Detected in many"	21	"Hofbauer cells: 235.7;Kupffer cells: 121.8;Late spermatids: 48.6;Macrophages: 101.0"	"Cancer enhanced"	"Detected in many"		"glioma: 10.3"					"Group enriched"	"Detected in some"	7	"classical monocyte: 35.6;intermediate monocyte: 14.0;myeloid DC: 9.5;neutrophil: 25.5"	"Group enriched"	"Detected in many"	80	"dendritic cells: 9.5;granulocytes: 25.5;monocytes: 35.6"	"Cell line enriched"	"Detected in some"	5	"THP-1: 61.0"									HPA026910			Uncertain	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			Vesicles	"Golgi apparatus, Plasma membrane"	"HPA026910: "	"unprognostic (5.27e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.97e-2)"	"unprognostic (8.44e-3)"	"unprognostic (1.73e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.18e-2)"	"prognostic unfavorable (4.83e-8)"	"unprognostic (1.28e-1)"	"unprognostic (4.51e-2)"	"unprognostic (9.99e-2)"	"unprognostic (9.03e-2)"	3.9	2.4	6.7	14.1	4.4	5.0	0.7	0.3	3.5	1.1	0.3			0.0	0.1	33.2	0.3	0.7	2.4	0.7	5.3	4.9	1.0	1.1	8.9	3.4	10.1		0.3	1.0	0.5	1.2	10.8		0.4	0.3		0.7	0.2	0.0	0.0	0.1	5.5	14.3	7.0	0.3	0.9			0.3		0.0	3.3	0.0	0.2	9.5	25.5	35.6	0.0	0.2	11.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	61.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.5	35.6	0.4	0.0	14.0	0.2	0.2	0.0	0.1	9.5	0.0	0.0	0.0	25.5	0.0	2.8	0.2	0.1	11.2											0.0	1.9	3.5	0.0	0.1	1.5	1.2	2.5	1.4	2.3	0.0	2.0	2.1	0.0	0.0	28.2	0.1	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	235.7	0.0	0.0	1.3	121.8	48.6	0.3	101.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.7	6.5	0.0	0.7	0.4	0.0	3.4	0.0	0.0	0.0
FCGR1B	CD64b	ENSG00000198019	"Fc fragment of IgG receptor Ib"	Q92637	1	121087345-121096310	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.8;epididymis: 36.9"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 68.7;Kupffer cells: 38.3;Macrophages: 36.3;Sertoli cells: 19.4"	"Cancer enhanced"	"Detected in single"		"glioma: 1.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 19.2;neutrophil: 21.8"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"NB-4: 10.7;THP-1: 40.9"									HPA026910			Uncertain	"Golgi apparatus,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA			Vesicles	"Golgi apparatus, Plasma membrane"	"HPA026910: "	"unprognostic (3.21e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.10e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.65e-1)"	"unprognostic (3.24e-10)"	"unprognostic (8.99e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.86e-3)"	"unprognostic (8.93e-2)"	4.2	2.3	6.6	13.2	6.2	3.9	1.3	0.8	3.2	0.8	0.5	3.0	0.2	0.5	0.9	36.9	0.5	0.8	1.5	7.4	5.0	4.2	1.0	1.1	4.8	7.9	8.9	0.2	1.1	1.9	0.4	1.5	8.1	6.4	0.6	0.6	0.4	1.3	0.5	0.2	0.0	0.4	4.2	11.3	6.8	0.5	0.5	6.2	0.4	1.8	0.2	0.4	1.5	0.2	0.0	5.2	21.8	19.2	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	40.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	19.2	0.2	0.0	11.3	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	21.8	0.0	6.2	0.1	0.0	5.3	6.6	6.2	0.8	3.0	5.0	4.2	8.9	0.2	6.4	6.2	0.0	1.3	0.8	0.0	0.0	0.8	2.0	0.0	0.0	1.2	0.0	2.0	0.5	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	68.7	3.2	0.0	0.0	38.3	8.2	1.1	36.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	19.4	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.0
FCGR2A	"CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, IGFR2"	ENSG00000143226	"Fc fragment of IgG receptor IIa"	P12318	1	161505430-161524013	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 182.8"	"Cell type enhanced"	"Detected in many"	17	"Hofbauer cells: 145.9;Kupffer cells: 155.0;Macrophages: 311.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 182.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 182.8"	"Cell line enhanced"	"Detected in some"		"HEL: 14.3;HMC-1: 28.9;K-562: 8.4;NB-4: 8.1;THP-1: 30.7;U-937: 13.2"									"HPA010718, HPA010776, HPA014730"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"		NA	NA		55000000	"Plasma membrane"	"Golgi apparatus"	"HPA010718: AB_1078463, HPA010776: , HPA014730: AB_2669074"	"unprognostic (2.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.12e-2)"	"unprognostic (5.89e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (6.49e-7)"	"unprognostic (8.85e-3)"	"unprognostic (6.47e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.42e-2)"	36.8	12.6	13.2	44.6	19.2	18.6	8.2	2.2	10.1	9.1	7.1	10.0	0.0	3.8	4.7	6.6	5.5	11.6	17.0	11.3	17.0	8.9	11.5	7.1	44.1	50.0	25.9	1.7	8.0	5.8	2.8	6.1	47.5	19.6	7.0	9.9	10.8	8.3	4.8	7.3	3.0	7.3	17.6	30.9	43.4	5.9	4.8	19.2	3.2	6.3	2.5	4.4	19.3	4.5	0.2	7.0	182.8	27.2	0.0	0.0	10.6	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.2	0.0	0.3	4.1	28.9	0.3	0.0	0.0	0.0	0.4	0.0	0.0	8.4	0.2	0.0	0.0	0.2	8.1	0.0	0.0	0.6	0.1	0.6	3.9	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	30.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	13.2	3.6	0.1	27.2	31.6	0.0	20.7	0.0	0.2	0.0	0.0	7.0	0.1	0.0	0.0	182.8	0.0	16.7	0.2	0.0	10.6	13.2	19.2	2.2	10.1	17.0	8.9	25.9	1.7	19.6	19.2	20.8	63.3	13.7	0.4	7.7	0.0	1.2	5.1	6.7	21.6	0.0	0.0	0.8	8.3	0.2	37.5	2.6	0.0	0.0	0.5	1.1	5.8	0.3	29.0	0.8	145.9	0.0	0.0	4.3	155.0	35.2	1.4	311.2	16.9	1.8	0.0	0.3	0.7	0.0	0.0	7.9	0.1	6.5	5.8	0.3	0.4	6.8	1.4	4.1	0.0	0.3
FCHSD2	"KIAA0769, SH3MD3"	ENSG00000137478	"FCH and double SH3 domains 2"	O94868	11	72836745-73142261	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Ito cells: 45.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 54.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038545, HPA038546"	Uncertain		Supported	"Nuclear speckles,Plasma membrane,Actin filaments,Focal adhesion sites"		Yes	No			"Plasma membrane"	"Nuclear speckles, Actin filaments, Focal adhesion sites"	"HPA038545: AB_2676074, HPA038546: AB_10673013"	"unprognostic (1.80e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.69e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.02e-1)"	"unprognostic (4.70e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.23e-1)"	18.5	15.1	28.4	41.5	27.8	19.0	26.5	16.9	25.2	13.2	11.4	17.0	6.8	7.0	12.7	10.2	9.7	11.5	18.1	19.2	24.8	21.4	10.6	13.3	26.2	31.7	19.7	12.1	26.3	9.2	10.2	7.6	24.1	17.6	11.2	11.2	12.5	11.1	11.7	7.4	7.0	14.4	16.4	15.6	30.8	10.1	17.4	26.3	19.2	11.9	4.8	33.0	17.9	11.3	16.8	19.0	11.6	4.8	1.1	2.4	2.0	5.2	4.5	9.3	12.2	3.8	9.5	8.7	9.3	19.9	5.7	4.8	3.5	7.7	28.5	11.5	11.9	5.5	7.5	5.4	5.4	7.6	9.8	2.8	22.9	5.1	11.5	9.8	11.2	2.9	5.7	6.0	5.6	6.8	12.5	13.6	9.9	5.0	18.5	7.3	5.6	13.5	19.3	2.0	5.6	5.5	20.7	14.5	54.2	9.0	7.0	4.7	6.6	3.4	6.4	12.1	4.4	4.6	8.2	17.6	18.3	7.1	12.7	2.9	17.8	9.9	25.3	3.1	18.7	5.3	11.0	4.8	10.5	1.7	3.1	1.2	13.0	1.8	2.0	4.8	16.8	2.1	2.4	11.6	1.1	1.6	19.0	1.8	2.0	28.4	27.8	16.9	20.2	24.8	21.4	19.7	12.1	17.6	26.3	8.9	12.3	31.6	4.7	7.6	11.3	15.3	10.2	2.7	5.7	3.5	23.6	9.4	1.7	4.1	5.8	26.5	1.1	23.3	5.3	7.7	6.1	3.0	2.3	10.0	15.9	9.5	4.6	45.4	25.4	8.2	10.0	19.2	5.0	15.4	6.2	8.3	4.0	5.1	15.6	3.3	16.1	6.5	21.5	7.5	10.9	5.1	10.1	7.5	4.2	3.8
FGD5	"FLJ00274, FLJ39957, ZFYVE23"	ENSG00000154783	"FYVE, RhoGEF and PH domain containing 5"	Q6ZNL6	3	14810853-14934565	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Endothelial cells: 35.2;Ito cells: 52.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 41.3;TIME: 33.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA014436, HPA014536, HPA019191"	Uncertain		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA014436: , HPA014536: AB_1848518, HPA019191: AB_1848519"	"unprognostic (2.57e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.08e-1)"	"unprognostic (4.10e-2)"	"unprognostic (6.34e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.39e-2)"	"unprognostic (6.84e-3)"	"unprognostic (1.71e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.32e-2)"	"prognostic favorable (7.50e-4)"	18.9	3.7	2.2	10.7	2.7	0.0	18.9	1.2	4.0	11.0	9.2	1.9	8.3	7.3	17.7	9.5	5.7	8.1	14.3	12.3	2.3	2.2	10.3	2.5	27.3	8.1	2.7	1.9	7.2	6.5	2.8	3.9	14.3	3.1	8.3	3.8	8.4	4.5	4.0	7.9	6.0	8.6	9.6	2.4	29.3	5.2	7.1	1.6	1.0	8.6	8.4	3.6	7.2	20.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	41.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.2	0.0	33.8	0.0	2.9	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.7	1.2	4.0	2.3	2.2	2.7	1.9	3.1	1.6	0.0	5.8	1.3	0.2	2.7	0.0	2.2	2.5	0.0	1.2	0.0	0.0	0.2	1.7	0.0	6.7	35.2	0.0	0.0	0.2	0.1	8.3	0.2	0.0	0.8	8.9	0.0	0.0	52.8	2.8	5.2	10.6	3.4	1.7	0.0	0.0	0.0	2.8	0.0	4.2	6.3	0.0	0.0	2.1	0.2	4.7	1.6	0.5	0.7	0.0	0.3
FLCN	"BHD, MGC17998, MGC23445"	ENSG00000154803	Folliculin	Q8NFG4	17	17212212-17237188	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		"GTPase activation"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cone photoreceptor cells: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 34.9"									"CAB015158, HPA028760"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"CAB015158: AB_2231645, HPA028760: AB_10601323"	"unprognostic (1.99e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.90e-1)"	"prognostic favorable (4.49e-4)"	"unprognostic (6.45e-3)"	"unprognostic (2.55e-3)"	"unprognostic (1.92e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.65e-1)"	11.9	15.3	23.6	10.8	41.6	15.6	13.9	49.4	26.9	18.0	21.3	18.5	10.4	25.0	22.1	15.8	11.0	14.5	17.6	17.2	17.2	8.6	9.6	15.5	15.6	11.6	24.2	13.5	25.2	13.7	6.1	20.3	13.3	18.1	15.4	10.7	14.8	10.5	14.8	22.7	12.6	20.2	15.4	14.8	16.5	15.3	12.5	29.1	6.6	15.8	3.9	8.0	15.0	14.8	6.0	2.4	10.5	6.8	4.5	5.0	3.1	5.9	14.5	5.3	6.9	17.4	9.9	7.9	5.3	8.9	8.5	11.8	11.0	4.9	2.9	7.4	6.4	19.6	6.9	6.5	3.3	4.4	5.6	5.5	6.0	4.3	6.3	16.1	2.2	16.8	14.6	11.4	13.3	9.9	7.7	6.9	4.3	8.2	7.7	8.1	7.7	3.9	3.7	5.4	8.2	3.6	8.0	24.7	3.4	5.1	6.6	6.5	4.1	5.6	3.4	9.3	34.9	5.1	4.2	8.1	20.0	8.7	27.6	7.0	3.8	3.6	2.8	12.7	5.1	7.9	3.6	4.7	2.8	2.9	6.8	4.1	5.3	3.5	2.5	2.4	6.0	3.9	3.4	10.5	4.5	2.2	2.4	5.0	3.1	23.6	41.6	49.4	26.9	17.2	8.6	24.2	13.5	18.1	29.1	23.8	13.0	15.9	10.7	16.4	17.0	17.3	7.6	4.0	4.5	7.0	74.6	8.1	1.7	10.3	10.9	10.1	26.4	46.7	7.2	5.4	15.2	11.3	1.1	20.2	14.4	44.5	24.6	23.4	23.7	13.4	25.9	13.7	10.1	5.4	9.4	18.9	9.6	12.2	19.1	4.3	16.8	19.4	11.4	5.2	10.2	15.8	28.3	11.3	10.6	11.6
FLNB	"ABP-278, FH1, FLN1L, LRS1, TABP, TAP"	ENSG00000136068	"Filamin B"	O75369	3	58008400-58172251	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Differentiation, Myogenesis"	"Actin-binding, Developmental protein"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 215.6;Extravillous trophoblasts: 184.6;Pancreatic endocrine cells: 247.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 15.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 71.8;TIME: 80.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004747, HPA004886, CAB019322"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Actin filaments,Cytosol"		NA	NA		37000000	"Plasma membrane"	"Golgi apparatus, Actin filaments, Cytosol"	"CAB019322: , HPA004747: AB_1848599, HPA004886: AB_1848600"	"unprognostic (1.29e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.61e-2)"	"unprognostic (5.02e-3)"	"prognostic unfavorable (8.45e-5)"	"unprognostic (9.23e-2)"	"prognostic favorable (3.45e-6)"	"unprognostic (4.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.33e-1)"	24.7	17.8	7.8	25.3	10.6	2.2	30.0	12.6	7.4	21.3	33.5	17.2	49.6	19.4	36.1	47.4	18.6	17.3	16.0	7.7	10.6	8.5	20.6	29.2	14.1	9.4	16.1	5.3	22.9	22.4	25.6	7.8	36.0	13.2	35.8	28.5	20.1	25.5	44.0	7.7	28.9	50.2	39.7	24.3	12.1	21.2	11.7	13.5	49.3	28.2	12.0	13.0	32.8	34.7	3.8	15.9	7.4	1.2	5.9	4.9	1.2	20.2	34.7	3.5	5.1	2.4	4.1	61.2	7.5	6.1	16.9	17.3	34.7	34.8	3.3	2.8	26.6	27.5	33.4	6.5	48.2	16.5	18.3	3.2	2.8	29.5	16.8	17.5	2.4	10.0	6.5	20.9	23.4	71.8	20.0	57.0	14.8	4.6	1.0	10.5	4.4	7.3	5.8	5.4	22.4	30.1	3.2	0.9	2.8	22.5	34.6	3.9	3.6	38.3	21.0	4.2	26.8	17.3	6.7	80.8	4.4	13.8	52.7	26.9	0.7	0.2	2.6	16.4	4.4	4.6	7.4	0.3	4.2	0.5	0.8	2.6	3.8	1.6	0.7	1.2	1.6	4.9	3.5	0.1	5.9	1.2	15.9	1.7	1.2	7.8	10.6	12.6	7.4	10.6	8.5	16.1	5.3	13.2	13.5	47.6	33.3	5.1	35.9	45.0	2.7	10.5	58.6	54.9	44.3	45.4	37.3	23.5	0.0	81.2	15.8	61.2	215.6	0.0	57.7	184.6	26.7	99.5	24.3	46.4	13.6	1.6	47.3	130.8	11.4	17.1	15.0	10.9	5.0	17.2	70.6	10.0	247.2	108.7	26.2	6.8	10.9	0.0	12.0	1.9	5.1	45.2	41.6	7.5	60.6	62.1
FLNC	"ABP-280, ABPL, FLN2"	ENSG00000128591	"Filamin C"	Q14315	7	128830377-128859274	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Actin-binding	"Cardiomyopathy, Disease mutation, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"skeletal muscle: 546.8"	"Cell type enriched"	"Detected in many"	40	"Cardiomyocytes: 1815.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 80.1;fHDF/TERT166: 36.4;hTEC/SVTERT24-B: 39.6;U-2 OS: 34.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA006135, HPA071007"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		54000000	"Plasma membrane, Cytosol"		"HPA006135: AB_1848602, HPA071007: "	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (2.80e-4)"	"unprognostic (1.64e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (2.17e-5)"	"unprognostic (1.03e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.37e-2)"	"prognostic unfavorable (5.69e-4)"	"unprognostic (5.68e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavorable (3.73e-5)"	2.6	0.8	0.5	7.1	0.7	0.2	0.7	0.3	1.0	5.2	24.4	1.4	18.4	1.9	14.0	10.1	16.0	4.8	13.3	70.0	0.8	0.5	0.4	0.3	1.4	0.3	1.4	0.5	3.1	0.6	1.0	0.3	0.6	1.9	11.9	2.1	1.7	3.1	20.2	546.8	1.0	5.2	69.0	4.7	0.3	10.0	1.3	0.6	0.0	4.7	40.0	2.2	39.6	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	7.3	8.8	0.8	80.1	15.2	22.8	11.0	24.9	0.2	0.0	13.5	36.4	9.3	0.0	4.8	0.1	13.6	0.0	2.7	0.0	4.1	0.0	9.2	0.0	0.0	16.6	0.0	39.6	0.0	9.3	14.2	0.0	9.6	0.0	15.5	0.0	0.0	0.3	13.3	0.0	4.6	0.0	26.5	0.2	0.0	0.0	0.4	1.4	0.1	0.0	0.0	19.2	0.1	0.3	29.3	8.0	34.2	2.0	0.0	0.0	0.0	0.0	27.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.3	0.6	0.8	0.5	1.4	0.5	1.9	0.6	3.0	0.3	0.0	0.1	3.3	0.4	1815.4	0.0	0.0	3.4	1.8	0.0	0.3	0.0	0.6	0.2	6.2	0.0	0.0	0.2	0.7	11.9	1.4	0.0	0.0	0.8	0.0	0.0	1.8	0.0	0.0	4.9	0.8	5.0	0.0	0.0	0.1	1.8	0.0	9.9	1.0	0.1	0.0	45.3	0.2	0.4	4.0	1.6	0.0	0.0	0.4
FLOT1		ENSG00000137312	"Flotillin 1"	O75955	6	30727709-30742733	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 29.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 54.3;hTERT-RPE1: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001393, CAB007766"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA		1500000	"Golgi apparatus"	"Vesicles, Plasma membrane"	"CAB007766: AB_562116, HPA001393: AB_1078892"	"unprognostic (2.68e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (3.06e-4)"	"unprognostic (1.81e-2)"	"unprognostic (9.36e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (6.43e-3)"	"unprognostic (3.92e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.46e-2)"	25.7	43.8	32.1	22.6	26.1	22.4	45.9	27.8	37.4	32.9	23.3	14.3	18.8	16.7	19.3	16.7	15.8	27.6	18.8	46.4	29.5	25.7	26.6	26.0	22.9	34.1	29.2	31.9	16.5	24.7	28.7	17.9	25.9	27.2	23.1	18.4	13.0	25.5	32.9	46.1	8.2	16.7	29.0	30.4	22.8	16.7	11.7	18.7	7.8	28.7	13.8	17.1	21.3	36.9	2.9	6.0	29.1	7.3	7.2	3.5	4.7	5.1	2.1	5.0	5.8	5.1	7.9	2.6	5.2	7.2	9.3	8.3	2.7	2.5	3.5	5.7	11.9	54.3	3.8	4.9	2.0	5.7	10.7	4.7	4.5	2.0	2.7	12.2	0.8	5.9	8.5	3.0	5.5	10.7	33.1	6.4	2.8	3.2	5.6	9.7	1.7	2.9	1.2	1.6	3.3	5.9	3.8	5.6	4.8	3.6	1.5	4.7	4.5	3.9	2.8	19.7	5.7	4.5	0.9	4.3	17.8	5.8	3.1	14.7	3.8	3.7	3.5	2.4	3.7	11.2	12.8	7.3	12.2	3.5	3.4	2.3	2.9	2.2	2.9	5.5	2.2	2.5	2.9	29.1	7.2	2.2	6.0	0.3	4.7	32.1	26.1	27.8	37.4	29.5	25.7	29.2	31.9	27.2	18.7	83.4	85.1	32.7	93.5	25.4	14.4	80.8	56.0	88.3	63.7	80.3	5.9	67.0	104.5	62.0	46.3	117.8	81.2	23.3	74.8	57.5	67.5	53.3	140.8	42.9	116.2	19.1	66.0	127.7	63.0	109.6	57.2	92.7	67.4	121.8	59.2	44.6	72.3	101.7	35.7	125.1	17.0	51.8	58.7	108.0	26.7	23.5	51.5	43.6	72.5	97.7
FLOT2	"ECS-1, ECS1, ESA, ESA1, M17S1"	ENSG00000132589	"Flotillin 2"	Q14254	17	28879335-28897679	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 90.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001396, CAB004395, HPA071038"	Supported		Supported	"Vesicles,Plasma membrane"		NA	NA		1900000	"Plasma membrane"	Vesicles	"CAB004395: AB_627618, HPA001396: AB_1078894, HPA071038: "	"unprognostic (6.04e-2)"	"unprognostic (8.76e-3)"	"unprognostic (3.01e-1)"	"unprognostic (8.92e-2)"	"unprognostic (4.15e-3)"	"unprognostic (2.17e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.12e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.20e-2)"	26.1	19.5	21.5	28.3	21.9	47.8	21.1	17.3	35.9	17.3	20.7	14.4	13.7	11.1	15.7	14.3	25.9	21.0	15.0	24.5	17.3	18.7	36.4	52.5	24.7	40.1	15.3	17.8	19.8	18.5	18.8	9.1	30.4	31.9	27.6	14.8	20.9	24.3	29.5	21.1	17.7	19.2	25.5	12.8	49.6	17.5	8.4	12.3	17.4	21.8	14.5	33.1	36.7	34.4	25.7	29.4	84.8	21.3	14.8	21.4	24.1	15.0	25.6	19.9	17.0	10.1	12.9	21.5	11.7	16.1	17.3	20.4	26.4	12.9	20.9	22.7	13.0	11.8	17.8	21.5	19.4	7.5	66.3	25.3	25.4	24.0	19.0	13.5	20.6	4.3	15.6	15.0	14.3	19.2	18.3	27.3	6.2	23.8	18.4	8.0	22.7	5.7	15.6	17.5	13.7	6.8	8.8	20.0	51.2	30.5	47.0	17.6	29.5	27.4	19.6	21.2	19.9	20.4	37.1	22.2	6.2	11.1	9.9	17.7	10.4	18.0	10.7	17.3	19.9	11.5	28.0	21.3	41.2	21.4	19.5	15.8	21.4	16.4	18.1	29.4	25.7	12.3	15.2	84.8	14.8	20.8	8.0	19.3	24.1	21.5	21.9	17.3	35.9	17.3	18.7	15.3	17.8	31.9	12.3	20.8	25.3	27.9	21.2	11.2	6.9	30.3	20.4	13.4	17.0	19.2	9.8	82.0	13.3	34.2	11.7	29.2	15.6	0.0	27.1	58.0	13.4	18.0	5.8	38.9	38.5	4.8	24.8	39.9	41.6	28.5	10.0	26.9	8.5	90.2	24.2	9.1	25.0	10.5	8.1	23.7	11.1	19.4	9.2	1.7	7.1	8.2	31.0	21.7	26.0	23.5
FLRT3		ENSG00000125848	"Fibronectin leucine rich transmembrane protein 3"	Q9NZU0	20	14322988-14337616	"Disease related genes, Predicted membrane proteins"	"Cell adhesion"	"Developmental protein"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 43.1"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 1: 202.5;Alveolar cells type 2: 116.8;Basal glandular cells: 129.3;Club cells: 126.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 15.6;hTCEpi: 29.4;RPTEC TERT1: 9.9;WM-115: 35.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056033	Enhanced		Supported	"Plasma membrane,Cell Junctions,Cytosol"	"Intracellular and membrane"	NA	NA		240000	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA056033: AB_2683016"	"unprognostic (2.14e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (9.85e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (3.05e-1)"	"prognostic favorable (1.49e-7)"	"unprognostic (1.54e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.65e-1)"	7.3	4.3	3.4	2.2	7.4	0.1	2.7	27.5	18.9	3.8	5.0	0.7	3.2	12.4	2.6	5.5	2.5	2.7	5.6	1.6	9.3	4.1	43.1	28.9	26.2	0.2	2.3	5.3	11.9	2.3	4.6	2.1	2.0	2.9	12.7	1.0	1.9	1.5	16.4	2.1	6.9	6.0	3.9	2.3	0.8	9.7	1.7	0.7	4.8	8.5	1.8	0.4	12.0	3.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	15.6	0.0	0.0	0.0	0.0	1.5	0.4	0.1	0.0	8.5	3.1	0.0	0.5	0.3	0.0	4.4	0.0	4.6	0.1	0.0	1.0	0.0	0.2	0.1	1.3	0.0	0.0	2.7	29.4	0.0	5.5	0.0	0.0	0.1	0.0	0.1	3.0	0.2	1.9	0.0	5.1	3.4	0.0	0.0	0.1	0.0	9.9	1.9	0.3	3.2	0.0	0.0	4.9	9.2	0.2	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	35.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	7.4	27.5	18.9	9.3	4.1	2.3	5.3	2.9	0.7	202.5	116.8	0.0	129.3	7.7	13.3	0.9	17.8	22.7	126.3	21.0	5.9	0.3	11.6	18.8	0.0	1.6	2.0	0.0	13.0	0.0	5.4	11.3	4.7	7.8	0.2	6.4	10.9	1.8	0.0	0.2	3.4	0.9	5.0	2.8	1.0	0.5	9.4	2.9	0.4	41.7	2.9	0.0	0.1	0.0	0.0	14.4	0.0	0.5	1.5	9.0
FLT1	"FLT, VEGFR1"	ENSG00000102755	"Fms related tyrosine kinase 1"	P17948	13	28300344-28495145	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Chemotaxis, Differentiation"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"placenta: 155.3"	"Cell type enhanced"	"Detected in many"	16	"Extravillous trophoblasts: 778.4;Ito cells: 284.2;Syncytiotrophoblasts: 942.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 28.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 1.1;naive B-cell: 3.7;neutrophil: 2.1"	"Group enriched"	"Detected in many"	5	"B-cells: 3.7;granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"BJ: 17.4;BJ hTERT+: 13.8;HMC-1: 86.4;HUVEC TERT2: 15.6;WM-115: 31.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011740, HPA014290, CAB068189, CAB068190"	Enhanced		Supported	"Plasma membrane,Actin filaments"	"Secreted to blood"	NA	NA	876000	54000	"Plasma membrane"	"Actin filaments"	"CAB068189: AB_2665636, CAB068190: AB_2665637, HPA011740: AB_1858737, HPA014290: AB_1858738"	"unprognostic (3.33e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.13e-3)"	"unprognostic (5.02e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.03e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.27e-3)"	"unprognostic (9.91e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (4.20e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.32e-2)"	18.9	4.0	9.9	4.0	14.3	1.2	13.5	8.0	15.9	7.1	4.6	3.5	1.7	3.5	7.2	2.2	3.4	4.0	6.9	18.3	11.4	7.3	10.3	7.6	12.3	2.5	10.3	3.2	5.1	5.4	13.4	3.7	155.3	13.8	5.1	3.1	9.1	3.0	5.0	12.5	2.6	3.4	7.3	9.6	7.2	4.6	6.8	10.2	0.0	19.1	3.8	2.8	7.6	9.2	3.7	0.5	2.1	0.1	0.2	0.4	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.0	17.4	13.8	6.3	3.7	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.6	0.0	11.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	86.4	0.1	0.0	0.0	0.2	0.0	15.6	1.4	0.4	0.0	0.0	0.0	1.0	0.8	9.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	11.4	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.5	0.2	0.0	0.1	0.0	31.0	0.2	0.1	0.1	0.1	0.1	0.0	1.1	0.1	0.1	0.0	3.7	0.4	0.4	2.1	0.2	0.1	0.5	0.2	0.2	9.9	14.3	8.0	15.9	11.4	7.3	10.3	3.2	13.8	10.2	0.0	8.9	2.2	0.5	3.7	5.9	12.6	5.1	2.7	1.2	0.0	3.9	155.4	1.7	0.0	116.6	192.1	0.0	0.0	0.0	778.4	17.5	1.1	1.1	2.1	28.1	1.6	0.0	284.2	16.1	130.7	17.3	5.3	0.0	0.0	0.0	172.0	0.0	0.0	45.6	0.0	7.3	90.5	6.6	12.9	2.8	4.3	942.6	2.9	0.0	0.5
FLT4	"PCL, VEGFR3"	ENSG00000037280	"Fms related tyrosine kinase 4"	P35916	5	180601506-180649624	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 56.3"	"Group enriched"	"Detected in some"	5	"Extravillous trophoblasts: 31.7;Ito cells: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"MAIT T-cell: 7.7"	"Lineage enriched"	"Detected in single"	35	"T-cells: 7.7"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 8.3;BEWO: 10.1;HEK 293: 12.5;HUVEC TERT2: 8.1;JURKAT: 10.0;T-47d: 11.9;TIME: 12.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000099, HPA046519, HPA067906, HPA074389"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cell Junctions"	"Secreted to blood"	NA	NA		270000000	"Nuclear speckles, Plasma membrane"	"Cell Junctions"	"CAB000099: , HPA046519: AB_2732527, HPA067906: AB_2732775, HPA074389: "	"unprognostic (7.35e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.45e-3)"	"unprognostic (3.81e-1)"	"unprognostic (9.26e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.88e-2)"	"unprognostic (9.41e-3)"	"unprognostic (1.83e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.32e-1)"	14.8	7.1	1.6	4.9	6.0	0.7	28.5	1.3	2.7	6.3	7.3	1.9	2.1	3.1	7.3	6.2	5.7	9.2	5.3	6.4	1.7	0.9	11.7	10.2	14.1	23.6	2.0	0.8	5.8	2.3	2.3	6.2	56.3	2.1	4.9	1.4	6.7	3.3	4.4	4.8	2.8	4.7	4.7	1.5	14.5	2.4	3.5	2.0	0.3	19.4	4.4	2.3	6.1	14.7	0.0	0.1	0.2	0.0	0.0	7.7	0.2	0.1	2.0	2.7	8.3	0.0	0.0	10.1	0.2	0.1	0.0	0.0	0.3	0.3	0.2	0.8	0.1	0.5	0.3	2.8	0.1	0.2	0.1	12.5	1.0	0.4	0.4	0.1	7.4	0.2	0.2	0.0	0.1	0.3	0.3	8.1	10.0	0.3	0.3	1.7	4.5	0.1	0.4	5.8	0.2	0.5	6.5	0.0	0.1	0.1	0.2	0.2	0.9	0.1	0.2	0.0	2.7	11.9	0.2	12.6	0.1	5.9	0.2	0.1	0.2	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.9	0.0	7.7	0.0	0.4	1.6	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.2	1.6	6.0	1.3	2.7	1.7	0.9	2.0	0.8	2.1	2.0	0.0	1.7	0.9	0.2	0.8	0.0	4.5	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.2	9.2	0.0	0.0	0.0	31.7	0.6	0.2	2.3	0.4	1.1	0.0	0.0	65.1	5.7	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	4.3	1.0	0.8	0.7	0.0	0.1
FMNL3	"DKFZp762B245, MGC45819, WBP3"	ENSG00000161791	"Formin like 3"	Q8IVF7	12	49636499-49708165	"Predicted intracellular proteins"	Angiogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 37.3;granulocytes: 26.6;monocytes: 36.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"TIME: 24.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002552, HPA023201"	Uncertain		Supported	"Golgi apparatus,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Golgi apparatus, Vesicles, Plasma membrane"	Cytosol	"HPA002552: AB_1078862, HPA023201: AB_1848575"	"unprognostic (2.97e-1)"	"unprognostic (2.77e-3)"	"unprognostic (4.97e-3)"	"unprognostic (7.19e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.33e-3)"	"unprognostic (5.37e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.69e-2)"	18.3	6.4	10.1	19.9	10.7	5.0	13.8	8.5	11.2	9.3	8.0	23.2	6.3	6.0	13.5	20.8	5.1	7.5	13.0	12.6	10.6	9.0	10.1	3.1	18.0	22.5	14.0	7.7	18.9	3.8	3.7	5.0	14.4	12.9	7.5	6.2	9.8	5.0	5.1	6.3	4.8	10.7	12.3	14.2	13.0	6.7	10.5	11.3	16.2	15.0	5.1	27.9	9.6	7.7	1.7	8.6	3.6	0.7	1.1	1.5	0.7	4.4	1.3	9.8	3.2	2.7	11.1	0.1	5.4	11.1	7.4	6.6	5.0	1.2	9.4	10.5	6.4	8.2	0.2	5.0	2.3	6.8	8.3	1.9	10.3	1.4	0.2	4.8	2.0	13.5	6.9	0.3	11.6	4.9	22.2	19.6	4.7	2.3	6.9	10.8	3.2	8.3	3.0	3.2	0.4	2.9	4.1	12.3	1.4	7.0	0.6	1.6	4.6	3.1	0.4	6.4	5.2	0.8	3.0	24.7	18.5	6.4	0.3	9.3	3.6	0.2	5.1	11.5	6.4	7.7	3.6	0.3	1.2	1.5	0.7	0.7	0.4	0.5	0.9	0.4	1.7	0.8	0.9	0.0	1.1	0.6	8.6	0.3	0.7	10.1	10.7	8.5	11.2	10.6	9.0	14.0	7.7	12.9	11.3	3.0	4.3	11.5	0.6	1.4	6.2	2.0	0.0	0.0	2.3	1.8	37.3	1.5	0.0	0.2	1.1	14.8	0.0	0.0	0.6	1.0	2.9	0.3	26.6	0.4	10.5	3.2	0.0	14.1	4.1	3.9	3.4	10.4	5.0	36.9	0.6	0.5	0.6	0.0	6.0	0.0	1.9	12.9	7.5	3.4	7.2	1.3	2.1	6.9	0.0	0.4
FNBP1	"FBP17, KIAA0554"	ENSG00000187239	"Formin binding protein 1"	Q96RU3	9	129887187-130043194	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"monocytes: 605.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 42.6;JURKAT: 45.5;MOLT-4: 42.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019635, HPA019691, HPA022119, HPA067742"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA019635: AB_2732423, HPA019691: AB_2670231, HPA022119: AB_2670897, HPA067742: "	"unprognostic (2.86e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.43e-2)"	"unprognostic (6.30e-3)"	"unprognostic (9.10e-2)"	"unprognostic (2.90e-1)"	"unprognostic (6.17e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (8.45e-5)"	"unprognostic (6.84e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.21e-1)"	11.5	6.5	20.7	30.5	27.3	20.0	10.1	56.0	21.3	16.9	42.5	30.1	12.2	8.5	23.6	10.2	23.0	15.6	15.9	8.7	22.3	18.6	7.8	10.4	14.1	39.8	25.1	14.5	13.4	5.5	6.2	8.6	9.2	22.8	20.8	17.4	11.4	7.7	26.7	12.2	13.4	15.7	64.7	29.9	32.1	15.3	9.1	27.3	52.1	15.7	5.7	40.4	34.6	12.4	13.5	8.2	12.3	6.9	6.5	13.4	4.9	13.1	6.1	11.3	13.1	6.9	8.6	9.5	7.5	6.4	5.7	4.8	6.3	5.1	25.8	6.6	14.0	6.7	6.6	10.5	6.8	5.7	42.6	3.1	7.1	7.4	4.2	11.9	19.1	24.5	6.2	3.0	10.5	6.4	8.3	8.3	45.5	1.6	0.3	5.2	10.5	42.8	18.8	8.8	1.7	10.4	9.9	9.1	7.4	7.1	7.2	1.8	5.7	13.7	13.8	5.2	11.3	9.6	8.8	10.0	5.4	6.8	9.8	4.6	5.3	19.5	1.2	6.5	13.2	8.0	12.3	6.0	10.5	13.4	6.6	11.7	13.5	12.2	12.7	6.8	9.0	11.3	10.9	11.4	6.5	6.9	8.2	12.3	4.9	20.7	27.3	56.0	21.3	22.3	18.6	25.1	14.5	22.8	27.3	32.8	31.8	93.1	17.5	29.5	17.2	13.2	7.6	44.2	37.5	21.0	49.1	14.3	16.6	18.3	1.3	38.0	14.7	0.0	15.0	20.9	49.4	46.8	77.5	14.7	40.2	27.0	17.4	46.1	165.2	3.6	43.1	119.6	72.6	605.1	8.3	55.6	16.4	17.3	48.4	11.3	28.0	58.2	45.6	12.6	39.8	35.9	53.4	178.7	14.4	26.8
FRMD8	"FKSG44, FLJ90369"	ENSG00000126391	"FERM domain containing 8"	Q9BZ67	11	65386599-65413525	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Suprabasal keratinocytes: 73.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 53.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002861	Approved		Approved	"Nucleoplasm,Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Plasma membrane, Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA002861: AB_1078878"	"unprognostic (1.54e-1)"	"unprognostic (4.07e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (9.94e-5)"	"unprognostic (9.12e-3)"	"unprognostic (1.51e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.90e-2)"	"unprognostic (6.41e-3)"	"unprognostic (4.19e-3)"	"unprognostic (1.47e-2)"	"unprognostic (7.36e-3)"	"unprognostic (3.34e-1)"	"unprognostic (2.91e-2)"	14.6	11.9	7.8	18.5	12.1	13.1	15.2	8.9	10.3	12.5	15.1	11.4	6.9	13.6	10.5	12.2	23.9	14.6	17.4	10.0	8.0	5.4	10.5	12.0	15.1	17.3	17.0	8.5	8.9	20.9	5.7	8.2	12.2	11.7	10.7	8.2	7.8	18.6	10.9	12.0	24.3	16.5	8.1	8.9	29.0	11.7	11.3	14.6	16.6	12.4	16.6	21.8	11.0	18.1	10.9	11.4	19.7	14.9	6.5	14.3	9.0	6.9	8.9	3.6	8.4	9.8	5.1	6.4	7.9	7.4	6.8	5.3	8.5	11.6	8.6	17.1	11.2	4.8	12.3	4.6	6.9	2.9	14.3	4.2	11.9	8.2	4.6	5.3	6.7	18.6	6.4	5.5	6.5	3.5	3.7	10.9	8.9	9.9	9.7	7.5	9.5	10.0	9.8	4.0	5.2	11.7	13.4	6.7	9.8	5.6	8.8	7.8	5.4	6.0	24.8	18.9	3.4	9.0	5.5	9.5	7.7	8.0	10.4	4.8	16.7	8.5	8.1	6.7	4.2	53.0	0.8	9.7	13.4	11.5	11.0	12.7	10.9	8.4	14.3	9.1	9.2	7.8	8.4	19.7	6.5	14.9	11.4	8.9	9.0	7.8	12.1	8.9	10.3	8.0	5.4	17.0	8.5	11.7	14.6	3.0	7.2	17.5	19.3	48.2	5.9	7.5	20.4	8.1	6.8	12.2	0.0	5.8	6.6	18.7	22.7	21.1	26.9	23.3	24.9	13.0	14.4	20.4	13.9	9.6	13.4	4.8	12.5	45.4	16.7	3.9	5.8	17.4	18.6	19.0	17.0	3.2	25.9	13.1	6.7	4.2	4.6	6.5	16.0	4.1	8.6	73.0	9.5	21.7	11.2	33.0
FSCN1	"FLJ38511, p55, SNL"	ENSG00000075618	"Fascin actin-bundling protein 1"	Q16658	7	5592823-5606655	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.9"	"Cell type enriched"	"Detected in many"	9	"monocytes: 1791.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 5.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 82.1;K-562: 68.7;NB-4: 78.0;PC-3: 68.7;SH-SY5Y: 65.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000121, HPA005723, CAB035991, HPA050654"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	Yes		4500000	Cytosol	"Plasma membrane"	"CAB000121: AB_2278596, CAB035991: , HPA005723: AB_1849159, HPA050654: AB_2681203"	"unprognostic (1.91e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.12e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (5.76e-4)"	"unprognostic (2.16e-3)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (6.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.27e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (8.15e-7)"	"unprognostic (1.21e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.93e-3)"	26.3	13.3	23.7	29.6	30.1	6.3	8.1	5.5	56.9	9.9	5.5	35.1	0.0	5.4	11.7	2.3	22.3	5.9	8.9	10.6	27.7	16.8	5.5	7.1	11.3	15.2	26.9	23.6	21.8	5.1	2.3	7.0	29.4	20.1	4.1	3.0	8.1	11.0	3.9	7.8	17.3	6.6	7.0	29.6	39.3	7.6	15.9	28.3	9.3	8.5	15.9	11.4	14.7	12.3	0.2	5.4	1.0	1.9	0.0	0.1	1.4	8.0	18.6	12.4	44.5	4.8	9.2	82.1	19.3	8.6	3.3	3.6	12.9	2.0	0.1	23.6	8.5	3.2	30.5	7.1	31.0	0.2	9.1	3.8	0.5	19.8	60.8	2.5	0.0	1.6	5.7	9.2	6.2	5.1	5.5	16.2	0.0	68.7	0.1	4.2	0.8	0.2	78.0	32.5	0.5	68.7	18.1	2.9	0.3	4.8	0.7	9.9	65.9	16.1	0.2	0.6	8.4	0.4	4.9	32.8	22.9	40.3	13.3	19.8	0.1	0.1	0.0	14.8	0.0	43.0	0.0	1.9	0.1	0.0	0.5	0.0	0.2	0.1	0.0	5.4	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	1.4	23.7	30.1	5.5	41.3	27.7	16.8	26.9	23.6	20.1	28.3	3.0	5.5	2.4	19.0	161.1	7.2	6.9	2.5	1.4	0.0	1.8	0.0	4.4	0.0	6.8	13.1	49.6	1.3	0.0	4.2	90.3	72.6	6.3	16.1	0.8	207.2	0.0	40.2	97.6	22.0	7.9	23.6	10.6	49.0	1791.8	0.7	69.1	10.4	0.0	8.5	0.2	2.3	0.0	16.5	4.7	9.0	128.6	12.2	4.3	0.9	28.3
FZD1	DKFZp564G072	ENSG00000157240	"Frizzled class receptor 1"	Q9UP38	7	91264364-91271326	"Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 61.2"	"Cell type enhanced"	"Detected in many"	13	"Cholangiocytes: 61.1;Horizontal cells: 133.5;Peritubular cells: 42.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 4.2;non-classical monocyte: 5.4"	"Lineage enriched"	"Detected in many"	4	"monocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"AF22: 16.6;HSkMC: 22.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013008	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB013008: "	"unprognostic (1.46e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.16e-2)"	"unprognostic (4.51e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.29e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.36e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.39e-3)"	"prognostic favorable (8.87e-7)"	"unprognostic (1.05e-2)"	"unprognostic (4.16e-2)"	"unprognostic (5.53e-2)"	"unprognostic (4.13e-2)"	5.8	4.6	2.6	4.9	3.5	0.9	10.7	8.2	2.8	17.6	8.5	4.1	9.3	4.9	10.1	9.9	7.8	6.1	11.0	12.3	6.1	1.8	15.3	3.9	10.5	1.4	2.0	3.2	15.0	7.9	2.5	4.6	10.0	5.7	12.3	3.7	11.1	9.2	17.5	3.1	10.7	8.3	7.2	4.6	3.4	4.5	4.4	3.5	1.4	61.2	6.5	2.9	10.4	13.9	0.1	1.3	0.2	5.4	0.0	0.0	0.4	0.5	1.6	16.6	1.7	13.5	11.7	3.0	6.0	3.8	2.2	1.6	0.7	2.8	0.0	1.5	3.8	2.8	3.0	2.5	1.3	1.5	0.0	3.2	0.1	3.2	0.8	1.0	2.7	0.7	22.1	2.4	5.1	1.6	8.5	0.5	1.8	0.9	2.4	6.4	3.9	0.5	0.7	4.2	0.8	2.8	3.3	10.2	0.3	3.5	7.7	2.3	4.3	4.5	3.7	0.9	4.0	1.9	2.4	2.5	9.4	7.1	10.0	2.4	2.2	1.5	0.2	10.1	2.3	10.9	0.0	1.4	0.0	0.0	4.2	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	5.4	0.1	0.0	0.4	2.6	3.5	8.2	2.8	6.1	1.8	2.0	3.2	5.7	3.5	3.0	1.0	1.3	30.9	3.8	0.8	12.1	61.1	0.0	4.5	12.2	2.0	3.0	0.0	4.5	0.2	3.6	4.6	0.0	1.8	1.6	12.0	11.7	12.7	0.5	3.6	133.5	3.4	10.4	14.3	0.4	30.8	11.2	16.9	0.0	3.2	3.7	2.1	3.4	42.5	10.8	3.1	0.0	9.4	0.4	2.0	4.4	1.7	0.5	3.5	5.9
FZD6	Hfz6	ENSG00000164930	"Frizzled class receptor 6"	O60353	8	103298433-103332866	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 41.7;Suprabasal keratinocytes: 39.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 7.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 41.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017991	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA017991: AB_1849138"	"unprognostic (8.22e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.75e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.22e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.01e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (1.20e-6)"	"unprognostic (3.62e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.92e-2)"	"unprognostic (7.54e-2)"	13.1	9.2	3.4	5.2	3.8	0.5	13.3	4.3	5.9	12.1	10.7	3.5	8.6	4.0	12.0	16.4	17.9	17.8	12.3	9.6	3.7	3.8	17.4	5.8	17.1	4.7	4.2	2.9	11.6	14.4	21.3	27.2	14.1	10.0	12.4	4.9	11.6	15.3	8.8	4.3	16.9	7.7	12.7	4.2	6.1	8.0	7.2	1.5	10.9	21.2	18.7	14.7	15.9	11.3	1.7	1.0	0.2	0.0	7.9	2.2	0.5	19.6	4.0	9.5	0.0	2.2	7.0	5.9	10.5	11.5	9.3	6.1	2.1	15.1	0.0	17.9	9.2	2.9	29.1	5.3	21.7	16.6	4.4	6.5	10.4	4.6	2.6	31.3	0.0	0.0	7.9	41.8	9.9	30.6	22.2	19.1	2.2	1.0	8.6	10.0	8.1	9.2	0.8	2.2	1.4	6.9	0.7	4.5	0.0	19.0	12.4	3.3	2.7	14.6	7.7	19.0	5.3	0.0	3.5	1.5	2.2	11.0	8.4	10.6	2.2	1.1	4.2	6.1	0.0	13.5	0.0	0.0	0.2	0.6	0.0	0.0	0.9	2.1	0.9	1.0	1.7	2.2	1.0	0.0	7.9	0.0	0.2	0.6	0.5	3.4	3.8	4.3	5.9	3.7	3.8	4.2	2.9	10.0	1.5	23.8	16.1	0.8	13.5	41.7	3.7	4.7	7.6	26.8	25.0	12.2	2.0	17.8	0.0	10.9	7.8	28.9	3.2	0.0	7.2	6.6	6.9	11.0	0.0	3.2	2.1	6.4	5.1	11.1	0.6	2.1	1.1	1.7	13.5	1.0	6.9	15.5	8.1	3.5	1.4	8.2	4.4	0.0	4.1	7.2	0.7	39.0	12.2	2.5	5.2	19.2
GAB2	KIAA0571	ENSG00000033327	"GRB2 associated binding protein 2"	Q9UQC2	11	78215297-78418348	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 49.1"	"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 2: 23.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 9.4;neutrophil: 16.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 16.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 19.8;SH-SY5Y: 31.7"									"HPA000271, HPA001368, CAB022159"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB022159: , HPA000271: AB_1078925, HPA001368: AB_2666287"	"unprognostic (2.51e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.56e-3)"	"unprognostic (1.99e-3)"	"unprognostic (1.04e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (9.32e-5)"	"unprognostic (6.95e-2)"	"unprognostic (4.35e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.67e-2)"	15.5	8.4	31.1	12.0	26.9	32.9	11.6	5.7	21.5	10.2	8.9	49.1	1.6	13.7	16.8	4.6	8.2	13.5	9.1	13.6	30.4	21.3	5.2	4.5	16.1	6.8	31.5	14.8	20.0	5.9	10.4	7.0	14.6	24.7	6.5	10.9	6.6	5.4	7.3	5.2	8.8	10.1	17.1	35.4	11.8	7.4	5.5	26.0	9.4	6.5	3.0	5.6	9.3	12.3	0.5	1.7	16.3	3.4	0.0	0.1	0.7	1.8	1.5	4.5	0.5	6.6	2.8	19.8	2.8	3.4	2.0	1.7	11.7	0.9	0.5	12.6	3.9	0.5	2.9	10.5	0.2	2.6	17.5	1.1	7.0	2.7	2.0	3.3	2.6	1.4	3.1	1.0	7.9	1.2	6.0	11.7	2.1	18.5	0.6	3.4	0.7	1.3	6.6	1.4	4.1	2.1	13.3	4.3	0.2	3.7	6.6	3.8	31.7	0.7	1.4	7.2	6.8	6.6	7.6	9.6	0.9	2.3	7.7	0.6	4.9	0.7	0.3	0.8	4.2	8.4	9.4	2.4	0.7	0.0	1.4	0.0	0.5	0.0	0.0	0.8	0.3	0.0	0.0	16.3	0.0	3.4	1.7	0.1	0.7	31.1	26.9	5.7	19.3	30.4	21.3	31.5	14.8	24.7	26.0	3.0	23.1	4.7	0.6	1.8	4.2	9.3	2.5	2.7	1.2	0.0	0.0	4.4	0.0	2.1	5.6	7.7	8.4	0.0	5.4	12.2	6.3	2.7	5.7	0.8	10.3	15.9	10.3	4.9	18.9	2.6	7.5	10.1	6.8	11.8	3.8	0.5	6.5	0.0	10.3	0.5	2.2	12.9	3.8	2.4	1.8	2.5	18.5	2.5	9.2	1.3
GABRG1		ENSG00000163285	"Gamma-aminobutyric acid type A receptor gamma1 subunit"	Q8N1C3	4	46035769-46124081	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	9	"brain: 35.7"	"Group enriched"	"Detected in some"	5	"Early spermatids: 5.9;Muller glia cells: 15.1;Sertoli cells: 6.5"	"Cancer enriched"	"Detected in single"	8	"glioma: 0.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.3;THP-1: 2.6;U-2 OS: 1.8;U-266/70: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035622, HPA058102"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA035622: AB_10603669, HPA058102: "	"unprognostic (2.50e-1)"				"unprognostic (2.20e-1)"		"unprognostic (6.06e-2)"			"unprognostic (1.46e-2)"	"unprognostic (7.39e-4)"		"unprognostic (1.23e-1)"		"unprognostic (1.28e-1)"	"unprognostic (1.99e-1)"		1.5	1.5	20.3	1.2	25.9	1.2	1.3	26.4	35.7	1.3	1.3	12.2	0.0	1.4	1.4	1.3	1.3	1.7	1.3	1.2	26.0	14.6	1.4	1.4	1.2	1.3	10.2	14.0	3.9	1.2	1.3	1.6	1.2	17.9	1.2	1.3	0.0	1.2	1.3	1.2	1.2	1.4	1.4	17.8	1.4	1.3	1.8	17.8	0.0	1.5	0.0	1.2	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.0	0.3	1.8	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.3	25.9	26.4	18.5	26.0	14.6	10.2	14.0	17.9	17.8	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	1.8	6.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
GAPDH	GAPD	ENSG00000111640	"Glyceraldehyde-3-phosphate dehydrogenase"	P04406	12	6533927-6538374	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Glycolysis, Translation regulation"	"Oxidoreductase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 1236.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB005197, CAB016392, HPA040067, HPA061280"	Supported		Supported	"Nuclear membrane,Vesicles,Plasma membrane,Cytosol"		No	No		2200000000	"Plasma membrane, Cytosol"	"Nuclear membrane, Vesicles"	"CAB005197: AB_641107, CAB016392: AB_627678, HPA040067: AB_10965903, HPA061280: AB_2684463"	"unprognostic (3.03e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.58e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.77e-3)"	"prognostic unfavorable (1.79e-6)"	"unprognostic (2.89e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.06e-2)"	"unprognostic (9.50e-3)"	"unprognostic (4.52e-1)"	"prognostic unfavorable (6.25e-10)"	"unprognostic (2.33e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.26e-2)"	50.0	59.4	104.1	57.6	101.0	195.5	38.4	58.0	151.3	49.4	73.3	80.7	24.0	75.8	37.3	46.8	146.9	50.2	58.0	215.1	95.0	95.5	88.4	221.0	41.3	90.1	111.8	58.0	62.0	27.0	66.1	46.1	98.2	115.9	48.3	76.7	74.5	60.8	63.2	1236.8	54.4	74.4	68.0	95.6	50.7	41.1	36.4	35.9	101.9	38.3	238.7	105.3	89.5	50.5	57.9	171.0	110.0	201.6	60.5	108.8	271.9	188.4	332.6	95.9	149.5	93.6	154.4	209.1	143.2	204.0	209.6	218.8	234.7	129.4	220.4	28.3	168.8	159.1	107.3	89.1	332.2	145.5	193.2	96.8	121.9	208.7	199.3	126.2	197.0	98.1	129.1	108.5	206.0	232.8	501.3	230.7	161.2	65.4	46.4	238.1	376.0	224.4	103.7	354.5	226.1	110.8	182.6	170.9	104.9	238.5	230.6	68.0	109.1	126.4	329.8	190.3	285.1	51.5	139.2	143.9	163.6	197.8	84.4	247.4	105.5	76.7	284.0	346.8	124.9	256.0	110.0	201.6	37.0	74.1	103.2	65.3	57.9	77.9	74.4	171.0	32.2	44.1	51.2	106.5	60.5	92.3	25.2	108.8	271.9	104.1	101.0	58.0	151.3	95.0	95.5	111.8	58.0	115.9	35.9	220.3	245.0	821.1	1485.4	1615.7	992.1	33.2	1355.4	275.7	444.7	970.1	392.7	4082.4	2934.5	4447.1	583.7	1564.4	2836.9	443.9	3299.5	7140.5	1484.6	1124.2	551.6	1346.2	3470.6	2218.3	1273.2	1144.2	2599.6	1556.8	823.5	2367.4	4003.5	3613.2	2061.2	5234.8	4742.6	2687.7	965.3	5345.0	1026.0	1131.8	2133.1	429.6	390.5	1399.2	3925.6	1271.1	3009.6	2464.1
GAPT	"C5orf29, FLJ33641"	ENSG00000175857	"GRB2 binding adaptor protein, transmembrane"	Q8N292	5	58491435-58497090	"Predicted intracellular proteins"	"B-cell activation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"blood: 117.8"	"Group enriched"	"Detected in some"	9	"B-cells: 29.7;granulocytes: 52.1;Hofbauer cells: 15.1;Kupffer cells: 25.6;Macrophages: 34.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"eosinophil: 117.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 117.8"	"Cell line enhanced"	"Detected in some"		"HEL: 27.4;HL-60: 15.8;NB-4: 16.5;THP-1: 13.0;U-937: 45.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA011048, HPA011070"	Uncertain		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	"Golgi apparatus, Vesicles"	"HPA011048: , HPA011070: AB_1848887"	"unprognostic (9.79e-2)"	"unprognostic (5.67e-3)"	"unprognostic (2.39e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.36e-2)"	"unprognostic (8.09e-4)"	"unprognostic (4.32e-1)"	"unprognostic (1.23e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.47e-3)"	"unprognostic (7.28e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.52e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.40e-2)"	1.4	0.8	1.4	15.5	2.7	8.5	1.0	0.6	1.2	1.8	1.4	1.6	0.4	1.8	1.3	2.2	3.3	1.2	3.1	1.1	1.5	1.7	1.6	1.0	7.2	19.4	4.5	0.9	0.7	1.2	0.0	1.5	0.8	4.4	2.6	2.0	1.4	2.3	0.4	0.5	0.9	8.2	2.4	5.9	25.8	1.7	0.8	3.2	5.2	1.1	0.5	23.5	5.1	1.2	12.0	25.4	117.8	8.2	0.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	15.8	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	16.5	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.7	0.0	12.3	8.2	117.8	0.0	5.7	0.0	12.0	0.0	0.0	9.4	11.9	0.0	0.0	10.1	0.1	6.6	25.4	0.0	3.4	1.4	2.7	0.6	1.2	1.5	1.7	4.5	0.9	4.4	3.2	3.0	3.4	29.7	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.1	0.0	15.1	0.0	0.0	0.6	25.6	0.0	0.0	34.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0
GHR	GHBP	ENSG00000112964	"Growth hormone receptor"	P10912	5	42423777-42721878	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"	Endocytosis	Receptor	"Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 44.4;breast: 31.5;liver: 82.4;skeletal muscle: 23.4"	"Cell type enhanced"	"Detected in many"	19	"Hepatocytes: 103.6;Syncytiotrophoblasts: 33.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"HSkMC: 13.6;T-47d: 34.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045339, HPA057705"	Enhanced		Supported	"Plasma membrane,Cytosol,Cytoplasmic bodies"	"Secreted to blood"	NA	NA	2200000	21000000	"Plasma membrane, Cytosol, Cytoplasmic bodies"		"HPA045339: AB_2679294, HPA057705: AB_2683507"	"unprognostic (2.18e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (2.73e-6)"	"unprognostic (1.06e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.73e-2)"	"unprognostic (6.15e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.67e-3)"	"unprognostic (4.29e-4)"	"unprognostic (7.82e-2)"	"unprognostic (7.33e-4)"	"unprognostic (8.35e-6)"	44.4	2.8	0.7	5.4	1.3	0.3	31.5	0.4	1.4	4.0	6.9	0.5	1.7	0.6	5.7	3.9	2.4	2.5	3.9	6.0	1.3	1.6	5.3	82.4	2.3	2.2	1.2	1.4	5.0	1.3	3.6	2.0	4.0	2.0	8.7	2.5	2.4	2.3	7.4	23.4	3.0	2.4	5.2	1.0	2.6	3.5	1.6	0.2	0.1	2.9	4.3	0.5	3.8	8.4	0.6	0.3	1.8	0.5	0.4	0.3	0.1	0.0	0.0	0.3	3.1	2.1	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	2.6	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.0	0.0	13.6	4.4	0.0	0.6	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	2.1	0.4	34.7	0.0	1.8	3.0	1.3	1.6	0.3	0.3	0.0	0.0	0.3	0.0	1.6	1.8	0.3	0.4	0.2	0.2	0.1	0.3	0.2	0.1	0.1	0.6	0.2	0.3	1.7	0.4	0.5	0.3	0.2	0.1	0.7	1.3	0.4	1.4	1.3	1.6	1.2	1.4	2.0	0.2	0.0	0.3	0.0	2.8	4.1	0.6	13.6	2.5	0.0	0.0	1.8	0.0	8.6	1.7	0.0	3.3	2.9	0.0	0.0	0.2	0.9	9.3	3.5	0.0	103.6	1.6	0.0	2.9	4.9	1.9	1.8	17.3	0.3	1.7	0.0	2.0	0.8	0.2	0.0	11.3	8.8	0.2	12.9	4.4	0.0	0.3	3.1	33.6	0.0	1.5	0.9
GJC2	"CX46.6, CX47, GJA12, SPG44"	ENSG00000198835	"Gap junction protein gamma 2"	Q5T442	1	228149852-228159826	"Disease related genes, Predicted membrane proteins"			"Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 34.3"	"Cell type enhanced"	"Detected in some"	14	"Cone photoreceptor cells: 11.8;Peritubular cells: 3.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"plasmacytoid DC: 1.6"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 1.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 9.9;SCLC-21H: 5.2;TIME: 4.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069619			Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA069619: "	"unprognostic (2.67e-1)"	"unprognostic (1.81e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.19e-3)"	"unprognostic (4.24e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.99e-2)"	"unprognostic (7.09e-2)"	"unprognostic (7.88e-3)"	"unprognostic (9.67e-2)"	"unprognostic (6.09e-3)"	"unprognostic (2.53e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.02e-1)"	2.4	1.9	4.6	1.2	10.0	0.5	2.0	2.2	14.8	2.8	2.6	34.3	0.0	0.6	4.5	2.0	1.7	4.8	1.4	1.6	9.3	5.3	0.6	0.5	3.1	1.2	27.2	5.6	3.4	0.9	2.9	0.6	1.2	18.3	2.1	0.8	0.0	1.5	4.0	1.5	2.4	1.2	3.8	32.6	1.9	1.2	1.0	15.7	0.0	0.9	0.0	0.7	1.3	1.8	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.4	0.4	0.2	0.5	1.4	0.7	1.9	1.4	0.4	0.6	0.8	0.9	1.2	0.2	9.9	2.6	0.8	1.0	0.3	0.3	0.3	0.4	1.6	0.3	2.5	2.2	2.5	0.0	0.0	0.4	0.2	0.8	0.5	1.2	0.2	1.7	1.1	0.3	0.4	0.6	1.9	0.6	0.6	0.0	2.0	0.4	0.3	0.1	0.8	0.0	5.2	3.0	0.4	0.1	0.3	0.1	0.1	0.3	4.6	1.4	3.8	4.5	1.6	0.3	0.6	0.2	0.5	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	4.6	10.0	2.2	10.4	9.3	5.3	27.2	5.6	18.3	15.7	0.0	1.1	0.0	1.2	3.1	1.5	1.4	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.4	0.0	1.2	0.3	0.0	0.0	0.1	3.2	0.0	0.0	0.6	0.0	2.3	0.0	1.7	0.0	0.0	0.3	0.7	0.0	3.9	0.0	0.6	0.0	1.7	0.0	0.0	1.5	0.0	0.0	0.1	0.9
GLO1	GLOD1	ENSG00000124767	"Glyoxalase I"	Q04760	6	38675925-38703141	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"HMC-1: 249.9"	"Low region specificity"	"Detected in all"							"CAB040541, CAB040542, HPA059791"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		1600000	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB040541: , CAB040542: , HPA059791: AB_2684126"	"unprognostic (4.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (5.09e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.61e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.54e-1)"	"unprognostic (6.21e-2)"	22.2	30.5	42.1	19.5	42.3	11.4	32.0	25.4	42.3	27.1	42.1	19.7	22.9	48.1	25.3	49.2	28.2	31.5	17.8	39.2	37.8	37.7	37.1	65.3	30.7	31.6	38.9	29.7	37.6	25.9	33.2	12.6	26.7	40.6	74.0	22.7	21.7	21.7	28.2	57.5	31.3	64.3	28.9	37.6	25.6	21.3	12.9	21.4	19.8	32.6	42.5	24.3	28.6	24.7	25.9	28.6	8.5	15.6	10.8	24.4	14.7	18.5	8.6	24.8	24.6	11.8	21.3	21.9	16.2	15.4	22.8	23.8	20.9	7.1	20.7	12.8	12.9	27.2	12.3	21.2	20.9	28.9	18.8	32.7	30.6	11.1	19.5	17.7	11.6	249.9	18.2	12.9	21.6	15.5	14.9	24.6	14.7	24.1	13.8	21.3	15.7	18.1	14.8	17.8	16.6	16.9	15.8	30.0	13.5	20.8	14.1	19.3	19.5	11.4	15.9	30.5	17.8	18.4	58.4	10.1	17.8	16.4	15.4	25.6	10.9	20.5	56.8	6.4	30.1	28.5	8.5	9.8	6.9	18.0	15.6	24.4	24.7	18.1	18.3	18.3	25.9	17.1	17.9	1.2	10.8	12.1	28.6	15.7	14.7	42.1	42.3	25.4	42.3	37.8	37.7	38.9	29.7	40.6	21.4	122.1	136.6	86.9	79.7	57.5	55.3	121.3	48.4	88.3	91.0	85.5	19.6	91.3	210.5	107.2	3.6	70.9	36.2	0.0	64.3	264.4	68.8	192.8	67.2	86.8	68.4	65.2	35.1	200.1	112.1	4.7	77.6	69.2	99.5	129.8	41.3	160.8	66.2	35.7	103.3	107.3	50.7	45.3	65.9	11.9	15.7	77.0	61.2	59.9	55.5	125.1
GLP2R		ENSG00000065325	"Glucagon like peptide 2 receptor"	O95838	17	9822206-9892102	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"gallbladder: 32.7"	"Cell type enriched"	"Detected in some"	6	"Rod photoreceptor cells: 24.5"	"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 1.1"	"Group enriched"	"Detected in some"	4	"basal ganglia: 2.9;cerebral cortex: 4.1;olfactory region: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HeLa: 42.8"	"Group enriched"	"Detected in some"	6	"cerebral cortex: 2.1;hippocampal formation: 2.6"	"Low region specificity"	"Detected in some"			"CAB022690, HPA049244"	Supported		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB022690: , HPA049244: AB_2680690"	"unprognostic (2.14e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.66e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.39e-2)"	"unprognostic (5.15e-2)"	"unprognostic (7.63e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.16e-3)"	"unprognostic (3.40e-8)"	"unprognostic (9.53e-5)"	"unprognostic (5.51e-2)"	"unprognostic (3.92e-1)"	"unprognostic (6.48e-3)"	7.9	0.7	0.6	2.0	2.9	0.0	2.6	0.3	4.3	6.6	14.5	0.0	1.7	12.4	1.9	0.4	5.3	1.4	32.7	0.9	0.6	0.5	0.4	3.2	1.4	0.7	0.6	1.6	0.8	2.1	0.0	0.3	1.5	0.5	8.4	7.5	0.8	0.4	0.2	0.3	0.3	15.4	15.6	0.6	0.3	4.9	1.1	0.2	0.0	0.5	0.1	0.4	13.5	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	42.8	0.3	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.9	0.3	4.1	0.6	0.5	0.6	1.6	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	24.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GLUL	GLNS	ENSG00000135821	"Glutamate-ammonia ligase"	P15104	1	182381704-182392206	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Angiogenesis	"Ligase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Late spermatids: 6809.8;Muller glia cells: 5699.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 92.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 92.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 141.5;ASC TERT1: 100.1;HSkMC: 86.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007316, HPA007571, CAB008636"	Approved		Supported	"Plasma membrane,Mitochondria,Cytosol"		NA	NA		28000	"Mitochondria, Cytosol"	"Plasma membrane"	"CAB008636: AB_1616669, HPA007316: AB_888438, HPA007571: AB_1078980"	"prognostic favorable (4.81e-4)"	"unprognostic (1.52e-3)"	"unprognostic (3.89e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.52e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.55e-2)"	"unprognostic (4.53e-3)"	173.3	19.2	83.7	37.2	91.0	47.6	63.1	48.5	80.7	41.9	20.4	49.9	9.4	6.2	20.5	29.7	54.0	31.6	26.2	23.5	74.0	48.7	15.6	64.9	39.5	36.9	71.0	48.8	66.2	49.0	7.4	8.9	41.8	70.6	17.4	23.3	39.3	30.4	25.5	159.8	27.9	16.4	30.5	51.3	36.1	71.4	24.0	55.2	8.6	63.9	15.5	24.2	34.7	32.2	2.5	11.0	92.2	21.1	3.4	6.3	18.6	3.0	1.2	14.0	0.0	141.5	100.1	10.3	5.1	16.6	3.1	2.8	7.4	3.1	2.6	5.6	9.9	2.8	7.0	6.1	36.4	2.6	7.0	17.0	34.3	5.8	14.3	7.5	15.1	27.4	86.5	43.7	3.9	46.4	4.7	6.2	8.4	28.8	1.5	11.0	1.7	23.5	14.5	10.4	4.2	6.5	8.5	3.7	4.4	5.4	13.3	9.6	6.3	1.4	18.7	2.0	11.7	18.2	19.1	4.6	0.1	0.2	0.0	1.1	0.5	0.3	0.0	2.7	8.6	0.5	43.6	21.1	54.9	6.3	20.5	2.6	1.6	4.5	5.2	11.0	2.5	2.3	3.9	92.2	3.4	17.1	6.1	1.7	18.6	83.7	91.0	48.5	80.7	74.0	48.7	71.0	48.8	70.6	55.2	116.1	193.4	39.3	480.1	119.7	83.9	198.1	163.1	242.2	133.1	78.5	49.1	126.6	63.0	92.2	1437.2	175.0	45.7	210.2	99.7	54.7	230.2	354.1	758.5	179.4	734.4	41.3	312.5	129.5	692.2	6809.8	451.3	662.6	129.9	48.7	226.1	5699.1	116.5	83.4	352.5	40.4	128.3	90.5	209.3	38.8	52.4	112.0	196.8	96.9	130.8	1061.5
GNAI2	"GIP, GNAI2B"	ENSG00000114353	"G protein subunit alpha i2"	P04899	3	50226292-50259355	"Predicted intracellular proteins"	"Cell cycle, Cell division"	Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007704	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		53000000	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA007704: AB_1849230"	"prognostic favorable (1.03e-4)"	"unprognostic (3.89e-1)"	"unprognostic (3.35e-2)"	"unprognostic (8.40e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.59e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.08e-3)"	"unprognostic (6.01e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.38e-1)"	81.9	37.8	50.8	69.5	47.2	102.5	53.4	17.7	45.3	56.2	47.9	67.2	34.5	22.6	51.4	41.1	44.4	47.1	55.5	57.0	44.6	48.0	34.1	50.9	72.8	78.7	53.3	34.3	54.0	21.4	24.9	42.1	81.3	46.8	44.3	22.5	38.5	25.8	60.0	29.6	29.0	35.7	53.6	81.8	96.7	30.1	28.5	45.9	70.0	37.7	32.4	55.5	60.7	49.8	5.3	14.2	35.8	19.4	6.1	8.4	5.6	15.3	8.3	25.2	25.2	31.0	38.9	4.5	33.5	54.1	48.4	49.8	9.3	21.7	18.3	14.7	75.6	26.2	12.3	17.9	46.8	31.0	39.1	6.3	46.2	22.6	14.5	30.6	42.2	61.6	37.7	20.9	43.7	17.9	40.0	113.3	15.7	3.0	39.9	48.2	19.9	35.6	45.6	13.5	7.5	32.6	22.4	12.1	26.8	31.1	17.4	6.1	10.6	24.5	7.4	15.4	21.6	11.7	43.8	98.5	41.7	24.5	39.3	33.5	25.2	32.2	16.1	47.0	57.6	49.9	2.6	16.5	23.4	8.4	19.4	4.9	5.0	6.3	7.6	14.2	5.3	5.0	5.7	35.8	6.1	15.0	11.7	6.6	5.6	50.8	47.2	17.7	45.3	44.6	48.0	53.3	34.3	46.8	45.9	38.7	40.4	91.6	50.8	50.5	26.8	19.8	53.5	14.7	25.0	41.8	13.7	65.7	5.0	114.9	164.1	226.6	12.0	23.3	53.2	68.9	80.2	40.6	86.7	69.5	291.0	6.4	88.5	179.9	279.9	235.2	84.0	263.9	79.2	299.4	19.5	264.2	106.8	32.8	89.8	22.6	18.1	51.8	75.6	14.0	24.7	55.0	97.4	119.3	13.3	55.9
GNAS	"GNAS1, GNASXL, GPSA, NESP, NESP55, SCG6, SgVI"	ENSG00000087460	"GNAS complex locus"	"O95467, P63092, P84996, Q5JWF2"	20	58839718-58911192	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		Transducer	"Cancer-related genes, Cushing syndrome, Disease mutation, Dwarfism, Obesity, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 303.3;thyroid gland: 304.5"	"Cell type enhanced"	"Detected in all"	5	"Horizontal cells: 1781.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010337, HPA018122, HPA027478, HPA028386"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"CAB010337: AB_631538, HPA018122: AB_1849236, HPA027478: AB_10599284, HPA028386: AB_10601983"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.90e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.82e-2)"	"unprognostic (4.53e-3)"	"unprognostic (8.01e-2)"	"unprognostic (4.29e-2)"	"prognostic favorable (8.76e-4)"	"unprognostic (2.07e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.36e-1)"	56.2	79.0	84.2	34.4	44.5	42.1	87.4	86.0	107.4	43.2	42.3	25.4	27.0	33.2	37.2	44.7	41.0	43.6	34.4	106.0	71.0	144.0	39.6	35.3	46.6	44.6	75.8	64.7	43.6	118.1	120.9	303.3	49.8	85.6	36.3	31.5	42.7	171.6	31.1	172.9	26.3	34.9	40.5	61.4	36.9	42.4	18.2	27.4	56.0	304.5	80.6	41.0	37.3	44.6	27.3	41.5	29.9	36.2	25.3	24.2	24.6	9.7	32.8	55.4	25.8	94.2	43.0	49.8	56.4	51.6	64.5	46.3	95.8	50.6	32.0	87.9	73.2	46.2	42.3	50.8	75.1	43.7	21.1	30.6	35.6	49.9	62.7	43.5	20.7	22.4	51.3	38.2	31.3	42.2	51.2	48.9	39.5	31.2	43.7	42.5	133.6	105.4	50.6	17.6	6.4	34.7	64.9	48.5	56.5	51.7	38.7	68.7	157.4	78.4	77.9	62.9	50.7	59.5	56.7	53.7	85.7	77.0	30.8	53.1	76.8	49.5	67.6	37.6	10.1	43.7	29.9	24.8	29.5	20.7	35.7	22.1	26.7	22.0	22.2	37.8	27.3	21.3	24.2	29.1	25.3	36.2	41.5	23.3	24.6	84.2	44.5	86.0	107.4	71.0	144.0	75.8	64.7	85.6	27.4	205.4	224.1	189.5	151.9	115.9	363.0	884.0	242.0	250.3	255.9	247.7	53.0	672.6	376.4	220.5	577.5	343.9	323.7	303.7	196.1	292.5	221.9	260.9	133.0	165.2	333.8	1781.3	444.7	335.7	327.9	1338.6	245.7	276.8	210.9	147.9	250.3	861.2	313.5	239.3	185.3	130.9	175.1	207.0	226.4	48.2	25.4	103.0	1013.3	142.4	268.2	212.5
GNB2		ENSG00000172354	"G protein subunit beta 2"	P62879	7	100673531-100679174	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 42.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010032, HPA040736"	Approved		Supported	"Plasma membrane"		NA	NA		36000000	"Plasma membrane"		"CAB010032: AB_2263466, HPA040736: AB_2677106"	"unprognostic (1.55e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.68e-3)"	"unprognostic (3.52e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.98e-1)"	49.9	45.9	43.8	41.6	58.4	60.9	88.8	31.7	40.9	40.5	43.1	22.3	39.4	34.8	41.1	39.7	74.6	49.6	44.0	54.0	38.9	36.1	39.1	72.9	49.1	94.9	32.5	42.3	47.5	45.6	33.5	45.9	38.0	35.6	47.7	29.0	28.8	77.8	42.5	39.2	59.9	38.3	39.1	23.6	50.7	42.2	31.9	33.9	43.7	40.9	45.8	35.1	37.8	50.1	6.3	9.9	42.7	14.8	5.2	7.9	4.0	51.8	40.0	33.7	40.9	26.4	31.4	29.2	31.3	43.6	44.9	37.3	30.4	50.1	23.3	34.2	46.2	50.8	36.3	26.6	46.5	15.9	32.4	22.8	17.5	30.7	24.9	44.1	22.8	38.2	40.4	44.4	46.3	37.7	36.5	51.5	19.7	32.6	45.9	40.7	140.1	36.1	64.8	26.2	32.9	43.5	34.1	20.6	37.1	35.8	43.2	35.8	58.0	41.3	68.0	28.8	19.9	29.1	28.3	48.5	48.2	53.4	93.6	39.0	13.3	15.9	34.4	36.5	51.0	66.5	7.8	10.6	23.6	6.5	14.8	6.1	4.8	6.8	5.7	9.9	6.3	4.5	4.7	42.7	5.2	12.2	8.5	7.9	4.0	43.8	58.4	31.7	40.9	38.9	36.1	32.5	42.3	35.6	33.9	53.6	112.8	83.5	121.5	134.9	6.7	29.5	107.0	37.5	28.4	80.3	3.9	158.6	137.6	144.7	22.9	125.4	215.4	46.7	189.3	250.9	125.4	201.1	43.8	58.7	231.1	68.3	173.2	118.4	164.4	15.3	134.0	187.0	133.3	161.5	167.9	119.9	203.3	197.2	122.4	84.0	7.1	64.7	122.6	36.1	47.7	170.3	245.8	92.2	152.9	221.4
GNB4		ENSG00000114450	"G protein subunit beta 4"	Q9HAV0	3	179396089-179451590	"Disease related genes, Predicted intracellular proteins, RAS pathway related proteins"		Transducer	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 75.0;Ito cells: 52.2;Kupffer cells: 78.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 41.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018383, CAB018737, HPA040736"	Supported		Supported	"Plasma membrane"		NA	NA		18000000	"Plasma membrane"		"CAB018383: AB_631542, CAB018737: AB_640712, HPA040736: AB_2677106"	"unprognostic (2.56e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.97e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.44e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (1.39e-6)"	"unprognostic (1.90e-3)"	"unprognostic (3.13e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.80e-3)"	16.6	5.3	11.9	16.7	9.9	20.7	12.4	3.2	16.6	10.4	11.1	13.9	2.2	4.4	11.3	10.7	16.1	10.2	11.9	11.0	9.8	6.2	5.0	6.3	14.3	12.6	10.1	8.0	6.3	3.7	2.1	4.3	16.6	9.9	5.1	7.2	6.6	8.8	3.6	4.3	27.0	7.7	16.9	19.4	14.9	10.6	3.7	9.4	5.6	8.8	9.6	8.6	9.5	11.9	8.2	13.6	7.0	15.3	1.8	0.3	4.2	10.4	4.6	12.6	0.2	8.4	14.4	14.6	14.8	10.1	16.5	19.6	0.1	1.1	19.4	3.4	16.2	16.1	0.2	11.1	13.4	17.6	41.4	8.3	21.9	17.6	0.1	8.2	19.2	5.1	11.8	2.1	13.0	6.6	4.1	18.1	4.3	5.7	0.2	14.7	0.4	9.4	7.8	6.4	0.0	5.5	18.9	16.2	8.1	12.2	0.5	2.0	6.7	11.9	11.3	19.7	8.0	22.3	8.7	14.7	16.2	9.0	4.1	19.7	0.0	0.2	0.2	8.8	17.1	11.2	2.2	11.5	5.4	0.1	15.3	0.1	3.6	0.2	0.1	13.6	8.2	0.2	0.1	7.0	1.8	12.6	6.9	0.3	4.2	11.9	9.9	3.2	14.7	9.8	6.2	10.1	8.0	9.9	9.4	23.8	13.8	11.5	1.7	16.7	1.3	17.0	0.0	13.4	21.6	3.5	5.9	11.9	3.3	1.0	1.1	32.9	0.0	0.0	1.4	16.3	18.6	1.7	10.4	0.9	75.0	1.6	0.0	52.2	78.1	0.9	9.5	47.8	13.5	29.7	0.0	1.4	2.0	0.0	14.9	0.0	3.9	25.8	22.8	2.1	17.5	22.2	3.4	1.3	0.0	1.1
GPC1	glypican	ENSG00000063660	"Glypican 1"	P35052	2	240435671-240468078	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 142.6"	"Cell type enhanced"	"Detected in many"	9	"Extravillous trophoblasts: 181.5;Syncytiotrophoblasts: 85.9;Urothelial cells: 90.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030571, HPA070449"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		6500000	"Plasma membrane, Cytosol"		"HPA030571: AB_10602322, HPA070449: "	"unprognostic (1.22e-2)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (5.78e-5)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.83e-3)"	"prognostic unfavorable (2.44e-6)"	"unprognostic (1.00e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.12e-2)"	13.6	22.8	32.4	7.2	21.0	1.9	8.1	42.7	33.6	11.5	8.1	10.1	9.5	5.4	9.6	9.8	26.3	7.8	7.1	40.7	26.5	11.9	8.5	11.0	7.4	4.0	8.8	22.5	14.1	18.1	5.8	14.4	20.2	13.6	29.5	4.0	6.3	16.3	17.6	62.9	142.6	4.9	12.0	8.3	5.2	6.5	20.0	10.5	1.7	4.5	24.3	10.7	10.5	15.2	0.9	0.1	0.0	0.0	0.1	0.8	0.3	16.2	22.4	5.3	13.9	16.2	15.6	21.6	39.0	19.4	4.5	5.3	7.9	18.2	0.4	5.4	41.3	24.7	44.9	2.8	27.7	0.9	7.8	2.4	0.0	20.6	9.8	23.3	0.3	1.5	13.7	18.1	10.1	5.3	9.5	2.3	0.8	0.1	0.8	11.5	8.5	0.3	0.1	8.3	1.8	5.0	2.9	24.2	3.7	3.6	26.3	5.3	3.5	25.5	22.5	2.3	5.0	7.1	1.6	10.9	24.3	41.2	11.5	16.1	0.1	0.1	0.1	17.3	0.4	27.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.2	0.1	0.9	0.0	0.2	0.0	0.1	0.0	0.0	0.8	0.3	32.4	21.0	42.7	33.6	26.5	11.9	8.8	22.5	13.6	10.5	14.9	6.7	0.0	52.5	40.8	12.0	50.2	22.9	8.1	23.9	24.4	2.0	58.0	6.6	25.6	0.6	3.7	0.9	0.0	9.3	181.5	28.8	15.7	4.6	19.2	8.0	23.8	0.0	15.4	0.0	2.1	17.5	2.7	33.7	2.8	4.3	27.8	13.4	0.0	7.1	2.2	4.9	25.8	16.5	0.5	4.9	40.4	85.9	0.7	2.7	90.8
GPC3	"DGSX, OCI-5, SDYS, SGB, SGBS, SGBS1"	ENSG00000147257	"Glypican 3"	P51654	X	133535745-133985895	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Protease inhibitor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"placenta: 262.7"	"Cell type enhanced"	"Detected in many"	10	"Fibroblasts: 127.3;Muller glia cells: 96.7;Syncytiotrophoblasts: 124.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 269.0"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	4	"naive CD4 T-cell: 5.0;naive CD8 T-cell: 3.5;NK-cell: 1.7"	"Group enriched"	"Detected in many"	12	"NK-cells: 1.7;T-cells: 5.0"	"Group enriched"	"Detected in some"	5	"HAP1: 54.2;Hep G2: 214.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA006316			Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"HPA006316: AB_1078994"	"unprognostic (2.06e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.51e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.92e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.81e-3)"	"prognostic unfavorable (4.83e-4)"	"unprognostic (1.43e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.60e-1)"	30.1	5.9	0.4	3.6	0.7	0.0	50.2	0.6	0.4	3.3	4.5	0.5	2.2	0.5	2.5	11.7	2.0	3.4	9.2	8.0	0.4	1.1	21.2	1.1	37.0	1.9	1.6	0.4	6.0	4.6	0.3	16.9	262.7	1.6	3.6	1.0	6.3	3.8	2.3	4.1	5.5	1.8	3.3	2.1	0.9	4.0	2.1	0.3	2.3	7.2	11.2	3.0	7.6	8.0	0.0	0.2	0.0	0.0	1.7	5.0	0.6	0.0	0.0	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	54.2	0.0	0.0	0.0	2.5	0.0	0.1	214.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	14.8	0.7	1.8	4.4	0.0	0.0	0.0	26.0	0.0	2.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.5	0.2	0.0	5.0	3.5	0.0	1.7	0.0	0.0	0.0	0.6	0.4	0.7	0.6	0.4	0.4	1.1	1.6	0.4	1.6	0.3	0.0	1.7	0.0	5.4	9.3	0.2	0.3	0.0	44.2	35.2	5.2	0.0	43.0	16.6	0.3	0.9	0.5	0.3	0.0	1.3	32.7	127.3	0.9	0.0	0.0	24.0	0.0	1.7	2.5	0.0	1.3	9.8	1.4	3.3	0.0	1.5	96.7	2.2	0.2	2.8	26.9	1.9	0.0	5.0	1.6	6.1	3.4	124.3	0.0	2.1	0.5
GPI	"AMF, NLK"	ENSG00000105220	"Glucose-6-phosphate isomerase"	P06744	19	34359480-34402413	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Gluconeogenesis, Glycolysis"	"Cytokine, Growth factor, Isomerase"	"Cancer-related genes, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 321.8;Late spermatids: 797.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB018655, HPA024305, CAB040563, HPA052171"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	No	No		140000000	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB018655: AB_2112653, CAB040563: , HPA024305: AB_1849922, HPA052171: AB_2681748"	"unprognostic (1.03e-1)"	"unprognostic (8.39e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.52e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.52e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.88e-2)"	62.1	66.6	43.4	27.6	58.2	83.3	34.8	62.6	88.7	20.6	36.6	20.8	23.7	48.2	21.1	20.6	45.3	24.2	33.5	107.2	42.0	45.6	51.3	77.9	19.6	29.6	39.3	64.3	22.5	21.4	66.9	33.7	20.4	50.2	23.7	37.2	36.2	34.6	33.9	144.7	29.4	44.3	34.2	22.8	23.1	26.7	19.7	19.0	23.8	26.1	68.5	32.6	32.5	25.2	16.2	26.3	74.8	40.9	14.5	27.5	24.6	76.8	108.3	9.5	74.2	31.2	23.2	22.7	29.7	23.5	37.5	45.2	61.0	27.3	50.7	44.1	29.0	25.5	53.6	57.3	64.5	42.6	56.3	23.2	65.0	52.2	64.2	20.2	84.2	42.4	31.8	26.7	44.2	23.0	47.4	35.0	34.4	33.1	40.1	26.3	65.2	36.6	29.5	25.7	69.7	38.4	34.3	25.1	95.7	46.9	51.8	51.9	30.2	59.8	105.5	21.6	17.8	23.9	26.9	30.1	14.2	31.2	40.1	45.7	74.2	42.1	46.0	47.2	64.1	28.6	38.5	22.9	74.8	22.5	35.2	27.5	16.2	20.7	25.5	26.3	13.3	17.5	20.7	1.6	14.5	40.9	8.7	21.6	24.6	43.4	58.2	62.6	88.7	42.0	45.6	39.3	64.3	50.2	19.0	26.8	40.2	23.1	22.0	23.0	92.5	198.3	38.2	21.4	25.0	54.1	70.7	38.6	97.8	77.9	321.8	30.6	90.3	0.0	57.9	60.0	36.8	27.8	22.0	68.1	78.6	224.1	61.2	47.9	41.6	797.8	34.2	41.9	33.7	45.9	67.6	28.6	75.7	25.9	28.7	79.1	62.2	19.4	38.7	6.9	7.6	28.7	32.8	47.1	102.1	32.5
GPR1		ENSG00000183671	"G protein-coupled receptor 1"	P46091	2	206175316-206218047	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"placenta: 19.1"	"Group enriched"	"Detected in some"	8	"Extravillous trophoblasts: 10.0;Muller glia cells: 4.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basal ganglia: 10.7;pons and medulla: 6.6"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"HHSteC: 53.7;hTCEpi: 24.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010525	Uncertain		Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	"Nucleoplasm, Vesicles"	"HPA010525: AB_1078919"	"unprognostic (5.32e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.27e-5)"	"unprognostic (1.36e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.49e-2)"	"unprognostic (7.89e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.42e-3)"	"unprognostic (5.65e-2)"	"unprognostic (4.29e-4)"	"unprognostic (8.48e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.06e-3)"	2.3	5.0	0.5	0.6	10.7	0.1	1.7	0.4	1.2	4.1	0.6	4.8	1.6	0.2	1.3	0.7	6.6	1.1	2.7	3.8	1.6	0.5	0.7	0.0	0.5	3.1	0.2	0.3	3.2	0.1	0.0	0.4	19.1	6.6	0.7	0.6	1.1	1.5	0.4	1.5	6.7	0.5	2.3	0.3	0.2	0.2	1.6	1.0	0.0	0.7	2.2	1.2	3.1	7.7	0.5	0.1	1.4	0.2	0.5	0.2	0.6	0.8	0.1	0.7	0.0	0.1	3.0	0.2	5.5	9.5	3.4	2.9	0.0	0.0	0.0	0.3	2.7	0.2	0.1	0.2	0.0	1.1	0.0	0.1	0.0	1.8	0.0	53.7	0.0	0.0	2.2	24.2	4.9	7.9	4.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	2.7	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	2.4	1.1	0.0	0.0	0.6	0.0	0.0	0.1	4.1	1.9	4.8	0.4	0.0	0.0	0.0	1.5	0.0	0.1	1.3	0.2	0.3	0.2	0.0	0.1	0.3	0.2	0.1	0.0	0.5	0.2	0.2	1.4	0.5	0.1	0.1	0.2	0.6	0.5	10.7	0.4	1.2	1.6	0.5	0.2	0.3	6.6	1.0	0.0	0.0	0.0	0.6	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.3	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.9	0.6	0.0	0.0	0.3
GPR156	"GABABL, PGR28"	ENSG00000175697	"G protein-coupled receptor 156"	Q8NFN8	3	120164645-120285094	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 7.7"	"Group enriched"	"Detected in some"	8	"Early spermatids: 6.5;Late spermatids: 14.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 3.1;PC-3: 3.0;SiHa: 8.1;U-2 OS: 4.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028642, HPA028644"	Uncertain		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA028642: AB_10599711, HPA028644: AB_10600441"	"unprognostic (2.85e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.53e-3)"	"unprognostic (2.02e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.62e-4)"	"unprognostic (2.03e-1)"	"unprognostic (4.54e-4)"	"unprognostic (5.03e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.03e-5)"	"unprognostic (2.43e-2)"	"unprognostic (3.43e-2)"	"unprognostic (4.91e-3)"	"unprognostic (6.71e-2)"	0.9	0.5	0.8	1.6	2.2	0.0	1.0	0.1	1.0	1.4	0.7	0.0	0.0	0.0	1.2	0.0	1.9	3.4	1.3	0.2	0.4	0.3	0.3	0.0	0.2	0.0	0.3	0.0	1.4	0.0	0.0	1.4	1.2	0.7	1.9	0.2	0.4	2.4	1.5	0.1	0.3	0.2	1.6	1.5	0.1	0.3	7.7	1.2	0.0	0.1	0.0	0.4	2.5	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.2	0.8	0.1	0.9	1.3	0.1	0.6	0.0	0.9	3.1	0.7	0.1	0.1	0.1	0.5	0.0	0.0	0.0	2.0	0.0	0.8	0.2	0.0	2.0	0.2	0.5	0.0	0.2	0.0	0.1	0.0	0.3	1.0	0.0	0.0	0.0	1.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	1.0	1.6	8.1	0.0	1.0	0.4	1.1	0.1	0.2	0.2	4.5	0.0	0.3	1.0	0.4	0.1	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	2.2	0.1	1.0	0.4	0.3	0.3	0.0	0.7	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.1	0.0	0.0	0.0
GPR160	"GPCR1, GPCR150"	ENSG00000173890	"G protein-coupled receptor 160"	Q9UJ42	3	170037929-170085403	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"parathyroid gland: 71.0"	"Cell type enhanced"	"Detected in many"	5	"Intestinal endocrine cells: 186.9;Rod photoreceptor cells: 156.5;Undifferentiated cells: 149.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 31.0;SK-BR-3: 24.8;THP-1: 48.9;U-266/70: 54.0;U-266/84: 31.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA006970	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA006970: AB_1849275"	"unprognostic (1.70e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.21e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (5.71e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (4.93e-7)"	"unprognostic (1.40e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (3.61e-4)"	7.0	1.4	3.1	21.7	2.5	23.6	8.2	0.9	1.8	2.6	31.2	1.5	7.9	18.0	1.9	21.5	2.6	1.8	16.2	3.0	1.9	1.7	27.4	2.1	23.2	25.6	2.7	0.4	1.6	14.7	71.0	3.5	2.9	1.8	10.7	18.1	11.8	14.2	4.7	2.0	1.8	43.2	0.9	4.7	17.9	18.0	2.9	2.4	6.6	3.8	1.0	10.7	9.1	6.9	11.2	2.9	10.1	1.1	0.3	3.0	1.2	15.9	0.3	0.0	0.1	0.1	0.1	4.0	0.1	0.1	0.1	0.5	2.9	2.0	7.4	3.4	0.1	1.0	0.1	2.2	0.1	0.2	11.3	4.4	4.8	0.2	6.0	0.0	9.4	6.5	0.0	0.2	0.5	0.6	0.7	0.3	3.5	1.5	19.2	0.1	10.2	0.7	2.0	2.6	9.8	0.6	1.3	0.3	31.0	8.4	22.1	1.6	0.4	0.2	24.8	1.1	2.2	14.5	48.9	0.5	0.0	0.1	1.8	1.2	54.0	31.0	12.9	0.2	10.2	0.7	1.5	1.1	8.1	0.5	0.4	0.9	6.8	0.9	0.4	2.2	11.2	3.0	1.1	10.1	0.3	0.1	2.9	0.3	1.2	3.1	2.5	0.9	1.8	1.9	1.7	2.7	0.4	1.8	2.4	8.9	39.0	27.8	3.1	0.3	7.9	1.0	25.5	18.7	18.2	59.3	37.3	2.6	46.4	10.6	24.4	4.5	103.3	0.0	63.8	15.0	0.4	47.4	1.1	0.5	7.0	14.3	186.9	16.0	9.2	32.2	0.6	10.0	27.0	97.4	129.6	7.7	48.2	137.8	0.4	121.7	156.5	0.0	0.3	6.4	11.9	0.6	22.8	2.5	149.6	25.7
GPR20		ENSG00000204882	"G protein-coupled receptor 20"	Q99678	8	141356500-141367267	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"Sertoli cells: 71.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"intermediate monocyte: 3.7;non-classical monocyte: 5.4"	"Lineage enriched"	"Detected in single"	14	"monocytes: 5.4"	"Cell line enriched"	"Detected in some"	4	"EFO-21: 7.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.3"	HPA071337			Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA071337: "	"unprognostic (4.47e-2)"	"unprognostic (2.64e-3)"	"unprognostic (5.18e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.41e-2)"	"unprognostic (5.50e-2)"	"unprognostic (6.23e-2)"	"unprognostic (4.07e-1)"	2.8	0.5	0.7	2.7	1.4	0.1	2.5	0.2	2.0	10.6	9.1	1.0	4.3	2.2	6.7	1.9	3.4	3.9	6.1	2.1	0.8	0.4	1.1	0.4	3.5	0.3	1.4	0.9	3.7	0.5	0.5	0.5	3.2	2.1	2.2	1.0	1.1	0.5	3.0	2.1	1.0	10.5	4.5	0.5	0.8	4.3	1.6	0.7	0.0	1.4	1.5	0.5	1.7	3.4	0.0	0.3	0.3	5.4	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.5	0.1	0.0	7.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.5	0.2	0.5	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	5.4	0.0	0.0	0.1	0.7	1.4	0.2	2.0	0.8	0.4	1.4	0.9	2.1	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	71.1	16.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0
GPR50	"H9, Mel1c"	ENSG00000102195	"G protein-coupled receptor 50"	Q13585	X	151176653-151181465	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"pituitary gland: 64.9"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEK 293: 9.6;SuSa: 8.1"	"Region enriched"	"Detected in some"	6	"hypothalamus: 16.8"	"Region enriched"	"Detected in some"	9	"hypothalamus: 6.4"	"HPA049862, HPA054678"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA049862: AB_2680920, HPA054678: AB_2682570"						"unprognostic (8.84e-3)"		"unprognostic (5.59e-2)"							"unprognostic (1.15e-1)"			0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.3	1.4	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	64.9	3.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPRIN1	"GRIN1, KIAA1893"	ENSG00000169258	"G protein regulated inducer of neurite outgrowth 1"	Q7Z2K8	5	176595802-176610133	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 28.2"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 13.2;Horizontal cells: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.7;SCLC-21H: 30.7"					"Low region specificity"	"Detected in all"			"HPA036478, HPA070892"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA036478: AB_2675145, HPA070892: AB_2686321"	"unprognostic (1.70e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.41e-2)"	"unprognostic (5.66e-2)"	"unprognostic (6.54e-3)"	"unprognostic (3.06e-1)"	"unprognostic (4.76e-6)"	"prognostic unfavorable (6.83e-6)"	"unprognostic (1.11e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.56e-3)"	"prognostic unfavorable (2.79e-7)"	"unprognostic (4.24e-3)"	"unprognostic (5.60e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.32e-3)"	1.3	3.2	16.9	1.8	6.4	0.9	0.9	16.9	28.2	1.1	1.6	0.2	0.0	6.4	1.3	0.6	1.1	0.7	1.1	0.7	11.1	11.1	0.7	0.7	1.1	1.7	3.6	11.4	0.5	1.5	0.7	5.8	1.0	4.4	0.7	1.3	0.7	0.7	0.6	0.7	1.5	4.0	1.7	1.9	0.9	1.9	2.2	0.7	0.0	0.8	0.0	2.3	0.9	0.1	0.9	0.0	0.0	0.0	0.5	0.3	0.0	3.6	3.9	5.0	7.2	1.1	2.4	4.2	4.9	2.5	3.8	5.0	4.7	2.4	8.4	10.1	2.6	11.3	3.2	3.2	3.4	3.4	27.7	2.1	0.1	2.1	1.6	0.4	0.2	2.1	1.2	2.6	4.1	0.6	0.8	2.8	1.9	4.4	12.2	3.2	9.6	0.8	0.0	5.0	2.5	7.8	15.6	5.6	4.9	4.3	3.8	30.7	17.6	5.7	1.6	8.7	0.6	3.8	3.2	3.4	7.2	8.3	2.7	7.2	0.2	1.1	2.4	6.2	0.4	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	16.9	6.4	16.9	14.3	11.1	11.1	3.6	11.4	4.4	0.7	0.0	0.0	0.0	0.0	2.2	13.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.7	0.0	0.0	1.5	0.7	0.4	0.2	0.0	0.0	0.7	20.6	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	1.2	0.0	0.0	0.0	3.1	0.0	0.0	0.5	2.3	1.3	0.1	0.0	0.2	0.0
GRAMD1A	"FLJ90346, KIAA1533"	ENSG00000089351	"GRAM domain containing 1A"	Q96CP6	19	34994784-35026471	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"monocytes: 235.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008852, HPA012570"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA008852: AB_1079203, HPA012570: AB_2112577"	"unprognostic (3.09e-2)"	"unprognostic (4.62e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.42e-3)"	"unprognostic (5.96e-2)"	"unprognostic (4.54e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (7.95e-12)"	"unprognostic (2.04e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.36e-2)"	15.6	19.1	14.6	21.4	14.0	17.1	19.4	13.8	18.1	16.8	13.2	10.4	17.4	13.0	16.9	12.9	7.8	17.2	13.8	17.2	15.9	12.0	13.3	11.0	27.5	42.0	13.7	12.2	21.8	44.1	11.5	14.9	14.1	16.6	15.6	7.5	11.5	45.3	17.2	35.7	6.8	10.9	21.3	12.8	21.1	16.1	11.7	12.1	17.9	12.7	11.5	12.1	17.3	21.4	1.1	4.1	13.1	14.9	3.8	5.5	2.5	5.5	42.9	8.4	16.6	9.8	11.2	7.0	6.7	11.1	9.0	8.9	16.2	4.8	3.1	13.4	10.0	7.9	3.6	8.7	13.2	3.4	13.3	15.2	9.2	10.6	14.9	19.8	6.5	14.7	19.8	8.2	6.4	10.9	14.2	29.2	20.5	10.0	2.2	6.2	5.3	14.8	8.0	13.2	11.0	4.8	14.0	2.6	3.9	9.6	1.0	12.7	25.6	6.8	5.1	11.0	7.7	7.8	7.2	15.9	14.4	7.4	2.9	9.5	2.4	7.9	7.6	9.5	7.2	10.7	13.1	4.5	3.6	2.9	7.3	5.5	0.5	3.9	2.1	4.1	1.1	2.9	4.2	9.8	3.8	14.9	1.4	3.1	2.5	14.6	14.0	13.8	18.1	15.9	12.0	13.7	12.2	16.6	12.1	20.8	34.1	13.4	49.1	18.4	13.5	8.1	0.0	16.0	14.8	15.7	15.7	10.8	3.3	29.5	0.8	46.6	1.8	0.0	49.7	25.1	19.4	49.8	9.2	6.7	44.3	7.9	37.8	51.0	37.3	1.8	23.9	26.0	32.1	235.4	12.5	28.8	44.0	10.5	23.7	11.5	14.9	12.9	32.0	0.0	2.7	13.4	27.7	41.5	18.6	48.2
GRAMD1B	"KIAA1201, LINC01059"	ENSG00000023171	"GRAM domain containing 1B"	Q3KR37	11	123358428-123627774	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 67.7;brain: 55.2;intestine: 21.7"	"Cell type enhanced"	"Detected in many"	14	"Bipolar cells: 41.9;Cone photoreceptor cells: 108.0;Horizontal cells: 42.9;Rod photoreceptor cells: 85.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.5"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 11.5"	"Group enriched"	"Detected in many"	4	"A549: 22.2;HDLM-2: 58.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008557, HPA075204"	Approved		Supported	"Endoplasmic reticulum,Vesicles,Plasma membrane"		NA	NA			"Endoplasmic reticulum, Plasma membrane"	Vesicles	"HPA008557: AB_1079197, HPA075204: "	"unprognostic (1.86e-1)"	"unprognostic (7.18e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.74e-3)"	"unprognostic (8.15e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.69e-3)"	"unprognostic (4.12e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.90e-2)"	"unprognostic (9.60e-2)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (4.30e-7)"	"unprognostic (1.39e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.69e-1)"	1.4	67.7	15.5	3.1	16.0	11.8	1.1	55.2	25.0	1.2	3.1	5.1	5.9	21.7	1.2	6.6	0.9	2.9	8.1	4.3	13.6	7.5	10.4	1.3	1.9	3.6	6.8	15.1	7.6	2.0	0.6	6.7	5.0	14.4	1.1	1.2	11.9	1.3	2.5	1.8	0.8	15.6	1.3	4.1	2.7	7.8	10.6	5.1	3.4	3.7	0.0	2.7	1.5	0.8	0.1	11.5	0.6	2.0	2.6	2.7	0.7	0.0	22.2	1.2	0.0	0.1	0.2	3.6	7.4	5.3	1.6	0.6	0.9	0.1	1.3	3.9	3.7	2.5	0.0	2.3	0.0	1.7	58.9	2.0	0.0	10.0	0.2	0.0	7.6	0.0	0.4	0.0	2.8	0.0	1.9	0.7	0.6	0.0	0.0	1.4	0.1	1.3	2.6	2.8	9.9	8.4	4.0	3.6	2.4	0.1	0.0	7.4	6.0	1.7	0.1	0.0	3.4	0.2	4.3	4.4	8.9	1.4	1.5	0.3	0.0	0.0	0.0	1.8	8.0	0.4	0.0	2.0	0.6	0.7	1.0	0.4	0.0	2.7	2.1	3.0	0.1	0.3	0.3	0.2	2.6	1.0	11.5	1.1	0.7	15.5	16.0	55.2	25.0	13.6	7.5	6.8	15.1	14.4	5.1	0.0	0.3	0.0	0.0	0.0	41.9	5.5	25.5	0.0	0.0	5.2	108.0	4.5	3.3	0.5	5.2	0.7	0.3	0.0	0.4	3.0	1.1	0.1	0.0	0.0	2.3	42.9	0.0	0.6	3.5	2.3	0.6	2.8	0.0	1.0	0.8	21.5	2.3	0.2	0.7	5.5	85.7	0.0	0.8	1.0	1.5	0.4	2.1	1.0	0.4	0.0
GRB7		ENSG00000141738	"Growth factor receptor bound protein 7"	Q14451	17	39737927-39747291	"Cancer-related genes, Predicted intracellular proteins"		"Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 53.9"	"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 79.7;Glandular cells: 69.7;Syncytiotrophoblasts: 82.5;Urothelial cells: 65.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	4	"cerebellum: 7.4"	"Cell type enriched"	"Detected in single"	20	"naive B-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"B-cells: 2.0"	"Cell line enriched"	"Detected in some"	5	"OE19: 193.7"	"Region enhanced"	"Detected in some"		"cerebellum: 9.3"	"Low region specificity"	"Detected in all"			"CAB005226, HPA057084, CAB073538"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB005226: AB_2113278, CAB073538: , HPA057084: AB_2683330"	"unprognostic (8.46e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (6.60e-7)"	"unprognostic (7.06e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (3.10e-4)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (2.59e-2)"	"prognostic favorable (8.23e-5)"	"unprognostic (1.83e-2)"	"unprognostic (4.77e-2)"	"unprognostic (5.49e-3)"	"unprognostic (4.01e-2)"	2.9	0.1	0.1	2.8	0.6	0.0	16.1	7.4	1.2	6.7	12.7	0.3	25.0	6.7	2.6	8.1	53.9	14.5	16.3	0.8	0.2	0.1	23.4	5.2	12.3	0.1	0.1	0.4	3.1	20.5	5.8	3.7	42.6	1.6	10.2	6.4	0.7	14.0	25.5	0.5	19.1	12.4	2.0	0.1	0.3	7.2	2.3	0.3	0.5	8.5	6.5	17.2	7.2	11.7	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.6	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	4.9	2.8	0.0	0.4	0.0	0.1	2.6	0.0	1.8	0.0	0.0	0.2	0.0	0.6	4.3	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.5	193.7	0.4	0.0	0.0	1.9	2.2	1.6	1.1	0.0	2.1	42.8	0.0	2.1	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	7.4	1.2	0.2	0.1	0.1	0.4	1.6	0.3	20.8	10.0	0.0	79.7	34.0	0.0	2.0	15.3	17.4	7.9	21.0	0.0	27.0	8.3	29.6	0.0	0.5	18.0	0.0	16.9	18.8	1.9	69.7	1.1	4.0	2.5	0.0	13.8	0.0	0.0	0.0	2.6	0.9	5.0	2.8	16.8	0.3	20.5	24.6	1.1	8.6	0.0	0.0	1.0	0.4	0.2	36.6	82.5	0.9	22.1	65.1
GRIK5	"GluK5, GRIK2, KA2"	ENSG00000105737	"Glutamate ionotropic receptor kainate type subunit 5"	Q16478	19	41998321-42069498	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.9"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 21.4;Horizontal cells: 17.5;Muller glia cells: 8.3;Rod photoreceptor cells: 20.6"	"Cancer enhanced"	"Detected in many"		"glioma: 15.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"eosinophil: 1.0"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"HEL: 9.0;hTERT-RPE1: 14.5;NTERA-2: 8.9;REH: 24.4;SCLC-21H: 7.0;SH-SY5Y: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074001			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA074001: AB_2732248"	"unprognostic (4.99e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.30e-3)"	"unprognostic (6.68e-3)"	"unprognostic (4.28e-2)"	"unprognostic (3.86e-1)"	"unprognostic (5.82e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.73e-2)"	"prognostic favorable (7.23e-4)"	"unprognostic (8.43e-2)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (6.47e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.12e-2)"	1.7	5.4	9.6	2.3	12.2	3.4	2.4	17.2	23.9	2.7	6.9	4.9	1.3	1.2	3.8	2.7	2.4	4.5	2.6	5.6	21.7	8.9	3.8	0.3	0.6	2.6	5.0	5.3	5.3	3.5	17.8	9.1	0.3	5.5	4.5	1.6	5.8	0.7	8.9	1.0	1.1	1.4	6.7	7.6	1.8	2.7	13.6	3.5	1.0	10.3	0.3	1.0	2.2	2.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.2	9.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	14.5	0.0	0.4	0.0	0.4	0.0	0.1	0.1	0.0	8.9	0.1	0.0	24.4	0.0	0.1	4.0	0.0	7.0	15.5	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	1.0	0.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	12.2	17.2	12.7	21.7	8.9	5.0	5.3	5.5	3.5	0.0	0.0	0.0	0.1	0.3	21.4	2.3	0.0	0.0	0.0	1.8	2.0	0.0	0.0	0.8	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.1	4.6	0.0	0.0	17.5	0.0	0.0	0.0	2.2	0.9	0.0	0.0	0.0	0.0	8.3	0.1	0.0	0.4	0.0	20.6	0.0	0.9	3.8	1.5	0.4	0.0	0.0	0.0	0.0
GRK5	GPRK5	ENSG00000198873	"G protein-coupled receptor kinase 5"	P34947	10	119207589-119459742	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 53.6;Sertoli cells: 58.2;Smooth muscle cells: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 35.6;HUVEC TERT2: 28.2;OE19: 27.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025579, HPA046838"	Approved		Supported	"Nuclear membrane,Nuclear speckles,Plasma membrane"		NA	NA			"Nuclear membrane, Nuclear speckles"	"Plasma membrane"	"CAB025579: , HPA046838: AB_2679833"	"unprognostic (1.09e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (2.38e-7)"	"unprognostic (1.10e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.90e-2)"	15.9	8.3	3.4	16.8	7.8	2.7	10.2	6.5	5.0	12.5	18.8	3.9	4.5	12.4	13.4	12.2	8.1	7.7	19.5	45.4	4.2	4.2	4.3	5.7	27.6	8.8	3.7	2.5	16.5	3.5	26.2	6.3	24.0	4.5	7.5	6.4	5.6	5.0	6.7	12.8	4.7	10.4	10.8	4.8	17.0	13.9	3.5	4.7	9.8	8.9	10.7	8.6	9.5	13.6	9.3	2.2	6.5	3.7	0.2	11.3	4.2	3.9	2.3	5.9	6.0	13.5	13.0	1.7	7.6	35.6	4.7	2.7	1.9	5.7	4.2	1.8	11.9	8.3	0.9	2.5	8.4	3.1	16.7	2.1	0.7	4.9	7.5	9.3	0.2	2.1	1.8	1.2	9.6	1.4	5.7	28.2	2.6	0.4	4.1	1.7	0.6	3.9	3.8	0.8	27.1	5.9	1.4	0.8	1.0	0.7	1.6	1.9	5.4	2.6	1.2	7.3	3.6	0.1	1.0	8.5	2.6	1.8	15.5	3.0	0.9	4.5	2.6	5.4	4.7	2.4	0.9	3.7	6.5	5.3	3.2	0.4	9.3	7.7	3.8	2.2	9.1	11.3	5.0	5.0	0.2	0.9	0.0	9.2	4.2	3.4	7.8	6.5	5.0	4.2	4.2	3.7	2.5	4.5	4.7	53.6	5.9	13.7	0.5	1.4	3.4	14.6	0.0	1.4	2.3	3.5	0.0	2.4	0.0	1.0	11.8	24.8	0.9	0.0	2.7	13.7	12.4	0.6	4.6	1.7	3.6	1.6	4.6	21.5	10.4	2.9	4.0	5.1	6.8	0.0	0.7	0.0	1.7	0.2	4.2	0.4	0.7	58.2	37.3	1.4	1.7	2.0	11.0	10.2	0.3	0.9
GRPR	"BB2, BB2R"	ENSG00000126010	"Gastrin releasing peptide receptor"	P30550	X	16123556-16153021	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 24.5"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"breast cancer: 6.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.9;non-classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	10	"PC-3: 18.0;T-47d: 22.5;U-138 MG: 30.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA069604			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA069604: AB_2686158"	"unprognostic (3.32e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.17e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.68e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.86e-2)"	0.5	0.4	3.4	4.7	2.3	0.2	3.5	0.3	3.5	3.7	1.4	0.0	2.5	0.2	1.0	2.8	7.5	0.3	0.2	0.5	3.5	0.4	0.3	0.3	0.4	0.2	0.3	1.9	0.3	24.5	0.4	0.3	0.2	1.1	0.7	0.6	2.0	0.4	0.4	0.4	0.3	0.5	1.2	0.4	0.3	2.1	0.4	0.0	0.0	0.4	0.0	0.2	0.4	0.4	0.6	0.2	0.4	1.9	0.0	0.1	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.2	0.0	0.5	0.0	2.3	1.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.3	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	22.5	0.0	0.1	30.8	0.3	0.0	0.9	0.1	0.1	0.1	0.0	0.0	0.4	0.0	1.1	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.4	0.0	1.6	0.1	0.0	0.4	3.4	2.3	0.3	3.5	3.5	0.4	0.3	1.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GSDMA	"FLJ39120, GSDM, GSDM1"	ENSG00000167914	"Gasdermin A"	Q96QA5	17	39953263-39977766	"Predicted intracellular proteins, Transporters"	Necrosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 35.7;tongue: 19.4"	"Cell type enhanced"	"Detected in some"	15	"Collecting duct cells: 3.5;Hofbauer cells: 4.9;Kupffer cells: 6.0;Suprabasal keratinocytes: 2.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 7.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 1.9;T-cells: 5.6"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 7.3;hTCEpi: 5.0;hTERT-HME1: 9.8"					"Not detected"	"Not detected"			"HPA023313, HPA064826"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA		7100	"Plasma membrane, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA023313: AB_1850378, HPA064826: AB_2685361"	"unprognostic (1.32e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.24e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.86e-2)"	"unprognostic (7.45e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.79e-2)"	2.1	0.4	0.2	0.4	0.1	0.0	2.2	0.1	0.1	1.1	0.6	0.0	0.0	0.1	0.4	8.6	1.9	0.3	0.3	2.0	0.2	0.2	0.4	0.2	0.7	8.5	0.2	0.7	0.2	0.2	1.0	0.9	0.9	0.1	0.2	0.6	0.0	0.6	0.0	0.9	35.7	0.3	0.5	0.2	0.3	0.2	0.9	0.0	0.8	0.2	19.4	7.8	0.8	1.1	0.6	0.5	1.9	0.4	0.6	5.6	1.0	0.4	0.1	0.0	0.3	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.0	0.1	0.0	7.3	0.0	0.2	0.5	0.9	0.6	0.5	0.0	0.3	1.6	0.0	5.0	0.9	9.8	0.1	0.0	0.1	0.2	2.4	0.0	1.0	0.0	0.2	0.1	0.5	0.1	0.6	0.0	0.9	0.2	0.7	0.0	0.2	0.2	0.3	0.0	0.1	0.6	0.1	0.1	0.3	0.7	0.1	0.1	0.3	0.1	0.6	0.4	0.1	0.0	1.7	0.4	0.4	4.8	0.2	5.6	0.3	3.1	1.8	0.2	0.6	1.6	2.5	1.9	0.6	0.3	0.5	1.1	1.0	0.2	0.1	0.1	0.1	0.2	0.2	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	1.3	6.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.4	0.0	0.0	0.0	0.0
GYPA	"CD235a, GPA, MN, MNS"	ENSG00000170180	"Glycophorin A (MNS blood group)"	P02724	4	144109303-144140786	"Blood group antigen proteins, CD markers, Predicted membrane proteins"	"Host-virus interaction"	"Blood group antigen, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"bone marrow: 56.9"	"Cell type enriched"	"Detected in some"	311	"Erythroid cells: 1331.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	4	"HEL: 57.0"									"CAB002658, HPA014811"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"CAB002658: , HPA014811: AB_1849827"					"unprognostic (1.60e-1)"								"unprognostic (2.47e-2)"					0.1	0.0	0.2	0.1	0.4	56.9	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.3	1.7	1.3	3.2	0.1	0.3	0.1	0.1	0.1	0.0	0.3	4.8	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	6.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.5	0.3	0.4	0.2	0.2	0.6	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.2	0.9	0.1	0.2	0.2	1.5	0.2	0.6	0.2	0.2	0.2	0.3	0.0	0.8	0.2	0.4	0.1	0.5	0.2	0.3	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.3	0.0	0.0	1331.6	0.0	1.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
GYPC	"CD236, CD236R, Ge, GPC, GYPD"	ENSG00000136732	"Glycophorin C (Gerbich blood group)"	P04921	2	126655933-126696670	"Blood group antigen proteins, CD markers, Predicted membrane proteins"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	18	"Erythroid cells: 1448.3;Hofbauer cells: 391.9"	"Cancer enhanced"	"Detected in all"		"melanoma: 66.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 62.6;K-562: 46.5;SK-MEL-30: 91.9;U-266/70: 51.9"	"Low region specificity"	"Detected in all"							"HPA008965, CAB009445"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB009445: AB_2116251, HPA008965: AB_1078455"	"unprognostic (1.63e-2)"	"unprognostic (7.14e-3)"	"unprognostic (8.39e-2)"	"unprognostic (3.31e-3)"	"unprognostic (4.19e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.00e-3)"	44.5	21.7	3.9	34.5	5.3	95.0	99.8	1.3	4.3	20.7	24.8	5.9	9.8	5.0	20.3	26.0	22.9	18.5	21.4	61.2	4.4	3.4	15.2	6.3	29.5	75.8	8.0	3.7	37.4	18.7	1.7	5.5	17.5	5.6	24.5	5.5	13.8	13.0	15.5	48.9	11.3	15.2	34.8	8.3	41.1	13.5	13.4	4.6	28.5	11.6	29.9	22.5	37.1	38.8	21.2	9.9	4.2	7.7	14.7	41.4	21.8	0.1	0.0	22.5	0.0	16.7	14.6	0.0	3.3	26.0	4.0	12.1	0.0	0.0	0.0	0.0	9.4	15.6	0.0	12.2	0.0	1.3	10.7	0.0	37.8	0.0	0.0	62.6	13.2	0.1	32.9	0.0	3.2	0.0	0.3	0.1	26.2	46.5	31.3	9.8	0.0	0.0	20.9	6.7	0.0	0.0	2.4	1.6	0.0	1.6	0.0	0.0	0.0	0.0	0.0	91.9	3.0	0.0	35.9	9.0	15.4	0.1	1.0	0.1	51.9	33.6	0.0	7.5	19.1	13.9	0.1	5.9	0.4	32.3	7.7	36.4	18.9	29.3	39.1	9.9	21.2	41.4	40.4	4.2	14.7	4.7	5.5	35.1	21.8	3.9	5.3	1.3	4.3	4.4	3.4	8.0	3.7	5.6	4.6	6.0	11.4	163.5	2.9	33.8	0.7	31.5	68.8	2.7	5.7	14.0	2.0	4.8	114.4	182.3	1.2	74.4	0.0	1448.3	4.2	6.4	148.3	3.8	23.0	3.4	391.9	0.0	0.0	252.3	99.7	1.5	80.8	80.7	290.1	117.2	0.0	4.9	8.0	0.0	65.0	3.9	2.3	58.2	117.4	0.3	0.8	23.2	7.6	235.7	0.0	0.9
HAS1	HAS	ENSG00000105509	"Hyaluronan synthase 1"	Q92839	19	51713112-51723994	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 23.7;lymphoid tissue: 13.7;ovary: 23.6"	"Cell type enhanced"	"Detected in some"	13	"Basal keratinocytes: 23.7;Fibroblasts: 9.0;Melanocytes: 8.5;Smooth muscle cells: 24.7;Suprabasal keratinocytes: 15.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"eosinophil: 5.9;neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 5.9"	"Cell line enriched"	"Detected in some"	4	"U-87 MG: 51.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067602	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA067602: AB_2685871"	"unprognostic (3.56e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.26e-4)"	"unprognostic (7.17e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.49e-4)"	"unprognostic (4.80e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.30e-11)"	"unprognostic (9.12e-4)"	"unprognostic (8.99e-2)"	"unprognostic (3.73e-4)"	"unprognostic (2.43e-2)"	23.7	0.5	0.6	13.7	1.3	2.8	1.0	1.5	1.9	0.6	1.2	0.4	1.1	0.1	0.8	2.5	1.3	5.8	5.5	5.9	1.4	2.0	0.3	0.6	4.5	0.3	0.6	0.3	23.6	2.2	0.0	0.3	0.3	0.6	0.4	0.5	1.0	0.3	1.2	2.1	2.7	4.0	3.6	0.9	0.7	0.7	0.9	0.3	0.3	0.3	0.8	0.3	1.8	0.3	0.1	0.1	5.9	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	51.0	0.0	0.1	0.0	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.6	0.0	0.0	0.1	0.0	0.1	0.6	1.3	1.5	1.7	1.4	2.0	0.6	0.3	0.6	0.3	0.0	2.6	0.0	0.1	23.7	4.2	0.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	9.0	0.1	2.3	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.3	0.3	8.5	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.6	0.0	24.7	0.0	0.1	15.6	0.1	0.0	0.0	0.1
HAUS4	"C14orf94, FLJ20424"	ENSG00000092036	"HAUS augmin like complex subunit 4"	Q9H6D7	14	22946228-22957161	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA029803, HPA071195"	Approved		Supported	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane, Focal adhesion sites"		"HPA029803: AB_10601428, HPA071195: "	"unprognostic (8.47e-3)"	"unprognostic (3.52e-1)"	"unprognostic (6.47e-2)"	"unprognostic (7.59e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.32e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.87e-2)"	"unprognostic (7.70e-2)"	"unprognostic (8.66e-2)"	"unprognostic (3.00e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (2.24e-4)"	17.2	16.7	11.0	28.8	15.0	29.8	22.3	9.9	15.6	20.3	24.0	13.8	22.3	15.3	17.8	20.7	25.4	16.9	30.6	19.5	12.3	8.3	16.8	17.9	24.0	30.6	17.7	9.2	33.8	29.1	17.5	9.8	12.1	13.4	19.1	16.9	14.2	22.0	19.2	14.4	21.7	24.9	23.3	17.6	24.5	19.3	12.2	17.4	33.7	23.2	17.2	21.2	18.9	19.5	14.0	35.3	34.5	28.2	7.8	15.4	15.3	25.8	17.6	20.4	20.1	15.0	18.8	30.6	13.0	17.4	14.2	20.0	12.6	30.9	50.0	6.2	7.8	10.5	26.1	10.8	15.5	12.0	13.4	8.1	16.8	12.4	30.7	13.7	21.5	28.0	12.8	30.1	6.1	18.6	17.7	24.7	29.2	11.7	25.0	15.2	19.9	23.5	19.1	10.7	20.6	17.9	22.5	24.5	19.2	12.3	14.2	8.2	13.3	18.6	19.3	11.4	9.2	16.8	17.4	13.6	13.0	16.8	9.4	11.4	26.5	22.7	23.2	6.1	24.4	7.4	2.1	28.2	5.8	5.8	18.3	7.8	14.0	10.9	8.3	35.3	11.6	15.4	11.8	34.5	7.8	11.3	9.9	14.6	15.3	11.0	15.0	9.9	15.6	12.3	8.3	17.7	9.2	13.4	17.4	20.8	5.0	11.0	5.1	11.0	0.4	0.8	20.4	10.7	5.7	1.8	0.0	10.2	5.0	13.0	0.2	5.8	8.7	0.0	23.7	11.7	5.8	2.6	3.5	3.9	15.2	0.0	7.5	7.4	24.9	0.0	5.2	13.2	5.0	42.3	17.3	3.9	20.7	17.5	3.9	4.9	0.3	0.0	5.2	2.5	5.4	9.7	6.9	7.9	30.1	5.4
HCK	JTK9	ENSG00000101336	"HCK proto-oncogene, Src family tyrosine kinase"	P08631	20	32052188-32101856	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Exocytosis, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, Phagocytosis"	"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 107.1;lymphoid tissue: 72.6"	"Group enriched"	"Detected in many"	8	"Hofbauer cells: 131.2;Kupffer cells: 133.2;Macrophages: 170.5;monocytes: 221.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"classical monocyte: 50.8;eosinophil: 62.5;intermediate monocyte: 96.5;myeloid DC: 31.6;neutrophil: 73.0;non-classical monocyte: 107.1"	"Group enriched"	"Detected in many"	15	"dendritic cells: 31.6;granulocytes: 73.0;monocytes: 107.1"	"Group enriched"	"Detected in some"	8	"THP-1: 23.1;U-937: 66.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005195, HPA063768"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"CAB005195: AB_631619, HPA063768: AB_2685118"	"unprognostic (6.22e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.26e-2)"	"unprognostic (7.98e-2)"	"unprognostic (8.83e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (4.92e-2)"	"unprognostic (4.42e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.12e-1)"	12.3	5.8	5.9	40.8	13.1	20.8	4.0	1.8	5.3	3.0	5.8	6.1	0.9	5.9	2.5	5.7	3.1	5.9	6.5	8.8	6.0	3.7	4.0	7.9	20.9	50.3	11.2	1.2	3.4	2.8	0.7	2.9	8.8	8.0	3.8	5.9	3.1	4.1	1.9	3.1	2.8	7.8	10.2	9.1	72.6	3.7	2.6	8.2	5.8	3.3	1.2	16.4	9.4	3.5	4.7	31.6	73.0	107.1	1.1	0.1	40.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.7	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.0	23.1	0.0	0.0	0.1	0.0	0.0	0.7	0.1	3.4	0.0	66.3	0.0	0.5	50.8	62.5	0.1	96.5	0.1	4.7	0.1	0.1	31.6	3.7	0.1	0.0	73.0	1.1	107.1	2.8	0.1	40.2	5.9	13.1	1.8	5.3	6.0	3.7	11.2	1.2	8.0	8.2	6.0	21.8	10.3	3.5	2.7	0.0	1.7	2.5	2.7	6.8	7.0	0.0	0.8	1.7	0.0	0.2	1.4	0.0	0.0	0.5	0.7	1.3	0.0	5.8	0.8	131.2	0.0	1.7	1.8	133.2	0.0	0.0	170.5	1.7	221.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	1.0	1.4	0.5	0.0	4.6
HCLS1	"CTTNL, HS1"	ENSG00000180353	"Hematopoietic cell-specific Lyn substrate 1"	P14317	3	121631399-121660927	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 149.7;lymphoid tissue: 110.1"	"Cell type enhanced"	"Detected in many"	15	"Kupffer cells: 535.9;Macrophages: 194.3;monocytes: 183.1;T-cells: 152.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 43.1;HMC-1: 61.2;Karpas-707: 39.8;RPMI-8226: 40.9;THP-1: 42.7;U-266/70: 60.6;U-698: 60.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA019143	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		200000	"Plasma membrane, Cytosol"		"HPA019143: AB_1850532"	"unprognostic (2.27e-2)"	"unprognostic (1.79e-3)"	"unprognostic (5.38e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.02e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.93e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	24.7	10.7	7.8	44.9	14.7	35.5	9.1	1.3	7.4	6.3	10.4	8.5	2.2	5.5	5.6	8.2	4.8	9.1	10.1	7.5	6.7	5.0	10.5	10.1	18.7	59.4	12.9	3.2	4.6	5.1	1.4	6.1	15.4	10.9	6.1	8.6	4.9	7.4	3.1	7.0	4.6	23.0	8.9	15.1	110.1	7.1	3.6	11.6	41.0	6.1	4.4	61.5	12.5	5.6	33.4	59.6	149.7	84.9	24.3	44.1	103.5	0.1	0.0	0.0	0.0	3.6	2.0	0.9	0.6	0.6	0.1	0.2	0.0	0.0	43.1	21.0	0.0	0.0	0.0	1.1	1.6	0.1	19.2	0.0	27.9	0.0	0.0	2.0	30.6	61.2	0.3	0.0	0.0	0.3	0.0	25.4	17.6	5.5	39.8	0.0	0.0	21.7	25.9	0.0	0.0	0.7	22.0	0.0	40.9	0.0	11.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	42.7	33.1	0.0	0.3	0.0	0.1	60.6	18.4	60.6	0.3	29.5	0.0	26.6	64.1	104.2	40.2	80.6	32.9	33.4	33.3	36.8	59.6	29.4	28.5	33.0	149.7	24.3	84.9	18.5	44.1	103.5	7.8	14.7	1.3	7.4	6.7	5.0	12.9	3.2	10.9	11.6	8.9	51.2	119.0	0.8	2.9	0.4	1.7	7.6	18.7	12.5	0.0	0.0	96.0	0.0	0.3	0.8	14.6	0.1	23.3	0.2	50.7	6.0	0.3	70.6	2.1	117.6	0.0	0.0	33.2	535.9	0.9	3.1	194.3	18.6	183.1	0.3	0.6	0.3	0.0	1.1	0.6	0.7	12.9	6.6	0.3	0.6	3.9	121.6	152.2	0.2	1.8
HCST	"DAP10, DKFZP586C1522, KAP10, PIK3AP"	ENSG00000126264	"Hematopoietic cell signal transducer"	Q9UBK5	19	35902480-35904377	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 134.0;bone marrow: 84.0;lymphoid tissue: 79.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 237.5;Hofbauer cells: 491.9;Kupffer cells: 329.9;Macrophages: 424.4;T-cells: 835.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 52.9;HL-60: 30.5;HMC-1: 35.3;THP-1: 40.0;U-937: 60.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB034435, HPA063026"	Enhanced		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Golgi apparatus, Plasma membrane"	Vesicles	"CAB034435: AB_2117803, HPA063026: "	"unprognostic (1.40e-3)"	"unprognostic (3.07e-2)"	"unprognostic (3.04e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.23e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (6.70e-4)"	"unprognostic (5.97e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.59e-10)"	"unprognostic (3.78e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.56e-1)"	29.4	4.0	6.5	19.9	5.2	84.0	5.9	1.4	3.1	3.9	4.9	4.8	0.5	4.5	5.4	6.0	3.0	4.5	6.3	7.3	5.7	5.9	5.6	6.9	38.4	79.1	7.7	2.2	3.4	2.9	0.7	4.3	10.6	4.9	5.5	3.6	7.1	6.2	3.7	2.4	2.8	10.9	4.5	12.7	49.5	5.6	1.7	4.4	56.8	3.4	3.3	26.7	5.2	3.6	6.1	66.6	15.9	57.0	96.4	134.0	89.5	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.2	0.0	0.1	0.2	0.2	5.7	0.3	0.4	0.1	0.2	0.0	0.0	0.0	0.1	0.0	52.9	0.1	0.1	0.1	30.5	35.3	0.3	0.0	0.0	0.0	0.1	0.0	3.2	0.4	7.6	0.1	0.0	3.5	11.9	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.1	40.0	0.1	0.3	0.4	0.0	0.0	0.3	0.2	8.7	0.3	60.0	0.0	7.3	57.0	7.9	134.0	42.0	99.3	6.1	57.4	108.5	32.6	3.7	48.3	96.4	15.9	96.4	23.0	66.6	48.5	89.5	6.5	5.2	1.4	3.1	5.7	5.9	7.7	2.2	4.9	4.4	6.0	65.6	87.2	1.1	25.3	0.2	0.8	5.1	8.1	11.4	8.7	0.0	3.2	0.0	2.1	0.3	9.0	1.4	0.0	1.0	3.2	13.1	0.6	237.5	11.3	491.9	1.6	0.0	19.6	329.9	1.8	2.0	424.4	42.2	31.5	0.7	0.2	1.1	0.9	0.0	4.4	1.9	19.4	1.9	1.7	2.8	18.3	5.0	835.8	1.7	0.8
HFE	HLA-H	ENSG00000010704	Hemochromatosis	Q30201	6	26087281-26098343	"Disease related genes, Predicted membrane proteins"	"Ion transport, Iron transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Kupffer cells: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 26.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017276, HPA053470"	Approved		Supported	"Nucleoplasm,Plasma membrane"		No	No			"Plasma membrane"	Nucleoplasm	"HPA017276: AB_1850677, HPA053470: AB_2682163"	"unprognostic (6.96e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.07e-3)"	"unprognostic (7.58e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.17e-1)"	7.2	13.7	2.2	4.4	2.7	0.0	6.2	1.2	2.5	6.7	7.1	3.5	10.3	4.2	6.8	13.9	7.6	5.2	13.3	8.9	2.0	1.4	5.4	12.8	9.0	16.1	2.3	2.0	8.1	16.2	14.6	2.2	7.6	4.3	12.6	5.3	13.7	7.0	8.1	3.1	3.2	5.8	10.4	3.2	14.4	6.1	4.9	1.2	2.0	7.7	3.9	5.0	8.6	5.2	3.5	4.6	1.9	10.5	0.2	2.2	3.4	8.2	18.9	0.3	9.2	14.0	10.8	0.0	5.9	14.1	7.6	12.0	1.6	16.8	0.8	16.1	9.7	11.5	5.3	0.0	6.9	9.7	2.1	0.1	0.2	4.5	1.2	2.7	0.0	0.3	11.1	2.0	8.4	0.7	6.7	5.1	0.0	0.3	0.2	6.5	3.4	0.0	0.1	0.4	3.9	0.0	1.1	0.0	0.1	6.3	5.5	0.0	0.0	3.5	0.0	5.1	0.1	26.9	0.9	3.9	5.4	0.5	5.3	5.1	0.1	0.1	0.1	8.0	0.1	11.6	1.2	10.5	0.0	1.7	10.2	1.3	3.5	1.7	2.2	4.6	1.5	0.4	1.2	1.9	0.2	8.2	0.3	0.3	3.4	2.2	2.7	1.2	2.5	2.0	1.4	2.3	2.0	4.3	1.2	3.0	3.2	1.9	2.3	1.4	0.7	2.8	5.1	6.7	7.9	5.2	2.0	1.2	0.0	2.5	0.1	3.0	3.4	0.0	3.0	0.6	3.0	3.8	2.3	8.1	8.8	0.0	1.7	8.6	21.1	0.0	3.4	5.7	0.0	0.0	3.7	3.7	2.5	0.0	5.6	2.2	2.0	0.0	1.4	0.2	1.0	3.0	1.5	0.7	3.7	1.3
HINT1	"HINT, PKCI-1, PRKCNH1"	ENSG00000169567	"Histidine triad nucleotide binding protein 1"	P49773	5	131159027-131171735	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Hydrolase	"Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044577	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		3600000	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA044577: AB_10795618"	"unprognostic (2.00e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.30e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.49e-2)"	"unprognostic (6.50e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.39e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.68e-1)"	28.5	46.5	56.6	46.2	51.6	50.5	64.7	42.9	78.4	29.8	53.3	20.4	49.1	36.5	30.6	43.8	44.3	42.3	36.7	61.4	47.3	43.9	65.4	124.4	38.9	54.7	48.7	50.6	32.2	62.9	43.9	39.6	24.6	40.8	41.3	50.0	22.6	44.4	41.8	84.0	38.3	41.3	37.9	37.5	32.5	32.5	30.5	25.1	29.4	47.5	56.6	39.4	29.1	45.1	26.6	46.5	19.2	25.3	20.9	40.3	52.9	37.7	55.2	43.5	88.9	30.9	33.6	40.1	28.8	26.9	29.1	33.8	53.9	52.9	52.0	57.4	36.8	60.7	23.3	34.6	75.7	26.9	45.4	63.6	20.0	78.3	69.0	64.9	31.2	6.4	44.8	66.9	34.8	58.6	58.2	36.3	80.5	30.4	113.7	37.2	41.6	52.6	78.5	42.1	42.2	44.1	38.1	43.4	94.0	54.6	48.7	53.3	33.4	38.1	26.1	45.4	61.9	31.6	45.6	39.9	38.4	21.8	30.5	58.4	32.7	41.8	45.1	53.8	50.4	35.4	19.2	25.3	9.6	21.7	12.8	29.7	26.6	40.3	28.6	39.2	25.7	32.0	25.3	5.0	20.9	12.9	46.5	27.0	52.9	56.6	51.6	42.9	78.4	47.3	43.9	48.7	50.6	40.8	25.1	262.0	219.1	629.2	1214.3	1155.8	179.6	456.1	1044.6	465.7	406.0	678.7	43.2	639.6	1409.2	899.0	635.9	429.8	1359.9	186.9	676.8	1374.0	368.2	1313.3	104.1	1865.9	757.5	139.8	670.7	421.1	431.2	132.3	363.3	562.9	916.1	1617.7	889.8	207.2	821.7	984.4	393.5	2245.6	149.7	239.3	466.3	357.2	194.1	1001.8	382.0	568.5	1197.2	1396.9
HLA-A		ENSG00000206503	"Major histocompatibility complex, class I, A"	"P04439, P13746, P16188"	6	29941260-29945884	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"monocytes: 4504.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 158.0;fHDF/TERT166: 42.3;HBEC3-KT: 43.4;RPMI-8226: 41.2;U-266/70: 42.1"									CAB078470			Supported	"Golgi apparatus,Plasma membrane"		NA	NA			"Plasma membrane"	"Golgi apparatus"	"CAB078470: AB_10985125"	"unprognostic (1.56e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.34e-2)"	"prognostic favorable (9.59e-4)"	"unprognostic (3.49e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.42e-2)"	"prognostic favorable (6.47e-4)"	"unprognostic (2.96e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.54e-2)"	69.4	57.5	16.0	69.1	18.2	41.2	40.8	9.1	20.7	54.4	92.6	20.4	28.6	105.7	38.4	76.2	48.4	27.8	92.3	59.1	14.6	16.6	80.5	47.6	112.0	90.5	19.5	8.9	57.2	30.0	22.5	33.3	38.7	22.7	64.1	38.5	52.4	28.3	19.2	44.0	110.4	129.4	30.3	22.8	150.0	115.9	26.6	12.3	71.1	62.3	38.5	97.7	86.4	41.0	23.0	10.9	65.8	25.2	25.9	46.7	45.4	158.0	4.0	0.0	0.0	25.5	24.1	0.1	0.1	0.3	0.2	0.3	0.0	0.0	0.4	0.0	42.3	21.5	3.9	0.0	43.4	0.0	0.3	1.6	27.6	1.2	0.8	1.4	0.0	1.8	0.2	0.0	0.3	0.1	0.0	0.0	21.2	0.0	0.1	0.0	0.0	0.1	2.5	0.3	0.0	0.4	3.3	0.3	41.2	29.6	32.5	0.0	1.4	3.5	0.0	1.4	10.4	0.2	3.7	0.6	2.4	0.1	0.7	0.5	42.1	10.7	8.9	0.0	23.3	0.0	65.8	25.2	35.4	38.3	17.9	28.8	23.0	29.6	34.4	4.1	14.9	21.7	29.7	47.9	25.9	19.8	10.9	46.7	45.4	16.0	18.2	9.1	20.7	14.6	16.6	19.5	8.9	22.7	12.3	345.4	508.3	1064.2	718.5	760.7	31.3	128.4	937.6	317.2	366.3	478.1	5.9	16.7	74.6	2692.4	38.8	1227.5	2851.3	186.9	1168.0	15.8	685.4	823.3	585.8	217.5	1814.8	35.0	917.5	1170.5	1323.9	66.9	652.4	1239.0	602.3	4504.1	1496.2	150.9	1505.1	2283.0	455.0	258.2	20.0	549.7	859.0	132.4	24.5	828.4	26.5	2218.3	1070.6	1059.3
HMGCS1	HMGCS	ENSG00000112972	"3-hydroxy-3-methylglutaryl-CoA synthase 1"	Q01581	5	43289395-43313512	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 117.0"	"Cell type enhanced"	"Detected in many"	5	"Suprabasal keratinocytes: 206.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 120.5;GAMG: 80.3;HBEC3-KT: 69.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032907, HPA036913, HPA036914"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		310000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB032907: AB_2118319, HPA036913: AB_2675380, HPA036914: AB_10671751"	"unprognostic (1.31e-1)"	"unprognostic (5.12e-3)"	"unprognostic (6.82e-3)"	"unprognostic (4.59e-2)"	"unprognostic (8.39e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.40e-3)"	"unprognostic (9.15e-2)"	"prognostic favorable (3.87e-6)"	"unprognostic (1.09e-1)"	"unprognostic (9.22e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.37e-2)"	6.0	16.5	13.3	8.1	24.4	4.3	12.8	8.4	38.2	16.9	15.5	16.9	9.5	27.8	6.8	11.5	53.0	4.1	7.5	5.1	19.4	18.8	10.5	117.0	26.9	6.2	10.4	20.7	15.4	8.4	10.8	5.0	6.9	59.3	12.9	14.2	13.0	18.5	7.7	5.0	25.2	17.1	6.3	25.8	4.4	13.4	9.8	8.1	3.3	7.5	58.1	23.3	6.1	21.4	9.3	7.8	6.9	7.7	6.7	7.9	3.3	14.9	7.2	120.5	13.8	7.0	27.9	8.1	2.4	9.5	3.4	6.9	12.5	21.6	15.9	5.4	3.4	80.3	11.8	30.0	69.5	3.6	3.4	36.0	5.9	6.6	16.9	11.1	12.8	4.2	15.3	8.4	18.1	7.2	2.1	3.5	14.8	10.5	43.5	2.8	6.9	11.5	15.6	21.6	6.0	3.8	8.3	16.9	17.6	53.4	23.2	10.3	5.0	12.3	6.2	3.6	18.2	9.6	17.0	4.2	2.6	13.0	2.7	2.2	5.9	8.9	21.7	2.3	15.4	2.3	5.5	4.0	3.7	5.6	7.4	5.6	9.3	6.2	7.9	7.8	7.5	5.3	7.3	6.9	6.7	7.7	6.5	5.7	3.3	13.3	24.4	8.4	32.1	19.4	18.8	10.4	20.7	59.3	8.1	62.5	124.5	45.6	35.9	96.3	27.9	7.4	56.0	48.2	36.4	45.4	49.1	20.4	11.6	30.6	5.0	19.7	86.8	0.0	52.0	35.5	35.0	65.2	59.8	78.4	20.7	46.1	88.4	23.4	20.8	1.8	11.8	17.2	25.3	78.5	44.0	19.7	36.3	30.9	13.4	17.7	43.3	0.0	24.9	14.1	7.8	206.6	37.2	20.1	31.2	65.0
HOMER3	HOMER-3	ENSG00000051128	"Homer scaffolding protein 3"	Q9NSC5	19	18929201-18941261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 64.8"	"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 64.5;Muller glia cells: 59.6;Proximal tubular cells: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 14.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 5.1;monocytes: 14.7"	"Cell line enhanced"	"Detected in many"		"NB-4: 62.2;THP-1: 74.8;U-266/84: 64.3"	"Region enriched"	"Detected in many"	6	"cerebellum: 212.2"	"Low region specificity"	"Detected in all"			"CAB032656, HPA040999, CAB079015"	Enhanced	Supported	Supported	"Plasma membrane,Cytosol,Cytoplasmic bodies"		NA	NA			Cytosol	"Plasma membrane, Cytoplasmic bodies"	"CAB032656: AB_2120801, CAB079015: , HPA040999: AB_2677242"	"unprognostic (3.41e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (4.24e-5)"	"unprognostic (1.19e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (4.93e-5)"	"unprognostic (1.07e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.11e-2)"	11.4	8.3	11.1	6.5	16.0	12.4	31.0	42.3	12.2	8.7	6.7	17.6	2.1	4.9	8.2	5.2	7.6	4.8	10.9	11.9	15.8	9.0	21.2	4.1	7.0	5.5	19.4	7.2	8.2	5.3	13.6	2.4	9.7	15.5	8.1	4.5	15.4	8.4	7.0	49.2	10.9	5.5	7.6	24.2	64.8	6.5	3.4	14.6	2.2	19.6	7.8	3.3	12.3	16.8	2.4	1.2	5.1	14.7	0.0	0.7	3.6	19.6	5.1	9.7	8.1	9.1	9.2	4.8	19.5	17.3	19.6	9.9	2.6	7.6	0.1	9.2	21.9	14.1	12.3	3.3	25.3	11.0	0.7	2.0	0.0	1.6	4.8	8.5	3.7	0.3	7.4	16.4	10.9	14.7	21.0	23.8	1.4	0.5	5.2	14.2	5.3	0.3	62.2	5.0	1.0	21.1	9.7	2.9	9.2	7.1	5.0	0.0	8.3	4.8	5.7	13.8	1.9	2.5	74.8	18.9	17.5	7.8	21.0	23.4	50.7	64.3	16.3	27.6	48.1	12.7	0.1	14.7	2.6	0.1	5.1	0.0	2.4	0.7	0.3	1.2	1.7	0.1	0.0	5.1	0.0	1.4	0.2	0.7	3.6	11.1	16.0	42.3	12.2	15.8	9.0	19.4	7.2	15.5	14.6	3.0	0.0	2.4	17.6	10.5	1.9	3.4	2.5	0.0	2.3	12.2	0.0	0.6	10.0	17.4	1.3	13.1	0.0	0.0	11.6	1.4	13.0	10.5	10.3	0.8	64.5	1.6	1.7	20.9	18.2	1.7	12.7	16.1	11.8	1.0	0.9	59.6	32.9	0.0	10.3	70.5	4.1	0.0	6.1	1.0	5.1	12.7	0.9	0.5	0.1	19.7
HRH1		ENSG00000196639	"Histamine receptor H1"	P35367	3	11137093-11263557	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 41.0;Club cells: 30.7;Enterocytes: 29.3;Suprabasal keratinocytes: 36.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.5"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.2;T-cells: 3.5"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 17.5;hTEC/SVTERT24-B: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029740	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA029740: AB_10601578"	"unprognostic (4.60e-3)"	"unprognostic (3.41e-2)"	"unprognostic (6.37e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.60e-3)"	"unprognostic (4.00e-3)"	"unprognostic (7.54e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (1.27e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.13e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.20e-1)"	9.1	4.4	7.3	4.6	4.4	0.2	9.6	0.5	10.6	8.0	13.5	1.3	2.4	3.8	6.2	7.2	5.7	10.6	9.9	7.0	5.1	4.0	3.3	1.1	8.2	1.8	2.2	2.1	8.7	2.1	1.7	1.2	5.5	3.2	7.2	7.2	2.0	3.4	6.1	3.0	8.0	10.5	9.2	8.6	1.4	3.3	2.4	2.0	0.1	2.5	7.2	3.1	11.2	16.2	0.1	0.3	1.2	0.2	0.1	3.5	0.1	1.5	3.5	0.0	0.0	1.6	17.5	2.4	2.6	8.8	7.8	5.3	0.6	12.6	0.0	7.8	6.1	8.0	9.9	0.0	3.6	10.7	5.5	0.0	0.8	5.7	0.0	5.3	2.4	1.4	6.1	2.2	17.7	6.2	10.9	10.9	0.1	0.0	0.0	3.5	0.0	0.0	1.1	0.0	1.5	3.2	0.2	0.9	0.3	14.0	2.0	0.1	0.0	3.7	2.7	0.0	0.1	0.0	2.0	16.2	8.8	5.5	9.0	13.1	0.0	0.9	0.0	13.5	2.2	7.6	0.4	0.2	0.0	0.1	0.2	0.0	0.0	1.3	0.5	0.3	0.1	0.1	0.1	1.2	0.1	0.0	0.1	3.5	0.1	7.3	4.4	0.5	8.4	5.1	4.0	2.2	2.1	3.2	2.0	6.0	1.4	0.0	7.7	41.0	0.0	0.4	0.0	2.7	30.7	1.8	0.0	0.2	0.0	0.4	0.3	9.3	29.3	0.0	0.6	1.0	6.7	3.9	2.3	0.0	21.0	0.0	3.4	0.6	6.9	0.0	3.4	5.7	0.0	0.0	8.0	0.0	8.3	11.4	0.0	0.3	0.1	0.0	2.3	2.3	2.8	36.3	0.5	0.0	8.8	18.2
HTR1B	"5-HT1B, 5-HT1DB, HTR1D2, S12"	ENSG00000135312	"5-hydroxytryptamine receptor 1B"	P28222	6	77461753-77463773	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 11.8;placenta: 14.2;stomach 1: 10.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"basal ganglia: 11.8"	"Cell type enriched"	"Detected in single"	17	"basophil: 1.6"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 1.6"	"Group enriched"	"Detected in some"	15	"HUVEC TERT2: 41.8;TIME: 18.4"	"Region enriched"	"Detected in many"	4	"basal ganglia: 34.5"					HPA028808	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA028808: AB_2672782"	"unprognostic (3.86e-2)"	"unprognostic (3.56e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.96e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-1)"	2.2	1.5	1.3	1.1	11.8	0.3	2.4	0.4	3.7	2.9	0.6	0.1	0.0	0.6	1.1	1.0	1.4	0.8	2.8	0.4	1.0	2.1	0.9	0.3	1.1	0.3	1.2	0.9	1.1	0.5	0.3	0.5	14.2	3.0	1.6	0.4	0.3	1.3	1.2	0.9	0.5	0.4	4.1	0.6	0.4	10.2	1.5	0.6	0.0	0.5	0.0	0.3	2.6	1.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.9	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.4	1.1	0.8	41.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	11.8	0.4	3.7	1.0	2.1	1.2	0.9	3.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTR7	5-HT7	ENSG00000148680	"5-hydroxytryptamine receptor 7"	P34969	10	90740823-90857698	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, RAS pathway related proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"parathyroid gland: 30.8;testis: 14.3"	"Cell type enhanced"	"Detected in some"	17	"Early spermatids: 4.8;Hofbauer cells: 1.3;Kupffer cells: 1.5;Late spermatids: 2.0;Spermatocytes: 1.4"	"Group enriched"	"Detected in some"	5	"cervical cancer: 0.9;head and neck cancer: 3.3;lung cancer: 0.9;urothelial cancer: 1.3"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"myeloid DC: 4.6"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 4.6"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 8.2;hTCEpi: 7.5;hTERT-HME1: 25.0;LHCN-M2: 10.0;U-87 MG: 7.7;WM-115: 9.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB022708, HPA073617"	Approved	Supported	Supported	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nuclear speckles, Cytosol"	"CAB022708: , HPA073617: AB_2732228"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.51e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.58e-3)"	"unprognostic (3.32e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.84e-2)"	"unprognostic (6.49e-2)"	1.0	0.5	2.4	1.1	2.5	0.5	0.7	0.3	4.3	0.6	0.8	1.7	1.2	0.8	0.4	0.3	1.0	0.4	1.3	0.6	9.9	5.1	0.3	0.6	0.5	0.7	1.7	1.8	0.4	1.4	30.8	0.2	0.5	3.1	1.0	1.2	0.4	0.6	0.3	1.7	0.9	2.2	3.6	1.5	1.3	1.5	14.3	1.0	0.0	0.3	0.1	0.6	3.5	2.1	0.0	4.6	0.0	0.3	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.5	0.2	0.5	0.8	0.0	0.9	0.0	0.0	0.1	1.5	3.4	0.9	8.2	2.1	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.4	5.9	7.5	2.5	25.0	4.7	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.1	0.9	0.0	1.2	0.7	0.1	0.0	0.0	0.9	0.3	0.0	0.3	0.0	3.9	0.4	0.0	0.2	0.2	4.6	0.0	0.0	6.9	0.0	0.0	0.0	7.7	0.0	9.5	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.1	4.6	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.1	0.1	2.4	2.5	0.3	4.3	9.9	5.1	1.7	1.8	3.1	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.6	1.5	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.0	0.1	0.1	0.0	0.0	0.2
HTRA1	"ARMD7, HtrA, IGFBP5-protease, PRSS11"	ENSG00000166033	"HtrA serine peptidase 1"	Q92743	10	122461525-122514908	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding, Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Horizontal cells: 591.1;Muller glia cells: 269.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4;memory CD4 T-cell: 1.6"	"Group enriched"	"Detected in many"	20	"monocytes: 2.4;T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 203.0;ASC TERT1: 75.4;fHDF/TERT166: 68.7;HSkMC: 132.4;LHCN-M2: 100.6;U-87 MG: 83.1"	"Low region specificity"	"Detected in all"							HPA036655	Approved		Supported	"Plasma membrane"	"Secreted to blood"	NA	NA	24800000	2600000	"Plasma membrane"		"HPA036655: AB_10671966"	"unprognostic (3.84e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.22e-3)"	"unprognostic (8.71e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.83e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (7.90e-7)"	"unprognostic (7.12e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (5.62e-6)"	40.8	21.8	64.5	9.1	79.0	0.5	48.2	16.2	62.8	50.4	19.3	60.8	7.2	5.6	47.6	67.0	15.6	19.5	78.7	28.7	50.8	35.4	34.7	60.4	14.6	9.1	62.7	32.5	111.3	14.5	37.6	26.9	114.1	41.9	19.5	14.0	20.7	19.3	31.5	7.5	29.6	9.3	40.5	46.5	10.5	12.9	9.8	49.5	1.7	13.3	8.5	7.1	41.5	27.3	0.0	0.0	0.0	2.4	0.0	1.6	0.7	0.0	3.5	1.6	0.4	203.0	75.4	0.0	8.7	15.9	3.6	1.9	0.0	0.0	0.0	2.4	68.7	5.6	1.0	0.6	9.9	0.5	0.0	0.4	0.0	5.8	0.0	10.3	0.0	0.0	132.4	36.4	2.1	17.0	41.7	16.7	0.0	0.0	0.1	100.6	1.7	0.0	0.0	1.7	0.0	5.5	0.0	0.1	0.0	23.0	0.1	0.1	0.3	21.9	0.0	9.4	7.8	0.7	0.0	10.9	25.6	0.3	11.5	7.4	0.0	0.0	0.0	83.1	0.0	12.0	0.0	2.4	0.0	0.6	0.0	0.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	64.5	79.0	16.2	54.6	50.8	35.4	62.7	32.5	41.9	49.5	20.8	8.6	0.0	31.0	39.2	55.4	23.4	10.2	14.7	0.0	61.1	51.1	15.8	0.0	2.1	2.5	64.7	0.0	0.0	3.9	127.5	77.4	8.5	1.1	85.6	53.0	591.1	0.0	54.6	17.2	3.1	29.4	7.2	43.9	12.6	0.1	269.0	4.2	0.2	72.9	18.8	110.5	6.5	59.8	0.1	0.2	26.7	73.3	4.5	0.2	12.7
IFIT5	RI58	ENSG00000152778	"Interferon induced protein with tetratricopeptide repeats 5"	Q13325	10	89414586-89421001	"Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 30.6;BJ hTERT+ SV40 Large T+ RasG12V: 36.6"					"Low region specificity"	"Detected in all"			"HPA037957, HPA062180"	Uncertain		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA037957: AB_10672499, HPA062180: AB_2684705"	"unprognostic (2.17e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-3)"	"unprognostic (4.19e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.73e-1)"	26.6	14.5	15.6	9.7	14.8	11.5	13.1	16.1	15.2	11.9	10.0	11.4	5.5	8.9	11.7	10.9	12.4	10.9	11.9	13.4	15.6	18.1	13.0	14.2	16.8	11.9	17.6	12.3	16.1	8.8	30.2	12.1	13.1	20.6	12.5	8.9	8.4	11.0	10.3	6.6	5.8	11.7	12.8	16.7	20.1	8.8	7.0	15.4	11.1	15.3	5.5	10.1	13.7	14.0	9.1	5.5	21.2	10.4	3.6	8.0	5.0	9.9	2.7	4.1	14.7	13.5	13.3	0.5	7.2	17.3	30.6	36.6	0.1	4.9	0.4	3.0	10.3	11.3	8.3	5.6	5.5	7.9	4.6	3.2	1.1	2.2	1.6	15.1	0.1	0.9	11.5	2.4	7.0	6.1	8.5	1.6	2.6	0.0	7.8	9.8	1.9	2.8	1.4	0.6	0.0	4.8	2.7	5.2	0.9	8.5	1.2	0.5	3.2	3.8	1.8	16.3	1.4	1.5	1.0	4.0	3.9	2.8	6.6	5.2	1.0	0.1	0.0	6.6	0.9	3.3	8.1	6.3	8.2	6.2	10.0	7.6	9.1	6.9	6.0	5.5	7.4	8.0	6.6	21.2	3.6	10.4	0.4	6.3	5.0	15.6	14.8	16.1	14.0	15.6	18.1	17.6	12.3	20.6	15.4	6.0	15.0	8.5	27.4	7.6	6.9	7.2	15.3	2.7	10.3	8.7	0.0	3.9	10.0	10.9	0.1	21.8	5.1	0.0	7.9	7.3	12.7	19.0	15.0	11.3	9.6	33.4	4.7	7.4	7.6	0.0	19.5	7.0	6.8	7.2	5.0	12.6	10.3	2.9	16.3	13.0	4.5	19.4	14.0	8.8	8.3	3.3	3.8	6.9	2.1	27.1
IFNGR1	"CD119, IFNGR"	ENSG00000027697	"Interferon gamma receptor 1"	P15260	6	137197484-137219449	"CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 258.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 57.1"					"Low region specificity"	"Detected in all"			"CAB025889, HPA029213, HPA063871"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB025889: , HPA029213: AB_10601023, HPA063871: AB_2685138"	"unprognostic (1.73e-1)"	"unprognostic (8.86e-2)"	"unprognostic (9.85e-3)"	"unprognostic (1.71e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.05e-1)"	"unprognostic (6.97e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.38e-3)"	69.5	22.2	17.4	36.9	23.5	37.7	65.3	8.4	18.5	23.6	27.1	27.8	13.8	28.0	19.2	21.2	23.0	20.3	25.9	53.7	20.6	17.4	19.3	66.4	58.7	86.9	33.8	13.2	19.2	17.5	9.2	12.8	47.0	29.9	20.1	22.8	11.6	24.5	18.0	25.3	24.0	46.7	22.5	45.7	69.1	20.3	14.1	26.3	14.5	22.8	19.7	38.2	25.0	22.3	12.2	39.4	92.3	65.4	5.4	29.7	52.3	4.8	4.7	6.2	8.0	40.8	21.5	5.2	13.9	20.7	9.1	12.3	30.5	9.5	4.8	22.3	8.0	13.2	30.3	5.4	14.1	12.7	10.4	7.5	7.6	5.8	45.1	23.1	23.7	11.4	47.5	57.1	7.6	12.3	8.4	11.4	7.0	6.4	8.3	6.8	5.5	3.8	10.9	5.1	44.4	3.8	11.7	6.5	7.3	15.8	23.0	6.2	9.6	17.2	10.1	12.6	12.3	3.6	15.7	15.8	8.9	6.5	11.5	7.3	6.1	5.7	5.4	4.6	15.8	8.6	16.5	65.4	43.3	14.1	63.0	29.7	10.9	8.0	11.8	39.4	12.2	5.2	5.8	92.3	5.4	44.1	10.1	5.6	52.3	17.4	23.5	8.4	18.5	20.6	17.4	33.8	13.2	29.9	26.3	74.5	64.2	57.6	146.1	113.3	14.2	38.0	33.1	83.0	77.3	26.2	11.8	63.2	6.6	61.6	3.2	106.4	70.3	0.0	88.3	59.0	70.9	89.3	61.2	50.3	132.8	9.5	12.6	63.8	258.9	4.3	40.9	249.4	47.2	88.4	19.2	19.7	74.0	28.1	46.3	15.1	20.6	12.9	65.2	8.4	20.4	99.0	175.5	67.8	27.9	144.7
IKZF5	"FLJ22973, Pegasus, ZNFN1A5"	ENSG00000095574	"IKAROS family zinc finger 5"	Q9H5V7	10	122990806-123008817	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015297, HPA051574"			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA015297: AB_1855183, HPA051574: AB_2681538"	"unprognostic (2.42e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.68e-1)"	"unprognostic (9.14e-3)"	"unprognostic (5.43e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.98e-3)"	"unprognostic (4.17e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.15e-2)"	11.7	11.7	20.3	9.2	23.5	38.0	16.6	24.9	20.5	12.0	9.2	22.1	7.5	8.8	12.5	13.6	9.4	9.9	8.4	9.4	18.0	14.5	11.8	14.7	10.6	13.4	28.9	13.5	19.3	14.8	14.2	22.9	10.7	21.2	11.6	9.8	11.2	10.6	8.8	12.3	13.7	10.8	9.8	21.8	11.6	9.9	13.4	26.8	14.7	13.6	7.0	12.4	9.4	11.1	7.6	6.7	8.2	8.0	9.7	13.4	6.7	6.0	3.0	6.1	10.3	9.8	9.0	6.7	5.1	10.9	6.8	8.3	4.8	7.1	15.2	3.8	6.2	3.7	8.3	10.7	7.6	10.0	8.4	9.5	9.7	5.0	7.2	6.5	11.7	8.8	7.1	10.5	8.1	17.6	9.4	7.4	10.1	13.3	10.2	7.3	4.4	10.6	12.9	5.6	4.5	4.2	8.7	7.6	8.6	5.6	4.2	6.6	5.9	4.2	5.2	9.8	5.1	4.3	7.5	7.5	4.9	4.1	7.1	8.1	9.5	5.1	14.3	6.3	20.6	2.9	7.5	6.3	8.2	9.4	8.0	10.9	6.2	8.6	9.0	6.7	7.6	11.9	13.4	6.1	9.7	7.7	4.7	10.9	6.7	20.3	23.5	24.9	20.5	18.0	14.5	28.9	13.5	21.2	26.8	11.9	12.5	11.4	9.2	28.6	11.6	12.9	7.6	14.7	14.8	5.2	13.7	5.2	8.3	4.5	3.4	10.1	6.6	0.0	4.5	5.0	9.9	14.8	16.2	13.2	5.6	11.1	17.2	6.7	9.7	2.0	12.4	9.8	15.1	4.6	8.4	7.7	3.6	6.5	9.9	8.9	14.1	12.9	11.3	24.0	22.1	28.2	12.0	15.8	6.0	7.6
IL10RA	"CD210, CD210a, CDW210A, HIL-10R, IL10R"	ENSG00000110324	"Interleukin 10 receptor subunit alpha"	Q13651	11	117986348-118003037	"CD markers, Disease related genes, Predicted membrane proteins"		Receptor	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 56.2"	"Cell type enhanced"	"Detected in many"	11	"Extravillous trophoblasts: 88.9;Kupffer cells: 162.4;Macrophages: 88.5;monocytes: 146.1;T-cells: 102.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 14.9;HDLM-2: 37.1;Karpas-707: 13.9;RPMI-8226: 16.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065647, HPA069086"			Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA065647: , HPA069086: "	"unprognostic (1.01e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.58e-2)"	"unprognostic (7.08e-2)"	"unprognostic (8.27e-2)"	"prognostic favorable (4.47e-4)"	"unprognostic (5.27e-2)"	"unprognostic (4.84e-2)"	"unprognostic (7.70e-3)"	"unprognostic (5.94e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.83e-1)"	"prognostic unfavorable (1.45e-5)"	"unprognostic (1.82e-1)"	"unprognostic (8.43e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.27e-1)"	11.3	6.5	2.9	29.6	3.5	27.2	7.2	1.1	3.0	3.4	7.9	4.7	0.5	3.8	5.5	11.0	4.3	4.9	9.7	7.6	3.0	3.6	5.0	6.4	13.6	49.8	4.7	1.4	3.4	3.6	1.3	3.4	6.9	4.5	5.8	7.5	6.4	7.9	1.9	2.6	3.0	17.6	5.0	8.0	56.2	4.9	3.1	3.5	9.6	3.6	3.9	32.2	9.5	3.4	4.6	15.4	1.2	23.9	23.7	30.7	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.1	0.0	0.3	0.0	0.2	0.0	0.0	37.1	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.7	13.9	0.0	0.0	0.2	2.9	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	2.9	0.4	3.9	0.0	5.6	0.0	1.1	15.8	0.8	19.7	23.9	14.2	4.6	19.0	22.7	15.4	2.3	6.9	12.3	1.2	23.7	18.8	6.0	30.7	22.8	2.9	3.5	1.1	3.0	3.0	3.6	4.7	1.4	4.5	3.5	6.0	26.0	27.4	0.5	5.0	0.0	2.0	0.0	2.7	2.3	0.0	0.0	1.2	0.0	0.1	0.0	1.2	0.0	0.0	0.7	88.9	2.8	0.0	11.6	0.5	54.1	0.0	0.0	4.3	162.4	0.0	0.3	88.5	16.9	146.1	0.0	0.5	0.1	0.0	0.0	0.6	0.0	0.0	1.0	0.1	0.2	3.6	2.7	102.0	0.0	0.4
IL17RB	"CRL4, EVI27, IL17BR, IL17RH1"	ENSG00000056736	"Interleukin 17 receptor B"	Q9NRM6	3	53846580-53865800	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 63.0;liver: 26.6"	"Group enriched"	"Detected in many"	4	"Intestinal endocrine cells: 28.0;Proximal tubular cells: 57.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 11.1;Hep G2: 32.2;OE19: 25.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002837, HPA005482"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitotic spindle,Centriolar satellite"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Plasma membrane"	"Mitotic spindle, Centriolar satellite"	"HPA002837: , HPA005482: AB_1234567"	"unprognostic (1.85e-3)"	"unprognostic (4.22e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.20e-3)"	"unprognostic (1.62e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.41e-2)"	"unprognostic (4.75e-2)"	"unprognostic (4.27e-2)"	"prognostic favorable (6.61e-4)"	"unprognostic (8.10e-2)"	"unprognostic (6.97e-2)"	"unprognostic (5.29e-1)"	"unprognostic (7.15e-3)"	1.1	2.1	13.4	2.2	12.2	0.9	9.2	15.1	14.7	17.1	5.8	6.8	0.0	5.1	5.0	1.3	1.9	3.2	2.4	2.5	17.1	7.4	63.0	26.6	3.5	2.3	11.9	6.4	1.8	5.3	1.4	3.9	1.2	11.2	2.5	6.1	1.9	4.1	1.0	1.4	2.3	5.1	1.2	11.3	1.4	3.4	2.5	15.2	0.0	2.9	0.0	1.0	1.7	1.0	0.9	1.1	4.1	0.6	0.5	3.1	0.5	0.8	1.7	2.5	1.9	0.0	0.0	4.0	1.7	0.0	0.0	0.0	11.1	0.8	2.5	0.6	0.5	0.9	0.4	6.8	0.0	0.0	0.9	1.9	3.3	3.4	32.2	0.0	3.0	1.8	0.0	0.0	0.0	0.0	2.2	0.0	0.9	2.6	1.2	0.0	2.2	0.5	1.2	6.8	25.2	1.4	0.9	1.0	2.9	0.7	2.9	3.6	2.1	5.6	1.3	1.0	1.9	5.2	1.1	1.3	1.7	1.9	1.5	2.1	2.6	2.9	1.6	1.5	1.8	0.9	4.1	0.6	0.2	1.0	0.6	0.6	0.5	2.1	0.6	0.2	0.9	0.8	0.9	0.3	0.5	0.2	1.1	3.1	0.5	13.4	12.2	15.1	14.7	17.1	7.4	11.9	6.4	11.2	15.2	0.0	2.6	0.0	2.0	0.2	0.0	3.4	10.2	0.0	2.3	0.0	0.0	0.3	8.3	3.7	0.8	0.0	1.3	0.0	1.3	0.9	0.2	6.7	2.3	8.9	0.1	0.0	28.0	0.6	0.0	0.0	1.1	0.8	0.0	0.0	4.3	4.5	2.7	2.0	0.4	57.9	0.0	0.0	0.6	0.4	1.3	0.1	0.3	0.0	6.6	0.5
IL1RL1	"DER4, FIT-1, IL33R, ST2, ST2L, ST2V, T1"	ENSG00000115602	"Interleukin 1 receptor like 1"	Q01638	2	102311502-102352037	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 49.7;lung: 77.2;placenta: 95.0"	"Cell type enriched"	"Detected in many"	11	"granulocytes: 477.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 11.4;cerebral cortex: 6.6;hippocampal formation: 5.6;midbrain: 3.8;pons and medulla: 14.6"	"Group enriched"	"Detected in some"	59	"basophil: 17.1;eosinophil: 17.0"	"Lineage enriched"	"Detected in single"	59	"granulocytes: 17.1"	"Group enriched"	"Detected in some"	6	"HHSteC: 55.4;HMC-1: 82.4;HUVEC TERT2: 40.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA007406, HPA007917"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"	"Secreted to blood"	NA	NA	19100000	1700000	"Plasma membrane"	"Focal adhesion sites, Cytosol"	"HPA007406: AB_1079128, HPA007917: AB_1079129"	"unprognostic (7.25e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.28e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.25e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.50e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.60e-3)"	10.7	7.5	1.4	2.0	11.4	0.9	6.9	0.5	6.6	2.6	3.1	0.1	0.1	1.3	1.7	0.9	2.7	0.8	7.8	16.6	5.6	1.8	49.7	6.2	77.2	1.4	3.8	0.0	0.7	2.8	0.8	1.8	95.0	14.6	1.9	2.3	1.0	0.7	5.7	2.8	1.1	2.0	3.3	5.0	1.0	6.7	0.8	0.3	0.0	5.6	0.7	0.9	6.0	2.6	0.0	0.0	17.1	0.0	0.2	0.2	0.0	0.2	0.0	0.1	0.0	3.4	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	1.3	0.1	0.0	0.0	9.7	0.1	0.1	55.4	0.4	82.4	1.1	0.3	1.3	8.9	0.1	40.2	0.0	0.2	0.1	0.1	0.0	0.1	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.1	0.7	0.1	0.0	0.0	0.0	0.1	0.1	0.1	17.1	0.0	17.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	11.4	0.5	6.6	5.6	1.8	3.8	0.0	14.6	0.3	8.9	22.8	0.0	15.1	7.6	0.0	1.8	0.0	12.0	13.6	1.8	0.0	0.0	0.0	0.0	0.2	29.2	0.0	0.0	0.4	0.1	4.2	8.9	477.2	0.0	0.0	0.0	0.0	44.2	0.3	0.9	0.9	11.2	3.3	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.2	38.8	5.2	0.0	0.0	4.4	0.0	4.3	0.0	11.1
IL4R	CD124	ENSG00000077238	"Interleukin 4 receptor"	P24394	16	27313668-27364778	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"granulocytes: 107.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 34.4"	"Group enriched"	"Detected in all"	6	"B-cells: 34.4;granulocytes: 11.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 36.5;HBEC3-KT: 35.1;U-698: 34.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004451, HPA050124, HPA070380"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Centriolar satellite"	"Secreted to blood"	NA	NA		49000	"Nucleoplasm, Plasma membrane"	"Centriolar satellite"	"CAB004451: AB_626889, HPA050124: AB_2681026, HPA070380: "	"unprognostic (6.80e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (6.43e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (1.49e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.58e-2)"	20.7	14.8	8.7	31.6	10.6	36.9	12.0	4.4	7.7	20.8	30.3	5.9	11.5	10.9	18.0	12.8	24.7	13.6	25.1	12.3	6.7	4.4	13.3	39.1	40.9	44.8	10.8	1.7	14.7	11.3	3.8	5.5	16.1	10.1	18.8	15.1	12.3	7.7	11.5	7.2	9.9	18.6	39.6	13.6	31.8	21.1	10.4	9.8	9.1	8.6	13.7	38.4	31.6	15.4	34.4	1.6	11.9	2.6	3.3	4.0	1.8	11.5	3.0	2.0	3.9	1.0	4.6	4.2	7.3	8.5	2.9	2.4	6.2	32.0	36.5	9.1	11.5	5.7	12.3	2.1	35.1	2.5	31.6	1.0	6.8	1.8	9.5	13.2	1.8	19.4	7.0	14.2	13.5	8.0	15.5	15.7	2.1	2.9	3.1	4.7	5.1	0.1	5.5	2.4	10.4	2.7	0.1	15.2	2.9	13.6	13.2	0.6	0.3	1.0	7.0	1.6	5.3	2.7	7.0	23.5	6.7	3.0	5.9	5.1	1.8	0.5	34.0	0.7	6.1	0.0	0.5	2.6	4.7	1.7	1.1	1.3	7.7	2.6	1.7	1.6	34.4	4.0	1.9	11.9	3.3	0.6	1.6	1.8	1.8	8.7	10.6	4.4	7.7	6.7	4.4	10.8	1.7	10.1	9.8	26.8	51.7	49.6	35.5	11.7	0.0	2.2	20.4	17.4	30.7	1.8	0.0	15.0	0.0	31.7	0.1	31.5	27.6	0.0	28.2	3.5	13.9	27.2	107.5	47.4	22.9	0.0	22.4	54.6	31.1	0.2	0.3	21.3	13.5	40.5	32.8	0.0	35.6	22.1	0.0	1.1	0.0	38.8	27.4	0.5	1.9	13.0	20.8	20.3	15.0	38.2
IL6ST	"CD130, GP130"	ENSG00000134352	"Interleukin 6 signal transducer"	P40189	5	55935095-55994993	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction"	Receptor	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	10	"Ito cells: 851.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 21.0"	"Lineage enriched"	"Detected in many"	5	"T-cells: 21.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 57.7;BJ hTERT+: 58.7;HHSteC: 65.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010558, CAB025784"	Approved		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	NA	NA		100000000	"Plasma membrane"	"Golgi apparatus"	"CAB025784: , HPA010558: AB_1078439"	"unprognostic (1.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.61e-2)"	"unprognostic (3.95e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.99e-2)"	"unprognostic (5.18e-2)"	"unprognostic (9.53e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (5.05e-4)"	"unprognostic (3.69e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.25e-1)"	44.8	34.2	24.7	25.5	23.4	8.8	76.9	15.9	22.9	38.1	23.9	15.0	29.0	8.7	26.1	24.9	22.7	23.1	31.1	31.9	21.9	19.7	37.2	71.2	36.3	70.0	25.8	14.7	42.1	16.4	35.8	36.2	97.0	22.5	31.9	17.1	20.0	26.3	33.0	27.1	12.5	20.6	36.6	33.8	35.5	19.7	13.7	20.3	19.4	37.6	12.5	18.7	33.7	51.1	0.7	2.1	0.9	3.8	0.8	21.0	4.0	9.5	11.9	3.9	9.2	27.6	57.7	15.9	28.5	58.7	15.4	22.9	16.7	9.2	0.3	21.4	17.6	35.0	4.1	3.0	8.5	31.6	0.8	3.1	2.2	9.8	13.7	65.6	0.2	4.6	50.5	4.6	33.4	16.3	22.9	35.1	0.8	1.6	40.2	17.7	1.6	0.4	0.4	0.6	1.2	3.9	0.5	10.8	5.5	8.4	5.6	2.1	3.4	11.5	3.8	11.7	10.7	19.2	1.5	56.4	5.9	6.7	24.1	15.0	9.9	4.2	0.3	15.9	0.4	15.5	0.2	3.8	0.1	0.8	3.5	0.4	0.7	4.9	0.8	2.1	0.6	21.0	5.9	0.9	0.8	0.6	1.8	3.4	4.0	24.7	23.4	15.9	22.9	21.9	19.7	25.8	14.7	22.5	20.3	125.0	112.6	23.8	82.7	92.3	54.8	67.9	140.1	99.0	149.0	64.6	33.4	63.8	6.6	64.2	9.5	210.0	31.1	23.3	53.6	60.1	240.2	110.2	31.3	186.2	46.3	15.9	19.0	851.3	103.7	11.5	98.1	51.0	75.9	21.6	29.0	179.7	66.2	30.6	122.7	46.2	33.9	97.0	142.0	37.1	34.3	73.0	85.1	35.0	13.3	89.2
IL7R	CD127	ENSG00000168685	"Interleukin 7 receptor"	P16871	5	35852695-35879603	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 70.3;intestine: 34.0;lung: 52.6;lymphoid tissue: 133.1"	"Group enriched"	"Detected in many"	5	"monocytes: 441.0;T-cells: 326.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdT-cell: 19.2;MAIT T-cell: 70.3;memory CD4 T-cell: 39.9;memory CD8 T-cell: 28.0;naive CD4 T-cell: 34.5;naive CD8 T-cell: 22.5;NK-cell: 19.1"	"Group enriched"	"Detected in many"	33	"NK-cells: 19.1;T-cells: 70.3"	"Cell line enhanced"	"Detected in many"		"BJ: 22.2;BJ hTERT+ SV40 Large T+: 20.1;fHDF/TERT166: 41.6;HBF TERT88: 38.3;REH: 86.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB010215, HPA067550"			Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		180000	"Plasma membrane"		"CAB010215: AB_673727, HPA067550: "	"unprognostic (2.93e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.82e-3)"	"unprognostic (5.58e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.51e-3)"	"unprognostic (5.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.27e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.78e-1)"	6.7	3.6	0.7	34.0	0.7	3.1	4.8	0.5	0.6	4.8	20.6	0.3	0.9	3.5	1.8	2.9	6.6	3.7	8.5	1.9	0.7	0.7	7.0	2.7	52.6	133.1	0.8	0.1	2.5	1.7	0.0	1.5	1.2	0.8	3.3	5.4	1.7	13.2	1.8	0.9	1.8	34.0	1.2	1.5	32.3	7.8	3.0	0.4	130.9	5.1	5.3	42.9	12.6	4.6	0.4	0.3	1.3	0.2	19.1	70.3	12.7	0.1	0.0	0.1	0.1	0.1	0.1	0.2	22.2	11.2	20.1	11.9	0.1	0.1	2.1	0.0	41.6	3.7	3.5	0.0	1.3	38.3	1.8	0.2	0.6	2.4	0.0	0.3	0.2	1.6	0.3	0.0	4.3	0.9	0.5	0.5	0.1	0.1	0.3	15.7	0.0	0.5	0.2	0.1	0.0	1.0	86.5	1.2	0.1	0.0	1.2	0.0	0.0	3.7	0.3	0.0	0.1	0.1	0.0	1.5	7.9	13.4	3.4	2.9	0.2	0.0	2.5	4.0	2.1	6.1	0.5	0.2	0.1	19.2	0.2	70.3	0.2	39.9	28.0	0.1	0.4	34.5	22.5	1.3	19.1	0.2	0.3	6.7	12.7	0.7	0.7	0.5	0.6	0.7	0.7	0.8	0.1	0.8	0.4	14.9	19.4	10.9	1.9	10.3	0.0	3.2	0.0	10.7	4.5	0.0	0.0	0.1	0.0	0.9	0.1	3.6	0.0	23.3	1.6	0.1	7.1	1.1	18.5	4.5	10.4	0.0	0.0	17.8	12.7	0.0	0.0	79.7	20.3	441.0	0.0	0.0	0.2	0.9	0.0	0.6	0.0	0.0	9.0	0.0	0.0	9.2	0.2	326.6	0.0	3.8
ILK		ENSG00000166333	"Integrin linked kinase"	Q13418	11	6603708-6610874	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004041, HPA048437"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA		130000000	"Plasma membrane, Focal adhesion sites"	Nucleoplasm	"CAB004041: AB_2127050, HPA048437: AB_2680391"	"unprognostic (1.78e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.12e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.19e-3)"	"unprognostic (5.25e-3)"	"unprognostic (1.49e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.12e-2)"	"prognostic favorable (2.44e-4)"	"unprognostic (4.01e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.42e-1)"	"unprognostic (6.36e-3)"	20.9	17.6	11.0	22.3	11.9	7.5	37.0	9.4	14.6	40.2	75.1	14.7	41.9	13.5	75.4	25.2	35.7	33.2	41.1	35.1	11.1	9.2	21.6	15.1	21.9	18.9	11.5	14.0	24.2	22.3	20.4	10.9	22.2	11.5	39.9	24.6	19.3	19.4	89.9	18.5	12.4	22.2	103.5	10.6	20.2	33.2	14.2	11.0	8.2	17.5	14.1	13.6	60.8	25.9	19.5	45.9	76.5	49.4	45.3	25.8	63.7	23.9	18.5	29.2	10.1	45.2	32.1	13.3	35.3	69.8	41.8	51.0	19.3	28.3	9.0	9.4	57.7	41.0	19.3	16.3	29.9	42.0	15.7	14.8	13.0	17.7	15.0	30.3	10.4	14.9	30.8	14.1	28.2	21.6	42.9	39.8	7.8	11.9	10.7	54.5	18.0	9.2	17.8	18.4	20.4	21.8	9.6	15.3	9.6	30.6	19.2	5.1	11.5	16.7	23.1	19.4	29.8	16.1	11.9	46.0	52.5	23.7	21.7	17.1	7.8	4.8	12.7	38.9	15.7	24.4	48.3	49.4	76.5	25.8	47.9	25.1	19.5	23.3	24.4	45.9	17.1	14.7	18.5	31.7	45.3	44.4	18.5	25.7	63.7	11.0	11.9	9.4	14.6	11.1	9.2	11.5	14.0	11.5	11.0	41.7	17.0	28.3	58.4	44.9	13.9	0.3	66.2	18.7	15.9	54.1	7.9	94.6	49.7	120.2	46.5	56.1	64.4	46.7	108.6	153.9	93.0	39.7	29.0	24.9	111.6	7.9	36.5	84.1	50.9	110.9	66.2	80.3	81.0	196.6	43.0	50.2	101.4	57.5	138.6	74.7	29.6	155.2	137.9	31.1	15.7	37.8	92.0	54.3	41.7	41.9
INSR	CD220	ENSG00000171105	"Insulin receptor"	P06213	19	7112255-7294034	"CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Carbohydrate metabolism"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Diabetes mellitus, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 64.5"	"Cell type enhanced"	"Detected in many"	4	"Peritubular cells: 230.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 8.8;granulocytes: 5.1;monocytes: 10.5"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 31.3;U-266/70: 23.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036302, HPA036303"	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA		72000	Vesicles	"Plasma membrane"	"HPA036302: AB_2675048, HPA036303: "	"unprognostic (4.64e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.65e-3)"	"unprognostic (9.70e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.45e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.75e-1)"	"unprognostic (8.82e-2)"	13.9	14.7	7.1	3.5	8.2	4.5	12.0	12.0	8.2	10.3	15.2	11.7	10.6	8.4	15.5	6.1	4.7	13.1	7.7	17.7	6.4	5.8	18.7	32.5	5.3	2.2	10.1	4.9	28.3	64.5	11.6	11.6	26.2	8.0	10.5	8.9	11.0	12.0	10.6	15.1	7.3	16.0	10.6	6.8	47.3	8.7	6.9	9.7	2.2	17.1	5.0	3.2	11.3	16.0	1.1	8.8	5.1	10.5	0.8	0.7	1.3	3.8	2.1	2.0	3.0	10.9	3.8	6.5	2.2	2.0	1.2	1.2	5.4	4.4	4.8	5.4	3.9	2.6	1.0	4.7	1.0	0.7	0.0	3.8	0.0	1.5	11.8	4.7	2.2	3.9	5.9	2.4	0.1	2.8	2.4	2.2	2.7	5.9	31.3	0.9	1.7	1.7	3.9	1.8	2.0	3.4	16.7	1.1	4.2	0.1	15.8	3.7	2.9	3.9	2.1	2.1	3.7	1.0	11.0	2.0	2.3	1.4	4.9	2.8	23.1	12.6	11.2	2.6	3.9	0.0	2.0	8.2	5.1	0.2	7.8	0.3	0.8	0.3	0.1	8.8	1.1	0.7	0.1	1.7	0.8	10.5	7.4	0.0	1.3	7.1	8.2	12.0	8.2	6.4	5.8	10.1	4.9	8.0	9.7	44.7	26.7	8.2	54.6	57.7	38.7	85.3	107.0	41.5	50.0	59.3	74.6	15.8	13.3	41.1	2.9	52.3	87.1	0.0	68.2	39.2	29.8	84.0	3.5	214.7	8.6	36.5	157.1	201.3	47.7	3.6	89.2	26.7	49.0	8.2	103.9	26.9	67.8	56.1	230.5	116.2	22.2	58.2	42.3	6.2	1.2	60.1	32.0	6.4	56.3	113.2
IQGAP1	"HUMORFA01, KIAA0051, p195, SAR1"	ENSG00000140575	"IQ motif containing GTPase activating protein 1"	P46940	15	90388218-90502243	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013302, HPA014055"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA		890000	"Plasma membrane, Cell Junctions"		"CAB013302: AB_2533146, HPA014055: AB_1851856"	"unprognostic (2.83e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.02e-2)"	"unprognostic (5.95e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (2.01e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.25e-3)"	46.2	23.2	9.9	27.8	17.1	23.7	31.7	5.9	11.2	41.8	26.7	18.1	19.7	12.3	50.8	28.8	41.3	27.4	22.0	17.6	12.0	9.1	25.9	9.8	38.3	45.3	17.5	6.6	31.3	16.4	27.6	19.1	53.7	15.5	28.9	27.1	12.0	37.8	22.0	23.1	32.7	25.8	37.6	17.4	48.0	20.3	11.4	15.4	39.5	32.7	29.6	34.9	43.0	40.8	5.9	9.9	39.3	12.4	11.5	9.9	6.3	31.5	17.5	8.7	10.3	22.7	29.6	51.2	30.2	28.0	27.8	30.0	20.0	33.0	17.6	14.8	50.4	24.8	57.0	17.5	33.7	33.8	22.4	12.4	11.8	33.8	7.3	27.5	21.5	25.3	17.4	31.2	32.7	46.8	34.5	38.1	11.6	10.1	24.9	42.4	16.4	11.6	6.5	11.4	51.0	10.0	14.3	23.6	15.4	28.7	50.2	11.1	8.3	42.0	21.6	22.4	38.3	18.8	18.6	48.3	31.8	16.5	26.6	31.1	9.7	13.8	17.9	28.9	21.2	17.0	10.5	11.6	8.1	9.9	10.9	8.9	5.6	6.2	8.5	9.9	5.9	3.8	6.6	39.3	11.5	12.4	6.0	6.7	6.3	9.9	17.1	5.9	11.2	12.0	9.1	17.5	6.6	15.5	15.4	247.1	255.8	85.7	86.1	91.5	2.3	11.8	40.8	176.7	226.3	73.3	15.7	77.6	6.6	78.9	6.5	111.9	155.2	23.3	85.6	126.0	70.8	89.0	199.2	6.8	130.4	1.6	58.3	93.3	343.0	9.3	44.3	168.0	67.4	158.7	118.3	14.0	97.0	121.4	45.3	15.9	25.3	77.6	70.3	11.5	32.6	99.1	80.0	132.1	104.7	126.4
IRS1	HIRS-1	ENSG00000169047	"Insulin receptor substrate 1"	P35568	2	226731317-226799759	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Transducer	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 56.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.0;naive B-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005261, HPA046433"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB005261: AB_649615, HPA046433: AB_2732524"	"unprognostic (2.20e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.80e-3)"	"unprognostic (5.47e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.46e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.23e-2)"	"unprognostic (7.55e-3)"	7.0	9.9	3.1	5.0	2.7	0.6	11.7	9.6	5.4	13.3	14.2	1.4	3.9	4.0	17.2	5.0	3.8	13.9	11.5	6.3	3.9	2.2	5.2	12.0	5.0	2.5	2.3	2.6	21.9	7.1	3.4	2.5	9.1	4.2	9.8	2.9	5.5	3.3	7.5	23.3	5.1	6.5	11.7	2.6	3.3	5.8	2.4	1.7	17.1	23.4	5.6	2.5	14.6	15.8	1.2	0.4	0.0	0.2	0.0	0.3	0.2	3.2	15.0	10.9	0.4	15.1	9.0	0.0	9.0	7.1	12.0	7.8	8.5	8.3	1.3	1.5	6.1	8.3	5.7	0.7	8.6	6.9	3.3	0.6	0.0	1.0	4.0	7.5	0.3	0.0	12.5	4.8	9.5	8.6	7.3	0.0	1.3	1.6	13.3	8.1	12.8	2.7	3.7	4.4	2.0	8.3	0.6	14.2	0.1	5.5	10.8	1.9	0.3	2.9	2.1	4.8	9.2	8.0	0.1	0.7	16.0	14.6	12.2	8.6	6.2	2.5	2.0	15.8	0.3	4.7	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.1	0.1	0.1	1.2	0.2	0.1	0.0	0.0	0.0	0.4	0.3	0.2	3.1	2.7	9.6	5.4	3.9	2.2	2.3	2.6	4.2	1.7	17.9	5.8	0.5	24.9	31.5	18.2	11.5	12.7	4.0	6.8	0.0	0.0	5.2	14.9	12.8	1.3	2.0	11.1	0.0	9.5	0.7	21.2	13.8	0.0	56.3	1.6	19.1	2.4	3.1	1.0	0.0	21.0	0.6	15.1	0.0	7.5	7.6	8.9	10.4	13.8	2.2	1.9	12.9	14.2	1.1	0.7	20.7	15.3	0.0	5.7	21.8
ITGA3	"CD49c, GAP-B3, MSK18, VCA-2, VLA3a"	ENSG00000005884	"Integrin subunit alpha 3"	P26006	17	50055968-50090481	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Ductal cells: 96.5;Exocrine glandular cells: 90.7;Pancreatic endocrine cells: 158.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 1.1"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 74.4;hTERT-RPE1: 68.2;RPTEC TERT1: 65.6;U-87 MG: 111.7;WM-115: 67.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008572, CAB018594"	Enhanced		Supported	"Plasma membrane"		NA	NA		180000	"Plasma membrane"		"CAB018594: AB_668044, HPA008572: AB_2668094"	"unprognostic (3.24e-3)"	"prognostic unfavorable (6.75e-4)"	"unprognostic (9.51e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.45e-3)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (8.28e-3)"	"unprognostic (2.76e-3)"	"unprognostic (1.26e-3)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (5.95e-5)"	"unprognostic (7.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.35e-2)"	15.7	15.8	4.1	8.6	5.1	0.1	8.7	7.7	6.5	10.9	20.9	2.3	8.9	17.1	11.6	11.6	12.8	14.5	32.6	8.4	4.2	5.4	36.0	1.7	37.6	3.2	3.2	6.7	10.7	8.0	13.0	11.2	26.4	4.3	12.0	8.9	11.6	10.0	9.7	6.6	17.3	37.3	11.6	3.3	6.5	13.7	3.9	1.5	3.3	36.1	13.3	8.3	19.0	8.1	0.2	0.0	0.0	0.0	0.0	1.1	0.2	20.4	27.1	0.1	0.8	0.5	2.1	4.4	9.6	20.7	14.5	11.1	0.6	31.9	0.0	60.6	6.9	48.4	14.6	0.2	74.4	8.9	2.5	0.4	0.0	6.8	0.1	12.8	0.0	0.6	2.6	36.7	14.5	64.6	68.2	10.6	1.0	0.0	0.3	27.3	5.9	0.0	0.0	0.6	9.2	16.4	0.0	1.4	1.5	65.6	35.7	1.1	0.4	10.4	1.4	24.0	6.9	2.4	0.2	23.0	64.8	20.4	0.6	37.3	0.9	1.5	0.6	111.7	0.2	67.3	0.0	0.0	0.0	0.8	0.0	1.0	0.2	0.1	0.1	0.0	0.2	0.2	0.6	0.0	0.0	0.0	0.0	1.1	0.2	4.1	5.1	7.7	6.5	4.2	5.4	3.2	6.7	4.3	1.5	50.6	29.6	5.7	51.4	50.9	14.4	4.4	33.1	4.0	27.3	73.3	23.6	1.8	0.0	96.5	0.4	11.2	77.3	0.0	90.7	2.6	4.5	26.1	3.5	0.0	1.1	3.2	13.9	4.9	1.5	0.0	1.7	3.8	16.9	7.2	21.8	2.3	158.1	31.7	3.9	2.2	13.1	12.9	18.6	0.2	1.6	20.3	1.5	1.3	29.6	70.4
ITGB1	"CD29, FNRB, GPIIA, MDF2, MSK12"	ENSG00000150093	"Integrin subunit beta 1"	P05556	10	32900319-33005792	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Ductal cells: 1163.1;Pancreatic endocrine cells: 917.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 196.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003434, HPA059297, HPA069003"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane,Focal adhesion sites"		NA	NA		540000000	"Plasma membrane, Focal adhesion sites"	"Endoplasmic reticulum"	"CAB003434: AB_303570, HPA059297: AB_2732634, HPA069003: AB_2732125"	"unprognostic (3.07e-2)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (8.67e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (3.36e-6)"	"unprognostic (3.22e-1)"	"unprognostic (2.36e-3)"	"unprognostic (3.68e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.08e-2)"	95.2	30.6	13.7	32.1	19.7	9.7	107.7	6.5	14.8	55.1	61.3	17.0	80.2	20.2	84.2	56.2	59.9	45.0	49.8	68.7	15.0	14.4	47.3	85.8	55.4	34.5	23.0	11.1	47.4	37.4	17.6	35.2	83.3	19.5	53.1	32.2	18.6	30.3	76.2	58.0	19.5	42.3	109.3	30.1	59.8	45.4	26.9	18.8	12.7	36.8	27.6	19.4	92.7	47.4	31.3	9.1	4.3	27.1	21.9	68.4	26.2	45.6	67.0	36.2	40.1	87.3	75.2	31.6	153.5	89.0	73.1	66.9	15.0	106.9	12.3	27.8	128.7	48.0	31.9	10.9	87.3	81.6	12.1	8.8	14.8	31.9	17.5	61.5	3.3	14.7	76.2	47.8	76.9	31.3	196.1	89.8	6.1	10.2	5.4	120.5	7.5	5.7	3.3	8.0	13.9	34.0	3.7	26.8	2.2	104.2	13.2	8.6	21.4	47.8	8.1	34.4	61.5	10.9	11.9	100.4	94.2	54.7	66.9	51.1	5.0	1.1	6.9	69.4	14.1	36.9	1.6	9.8	4.3	25.5	17.8	6.0	31.3	54.6	37.5	9.1	8.6	7.1	19.1	2.3	21.9	27.1	3.7	68.4	26.2	13.7	19.7	6.5	14.8	15.0	14.4	23.0	11.1	19.5	18.8	318.6	128.6	76.4	295.7	485.6	32.6	175.3	242.0	164.6	252.5	214.6	29.5	156.7	11.6	1163.1	4.3	314.7	83.6	70.0	355.7	460.3	265.1	177.2	86.6	221.3	161.3	36.5	185.6	387.9	152.7	9.7	235.6	174.3	325.6	83.0	81.4	76.8	917.0	113.2	565.7	64.3	45.2	627.3	497.4	10.0	63.7	149.1	183.8	106.6	98.8	257.2
ITGB2	"CD18, LFA-1, MAC-1, MFI7"	ENSG00000160255	"Integrin subunit beta 2"	P05107	21	44885953-44931989	"CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Phagocytosis"	"Integrin, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 159.7;bone marrow: 91.4;lymphoid tissue: 75.6"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 620.8;Kupffer cells: 458.1;Macrophages: 428.6;T-cells: 303.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"THP-1: 117.5;U-937: 87.3"					"Low region specificity"	"Detected in all"			"HPA008877, HPA016894"	Enhanced		Supported	"Plasma membrane,Rods & Rings"		NA	NA		2500000	"Plasma membrane"	"Rods & Rings"	"HPA008877: AB_1846256, HPA016894: AB_1846257"	"unprognostic (1.94e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.95e-2)"	"unprognostic (9.73e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.42e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.83e-2)"	59.1	9.8	9.0	47.5	16.8	91.4	8.4	1.7	8.0	5.6	7.4	12.2	1.2	6.3	4.9	9.0	4.8	10.7	10.3	9.7	7.2	6.4	8.1	7.0	32.9	73.8	14.3	2.9	6.6	5.1	1.1	3.3	12.7	12.1	6.9	4.2	5.2	8.8	2.7	3.0	4.1	13.2	12.3	18.3	75.6	7.6	4.2	12.2	53.5	4.5	2.2	29.0	15.7	4.2	9.5	76.0	104.6	122.9	41.0	57.4	159.7	0.2	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	2.5	20.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	2.4	0.0	0.4	0.0	15.3	4.0	0.2	0.0	0.0	0.0	0.0	0.0	8.1	0.1	0.2	1.0	0.5	17.4	18.5	0.0	0.0	0.3	0.2	3.6	9.5	0.7	0.0	0.1	0.2	0.5	0.3	0.3	0.0	0.0	117.5	0.3	0.0	1.0	0.0	0.5	0.1	0.8	0.4	0.0	87.3	0.1	10.5	122.9	85.7	57.4	84.1	25.8	6.7	28.4	39.5	76.0	9.5	19.1	32.0	104.6	41.0	81.0	11.6	20.7	159.7	9.0	16.8	1.7	8.0	7.2	6.4	14.3	2.9	12.1	12.2	14.9	42.5	86.5	0.5	4.8	0.0	3.5	15.3	5.3	19.4	5.2	0.0	3.4	0.0	2.7	0.5	5.2	0.0	0.0	0.3	3.3	5.7	0.5	23.1	4.3	620.8	0.0	0.0	11.6	458.1	2.1	0.6	428.6	5.0	109.2	0.1	0.3	0.4	0.0	1.4	3.4	0.6	6.5	3.1	0.2	1.1	4.4	4.7	303.6	0.2	0.6
ITGB3	"CD61, GP3A, GPIIIa"	ENSG00000259207	"Integrin subunit beta 3"	P05106	17	47253846-47311816	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 36.6"	"Cell type enhanced"	"Detected in some"	10	"Late spermatids: 4.1;Proximal tubular cells: 3.5;Sertoli cells: 6.5"	"Group enriched"	"Detected in many"	6	"melanoma: 7.5;renal cancer: 3.6;thyroid cancer: 11.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	19	"basophil: 2.8;neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 2.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 46.6;HEL: 41.2;RPTEC TERT1: 26.8;U-87 MG: 21.1;WM-115: 67.2"									HPA027852	Approved		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA		710000000	"Plasma membrane"	Nucleoplasm	"HPA027852: AB_10601760"	"unprognostic (1.13e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.47e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.04e-3)"	"unprognostic (3.70e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-1)"	"unprognostic (6.35e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-3)"	10.0	0.6	1.0	6.2	2.5	2.7	7.0	0.4	1.6	4.6	13.6	0.9	2.4	2.2	9.7	5.7	6.4	6.4	2.8	8.5	0.7	0.6	16.0	3.7	5.2	1.2	2.3	0.1	4.6	0.6	0.7	1.6	23.5	1.6	6.4	4.8	1.8	2.5	11.5	4.9	2.4	5.0	17.0	1.8	9.5	3.6	2.6	0.6	0.2	36.6	1.9	0.9	11.0	7.8	0.1	0.0	2.8	0.1	0.0	0.0	9.5	0.0	0.4	0.1	0.0	2.4	1.0	0.0	1.2	6.1	2.6	2.4	0.0	0.0	0.1	46.6	0.3	3.6	0.0	0.0	0.0	3.4	0.9	0.0	41.2	0.1	0.0	2.0	0.0	0.0	1.0	0.0	15.6	0.4	1.8	11.6	0.6	0.1	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.1	0.0	26.8	0.0	0.0	0.1	1.5	0.0	8.4	2.4	0.0	0.0	12.6	0.5	0.7	0.3	2.8	0.0	0.0	0.3	21.1	0.0	67.2	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	9.5	1.0	2.5	0.4	1.6	0.7	0.6	2.3	0.1	1.6	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.1	2.7	1.4	0.0	0.0	0.4	0.0	0.8	0.1	0.0	0.8	0.8	0.0	0.0	1.8	0.0	4.1	0.3	0.3	0.0	0.0	0.0	0.0	1.0	0.0	1.1	3.5	0.0	6.5	1.9	0.0	2.3	0.4	1.0	0.0	0.0	0.1
ITGB4	CD104	ENSG00000132470	"Integrin subunit beta 4"	P16144	17	75721328-75757818	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 84.6;Pancreatic endocrine cells: 175.0;Syncytiotrophoblasts: 92.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 120.2;HaCaT: 46.0;HBEC3-KT: 102.5;hTCEpi: 35.1;RT4: 33.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB002422, CAB005258, HPA036348, HPA036349"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA		79000	"Plasma membrane, Cell Junctions"		"CAB002422: AB_563480, CAB005258: AB_2129021, HPA036348: AB_2675077, HPA036349: AB_2675078"	"unprognostic (3.17e-3)"	"unprognostic (3.52e-1)"	"unprognostic (4.19e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (7.18e-4)"	"unprognostic (1.05e-1)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (6.39e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.43e-1)"	6.3	3.4	9.7	10.9	9.7	1.4	13.7	4.7	7.7	14.3	32.1	15.6	10.0	35.3	9.7	8.8	24.0	13.7	47.8	4.3	9.4	7.9	4.8	1.5	7.4	3.7	10.1	9.1	4.7	6.7	3.1	5.7	50.0	17.2	19.7	10.4	9.8	52.3	13.2	2.4	47.0	58.5	7.4	10.7	17.0	41.0	3.9	9.8	1.8	3.2	22.1	15.9	17.2	20.5	2.4	8.2	1.3	0.7	0.0	2.2	0.8	22.3	19.7	0.0	0.2	0.0	0.1	27.2	0.1	0.0	0.0	0.1	2.1	120.2	0.0	4.3	0.0	0.1	46.0	0.1	102.5	0.0	0.1	0.0	0.1	5.0	2.2	0.1	0.0	0.2	0.1	35.1	0.0	21.9	2.4	0.7	0.0	0.0	2.1	0.0	12.5	0.2	0.2	0.1	12.1	17.2	0.3	0.6	0.2	27.5	33.8	0.0	0.2	0.6	2.0	0.3	0.7	8.6	0.2	2.2	0.6	1.1	0.0	0.2	0.7	0.2	0.0	0.2	0.1	0.3	0.0	0.4	0.0	0.7	0.7	2.2	1.4	0.3	1.0	0.1	2.4	0.9	0.6	1.3	0.0	0.0	8.2	1.4	0.8	9.7	9.7	4.7	7.7	9.4	7.9	10.1	9.1	17.2	9.8	11.9	2.1	0.5	35.9	44.0	0.2	5.9	20.4	12.0	14.8	22.7	2.0	70.7	1.7	26.1	0.3	15.7	84.6	0.0	25.5	15.4	4.9	5.9	2.3	0.0	8.2	0.0	9.2	9.8	0.0	0.0	3.4	2.5	11.8	0.0	49.0	40.4	175.0	66.4	1.4	2.0	0.4	0.0	2.5	0.1	5.9	11.4	92.9	2.2	50.4	34.6
ITSN1	"ITSN, MGC134948, MGC134949, SH3D1A, SH3P17"	ENSG00000205726	"Intersectin 1"	Q15811	21	33642400-33899861	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Exocytosis, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Rod photoreceptor cells: 150.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 5.9;eosinophil: 7.2;intermediate monocyte: 4.1;myeloid DC: 1.8;non-classical monocyte: 6.3"	"Group enriched"	"Detected in many"	7	"dendritic cells: 1.8;granulocytes: 7.2;monocytes: 6.3"	"Cell line enhanced"	"Detected in all"		"BEWO: 43.0;NTERA-2: 38.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018007	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA018007: AB_1851836"	"unprognostic (2.12e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.94e-2)"	"unprognostic (7.33e-3)"	"unprognostic (1.31e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.37e-1)"	"unprognostic (6.02e-2)"	"unprognostic (5.64e-2)"	47.4	14.9	24.9	8.9	24.5	5.7	21.7	24.2	24.8	15.5	11.2	10.2	12.3	8.3	17.9	11.8	11.0	13.6	18.5	18.3	24.6	12.1	10.7	23.1	9.5	5.9	12.1	20.4	19.2	4.9	8.4	7.7	22.0	21.1	14.2	10.6	11.4	6.9	21.9	18.0	11.0	9.0	17.4	11.1	13.4	10.3	11.2	15.0	2.4	9.3	4.0	3.9	13.1	12.5	0.0	1.8	7.2	6.3	0.1	0.7	1.1	12.8	5.4	26.1	8.6	12.3	11.8	43.0	13.0	12.6	7.7	7.4	20.4	9.9	3.0	10.6	15.6	16.0	5.0	15.5	9.0	8.3	1.2	6.8	3.7	11.2	9.5	9.3	2.6	3.7	11.6	8.2	14.4	8.0	8.8	20.3	3.5	4.8	2.1	12.3	2.9	3.6	3.5	38.7	4.5	4.1	4.7	12.5	6.2	11.5	5.3	4.9	5.4	18.7	3.9	4.7	17.4	4.8	2.6	18.2	8.6	11.7	6.7	4.5	2.6	7.2	2.8	7.8	8.2	9.5	0.0	5.9	7.2	0.4	4.1	0.5	0.0	0.7	0.2	1.8	0.0	0.3	0.1	0.3	0.1	6.3	0.4	0.0	1.1	24.9	24.5	24.2	24.8	24.6	12.1	12.1	20.4	21.1	15.0	23.8	15.2	5.8	17.3	16.1	68.6	68.0	20.4	20.1	12.5	10.4	86.4	19.3	0.0	18.1	5.9	22.4	16.9	70.0	10.9	21.5	25.7	14.8	2.3	43.3	44.1	62.0	8.7	28.8	27.1	6.5	23.0	11.3	10.1	11.8	5.7	43.1	25.1	9.1	67.1	13.6	150.8	12.9	23.6	20.0	46.4	10.3	13.0	3.2	9.6	16.1
IYD	"C6orf71, DEHAL1, dJ422F24.1"	ENSG00000009765	"Iodotyrosine deiodinase"	Q6PHW0	6	150368892-150405969	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		Oxidoreductase	"Congenital hypothyroidism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"thyroid gland: 212.3"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 2: 8.5;Cholangiocytes: 20.4;Club cells: 12.5;Enterocytes: 25.8;Hepatocytes: 18.3;Mucus-secreting cells: 15.4;Paneth cells: 17.3;Proximal tubular cells: 33.8;Undifferentiated cells: 10.3"	"Cancer enriched"	"Detected in many"	20	"thyroid cancer: 80.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.9"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"CACO-2: 3.0;OE19: 6.8;SK-BR-3: 7.4"	"Group enriched"	"Detected in some"	13	"hippocampal formation: 8.1;thalamus: 2.6"	"Low region specificity"	"Detected in many"			HPA059627	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA059627: AB_2684086"	"unprognostic (3.73e-4)"	"unprognostic (2.93e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-2)"	"prognostic favorable (6.22e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.07e-9)"	"unprognostic (9.79e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.18e-2)"	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	8.2	0.1	0.1	3.6	0.1	0.3	0.1	0.1	6.7	0.1	0.1	0.1	5.4	6.8	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.5	0.1	1.2	0.0	0.3	0.0	0.1	0.2	13.5	0.0	0.1	0.1	0.3	0.1	0.0	0.0	212.3	0.0	0.1	0.1	0.1	1.4	1.0	5.9	1.3	2.3	0.7	2.3	0.1	0.0	0.2	0.3	0.1	0.8	0.4	0.0	0.0	0.0	0.0	3.0	0.5	0.2	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.4	0.2	0.4	0.8	0.3	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.3	0.6	0.0	0.4	0.0	0.3	0.3	6.8	0.2	0.3	0.2	0.2	0.0	0.7	0.3	0.2	0.0	7.4	0.0	0.1	0.7	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.0	0.1	0.4	0.2	0.1	3.3	1.3	0.7	0.7	1.1	0.5	0.6	0.6	0.5	0.1	1.4	0.6	0.7	5.9	2.3	0.5	1.0	0.5	2.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.0	3.0	8.5	0.0	0.5	0.1	0.0	0.5	20.4	1.4	12.5	0.0	0.0	0.0	1.7	0.1	0.0	0.0	25.8	0.0	0.2	0.0	0.0	1.0	1.1	18.3	0.1	0.0	3.5	1.3	0.0	0.0	0.0	0.5	0.0	0.0	15.4	0.0	0.2	17.3	0.0	33.8	1.1	0.0	0.0	0.0	0.2	0.4	0.2	0.0	10.3	0.7
JAM2	"C21orf43, CD322, JAM-B, JAMB, VE-JAM"	ENSG00000154721	"Junctional adhesion molecule 2"	P57087	21	25639272-25717562	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 66.7"	"Cell type enhanced"	"Detected in many"	20	"Cardiomyocytes: 31.9;Endothelial cells: 151.0;Ito cells: 49.7"	"Cancer enriched"	"Detected in all"	9	"glioma: 27.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 18.2;BJ hTERT+: 11.6;HDLM-2: 11.3;hTERT-RPE1: 16.2;U-138 MG: 13.1;U-87 MG: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028789, HPA077346"			Supported	"Nucleoplasm,Plasma membrane"		NA	NA		17000	"Plasma membrane"	Nucleoplasm	"HPA028789: AB_2732443, HPA077346: AB_2732341"	"unprognostic (1.42e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.53e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.61e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.46e-2)"	"unprognostic (3.81e-1)"	"unprognostic (8.86e-2)"	"unprognostic (5.71e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.85e-3)"	16.6	17.2	13.8	8.4	18.9	1.5	14.6	9.9	23.4	18.1	14.7	14.5	8.0	7.5	20.5	13.5	13.3	12.0	14.4	21.9	13.5	12.5	6.5	3.5	17.1	4.6	17.6	13.5	18.9	3.9	5.8	7.7	66.7	18.5	12.0	9.7	11.1	5.5	18.0	8.4	6.9	9.2	21.8	23.0	2.8	9.7	25.8	12.2	0.6	9.5	10.1	6.3	13.5	15.1	3.1	1.9	1.9	0.7	2.8	1.1	0.4	0.0	0.0	18.2	0.1	0.7	0.2	0.4	0.5	11.6	1.5	5.5	0.0	0.0	0.1	0.0	0.2	7.0	0.0	1.6	0.0	3.4	11.3	0.5	0.1	0.0	0.0	0.0	0.0	0.1	1.0	0.0	1.3	0.0	16.2	0.0	0.4	0.0	0.2	5.6	0.1	0.3	0.1	5.7	0.1	0.0	2.1	3.7	0.0	0.0	0.0	0.3	2.7	0.1	0.2	0.0	0.2	0.6	0.1	0.0	13.1	1.2	0.1	1.8	1.5	0.0	0.0	9.6	0.1	0.5	1.4	0.7	0.3	0.4	0.5	0.6	0.3	0.4	0.9	0.4	3.1	0.7	1.1	1.9	2.8	0.6	1.9	0.2	0.4	13.8	18.9	9.9	20.5	13.5	12.5	17.6	13.5	18.5	12.2	0.0	2.9	1.4	1.4	6.6	1.5	31.9	0.0	1.4	0.0	3.5	13.7	0.3	0.0	0.3	12.9	151.0	0.0	0.0	0.2	2.2	18.5	1.2	0.0	0.0	1.0	0.0	0.0	49.7	2.2	13.2	9.2	1.4	15.1	0.0	0.0	0.9	0.1	0.0	23.0	0.0	3.6	0.0	7.6	4.8	3.9	5.8	0.7	0.0	0.0	0.7
JAML	"AMICA, AMICA1, Gm638"	ENSG00000160593	"Junction adhesion molecule like"	Q86YT9	11	118193740-118225094	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"blood: 202.6"	"Cell type enhanced"	"Detected in some"	19	"Alveolar cells type 2: 48.3;Kupffer cells: 117.5;Macrophages: 185.0;T-cells: 45.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 202.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 60.5;granulocytes: 202.6;monocytes: 59.0"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 24.9"	"Region enriched"	"Detected in single"	9	"cerebellum: 7.0"	"Region enriched"	"Detected in many"	12	"cerebellum: 113.6"	"HPA005854, HPA047919"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		1400000	"Plasma membrane"	Nucleoplasm	"HPA005854: , HPA047919: AB_2680209"	"unprognostic (3.91e-3)"	"unprognostic (1.55e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.87e-3)"	"prognostic favorable (3.11e-4)"	"unprognostic (2.80e-1)"	"prognostic favorable (3.92e-4)"	"unprognostic (1.14e-1)"	"unprognostic (3.17e-1)"	"unprognostic (8.69e-2)"	"unprognostic (5.08e-1)"	"unprognostic (6.43e-3)"	"unprognostic (8.96e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.58e-2)"	6.7	2.1	0.9	23.1	1.1	6.6	2.1	5.3	0.8	4.1	8.4	0.7	1.3	6.1	3.8	9.6	4.0	3.1	8.9	3.1	0.9	0.9	3.4	4.3	34.4	43.2	3.7	0.5	2.1	1.8	0.0	2.7	4.2	2.3	3.4	8.3	6.7	6.7	1.1	1.0	2.2	14.0	4.7	1.8	43.4	3.9	1.9	0.6	14.3	2.6	5.9	25.0	9.8	3.0	0.3	60.5	202.6	59.0	1.4	25.2	40.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.1	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.7	0.0	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.3	2.3	0.3	2.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.2	0.0	5.8	59.0	202.6	3.9	36.6	25.2	0.3	7.0	7.4	60.5	0.1	8.3	6.7	126.6	1.4	17.1	46.6	11.1	40.1	0.9	1.1	5.3	0.8	0.9	0.9	3.7	0.5	2.3	0.6	6.0	48.3	15.4	0.1	0.0	0.0	0.0	0.0	4.0	10.3	1.8	0.0	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.3	0.2	0.4	0.1	14.0	2.1	29.9	0.0	0.0	8.0	117.5	0.9	0.0	185.0	0.0	11.8	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.1	1.4	0.0	0.3	45.3	0.0	0.1
JUP	"CTNNG, DP3, DPIII, PDGB, PKGB"	ENSG00000173801	"Junction plakoglobin"	P14923	17	41754604-41786931	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cancer-related genes, Cardiomyopathy, Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 146.3;skin 1: 126.1;tongue: 122.8"	"Cell type enhanced"	"Detected in many"	5	"Suprabasal keratinocytes: 335.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 7.6;eosinophil: 14.8;intermediate monocyte: 12.8;memory B-cell: 7.9;myeloid DC: 7.8;naive B-cell: 7.4;non-classical monocyte: 20.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 81.5;OE19: 288.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002139, HPA032047"	Supported		Supported	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		61000000	"Plasma membrane, Cell Junctions"	Vesicles	"CAB002139: AB_563468, HPA032047: AB_2674124"	"unprognostic (3.96e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.41e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.29e-3)"	"unprognostic (9.60e-2)"	"prognostic favorable (2.06e-10)"	"unprognostic (2.50e-1)"	"unprognostic (9.49e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.51e-2)"	12.5	2.6	2.8	9.5	4.5	3.3	13.0	6.5	3.7	34.5	17.9	8.7	12.3	15.6	12.2	9.6	146.3	13.0	19.0	34.5	3.3	1.6	31.6	11.7	13.2	4.0	5.3	2.2	12.5	12.8	3.6	5.8	42.4	4.0	14.0	8.8	8.3	34.3	14.3	17.6	126.1	36.1	4.3	3.2	4.5	15.4	3.6	4.6	10.8	27.9	122.8	84.8	12.5	55.4	7.9	7.8	14.8	20.6	0.3	0.1	2.9	19.5	16.2	1.6	1.4	0.0	0.0	25.4	1.1	6.7	0.4	0.4	24.6	21.7	0.3	12.1	0.7	0.5	81.5	2.3	18.1	0.0	0.0	5.8	0.8	12.9	5.4	2.7	0.5	8.7	0.0	41.2	0.0	3.3	4.9	7.2	0.5	7.2	7.1	0.0	25.1	0.1	7.0	3.2	288.5	2.7	22.9	0.0	14.6	12.6	50.1	4.0	2.9	2.5	49.5	0.1	7.9	41.3	0.5	11.4	0.0	1.1	0.5	0.3	0.6	2.2	0.3	0.1	0.9	0.1	1.7	7.6	14.8	0.0	12.8	0.0	7.9	0.0	0.1	7.8	7.4	0.1	0.1	0.3	0.3	20.6	2.5	0.0	2.9	2.8	4.5	6.5	3.7	3.3	1.6	5.3	2.2	4.0	4.6	56.6	33.7	8.4	158.6	174.9	1.1	80.3	53.5	18.7	43.3	125.6	3.9	81.5	23.2	189.4	28.7	23.2	158.5	0.0	119.3	141.0	19.6	196.2	10.5	29.3	12.8	0.0	64.1	28.3	5.6	6.4	4.6	9.8	11.8	6.4	91.0	16.2	237.1	128.7	0.0	33.8	4.3	6.5	14.0	2.1	4.2	335.0	155.3	5.1	94.4	236.4
KANK1	"ANKRD15, KANK, KIAA0172"	ENSG00000107104	"KN motif and ankyrin repeat domains 1"	Q14678	9	470291-746106	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 178.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 7.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 35.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005539, HPA056090"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA005539: AB_1078164, HPA056090: AB_2683034"	"unprognostic (6.59e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.69e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.23e-2)"	"unprognostic (4.91e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.61e-1)"	28.9	5.3	23.9	8.7	23.2	1.4	15.5	17.7	18.2	18.2	17.4	28.5	7.6	8.8	26.5	10.3	33.7	12.7	13.2	46.5	21.9	10.4	19.8	39.4	10.0	6.9	21.4	14.8	16.9	17.0	9.5	14.7	18.2	16.5	23.4	11.2	14.8	17.9	24.4	24.2	20.0	9.2	27.6	21.3	3.9	10.7	12.1	23.5	2.8	16.2	8.2	8.8	28.9	26.3	1.5	7.1	0.0	0.2	0.2	4.4	1.0	2.1	4.4	1.5	27.2	22.6	8.6	7.5	13.9	9.7	1.1	1.4	11.1	0.9	16.9	3.4	17.1	2.6	4.5	5.8	11.3	2.0	8.1	3.1	0.0	6.4	35.0	3.2	4.0	0.0	4.9	15.9	1.2	13.7	5.0	11.7	0.5	0.8	21.3	8.7	5.2	1.6	17.1	1.9	3.2	3.4	0.6	3.0	3.1	9.2	13.4	0.6	0.0	1.3	4.1	18.4	13.2	2.7	3.2	17.2	3.2	1.2	4.0	6.3	3.7	21.9	0.0	2.1	7.7	5.9	0.0	0.2	0.0	0.2	0.2	0.0	1.5	2.3	0.8	0.7	1.2	4.4	1.4	0.0	0.2	0.0	7.1	3.0	1.0	23.9	23.2	17.7	17.6	21.9	10.4	21.4	14.8	16.5	23.5	11.9	32.2	2.2	72.1	20.5	22.8	86.0	25.5	6.7	6.8	17.4	39.3	71.9	6.6	10.2	85.1	17.5	9.5	23.3	6.9	5.7	13.2	37.8	1.1	61.8	11.9	0.0	17.2	17.2	4.7	178.6	30.0	3.3	21.9	0.0	11.2	7.5	11.3	10.2	19.4	12.6	20.9	25.8	23.4	16.2	23.9	22.5	55.4	3.2	20.9	53.1
KANSL2	"C12orf41, FLJ20436, NSL2"	ENSG00000139620	"KAT8 regulatory NSL complex subunit 2"	Q9H9L4	12	48653401-48682238	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038497, HPA038498"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA038497: AB_10674685, HPA038498: AB_2676046"	"unprognostic (3.87e-3)"	"unprognostic (6.18e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (4.98e-4)"	"unprognostic (5.46e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.16e-2)"	"unprognostic (6.75e-3)"	"unprognostic (4.19e-3)"	"unprognostic (8.05e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (4.32e-4)"	11.4	12.3	9.8	9.0	14.0	41.3	14.5	19.7	14.7	12.0	10.7	15.6	8.9	8.9	14.9	14.3	13.7	12.0	9.0	12.8	8.6	8.6	13.8	10.2	11.0	16.8	13.0	11.2	17.4	14.3	10.6	21.0	18.2	11.3	12.5	11.3	14.1	13.2	10.4	36.3	13.1	11.6	13.5	11.2	14.0	10.8	16.5	12.7	20.1	16.4	12.6	16.5	11.8	12.8	23.6	21.3	28.2	18.4	19.8	26.8	18.7	9.5	13.0	11.7	5.6	13.1	11.6	24.6	10.9	8.7	17.8	10.2	22.8	12.4	15.6	19.4	12.9	7.5	9.7	19.0	12.7	14.9	14.0	11.3	18.2	11.6	6.4	14.7	20.1	7.1	12.1	16.1	13.5	23.7	9.8	8.6	13.5	21.1	10.4	12.9	8.9	19.7	15.4	15.1	14.1	13.1	17.0	11.5	17.8	9.6	13.3	13.3	9.2	21.1	15.7	12.9	13.1	20.6	19.7	7.4	13.6	10.0	5.8	9.9	15.8	23.3	22.8	6.7	45.9	6.9	28.2	16.8	19.3	23.0	17.4	22.0	23.6	22.9	23.8	21.3	21.1	26.8	25.5	7.7	19.8	18.4	17.3	25.1	18.7	9.8	14.0	19.7	14.7	8.6	8.6	13.0	11.2	11.3	12.7	3.0	11.0	11.3	11.5	10.5	13.7	8.9	7.6	12.0	14.8	14.0	27.5	18.9	8.3	10.4	20.7	12.1	9.3	0.0	8.7	9.9	12.8	9.0	11.5	8.7	10.5	14.3	8.6	14.7	13.9	11.8	11.5	13.8	15.1	13.6	8.4	6.6	9.4	3.5	9.6	12.2	21.4	25.8	15.9	26.4	33.2	9.8	21.2	22.3	11.4	8.6
KARS	"DFNB89, KARS1, KARS2"	ENSG00000065427	"Lysyl-tRNA synthetase"	Q15046	16	75627474-75648643	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, Transferase"	"Charcot-Marie-Tooth disease, Deafness, Disease mutation, Neurodegeneration, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041345, HPA041550"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			Cytosol	"Plasma membrane"	"HPA041345: AB_10795589, HPA041550: AB_10794520"	"unprognostic (1.56e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.39e-2)"	"prognostic unfavorable (8.84e-6)"	"unprognostic (6.24e-3)"	"unprognostic (8.97e-3)"	"unprognostic (1.18e-1)"	"unprognostic (9.11e-3)"	"unprognostic (8.71e-3)"	"unprognostic (8.46e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.13e-1)"	25.4	21.1	19.2	29.2	22.0	24.6	28.0	17.5	19.5	26.3	28.3	15.2	28.1	20.6	23.4	26.7	35.8	24.1	27.5	49.6	16.3	18.6	31.7	47.1	25.8	26.6	18.8	16.2	34.9	62.6	28.5	22.4	30.4	19.6	30.7	29.7	20.1	31.7	23.2	80.0	26.6	32.3	28.4	17.1	37.3	26.3	33.6	14.5	41.3	34.4	43.6	34.7	38.6	33.4	32.8	39.0	35.5	44.2	35.0	62.4	39.5	27.2	31.9	23.3	32.0	25.0	25.3	45.9	23.1	28.4	50.9	38.4	56.3	35.9	49.2	25.6	30.7	24.3	39.3	46.9	42.2	55.7	14.3	24.1	27.0	27.9	58.2	45.9	40.6	30.5	29.7	30.4	45.0	73.3	26.0	41.4	43.5	45.0	11.8	38.4	63.0	41.7	43.5	49.3	40.1	23.5	55.0	20.9	60.0	40.8	23.2	35.1	28.5	58.1	21.2	25.8	26.6	28.7	38.5	22.8	28.2	29.1	21.5	33.0	25.4	29.0	117.4	24.6	34.8	34.3	20.9	31.5	35.5	34.1	44.2	62.4	32.8	42.3	40.2	39.0	27.6	40.1	36.1	7.2	35.0	43.2	24.6	43.5	39.5	19.2	22.0	17.5	19.5	16.3	18.6	18.8	16.2	19.6	14.5	41.7	22.7	66.3	80.5	40.9	19.6	83.2	53.5	42.8	59.1	38.4	33.4	104.3	89.5	100.0	165.6	61.2	50.2	46.7	126.0	122.6	54.5	53.6	38.2	37.5	80.9	11.1	54.8	39.3	59.8	236.5	43.4	52.9	33.7	143.3	61.7	20.0	101.6	42.1	47.7	58.7	38.2	45.3	49.9	89.9	114.1	39.5	92.0	63.4	85.8	94.5
KCNAB1	"AKR6A3, hKvb3, hKvBeta3, KCNA1B, Kvb1.3"	ENSG00000169282	"Potassium voltage-gated channel subfamily A member regulatory beta subunit 1"	Q14722	3	156037701-156539138	"Predicted intracellular proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 41.1;thyroid gland: 25.7"	"Group enriched"	"Detected in many"	5	"Bipolar cells: 54.8;Cone photoreceptor cells: 29.5;Sertoli cells: 77.6;Smooth muscle cells: 66.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 5.9;hTEC/SVTERT24-B: 9.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 300.5"	"Low region specificity"	"Detected in all"			"HPA036110, HPA044550"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			Vesicles	"Nucleoplasm, Plasma membrane"	"HPA036110: , HPA044550: AB_10797032"	"unprognostic (1.52e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.98e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.83e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.87e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.00e-1)"	12.6	5.9	7.5	1.1	41.1	1.4	3.5	10.7	16.4	5.7	2.9	4.6	2.5	1.6	3.4	11.9	2.1	2.7	2.7	4.8	12.3	4.3	1.8	2.3	3.1	0.9	3.7	10.3	2.8	3.7	1.8	1.2	1.3	3.0	21.1	1.8	7.2	3.4	17.9	1.7	1.3	1.9	2.6	2.6	4.3	1.3	2.7	12.3	0.0	25.7	1.0	0.5	2.0	3.0	1.0	4.3	2.4	1.2	0.9	2.7	0.4	0.9	0.8	1.3	0.3	0.1	0.0	2.5	2.2	0.0	0.0	0.2	1.7	0.2	0.6	1.2	0.0	0.5	0.6	0.0	0.0	0.0	0.7	1.7	5.9	1.1	2.7	0.0	1.7	0.5	0.0	0.0	9.2	0.0	2.1	3.7	0.9	0.2	0.5	0.4	0.2	0.5	1.0	1.9	2.6	0.5	0.9	1.3	4.7	0.0	0.4	1.4	1.4	0.5	1.1	1.2	0.9	1.5	0.9	3.8	1.5	0.9	2.5	2.0	3.2	0.7	0.7	4.5	1.9	1.7	2.4	0.6	0.2	1.5	0.7	2.7	0.9	1.4	1.3	0.9	1.0	1.2	1.3	0.1	0.9	1.2	4.3	1.7	0.4	7.5	41.1	10.7	16.4	12.3	4.3	3.7	10.3	3.0	12.3	0.0	0.0	0.5	0.1	0.7	54.8	4.1	0.0	0.0	1.2	0.0	29.5	0.1	0.0	0.4	11.9	1.4	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	3.6	0.0	0.0	1.3	9.3	4.7	0.0	1.1	1.7	0.0	0.0	1.6	0.0	0.0	2.5	0.0	6.1	77.6	66.2	0.1	0.9	0.6	0.1	0.0	0.0	0.1
KCNH8	"elk3, Kv12.1"	ENSG00000183960	"Potassium voltage-gated channel subfamily H member 8"	Q96L42	3	19148454-19535646	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 31.3;pituitary gland: 16.1"	"Cell type enhanced"	"Detected in some"	8	"Bipolar cells: 4.7;Early spermatids: 2.7;Intestinal endocrine cells: 3.5;Melanocytes: 3.3;Muller glia cells: 3.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.1;naive B-cell: 4.5"	"Lineage enriched"	"Detected in single"	5	"B-cells: 4.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 2.1;OE19: 4.0;SH-SY5Y: 9.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA016586, HPA077537, HPA077773"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA016586: AB_1852127, HPA077537: , HPA077773: "	"unprognostic (6.68e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.99e-2)"	"unprognostic (8.56e-6)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.13e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.04e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.89e-2)"	"unprognostic (8.71e-5)"	"unprognostic (1.72e-1)"	0.6	7.0	8.4	1.6	22.0	1.4	2.4	1.3	11.4	1.3	1.9	31.3	0.0	2.2	1.2	1.2	0.7	1.4	2.2	1.0	11.8	5.7	0.7	0.7	0.8	3.2	16.4	10.2	0.7	2.7	0.8	16.1	0.6	15.0	2.2	2.5	0.1	3.3	1.4	0.6	1.9	1.8	1.1	9.9	2.6	5.9	4.0	18.1	0.0	1.1	0.0	3.2	0.9	0.5	4.5	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.8	4.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	9.4	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	4.5	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	8.4	22.0	1.3	11.4	11.8	5.7	16.4	10.2	15.0	18.1	0.0	0.0	0.0	1.6	0.5	4.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.7	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.0	0.0	0.1	0.0	3.5	0.0	0.0	1.1	0.0	0.0	3.3	0.0	1.7	3.7	0.6	0.0	0.0	0.0	0.9	0.0	0.2	0.7	1.9	0.0	0.1	0.0	0.2	0.2
KCNK17	"K2p17.1, TALK-2, TALK2, TASK-4, TASK4"	ENSG00000124780	"Potassium two pore domain channel subfamily K member 17"	Q96T54	6	39299001-39314553	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 29.1;retina: 20.0"	"Group enriched"	"Detected in some"	4	"Exocrine glandular cells: 7.3;granulocytes: 5.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	34	"plasmacytoid DC: 29.1"	"Lineage enriched"	"Detected in single"	34	"dendritic cells: 29.1"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 42.5"					"Not detected"	"Not detected"			HPA043892	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA043892: AB_10962838"	"unprognostic (5.33e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.95e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.77e-11)"	"unprognostic (5.89e-2)"	"unprognostic (5.36e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.86e-3)"	0.7	0.4	0.3	0.6	1.1	1.4	3.3	0.3	0.8	0.7	1.3	0.8	1.9	3.0	1.9	0.5	1.0	1.3	6.5	7.9	0.6	0.6	0.3	4.6	10.4	0.9	2.6	0.8	0.4	6.1	0.4	2.7	6.3	1.9	1.1	0.6	20.0	2.9	1.0	0.2	0.1	1.7	1.5	0.6	1.1	5.4	0.6	0.1	3.4	9.3	2.6	2.4	0.9	0.5	0.0	29.1	0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	42.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	29.1	0.0	0.1	0.3	1.1	0.3	0.8	0.6	0.6	2.6	0.8	1.9	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	5.8	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNS3	Kv9.3	ENSG00000170745	"Potassium voltage-gated channel modifier subfamily S member 3"	Q9BQ31	2	17877847-18361616	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 54.4"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 26.8;Intestinal endocrine cells: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"memory B-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"B-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"RH-30: 33.8;RPMI-8226: 13.6;RT4: 23.0;U-266/84: 15.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA014864	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Golgi apparatus, Plasma membrane"	"HPA014864: AB_1852155"	"unprognostic (5.62e-2)"	"unprognostic (4.27e-3)"	"unprognostic (6.87e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.30e-1)"	"unprognostic (9.47e-3)"	"unprognostic (9.06e-2)"	"unprognostic (8.45e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.71e-2)"	2.2	1.1	2.7	5.6	3.2	0.4	14.8	0.5	5.1	6.8	7.9	4.8	1.3	3.1	4.5	2.4	7.2	3.3	5.3	4.6	3.9	3.4	4.2	2.6	17.6	1.2	6.8	1.4	1.1	7.7	1.9	0.8	8.3	15.2	4.4	4.1	9.9	7.6	2.8	54.4	3.7	4.3	9.7	4.7	1.1	7.0	3.9	1.4	0.2	2.4	19.0	3.6	5.0	4.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.7	0.3	0.0	0.8	0.4	1.8	1.3	4.1	0.8	1.0	0.0	8.3	0.0	0.4	1.4	0.9	1.2	10.0	0.0	0.9	0.0	2.6	0.0	0.1	0.0	4.0	0.1	0.3	0.3	6.3	0.0	0.6	7.7	0.2	1.8	0.2	0.0	0.5	1.0	0.0	0.0	5.0	5.4	0.1	1.1	33.8	13.6	0.8	23.0	10.0	0.3	0.0	2.6	2.7	2.4	1.3	0.0	0.1	1.3	0.0	0.1	10.1	0.0	15.7	0.0	7.5	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.2	0.5	5.1	3.9	3.4	6.8	1.4	15.2	1.4	26.8	5.1	0.0	10.1	12.4	0.0	0.4	20.4	0.0	4.5	10.4	0.0	0.5	0.0	16.1	0.2	6.0	3.2	0.0	0.3	2.9	16.6	8.1	1.1	3.2	0.4	0.0	31.2	3.1	0.0	0.2	1.4	0.6	20.3	1.0	3.0	0.1	3.7	3.5	3.5	2.6	0.1	6.5	9.5	0.2	3.1	5.1	0.7	0.0	9.9	5.4
KDR	"CD309, FLK1, VEGFR, VEGFR2"	ENSG00000128052	"Kinase insert domain receptor"	P35968	4	55078259-55125595	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Endothelial cells: 100.3;Ito cells: 200.7;Muller glia cells: 229.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HUVEC TERT2: 32.5;TIME: 36.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB004028	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		7400000	"Plasma membrane"		"CAB004028: AB_2212507"	"unprognostic (1.61e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.86e-1)"	19.7	6.2	1.8	4.4	3.1	0.4	20.5	1.1	2.2	11.4	6.0	1.8	11.5	2.3	28.8	10.2	5.2	9.5	6.2	12.1	2.3	1.7	7.8	10.4	13.2	14.1	3.1	2.9	6.0	8.1	8.0	6.8	34.5	3.9	9.5	1.4	27.6	7.1	10.3	5.3	3.0	3.8	7.7	2.6	4.4	4.2	5.3	1.2	0.5	20.0	5.3	3.0	4.4	12.0	0.1	0.1	0.7	0.0	0.2	0.2	0.1	0.0	0.0	1.7	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	3.8	0.0	0.0	0.3	0.0	0.0	0.2	0.2	32.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	1.8	3.1	1.1	2.2	2.3	1.7	3.1	2.9	3.9	1.2	0.0	8.2	7.5	0.4	2.3	7.4	4.8	0.0	6.7	30.7	0.0	0.0	0.1	0.0	0.5	0.8	100.3	0.0	0.0	0.0	0.1	1.9	0.4	2.3	1.3	0.4	0.0	0.0	200.7	14.5	0.6	0.0	1.0	6.8	0.0	0.0	229.2	0.3	0.0	0.4	0.0	6.0	0.0	1.4	0.2	0.2	2.4	0.1	0.0	0.0	0.4
KEL	"CD238, ECE3"	ENSG00000197993	"Kell blood group, metallo-endopeptidase"	P23276	7	142941114-142962681	"Blood group antigen proteins, Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Blood group antigen, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 21.1;testis: 36.4"	"Cell type enriched"	"Detected in some"	14	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	7	"intermediate monocyte: 1.4"	"Lineage enriched"	"Detected in single"	14	"monocytes: 1.4"	"Group enriched"	"Detected in some"	12	"HEL: 15.3;K-562: 12.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064442			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA064442: "	"unprognostic (5.78e-3)"	"unprognostic (1.08e-5)"	"unprognostic (5.29e-3)"	"unprognostic (4.85e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.29e-3)"	"unprognostic (9.24e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.25e-3)"	0.2	0.0	0.9	2.5	1.1	21.1	0.2	0.2	0.4	0.4	0.2	0.3	0.2	0.0	0.2	0.2	0.6	0.1	0.2	0.2	1.4	0.7	0.4	0.2	1.4	5.0	2.0	0.2	0.2	0.2	0.0	0.2	1.1	0.3	0.2	0.0	0.3	2.5	0.2	0.2	0.0	0.5	0.2	4.4	3.8	0.0	36.4	0.3	0.4	0.2	0.2	3.7	0.2	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.4	0.1	0.0	0.0	0.5	0.3	0.3	0.0	0.0	0.1	0.0	0.1	0.0	1.2	0.0	0.1	0.2	0.0	0.5	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	1.1	0.2	0.4	1.4	0.7	2.0	0.2	0.3	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	2.3	3.5	0.0	0.0	1.7	0.2	1.9	0.0	0.0	46.7	0.0	0.2	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	1.0
KIAA1324	"EIG121, maba1"	ENSG00000116299	KIAA1324	Q6UXG2	1	109113679-109206781	"Predicted intracellular proteins, Predicted membrane proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 79.8;salivary gland: 169.4"	"Cell type enhanced"	"Detected in many"	9	"Glandular cells: 98.1;Intestinal endocrine cells: 156.4;Mucus-secreting cells: 151.0;Undifferentiated cells: 73.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 33.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 33.8"	"Cell line enhanced"	"Detected in some"		"MCF7: 14.5;SCLC-21H: 9.3;SK-BR-3: 11.3;T-47d: 38.6;U-87 MG: 7.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA029869, HPA070749"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA029869: AB_10794320, HPA070749: AB_2686304"	"unprognostic (2.10e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.99e-2)"	"prognostic favorable (2.14e-7)"	"unprognostic (4.18e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.96e-3)"	"prognostic favorable (5.69e-5)"	"unprognostic (2.79e-2)"	"prognostic favorable (2.16e-4)"	"unprognostic (3.50e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.22e-16)"	"unprognostic (2.46e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.02e-2)"	0.7	0.9	3.7	3.6	7.9	0.0	16.4	0.7	5.6	23.9	11.8	0.4	0.0	14.6	5.5	5.7	1.3	7.8	19.1	0.6	3.3	2.3	0.6	0.6	2.2	0.7	1.0	2.7	1.2	79.8	6.1	46.6	0.0	1.1	15.8	10.0	0.0	169.4	0.0	0.6	2.5	16.5	0.2	0.9	0.9	27.3	9.4	1.1	0.0	3.9	5.2	11.5	0.9	0.6	0.2	0.0	33.8	0.0	0.2	4.6	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.4	0.1	0.0	0.1	0.0	0.0	0.2	0.5	0.8	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.3	14.5	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.5	0.2	0.0	9.3	0.2	0.0	11.3	0.0	0.0	38.6	0.0	0.2	0.0	1.4	0.0	0.1	0.8	2.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	2.2	0.0	3.9	0.2	3.9	1.7	0.0	0.0	1.8	0.7	33.8	0.2	0.0	0.0	4.6	1.0	3.7	7.9	0.7	5.6	3.3	2.3	1.0	2.7	1.1	1.1	14.9	43.1	0.0	6.2	0.5	5.1	1.5	0.0	34.8	62.6	0.0	3.9	0.5	0.0	0.9	32.7	0.5	13.1	0.0	33.1	0.6	1.6	98.1	22.1	0.0	0.9	1.6	156.4	1.3	1.6	12.3	4.0	2.3	3.3	0.0	151.0	1.4	16.5	24.6	2.1	0.0	2.6	0.0	1.4	13.7	1.7	1.4	0.5	4.4	73.4	8.3
KIAA1522		ENSG00000162522	KIAA1522	Q9P206	1	32741885-32774970	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 90.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 38.4;hTCEpi: 32.0;RT4: 35.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA032050, HPA032051, HPA064839"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA032050: AB_10601764, HPA032051: AB_2674126, HPA064839: AB_2685366"	"unprognostic (7.98e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (6.29e-7)"	"unprognostic (1.58e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (8.25e-5)"	"unprognostic (4.55e-2)"	"prognostic favorable (1.29e-5)"	"unprognostic (1.35e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.12e-1)"	3.7	39.4	12.1	8.6	8.7	0.7	14.1	1.6	15.8	8.7	25.9	2.7	27.8	28.1	5.4	8.7	33.8	13.5	28.8	2.3	6.4	4.5	23.1	5.9	13.4	0.8	2.4	6.6	18.0	32.8	21.7	4.8	19.3	7.3	18.5	17.4	10.0	36.9	44.6	1.8	33.4	36.0	6.8	1.6	1.1	25.5	2.9	3.0	3.1	19.2	17.9	20.3	15.0	22.3	0.0	2.1	0.0	1.0	0.0	0.4	0.2	19.4	10.2	1.6	2.8	0.7	1.5	7.6	2.4	4.7	2.8	2.7	11.1	38.4	0.0	10.1	3.5	8.2	29.0	3.1	20.6	1.4	0.0	4.1	4.0	14.5	9.0	1.2	0.0	10.4	0.5	32.0	7.3	8.8	12.5	5.7	0.8	5.8	0.1	1.3	16.1	0.1	0.1	3.4	16.8	6.4	2.6	2.1	4.9	26.5	35.5	1.4	1.4	15.0	21.6	2.9	10.9	23.0	1.3	5.3	4.6	12.6	4.2	5.1	0.2	0.1	0.1	4.7	0.7	5.3	0.0	0.6	0.0	0.0	1.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	12.1	8.7	1.6	15.8	6.4	4.5	2.4	6.6	7.3	3.0	11.9	49.9	0.5	31.7	65.7	0.5	3.3	76.5	20.1	23.9	26.2	2.0	12.1	8.3	38.3	3.6	6.7	90.1	0.0	57.6	3.7	5.6	56.0	26.6	8.6	2.5	0.0	27.9	1.3	0.3	3.6	8.1	2.5	6.8	3.6	55.5	0.8	52.7	49.1	4.6	12.5	0.0	6.5	5.0	1.8	2.5	72.6	6.6	1.9	54.5	60.9
KISS1R	"AXOR12, GPR54, HOT7T175"	ENSG00000116014	"KISS1 receptor"	Q969F8	19	917287-921015	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.8;lymphoid tissue: 12.4"	"Cell type enriched"	"Detected in some"	18	"Extravillous trophoblasts: 31.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 3.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.0;neutrophil: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"K-562: 10.8;RPMI-8226: 26.3;SCLC-21H: 5.5;SH-SY5Y: 14.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007156, HPA071913"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA007156: , HPA071913: AB_2686471"	"unprognostic (1.54e-1)"	"unprognostic (3.01e-2)"	"unprognostic (9.42e-2)"	"unprognostic (2.15e-1)"	"unprognostic (8.46e-3)"	"unprognostic (9.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.17e-2)"	"prognostic unfavorable (3.33e-6)"	"unprognostic (1.87e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.05e-2)"	0.2	0.2	2.1	2.1	4.1	0.2	0.3	0.1	4.7	0.1	0.3	0.1	0.1	0.4	0.2	0.1	0.1	0.2	0.1	0.1	1.0	6.8	1.4	0.1	0.3	12.4	1.1	0.1	0.4	3.6	0.1	2.0	1.0	0.8	0.2	0.2	0.3	0.3	0.1	0.1	0.1	0.7	0.5	1.0	2.4	0.4	0.1	0.1	0.1	0.1	0.1	0.6	0.5	0.1	0.6	0.0	1.8	0.0	0.0	2.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.2	2.9	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.8	0.0	0.0	0.2	0.1	0.0	0.4	0.8	0.3	0.7	0.0	26.3	0.0	0.0	5.5	14.7	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.7	0.0	0.0	0.1	2.0	0.6	1.8	0.0	0.0	0.0	0.1	0.0	2.1	4.1	0.1	1.5	1.0	6.8	1.1	0.1	0.8	0.1	0.0	0.0	1.4	0.1	0.1	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.2	31.2	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.3	1.4	0.0	0.0	0.0
KIT	"C-Kit, CD117, PBT, SCFR"	ENSG00000157404	"KIT proto-oncogene receptor tyrosine kinase"	P10721	4	54657918-54740715	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 65.5"	"Group enriched"	"Detected in many"	10	"granulocytes: 496.5;Melanocytes: 200.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 12.7;eosinophil: 10.0;NK-cell: 9.7"	"Group enriched"	"Detected in many"	6	"granulocytes: 12.7;NK-cells: 9.7"	"Group enriched"	"Detected in some"	13	"HEL: 48.8;HMC-1: 102.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003288, HPA004471, CAB068253, CAB072867, HPA073252"	Enhanced	Supported	Supported	"Plasma membrane"		NA	NA		48000000	"Plasma membrane"		"CAB003288: AB_2335702, CAB068253: AB_2665717, CAB072867: AB_2665718, HPA004471: AB_1078431, HPA073252: AB_2686589"	"unprognostic (1.55e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (5.63e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.30e-1)"	8.1	1.6	9.5	6.6	11.8	3.7	65.5	18.3	12.0	12.1	10.3	6.5	10.2	5.8	8.9	4.2	9.9	2.5	15.5	2.4	36.0	4.4	9.4	1.1	13.8	3.8	3.6	6.0	28.5	2.1	1.3	2.3	6.2	5.7	9.6	10.4	20.7	12.9	6.9	1.3	14.6	8.9	10.2	3.9	3.2	12.8	4.0	4.5	0.4	28.9	4.3	4.9	9.8	12.5	0.0	1.8	12.7	0.9	9.7	1.9	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.6	0.9	2.6	3.2	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.5	0.0	2.2	0.0	1.2	48.8	0.0	0.0	0.0	0.0	102.6	0.0	0.0	0.0	0.0	0.0	5.7	0.8	0.6	0.1	0.0	0.0	0.2	0.4	1.4	0.0	0.0	0.1	0.0	0.0	0.0	4.8	1.2	0.4	0.0	0.0	0.0	3.0	0.0	0.5	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	12.7	0.0	10.0	0.1	0.0	1.9	0.0	0.3	0.7	1.8	0.0	0.0	0.0	0.8	9.7	0.9	0.0	0.0	0.1	9.5	11.8	18.3	12.0	36.0	4.4	3.6	6.0	5.7	4.5	6.0	34.8	1.4	1.1	12.7	0.0	0.4	5.1	0.0	5.7	3.5	0.0	0.0	3.3	0.8	0.0	2.4	0.0	0.0	0.0	0.1	1.3	0.5	496.5	0.0	0.3	0.0	5.2	1.8	0.3	0.0	1.1	3.1	200.8	0.0	0.3	2.4	0.0	0.0	0.0	0.6	0.3	0.0	0.5	0.0	8.2	3.3	0.2	2.2	0.3	0.3
KLK7	"PRSS6, SCCE"	ENSG00000169035	"Kallikrein related peptidase 7"	P49862	19	50976482-50984099	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 29.1;skin 1: 77.5;tongue: 90.2"	"Cell type enhanced"	"Detected in some"	20	"Alveolar cells type 1: 6.0;Basal keratinocytes: 4.4;Suprabasal keratinocytes: 9.4"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 139.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"CAPAN-2: 6.7;HaCaT: 26.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018994, CAB026342, HPA062126"	Enhanced		Supported	"Nuclear membrane,Plasma membrane"	"Secreted in other tissues"	NA	NA		960000	"Plasma membrane"	"Nuclear membrane"	"CAB026342: , HPA018994: AB_1852607, HPA062126: AB_2684691"	"unprognostic (1.88e-2)"	"unprognostic (6.41e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (8.06e-5)"	"unprognostic (4.33e-3)"	"unprognostic (2.28e-1)"		"unprognostic (4.44e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.25e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.60e-3)"	2.1	0.3	5.4	0.3	4.3	0.4	5.6	0.5	11.3	5.4	0.3	0.0	0.0	0.5	0.7	0.3	29.1	7.8	3.3	0.2	4.8	0.5	2.6	0.2	1.6	0.3	0.3	3.5	1.0	0.2	0.2	0.1	0.5	4.2	0.3	0.2	0.0	7.4	0.3	0.6	77.5	0.3	0.4	0.3	0.5	0.4	0.3	0.0	0.0	0.4	90.2	15.3	0.2	9.0	1.1	0.4	1.3	0.8	2.1	1.0	0.6	2.7	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.5	6.7	0.0	1.0	0.0	0.1	26.6	0.0	0.9	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.1	1.3	0.8	0.4	0.4	0.4	0.7	0.6	0.6	0.4	0.4	1.1	1.0	0.9	0.9	2.1	0.4	0.4	0.7	0.6	5.4	4.3	0.5	11.3	4.8	0.5	0.3	3.5	4.2	0.0	6.0	0.6	0.0	0.1	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	9.4	0.0	0.0	0.0	1.8
KLRK1	"CD314, D12S2489E, KLR, NKG2-D, NKG2D"	ENSG00000213809	"Killer cell lectin like receptor K1"	P26718	12	10372353-10391874	"Cancer-related genes, CD markers, Predicted membrane proteins, Transporters"	"Adaptive immunity, Differentiation, Immunity, Innate immunity"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 50.8;lymphoid tissue: 30.7"	"Cell type enriched"	"Detected in some"	9	"T-cells: 20.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	39	"gdT-cell: 49.4;MAIT T-cell: 18.5;memory CD8 T-cell: 44.0;naive CD8 T-cell: 44.3;NK-cell: 50.8"	"Group enriched"	"Detected in many"	47	"NK-cells: 50.8;T-cells: 49.4"	"Cell line enriched"	"Detected in some"	8	"U-698: 36.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB021896, HPA068877"	Enhanced		Supported	"Plasma membrane"		NA	NA		33000	"Plasma membrane"		"CAB021896: , HPA068877: AB_2686052"	"unprognostic (3.34e-4)"	"unprognostic (2.65e-4)"	"unprognostic (3.25e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.01e-5)"	"unprognostic (5.61e-4)"	"unprognostic (1.00e-3)"	"unprognostic (1.33e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.10e-2)"	"unprognostic (6.56e-10)"	"unprognostic (1.24e-2)"	"unprognostic (6.32e-2)"	"unprognostic (7.59e-2)"	"unprognostic (7.08e-10)"	4.1	0.9	1.3	18.3	1.1	10.6	2.1	0.4	0.8	2.8	4.5	1.2	0.6	2.0	2.4	2.7	3.1	2.0	7.7	1.3	1.3	1.1	2.4	3.6	13.6	22.2	2.1	0.1	1.5	3.3	0.0	1.2	1.6	1.2	2.2	2.1	2.4	7.0	0.6	0.5	1.1	13.1	1.3	2.1	30.7	3.3	1.9	0.6	6.0	2.9	2.8	11.4	11.3	2.5	1.0	0.2	0.8	0.1	50.8	49.4	16.7	0.2	0.0	0.4	1.9	0.1	4.7	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.1	0.1	0.0	0.4	0.7	0.0	0.2	0.0	0.2	0.1	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	1.2	0.1	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	36.9	0.1	0.0	0.2	0.0	0.0	0.0	49.4	0.1	18.5	0.8	0.3	44.0	0.1	1.0	0.4	44.3	0.8	50.8	0.1	0.2	0.1	16.7	1.3	1.1	0.4	0.8	1.3	1.1	2.1	0.1	1.2	0.6	0.0	2.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	20.3	0.0	0.0
L1CAM	"CD171, HSAS, HSAS1, MASA, MIC5, S10, SPG1"	ENSG00000198910	"L1 cell adhesion molecule"	P32004	X	153861514-153886174	"CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein"	"Disease mutation, Hereditary spastic paraplegia, Hirschsprung disease, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 29.6;brain: 54.5"	"Group enriched"	"Detected in some"	6	"Collecting duct cells: 80.3;Horizontal cells: 31.8;Melanocytes: 42.2"	"Cancer enhanced"	"Detected in many"		"melanoma: 34.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 1.0;naive B-cell: 2.2"	"Lineage enriched"	"Detected in single"	7	"B-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 73.5;BJ hTERT+ SV40 Large T+ RasG12V: 40.4;HeLa: 53.0;RH-30: 32.2;RPTEC TERT1: 43.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010896	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		59000000	"Nucleoplasm, Plasma membrane"		"CAB010896: AB_609903"	"unprognostic (1.33e-3)"	"unprognostic (3.43e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (8.51e-10)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (3.81e-4)"	"unprognostic (9.44e-2)"	"prognostic unfavorable (2.36e-6)"	"unprognostic (1.13e-1)"	"unprognostic (9.12e-2)"	"unprognostic (8.52e-3)"	"unprognostic (8.02e-2)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (3.07e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.47e-3)"	4.4	29.6	19.9	8.0	21.9	1.2	1.7	54.5	43.6	2.8	16.3	1.5	2.0	4.9	1.7	3.0	5.3	2.6	3.2	5.2	11.2	20.6	12.3	1.3	1.3	3.7	7.3	22.4	1.4	3.0	1.0	6.1	1.4	19.3	3.5	5.7	6.2	5.9	10.8	1.6	9.9	7.6	6.1	3.5	1.7	4.8	1.5	3.4	0.0	1.2	1.3	2.6	2.3	3.9	2.2	0.0	0.0	0.0	0.0	0.3	0.2	17.9	1.4	5.4	0.0	0.0	0.0	2.3	25.5	73.5	24.6	40.4	7.3	0.1	0.0	24.3	0.1	20.6	0.7	0.6	0.4	12.9	0.0	0.1	0.0	53.0	1.1	0.0	0.0	4.0	0.1	0.3	3.7	2.5	0.0	0.0	0.0	0.0	0.0	0.1	24.4	0.0	0.5	1.2	0.0	0.9	0.0	32.2	0.1	43.2	0.3	16.2	10.6	14.3	12.7	10.3	12.7	1.3	0.3	0.0	0.0	10.8	1.1	12.1	0.2	0.3	0.1	0.1	0.2	20.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	19.9	21.9	54.5	30.2	11.2	20.6	7.3	22.4	19.3	3.4	0.0	0.0	0.8	0.0	1.0	8.5	0.8	0.0	0.0	0.0	80.3	3.9	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.1	31.8	0.0	1.8	0.0	0.0	0.9	0.0	42.2	0.0	0.0	0.8	0.0	0.0	0.0	0.2	8.6	0.0	0.4	0.0	0.1	1.1	0.1	0.0	0.0	0.1
LAIR1	CD305	ENSG00000167613	"Leukocyte associated immunoglobulin like receptor 1"	Q6GTX8	19	54351384-54370558	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 39.0"	"Cell type enhanced"	"Detected in many"	12	"granulocytes: 103.2;Hofbauer cells: 178.5;Kupffer cells: 84.4;Macrophages: 142.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HMC-1: 6.6;Karpas-707: 17.1;THP-1: 19.4"									HPA011155	Enhanced		Supported	"Plasma membrane"		NA	NA		130000	"Plasma membrane"		"HPA011155: AB_1852685"	"unprognostic (1.91e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (5.01e-5)"	"unprognostic (1.72e-1)"	"unprognostic (2.72e-3)"	"unprognostic (3.52e-2)"	"unprognostic (5.22e-2)"	12.7	7.0	4.5	10.9	9.9	13.5	6.9	0.5	4.5	2.7	5.1	6.7	0.2	2.7	2.2	6.8	2.5	3.6	4.4	3.9	5.2	4.2	3.8	2.9	16.5	33.1	10.2	1.9	2.0	2.4	1.4	2.8	7.0	7.0	3.0	2.0	3.1	3.9	2.2	2.3	2.3	7.6	7.8	11.9	28.6	2.9	3.1	7.4	39.0	2.0	0.5	6.1	3.7	1.7	6.0	10.3	12.4	8.8	5.8	8.0	5.7	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	2.8	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	17.1	0.0	0.0	2.2	1.5	0.0	0.0	0.0	2.2	0.1	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	19.4	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2	2.7	0.2	12.4	4.2	10.0	8.0	8.3	4.6	2.3	2.4	4.3	0.1	6.0	3.8	4.9	0.6	5.8	8.8	10.3	1.6	5.7	4.5	9.9	0.5	4.5	5.2	4.2	10.2	1.9	7.0	7.4	14.9	34.1	29.8	0.5	0.6	5.5	1.3	0.0	20.1	20.5	0.0	35.3	4.4	0.0	0.0	15.9	0.7	0.0	0.0	0.0	4.1	1.9	0.5	103.2	0.8	178.5	1.6	0.0	4.3	84.4	20.4	0.3	142.0	0.0	1.0	0.0	1.1	0.1	0.0	0.0	0.1	14.8	0.0	0.9	1.4	1.0	1.0	8.4	33.0	0.0	0.8
LAMP2	CD107b	ENSG00000005893	"Lysosomal associated membrane protein 2"	P13473	X	120427827-120469365	"CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Autophagy		"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 336.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 112.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 112.9"	"Cell line enhanced"	"Detected in all"		"ASC diff: 112.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005272, HPA029100, HPA029101"	Supported		Supported	"Vesicles,Plasma membrane"		NA	NA		820000000	"Vesicles, Plasma membrane"		"CAB005272: AB_647855, HPA029100: AB_10795022, HPA029101: "	"unprognostic (2.99e-3)"	"unprognostic (5.26e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.50e-2)"	"unprognostic (4.84e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.53e-3)"	21.8	33.6	39.9	16.1	87.9	22.6	27.1	16.2	55.5	33.0	18.3	88.7	27.9	25.1	20.8	37.5	34.6	22.4	43.3	20.9	52.5	30.3	55.0	83.7	25.3	14.3	131.0	36.9	22.7	27.4	28.8	20.2	35.4	58.6	37.3	19.7	17.2	47.8	32.9	32.4	26.9	20.5	21.1	84.3	17.9	23.6	11.9	116.9	21.2	33.7	14.3	15.4	21.1	27.0	3.7	11.6	112.9	21.7	5.4	5.8	10.5	11.7	11.6	8.6	10.9	112.3	38.3	23.6	20.3	35.4	19.7	37.0	9.6	21.0	8.3	17.9	35.2	63.0	19.7	12.4	15.3	32.2	9.3	8.8	6.5	12.9	12.9	37.4	28.7	18.2	41.5	30.9	26.3	17.4	52.1	26.9	5.9	7.5	29.7	31.9	21.6	8.0	14.7	6.6	16.8	10.2	6.2	14.5	14.8	28.9	8.7	2.9	4.5	21.7	22.1	43.3	15.8	13.1	32.1	27.8	28.4	13.8	36.5	54.7	14.9	14.2	5.4	27.1	34.7	67.9	4.9	21.7	41.3	5.0	18.7	4.0	3.1	4.8	4.7	11.6	3.7	4.3	4.1	112.9	5.4	17.3	6.3	5.8	10.5	39.9	87.9	16.2	55.5	52.5	30.3	131.0	36.9	58.6	116.9	68.5	48.0	23.8	73.6	89.6	15.0	29.0	186.0	44.2	52.4	62.8	13.7	140.2	33.2	170.8	2.3	65.2	53.1	0.0	62.0	111.7	86.5	124.2	16.3	167.8	191.1	17.5	35.2	100.7	120.2	4.2	105.3	97.6	124.9	124.4	31.2	128.8	66.8	43.5	103.3	128.2	9.3	38.8	61.8	5.6	13.2	119.1	336.5	30.5	31.0	76.1
LAMTOR1	"C11orf59, FLJ20625, p18, p27RF-Rho, Pdro, Ragulator1"	ENSG00000149357	"Late endosomal/lysosomal adaptor, MAPK and MTOR activator 1"	Q6IAA8	11	72085895-72103387	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002997	Approved		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA		270000	"Golgi apparatus"	"Vesicles, Plasma membrane"	"HPA002997: AB_1845531"	"unprognostic (7.32e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.71e-2)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (1.00e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.78e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.04e-1)"	47.3	55.3	51.3	33.3	55.6	49.7	69.1	23.1	51.1	43.3	40.4	44.1	39.4	35.1	36.0	48.1	42.2	40.7	44.0	59.9	45.4	41.4	58.0	60.5	44.3	71.5	52.5	29.9	38.0	45.0	33.3	37.6	41.6	38.1	39.8	40.2	40.4	45.0	45.5	57.6	33.2	41.8	38.8	49.0	52.9	35.6	22.6	31.9	28.2	61.3	39.4	40.0	32.7	35.0	25.7	57.7	44.9	68.7	19.7	16.4	55.4	17.7	35.1	19.0	23.1	41.8	29.0	19.1	24.7	35.2	38.1	29.0	44.4	24.4	17.9	32.0	38.8	41.8	25.8	29.7	49.6	27.5	22.4	19.7	46.8	22.6	29.7	59.6	18.1	27.9	50.1	36.3	40.3	38.5	22.0	30.5	20.3	19.6	16.6	37.4	56.1	14.0	28.2	17.9	52.5	38.5	12.3	32.9	14.4	47.6	37.6	11.6	19.8	25.0	23.5	62.8	19.9	34.6	16.1	24.5	26.2	19.3	61.8	17.1	22.3	25.3	13.7	15.3	14.5	19.8	17.7	68.7	44.9	15.0	38.6	14.4	23.8	14.2	14.9	57.7	25.7	12.0	14.6	40.5	19.7	29.3	34.3	16.4	55.4	51.3	55.6	23.1	51.1	45.4	41.4	52.5	29.9	38.1	31.9	41.7	67.1	112.5	126.6	49.5	55.8	59.6	117.2	40.2	38.7	122.1	11.8	215.3	250.4	239.8	8.2	119.1	202.2	23.3	296.4	256.0	106.0	156.2	96.8	74.4	406.3	73.1	111.8	121.5	233.5	14.8	99.8	203.7	108.0	462.5	116.1	147.8	252.3	157.8	96.5	288.8	41.4	109.9	92.7	47.9	102.2	48.4	235.8	114.6	149.4	137.5
LASP1	"Lasp-1, MLN50"	ENSG00000002834	"LIM and SH3 protein 1"	Q14847	17	38869859-38921770	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ion transport, Transport"	Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 124.5"	"Cell type enhanced"	"Detected in many"	8	"Late spermatids: 467.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012072, CAB022049"	Enhanced		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA		26000000	"Plasma membrane, Cytosol"	"Focal adhesion sites"	"CAB022049: , HPA012072: AB_1852714"	"unprognostic (1.23e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (1.06e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.60e-2)"	"unprognostic (9.87e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.29e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.60e-3)"	"unprognostic (4.53e-2)"	51.2	20.0	23.8	40.3	22.4	45.4	35.5	15.5	25.7	23.6	57.4	16.3	18.7	54.4	23.4	24.1	22.4	20.8	48.3	15.2	18.4	23.3	33.1	47.5	33.3	44.2	20.0	14.3	28.4	30.1	10.1	17.6	40.0	16.1	18.9	38.6	24.2	22.4	24.1	10.7	18.3	124.5	21.3	12.2	43.1	39.5	13.9	12.9	40.5	18.3	18.7	33.7	22.0	28.3	6.4	13.9	34.0	19.9	17.3	16.5	13.1	35.4	73.9	21.6	19.1	31.8	34.5	37.3	44.6	43.6	47.0	34.6	22.0	38.6	16.2	37.3	68.9	26.7	56.5	9.8	33.9	41.2	11.8	5.3	7.7	21.4	38.3	30.2	17.8	23.4	30.6	11.9	39.8	11.3	29.4	31.5	10.0	13.1	5.4	65.4	11.7	21.1	27.5	10.8	31.2	18.5	11.9	11.5	20.4	57.7	31.2	3.2	7.9	26.5	27.9	23.1	41.8	44.0	21.8	55.0	28.2	41.2	33.0	27.0	14.0	18.4	12.6	29.8	16.0	33.9	9.9	14.8	16.8	16.5	17.1	11.3	6.4	8.4	11.0	13.9	6.3	7.2	10.9	34.0	17.3	19.9	10.7	10.7	13.1	23.8	22.4	15.5	25.7	18.4	23.3	20.0	14.3	16.1	12.9	38.7	25.9	38.3	19.5	37.2	55.7	0.8	66.2	32.1	19.4	69.8	9.8	4.3	14.9	58.2	85.5	48.9	225.0	0.0	65.7	33.5	47.6	22.3	51.8	85.9	75.8	25.4	83.1	70.6	116.7	467.6	48.1	58.0	33.7	52.3	91.2	21.1	95.7	106.3	37.4	62.1	22.0	64.7	29.7	2.1	4.1	24.8	5.4	60.9	75.9	23.8
LAT	LAT1	ENSG00000213658	"Linker for activation of T cells"	O43561	16	28984826-28990783	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Adaptive immunity, Immunity, Mast cell degranulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	10	"blood: 58.1;lymphoid tissue: 193.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 73.2;T-cells: 103.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	18	"basophil: 38.2;gdT-cell: 47.9;MAIT T-cell: 33.5;memory CD4 T-cell: 46.9;memory CD8 T-cell: 47.9;naive CD4 T-cell: 44.6;naive CD8 T-cell: 42.6;NK-cell: 15.7;T-reg: 58.1"	"Group enriched"	"Detected in many"	134	"granulocytes: 38.2;NK-cells: 15.7;T-cells: 58.1"	"Cell line enhanced"	"Detected in some"		"HEL: 31.0;HMC-1: 131.1;MOLT-4: 44.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002223, HPA011157, CAB012978"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA		75000	"Plasma membrane"	"Golgi apparatus"	"CAB002223: AB_563852, CAB012978: , HPA011157: AB_1079237"	"unprognostic (4.35e-3)"	"unprognostic (5.17e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.15e-5)"	"unprognostic (1.17e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.52e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.02e-8)"	"unprognostic (1.04e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.51e-4)"	4.8	1.8	1.6	27.6	3.0	8.5	2.5	6.6	2.3	3.9	10.8	2.0	2.0	4.9	7.7	3.1	4.3	4.2	5.8	3.1	1.9	1.9	6.0	3.3	7.8	33.2	1.7	1.7	3.0	2.7	1.4	6.0	2.8	1.8	8.5	2.8	3.1	12.2	5.4	2.0	5.8	9.0	3.1	1.9	13.9	5.1	2.3	1.7	193.6	7.3	4.6	50.3	6.4	5.4	0.2	0.2	38.2	0.2	15.7	58.1	26.8	0.1	0.3	0.2	0.4	0.6	0.3	0.8	0.8	0.2	0.2	0.3	0.3	0.5	0.1	1.1	0.3	0.1	0.4	0.4	0.2	0.1	0.2	0.5	31.0	0.7	0.5	0.1	0.9	131.1	0.3	0.6	0.2	0.1	0.4	0.1	10.5	0.4	3.7	0.1	0.8	44.6	6.1	0.5	0.0	0.4	0.5	0.1	3.9	0.3	0.2	0.8	0.1	0.1	0.3	0.3	0.2	0.4	5.1	0.6	0.6	3.0	0.6	0.2	1.2	1.0	0.4	7.9	0.4	0.5	38.2	0.2	0.1	47.9	0.2	33.5	0.2	46.9	47.9	0.1	0.2	44.6	42.6	2.3	15.7	0.1	0.2	58.1	26.8	1.6	3.0	6.6	2.3	1.9	1.9	1.7	1.7	1.8	1.7	0.0	19.1	1.9	1.7	6.4	10.4	0.4	7.6	0.0	4.5	8.7	5.9	1.9	1.7	1.3	0.1	2.4	0.7	0.0	0.5	0.8	2.7	1.8	73.2	2.6	14.9	6.4	0.0	8.6	6.5	0.0	1.4	9.0	10.1	1.8	1.5	5.7	0.7	0.0	0.7	0.4	10.7	0.0	3.4	1.4	2.4	4.5	2.3	103.8	1.3	0.7
LAT2	"HSPC046, LAB, NTAL, WBSCR15, WBSCR5, WSCR5"	ENSG00000086730	"Linker for activation of T cells family member 2"	Q9GZY6	7	74199652-74229834	"Disease related genes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Mast cell degranulation"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 98.4;lymphoid tissue: 36.7"	"Cell type enhanced"	"Detected in many"	12	"B-cells: 89.1;granulocytes: 165.4;Hofbauer cells: 75.1;Kupffer cells: 75.9;Macrophages: 83.0;monocytes: 54.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 98.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"NB-4: 46.6;REH: 53.0;RPMI-8226: 19.0;THP-1: 48.0;U-937: 46.8"					"Low region specificity"	"Detected in all"			HPA003462	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"HPA003462: AB_1079238"	"unprognostic (1.24e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.30e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.34e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (4.10e-4)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (7.44e-2)"	"unprognostic (2.03e-1)"	4.6	3.7	10.3	21.4	19.3	32.8	2.5	2.7	9.6	2.8	3.9	11.6	0.5	3.3	2.5	2.4	2.5	3.8	5.9	2.4	8.8	6.5	3.0	3.8	11.6	29.3	21.9	2.5	1.4	2.8	1.0	2.8	4.4	15.7	4.5	4.7	2.3	3.6	2.2	2.7	1.8	9.9	5.0	19.3	36.7	3.6	1.6	17.6	3.2	2.4	1.0	32.7	5.8	4.6	26.8	32.5	98.4	39.5	10.0	1.3	24.7	0.4	0.2	0.2	0.8	0.0	0.0	0.3	0.3	0.3	0.2	0.2	0.5	8.1	5.3	0.1	0.1	1.6	0.2	0.0	0.3	0.1	8.5	0.3	2.1	0.3	0.3	0.0	15.5	15.6	0.1	0.2	0.5	0.1	0.3	0.0	0.2	0.3	2.4	0.2	0.3	0.3	46.6	0.2	1.3	0.5	53.0	0.2	19.0	0.0	0.4	0.2	0.2	0.1	0.3	0.2	0.2	0.2	48.0	0.6	0.6	5.6	0.2	0.4	0.2	1.5	8.3	2.7	46.8	0.3	98.4	39.5	5.9	1.3	22.3	0.1	24.4	0.3	0.1	32.5	26.8	0.1	0.4	69.1	10.0	12.4	1.2	0.6	24.7	10.3	19.3	2.7	9.6	8.8	6.5	21.9	2.5	15.7	17.6	3.0	23.9	89.1	0.6	3.1	0.0	0.8	7.6	10.7	5.7	3.5	0.0	0.5	0.0	0.0	2.3	1.0	0.0	0.0	0.2	0.9	1.4	1.0	165.4	3.2	75.1	0.0	7.5	4.9	75.9	1.9	0.0	83.0	1.7	54.1	0.2	0.3	0.6	0.0	0.7	0.0	1.3	0.0	0.7	0.4	1.1	2.3	1.0	51.6	0.4	0.5
LINGO1	"FLJ14594, LERN1, LRRN6A"	ENSG00000169783	"Leucine rich repeat and Ig domain containing 1"	Q96FE5	15	77613027-77820900	"Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 67.2"	"Cell type enhanced"	"Detected in some"	22	"Horizontal cells: 125.5;Muller glia cells: 49.3;Sertoli cells: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 13.2;AN3-CA: 11.0;HAP1: 16.7;HEK 293: 11.7;NTERA-2: 31.4;SuSa: 13.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074653	Enhanced		Supported	"Plasma membrane"		NA	NA		8400	"Plasma membrane"		"HPA074653: AB_2686706"	"unprognostic (1.06e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (3.23e-7)"	"unprognostic (2.07e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.59e-2)"	3.0	1.6	27.4	1.7	21.8	0.8	1.3	9.1	67.2	3.8	2.0	5.9	0.0	2.0	3.3	2.7	1.4	3.1	2.5	9.7	29.8	12.2	2.2	1.1	1.1	1.3	10.3	21.8	1.7	2.7	1.1	0.5	6.1	6.8	1.7	1.5	1.8	3.4	2.5	1.0	3.0	1.5	4.5	6.8	3.3	2.0	3.7	3.9	0.0	1.7	0.0	1.1	3.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	13.2	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.2	0.0	16.7	0.0	0.0	0.0	11.7	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	7.2	0.0	0.0	31.4	0.7	0.0	0.0	0.0	0.2	0.0	0.0	2.4	0.7	0.0	1.3	2.8	13.1	0.2	0.2	1.1	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.4	21.8	9.1	47.5	29.8	12.2	10.3	21.8	6.8	3.9	0.0	0.0	0.0	0.1	0.2	14.5	6.1	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.5	8.3	0.9	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.2	125.5	0.0	3.7	0.0	13.7	0.3	0.0	3.3	0.0	0.0	49.3	0.3	8.6	0.4	0.0	15.9	25.8	5.7	0.1	2.5	0.1	0.2	0.0	0.0	0.0
LPAR1	"edg-2, EDG2, Gpcr26, GPR26, LPA1, Mrec1.3, rec.1.3, vzg-1"	ENSG00000198121	"Lysophosphatidic acid receptor 1"	Q92633	9	110873263-111038458	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.4"	"Cell type enhanced"	"Detected in many"	12	"Fibroblasts: 45.6;Leydig cells: 35.9;Peritubular cells: 66.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 7.5;eosinophil: 15.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 15.6;monocytes: 7.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 98.3;ASC TERT1: 57.4;BJ hTERT+: 69.5;HSkMC: 41.7"	"Low region specificity"	"Detected in all"							HPA050667			Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Nuclear speckles"	"Plasma membrane"	"HPA050667: "	"unprognostic (1.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.79e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.29e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.42e-3)"	"unprognostic (2.78e-2)"	"unprognostic (9.97e-3)"	"unprognostic (1.65e-1)"	16.3	9.5	55.8	12.0	56.2	0.3	14.8	4.7	30.9	43.7	12.3	71.4	3.4	9.4	12.1	12.3	10.6	10.1	9.8	8.5	55.6	30.6	5.7	1.9	7.3	10.5	59.4	17.0	8.9	4.6	1.1	2.3	25.7	29.1	9.4	12.8	3.5	5.6	17.2	3.3	6.9	10.2	14.0	69.8	9.5	6.5	4.8	49.4	0.1	6.2	3.2	11.3	15.4	17.8	0.0	1.9	15.6	7.5	1.8	0.0	1.6	1.8	3.5	5.0	0.0	98.3	57.4	0.0	24.5	69.5	17.2	7.8	0.4	0.3	0.0	0.0	25.3	3.1	7.3	0.0	19.1	14.2	0.0	0.6	0.0	0.2	0.0	26.6	0.0	0.0	41.7	1.1	8.5	16.2	10.3	0.3	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.9	0.0	19.8	0.0	3.7	0.0	3.9	3.3	0.1	1.2	0.5	0.0	0.0	1.0	1.7	0.0	0.0	8.1	0.2	5.8	0.0	0.2	0.0	0.0	1.2	0.0	8.9	0.9	7.5	15.6	0.0	2.6	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.6	1.8	1.1	0.1	0.0	1.6	55.8	56.2	4.7	29.5	55.6	30.6	59.4	17.0	29.1	49.4	0.0	0.6	0.0	10.4	11.6	0.0	0.8	0.0	2.7	10.3	0.0	0.0	0.5	1.7	1.3	1.0	1.7	5.1	0.0	2.5	0.3	45.6	9.6	0.0	0.0	3.3	0.0	0.0	3.1	3.3	1.5	35.9	2.5	13.5	12.6	3.7	1.1	1.7	0.0	66.4	0.0	0.0	0.0	7.2	0.0	2.4	8.2	0.7	0.0	4.0	5.5
LPAR3	"Edg-7, EDG7, HOFNH30, LP-A3, LPA3, RP4-678I3"	ENSG00000171517	"Lysophosphatidic acid receptor 3"	Q9UBY5	1	84811602-84893213	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 32.0"	"Cell type enhanced"	"Detected in some"	10	"Basal glandular cells: 13.1;Cardiomyocytes: 24.9;Ciliated cells: 25.4;Glandular cells: 15.0;Urothelial cells: 10.8"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 24.7"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HAP1: 13.3;HBEC3-KT: 16.3;hTCEpi: 17.6;NTERA-2: 14.8;PC-3: 16.6;SK-MEL-30: 15.6"	"Region enhanced"	"Detected in some"		"olfactory region: 3.5"	"Low region specificity"	"Detected in some"			HPA013421			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA013421: AB_1847990"	"unprognostic (2.85e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.42e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (4.31e-5)"	"unprognostic (1.11e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.13e-4)"	"unprognostic (4.11e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.27e-2)"	"unprognostic (5.43e-2)"	0.0	1.2	2.4	0.5	1.9	0.3	0.7	0.2	3.5	8.8	0.4	2.2	2.9	0.1	2.4	11.8	7.2	32.0	0.5	12.4	3.7	0.9	0.0	0.1	4.2	0.1	0.1	2.6	5.1	8.6	0.3	0.4	1.1	6.8	11.5	0.5	0.7	5.0	4.7	0.3	4.0	0.5	0.5	0.3	0.1	0.2	14.7	0.2	0.7	0.2	3.3	4.3	4.8	6.9	0.6	0.4	1.1	0.1	1.8	0.5	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.5	0.2	1.2	1.1	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.2	13.3	16.3	1.0	0.1	2.7	0.0	0.0	0.0	0.4	0.0	0.0	0.1	17.6	4.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	16.6	0.0	0.0	0.0	0.0	3.8	0.9	0.7	0.0	0.3	15.6	1.0	0.0	1.3	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.1	0.2	0.3	0.0	0.2	0.4	0.5	0.5	0.3	0.6	0.4	0.3	1.1	1.8	0.1	0.4	0.1	0.1	2.4	1.9	0.2	3.5	3.7	0.9	0.1	2.6	6.8	0.2	0.0	0.3	0.0	13.1	3.1	0.0	24.9	0.0	25.4	7.9	0.0	0.0	0.4	0.0	0.0	2.4	0.0	0.0	0.0	1.1	0.0	0.2	15.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.1	0.6	0.6	1.7	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.4	0.2	4.4	8.0	0.1	0.0	0.0	10.8
LPAR4	"GPR23, LPA4, P2RY9, P2Y5-LIKE, P2Y9"	ENSG00000147145	"Lysophosphatidic acid receptor 4"	Q99677	X	78747709-78757094	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 15.8;ovary: 10.0"	"Cell type enriched"	"Detected in some"	7	"Leydig cells: 18.7"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	12	"basophil: 7.4"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 7.4"	"Cell line enhanced"	"Detected in some"		"AF22: 10.3;NTERA-2: 16.7;RH-30: 7.0;SuSa: 4.0;U-937: 4.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA046563, HPA054951, HPA055571"	Uncertain		Supported	"Nuclear bodies,Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	"Nuclear bodies, Vesicles"	"HPA046563: AB_2732529, HPA054951: AB_2682646, HPA055571: AB_2682853"	"unprognostic (1.62e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.81e-4)"	"unprognostic (3.12e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.57e-1)"	"unprognostic (6.75e-2)"	"unprognostic (6.73e-2)"	"unprognostic (8.91e-2)"	"unprognostic (4.86e-4)"	"unprognostic (2.99e-5)"	"unprognostic (9.27e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.58e-2)"	"unprognostic (6.03e-3)"	1.5	0.2	6.0	1.0	2.1	0.6	2.0	4.9	3.7	1.8	0.9	7.4	0.7	0.2	2.9	0.8	1.8	1.1	2.1	1.9	15.8	1.4	0.3	0.3	0.3	0.2	2.4	4.0	10.0	0.7	0.1	0.7	0.2	3.6	0.6	1.2	0.5	1.0	1.6	0.2	1.6	0.9	1.3	3.8	0.4	1.5	0.8	5.6	0.0	0.6	0.8	1.2	1.4	0.9	0.0	0.5	7.4	0.0	0.0	0.0	0.1	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.6	1.1	1.4	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.7	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.1	2.3	0.0	0.5	1.8	16.7	0.0	0.2	0.9	7.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	2.7	0.0	0.0	0.2	0.0	0.7	1.4	0.0	0.7	0.7	4.0	1.6	7.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	6.0	2.1	4.9	3.5	15.8	1.4	2.4	4.0	3.6	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	18.7	0.0	1.7	1.0	0.0	0.5	0.0	0.0	2.5	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1
LRRC26	bA350O14.10	ENSG00000184709	"Leucine rich repeat containing 26"	Q2I0M4	9	137168758-137170051	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"salivary gland: 173.1"	"Cell type enriched"	"Detected in some"	9	"Mucus-secreting cells: 513.0"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 47.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	408	"plasmacytoid DC: 40.8"	"Lineage enriched"	"Detected in single"	408	"dendritic cells: 40.8"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 52.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056312	Approved		Supported	"Nucleoli fibrillar center,Plasma membrane"		NA	NA			"Plasma membrane"	"Nucleoli fibrillar center"	"HPA056312: AB_2683098"	"unprognostic (1.75e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.04e-2)"	"prognostic favorable (4.82e-6)"	"unprognostic (3.39e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.13e-2)"		"unprognostic (1.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.75e-1)"		"prognostic favorable (3.48e-4)"	"unprognostic (3.27e-1)"		"unprognostic (2.29e-1)"	0.1	0.0	0.0	1.3	0.0	0.0	2.1	0.7	0.1	0.3	6.8	0.0	11.2	1.2	0.3	0.1	0.7	0.3	0.4	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	15.4	0.4	0.0	173.1	20.0	0.0	1.3	4.0	0.0	0.0	0.1	1.0	0.0	0.0	0.7	0.0	10.3	4.6	0.0	0.1	0.0	40.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.3	8.7	0.0	52.8	0.0	0.0	0.4	0.1	0.2	2.6	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.8	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	13.9	0.0	0.4	0.0	0.1	45.8	0.0	0.0	0.1	0.0	8.6	0.0	0.0	0.6	0.0	0.0	54.0	1.0	513.0	0.0	0.2	12.5	0.0	0.0	0.0	0.0	0.0	0.2	2.6	0.3	0.0	0.0	16.2	3.3
LSR	"ILDR3, LISCH7"	ENSG00000105699	"Lipolysis stimulated lipoprotein receptor"	Q86X29	19	35248330-35267964	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 106.3;pancreas: 98.6"	"Cell type enhanced"	"Detected in many"	5	"Ductal cells: 229.3;Exocrine glandular cells: 243.9;Pancreatic endocrine cells: 273.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 88.1;CACO-2: 38.6;CAPAN-2: 41.0;HaCaT: 37.0;OE19: 53.1;RT4: 35.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007270, HPA075309"	Approved		Supported	"Plasma membrane"		NA	NA		2100000	"Plasma membrane"		"HPA007270: AB_1079253, HPA075309: "	"unprognostic (3.90e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.28e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.84e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.42e-2)"	"prognostic favorable (8.09e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.54e-2)"	5.0	11.2	2.9	20.9	4.0	0.9	12.4	2.0	4.5	8.7	32.8	4.0	24.4	29.5	6.5	21.4	20.3	10.6	58.2	2.6	3.4	3.1	15.7	106.3	21.1	17.0	4.1	2.6	4.8	98.6	6.2	13.4	36.6	7.1	11.2	15.4	40.9	26.2	33.8	1.9	16.8	39.5	1.8	3.8	9.1	46.7	21.0	1.9	3.4	24.0	20.1	20.9	9.9	9.5	5.3	0.3	5.9	0.2	6.1	7.1	3.2	88.1	1.4	0.1	0.1	0.2	0.1	16.0	0.2	0.3	0.4	0.3	38.6	41.0	3.5	13.6	0.2	1.3	37.0	8.2	13.5	0.0	5.3	14.9	0.0	1.2	17.0	0.3	0.0	0.1	0.2	15.1	0.3	4.5	0.1	0.1	0.1	13.9	3.1	0.2	31.3	0.1	0.1	12.7	53.1	0.5	0.7	0.1	9.5	8.5	35.7	7.0	0.2	7.4	24.1	6.6	4.2	20.6	0.4	0.0	0.7	8.4	0.5	0.4	5.0	8.9	8.0	0.6	0.1	2.2	5.9	0.2	0.2	3.3	0.0	3.3	5.3	7.1	6.7	0.1	4.1	5.5	6.0	0.1	6.1	0.0	0.3	4.8	3.2	2.9	4.0	2.0	4.5	3.4	3.1	4.1	2.6	7.1	1.9	14.9	17.1	13.9	106.8	45.9	1.4	3.2	79.0	12.0	27.3	34.9	15.7	183.2	10.0	229.3	8.5	29.2	159.2	0.0	243.9	80.3	15.6	94.1	31.1	77.6	19.8	0.0	54.2	17.2	1.5	2.1	6.1	3.7	13.5	11.8	103.4	9.1	273.3	171.7	3.2	20.3	11.0	0.0	24.6	5.4	13.4	45.2	207.4	8.6	101.9	201.4
LTB4R2	"BLT2, BLTR2, JULF2, NOP9"	ENSG00000213906	"Leukotriene B4 receptor 2"	Q9NPC1	14	24305734-24312053	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 38.9;lymphoid tissue: 26.8;skin 1: 21.4;tongue: 43.6"	"Cell type enhanced"	"Detected in some"	7	"Basal glandular cells: 3.0;Horizontal cells: 3.2;Kupffer cells: 2.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 15.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB022689, HPA029680, HPA072921"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB022689: , HPA029680: AB_10603013, HPA072921: AB_2686557"	"unprognostic (2.01e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.53e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.18e-2)"	"unprognostic (7.05e-11)"	"unprognostic (1.84e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.19e-1)"	1.5	1.2	0.4	1.8	0.5	4.8	1.1	0.4	0.6	7.9	0.4	0.6	0.8	2.4	1.0	4.7	38.9	0.8	0.7	0.4	0.5	0.1	6.1	0.5	1.1	1.8	0.4	0.7	0.7	0.5	0.3	0.7	0.8	0.5	1.8	0.3	0.5	4.7	1.1	0.9	21.4	1.8	0.4	0.4	3.5	1.0	1.4	0.4	3.1	0.9	43.6	26.8	0.6	9.0	0.3	2.2	1.4	2.0	0.9	2.7	1.1	2.5	4.4	1.9	1.8	0.4	0.6	7.7	0.9	0.4	1.3	0.9	3.4	1.5	3.2	1.6	0.6	1.9	15.9	1.3	2.7	1.0	4.0	4.9	2.2	3.5	1.6	0.5	3.6	4.2	0.5	3.6	2.0	2.3	1.2	0.6	5.8	2.8	3.6	0.6	4.8	1.9	3.8	1.0	0.1	5.4	7.9	1.7	1.8	0.4	3.1	3.4	1.6	1.6	2.0	1.3	2.1	3.7	2.7	1.6	2.6	3.2	4.0	1.3	7.9	2.3	5.2	0.5	6.1	2.0	0.0	2.0	1.4	2.7	1.6	1.6	0.1	2.2	2.0	2.2	0.3	1.7	0.9	1.3	0.9	0.8	0.6	0.4	1.1	0.4	0.5	0.4	0.6	0.5	0.1	0.4	0.7	0.5	0.4	0.0	0.0	0.0	3.0	0.2	0.2	0.0	0.0	1.4	0.0	1.8	0.0	0.1	0.0	0.2	0.0	0.9	0.3	0.0	1.2	0.1	0.0	0.2	0.0	0.8	0.6	3.2	1.7	1.3	2.2	0.0	0.3	0.2	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.2	0.5	0.0	0.0	0.7	0.2	0.1	0.2	0.0	0.6	0.9
LYN	JTK8	ENSG00000254087	"LYN proto-oncogene, Src family tyrosine kinase"	P07948	8	55879813-56014168	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Inflammatory response, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.9"	"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 110.4;Kupffer cells: 161.3;Macrophages: 122.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 36.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 57.7;HMC-1: 58.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001231, CAB004492"	Enhanced		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA		11000000	"Golgi apparatus, Plasma membrane"	Vesicles	"CAB004492: AB_627897, HPA001231: AB_1079286"	"unprognostic (7.87e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.74e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.80e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (2.13e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.39e-2)"	8.8	6.8	4.5	34.0	6.3	33.6	11.1	9.5	4.1	5.3	10.5	5.8	7.2	15.6	3.4	7.8	7.2	6.7	13.7	8.9	4.8	3.6	6.1	13.8	34.6	70.9	7.7	2.1	5.3	9.8	3.1	4.9	19.1	5.6	5.7	6.6	6.3	14.9	8.5	2.7	3.4	16.2	6.6	8.5	69.4	7.4	3.6	5.1	3.8	9.4	5.3	25.8	10.7	7.5	8.4	9.2	36.8	26.5	1.9	0.9	2.7	12.8	7.7	1.8	0.3	0.1	0.0	13.9	9.8	14.5	6.2	4.4	5.3	4.4	12.4	4.4	3.9	4.8	6.0	7.2	7.3	5.3	20.1	7.2	57.7	2.3	1.9	1.9	5.8	58.6	0.3	2.5	0.1	4.5	3.6	8.3	0.0	30.5	26.9	0.9	0.7	0.0	6.1	11.1	20.2	0.9	0.9	2.8	1.5	4.0	6.1	1.2	22.3	4.9	0.0	2.0	13.8	1.1	13.6	9.7	0.0	2.9	0.0	4.4	9.0	3.3	28.1	0.6	11.5	0.4	2.1	7.2	12.3	0.9	16.8	0.7	8.2	0.2	0.3	6.4	8.4	0.1	0.4	36.8	1.9	26.5	9.2	0.0	2.7	4.5	6.3	9.5	4.1	4.8	3.6	7.7	2.1	5.6	5.1	32.8	35.7	89.3	18.6	4.7	2.1	1.4	17.8	22.7	31.8	8.7	2.0	2.5	0.0	18.6	0.6	18.5	14.9	0.0	44.9	61.3	8.4	36.9	70.5	10.9	110.4	0.0	5.8	25.8	161.3	1.7	3.1	122.4	5.0	73.1	13.5	61.7	37.6	13.5	1.1	1.3	1.5	19.4	4.3	0.2	1.2	5.1	32.4	24.5	12.3	92.1
MACF1	"ABP620, ACF7, FLJ45612, FLJ46776, KIAA0465, KIAA1251, MACF"	ENSG00000127603	"Microtubule-actin crosslinking factor 1"	Q9UPN3	1	39081316-39487177	"Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	Actin-binding	"Disease mutation, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 734.3;Rod photoreceptor cells: 425.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013713, HPA068064, HPA068103"	Approved		Supported	"Plasma membrane,Cell Junctions,Actin filaments"		NA	NA			"Plasma membrane, Cell Junctions, Actin filaments"		"HPA013713: AB_10600821, HPA068064: AB_2685946, HPA068103: AB_2685953"	"unprognostic (2.71e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.00e-2)"	"unprognostic (6.19e-3)"	"unprognostic (1.32e-1)"	"unprognostic (7.40e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.98e-1)"	"prognostic favorable (2.77e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.22e-2)"	24.1	22.6	41.4	21.4	44.0	21.2	25.2	62.6	54.0	37.1	42.2	35.3	22.7	11.9	66.5	33.6	20.3	28.0	31.5	39.0	35.9	32.7	27.2	24.4	53.5	21.2	41.1	28.6	41.5	25.0	46.2	37.1	22.8	40.5	26.3	18.2	23.3	26.0	32.0	40.8	59.2	18.4	56.7	37.0	29.7	22.9	17.7	39.0	13.3	34.5	17.9	16.0	28.0	34.8	4.8	2.6	4.9	2.8	6.4	13.7	2.0	12.6	15.4	19.0	8.6	16.8	17.4	8.2	17.4	23.6	10.8	10.8	9.2	15.3	6.6	18.4	24.7	18.1	8.4	3.4	12.5	15.1	12.7	9.4	11.7	11.5	14.9	19.2	10.8	5.0	11.8	12.9	29.9	16.1	24.8	38.2	23.1	17.2	9.0	42.4	4.2	6.1	14.1	26.2	5.3	9.1	11.5	29.1	1.2	56.4	13.7	10.5	10.7	6.9	4.7	16.6	23.9	2.0	10.7	43.0	17.7	14.2	8.4	30.4	5.4	5.2	7.9	29.0	10.3	16.2	4.9	1.5	3.8	13.7	2.7	6.7	2.3	6.8	8.6	1.9	4.8	5.4	6.8	1.3	6.4	2.8	2.6	2.9	2.0	41.4	44.0	62.6	54.0	35.9	32.7	41.1	28.6	40.5	39.0	140.0	115.4	34.3	51.5	137.1	376.9	222.7	76.5	60.2	85.3	76.8	734.3	41.1	0.0	105.2	8.2	146.8	21.9	0.0	98.3	49.9	58.2	60.0	73.1	41.2	44.1	111.2	34.7	127.1	56.4	6.8	40.6	41.9	67.4	45.1	23.8	104.0	136.1	16.9	105.7	7.9	425.5	103.5	69.7	34.4	25.0	167.4	58.5	78.3	17.8	61.3
MAP3K7	"MEKK7, TAK1"	ENSG00000135341	"Mitogen-activated protein kinase kinase kinase 7"	O43318	6	90513573-90587045	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007633, HPA075335"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nuclear speckles, Plasma membrane"	"HPA007633: AB_1079359, HPA075335: "	"unprognostic (1.48e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (9.77e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.56e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.17e-1)"	15.5	17.6	19.6	17.3	26.3	10.3	21.6	27.5	27.3	21.1	16.4	15.7	15.8	12.5	23.1	23.6	15.2	15.5	17.6	22.2	20.5	17.5	15.9	15.5	20.0	22.2	22.9	16.4	25.0	13.5	25.8	25.6	23.6	20.7	21.2	15.3	12.4	17.0	23.3	24.3	18.7	14.7	19.4	23.0	23.3	14.7	13.8	21.7	28.2	20.3	10.8	21.9	17.2	18.9	14.2	15.9	19.4	17.7	18.2	22.1	13.6	7.9	7.0	20.5	17.6	15.0	20.1	14.5	16.0	18.5	14.4	18.2	9.0	7.6	17.7	10.2	17.2	12.8	8.5	12.9	12.4	24.6	9.0	13.7	15.8	9.7	11.9	15.8	17.5	12.2	16.6	15.3	14.0	17.2	16.6	13.5	15.6	31.5	14.5	20.6	9.7	8.1	14.8	16.8	12.4	8.9	14.0	36.9	8.6	12.1	8.9	10.4	14.8	11.1	7.7	12.0	16.8	7.7	31.1	12.9	11.7	7.4	10.7	14.8	12.9	11.5	7.7	18.0	19.2	17.2	15.5	12.7	19.4	15.1	17.4	16.8	14.2	14.5	14.4	15.9	10.5	16.5	16.0	12.5	18.2	17.7	9.8	22.1	13.6	19.6	26.3	27.5	27.3	20.5	17.5	22.9	16.4	20.7	21.7	14.9	24.0	20.7	17.4	32.3	22.8	28.8	12.7	16.0	10.3	15.7	25.5	27.6	6.6	16.6	2.6	20.3	9.3	0.0	18.3	26.6	23.5	24.4	12.8	17.9	21.1	27.0	11.6	30.7	26.3	2.2	24.7	25.3	20.3	27.9	15.6	18.9	15.5	7.0	38.5	13.1	21.1	19.4	19.1	24.6	24.0	32.5	40.5	25.5	15.1	23.0
MAPT	"DDPAC, FLJ31424, FTDP-17, MAPTL, MGC138549, MSTD, MTBT1, MTBT2, PPND, PPP1R103, tau"	ENSG00000186868	"Microtubule associated protein tau"	P10636	17	45894382-46028334	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"Alzheimer disease, Disease mutation, FDA approved drug targets, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 89.9;skeletal muscle: 43.7"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 300.5;Early spermatids: 153.8;Horizontal cells: 341.7;Late spermatids: 194.8;Muller glia cells: 139.1"	"Group enriched"	"Detected in many"	11	"breast cancer: 9.5;glioma: 13.3;prostate cancer: 3.0;renal cancer: 4.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 27.9;SCLC-21H: 10.1;T-47d: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000151, HPA048895, HPA069524, HPA069570, CAB072344"	Enhanced		Supported	"Nuclear speckles,Plasma membrane"		NA	NA			"Plasma membrane"	"Nuclear speckles"	"CAB000151: , CAB072344: , HPA048895: AB_2680550, HPA069524: AB_2686145, HPA069570: AB_2686155"	"unprognostic (1.78e-3)"	"unprognostic (7.51e-2)"	"unprognostic (3.71e-2)"	"unprognostic (8.40e-5)"	"unprognostic (1.40e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.06e-5)"	"unprognostic (6.04e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.88e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.72e-3)"	"unprognostic (6.53e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.85e-2)"	"unprognostic (5.47e-2)"	3.8	7.1	28.9	2.4	31.2	2.1	8.8	40.1	89.9	2.4	2.7	21.4	1.7	2.5	2.6	2.3	6.4	2.5	2.8	6.5	28.7	29.7	15.3	2.2	2.4	2.3	22.6	35.2	2.3	2.8	8.5	8.8	5.2	29.1	5.1	2.5	2.2	8.1	5.3	43.7	4.6	2.8	2.5	13.6	2.2	2.3	6.5	27.7	0.0	2.3	3.1	2.3	3.2	0.8	0.0	0.0	0.3	0.1	0.5	1.7	0.1	0.8	0.3	0.2	2.6	0.0	0.5	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.0	1.3	0.1	0.0	27.9	1.4	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	1.6	0.2	1.4	0.0	4.2	0.5	0.1	0.0	0.4	1.1	0.0	2.3	2.8	0.0	3.6	10.1	4.7	1.0	0.0	1.0	0.6	12.7	0.0	0.0	0.2	0.3	0.6	0.1	0.5	0.2	0.0	0.2	0.5	0.3	0.0	0.1	0.3	0.8	0.0	0.6	0.0	0.4	1.2	0.0	0.0	0.9	0.9	0.0	0.5	0.1	0.0	1.7	0.1	28.9	31.2	40.1	46.3	28.7	29.7	22.6	35.2	29.1	27.7	0.0	9.8	0.8	1.1	0.9	300.5	32.3	0.0	0.0	0.0	1.8	60.9	0.1	6.6	0.4	153.8	1.3	0.0	0.0	0.4	8.0	1.9	2.9	4.6	0.5	0.3	341.7	0.0	0.6	0.3	194.8	2.6	1.3	5.0	1.0	0.0	139.1	0.6	0.0	2.5	44.6	24.8	0.0	4.1	11.4	5.9	2.9	0.2	0.0	0.1	0.5
MARCH7	"AXOT, MARCH-VII, RNF177"	ENSG00000136536	"Membrane associated ring-CH-type finger 7"	Q9H992	2	159712457-159771027	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 208.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014275, HPA022152"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA014275: AB_10599820, HPA022152: AB_10601107"	"unprognostic (2.42e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (2.46e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (1.84e-4)"	"unprognostic (1.41e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.61e-1)"	31.6	21.1	18.3	27.4	29.0	22.6	28.9	33.1	23.0	33.4	25.3	17.0	22.0	17.1	32.3	24.1	47.6	22.7	22.4	28.1	16.9	14.4	21.8	30.9	29.5	32.9	21.6	17.8	31.6	15.4	25.3	31.5	41.3	21.5	28.8	22.3	24.8	25.7	22.6	48.0	24.2	25.2	33.8	20.4	28.9	20.0	34.1	21.8	60.4	28.5	25.5	32.9	30.0	35.1	10.0	10.1	46.1	14.5	14.0	14.6	10.5	18.4	12.7	34.2	15.3	24.9	32.9	33.1	31.0	31.3	31.9	29.3	26.2	22.2	26.2	14.1	32.2	18.1	23.3	21.0	28.6	40.9	26.8	15.5	35.6	18.4	19.8	24.2	29.1	27.8	29.2	32.7	38.9	33.8	36.4	38.2	19.2	27.0	25.4	32.2	15.1	18.6	27.9	32.3	20.3	18.2	27.7	25.3	21.7	29.3	38.5	20.4	19.1	25.3	18.6	24.8	38.8	21.6	35.4	34.4	34.2	20.6	20.9	17.5	20.2	21.3	35.8	21.2	17.6	31.8	24.8	10.3	20.6	11.1	10.6	13.3	10.0	12.1	12.6	10.1	9.7	14.6	14.1	46.1	14.0	14.5	7.9	12.5	10.5	18.3	29.0	33.1	23.0	16.9	14.4	21.6	17.8	21.5	21.8	68.5	35.6	53.7	0.0	76.4	37.4	78.7	10.2	57.6	44.3	34.9	25.5	31.0	16.6	0.0	208.1	38.3	17.5	23.3	0.0	29.9	37.4	0.0	53.3	28.0	29.4	46.1	27.6	52.2	38.4	46.0	45.8	42.0	21.9	0.0	24.9	38.9	0.0	17.5	38.5	32.1	34.2	58.2	45.3	77.0	31.7	79.3	37.0	41.5	21.9	0.0
MARCKS	"80K-L, MACS, PKCSL"	ENSG00000277443	"Myristoylated alanine rich protein kinase C substrate"	P29966	6	113857362-113863471	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 652.8"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 10.1;neutrophil: 15.0"	"Group enriched"	"Detected in many"	10	"B-cells: 3.9;granulocytes: 15.0;monocytes: 10.1"	"Cell line enhanced"	"Detected in many"		"AF22: 74.7;TIME: 58.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022062, HPA054820, HPA067595, HPA069443"	Enhanced		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA		17000000	"Plasma membrane"	"Nucleoplasm, Endoplasmic reticulum, Cytosol"	"CAB022062: AB_309681, HPA054820: AB_2682613, HPA067595: AB_2732772, HPA069443: AB_2732133"	"unprognostic (4.71e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.51e-3)"	"unprognostic (8.22e-3)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (2.78e-8)"	"unprognostic (7.82e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (1.36e-3)"	"unprognostic (2.77e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.70e-2)"	13.0	5.0	11.2	17.0	12.9	26.9	16.0	18.5	43.3	12.1	23.2	17.9	0.9	11.6	9.7	4.0	17.0	8.4	10.9	9.7	10.5		5.3	8.7	12.9	13.3	8.8	15.9	12.6	11.2	1.2	6.5	39.5	13.8	14.1	21.6	11.4	8.2	5.6	5.0	9.5	12.9	9.1	42.3	20.9	18.8	5.2	8.5	30.0	4.9	7.9	13.6	23.5	7.8	3.9	0.9	15.0	10.1	0.0	0.0	0.4	6.8	4.0	74.7	4.0	25.3	16.5	0.4	22.2	31.2	15.7	26.2	7.2	9.8	0.0	4.7	40.9	12.4	21.3	12.3	6.4	20.5	0.0	7.3	0.0	4.3	9.4	16.9	1.8	0.1	17.0	12.7	15.1	14.4	43.1	44.2	0.0	0.8	19.7	22.2	0.0	0.2	0.0	9.6	7.7	5.3	0.0	7.5	0.7	4.9	13.2	10.4	30.3	14.2	7.2	15.2	18.4	0.3	2.0	58.7	14.6	0.1	23.9	37.8	53.3	3.8	2.0	11.2	9.9	27.9	0.0	3.4	0.0	0.0	10.1	0.0	3.9	0.0	0.0	0.9	1.6	0.0	0.0	15.0	0.0	5.5	0.0	0.0	0.4											8.9	19.9	84.3	477.4	447.8	131.4	10.5	56.0	99.0	62.6	36.6	27.5	5.0	31.5	120.8	46.4	214.9	254.5	0.0	195.2	5.5	224.2	281.9	2.3	4.3	324.8	79.4	322.8	234.5	223.1	24.8	111.7	249.4	259.8	652.8	331.8	330.7	220.9	241.8	62.9	3.4	33.7	38.8	128.7	20.0	15.6	558.1	24.6	7.5	259.9	481.3
MARK2	"EMK1, PAR-1, PAR-1B, Par1b"	ENSG00000072518	"Microtubule affinity regulating kinase 2"	Q7KZI7	11	63838928-63911019	"Enzymes, Predicted intracellular proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038790, HPA074905"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA038790: AB_10674840, HPA074905: AB_2686722"	"unprognostic (1.33e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (7.13e-2)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (2.73e-3)"	"unprognostic (4.41e-1)"	"unprognostic (5.79e-2)"	"unprognostic (3.94e-3)"	"unprognostic (3.77e-1)"	"unprognostic (5.20e-3)"	"unprognostic (5.15e-3)"	"unprognostic (6.78e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.40e-1)"	9.7	11.6	16.5	16.3	21.4	18.5	13.8	24.7	26.1	15.2	20.5	20.0	11.1	21.3	13.6	7.5	48.4	13.6	14.4	14.7	17.0	10.1	11.9	12.4	15.4	16.3	18.1	13.7	11.0	17.3	21.8	22.4	21.1	15.0	14.9	19.8	10.6	20.7	14.3	15.7	35.8	26.9	13.3	13.3	21.6	16.8	9.8	18.7	22.9	15.9	13.6	23.5	14.8	21.3	2.9	1.9	9.8	1.9	3.3	4.5	1.2	22.7	15.2	12.5	13.1	6.9	9.0	17.3	9.3	8.9	13.4	10.4	16.3	24.1	16.8	16.4	9.7	14.5	29.5	12.0	14.5	11.6	11.6	9.4	18.5	12.0	10.6	7.7	20.1	24.5	4.9	19.8	12.3	10.7	6.3	11.0	15.9	15.7	19.4	8.8	28.0	21.0	14.3	14.2	18.4	11.1	17.4	9.3	18.6	10.0	18.8	17.2	11.6	16.0	41.1	10.7	14.0	29.9	12.0	10.4	14.2	8.9	18.3	10.3	11.8	12.2	16.5	9.7	10.6	11.3	2.7	1.7	4.4	2.9	1.5	4.5	2.3	3.2	3.1	1.9	2.9	2.6	2.4	9.8	3.3	1.9	1.7	1.5	1.2	16.5	21.4	24.7	26.1	17.0	10.1	18.1	13.7	15.0	18.7	6.0	5.0	13.9	16.2	22.3	26.0	10.9	35.7	6.7	6.8	19.2	7.9	19.2	1.7	18.5	0.4	11.9	59.3	0.0	18.5	16.8	10.6	28.8	17.3	12.1	15.7	19.1	28.7	13.5	19.5	0.7	11.8	11.3	3.3	8.2	35.1	19.1	20.0	35.9	10.3	6.9	17.8	19.4	9.2	8.4	21.8	30.1	54.3	23.6	28.2	30.9
MC5R		ENSG00000176136	"Melanocortin 5 receptor"	P33032	18	13824149-13827323	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 7.9;esophagus: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.1;OE19: 1.6;SiHa: 1.7;U-138 MG: 6.2;U-2 OS: 1.4;U-2197: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA042365, HPA058088"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA042365: AB_2677961, HPA058088: "	"unprognostic (1.57e-2)"				"unprognostic (1.37e-1)"			"unprognostic (8.77e-2)"	"unprognostic (7.10e-2)"		"unprognostic (2.64e-2)"	"unprognostic (1.30e-2)"		"unprognostic (9.04e-3)"	"unprognostic (1.54e-1)"			0.3	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.5	0.0	0.0			0.0	0.0	7.9	2.7	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.1		0.0	0.0	0.0	0.2	0.0		0.0	0.0		0.2	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.1	1.6			0.0		0.2	0.0	0.4	0.1	1.1	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.5	0.0	0.0	6.2	1.4	1.2	0.4	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.4	0.0	0.0	1.1	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MCEMP1	"C19orf59, MGC132456"	ENSG00000183019	"Mast cell expressed membrane protein 1"	Q8IX19	19	7676628-7679826	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"blood: 36.5;bone marrow: 30.9;lung: 66.4;lymphoid tissue: 24.2"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 1: 17.9;Alveolar cells type 2: 34.6;Club cells: 20.5;Hofbauer cells: 30.0;Kupffer cells: 41.3;Macrophages: 51.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"midbrain: 2.9"	"Group enriched"	"Detected in some"	5	"classical monocyte: 36.5;neutrophil: 16.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 16.6;monocytes: 36.5"	"Group enriched"	"Detected in some"	6	"THP-1: 19.2;U-937: 59.8"									HPA014731	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA014731: AB_1845619"	"unprognostic (4.84e-2)"	"unprognostic (9.81e-4)"	"unprognostic (2.41e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.62e-3)"	"unprognostic (5.57e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.69e-5)"	"unprognostic (1.15e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.95e-2)"	2.2	0.3	0.3	10.0	0.5	30.9	0.5	0.4	0.9	0.1	0.3	0.0	0.0	0.1	0.1	0.2	0.3	1.2	0.2	4.8	0.2	0.2	0.6	1.3	66.4	11.8	2.9	0.0	0.4	0.4	0.0	0.1	0.8	0.6	0.4	0.0	0.1	0.6	0.0	0.2	0.1	0.3	2.4	0.9	24.2	0.6	0.7	0.3	0.3	0.7	0.0	0.1	0.5	2.9	0.0	5.3	16.6	36.5	0.2	0.1	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.8	0.0	0.0	36.5	0.9	0.1	2.1	0.0	0.0	0.1	0.0	5.3	0.0	0.0	0.1	16.6	0.2	0.1	0.3	0.1	11.6	0.3	0.5	0.4	0.9	0.2	0.2	2.9	0.0	0.6	0.3	17.9	34.6	1.4	0.0	0.0	0.0	0.3	0.0	9.4	20.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	7.0	0.0	30.0	0.0	0.0	0.0	41.3	0.0	0.0	51.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
MDGA1	"GPIM, MAMDC3"	ENSG00000112139	"MAM domain containing glycosylphosphatidylinositol anchor 1"	Q8NFP4	6	37630679-37699306	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 94.7"	"Group enriched"	"Detected in many"	5	"Bipolar cells: 31.7;Cone photoreceptor cells: 47.1;Horizontal cells: 54.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	17	"cerebellum: 94.7"	"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 3.1"	"Group enriched"	"Detected in many"	22	"B-cells: 1.1;T-cells: 3.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 13.8;HaCaT: 8.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031235, HPA050382"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA		490000	"Plasma membrane"	"Golgi apparatus"	"HPA031235: AB_10603017, HPA050382: AB_2681108"	"unprognostic (4.67e-2)"	"unprognostic (6.97e-3)"	"unprognostic (3.24e-1)"	"unprognostic (5.69e-4)"	"unprognostic (2.75e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.52e-5)"	"unprognostic (9.19e-3)"	"unprognostic (5.28e-3)"	"unprognostic (3.80e-3)"	"unprognostic (4.60e-2)"	1.5	3.7	3.4	3.1	2.4	0.0	1.0	94.7	5.1	3.0	1.3	1.5	1.0	0.0	3.0	1.5	1.8	2.1	3.4	1.2	5.0	2.0	0.8	0.5	3.5	3.4	1.7	2.4	8.4	2.6	6.6	2.6	0.5	5.4	1.5	1.1	3.4	0.7	1.2	0.9	6.7	1.5	2.6	4.1	3.9	1.2	1.4	1.3	0.6	1.1	1.7	2.7	1.1	3.1	1.1	0.0	0.0	0.0	0.0	3.1	0.4	0.1	3.8	6.9	2.6	13.8	5.6	3.0	2.7	2.7	3.4	3.9	0.7	0.0	0.9	0.6	1.7	3.6	8.9	0.5	0.0	1.1	6.9	4.0	0.0	0.5	0.0	0.6	0.0	0.9	1.0	0.1	1.4	0.0	8.0	0.0	0.1	0.1	0.0	1.2	0.1	0.0	0.5	0.0	0.1	0.4	7.3	2.4	0.0	0.8	4.2	6.3	0.0	1.5	0.4	3.3	0.2	3.2	0.6	0.5	3.7	1.2	1.3	5.0	0.0	0.1	0.0	5.8	1.1	2.4	0.0	0.0	0.0	1.4	0.0	0.4	1.1	1.2	0.8	0.0	1.0	3.1	0.8	0.0	0.0	0.0	0.0	1.8	0.4	3.4	2.4	94.7	2.7	5.0	2.0	1.7	2.4	5.4	1.3	8.9	0.3	0.0	1.7	2.1	31.7	5.2	0.0	2.7	1.2	3.5	47.1	0.1	0.0	0.6	1.9	1.0	0.0	0.0	0.0	1.2	2.4	1.5	0.0	0.0	0.1	54.0	1.7	1.8	0.0	0.0	9.5	0.0	1.7	0.0	0.0	2.3	0.6	0.0	4.6	0.1	1.3	0.0	3.4	2.3	1.0	2.6	0.6	0.5	0.0	3.8
MFSD2A	"FLJ14490, MFSD2"	ENSG00000168389	"Major facilitator superfamily domain containing 2A"	Q8NA29	1	39955112-39969968	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Symport, Transport"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 96.9;liver: 87.9;placenta: 111.3;seminal vesicle: 121.2"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 2: 112.2;Enterocytes: 112.9;Hepatocytes: 268.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"classical monocyte: 9.3;intermediate monocyte: 4.6;myeloid DC: 10.3;plasmacytoid DC: 16.7"	"Group enriched"	"Detected in many"	11	"dendritic cells: 16.7;monocytes: 9.3"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 18.9;THP-1: 59.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043107	Uncertain		Approved	"Plasma membrane,Cytosol,Cytoplasmic bodies"		NA	NA			Cytosol	"Plasma membrane, Cytoplasmic bodies"	"HPA043107: AB_10794387"	"unprognostic (2.20e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.23e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.33e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (4.22e-6)"	"unprognostic (9.26e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.33e-4)"	2.0	0.9	6.0	1.6	7.2	3.3	6.2	2.4	6.5	1.6	5.6	4.3	96.9	6.4	4.3	45.0	5.0	1.5	1.2	0.7	7.6	6.1	7.2	87.9	15.8	1.1	7.5	2.6	0.8	0.5	0.3	3.0	111.3	7.8	1.0	2.5	2.0	1.7	121.2	0.3	27.0	20.4	1.8	7.3	0.8	1.0	17.7	2.3	0.2	2.9	4.7	1.7	2.6	4.6	1.1	16.7	0.9	9.3	0.1	0.1	2.3	2.1	0.9	4.5	6.8	3.2	0.6	0.0	2.0	4.0	4.6	5.5	0.2	1.2	13.3	1.2	1.0	3.2	5.3	4.4	7.7	3.6	1.7	2.1	1.6	0.0	0.0	10.7	2.3	7.9	3.6	4.8	18.9	7.8	0.8	1.1	4.1	0.0	3.4	2.0	0.2	3.6	3.6	3.6	7.4	1.6	2.5	6.6	3.0	0.7	6.3	1.6	2.4	1.6	11.4	1.1	0.4	0.5	59.5	0.7	1.0	2.0	3.4	8.7	0.6	1.2	2.9	10.6	9.0	3.3	0.0	9.3	0.9	0.1	4.6	0.1	1.1	0.0	0.1	10.3	0.2	0.0	0.0	0.5	0.1	0.8	16.7	0.0	2.3	6.0	7.2	2.4	6.5	7.6	6.1	7.5	2.6	7.8	2.3	17.9	112.2	11.5	13.4	46.9	1.9	0.6	12.7	12.0	31.8	15.7	0.0	0.3	0.0	3.2	0.6	6.7	112.9	0.0	22.5	6.5	9.7	5.7	17.3	268.3	6.4	0.0	1.2	10.4	12.4	0.9	0.6	11.4	0.0	2.8	16.4	41.8	16.3	3.5	0.4	3.7	1.8	0.0	3.4	1.1	1.0	47.9	43.9	2.2	10.0	23.0
MIB1	"DIP-1, KIAA1323, MIB, ZZANK2, ZZZ6"	ENSG00000101752	"Mindbomb E3 ubiquitin protein ligase 1"	Q86YT6	18	21704957-21870957	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 52.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019100, CAB037044"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"CAB037044: AB_1841007, HPA019100: AB_1853934"	"unprognostic (1.38e-1)"	"unprognostic (6.92e-2)"	"unprognostic (7.29e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.66e-2)"	"unprognostic (3.23e-2)"	"unprognostic (8.45e-3)"	"unprognostic (2.70e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.78e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.33e-3)"	"unprognostic (4.91e-3)"	"unprognostic (1.73e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.85e-2)"	12.1	9.1	15.3	7.9	20.6	5.9	15.7	16.1	17.4	16.6	10.9	16.3	9.7	6.9	19.1	13.7	11.4	11.5	12.0	9.4	16.3	12.9	15.7	14.1	10.1	9.6	17.4	16.5	17.2	11.7	18.4	11.5	14.9	15.5	14.7	10.1	14.6	12.0	12.6	9.6	12.5	8.4	17.9	13.8	9.4	10.7	11.5	18.1	13.9	19.1	9.8	10.6	13.0	13.8	1.2	1.2	3.5	1.7	2.5	2.0	0.6	8.5	3.4	16.8	11.7	9.0	10.8	4.0	6.9	7.8	5.0	7.3	5.0	3.2	7.3	6.4	9.6	5.4	5.8	9.7	9.4	11.3	9.6	4.5	8.2	4.4	6.9	7.3	16.6	3.5	6.9	10.4	5.8	14.9	7.3	12.4	2.9	11.2	21.7	7.7	4.2	8.0	6.3	4.2	5.3	4.5	52.4	13.9	18.1	8.5	7.6	5.5	13.6	11.9	5.6	6.1	8.9	3.9	10.9	10.6	12.8	6.4	5.3	9.2	11.4	4.0	11.3	5.4	10.6	7.6	3.5	1.7	0.6	1.0	0.9	1.2	1.2	1.5	1.0	0.6	0.6	1.2	0.9	1.5	2.5	0.5	1.2	2.0	0.6	15.3	20.6	16.1	17.4	16.3	12.9	17.4	16.5	15.5	18.1	44.7	17.7	5.9	14.0	19.5	29.4	15.1	20.4	21.4	34.2	15.7	23.6	10.7	3.3	11.3	3.3	22.5	10.5	0.0	11.2	6.2	22.6	33.3	13.9	26.3	10.8	14.3	23.1	21.5	18.7	3.7	19.0	11.5	25.3	5.4	15.4	16.5	16.7	5.8	23.3	14.4	14.7	0.0	23.4	16.7	11.5	21.5	21.2	10.1	9.4	14.4
MIEN1	"C17orf37, C35, MGC14832, ORB3, Rdx12, XTP4"	ENSG00000141741	"Migration and invasion enhancer 1"	Q9BRT3	17	39728496-39730787	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	14	"OE19: 214.8;SK-BR-3: 64.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056650, HPA061344"	Approved		Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Centriolar satellite, Cytosol"	"HPA056650: , HPA061344: AB_2684484"	"unprognostic (2.48e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.37e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.17e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.22e-3)"	16.9	18.6	27.0	16.7	38.6	23.2	19.8	14.9	26.1	12.4	25.2	18.0	37.5	30.2	13.6	19.1	26.3	17.2	19.4	37.2	25.8	21.8	32.2	40.6	16.1	19.7	27.1	17.5	11.7	26.3	14.1	18.9	27.0	18.3	23.5	13.9	12.5	45.6	30.1	24.5	16.0	26.8	11.5	27.2	17.3	32.8	18.6	20.9	21.4	34.5	17.5	14.9	15.6	19.6	41.2	37.8	59.2	45.4	23.7	40.4	48.1	4.6	9.1	1.9	4.4	3.2	2.1	2.1	4.9	3.7	4.5	4.2	2.4	3.6	3.5	6.8	2.6	5.0	5.9	2.1	2.5	1.0	6.8	10.0	3.1	4.3	5.4	5.9	4.2	5.0	2.4	4.5	2.0	1.7	2.5	3.0	8.0	4.7	6.3	2.4	3.7	9.1	4.9	1.5	214.8	4.4	3.9	3.0	7.2	2.0	3.1	5.8	5.4	5.1	64.0	8.7	1.4	8.3	5.5	5.1	2.0	5.2	9.8	5.5	7.8	7.1	6.7	9.0	5.2	4.0	51.7	37.3	47.1	38.0	43.9	21.6	41.2	27.0	33.8	25.9	35.7	20.5	30.2	59.2	23.7	45.4	37.8	40.4	48.1	27.0	38.6	14.9	26.1	25.8	21.8	27.1	17.5	18.3	20.9	41.7	48.6	67.4	114.7	53.3	25.2	45.2	58.6	85.6	33.0	94.2	3.9	131.8	257.0	122.9	87.4	56.2	154.8	46.7	153.4	61.5	51.5	183.7	80.7	101.9	128.4	33.4	181.2	58.3	96.9	55.5	39.1	66.0	131.6	84.8	136.7	78.2	163.9	235.0	46.7	153.1	13.5	45.3	67.4	80.7	70.9	61.5	222.5	83.1	110.2	164.5
MLKL	FLJ34389	ENSG00000168404	"Mixed lineage kinase domain like pseudokinase"	Q8NB16	16	74671855-74700960	"Enzymes, Predicted intracellular proteins, Transporters"	Necrosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 50.4"	"Cell type enhanced"	"Detected in many"	6	"granulocytes: 27.8;Macrophages: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA078638			Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA078638: "	"unprognostic (7.53e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.57e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.23e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.67e-3)"	"unprognostic (1.90e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.60e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.53e-3)"	18.5	4.7	5.2	15.1	8.9	21.6	13.2	2.9	7.9	6.4	8.0	3.2	5.3	8.5	7.5	3.8	11.5	5.2	9.1	6.8	6.4	3.5	7.4	6.7	17.3	14.8	10.5	1.8	2.8	8.2	1.6	3.0	7.1	8.1	6.3	9.2	6.5	12.6	4.3	2.3	3.6	10.0	6.0	11.2	26.2	8.2	1.9	8.4	4.3	6.5	4.9	10.4	9.2	50.4	4.2	9.2	25.2	17.7	1.7	8.1	7.1	6.5	12.2	0.1	0.1	3.2	6.7	0.1	8.5	7.4	8.0	11.9	7.0	13.2	0.1	9.8	7.2	6.9	10.5	2.2	12.2	3.0	4.1	0.3	9.2	9.1	8.0	2.3	6.0	9.6	4.5	1.2	8.5	3.0	4.7	19.3	10.7	1.3	1.3	6.2	10.9	3.4	12.0	1.1	14.3	15.0	6.7	0.9	11.7	11.4	4.8	0.5	0.4	6.7	4.5	3.7	0.0	3.2	6.3	21.0	4.0	2.4	3.6	5.8	5.7	19.2	1.6	7.3	21.2	1.9	8.3	17.7	21.7	5.8	10.6	7.9	4.2	6.5	6.0	9.2	2.8	3.6	5.5	25.2	1.7	10.2	0.5	8.1	7.1	5.2	8.9	2.9	7.9	6.4	3.5	10.5	1.8	8.1	8.4	3.0	15.4	8.1	4.8	3.1	0.0	1.6	2.5	2.7	7.9	1.8	0.0	0.2	1.7	4.0	2.6	17.9	5.8	0.0	4.6	0.5	3.8	2.0	27.8	0.9	14.2	1.6	1.2	14.7	15.5	3.8	0.9	24.1	6.8	1.0	5.6	0.0	4.1	9.1	0.4	0.3	0.4	0.0	3.3	0.0	0.2	2.5	0.2	10.0	6.4	5.1
MMP25	"MMP20, MMPL1, MT6-MMP"	ENSG00000008516	"Matrix metallopeptidase 25"	Q9NPA2	16	3046681-3060726	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.6;bone marrow: 25.6;lymphoid tissue: 54.1"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 10.7;Kupffer cells: 5.9;monocytes: 23.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.1"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	6	"basophil: 10.2;eosinophil: 6.0;neutrophil: 17.6"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 17.6"	"Cell line enriched"	"Detected in some"	12	"HMC-1: 50.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB025177, HPA055640"	Uncertain		Supported	"Plasma membrane"	"Secreted to blood"	NA	NA			"Plasma membrane"		"CAB025177: , HPA055640: "	"unprognostic (4.51e-3)"	"unprognostic (9.28e-3)"	"unprognostic (7.57e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.26e-1)"	"prognostic favorable (1.09e-5)"	"unprognostic (1.36e-1)"	"unprognostic (7.39e-3)"	"unprognostic (7.63e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.17e-2)"	"unprognostic (8.30e-2)"	"unprognostic (4.01e-1)"	"unprognostic (2.02e-1)"	4.0	0.3	0.6	12.3	0.4	25.6	0.8	0.5	0.6	0.8	1.1	0.2	0.0	1.0	0.4	0.5	0.8	3.8	1.1	2.8	0.5	0.4	0.7	2.5	10.7	54.1	1.8	0.0	0.6	0.8	0.0	0.5	2.0	1.1	0.6	1.0	1.0	0.9	0.0	2.4	0.6	1.8	0.5	0.4	43.9	1.1	0.7	0.5	4.1	0.7	0.9	4.2	1.5	2.5	0.0	0.3	17.6	0.2	1.7	0.5	0.1	0.2	0.1	0.7	1.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.3	0.6	0.3	0.0	0.0	4.0	0.8	0.1	0.1	0.0	0.0	0.1	50.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.3	0.0	0.5	0.2	3.0	1.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.3	3.6	0.1	0.1	0.4	0.1	0.0	1.2	0.1	0.1	0.0	1.0	0.1	10.2	0.2	6.0	0.3	0.0	0.5	0.0	0.2	0.2	0.0	0.0	0.3	0.2	17.6	1.7	0.0	0.3	0.3	0.1	0.6	0.4	0.5	0.6	0.5	0.4	1.8	0.0	1.1	0.5	3.0	10.7	0.0	0.2	0.3	0.6	0.4	0.0	0.0	1.2	1.8	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.5	0.1	0.2	0.5	1.1	0.0	0.1	0.0	0.0	0.0	5.9	0.0	0.0	2.0	0.0	23.4	0.0	0.1	1.1	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	3.1	0.1	0.1
MPL	"CD110, TPOR"	ENSG00000117400	"MPL proto-oncogene, thrombopoietin receptor"	P40238	1	43337849-43352772	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 8.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.6"	"Cell line enriched"	"Detected in single"	78	"HEL: 41.7"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.4"	"Low region specificity"	"Detected in all"			HPA007619			Supported	"Nuclear membrane,Plasma membrane"		NA	NA			"Plasma membrane"	"Nuclear membrane"	"HPA007619: AB_1854080"	"unprognostic (2.74e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.95e-1)"	"unprognostic (8.71e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.94e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.19e-4)"	"unprognostic (2.39e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.03e-4)"	"unprognostic (1.42e-1)"	1.1	0.3	0.9	0.5	0.8	2.0	0.9	0.5	2.2	0.6	0.6	0.5	0.5	0.3	0.9	1.7	0.9	2.1	0.5	3.9	0.8	0.6	0.5	0.5	2.0	0.5	0.9	0.5	6.6	1.1	0.6	0.6	2.2	0.5	1.5	0.7	0.5	0.5	0.7	0.6	0.4	1.2	2.1	2.5	8.6	0.5	2.1	0.5	0.5	2.2	2.4	0.5	0.9	0.5	0.0	0.0	1.6	0.3	0.0	0.0	4.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	41.7	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.4	0.2	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	4.0	0.9	0.8	0.5	2.2	0.8	0.6	0.9	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MPP1	"DXS552E, PEMP"	ENSG00000130830	"Membrane palmitoylated protein 1"	Q00013	X	154778684-154821007	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Cytotrophoblasts: 338.8;Erythroid cells: 163.5;Hofbauer cells: 251.9;Syncytiotrophoblasts: 380.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 46.4;neutrophil: 45.3"	"Group enriched"	"Detected in all"	7	"dendritic cells: 12.7;granulocytes: 46.4;monocytes: 20.9"	"Cell line enhanced"	"Detected in many"		"HEL: 59.4;REH: 37.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076675	Enhanced		Supported	"Plasma membrane,Centriolar satellite"		NA	NA		4300000	"Plasma membrane"	"Centriolar satellite"	"HPA076675: "	"unprognostic (2.15e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.83e-3)"	"unprognostic (7.14e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.79e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.70e-3)"	"prognostic favorable (4.60e-6)"	"unprognostic (6.69e-2)"	"unprognostic (2.53e-2)"	"unprognostic (4.68e-2)"	"unprognostic (6.67e-3)"	18.7	18.2	12.7	14.4	19.2	52.9	9.9	25.8	30.9	7.1	18.3	10.0	15.1	32.0	8.9	9.5	6.1	10.0	13.5	14.1	14.3	13.0	23.3	20.4	18.2	11.9	15.9	13.5	7.2	18.9	19.5	6.5	45.6	28.8	9.1	10.1	6.4	17.1	10.9	14.6	6.3	42.7	11.0	15.8	27.4	7.9	4.1	7.4	27.1	8.3	6.4	6.9	10.0	7.1	1.6	12.7	46.4	20.9	2.0	3.8	15.8	11.3	2.3	5.3	5.3	5.5	5.8	17.1	4.3	6.5	7.2	8.9	6.4	1.0	8.8	8.4	4.7	19.3	1.3	6.0	1.9	5.7	9.4	10.6	59.4	1.6	6.8	8.3	12.1	34.5	5.6	2.5	7.9	2.0	7.4	16.3	12.0	25.6	1.4	8.1	0.0	27.4	16.0	0.5	1.0	7.8	37.5	1.3	4.2	4.1	0.9	1.3	2.1	3.5	0.3	3.7	5.5	0.9	7.1	7.5	6.6	3.6	14.5	11.5	10.4	14.2	3.4	9.3	17.0	3.1	9.0	20.9	46.4	1.2	16.7	1.4	1.6	1.4	1.3	12.7	0.7	3.8	1.9	45.3	2.0	20.3	3.5	0.7	15.8	12.7	19.2	25.8	30.9	14.3	13.0	15.9	13.5	28.8	7.4	3.0	15.7	7.6	4.2	7.7	10.2	15.7	25.5	4.0	11.4	7.0	3.9	338.8	18.3	8.9	0.5	15.7	22.0	163.5	2.4	10.5	13.4	3.6	87.8	9.6	251.9	15.9	11.1	9.2	95.5	1.9	8.1	69.1	10.1	33.3	4.1	14.8	4.2	4.3	12.4	51.8	6.7	0.0	12.0	0.7	2.5	5.3	380.0	8.9	4.6	0.7
MPZL1	"FLJ21047, PZR"	ENSG00000197965	"Myelin protein zero like 1"	O95297	1	167721192-167791919	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 51.4"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 51.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026966, HPA063538"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA026966: AB_10600931, HPA063538: AB_2685034"	"unprognostic (6.54e-2)"	"unprognostic (9.26e-3)"	"unprognostic (4.59e-2)"	"unprognostic (4.88e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (4.27e-6)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (3.99e-7)"	"unprognostic (3.55e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (8.08e-4)"	"unprognostic (4.21e-2)"	34.4	19.1	13.6	21.4	13.9	3.2	42.0	14.3	13.7	32.2	27.3	15.4	15.9	18.5	34.8	25.2	32.1	30.1	34.3	29.2	12.0	14.0	22.2	20.9	22.2	20.7	14.4	10.0	38.3	25.4	13.7	24.3	34.0	14.3	28.3	28.2	28.0	51.7	19.4	11.0	17.7	26.6	30.5	13.0	19.6	21.3	27.7	10.9	9.7	29.0	25.8	28.0	33.6	35.0	4.2	12.5	51.4	8.9	2.9	2.4	3.0	18.1	26.5	20.8	16.1	67.3	30.5	65.9	28.4	36.8	18.6	23.2	48.9	25.4	6.4	33.3	35.9	16.4	30.7	20.7	31.4	15.8	14.5	11.2	5.3	14.2	11.7	41.9	6.2	3.4	28.0	39.7	29.7	33.4	26.3	24.7	19.7	19.7	13.5	22.0	6.0	20.9	7.4	13.2	36.6	11.4	12.8	17.9	28.3	28.5	17.6	12.1	19.9	25.3	26.4	14.6	50.2	14.2	3.3	28.0	21.4	9.6	27.4	15.3	20.3	31.3	29.8	30.6	7.3	3.3	1.9	8.1	5.4	0.8	6.8	0.4	4.2	0.8	1.2	10.9	2.5	2.4	0.8	51.4	2.9	8.9	12.5	0.1	3.0	13.6	13.9	14.3	13.7	12.0	14.0	14.4	10.0	14.3	10.9	26.8	25.9	20.1	58.0	67.9	7.6	5.3	20.4	21.4	37.5	19.2	5.9	107.3	5.0	59.9	1.4	40.7	44.8	0.0	66.1	111.2	70.6	98.3	3.5	16.9	33.1	9.5	45.9	22.7	24.2	2.4	64.7	22.2	15.1	124.4	41.1	10.6	61.2	28.8	78.8	10.2	13.2	19.4	47.4	9.7	24.9	48.6	64.3	5.2	51.7	53.8
MR1	HLALS	ENSG00000153029	"Major histocompatibility complex, class I-related"	Q95460	1	181033425-181061938	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA048304			Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"HPA048304: AB_2680347"	"unprognostic (6.89e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.96e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.49e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.40e-3)"	"unprognostic (4.69e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.07e-2)"	10.5	13.8	5.3	10.2	7.1	7.7	8.3	1.7	5.5	8.6	8.2	5.3	6.8	5.3	10.4	10.9	12.6	8.6	13.2	8.9	5.2	3.1	10.5	10.7	16.6	16.2	5.9	5.0	13.9	5.1	12.4	17.6	11.5	5.1	13.2	6.3	12.3	8.1	8.6	3.8	10.1	7.8	9.6	6.1	14.9	6.7	5.5	6.2	23.2	13.6	7.1	18.4	16.4	9.6	12.9	15.6	24.0	22.2	14.9	14.3	11.1	3.7	2.6	0.1	2.2	16.0	19.5	6.8	7.4	20.4	6.2	10.6	1.0	15.2	4.5	15.5	13.3	4.9	9.9	0.3	8.7	5.4	13.7	2.4	6.6	3.0	4.5	5.4	5.3	19.9	12.7	24.3	9.2	10.0	11.6	0.6	8.5	12.2	12.4	12.0	4.1	5.6	3.8	0.0	0.0	0.4	6.4	0.1	12.6	6.7	11.0	0.1	0.2	3.9	7.2	5.2	3.1	7.6	11.5	3.8	6.1	0.8	10.6	3.6	20.6	6.9	8.5	5.7	7.2	0.6	24.0	17.9	18.1	14.3	22.2	12.7	12.1	13.0	12.7	15.6	12.9	9.7	14.3	13.4	14.9	18.7	8.4	13.6	11.1	5.3	7.1	1.7	5.5	5.2	3.1	5.9	5.0	5.1	6.2	17.9	25.9	17.9	7.5	4.4	0.8	3.9	10.2	10.7	11.4	14.0	0.0	13.9	5.0	7.7	0.2	4.4	1.4	23.3	5.6	7.4	9.3	6.2	16.2	9.0	24.5	0.0	2.4	1.8	22.5	0.0	10.0	17.1	6.8	25.2	3.2	4.5	6.1	5.5	11.3	2.1	0.4	0.0	6.6	0.3	1.1	4.6	20.5	15.2	4.0	12.7
MRGPRF	"GPR140, GPR168, MGC21621, mrgF"	ENSG00000172935	"MAS related GPR family member F"	Q96AM1	11	69004395-69013409	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Fibroblasts: 34.7;Leydig cells: 61.2;Peritubular cells: 94.7;Sertoli cells: 51.8;Smooth muscle cells: 90.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"cerebellum: 7.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 26.8;ASC TERT1: 12.0;BJ: 15.1;BJ hTERT+: 38.1;BJ hTERT+ SV40 Large T+: 14.3;fHDF/TERT166: 11.6;U-2197: 18.2"	"Region enriched"	"Detected in some"	5	"cerebellum: 16.6"	"Low region specificity"	"Detected in all"			HPA028811	Approved		Supported	"Nuclear membrane,Plasma membrane"		NA	NA			"Nuclear membrane, Plasma membrane"		"HPA028811: AB_10603875"	"unprognostic (2.49e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.03e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.52e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.55e-7)"	"unprognostic (2.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.62e-3)"	10.8	1.7	0.8	7.6	1.2	0.0	26.6	7.8	1.5	61.9	39.5	1.2	13.9	4.8	49.2	22.3	28.2	28.0	30.6	6.2	0.7	0.4	4.2	2.1	4.8	5.6	1.1	1.3	25.6	0.9	0.4	1.1	5.9	1.8	29.6	4.8	5.8	2.9	25.5	3.1	4.0	10.1	41.1	1.0	8.2	14.2	13.1	0.6	0.1	3.8	6.4	2.7	42.2	19.6	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	26.8	12.0	0.5	15.1	38.1	14.3	9.5	0.0	0.6	0.0	0.3	11.6	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	1.1	0.0	3.3	0.0	0.0	8.8	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.6	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	8.8	0.0	18.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	7.8	1.5	0.7	0.4	1.1	1.3	1.8	0.6	0.0	0.0	0.0	0.2	4.4	0.0	0.6	2.5	0.0	0.0	10.4	0.0	0.6	0.0	0.0	3.6	0.6	0.0	0.0	0.0	0.6	34.7	0.3	0.0	3.4	0.9	0.0	0.0	5.5	0.0	5.2	61.2	0.0	6.8	0.0	0.0	2.8	0.1	0.0	94.7	0.6	0.2	51.8	90.4	1.0	0.5	3.3	0.9	0.0	0.0	0.2
MS4A1	"B1, Bp35, CD20, MS4A2"	ENSG00000156738	"Membrane spanning 4-domains A1"	P11836	11	60455752-60470760	"CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"B-cell activation"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 77.7;intestine: 46.1;lymphoid tissue: 134.1"	"Cell type enriched"	"Detected in some"	61	"B-cells: 527.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	105	"memory B-cell: 77.7;naive B-cell: 77.7"	"Lineage enriched"	"Detected in single"	105	"B-cells: 77.7"	"Group enriched"	"Detected in some"	25	"Daudi: 122.9;U-698: 61.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000015, HPA014341, HPA014391"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB000015: AB_2282030, HPA014341: AB_1846265, HPA014391: AB_1846264"	"prognostic favorable (4.34e-5)"	"unprognostic (4.45e-4)"	"unprognostic (1.19e-4)"	"unprognostic (2.04e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.53e-7)"	"unprognostic (2.46e-3)"	"unprognostic (1.85e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.89e-4)"	"unprognostic (6.96e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.96e-5)"	"unprognostic (2.23e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.30e-1)"	1.6	0.3	0.3	79.0	0.3	3.6	0.6	0.3	0.3	0.5	2.0	0.0	0.0	0.2	0.4	0.5	7.0	0.4	1.3	0.7	0.3	0.3	2.0	0.9	2.7	81.2	0.3	0.1	0.3	0.4	0.0	0.4	0.4	0.1	1.1	1.7	0.6	14.5	0.2	0.3	0.3	46.1	0.1	0.4	90.7	2.6	0.6	0.0	15.7	2.5	2.7	134.1	6.4	0.8	77.7	0.0	0.2	0.0	0.7	0.6	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	122.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	77.7	0.3	0.6	0.0	77.7	0.0	0.2	0.2	0.7	0.0	0.0	0.0	3.5	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.1	0.0	0.0	6.7	527.8	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.6	1.8	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.7	0.0	0.0
MSRA		ENSG00000175806	"Methionine sulfoxide reductase A"	Q9UJ68	8	10054268-10428891	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 78.4"	"Cell type enriched"	"Detected in many"	6	"Proximal tubular cells: 597.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 78.4"	"Cell type enhanced"	"Detected in many"		"eosinophil: 9.0"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.3;granulocytes: 9.0;monocytes: 3.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023804, HPA075766"	Approved		Supported	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"	No	No		25000	"Nucleoplasm, Plasma membrane, Cytosol"	"Actin filaments"	"HPA023804: AB_1853826, HPA075766: "	"unprognostic (1.55e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.45e-3)"	"unprognostic (1.00e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.40e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.43e-3)"	"unprognostic (4.02e-1)"	"unprognostic (6.36e-3)"	"unprognostic (3.07e-1)"	7.0	8.1	8.0	5.2	7.5	36.1	5.9	78.4	13.7	3.6	5.9	4.3	2.2	5.9	4.8	3.7	5.5	4.2	4.4	8.5	8.9	5.5	32.4	22.9	5.7	6.8	6.8	9.5	4.2	10.2	2.9	3.4	4.6	8.1	3.4	4.0	3.9	6.0	5.0	4.7	3.8	12.7	4.9	6.7	7.2	4.9	8.5	5.5	3.5	4.4	2.6	3.8	3.9	2.7	1.1	2.3	9.0	3.2	1.1	0.8	0.3	0.1	1.1	1.8	5.4	1.6	1.8	0.6	3.3	0.7	0.5	2.2	0.7	2.7	0.0	0.8	3.0	7.2	2.9	0.5	0.2	1.7	0.4	0.0	0.5	1.7	2.5	5.3	1.0	15.2	0.5	3.9	0.4	0.0	1.8	0.9	0.3	0.5	0.3	5.9	0.2	0.0	0.3	0.8	3.9	1.0	1.8	1.7	2.3	1.3	1.3	3.1	2.0	5.4	0.2	0.7	0.6	2.8	3.3	3.2	2.2	2.6	0.5	1.6	0.2	0.1	0.9	5.9	1.0	4.1	0.8	3.2	9.0	0.7	2.2	0.6	1.1	0.8	0.5	2.3	0.4	0.6	0.5	3.8	1.1	1.6	0.3	0.5	0.3	8.0	7.5	78.4	13.7	8.9	5.5	6.8	9.5	8.1	5.5	0.0	9.0	10.0	24.1	14.5	10.7	18.1	17.8	5.3	4.5	24.4	29.5	5.8	77.9	27.0	64.1	26.4	29.0	0.0	41.4	4.5	11.3	16.9	81.6	82.9	42.3	15.9	9.2	16.5	31.0	107.2	8.6	33.1	28.7	14.4	19.7	13.4	40.7	28.8	9.2	597.4	5.8	12.9	17.6	27.7	18.8	12.3	7.0	15.3	17.4	28.6
MTM1		ENSG00000171100	"Myotubularin 1"	Q13496	X	150568619-150673322	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Protein transport, Transport"	"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010008, HPA010665"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA010008: AB_1079426, HPA010665: AB_1079425"	"unprognostic (3.66e-3)"	"unprognostic (8.43e-3)"	"unprognostic (3.52e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.74e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.59e-2)"	"prognostic favorable (7.40e-7)"	"unprognostic (4.46e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.46e-1)"	10.7	17.9	15.0	10.2	16.4	11.1	9.2	10.6	10.8	9.1	21.5	12.5	12.7	12.8	10.9	10.9	11.1	11.1	8.0	9.0	14.3	12.0	17.9	19.9	12.2	12.4	17.3	9.3	13.8	7.5	21.4	11.9	21.5	12.9	9.5	21.6	8.3	10.2	12.9	11.2	10.2	21.0	8.0	17.2	15.3	8.6	12.1	16.4	14.5	12.7	8.3	13.9	8.5	9.1	6.9	7.9	18.4	7.2	10.1	7.7	4.6	8.5	3.9	5.5	2.0	5.1	5.0	3.5	4.1	5.6	4.7	5.2	3.0	4.8	13.8	7.3	5.2	14.8	6.1	4.0	7.9	5.8	3.7	3.5	3.7	3.7	9.1	3.8	15.3	12.6	3.0	9.5	3.8	8.1	4.7	6.1	6.0	2.4	12.8	5.7	2.9	4.2	15.9	2.8	8.5	5.1	5.1	3.1	2.7	8.1	4.8	1.4	1.5	3.5	7.4	5.2	8.1	2.6	22.3	5.3	3.2	1.9	8.1	4.2	2.6	5.9	13.1	4.0	9.4	5.1	17.6	6.3	18.4	1.5	7.2	4.9	5.5	6.8	5.2	7.9	6.9	6.5	3.9	8.5	10.1	6.2	5.1	7.7	4.6	15.0	16.4	10.6	10.8	14.3	12.0	17.3	9.3	12.9	16.4	8.9	18.3	3.7	5.8	13.5	0.0	12.3	2.5	9.4	5.7	3.5	0.0	1.9	1.7	2.8	27.7	7.8	12.8	0.0	3.8	2.2	4.2	4.9	8.1	10.5	7.2	0.0	9.2	17.2	13.4	15.8	5.8	11.0	5.0	6.4	18.9	0.0	3.6	7.0	12.0	10.8	0.0	0.0	2.7	4.4	2.5	16.7	6.1	7.5	10.3	8.1
MUC1	"ADMCKD, ADMCKD1, CD227, MCD, MCKD, MCKD1, PEM, PUM"	ENSG00000185499	"Mucin 1, cell surface associated"	P15941	1	155185824-155192916	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 168.1;kidney: 158.5;lung: 143.5"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 2: 1308.2;Collecting duct cells: 465.9;Exocrine glandular cells: 994.6;Pancreatic endocrine cells: 807.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.0"	"Group enriched"	"Detected in many"	10	"granulocytes: 1.3;T-cells: 4.0"	"Group enriched"	"Detected in many"	6	"CAPAN-2: 139.4;OE19: 65.3;RPTEC TERT1: 107.0;T-47d: 47.0"									"CAB000036, CAB001986, HPA004179, HPA007235, HPA008855"	Enhanced		Supported	"Plasma membrane"	"Secreted in other tissues"	NA	NA		4900000	"Plasma membrane"		"CAB000036: AB_2148557, CAB001986: , HPA004179: AB_1846282, HPA007235: AB_1846281, HPA008855: AB_1846283"	"unprognostic (4.74e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.61e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (4.60e-4)"	"unprognostic (4.75e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.21e-1)"	1.5	0.7	0.8	12.6	1.2	0.9	12.6	0.4	0.7	31.6	15.9	1.2	2.4	2.9	10.5	9.8	51.8	18.7	168.1	0.8	0.5	0.3	158.5	2.0	143.5	0.3	0.5	0.3	14.9	74.2	0.0	4.7	15.5	2.1	6.1	16.1	0.8	17.0	5.9	0.8	1.8	3.6	2.8	0.7	0.6	105.0	4.3	0.5	0.7	15.7	10.5	47.8	12.3	5.2	0.0	0.2	1.3	0.1	0.0	4.0	0.2	1.8	0.9	0.6	0.5	0.4	0.5	0.2	0.6	1.4	0.7	1.9	0.0	139.4	0.0	10.1	1.1	0.3	2.8	0.1	0.0	0.2	1.2	0.1	0.2	11.8	0.0	0.3	0.0	4.4	1.2	0.2	0.3	0.2	1.5	0.2	0.2	1.0	1.9	0.5	14.2	0.1	0.1	0.4	65.3	0.2	0.2	0.0	3.4	107.0	0.1	0.6	0.2	3.3	5.9	0.1	0.5	47.0	0.6	0.2	0.4	0.8	1.3	0.1	2.1	1.1	0.0	0.7	0.1	0.1	1.3	0.1	0.0	0.0	0.0	0.8	0.0	2.3	0.4	0.2	0.0	0.3	0.7	0.0	0.0	0.0	0.0	4.0	0.2	0.8	1.2	0.4	0.7	0.5	0.3	0.5	0.3	2.1	0.5	402.0	1308.2	0.9	16.1	0.6	1.0	0.4	384.7	92.3	252.5	465.9	3.9	0.1	29.9	144.7	27.3	3.5	49.2	0.0	994.6	1.2	3.1	11.6	45.2	0.5	0.2	1.6	29.4	1.3	3.4	68.9	2.3	2.6	5.0	42.3	249.7	1.1	807.2	66.2	1.4	0.9	0.2	0.0	1.9	6.2	0.8	1.0	0.2	0.0	132.5	164.3
MYH9	"DFNA17, EPSTS, FTNS, MHA, NMHC-II-A, NMMHCA"	ENSG00000100345	"Myosin heavy chain 9"	P35579	22	36281277-36388067	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Alport syndrome, Cancer-related genes, Cataract, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001644, CAB015386, HPA064783"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytosol"		No	No		3100000000	"Plasma membrane, Actin filaments"	Cytosol	"CAB015386: AB_784698, HPA001644: AB_1079439, HPA064783: AB_2732721"	"unprognostic (1.38e-1)"	"unprognostic (9.12e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.90e-2)"	"unprognostic (9.56e-2)"	"unprognostic (8.28e-2)"	"unprognostic (5.50e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.98e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.59e-2)"	115.5	26.1	11.9	43.7	12.9	55.6	59.0	9.3	16.8	67.1	44.6	18.0	26.4	26.9	120.8	39.7	48.3	45.6	66.9	39.2	11.0	8.1	45.0	42.8	74.4	57.7	15.1	9.2	56.4	43.9	19.0	15.4	65.7	17.9	47.6	23.6	32.4	66.2	27.2	36.9	40.3	49.8	46.7	13.5	91.5	37.1	25.8	11.9	76.0	42.5	38.4	65.0	56.0	53.7	6.9	8.2	28.5	11.5	4.2	16.6	19.3	61.6	28.6	9.1	7.8	17.0	21.4	46.4	41.4	53.6	59.1	44.4	30.9	17.7	16.0	24.6	69.2	28.2	42.8	13.3	80.9	60.9	36.0	12.6	30.8	30.7	26.3	52.3	34.9	49.4	25.3	24.9	79.9	67.9	58.0	48.7	11.8	6.7	21.7	47.2	16.4	12.4	20.6	5.4	17.4	17.7	23.6	28.3	14.8	33.4	60.0	13.8	5.6	58.1	22.9	26.7	24.6	17.0	18.1	139.1	131.2	39.8	25.1	74.7	14.3	11.3	13.5	49.6	17.7	38.0	26.8	10.4	28.5	16.6	9.6	14.7	6.9	12.0	13.2	8.2	6.4	9.6	10.1	19.7	4.2	11.5	3.8	12.6	19.3	11.9	12.9	9.3	16.8	11.0	8.1	15.1	9.2	17.9	11.9	110.2	86.9	60.5	130.0	128.0	2.3	53.2	81.5	28.1	77.3	87.2	2.0	72.9	6.6	289.4	34.4	187.8	163.7	0.0	209.5	151.1	61.7	129.5	90.2	89.4	89.7	77.9	70.9	122.8	115.2	27.9	63.0	105.6	81.0	160.5	123.0	11.0	299.7	150.8	198.7	19.2	4.7	200.5	251.3	3.0	6.8	118.2	38.8	112.2	120.6	111.1
MYLK	"MLCK, MLCK1, MYLK1, smMLCK"	ENSG00000065534	"Myosin light chain kinase"	Q15746	3	123610049-123884331	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 191.1"	"Cell type enhanced"	"Detected in many"	16	"Peritubular cells: 649.2;Sertoli cells: 271.7;Smooth muscle cells: 829.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"basophil: 3.6;classical monocyte: 1.3;myeloid DC: 2.8;neutrophil: 4.5;plasmacytoid DC: 2.7"	"Group enriched"	"Detected in many"	13	"dendritic cells: 2.8;granulocytes: 4.5;monocytes: 1.3"	"Cell line enhanced"	"Detected in many"		"BJ: 36.4;BJ hTERT+: 55.1;fHDF/TERT166: 45.0;HBF TERT88: 29.0;hTERT-RPE1: 38.5;RPTEC TERT1: 59.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB020789, HPA031677, HPA048055"	Enhanced		Enhanced	"Plasma membrane,Actin filaments"		NA	NA		3000000	"Actin filaments"	"Plasma membrane"	"CAB020789: , HPA031677: AB_10794617, HPA048055: AB_2732543"	"unprognostic (2.80e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (5.26e-3)"	"unprognostic (9.60e-2)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (4.46e-4)"	14.9	4.9	4.5	19.8	10.9	0.0	14.4	0.8	5.8	77.1	107.3	22.0	93.2	9.4	111.2	48.3	96.0	56.3	40.6	6.6	4.7	3.2	8.3	5.4	13.2	6.5	25.8	2.8	50.2	1.6	0.5	1.1	8.0	16.0	85.1	27.6	6.0	17.6	158.6	1.6	4.8	33.3	191.1	28.8	7.4	38.7	17.4	13.0	0.2	4.1	2.5	3.4	137.1	21.3	0.2	2.8	4.5	1.3	0.0	0.2	17.3	2.5	7.7	2.0	1.3	2.1	0.4	0.9	36.4	55.1	23.6	16.9	1.6	1.4	0.1	8.2	45.0	11.2	0.9	0.9	0.3	29.0	0.0	0.1	20.3	0.2	5.0	10.9	0.1	1.9	6.8	0.7	4.6	6.9	38.5	1.8	0.2	0.2	0.1	17.4	0.3	0.0	0.5	2.2	0.1	1.0	2.3	1.2	6.6	59.6	1.4	0.3	1.1	3.7	0.4	0.6	5.0	0.2	0.0	6.7	7.2	2.6	1.7	5.9	0.6	0.7	0.0	18.5	0.2	1.8	3.6	1.3	0.3	0.1	0.2	0.0	0.2	0.0	0.0	2.8	0.1	0.2	0.1	4.5	0.0	0.0	2.7	0.1	17.3	4.5	10.9	0.8	5.8	4.7	3.2	25.8	2.8	16.0	13.0	14.9	34.7	2.9	24.1	18.2	2.5	16.5	33.1	5.3	6.8	26.2	117.8	0.6	3.3	4.5	38.5	34.3	13.8	0.0	3.6	0.6	23.4	4.9	2.3	169.4	4.0	3.2	10.9	66.9	9.2	26.0	97.0	8.0	18.6	0.0	3.0	4.8	2.7	24.0	649.2	9.6	18.7	271.7	829.4	3.0	3.3	17.7	2.1	0.5	3.7	1.6
MYO10	KIAA0799	ENSG00000145555	"Myosin X"	Q9HD67	5	16661914-16936276	"Plasma proteins, Predicted intracellular proteins"	Transport	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Muller glia cells: 290.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 6.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 6.0"	"Cell line enhanced"	"Detected in many"		"HAP1: 39.5;SK-MEL-30: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015224, HPA024223"	Enhanced		Supported	"Nucleoli rim,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Nucleoli rim"	"CAB015224: , HPA024223: AB_1854248"	"unprognostic (1.13e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (7.63e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.96e-2)"	"unprognostic (4.40e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.16e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.75e-4)"	"unprognostic (8.93e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.84e-1)"	10.5	3.4	28.1	5.1	30.1	3.0	8.0	8.9	39.7	6.3	15.3	17.3	6.6	19.5	5.7	4.3	7.7	3.8	7.7	3.7	26.2	10.9	13.3	7.1	14.5	1.6	14.6	15.3	12.1	22.0	10.4	16.2	22.0	10.6	5.4	15.8	19.7	9.8	7.4	6.6	13.4	14.6	4.3	11.1	10.9	24.2	12.4	18.5	0.5	28.6	3.3	2.3	6.6	7.1	0.9	0.5	1.1	6.0	0.5	0.6	0.3	13.4	21.3	8.9	4.2	6.6	3.6	8.2	24.1	17.0	6.7	5.5	13.5	2.2	0.4	16.5	10.9	9.0	7.1	39.5	15.8	12.5	0.0	3.9	0.0	35.6	3.7	24.0	0.1	0.4	7.3	6.9	16.2	19.4	13.0	22.4	0.0	0.0	1.3	6.5	2.6	0.1	0.1	22.9	14.0	7.7	5.4	2.2	14.2	6.8	10.4	1.2	0.6	5.2	2.7	46.2	14.0	1.7	2.2	27.1	16.3	6.0	0.2	13.2	0.2	0.1	0.1	8.0	2.5	16.2	1.0	0.6	0.5	0.3	1.5	0.4	0.3	0.4	0.3	0.5	0.9	0.6	0.6	1.1	0.5	6.0	0.4	0.3	0.3	28.1	30.1	8.9	20.7	26.2	10.9	14.6	15.3	10.6	18.5	32.8	31.7	1.4	29.1	36.4	7.9	2.8	30.6	21.4	28.4	29.6	17.7	18.9	14.9	93.1	19.9	41.2	28.6	0.0	35.5	49.8	11.5	32.7	26.6	0.8	4.8	77.9	71.0	93.3	9.4	6.5	11.8	4.4	64.1	5.4	48.0	290.6	80.7	37.4	18.0	3.6	6.4	64.7	26.7	1.4	6.4	27.9	123.6	2.5	57.5	32.3
MYO1G	HA-2	ENSG00000136286	"Myosin IG"	B0I1T2	7	44962662-44979098	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 37.9;bone marrow: 27.4;lymphoid tissue: 46.8"	"Cell type enriched"	"Detected in many"	7	"monocytes: 573.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 20.2;HEL: 24.5;HL-60: 14.0;JURKAT: 30.5;MOLT-4: 31.0;NB-4: 13.1;THP-1: 27.5;U-937: 20.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021252	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		120000	"Plasma membrane"	Nucleoplasm	"HPA021252: AB_1854254"	"unprognostic (2.74e-2)"	"prognostic favorable (8.26e-4)"	"unprognostic (5.20e-3)"	"unprognostic (9.91e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.54e-3)"	"unprognostic (6.47e-2)"	"unprognostic (6.40e-2)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (8.71e-8)"	"unprognostic (3.20e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.92e-2)"	2.5	1.2	1.6	11.0	3.0	27.4	1.5	0.4	2.0	1.0	1.9	0.7	0.0	1.8	1.2	2.1	2.4	1.9	3.6	3.2	1.0	0.9	1.9	1.9	13.0	18.6	4.5	0.0	0.9	0.8	0.0	0.9	1.5	2.7	1.5	1.1	1.5	5.8	0.5	0.6	1.2	8.3	1.9	2.6	22.3	2.1	0.9	1.8	46.8	2.1	2.2	26.6	4.7	1.3	9.9	14.0	9.4	37.9	6.7	24.4	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	24.5	0.8	0.0	0.0	14.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	30.5	0.0	0.0	0.0	0.0	31.0	13.1	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	27.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	20.2	0.0	9.4	17.0	5.2	19.9	29.6	12.6	9.9	12.7	17.4	14.0	6.6	4.6	9.0	1.7	6.7	37.9	1.2	24.4	19.3	1.6	3.0	0.4	2.0	1.0	0.9	4.5	0.0	2.7	1.8	3.0	11.4	56.6	0.3	2.5	0.0	1.1	0.0	1.4	2.3	0.0	0.0	0.1	0.0	0.1	0.3	0.6	0.0	0.0	0.9	0.2	1.7	0.4	30.0	0.9	10.8	3.2	0.0	2.5	71.9	1.2	0.0	51.5	3.3	573.5	0.0	0.2	0.2	0.0	0.4	0.3	0.0	6.5	1.6	0.4	0.2	1.5	0.1	86.3	0.0	0.1
MYOF	"FER1L3, KIAA1207"	ENSG00000138119	Myoferlin	Q9NZM1	10	93306429-93482317	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Pancreatic endocrine cells: 95.7;Urothelial cells: 93.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 15.9;non-classical monocyte: 18.0"	"Group enriched"	"Detected in many"	65	"dendritic cells: 6.2;monocytes: 18.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 76.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014245	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA		14000	Vesicles	"Plasma membrane"	"HPA014245: AB_1848495"	"unprognostic (3.41e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.50e-2)"	"unprognostic (8.57e-3)"	"unprognostic (3.48e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.74e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.17e-2)"	"unprognostic (9.18e-2)"	27.5	7.3	2.1	8.9	4.1	0.2	21.7	1.3	2.7	27.0	12.3	5.1	16.0	2.0	27.2	17.7	27.2	16.2	11.4	7.2	3.5	2.1	12.2	1.7	18.7	7.5	5.8	2.5	12.7	3.3	16.1	4.2	31.9	15.0	20.7	12.8	10.1	14.9	17.4	5.7	22.4	6.8	49.0	9.4	10.0	8.8	5.7	4.4	1.5	15.7	14.2	9.4	35.0	20.0	0.0	6.2	0.1	18.0	0.0	0.1	1.1	36.1	34.2	3.7	2.3	25.6	57.0	10.4	31.8	76.2	19.4	19.2	8.2	28.4	0.0	12.7	58.2	19.9	55.3	0.3	32.6	14.3	0.2	0.1	0.0	13.4	0.3	8.9	0.0	0.0	29.9	11.3	13.1	53.6	48.5	50.3	0.0	0.0	0.0	45.7	5.7	0.0	0.1	0.2	10.9	30.5	0.0	2.6	0.0	50.3	45.2	0.0	0.0	21.8	4.6	8.0	14.3	22.6	0.7	62.8	28.6	1.9	18.9	18.5	0.0	0.0	0.0	21.2	0.4	33.7	0.0	4.3	0.0	0.0	15.9	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.1	0.0	18.0	2.1	0.1	1.1	2.1	4.1	1.3	2.7	3.5	2.1	5.8	2.5	15.0	4.4	56.6	42.0	2.7	42.9	21.1	0.0	7.6	10.2	32.1	66.0	21.0	0.0	48.8	1.7	48.5	0.5	20.4	36.0	0.0	28.8	20.4	33.3	62.3	1.1	0.0	21.2	0.0	1.7	27.0	31.3	0.6	5.5	20.9	8.5	3.6	24.4	0.0	95.7	18.2	8.5	0.5	0.9	6.5	31.9	0.1	0.1	26.8	42.8	0.0	13.3	93.6
NCAM2	"MGC51008, NCAM21"	ENSG00000154654	"Neural cell adhesion molecule 2"	O15394	21	20998315-21543329	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 15.9;brain: 52.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 44.1;Late spermatids: 20.9"	"Cancer enhanced"	"Detected in some"		"glioma: 5.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"T-47d: 45.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030900, HPA030901"	Enhanced	Supported	Supported	"Nuclear bodies,Plasma membrane"		No	No		100000000	"Nuclear bodies, Plasma membrane"		"HPA030900: AB_10602037, HPA030901: AB_2673650"	"unprognostic (9.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.61e-1)"	"unprognostic (3.07e-4)"	"unprognostic (2.47e-4)"	"unprognostic (1.62e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.35e-3)"	2.0	15.9	25.8	2.0	22.3	1.1	3.1	7.0	52.7	3.3	2.1	14.7	0.0	1.3	2.3	1.8	1.7	1.8	2.6	3.1	18.7	13.9	1.3	9.1	4.4	1.2	21.6	19.4	1.4	1.3	1.1	1.0	1.7	17.9	2.2	2.4	0.5	1.8	2.3	1.5	2.0	1.9	2.7	17.3	2.0	1.3	8.3	26.6	0.0	1.5	0.0	1.3	1.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.3	2.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.2	0.6	0.0	1.1	0.0	0.0	5.7	0.0	1.7	0.0	0.2	0.0	0.0	5.3	1.2	0.1	7.2	0.1	0.0	0.2	0.0	0.0	0.5	0.0	2.2	0.0	0.0	0.0	2.6	0.0	0.4	0.3	0.0	45.2	3.4	0.0	0.6	0.4	0.0	0.0	0.3	0.0	0.0	1.2	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.8	22.3	7.0	22.4	18.7	13.9	21.6	19.4	17.9	26.6	3.0	2.2	0.0	0.2	0.5	0.2	1.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	44.1	0.0	0.0	0.0	0.0	0.4	2.4	0.8	0.0	0.0	0.3	0.0	0.0	3.7	0.0	20.9	0.9	0.0	1.7	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.1	3.3	8.0	0.1	0.2	0.0	0.0	0.1
NECTIN4	"LNIR, nectin-4, PRR4, PVRL4"	ENSG00000143217	"Nectin cell adhesion molecule 4"	Q96NY8	1	161070995-161089599	"Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.1;placenta: 46.6;skin 1: 39.3"	"Cell type enriched"	"Detected in some"	7	"Syncytiotrophoblasts: 321.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"basophil: 1.5;eosinophil: 1.2;neutrophil: 3.6"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 28.2;HaCaT: 18.2;MCF7: 11.4;OE19: 11.8;SK-BR-3: 23.7;T-47d: 15.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA010775	Enhanced		Supported	"Plasma membrane"	"Secreted in other tissues"	No	No		11000	"Plasma membrane"		"HPA010775: AB_1079720"	"unprognostic (1.09e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.09e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-8)"	"unprognostic (2.98e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.97e-2)"	0.2	0.1	0.1	0.8	0.1	0.1	7.7	0.1	0.1	9.8	0.6	0.1	5.4	0.2	1.5	3.7	40.1	1.4	5.6	0.1	0.1	0.1	1.3	0.2	3.1	0.0	0.1	0.0	0.5	4.4	0.0	0.3	46.6	0.1	7.8	0.7	0.1	13.5	5.5	0.1	39.3	0.4	2.0	0.1	0.1	4.5	0.2	0.0	0.5	0.1	22.7	23.1	12.6	18.5	0.2	0.3	3.6	0.1	0.1	0.2	0.0	5.2	0.1	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.1	0.0	7.1	0.0	0.1	0.0	0.0	18.2	0.0	0.6	0.1	0.0	0.2	0.0	0.4	5.3	0.0	0.0	0.3	0.0	7.2	1.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.1	0.1	23.7	0.0	3.3	15.3	0.0	0.0	0.0	1.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.5	0.1	1.2	0.2	0.0	0.1	0.2	0.2	0.0	0.3	0.2	0.1	0.1	3.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	6.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	18.7	14.8	15.7	0.0	24.1	0.0	34.7	0.0	0.0	0.0	0.0	26.2	43.5	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.8	0.0	0.0	47.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	321.3	0.0	0.0	0.0
NEO1	"HsT17534, IGDCC2, NGN, NTN1R2"	ENSG00000067141	"Neogenin 1"	Q92859	15	73051710-73305206	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Intestinal endocrine cells: 57.8;Peritubular cells: 59.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009320, HPA027804, HPA027805, HPA027806"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA		280000000	"Nucleoplasm, Plasma membrane"	"Golgi apparatus"	"CAB009320: AB_2150998, HPA027804: AB_10600771, HPA027805: AB_10601755, HPA027806: AB_10601006"	"unprognostic (1.90e-1)"	"unprognostic (2.38e-2)"	"unprognostic (7.60e-3)"	"unprognostic (3.76e-2)"	"unprognostic (5.44e-1)"	"unprognostic (3.83e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.51e-2)"	"unprognostic (8.05e-2)"	"prognostic favorable (4.39e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.75e-1)"	7.3	5.8	19.2	6.2	22.4	1.2	11.4	12.7	23.9	13.4	30.0	44.5	14.8	17.9	14.2	7.2	8.0	15.4	13.4	6.8	20.1	14.1	16.2	5.9	10.7	2.7	27.1	15.7	17.5	11.5	44.4	6.9	1.5	19.3	23.1	36.9	16.0	11.5	25.5	17.9	24.6	19.0	16.0	22.3	3.6	15.1	9.0	22.5	2.1	12.5	3.8	4.7	10.1	9.5	0.0	0.3	1.4	0.3	0.8	3.1	0.3	3.7	18.3	21.9	14.4	13.3	3.9	5.5	1.4	1.8	3.6	0.7	2.7	18.5	1.0	2.2	4.0	13.6	0.8	15.3	8.4	1.5	6.6	11.3	12.3	0.2	2.5	3.8	0.3	0.4	9.6	15.6	0.7	7.2	4.2	0.0	9.6	0.0	23.5	0.8	11.2	4.3	0.2	20.9	2.8	1.5	10.0	11.7	2.4	7.0	10.1	10.0	14.1	17.2	7.7	9.1	18.4	8.1	2.2	0.0	16.9	9.0	5.4	3.9	10.1	18.6	2.6	3.6	3.5	4.7	0.0	0.3	0.4	1.8	0.0	3.1	0.0	1.1	1.4	0.0	0.0	0.6	0.5	1.4	0.8	0.0	0.3	0.0	0.3	19.2	22.4	12.7	23.9	20.1	14.1	27.1	15.7	19.3	22.5	8.9	7.2	1.7	6.9	12.6	14.6	4.2	22.9	4.0	6.8	21.0	13.7	0.5	1.7	8.7	3.0	2.9	34.1	0.0	5.5	0.6	7.9	14.5	0.0	5.9	0.7	9.5	57.8	8.0	0.3	4.1	29.4	0.5	10.1	0.0	37.7	10.4	9.4	38.6	59.1	14.3	21.5	6.5	8.6	5.7	18.1	22.2	0.2	4.5	47.7	6.1
NGFR	"CD271, p75NTR, TNFRSF16"	ENSG00000064300	"Nerve growth factor receptor"	P08138	17	49495293-49515017	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Apoptosis, Biological rhythms, Differentiation, Neurogenesis"	"Developmental protein, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	17	"Basal glandular cells: 33.8;Leydig cells: 88.9;Muller glia cells: 122.0;Sertoli cells: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"plasmacytoid DC: 4.2"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 4.2"	"Group enriched"	"Detected in some"	7	"RH-30: 56.0;WM-115: 62.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basal ganglia: 13.1;hypothalamus: 8.2;pons and medulla: 3.7"	"CAB000143, CAB001995, HPA004765"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		100000	"Nucleoplasm, Plasma membrane"		"CAB000143: , CAB001995: , HPA004765: AB_1079233"	"unprognostic (6.25e-3)"	"unprognostic (1.06e-3)"	"unprognostic (3.39e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.10e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.37e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.77e-3)"	"prognostic unfavorable (3.40e-4)"	30.9	24.0	1.2	9.2	7.4	1.0	11.7	6.1	4.5	7.6	9.4	10.4	7.9	3.2	6.8	15.0	11.3	12.6	10.8	22.2	2.4	2.9	4.8	29.1	1.4	11.6	13.8	1.3	7.6	6.2	2.8	6.7	16.7	15.9	17.7	3.4	20.2	17.2	9.7	4.8	8.4	5.0	10.7	22.4	18.9	4.9	12.2	4.4	0.4	25.8	7.4	7.0	13.1	6.8	0.0	4.2	0.0	0.4	0.0	0.5	0.2	0.0	0.0	1.7	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.9	1.3	0.4	1.2	0.0	0.1	0.2	0.1	0.0	1.0	0.1	0.0	0.1	6.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	8.1	0.1	0.0	0.0	1.0	0.0	0.0	1.0	56.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	3.7	2.2	0.1	0.0	0.0	0.0	1.0	0.1	2.7	0.0	0.0	0.0	0.0	0.5	62.2	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	4.2	0.0	0.2	1.2	7.4	6.1	4.0	2.4	2.9	13.8	1.3	15.9	4.4	0.0	0.0	0.5	33.8	3.2	6.1	0.5	0.0	1.4	2.3	0.0	3.9	0.2	0.0	0.0	0.6	1.3	0.0	0.0	0.0	0.4	3.3	2.4	0.0	0.0	0.1	0.0	0.0	3.1	0.0	0.9	88.9	1.8	15.1	0.0	0.0	122.0	0.0	0.0	26.2	0.0	5.7	32.3	9.5	0.5	0.9	1.5	0.1	1.0	0.0	2.0
NINJ2		ENSG00000171840	"Ninjurin 2"	Q9NZG7	12	564296-663779	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 44.7;brain: 43.6"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 32.8;Hofbauer cells: 25.9;Kupffer cells: 33.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 41.4;MOLT-4: 70.0;THP-1: 14.8;U-698: 13.3"	"Low region specificity"	"Detected in many"							"HPA058980, HPA067226"			Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Endoplasmic reticulum"	"Nucleoplasm, Plasma membrane, Centriolar satellite, Cytosol"	"HPA058980: AB_2683869, HPA067226: "	"unprognostic (1.16e-1)"	"unprognostic (2.19e-1)"	"unprognostic (9.51e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.37e-1)"	"prognostic favorable (5.31e-4)"	"unprognostic (5.72e-3)"	"unprognostic (1.90e-3)"	"unprognostic (4.60e-2)"	"unprognostic (4.98e-3)"	"unprognostic (5.88e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.68e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.23e-1)"	11.8	1.4	9.8	9.2	14.1	27.8	9.2	2.4	18.5	7.3	5.0	43.6	1.6	4.6	2.9	3.3	8.4	3.8	4.7	7.9	16.4	8.7	1.4	13.8	31.3	10.8	21.8	10.2	0.8	1.8	0.9	1.1	3.9	17.2	2.7	4.5	2.9	4.5	2.8	20.1	6.7	3.9	4.8	26.4	8.8	3.6	3.9	21.1	3.6	2.6	2.2	9.2	9.0	3.9	5.6	14.9	34.2	17.7	5.7	44.7	9.1	0.4	0.1	0.0	0.4	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.8	3.2	0.0	0.1	1.6	0.4	0.0	0.0	0.0	0.0	2.3	0.0	41.4	9.9	0.5	0.0	1.1	1.7	0.6	0.0	0.0	0.0	0.0	0.8	0.8	2.4	7.1	0.0	0.0	70.0	2.2	0.7	0.0	0.0	1.8	0.0	0.2	0.7	0.0	0.0	0.0	7.8	0.0	0.0	0.1	0.0	14.8	0.2	0.0	0.4	2.7	0.0	0.0	1.1	13.3	0.1	7.7	0.0	2.0	17.7	14.1	10.5	13.7	3.1	5.6	11.8	11.1	14.9	4.5	2.6	5.5	34.2	5.7	11.2	7.8	44.7	9.1	9.8	14.1	2.4	18.5	16.4	8.7	21.8	10.2	17.2	21.1	20.8	32.8	6.5	0.2	5.0	0.0	1.2	0.0	6.7	14.8	0.0	0.0	2.3	1.7	0.0	2.1	5.4	1.6	0.0	0.0	3.2	5.6	0.2	2.3	10.6	25.9	0.0	4.1	5.5	33.3	1.9	7.5	17.3	6.8	6.4	3.2	0.3	0.5	3.5	3.9	0.0	0.0	0.0	1.0	3.2	2.5	4.8	0.7	14.4	3.3	0.0
NMBR	"BB1, BB1R"	ENSG00000135577	"Neuromedin B receptor"	P28336	6	142058330-142088799	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"brain: 2.5;fallopian tube: 3.3;testis: 5.1"	"Cell type enhanced"	"Detected in some"	35	"Early spermatids: 5.9;Late spermatids: 1.6;Spermatocytes: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.9;RPTEC TERT1: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA026665			Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA026665: AB_1854527"	"unprognostic (6.24e-2)"	"unprognostic (3.05e-1)"		"unprognostic (2.77e-2)"	"unprognostic (7.88e-2)"			"unprognostic (3.54e-2)"		"unprognostic (8.21e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.95e-1)"	"unprognostic (7.94e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.45e-2)"	0.1	0.0	0.6	0.0	2.5	0.0	0.4	0.0	0.8	0.5	0.0			0.0	0.2	0.3	0.6	3.3	0.0	0.0	0.5	1.6	0.2	0.0	0.2	0.0	0.6		0.3	0.0	0.0	0.0	0.1		0.0	0.0		0.2	0.6	0.0	0.0	0.0	0.2	0.8	0.1	0.2	5.1			0.4		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.9	0.9	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.2	0.0	0.1	0.4	0.2	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.9	0.0	0.6	0.1	0.0	0.3	0.5	0.0	0.0	0.5	0.2	0.0	0.4	0.0	0.2	1.3	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0
NME2	"NDPKB, NM23-H2"	ENSG00000243678	"NME/NM23 nucleoside diphosphate kinase 2"	P22392	17	51165435-51171747	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 115.1;Club cells: 150.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB036213, CAB036214, CAB036215, HPA041113"	Approved		Supported	"Plasma membrane,Midbody ring,Cytosol"		NA	NA			Cytosol	"Plasma membrane, Midbody ring"	"CAB036213: , CAB036214: , CAB036215: , HPA041113: AB_2677305"	"unprognostic (7.21e-3)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (4.85e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (6.62e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.41e-2)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (2.82e-1)"	"unprognostic (9.09e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.19e-2)"	62.1	54.6	42.3	58.2	44.1	44.2	188.9	20.1	43.7	58.9	74.0	16.3	67.7	52.5	65.0	52.0	104.3	56.8	65.3	115.1	38.2	32.1	77.3	115.7	59.0	174.7	45.0	23.7	90.7	234.3	17.5	30.4	37.9	34.0	64.0	62.7	29.9	109.4	65.8	105.3	63.3	45.1	88.3	34.6	69.4	50.2	32.3	24.4	42.5	66.9	102.0	56.6	81.3	140.8	49.3	71.3	8.3	43.7	32.6	34.5	38.2	89.1	131.0	31.4	54.7	70.2	102.4	86.6	61.8	64.3	94.6	72.1	105.7	47.5	75.0	100.2	63.3	48.6	57.1	65.8	84.3	78.0	90.4	194.5	63.0	91.4	153.0	76.6	99.5	44.2	92.6	98.5	61.0	107.4	67.1	56.3	53.7	86.3	50.6	68.1	158.5	49.8	124.4	46.7	205.0	201.3	47.8	104.0	119.7	102.4	112.7	71.5	44.3	38.0	95.6	92.8	61.7	65.9	76.3	57.1	91.3	66.0	64.8	98.2	88.4	114.8	85.9	49.3	50.7	45.7	8.3	35.1	2.0	24.7	43.7	34.5	49.3	33.0	26.9	61.5	36.2	23.8	25.6	2.1	32.6	38.0	71.3	29.9	38.2	42.3	44.1	20.1	43.7	38.2	32.1	45.0	23.7	34.0	24.4	26.8	56.3	13.7	6.1	12.9	0.9	0.0	22.9	115.1	150.2	5.2	0.0	10.6	31.5	37.0	0.4	14.4	5.6	23.3	30.1	24.4	10.8	3.7	39.5	37.1	14.9	0.0	14.0	31.9	41.2	1.1	23.9	13.6	10.1	88.4	24.3	0.2	47.4	14.0	12.0	26.2	0.8	6.5	5.7	0.5	5.0	13.0	7.3	18.1	29.3	6.8
NMT2		ENSG00000152465	"N-myristoyltransferase 2"	O60551	10	15102584-15168693	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"granulocytes: 89.2;Hepatocytes: 122.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 8.7;eosinophil: 7.9;gdT-cell: 7.2;MAIT T-cell: 12.9;memory CD4 T-cell: 11.5;memory CD8 T-cell: 8.3;naive CD4 T-cell: 14.7;naive CD8 T-cell: 9.3;NK-cell: 12.9;T-reg: 17.5"	"Group enriched"	"Detected in many"	7	"granulocytes: 8.7;NK-cells: 12.9;T-cells: 17.5"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 33.8;TIME: 49.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001303	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Golgi apparatus, Plasma membrane, Cytosol"		"HPA001303: AB_1079494"	"unprognostic (1.08e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.15e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.13e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.01e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-1)"	29.3	5.4	18.9	6.5	17.3	3.8	19.2	35.6	25.3	12.0	9.9	6.0	4.7	7.4	14.5	5.0	8.2	8.9	8.1	9.6	12.8	9.2	10.8	18.5	7.2	9.0	8.8	15.0	18.2	7.1	28.5	7.9	5.1	10.3	10.7	10.7	8.3	5.8	9.4	18.8	11.5	11.9	12.5	10.3	10.1	8.8	14.5	9.9	23.7	6.9	4.5	8.9	10.1	20.1	1.9	0.3	8.7	0.5	12.9	17.5	3.9	2.8	3.6	4.2	3.1	11.5	12.4	0.8	6.2	5.0	5.7	7.8	3.5	12.7	0.1	4.3	33.8	15.7	3.5	3.7	3.5	9.6	3.7	4.8	7.6	1.8	4.8	7.7	0.5	28.3	11.0	3.6	8.1	2.4	20.9	22.0	5.3	3.6	0.5	21.2	3.5	5.8	1.4	3.1	3.2	3.5	4.3	6.2	0.5	4.2	0.6	1.2	4.8	7.5	1.2	2.0	3.7	3.8	2.3	49.0	5.7	8.4	25.0	4.4	4.3	4.5	0.3	7.0	2.0	4.1	8.7	0.3	7.9	7.2	0.4	12.9	1.4	11.5	8.3	0.3	1.9	14.7	9.3	1.2	12.9	0.5	0.2	17.5	3.9	18.9	17.3	35.6	25.3	12.8	9.2	8.8	15.0	10.3	9.9	8.9	9.1	18.2	17.3	14.7	21.8	11.1	76.5	5.3	14.8	26.2	3.9	0.8	8.3	23.8	6.4	20.4	30.1	46.7	16.8	2.1	11.6	13.9	89.2	122.4	2.4	19.1	17.2	24.5	6.9	9.6	20.1	6.5	11.8	13.6	9.9	12.0	21.3	12.2	19.4	44.1	14.9	0.0	15.3	7.4	50.5	12.9	2.2	38.3	16.9	13.4
NMUR2	NMU2R	ENSG00000132911	"Neuromedin U receptor 2"	Q9GZQ4	5	152391532-152433368	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 8.9;stomach 1: 5.0;testis: 8.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"colorectal cancer: 0.5;endometrial cancer: 0.6;pancreatic cancer: 1.8;stomach cancer: 2.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"EFO-21: 14.8"	"Region enhanced"	"Detected in single"		"hypothalamus: 2.0"	"Low region specificity"	"Detected in all"			"HPA027800, HPA045836"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA027800: , HPA045836: AB_10968856"	"unprognostic (1.82e-1)"	"unprognostic (3.83e-1)"	"unprognostic (2.66e-1)"	"unprognostic (9.29e-2)"	"unprognostic (5.87e-2)"	"unprognostic (6.44e-3)"		"unprognostic (3.13e-1)"		"unprognostic (6.47e-2)"	"unprognostic (5.63e-2)"	"unprognostic (8.20e-3)"	"unprognostic (8.90e-5)"	"unprognostic (1.48e-2)"	"unprognostic (9.24e-2)"	"unprognostic (9.56e-2)"	"unprognostic (2.29e-1)"	0.1	0.5	0.6	0.7	1.0	0.0	0.1	0.2	1.2	0.4	0.2	0.7	1.1	0.6	0.9	0.2	0.4	0.1	0.6	1.4	0.9	2.8	2.0	0.1	2.9	0.1	4.3	0.4	0.1	0.0	0.0	0.7	0.5	1.6	0.2	0.4	0.0	0.0	0.2	0.8	0.0	0.3	0.2	8.9	0.0	5.0	8.0	1.4	0.9	2.5	0.0	0.3	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.7	14.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	1.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.2	1.2	0.9	2.8	4.3	0.4	1.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NOS1	"nNOS, NOS"	ENSG00000089250	"Nitric oxide synthase 1"	P29475	12	117208142-117452170	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Oxidoreductase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 13.4;skeletal muscle: 36.3"	"Cell type enhanced"	"Detected in some"	12	"Basal glandular cells: 7.9;Basal keratinocytes: 3.4;Glandular cells: 2.8;Ito cells: 8.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HaCaT: 6.3;RH-30: 13.1;RPTEC TERT1: 8.2;U-2 OS: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002167, HPA058312, HPA069509"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB002167: AB_564073, HPA058312: AB_2683676, HPA069509: "	"unprognostic (1.63e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.64e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.12e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.97e-4)"	"unprognostic (1.87e-1)"	0.5	0.6	3.8	3.5	13.4	0.7	0.6	4.4	4.8	0.7	2.0	1.1	0.0	0.5	0.6	0.7	1.3	0.8	0.5	0.5	2.8	4.4	1.9	0.5	1.4	0.6	2.4	1.6	0.5	1.9	0.4	0.8	0.4	5.9	1.6	0.9	0.6	3.8	0.6	36.3	2.2	0.6	0.8	1.2	0.5	0.5	0.9	3.0	0.0	0.6	0.0	0.5	0.9	0.6	0.9	0.6	2.1	0.5	0.8	0.5	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	6.3	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	1.5	0.0	13.1	0.1	8.2	0.1	0.3	1.3	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	2.5	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	2.1	0.5	0.5	0.5	0.4	0.4	0.7	0.4	0.3	0.2	0.9	0.5	0.5	1.9	0.8	0.5	0.6	0.3	0.0	3.8	13.4	4.4	4.8	2.8	4.4	2.4	1.6	5.9	3.0	0.0	0.0	0.0	7.9	3.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.9	0.4	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.2	0.3	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.5	0.0	0.0	0.0	1.0
NOTCH2		ENSG00000134250	"Notch 2"	Q04721	1	119911553-120069626	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Paneth cells: 129.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048743	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		67000000	"Nucleoplasm, Plasma membrane"		"HPA048743: AB_2680508"	"unprognostic (1.33e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.40e-3)"	"unprognostic (7.98e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.32e-2)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (5.24e-4)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (3.86e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.35e-3)"	12.0	7.3	6.0	9.4	6.8	4.4	10.6	3.0	5.6	14.5	7.6	4.4	11.3	1.6	12.3	11.8	13.4	11.4	12.8	7.9	6.8	2.3	5.5	11.4	10.6	5.7	5.3	7.6	15.5	27.6	6.1	3.3	10.3	6.5	9.9	5.2	9.4	17.7	10.0	9.3	17.2	6.1	12.4	6.2	11.5	5.8	15.7	4.4	8.0	11.4	8.6	6.6	9.6	13.0	4.2	5.2	7.7	9.6	1.5	1.7	2.0	15.0	5.1	7.9	6.1	33.0	28.3	7.9	11.5	15.9	15.4	16.7	4.7	4.1	0.3	9.7	21.8	13.7	5.7	12.5	10.2	24.6	18.1	8.0	8.7	13.7	0.4	12.3	9.1	2.3	22.7	6.6	46.1	30.7	23.3	7.8	4.1	0.1	19.2	18.5	16.9	3.8	2.6	10.2	1.4	5.7	2.5	27.9	9.7	8.1	9.6	0.3	4.0	15.6	14.7	8.3	16.7	8.1	3.1	27.4	20.1	13.9	30.1	18.0	8.0	3.9	4.4	29.5	8.4	19.1	5.6	6.4	6.4	1.5	6.6	1.7	4.2	1.3	1.1	5.2	3.9	1.0	1.7	7.7	1.5	9.6	4.2	0.8	2.0	6.0	6.8	3.0	5.6	6.8	2.3	5.3	7.6	6.5	4.4	32.8	21.6	24.1	40.5	41.1	3.5	11.2	25.5	2.7	13.6	17.4	5.9	1.2	0.0	37.1	15.7	3.7	3.0	0.0	11.3	6.7	53.5	36.6	15.1	35.0	29.9	3.2	5.8	5.5	68.6	9.3	50.9	36.3	37.1	13.6	7.5	46.7	22.9	129.8	80.2	4.3	10.2	19.4	32.3	4.8	3.6	77.8	1.4	13.6	13.8	52.7
NPFFR2	"GPR74, NPFF2, NPGPR"	ENSG00000056291	"Neuropeptide FF receptor 2"	Q9Y5X5	4	72031804-72148067	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.4;seminal vesicle: 10.1"	"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 5.4;Extravillous trophoblasts: 7.3;Horizontal cells: 3.2;Muller glia cells: 4.8;Syncytiotrophoblasts: 8.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"GAMG: 22.5;NTERA-2: 7.3;RPTEC TERT1: 9.5;SH-SY5Y: 11.2;U-2 OS: 11.2"	"Region enriched"	"Detected in single"	4	"olfactory region: 5.3"	"Low region specificity"	"Detected in many"			HPA026825			Approved	"Plasma membrane,Actin filaments"	"Intracellular and membrane"	NA	NA			"Plasma membrane"	"Actin filaments"	"HPA026825: AB_10603123"	"unprognostic (1.28e-1)"		"unprognostic (1.05e-2)"		"unprognostic (1.53e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.68e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.40e-5)"	"unprognostic (5.75e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.48e-1)"	0.9	0.2	5.5	0.7	2.6	0.2	1.4	0.2	3.5	0.5	0.5	0.0	0.0	0.5	0.1	2.8	0.3	0.8	0.4	0.4	0.9	2.9	0.6	0.2	0.2	0.6	0.5	4.0	0.3	1.2	0.1	1.0	4.6	1.5	3.2	0.9	1.4	0.3	10.1	0.3	0.7	0.5	0.2	0.6	0.5	0.4	1.6	0.0	15.4	1.2	0.0	0.6	2.5	0.7	0.6	0.3	2.3	0.3	0.8	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	11.2	0.0	0.0	0.0	1.6	0.0	0.0	1.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.2	0.4	0.2	0.2	0.1	0.3	0.2	0.1	0.1	0.6	0.2	0.2	1.1	0.8	0.3	0.3	0.2	0.1	5.5	2.6	0.2	3.5	0.9	2.9	0.5	4.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.2	0.4	0.1	0.0	0.0	0.2	7.3	1.0	0.0	0.0	0.0	0.9	3.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.8	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	8.1	0.0	0.0	0.0
NRAS	N-ras	ENSG00000213281	"NRAS proto-oncogene, GTPase"	P01111	1	114704469-114716894	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB010157, HPA049830, CAB079912"	Uncertain		Supported	"Plasma membrane"		NA	NA		4800000	"Plasma membrane"		"CAB010157: AB_632073, CAB079912: AB_2784586, HPA049830: AB_2680903"	"unprognostic (4.75e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.11e-2)"	"unprognostic (8.59e-3)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (3.03e-7)"	"unprognostic (7.76e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (6.60e-3)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.33e-2)"	18.0	9.7	13.1	16.5	14.4	33.5	12.4	9.7	16.6	10.0	18.4	15.8	3.8	14.4	9.8	6.2	19.7	8.7	11.8	7.1	11.7	13.8	24.0	23.9	13.4	18.7	15.3	9.6	10.3	14.2	8.3	7.6	27.4	19.0	9.2	18.5	8.4	12.4	5.2	7.9	16.1	23.4	9.6	20.9	19.5	14.4	9.8	9.7	45.0	11.1	14.0	19.6	13.2	10.5	11.0	9.9	23.7	15.0	12.1	11.1	10.1	24.7	6.7	18.1	6.8	7.5	16.1	12.9	11.8	13.2	22.2	25.0	13.5	9.3	18.8	15.7	15.9	15.5	7.1	24.1	19.2	31.9	25.6	9.4	12.7	10.2	16.0	14.9	31.6	19.8	14.5	15.6	25.4	18.6	7.0	28.2	14.9	20.2	21.7	19.5	66.1	21.8	12.3	30.7	8.1	4.9	16.7	32.2	11.7	19.6	13.4	11.0	16.5	12.1	10.0	28.4	22.0	8.8	25.7	21.5	12.1	23.2	22.6	24.2	38.4	26.4	22.1	24.2	17.3	43.6	23.7	10.0	9.6	9.8	15.0	8.9	11.0	8.0	9.7	9.9	8.8	8.7	11.1	2.7	12.1	12.7	7.7	10.4	10.1	13.1	14.4	9.7	16.6	11.7	13.8	15.3	9.6	19.0	9.7	14.9	13.9	22.5	24.9	27.2	4.4	4.0	25.5	18.7	12.5	21.0	7.9	18.9	11.6	31.0	2.9	23.3	32.2	0.0	27.3	39.9	16.8	25.2	31.1	24.5	43.1	4.8	23.6	40.5	41.2	4.4	7.5	27.8	21.9	41.5	29.5	7.1	39.8	29.4	6.0	27.8	2.2	6.5	10.8	6.5	14.1	31.7	26.1	20.3	24.7	34.0
NRXN1	"Hs.22998, KIAA0578"	ENSG00000179915	"Neurexin 1"	"P58400, Q9ULB1"	2	49918505-51225575	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Angiogenesis, Cell adhesion"		"Mental retardation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 81.9"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 70.6;Early spermatids: 130.0;Horizontal cells: 73.1;Late spermatids: 79.3"	"Cancer enriched"	"Detected in single"	8	"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"neutrophil: 4.4"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 4.4"	"Cell line enriched"	"Detected in some"	8	"SCLC-21H: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071400			Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		620000	"Plasma membrane"		"HPA071400: AB_2732180"	"unprognostic (7.01e-2)"	"unprognostic (9.96e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.74e-4)"	"unprognostic (2.46e-1)"	"unprognostic (8.95e-2)"		"unprognostic (2.02e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.19e-2)"	"unprognostic (6.37e-4)"	"unprognostic (2.85e-2)"	"unprognostic (6.68e-7)"	"unprognostic (3.40e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.99e-3)"	2.1	3.2	22.4	2.1	20.3	1.4	1.7	56.5	81.9	2.8	5.1	3.0	0.5	2.1	2.1	3.7	3.0	1.4	2.2	3.8	16.9	13.8	1.5	1.6	1.5	1.4	8.3	25.9	2.1	2.3	1.3	4.8	1.1	12.6	2.5	3.8	2.0	3.5	9.3	1.3	2.0	3.1	2.1	6.5	1.3	2.3	6.5	4.7	0.0	1.4	0.0	1.4	2.0	1.6	0.0	0.0	4.4	0.1	0.3	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	29.0	1.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	2.4	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.4	0.3	0.0	0.0	0.0	0.0	22.4	20.3	56.5	33.2	16.9	13.8	8.3	25.9	12.6	4.7	0.0	0.0	0.0	0.4	0.0	70.6	15.4	0.0	0.0	0.0	0.0	2.0	0.0	1.7	0.0	130.0	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	73.1	1.7	5.5	0.0	79.3	2.3	0.2	1.7	0.0	0.0	20.9	0.3	0.0	0.7	0.0	8.0	0.0	0.3	9.9	3.8	0.1	0.2	0.0	0.0	0.0
NSD1	"ARA267, FLJ22263, KMT3B, STO"	ENSG00000165671	"Nuclear receptor binding SET domain protein 1"	Q96L73	5	177133025-177300215	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 141.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048431, HPA070333, HPA073705"	Supported		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA048431: AB_2680388, HPA070333: AB_2686255, HPA073705: AB_2732239"	"unprognostic (3.48e-2)"	"unprognostic (7.46e-2)"	"unprognostic (7.14e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.68e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.09e-1)"	"unprognostic (7.77e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.32e-2)"	11.8	13.2	11.9	25.4	15.7	23.9	14.0	28.9	16.7	15.6	14.2	18.5	17.0	10.6	19.0	13.9	17.8	13.6	15.8	11.7	12.8	11.5	14.4	10.5	12.3	19.4	12.9	11.7	16.6	27.1	24.6	19.3	16.0	13.4	14.2	14.3	13.8	13.5	18.7	20.6	16.1	14.5	15.6	13.2	16.1	13.1	28.1	16.1	27.3	20.1	10.6	22.7	13.4	20.2	10.2	8.9	18.7	10.8	10.9	7.8	2.9	9.9	12.8	13.3	11.5	6.6	8.5	0.4	9.0	9.0	12.7	11.8	2.8	8.3	20.5	10.2	12.4	11.7	8.5	21.2	20.0	15.4	34.7	12.8	9.1	14.5	0.1	10.9	19.6	10.8	8.0	12.1	15.0	14.1	9.0	18.4	13.0	12.4	7.2	12.7	20.8	13.6	6.3	14.5	6.7	11.3	15.1	1.7	6.3	8.2	12.1	16.3	11.2	23.4	10.2	7.0	12.9	10.2	16.3	13.5	8.8	12.9	5.6	11.1	8.5	7.4	14.7	5.1	9.6	9.4	10.7	9.1	9.4	7.5	6.1	6.3	8.5	6.3	5.0	6.7	10.2	7.8	6.3	18.7	10.9	10.8	8.9	5.7	2.9	11.9	15.7	28.9	16.7	12.8	11.5	12.9	11.7	13.4	16.1	20.8	26.1	42.4	26.2	15.0	91.7	37.5	33.1	13.4	36.4	52.4	141.4	34.8	14.9	22.8	25.5	31.5	21.9	0.0	18.5	20.4	23.3	24.0	39.4	16.3	24.2	84.2	40.3	31.3	29.2	33.9	47.2	39.1	15.1	50.5	19.4	35.7	20.1	24.6	31.1	13.9	100.0	51.8	19.6	63.2	47.7	18.1	29.6	51.1	21.5	23.5
NT5E	"CALJA, CD73, eN, eNT, NT5"	ENSG00000135318	"5'-nucleotidase ecto"	P21589	6	85449584-85495791	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Ito cells: 45.4;Pancreatic endocrine cells: 72.9;Rod photoreceptor cells: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 13.4;memory CD8 T-cell: 6.6;naive B-cell: 19.9;naive CD8 T-cell: 17.3"	"Group enriched"	"Detected in many"	47	"B-cells: 19.9;T-cells: 17.3"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 93.4;LHCN-M2: 105.7;TIME: 61.2;U-87 MG: 95.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA017357	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		1600000	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA017357: AB_1846330"	"unprognostic (1.92e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (5.45e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (1.39e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.78e-1)"	12.2	3.2	9.3	7.7	11.6	0.5	16.6	1.1	6.9	58.8	13.9	3.6	8.1	18.6	33.3	14.8	7.6	12.2	15.4	6.1	5.7	5.5	8.8	26.0	3.4	6.8	6.3	6.6	25.4	1.4	1.6	9.3	42.2	5.3	16.4	15.6	15.3	4.6	17.8	5.7	4.5	14.9	35.3	6.3	7.0	6.0	12.4	4.2	1.6	26.5	7.3	7.1	16.6	20.2	19.9	0.0	0.2	0.0	0.4	17.3	3.9	5.3	2.8	4.9	0.1	11.2	35.7	0.0	34.5	37.8	17.0	32.0	0.0	53.0	0.0	12.4	30.1	43.8	2.7	0.0	34.7	40.6	0.0	0.0	0.0	0.8	0.6	5.6	0.0	0.0	9.1	0.4	34.7	22.1	93.4	14.1	0.0	0.0	0.1	105.7	0.9	0.0	0.0	0.1	0.9	3.8	0.1	1.1	0.1	36.8	2.4	0.0	0.6	0.4	2.1	11.7	0.2	0.0	0.9	61.2	13.9	0.1	17.5	56.1	2.6	1.6	0.0	95.4	0.0	43.5	0.0	0.0	0.2	2.0	0.0	3.5	13.4	2.3	6.6	0.0	19.9	2.4	17.3	0.2	0.4	0.0	0.0	0.8	3.9	9.3	11.6	1.1	6.9	5.7	5.5	6.3	6.6	5.3	4.2	0.0	4.3	15.6	1.0	4.6	4.6	0.8	20.4	6.7	6.8	1.8	9.8	0.4	3.3	3.7	0.5	13.5	10.3	0.0	3.7	1.5	16.9	0.9	0.0	29.0	1.3	0.0	0.0	45.4	5.3	0.9	12.0	2.5	6.8	0.0	33.2	5.6	72.9	31.7	24.1	20.6	77.4	0.0	8.0	0.0	0.2	4.3	12.7	2.2	13.8	5.9
NTNG1	"KIAA0976, Lmnt1"	ENSG00000162631	"Netrin G1"	Q9Y2I2	1	107140007-107483458	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.4"	"Cell type enhanced"	"Detected in some"	16	"Basal glandular cells: 6.0;Bipolar cells: 23.3;Collecting duct cells: 7.0;Early spermatids: 7.6;Leydig cells: 7.5;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 28.6;fHDF/TERT166: 13.9;RPTEC TERT1: 15.6;U-138 MG: 13.1;U-251 MG: 9.4;U-87 MG: 14.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065954			Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"HPA065954: AB_2685585"	"unprognostic (1.79e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.67e-2)"	"unprognostic (9.38e-5)"	"unprognostic (1.93e-3)"	"unprognostic (9.87e-3)"		"unprognostic (3.34e-1)"	"unprognostic (8.38e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.10e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.93e-5)"	4.2	11.0	6.8	1.3	6.4	0.9	1.1	7.3	12.8	7.0	2.9	9.6	0.3	0.8	2.2	0.9	1.2	1.3	2.1	0.9	9.8	16.4	13.0	0.8	9.2	1.7	5.0	5.3	1.9	1.1	0.7	7.4	3.2	10.0	9.0	1.7	6.4	2.8	12.1	1.1	1.9	1.7	7.5	7.4	1.3	1.4	1.7	6.1	0.0	0.8	0.0	2.0	5.3	3.0	4.4	0.8	1.4	0.7	0.8	0.6	0.3	0.0	0.0	1.7	0.0	2.9	28.6	0.0	7.8	1.1	0.7	0.6	0.0	0.0	0.0	0.3	13.9	0.0	0.0	0.0	0.8	1.6	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	8.2	0.2	2.0	1.1	8.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.5	0.0	3.6	0.0	1.9	0.0	15.6	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.1	13.1	2.5	4.8	9.4	0.0	0.0	0.0	14.6	0.0	1.4	1.4	0.3	0.4	0.3	0.4	0.5	4.4	0.4	0.3	0.4	1.0	0.6	0.5	0.9	0.8	0.7	0.8	0.4	0.3	6.8	6.4	7.3	12.3	9.8	16.4	5.0	5.3	10.0	6.1	0.0	0.0	0.5	6.0	0.5	23.3	0.8	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	7.6	0.3	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.5	7.5	0.0	1.7	0.0	0.0	0.8	0.2	0.0	0.0	0.0	2.1	6.5	1.4	0.2	0.4	0.5	0.0	0.0	0.0	4.3
NTNG2	"KIAA1857, Lmnt2, NTNG1"	ENSG00000196358	"Netrin G2"	Q96CW9	9	132161676-132244534	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Autism spectrum disorder, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.9;brain: 32.0"	"Group enriched"	"Detected in many"	7	"Bipolar cells: 56.2;Cone photoreceptor cells: 161.0;Rod photoreceptor cells: 109.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 4.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 4.0"	"Cell line enhanced"	"Detected in some"		"HL-60: 4.8;HMC-1: 12.2;NB-4: 27.6;U-937: 7.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA065089, HPA071290"	Approved		Approved	"Plasma membrane,Cytokinetic bridge,Midbody ring"	"Intracellular and membrane"	NA	NA			"Plasma membrane"	"Cytokinetic bridge, Midbody ring"	"HPA065089: AB_2732730, HPA071290: AB_2686381"	"unprognostic (5.01e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.59e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.62e-2)"	"prognostic favorable (6.06e-4)"	"unprognostic (9.30e-12)"	"unprognostic (1.66e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.00e-1)"	1.2	1.4	11.9	1.6	10.9	38.9	0.6	4.4	32.0	1.0	0.8	11.5	0.2	1.8	0.7	0.9	0.8	0.7	1.4	4.6	11.4	3.1	0.8	0.8	2.0	1.9	4.4	7.4	0.6	1.8	11.9	1.0	1.1	11.7	7.4	0.7	10.7	1.3	1.8	0.9	0.8	1.1	0.8	5.3	2.8	1.2	1.8	2.8	0.0	0.7	0.0	1.0	1.1	0.9	0.1	0.1	4.0	0.2	0.0	0.4	0.0	0.0	0.3	0.2	0.4	0.4	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.2	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.7	4.8	12.2	0.0	0.0	0.2	0.0	1.0	0.0	1.0	0.0	0.0	0.3	0.1	0.2	27.6	1.0	0.0	0.1	0.3	0.3	0.1	0.0	0.0	3.4	3.1	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.6	2.2	2.6	0.1	0.1	0.0	0.0	1.0	7.2	0.8	0.6	0.2	0.6	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.0	0.0	0.1	0.1	0.1	0.0	11.9	10.9	4.4	32.0	11.4	3.1	4.4	7.4	11.7	2.8	0.0	1.1	0.0	0.5	0.2	56.2	2.8	0.0	0.0	1.2	0.0	161.0	0.0	0.0	0.3	1.3	0.1	0.0	0.0	0.0	0.0	1.5	1.4	1.1	0.0	0.6	1.6	0.0	1.3	0.3	1.0	0.6	0.1	1.7	0.0	0.0	15.3	0.2	0.0	1.1	0.0	109.1	6.5	0.6	0.2	0.0	0.3	0.1	0.0	0.0	0.3
NTSR1	NTR	ENSG00000101188	"Neurotensin receptor 1"	P30989	20	62708837-62762771	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.0;intestine: 15.1"	"Cell type enhanced"	"Detected in single"	29	"Kupffer cells: 3.2"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"PC-3: 35.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA050299			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA050299: "	"unprognostic (4.14e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.75e-2)"	"unprognostic (8.87e-4)"	"unprognostic (9.27e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.80e-3)"	"unprognostic (7.16e-2)"	"unprognostic (3.10e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.49e-1)"	0.3	0.1	3.7	2.5	3.6	3.8	0.1	0.1	7.0	0.1	15.1	0.0	0.0	0.4	0.2	0.1	0.1	0.1	1.4	0.1	2.0	1.1	0.6	0.2	0.3	0.3	3.3	1.0	0.4	0.1	0.2	0.3	0.2	1.4	0.2	0.5	1.2	0.3	0.1	0.2	0.2	1.5	0.8	0.8	0.6	0.5	0.5	0.0	0.0	0.1	0.3	0.1	0.3	0.1	0.0	0.3	0.0	0.3	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.2	6.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	1.7	0.1	1.6	0.2	0.7	35.8	1.1	0.0	5.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.5	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.7	3.6	0.1	7.0	2.0	1.1	3.3	1.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OCLN	PPP1R115	ENSG00000197822	Occludin	Q16625	5	69492292-69558104	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 58.1"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 101.3;Urothelial cells: 183.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 21.3;CAPAN-2: 28.4;HaCaT: 22.9;MCF7: 22.6;RPTEC TERT1: 17.7;RT4: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005933, CAB013075, CAB068212, CAB068213, CAB068214"	Enhanced		Supported	"Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA			"Plasma membrane, Cell Junctions"		"CAB013075: AB_2533101, CAB068212: AB_2665711, CAB068213: AB_2665712, CAB068214: AB_2665713, HPA005933: AB_1079520"	"unprognostic (2.28e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.25e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.48e-1)"	"prognostic favorable (6.59e-11)"	"unprognostic (2.83e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.35e-1)"	1.2	0.8	3.4	3.8	3.7	0.5	7.6	3.9	2.9	4.3	15.5	3.2	21.9	10.2	1.7	7.4	10.6	7.9	17.1	1.1	4.0	2.9	15.3	31.7	29.2	0.4	4.0	1.7	2.3	33.2	12.0	3.2	9.0	6.7	5.7	10.9	7.7	7.1	25.0	0.5	8.7	24.5	1.2	3.8	2.1	15.1	2.0	1.5	0.4	58.1	9.8	8.6	5.0	6.5	1.2	1.2	1.8	0.3	2.0	0.9	0.1	15.4	6.2	0.1	0.5	0.2	0.4	12.5	0.0	1.5	2.1	3.1	21.3	28.4	0.1	5.4	0.3	7.8	22.9	6.3	3.0	5.8	0.1	11.1	1.2	0.2	6.5	0.1	0.5	1.6	0.0	3.2	4.8	0.2	1.1	1.2	2.1	0.0	0.1	0.0	22.6	0.6	0.4	2.4	6.8	2.6	0.0	4.7	0.5	17.7	19.3	2.1	1.0	0.1	16.9	0.2	4.4	9.5	1.9	0.2	0.1	6.4	1.3	1.5	0.3	0.1	0.1	0.1	0.1	0.1	0.8	0.3	0.7	0.8	0.2	0.2	0.8	0.9	0.3	0.1	1.2	0.7	0.9	1.8	2.0	0.2	1.2	0.4	0.1	3.4	3.7	3.9	2.9	4.0	2.9	4.0	1.7	6.7	1.5	101.3	47.6	3.2	51.5	3.3	6.0	1.3	56.0	48.2	55.7	24.4	13.7	26.5	8.3	49.2	2.0	5.3	55.1	0.0	52.8	1.2	3.2	76.5	2.3	42.9	2.6	6.4	25.2	16.0	25.3	1.1	2.8	2.6	1.7	5.4	35.4	3.5	63.1	47.2	1.4	11.3	6.2	12.9	2.7	4.2	7.8	13.6	13.7	4.9	33.9	183.7
OGT	"FLJ23071, HRNT1, MGC22921, O-GLCNAC, OGT1"	ENSG00000147162	"O-linked N-acetylglucosamine (GlcNAc) transferase"	O15294	X	71533083-71575897	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Host-virus interaction, Ubl conjugation pathway"	"Chromatin regulator, Glycosyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030751, HPA030752, HPA030753, HPA030754, CAB034099"	Approved		Supported	"Nucleoplasm,Plasma membrane"		Yes	No			Nucleoplasm	"Plasma membrane"	"CAB034099: AB_2157067, HPA030751: AB_10600217, HPA030752: AB_10601445, HPA030753: AB_2673594, HPA030754: AB_2673595"	"unprognostic (1.37e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (8.33e-4)"	"unprognostic (3.40e-2)"	"prognostic favorable (1.97e-4)"	"unprognostic (9.56e-3)"	"unprognostic (1.96e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.74e-3)"	"prognostic unfavorable (2.36e-6)"	"unprognostic (2.99e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.03e-3)"	"prognostic favorable (6.85e-7)"	26.1	24.0	33.3	39.7	36.6	38.7	33.7	75.7	43.8	25.0	23.0	22.0	31.1	22.5	36.7	48.3	24.3	33.4	21.2	25.1	29.3	15.4	27.4	20.3	31.0	47.9	30.2	25.6	42.8	46.1	26.5	34.5	19.5	26.6	34.2	30.3	29.9	35.9	30.9	35.0	45.4	38.4	31.1	32.3	56.7	28.2	11.8	36.6	35.7	34.1	27.6	41.4	24.9	31.0	9.7	7.6	3.2	7.2	12.5	9.9	6.0	14.2	13.3	17.3	15.2	18.7	17.3	11.7	10.9	19.8	11.9	18.3	14.0	16.4	17.0	7.7	13.4	12.4	17.8	18.9	10.7	14.7	14.5	19.4	10.7	31.9	10.0	14.2	22.0	17.8	16.5	21.8	13.0	24.6	20.6	11.1	36.5	10.8	59.1	11.3	12.1	16.9	26.5	11.5	12.7	18.3	16.8	19.5	21.7	18.4	16.5	8.9	7.8	17.0	11.3	10.5	13.7	8.3	15.0	12.8	12.9	10.5	13.4	6.3	16.1	11.6	20.4	9.1	23.2	7.8	3.2	5.3	2.3	9.9	7.2	9.0	9.7	8.3	8.0	7.5	8.5	9.7	9.5	2.4	12.5	6.5	7.6	7.6	6.0	33.3	36.6	75.7	43.8	29.3	15.4	30.2	25.6	26.6	36.6	32.8	80.7	38.6	31.8	78.3	24.7	38.6	20.4	20.1	31.8	47.1	7.9	11.8	8.3	11.5	1.7	42.7	29.0	46.7	12.1	7.0	45.0	42.9	26.6	24.9	14.0	38.1	33.6	45.4	64.9	1.8	49.5	36.1	33.7	15.4	36.2	13.8	15.0	31.6	28.0	12.2	23.2	32.3	32.5	1.8	6.0	73.5	9.2	59.0	30.2	38.6
OLFM4	"GC1, GW112, OlfD"	ENSG00000102837	"Olfactomedin 4"	Q6UX06	13	53028759-53052057	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 280.2;pancreas: 105.8"	"Group enriched"	"Detected in many"	6	"Exocrine glandular cells: 804.6;Pancreatic endocrine cells: 1519.9;Undifferentiated cells: 937.7;Urothelial cells: 2045.0"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 711.4;pancreatic cancer: 594.7;stomach cancer: 724.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.4;BJ hTERT+: 15.3;HaCaT: 21.4;OE19: 8.3;RPMI-8226: 4.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA077718	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"	"Secreted in other tissues"	Yes	NA			"Nucleoplasm, Plasma membrane"	"Cytokinetic bridge, Cytosol"	"HPA077718: AB_2732358"	"prognostic favorable (8.77e-4)"	"unprognostic (4.84e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.33e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.37e-2)"	"unprognostic (4.84e-3)"	0.3	0.0	0.3	18.1	0.3	11.4	2.5	0.3	0.5	50.3	132.5	0.4	0.2	121.4	0.8	3.3	0.5	0.9	6.0	1.1	0.3	0.1	7.5	0.3	1.6	0.4	0.3	0.2	0.7	105.8	0.0	0.2	0.9	0.3	16.2	58.9	0.2	2.9	0.2	0.3	0.1	280.2	5.6	0.2	2.2	2.4	1.4	0.3	1.8	0.3	0.4	0.3	18.4	40.9	0.0	0.0	1.4	0.6	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	4.4	1.9	15.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	21.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	8.3	0.0	0.0	0.7	4.7	0.1	0.0	0.9	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.5	0.7	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.6	0.0	0.0	0.9	0.3	0.3	0.3	0.5	0.3	0.1	0.3	0.2	0.3	0.3	0.0	0.0	0.0	149.7	0.1	0.0	0.4	0.0	0.0	0.0	132.6	0.0	0.0	1.7	216.4	0.2	0.0	104.8	0.0	804.6	0.0	0.0	16.5	0.0	0.0	0.1	0.0	88.9	0.0	0.0	0.0	0.0	0.0	0.0	18.0	135.9	3.2	1519.9	238.2	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	937.7	2045.0
OLR1	"CLEC8A, LOX-1, SCARE1"	ENSG00000173391	"Oxidized low density lipoprotein receptor 1"	P78380	12	10158301-10172138	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity, Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.5;lung: 46.8;placenta: 53.4"	"Group enriched"	"Detected in many"	7	"Cytotrophoblasts: 386.0;Hofbauer cells: 209.3;Macrophages: 102.1;Syncytiotrophoblasts: 387.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 5.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 5.9;granulocytes: 3.3;monocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 32.7;HaCaT: 17.2;HHSteC: 34.6;hTCEpi: 15.9;SiHa: 65.9;SK-BR-3: 26.2"					"Low region specificity"	"Detected in all"			HPA050798			Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA	1060000		"Nucleoplasm, Plasma membrane"	Vesicles	"HPA050798: AB_2756318"	"unprognostic (2.30e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.81e-2)"	"prognostic unfavorable (8.24e-5)"	"unprognostic (6.34e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.40e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.94e-3)"	"unprognostic (3.47e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.42e-1)"	2.0	1.9	6.0	14.1	10.3	10.6	2.0	1.3	10.2	1.9	0.5	21.3	0.0	0.8	1.0	0.9	0.5	1.2	3.9	1.1	8.5	6.7	6.9	1.8	46.8	0.5	16.4	4.4	0.4	1.6	2.8	1.9	53.4	12.3	1.4	0.7	0.2	2.0	0.7	0.4	0.5	0.8	1.2	28.5	0.6	1.4	2.8	10.5	0.0	1.5	0.0	0.6	4.3	0.4	0.5	5.9	3.3	1.5	0.3	0.3	1.1	1.8	0.1	0.0	0.1	0.0	0.0	4.5	3.1	0.5	2.0	0.7	32.7	0.0	0.4	0.0	4.2	0.1	17.2	0.0	0.1	1.3	0.0	0.0	0.0	1.6	0.0	34.6	0.0	0.0	0.2	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.0	65.9	26.2	0.0	4.9	7.3	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.0	1.5	2.7	0.2	0.2	0.3	0.3	0.3	0.2	5.9	0.5	0.3	0.3	3.3	0.3	0.4	0.8	0.2	1.1	6.0	10.3	1.3	7.4	8.5	6.7	16.4	4.4	12.3	10.5	26.8	30.9	0.0	0.2	1.3	0.4	0.0	2.5	12.0	7.9	0.0	0.0	386.0	0.0	0.0	9.4	1.2	0.0	0.0	0.0	8.5	1.3	0.0	14.0	0.8	209.3	0.0	0.0	0.0	21.9	7.6	0.3	102.1	0.0	36.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	387.3	0.0	0.0	0.0
OPRK1	"KOR, OPRK"	ENSG00000082556	"Opioid receptor kappa 1"	P41145	8	53225716-53251697	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 18.0;prostate: 6.7"	"Group enriched"	"Detected in some"	8	"Extravillous trophoblasts: 7.3;Leydig cells: 4.4"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"U-937: 22.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067549	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA067549: AB_2732770"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-2)"		"unprognostic (8.70e-3)"	"unprognostic (3.73e-2)"	"unprognostic (6.74e-2)"		"unprognostic (2.22e-3)"		"unprognostic (8.09e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.28e-3)"		"unprognostic (3.29e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.54e-4)"	"unprognostic (1.61e-1)"	0.7	0.7	15.9	0.3	18.0	0.4	0.3	2.2	8.8	0.4	0.4	0.3	0.0	0.4	0.4	0.6	0.5	0.7	0.4	0.8	4.5	6.2	0.3	0.5	0.8	0.4	1.7	5.8	0.4	0.3	0.4	0.8	2.8	3.1	6.7	0.4	0.0	0.3	0.4	3.8	0.4	0.5	0.5	0.5	0.6	0.3	2.8	1.6	0.2	0.9	0.0	0.3	0.3	0.1	0.2	0.8	1.2	0.2	0.1	0.4	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	22.1	0.1	1.2	0.2	0.1	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.1	0.1	0.8	0.0	0.0	15.9	18.0	2.2	8.8	4.5	6.2	1.7	5.8	3.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.3	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0
OR10P1	"OR10P1P, OR10P2P, OR10P3P, OST701"	ENSG00000175398	"Olfactory receptor family 10 subfamily P member 1"	Q8NGE3	12	55636860-55637854	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"blood: 2.0;heart muscle: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.0;T-reg: 1.7"	"Lineage enriched"	"Detected in single"	7	"T-cells: 2.0"	"Cell line enhanced"	"Detected in single"		"THP-1: 2.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA074114			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA074114: "																		0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.1		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3			0.0		0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	1.7	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR1N2		ENSG00000171501	"Olfactory receptor family 1 subfamily N member 2"	Q8NGR9	9	122553112-122554214	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"	33	"Cardiomyocytes: 2.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"RT4: 1.1"	"Not detected"	"Not detected"							HPA060968			Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Nucleoli, Plasma membrane"	Nucleoplasm	"HPA060968: "																		0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.3	0.0			0.0	0.2	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3			0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
OR6C6		ENSG00000188324	"Olfactory receptor family 6 subfamily C member 6"	A6NF89	12	55293988-55296569	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 2.3;skin 1: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.1;MCF7: 1.6;THP-1: 1.0"									HPA051090	Uncertain		Approved	"Lipid droplets,Plasma membrane"		NA	NA			"Lipid droplets, Plasma membrane"		"HPA051090: AB_2681341"																		0.0	0.0	0.0	0.4	0.1	1.1	0.1	0.1	0.2	0.5	0.1			0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.0	0.1	0.0	0.2		0.1	0.0		0.2	0.0	0.5	1.7	0.0	0.2	0.1	0.1	0.1	0.3			0.0		0.0	0.0	0.0	1.1	1.0	2.3	0.5	0.5	0.6	0.1	0.0	0.6	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.4	0.0	0.0	0.4	0.0	0.4	0.0	0.5	0.0	0.0	1.1	0.4	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.5	0.8	0.0	1.6	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.1	0.2	1.0	0.0	0.0	0.3	0.0	0.3	0.2	0.2	0.0	0.0	0.5	0.2	2.3	0.5	0.9	0.6	0.1	0.3	0.6	0.5	0.4	0.1	1.1	0.5	0.6	1.8	0.5	0.3	1.0	0.6	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR8S1		ENSG00000284723	"Olfactory receptor family 8 subfamily S member 1"	Q8NH09	12	48525632-48528103	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"intestine: 1.2;ovary: 1.0"	"Cell type enriched"	"Detected in single"	7	"Spermatocytes: 4.1"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;CAPAN-2: 1.6"					"Not detected"	"Not detected"			HPA045595	Uncertain		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA045595: AB_10964447"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			1.2	0.1	0.0	0.0	0.0	0.5	0.0			0.0	0.0	0.0	0.0			1.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.7			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.4	0.0	0.0	0.0	0.0	0.0
OSBPL7	"MGC71150, ORP7"	ENSG00000006025	"Oxysterol binding protein like 7"	Q9BZF2	17	47807372-47821834	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 37.9"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 25.9;Mucus-secreting cells: 23.6;Paneth cells: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036076, HPA053083, HPA073967"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA036076: AB_10601042, HPA053083: AB_2682038, HPA073967: "	"unprognostic (3.88e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.05e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.78e-2)"	"prognostic unfavorable (8.30e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.08e-1)"	"prognostic favorable (1.19e-5)"	4.1	3.4	9.0	9.6	13.4	7.3	3.9	10.7	11.9	6.8	16.8	12.0	7.5	24.6	6.7	3.7	2.8	6.1	10.5	4.6	9.7	7.3	7.2	1.4	6.3	7.9	13.9	9.8	7.4	11.4	5.3	7.8	3.2	10.3	10.1	10.3	7.7	8.8	10.1	20.2	1.9	32.2	6.2	6.6	12.3	37.9	1.4	16.4	7.9	8.4	2.9	8.1	6.8	5.2	2.6	2.9	1.7	1.4	1.1	5.5	2.1	3.8	4.6	2.0	2.3	2.2	3.2	1.7	1.5	2.1	2.5	2.9	4.6	11.8	3.9	5.8	2.1	0.9	28.9	1.1	3.1	0.8	13.1	1.6	2.9	8.6	3.0	2.0	6.0	0.1	5.0	0.6	1.6	1.1	7.9	5.1	6.9	2.8	5.4	3.9	5.0	6.0	6.4	1.2	15.5	5.8	5.6	3.1	5.4	3.4	3.0	2.0	4.8	2.4	0.8	2.2	2.6	4.2	3.9	5.9	3.9	3.4	0.0	1.2	9.9	3.6	3.8	4.2	5.1	1.4	0.0	1.4	1.7	5.5	1.0	2.3	2.6	2.2	3.1	1.7	1.4	1.6	2.3	0.9	1.1	0.0	2.9	2.7	2.1	9.0	13.4	10.7	11.9	9.7	7.3	13.9	9.8	10.3	16.4	0.0	3.8	4.5	1.0	0.1	5.7	2.8	2.5	1.4	7.9	3.5	5.9	0.2	0.0	2.4	0.0	3.7	25.9	0.0	13.3	0.1	1.5	2.4	2.3	0.4	2.3	11.1	5.8	5.5	2.8	0.0	2.6	0.8	1.7	1.0	23.6	7.7	6.3	26.8	2.5	0.8	7.7	0.0	1.0	0.0	0.2	0.1	0.5	7.2	13.6	0.5
OXGR1	"aKGR, GPR80, GPR99, P2RY15, P2Y15"	ENSG00000165621	"Oxoglutarate receptor 1"	Q96P68	13	96985719-96994730	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"kidney: 7.0"	"Cell type enriched"	"Detected in some"	11	"Extravillous trophoblasts: 35.1"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	5	"myeloid DC: 2.9;plasmacytoid DC: 5.2"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 5.2"	"Cell line enhanced"	"Detected in some"		"RT4: 7.8;SK-BR-3: 3.6;T-47d: 1.7;U-2 OS: 4.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA067673			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA067673: AB_2685883"	"unprognostic (1.83e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.97e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.52e-1)"		"unprognostic (8.38e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.22e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.68e-2)"	2.1	0.0	0.7	1.7	0.2	0.0	6.7	0.0	2.0	1.6	3.0			0.1	0.6	4.0	3.2	2.5	0.0	0.0	0.8	0.8	7.0	0.0	0.5	0.0	0.7		0.0	0.6	0.0	0.3	1.2		0.5	2.4		4.9	0.3	0.1	4.3	0.5	0.5	1.6	0.3	0.1	0.0			0.8		0.9	1.8	0.9	0.0	5.2	0.1	0.5	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	7.8	0.0	0.2	0.0	3.6	0.0	0.2	1.7	0.0	0.0	0.0	4.1	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.3	0.0	0.5	0.1	0.0	0.1	0.8	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.1	0.0	0.0	5.2	0.0	0.1											0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	1.1	1.7	0.0	0.2	0.1	0.0	0.0	0.0	35.1	0.1	0.0	0.0	0.0	1.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.8	0.0
PACSIN2	SDPII	ENSG00000100266	"Protein kinase C and casein kinase substrate in neurons 2"	Q9UNF0	22	42835412-43015145	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 37.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049854, HPA056520"	Enhanced		Supported	"Nuclear speckles,Vesicles,Plasma membrane,Cytosol"		NA	NA		83000	"Nuclear speckles, Vesicles, Cytosol"	"Plasma membrane"	"HPA049854: AB_2680915, HPA056520: AB_2683163"	"unprognostic (5.62e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.96e-1)"	"prognostic unfavorable (7.33e-4)"	"unprognostic (4.48e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (1.09e-13)"	"unprognostic (2.87e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.95e-1)"	20.1	42.0	19.4	19.4	20.7	14.3	22.9	32.3	21.3	18.7	28.4	17.5	21.1	22.5	20.8	18.9	19.3	17.5	33.3	28.0	17.9	19.5	32.5	20.7	25.8	16.9	20.6	15.7	17.4	77.3	14.3	21.5	33.8	32.4	24.6	23.5	26.6	31.7	16.6	23.9	19.4	25.6	25.1	17.8	22.5	27.8	12.6	19.2	13.1	31.0	15.8	18.4	17.7	17.6	4.7	8.3	37.9	12.6	6.7	4.5	5.0	24.7	26.0	21.9	14.0	11.3	12.1	18.0	22.6	13.7	20.5	17.1	27.0	14.6	11.5	19.2	16.7	14.0	17.6	14.3	24.0	13.5	11.7	14.2	18.6	13.3	38.4	16.1	13.1	40.4	11.6	23.8	26.9	11.8	16.7	16.8	10.7	16.0	8.4	17.6	16.2	13.8	20.6	12.1	36.2	11.0	17.0	32.9	7.7	23.5	14.7	14.3	6.4	27.0	18.7	50.7	14.8	13.5	17.4	24.7	15.3	19.5	16.9	13.3	6.3	8.6	12.6	14.6	11.6	33.2	7.9	7.0	17.4	2.8	12.6	3.0	4.2	3.2	2.4	8.3	4.7	3.2	2.4	37.9	6.7	12.1	3.1	4.5	5.0	19.4	20.7	32.3	21.3	17.9	19.5	20.6	15.7	32.4	19.2	65.5	52.9	11.5	38.7	20.6	14.4	20.9	28.1	28.1	35.2	43.6	37.3	28.5	38.1	63.1	2.7	25.4	95.4	0.0	56.4	21.0	22.1	70.2	69.3	19.8	37.7	6.4	23.7	14.1	37.5	4.3	20.1	36.1	79.2	65.9	46.1	7.8	79.7	43.8	21.9	34.2	23.4	90.5	44.3	22.0	26.4	14.8	40.3	17.5	33.5	27.3
PAK1		ENSG00000149269	"P21 (RAC1) activated kinase 1"	Q13153	11	77321707-77474635	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Exocytosis"	"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 70.0;brain: 71.4"	"Cell type enhanced"	"Detected in many"	4	"granulocytes: 126.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 29.3;eosinophil: 45.0;intermediate monocyte: 28.7;myeloid DC: 42.3;neutrophil: 70.0;non-classical monocyte: 30.4"	"Group enriched"	"Detected in all"	11	"dendritic cells: 42.3;granulocytes: 70.0;monocytes: 30.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003565, CAB005312"	Enhanced	Supported	Supported	"Plasma membrane,Cytosol"		NA	NA		200000	"Plasma membrane, Cytosol"		"CAB005312: AB_2160720, HPA003565: AB_1854935"	"unprognostic (1.15e-2)"	"unprognostic (3.23e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (6.62e-2)"	"unprognostic (8.19e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.52e-2)"	5.4	6.0	30.5	13.8	39.5	22.9	7.8	49.1	71.4	9.8	18.2	8.4	2.3	18.2	9.1	13.3	9.9	9.8	13.2	5.3	19.0	16.9	11.3	6.0	6.9	7.5	12.8	40.6	10.4	9.2	11.8	10.8	11.9	39.2	12.2	20.2	5.4	10.4	8.8	34.0	6.7	18.9	11.6	7.8	11.7	17.1	11.1	6.6	7.6	17.7	3.9	9.4	10.5	10.4	2.7	42.3	70.0	30.4	4.3	2.4	12.2	11.4	7.7	16.8	7.6	6.8	11.5	13.4	13.1	9.4	12.4	14.7	11.0	15.3	10.2	4.8	11.3	16.2	5.9	11.7	13.8	19.7	11.8	9.4	10.8	5.2	0.7	4.5	18.2	16.0	8.5	8.4	14.6	21.7	11.0	2.9	12.0	7.1	18.0	22.6	0.8	11.6	8.4	24.7	47.4	6.6	17.8	21.7	0.4	3.1	9.5	7.2	7.1	7.0	3.0	5.5	17.3	13.4	8.3	0.2	8.3	14.4	44.3	10.9	49.6	25.5	6.8	6.9	12.2	8.9	0.3	29.3	45.0	1.9	28.7	1.5	2.7	1.4	1.8	42.3	1.9	1.3	2.4	70.0	4.3	30.4	3.6	1.1	12.2	30.5	39.5	49.1	71.4	19.0	16.9	12.8	40.6	39.2	6.6	3.0	21.5	16.1	27.9	10.5	48.2	3.1	33.1	41.5	33.0	24.4	7.9	23.0	38.1	26.3	31.5	3.0	46.3	0.0	49.4	46.4	13.1	25.6	126.2	10.9	45.2	1.6	36.2	3.1	43.9	20.0	13.3	71.3	28.7	94.6	47.0	14.0	41.8	55.2	12.4	28.6	6.7	12.9	18.2	25.6	42.1	9.2	79.4	12.2	47.1	27.2
PAK4		ENSG00000130669	"P21 (RAC1) activated kinase 4"	O96013	19	39125770-39182816	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 45.4;MCF7: 50.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025747, CAB044670, HPA070175, HPA072220"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	Yes			"Plasma membrane, Cell Junctions"		"CAB025747: , CAB044670: AB_1854940, HPA070175: AB_2686232, HPA072220: AB_2686497"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.13e-3)"	"unprognostic (3.90e-2)"	"unprognostic (4.04e-2)"	"unprognostic (7.29e-2)"	"prognostic unfavorable (9.85e-4)"	"prognostic favorable (5.29e-5)"	"unprognostic (2.39e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.85e-2)"	6.8	11.1	11.0	12.7	12.3	4.8	11.9	13.7	12.4	17.3	19.6	13.7	19.9	26.0	12.2	17.3	20.1	15.3	16.5	8.1	10.9	8.1	19.4	17.0	18.7	5.4	13.7	7.7	13.8	29.6	11.2	17.0	23.0	10.3	29.6	8.1	19.7	40.9	18.5	10.3	18.6	25.1	9.0	8.3	7.9	18.6	22.3	12.5	8.8	15.2	10.1	14.7	11.5	15.0	2.8	3.4	4.2	2.5	3.6	4.5	1.9	17.9	45.4	6.8	10.3	2.1	2.3	20.5	8.6	3.5	5.8	5.9	29.7	15.3	4.1	13.1	5.4	7.6	6.6	3.7	6.8	2.2	10.9	10.4	4.8	8.3	14.4	3.4	4.9	7.1	2.7	3.0	5.4	3.9	3.8	7.5	6.3	9.7	3.2	3.4	50.0	5.2	5.4	12.3	15.9	10.9	5.3	5.3	3.1	5.6	19.8	21.7	15.0	8.7	39.0	9.7	3.7	17.3	8.2	12.5	9.9	17.0	11.3	15.3	3.7	3.5	3.4	12.1	2.9	11.8	1.0	2.5	4.2	2.6	1.4	3.6	2.2	2.9	4.5	3.4	2.8	2.2	2.2	2.1	3.6	2.1	2.9	3.0	1.9	11.0	12.3	13.7	12.4	10.9	8.1	13.7	7.7	10.3	12.5	0.0	1.0	0.5	15.0	12.8	14.8	1.2	20.4	6.7	0.0	17.4	23.6	35.6	26.6	18.7	2.7	15.8	35.5	0.0	17.2	46.7	10.8	17.8	5.7	10.5	8.3	20.6	43.0	12.3	5.6	4.9	10.9	2.5	6.8	14.4	30.6	14.1	16.5	40.3	9.9	10.6	13.1	0.0	7.2	5.7	17.7	16.4	54.7	8.7	29.9	20.6
PANX2	"hPANX2, PX2"	ENSG00000073150	"Pannexin 2"	Q96RD6	22	50170731-50180294	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.4"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 10.2;Hepatocytes: 6.8;Muller glia cells: 21.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 5.2"	"Group enriched"	"Detected in many"	36	"dendritic cells: 1.8;granulocytes: 5.2"	"Cell line enhanced"	"Detected in many"		"EFO-21: 9.1;HDLM-2: 13.9;Hep G2: 16.3;MCF7: 9.0;SCLC-21H: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004624, HPA039117"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA004624: , HPA039117: AB_10805354"	"unprognostic (1.00e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.01e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.43e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.65e-9)"	"unprognostic (2.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.00e-1)"	"unprognostic (4.08e-1)"	1.6	2.6	10.3	2.6	9.2	5.3	1.4	22.4	31.4	1.8	1.1	1.2	10.5	1.1	2.4	2.7	3.8	4.9	2.3	1.1	14.2	8.8	3.4	7.8	2.4	1.2	15.9	7.9	3.5	3.0	1.0	4.1	1.6	23.9	3.8	1.0	1.5	5.5	6.2	1.5	2.6	1.2	1.2	4.5	2.7	1.4	2.6	2.4	0.0	3.8	0.2	1.5	1.8	0.9	0.0	1.8	5.2	0.0	0.0	0.0	0.0	0.8	1.8	0.3	2.0	0.0	0.2	4.3	2.2	2.2	0.5	0.4	0.4	6.9	0.0	9.1	0.2	1.3	0.4	1.1	0.9	0.1	13.9	1.2	0.3	2.9	16.3	0.7	0.1	1.1	0.2	0.9	0.6	0.0	1.0	0.5	0.0	1.1	0.0	0.2	9.0	0.0	0.8	3.4	0.0	3.7	0.8	0.0	3.3	0.0	1.4	8.6	0.8	1.4	0.1	5.2	0.4	0.6	0.6	3.8	0.4	3.7	5.9	4.1	1.6	0.1	0.5	0.2	0.0	6.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	1.8	0.0	0.0	10.3	9.2	22.4	31.4	14.2	8.8	15.9	7.9	23.9	2.4	0.0	1.4	0.0	2.3	0.5	10.2	0.6	2.5	4.0	4.5	0.0	0.0	0.0	5.0	1.7	0.2	0.0	0.0	0.0	2.4	0.1	0.5	4.0	0.0	6.8	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.8	0.0	21.1	2.2	0.0	1.1	1.2	3.6	0.0	0.4	0.0	0.4	0.3	0.0	0.0	0.0	2.8
PAQR8	"C6orf33, LMPB1, MPRB"	ENSG00000170915	"Progestin and adipoQ receptor family member 8"	Q8TEZ7	6	52361421-52407777	"Predicted membrane proteins"	"Differentiation, Oogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 69.2"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 94.7;Mucus-secreting cells: 40.0;Paneth cells: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 19.4;OE19: 41.1;SuSa: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064625			Supported	"Golgi apparatus,Plasma membrane"		NA	NA			"Plasma membrane"	"Golgi apparatus"	"HPA064625: AB_2685304"	"prognostic favorable (4.61e-4)"	"unprognostic (7.39e-3)"	"unprognostic (2.77e-3)"	"unprognostic (8.23e-2)"	"unprognostic (4.33e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.66e-2)"	"unprognostic (5.67e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.55e-2)"	"unprognostic (8.82e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.14e-2)"	"prognostic favorable (6.40e-4)"	2.4	3.5	25.6	6.6	32.4	1.3	2.2	14.9	31.0	4.2	28.9	35.5	14.2	14.5	4.4	6.7	13.7	5.4	4.9	2.9	27.3	17.5	5.3	1.5	5.8	7.2	48.5	15.8	19.5	2.5	3.7	1.8	5.5	28.2	3.8	28.1	1.9	1.9	28.5	1.1	2.7	25.1	5.2	69.2	4.8	24.1	3.1	36.5	3.1	2.6	0.4	6.0	7.3	3.3	1.0	6.0	2.0	2.6	7.0	16.3	3.2	0.4	0.4	5.2	2.2	3.1	5.1	3.5	1.5	5.8	1.0	2.1	1.9	1.8	0.5	0.5	1.0	2.3	0.2	0.6	2.5	1.6	6.9	0.8	3.1	0.4	19.4	0.8	0.8	0.4	1.4	0.3	0.6	3.7	3.6	5.5	6.1	0.7	3.1	4.0	0.7	2.0	2.8	2.6	41.1	0.2	5.3	0.8	1.2	6.0	1.4	1.9	4.2	0.4	0.1	5.8	17.5	0.1	6.9	2.3	2.0	0.8	0.5	0.9	0.9	1.2	0.7	1.8	8.0	10.3	2.0	2.6	1.3	2.5	0.5	3.8	0.9	7.6	5.2	6.0	1.0	16.3	7.6	0.5	7.0	0.5	3.0	4.7	3.2	25.6	32.4	14.9	22.8	27.3	17.5	48.5	15.8	28.2	36.5	3.0	8.8	0.0	3.2	1.8	1.6	4.6	15.3	0.0	1.2	3.5	7.9	1.4	0.0	3.2	0.4	3.8	94.7	0.0	1.0	2.6	4.7	6.0	4.6	0.0	7.9	0.0	22.1	3.7	16.7	1.0	5.2	3.9	13.5	5.4	40.0	4.5	3.0	55.1	9.6	0.0	3.0	0.0	1.9	11.4	2.9	0.9	0.7	5.9	24.1	7.8
PARD3	"ASIP, Baz, Bazooka, PAR3, PARD3A, PPP1R118"	ENSG00000148498	"Par-3 family cell polarity regulator"	Q8TEW0	10	34109560-34815325	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"basophil: 9.0"	"Lineage enriched"	"Detected in single"	73	"granulocytes: 9.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030443	Approved		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"		"HPA030443: AB_10600926"	"unprognostic (9.49e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (3.48e-1)"	"unprognostic (3.49e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.54e-1)"	"unprognostic (9.20e-2)"	"prognostic unfavorable (4.41e-4)"	16.4	12.9	13.8	7.0	15.8	0.3	16.8	4.4	8.3	24.8	20.3	7.4	19.7	7.1	21.4	13.6	34.5	14.7	13.2	17.1	10.7	6.3	18.0	15.9	15.2	3.0	7.8	4.3	28.4	26.2	19.0	15.8	14.4	8.8	20.5	15.3	11.7	15.5	17.3	28.3	34.4	14.9	21.1	8.7	3.3	14.2	9.1	9.2	12.8	15.6	14.6	13.4	20.7	29.5	0.0	0.0	9.0	0.1	0.0	0.0	2.1	19.3	47.1	16.0	10.8	12.0	10.3	22.9	8.8	10.6	15.6	17.6	17.2	16.5	0.1	12.8	18.4	11.8	14.1	13.6	22.8	20.3	0.1	10.2	0.0	5.9	17.6	15.3	2.1	0.0	12.4	21.9	20.5	15.5	14.4	9.8	12.7	13.0	6.1	18.7	13.5	21.8	1.5	6.7	12.0	16.7	17.4	16.2	8.4	32.4	14.9	8.2	8.3	10.4	15.0	16.3	19.8	8.3	2.5	11.3	7.9	22.9	14.6	9.2	5.0	6.2	0.0	8.5	0.0	8.6	9.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	2.1	13.8	15.8	4.4	8.3	10.7	6.3	7.8	4.3	8.8	9.2	32.8	27.0	0.0	30.8	30.2	12.2	34.3	20.4	34.8	27.3	14.0	27.5	21.2	0.0	30.4	13.4	7.7	15.1	0.0	31.0	18.3	12.5	26.7	1.1	20.2	2.9	11.1	23.1	10.4	0.3	11.2	28.1	2.1	5.0	0.0	24.6	29.8	33.8	23.0	36.0	21.0	19.8	25.8	17.0	4.2	23.4	53.8	33.5	1.3	19.5	41.6
PCDHA4	"CNR1, CNRN1, CRNR1, PCDH-ALPHA4"	ENSG00000204967	"Protocadherin alpha 4"	Q9UN74	5	140806929-141012344	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.1"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 1: 3.0;Ciliated cells: 5.3;granulocytes: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 9.1;AF22: 8.9;EFO-21: 7.7;T-47d: 7.7"	"Low region specificity"	"Detected in all"							"HPA043180, HPA073478"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane"	Cytosol	"HPA043180: AB_10806381, HPA073478: AB_2686608"	"unprognostic (2.71e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.85e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.90e-3)"	"unprognostic (7.14e-3)"	"unprognostic (7.00e-2)"	"unprognostic (5.06e-3)"	"unprognostic (6.94e-5)"	"unprognostic (5.01e-3)"	"unprognostic (6.21e-2)"	"unprognostic (3.98e-1)"	"unprognostic (6.29e-3)"	"unprognostic (4.79e-2)"	0.9	0.8	5.1	0.9	6.5	3.2	1.7	12.1	8.7	2.1	1.1	1.6	0.4	0.9	2.3	2.0	0.6	1.6	5.1	1.2	4.5	3.2	2.0	0.6	1.7	1.5	1.9	2.1	1.1	4.1	1.0	1.4	0.7	3.9	1.8	1.1	0.4	1.1	1.3	1.1	2.0	0.9	1.1	3.0	1.1	1.0	1.4	2.4	0.0	1.3	0.1	0.7	1.3	0.8	1.5	1.3	2.0	0.7	0.8	1.1	0.0	0.2	9.1	8.9	0.4	0.1	0.3	0.3	0.2	0.1	0.1	0.1	0.2	1.8	0.3	7.7	0.2	0.4	0.3	0.0	0.1	0.2	0.2	0.2	0.4	0.6	0.3	0.1	0.3	0.5	0.4	2.4	0.2	0.4	0.6	0.5	0.4	0.2	1.2	0.3	0.2	0.2	0.3	2.5	1.9	1.3	0.2	0.2	0.3	0.3	0.4	0.4	3.8	0.1	2.0	0.8	1.6	7.7	0.3	0.9	2.0	1.3	0.7	0.2	0.5	0.2	0.2	0.3	0.4	0.8	1.8	0.7	0.7	1.1	0.4	0.8	0.8	0.8	0.7	0.3	1.5	0.8	1.1	2.0	0.8	0.7	1.3	0.6	0.0	5.1	6.5	12.1	6.6	4.5	3.2	1.9	2.1	3.9	2.4	3.0	1.3	0.0	0.5	0.0	0.9	0.8	0.0	5.3	1.2	0.0	0.0	0.0	0.0	0.4	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	3.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.1	0.0	0.0	0.0	0.7	0.0	0.3	0.5	0.2	0.0	0.0	0.0	0.0	0.3
PCDHGB2	PCDH-GAMMA-B2	ENSG00000253910	"Protocadherin gamma subfamily B, 2"	Q9Y5G2	5	141360042-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	5	"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 14.4;ASC TERT1: 10.5;LHCN-M2: 8.5;REH: 7.8"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA077526"	Uncertain		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane, Cytosol"	Nucleoplasm	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077526: AB_2732350"	"unprognostic (7.14e-3)"	"unprognostic (8.79e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (8.67e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.19e-4)"	"unprognostic (2.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.46e-3)"	"unprognostic (4.59e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.36e-4)"	4.9	3.6	11.3	2.2	9.7	0.9	3.7	8.7	12.2	7.2	2.4	11.6	0.3	1.2	9.2	3.2	3.2	5.6	6.2	4.6	9.3	7.0	2.7	2.7	5.4	1.4	7.0	8.6	9.0	2.6	7.5	3.0	3.9	7.3	4.4	2.8	3.1	2.4	4.4	1.9	2.9	2.1	5.0	7.0	2.2	2.0	1.8	7.8	0.1	2.6	1.3	1.4	2.8	3.3	0.9	0.9	0.5	0.0	0.0	0.7	0.0	0.1	0.3	2.1	0.2	14.4	10.5	0.1	2.2	3.0	0.6	3.4	0.0	0.3	3.8	1.0	1.7	7.5	0.5	0.5	0.3	1.0	0.0	0.2	0.0	0.3	0.4	0.6	0.2	0.2	2.7	0.5	0.2	0.1	4.9	1.7	0.1	0.2	1.2	8.5	0.4	2.9	0.6	0.1	0.9	0.9	7.8	2.7	0.2	0.2	0.3	1.6	1.7	0.2	0.4	0.4	1.6	3.1	0.2	6.0	3.0	0.7	4.6	3.9	0.2	2.2	0.7	3.3	1.0	1.4	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.4	0.0	0.0	0.4	0.0	0.6	0.5	0.0	0.0	0.9	0.0	0.0	11.3	9.7	8.7	10.6	9.3	7.0	7.0	8.6	7.3	7.8	0.0	0.3	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PDE4A	DPDE2	ENSG00000065989	"Phosphodiesterase 4A"	P27815	19	10416773-10469631	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.5;testis: 31.8"	"Cell type enhanced"	"Detected in many"	13	"Late spermatids: 164.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 22.0;NB-4: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017632, HPA043310, HPA076091"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB017632: AB_1127109, HPA043310: AB_2678419, HPA076091: AB_2686775"	"unprognostic (1.29e-2)"	"unprognostic (3.98e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.00e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.15e-1)"	6.4	2.5	9.0	4.2	13.9	3.4	6.3	15.0	38.5	8.4	4.3	3.2	0.4	2.0	4.4	1.1	3.1	4.8	5.0	4.1	12.4	6.9	2.8	1.9	7.7	2.0	5.3	19.4	1.7	9.8	17.3	2.3	4.9	34.7	3.7	3.0	3.1	7.1	4.0	26.1	2.2	2.7	4.7	3.6	4.1	6.1	31.8	4.5	0.0	5.4	1.0	1.9	4.6	3.5	0.2	3.3	5.9	4.4	5.3	2.0	1.3	0.0	1.4	0.3	3.9	11.6	6.9	2.2	3.3	6.6	0.4	1.1	3.5	3.2	1.5	9.7	8.5	0.2	0.3	2.3	0.4	0.2	3.8	3.3	13.6	4.7	3.8	7.5	2.2	22.0	5.1	0.4	3.7	0.0	0.4	3.1	1.2	10.7	3.3	2.3	1.0	1.3	25.3	1.8	3.9	2.8	8.9	2.2	11.7	0.6	0.8	2.5	0.9	0.2	0.1	3.6	0.6	0.5	4.5	6.6	5.0	6.5	3.4	2.1	6.5	0.5	7.2	2.1	0.1	4.0	5.9	2.6	5.1	1.5	4.4	0.8	0.2	0.5	2.0	3.3	0.1	0.1	0.7	0.2	5.3	4.4	0.2	1.2	1.3	9.0	13.9	15.0	38.5	12.4	6.9	5.3	19.4	34.7	4.5	3.0	15.2	8.0	2.7	9.0	23.9	5.8	12.7	10.7	7.9	8.7	0.0	0.3	0.0	2.8	44.2	10.9	1.3	0.0	11.1	4.3	13.4	3.1	32.2	0.8	9.8	52.4	0.0	11.6	18.3	164.4	16.1	37.2	13.5	14.4	6.2	1.3	10.6	0.0	17.0	0.0	2.6	6.5	8.1	7.7	7.8	7.0	0.3	16.0	6.8	1.4
PDE4D	DPDE3	ENSG00000113448	"Phosphodiesterase 4D"	Q08499	5	58969038-60522120	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 60.0"	"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 2: 76.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"eosinophil: 28.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 28.1"	"Cell line enhanced"	"Detected in many"		"A549: 25.3;AN3-CA: 29.1;HeLa: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045895	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA045895: AB_10960275"	"unprognostic (1.14e-1)"	"unprognostic (8.73e-3)"	"unprognostic (4.35e-2)"	"unprognostic (7.87e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.10e-4)"	"unprognostic (1.17e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (4.00e-5)"	"unprognostic (1.51e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.56e-2)"	8.2	1.9	4.4	6.8	8.6	46.2	5.3	4.2	13.0	13.5	18.6	1.4	14.7	4.1	17.1	14.0	10.3	6.6	12.7	15.5	4.5	5.8	12.8	3.4	11.1	3.7	5.2	6.6	5.3	2.9	7.0	9.0	11.8	2.7	18.2	11.2	8.6	24.4	16.5	60.0	5.1	7.5	35.8	5.0	3.8	10.2	2.6	2.8	4.4	6.2	11.3	9.5	20.0	11.2	6.1	0.7	28.1	1.1	0.1	0.8	0.5	0.0	25.3	5.3	29.1	1.0	1.9	4.2	0.6	0.7	1.4	2.1	9.9	0.8	1.9	0.1	0.2	4.3	4.3	0.0	1.1	2.5	1.1	2.9	3.7	41.9	2.1	3.9	1.7	0.2	3.9	0.9	4.0	0.7	0.4	3.0	0.1	0.0	0.6	2.4	1.8	1.4	4.1	1.0	0.7	1.3	0.4	6.7	4.2	6.6	9.5	0.9	3.3	6.7	11.3	5.7	5.0	0.8	3.7	3.4	0.3	0.1	5.0	1.3	1.4	0.0	0.2	4.3	7.0	1.1	2.0	1.1	28.1	0.8	0.0	0.8	6.1	0.7	0.3	0.7	6.1	0.5	0.4	1.5	0.1	0.1	0.0	0.4	0.5	4.4	8.6	4.2	13.0	4.5	5.8	5.2	6.6	2.7	2.8	29.8	76.9	9.1	30.5	9.4	13.6	32.7	10.2	22.7	48.9	40.1	68.7	9.2	10.0	0.5	16.6	12.4	16.7	0.0	1.6	14.8	13.1	46.1	21.9	0.8	4.3	1.6	32.0	14.1	6.0	29.3	1.4	9.4	10.1	4.6	18.4	16.1	5.4	10.5	4.6	17.7	52.1	0.0	5.3	0.5	7.1	7.8	2.6	37.3	10.1	21.1
PDE9A		ENSG00000160191	"Phosphodiesterase 9A"	O76083	21	42653636-42775509	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	15	"Enterocytes: 168.7;Paneth cells: 77.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 31.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 6.8"	"Group enriched"	"Detected in many"	4	"NK-cells: 1.7;T-cells: 6.8"	"Cell line enhanced"	"Detected in many"		"AF22: 16.3;EFO-21: 16.5;MCF7: 12.2;NB-4: 18.2;NTERA-2: 22.5;SCLC-21H: 12.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011380, HPA011978"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA011380: AB_1855132, HPA011978: "	"unprognostic (5.75e-2)"	"unprognostic (9.92e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.06e-2)"	"unprognostic (3.99e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.90e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.97e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.79e-1)"	6.1	6.6	9.9	6.8	15.2	0.8	9.4	13.7	9.0	3.7	37.1	11.9	14.0	3.0	5.7	18.8	6.1	10.3	7.7	3.5	6.2	7.7	13.2	2.5	4.7	4.6	10.0	4.9	4.1	4.0	4.7	6.0	9.6	6.9	33.2	15.8	9.7	8.8	15.9	2.3	3.8	26.1	22.3	8.0	15.9	8.4	1.5	8.9	4.9	5.2	2.1	4.1	12.6	4.0	0.5	0.9	1.0	0.1	1.7	6.8	0.5	0.0	1.5	16.3	2.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	1.8	9.8	0.0	16.5	0.0	1.1	0.0	1.4	5.3	0.0	0.0	5.6	0.0	0.0	3.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	12.2	0.8	18.2	22.5	8.0	0.0	0.0	0.0	0.6	11.2	4.5	12.5	7.4	2.8	0.0	0.2	4.0	0.1	10.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	2.1	0.6	0.2	0.5	6.8	1.7	1.0	1.7	0.1	0.9	2.2	0.5	9.9	15.2	13.7	6.7	6.2	7.7	10.0	4.9	6.9	8.9	3.0	5.3	0.0	8.5	0.9	21.0	1.4	5.1	1.4	0.0	17.4	0.0	0.0	24.9	6.2	0.3	6.7	168.7	0.0	2.1	0.1	3.1	27.6	1.1	0.8	5.6	33.4	12.6	3.7	0.6	1.7	10.9	1.0	27.0	1.8	19.3	9.4	5.1	77.2	5.6	7.6	2.7	12.9	5.9	0.4	0.7	0.5	0.3	2.1	22.2	13.1
PDGFC	"fallotein, SCDGF"	ENSG00000145431	"Platelet derived growth factor C"	Q9NRA1	4	156760454-156971394	"Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 44.1;Cholangiocytes: 45.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 2.1;intermediate monocyte: 1.0;non-classical monocyte: 1.4"	"Lineage enriched"	"Detected in single"	11	"monocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 27.1;hTERT-RPE1: 26.6;U-138 MG: 19.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA009134	Approved		Supported	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA			"Plasma membrane, Cytosol"		"HPA009134: AB_10601981"	"unprognostic (3.12e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.67e-2)"	"unprognostic (3.97e-1)"	"unprognostic (3.41e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.35e-5)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (3.17e-4)"	11.5	9.1	3.2	6.5	3.4	0.7	7.9	1.3	3.5	21.8	6.1	1.9	8.4	2.2	21.3	9.4	6.1	9.0	12.7	3.6	2.4	2.0	9.7	10.3	6.9	4.3	2.2	3.8	10.4	9.8	28.0	2.2	4.9	1.9	17.7	2.4	5.5	26.6	9.3	6.5	4.1	5.4	11.9	2.0	4.1	5.6	4.3	1.7	2.2	10.4	4.4	1.5	8.3	4.7	0.0	0.2	0.0	2.1	0.0	0.0	0.7	1.0	1.6	17.8	11.7	3.3	6.5	0.4	9.3	9.9	5.6	7.5	1.0	4.2	0.0	1.6	27.1	4.3	1.1	4.9	6.1	7.7	0.0	2.2	10.8	1.6	1.0	8.7	1.6	0.1	6.7	3.0	14.2	10.2	26.6	2.7	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.2	0.0	0.7	0.0	3.7	0.0	10.6	0.4	0.0	0.0	0.0	0.0	0.1	2.9	1.4	0.5	12.0	19.4	0.2	4.9	7.5	0.0	0.0	0.0	7.4	0.0	0.7	0.0	2.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.7	3.2	3.4	1.3	3.5	2.4	2.0	2.2	3.8	1.9	1.7	6.0	13.9	0.0	18.3	44.1	0.3	13.7	45.9	0.0	7.9	12.2	0.0	0.4	0.0	13.8	31.1	4.9	0.4	0.0	6.2	0.2	15.8	6.7	1.1	13.0	10.6	0.0	0.0	11.6	21.7	18.1	4.9	14.8	10.1	16.2	2.0	6.7	12.6	0.0	21.5	14.9	0.3	6.5	17.3	0.2	2.2	11.8	0.5	0.5	1.3	4.3
PDGFRA	"CD140a, GAS9, PDGFR2"	ENSG00000134853	"Platelet derived growth factor receptor alpha"	P16234	4	54229097-54298247	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Chemotaxis, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 81.5"	"Group enriched"	"Detected in many"	9	"Fibroblasts: 171.4;Leydig cells: 416.6;Peritubular cells: 384.4"	"Cancer enhanced"	"Detected in all"		"glioma: 30.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 82.8;ASC TERT1: 38.8;BJ hTERT+: 48.0;fHDF/TERT166: 33.4;HHSteC: 28.0;HSkMC: 70.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004947, CAB018143"	Supported		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		150000	"Nucleoplasm, Plasma membrane, Cell Junctions"		"CAB018143: AB_2162351, HPA004947: AB_2732399"	"unprognostic (1.67e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.92e-2)"	"prognostic favorable (9.33e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (9.79e-6)"	"unprognostic (9.58e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.72e-3)"	35.0	12.4	12.6	16.1	7.6	0.9	17.2	2.4	20.1	33.2	19.1	9.2	6.4	9.6	27.6	14.6	21.9	22.5	16.2	15.3	8.9	7.4	22.8	8.4	24.1	26.9	9.2	4.0	81.5	6.8	1.6	2.1	25.1	7.2	18.6	15.2	19.2	8.5	8.3	11.9	7.0	17.4	19.7	8.8	51.6	13.6	19.0	9.3	0.5	11.3	12.8	4.3	35.9	24.6	0.9	0.4	2.5	0.4	0.3	0.8	0.3	0.0	0.0	0.2	0.1	82.8	38.8	0.1	4.3	48.0	0.0	0.1	11.5	0.0	0.1	0.1	33.4	0.1	0.1	3.3	0.0	0.0	0.4	0.1	0.1	0.1	0.2	28.0	0.0	0.0	70.4	0.0	5.5	0.0	0.9	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	6.7	0.0	0.1	0.0	0.3	0.1	0.0	0.1	15.2	0.5	16.6	0.0	0.0	0.0	0.1	0.4	0.0	0.3	2.5	0.4	0.2	0.5	0.2	0.2	0.6	0.8	0.4	0.0	0.9	0.7	0.4	2.3	0.3	0.3	0.4	0.2	0.3	12.6	7.6	2.4	7.3	8.9	7.4	9.2	4.0	7.2	9.3	0.0	0.3	0.9	0.3	15.1	0.7	4.0	0.0	0.0	0.0	0.0	0.0	1.3	1.7	2.9	1.6	3.3	0.0	0.0	5.8	1.2	171.4	0.4	0.0	0.8	2.8	0.0	0.0	38.1	0.6	3.7	416.6	1.6	21.9	8.2	0.0	18.3	12.2	0.0	384.4	0.0	0.4	0.0	13.2	1.1	3.5	13.8	1.1	0.0	0.0	0.8
PDLIM5	"Enh, LIM"	ENSG00000163110	"PDZ and LIM domain 5"	Q96HC4	4	94451857-94668227	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 129.6;skeletal muscle: 173.0"	"Cell type enriched"	"Detected in all"	8	"Cardiomyocytes: 1784.7"	"Cancer enriched"	"Detected in all"	8	"prostate cancer: 132.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"basophil: 51.1"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 51.1"	"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013511, HPA016740, HPA020026"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA		2200000	"Nucleoplasm, Plasma membrane, Focal adhesion sites"		"CAB013511: AB_2533388, HPA016740: AB_1855153, HPA020026: AB_1855154"	"unprognostic (6.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.46e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.04e-1)"	11.6	4.8	6.2	4.2	6.1	8.7	9.8	3.4	5.8	12.7	11.0	3.7	7.1	5.6	37.5	12.9	14.0	10.2	11.0	129.6	5.3	5.2	12.9	13.9	5.6	5.3	5.4	4.5	10.3	8.1	3.4	6.8	18.9	10.2	15.3	5.4	12.6	15.3	12.5	173.0	5.6	15.8	22.1	4.9	7.0	5.6	5.5	3.7	1.0	5.3	52.9	9.5	17.7	7.1	3.2	5.6	51.1	12.2	2.7	3.9	3.8	8.2	24.4	9.5	3.7	21.0	14.4	3.7	20.1	16.7	11.5	9.3	22.5	18.3	3.3	20.6	20.1	5.9	8.5	12.9	18.8	19.3	5.8	5.4	12.0	15.9	8.5	30.3	3.9	10.8	19.3	16.6	27.6	21.5	51.4	25.9	3.4	5.1	3.6	24.5	8.1	4.0	1.3	3.2	18.1	10.2	1.9	7.0	2.9	12.9	26.4	4.7	6.3	11.0	25.1	5.6	8.0	2.9	1.2	32.4	30.1	4.8	13.0	12.2	2.5	3.2	3.3	16.4	2.8	7.0	51.1	6.8	5.9	3.8	11.8	3.1	3.2	3.7	3.9	5.6	2.5	2.5	3.2	6.8	2.7	12.2	1.9	3.4	3.8	6.2	6.1	3.4	3.9	5.3	5.2	5.4	4.5	10.2	3.7	41.7	23.4	12.7	232.1	172.6	4.3	1784.7	58.6	30.8	37.5	47.1	29.5	9.2	11.6	82.1	14.6	128.1	146.3	23.3	81.9	91.7	90.4	234.4	50.8	159.4	34.4	1.6	105.0	135.1	57.1	6.8	38.3	60.2	59.1	29.7	89.1	79.1	115.5	83.5	62.6	63.8	35.6	77.6	141.3	13.2	30.2	137.1	19.9	15.0	51.0	185.7
PDPN	"aggrus, Gp38, GP40, PA2.26, T1A-2"	ENSG00000162493	Podoplanin	Q86YL7	1	13583465-13617957	"Predicted membrane proteins"	"Cell shape"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 71.8"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 1: 98.3;Fibroblasts: 108.5;monocytes: 202.8;Muller glia cells: 85.7;Peritubular cells: 59.1"	"Cancer enhanced"	"Detected in many"		"testis cancer: 102.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.1"	"Cell line enhanced"	"Detected in some"		"AF22: 30.3;EFO-21: 72.6;HAP1: 50.4;HHSteC: 44.7;NTERA-2: 23.3;SuSa: 25.2;TIME: 48.3"									"HPA007534, HPA007949, CAB008376"	Enhanced		Supported	"Plasma membrane,Cell Junctions,Mitochondria"		NA	NA			"Plasma membrane"	"Cell Junctions, Mitochondria"	"CAB008376: AB_592530, HPA007534: AB_1857718, HPA007949: "	"unprognostic (1.75e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.23e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.62e-3)"	"unprognostic (9.20e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.78e-2)"	27.7	2.0	6.3	29.8	10.9	0.5	30.3	5.0	6.7	21.4	12.8	11.0	4.1	2.5	16.8	15.3	8.9	19.8	23.7	18.6	5.7	6.5	1.9	0.8	17.8	10.4	10.0	2.4	18.4	3.9	0.7	2.3	71.8	13.5	11.3	6.4	26.6	6.0	8.6	21.9	10.0	7.6	18.6	17.5	0.7	15.1	9.7	7.9	3.2	5.7	9.7	9.9	27.3	28.9	0.4	0.2	3.1	0.4	0.3	0.4	0.1	0.0	0.0	30.3	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	72.6	1.7	0.0	0.1	50.4	9.0	0.0	0.1	9.2	0.0	0.0	0.0	44.7	0.0	0.0	6.1	16.8	3.8	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	25.2	0.0	0.1	48.3	8.5	7.3	0.1	0.0	0.0	0.0	0.1	18.1	0.0	0.0	1.0	0.4	0.6	0.2	0.2	0.2	0.4	0.3	0.3	0.2	0.4	0.4	0.3	3.1	0.3	0.2	0.2	0.2	0.1	6.3	10.9	5.0	4.8	5.7	6.5	10.0	2.4	13.5	7.9	98.3	9.1	0.0	29.7	12.9	1.2	6.9	0.0	6.7	29.6	0.0	3.9	1.8	0.0	0.4	0.5	7.4	0.0	0.0	0.0	1.6	108.5	3.5	1.1	0.0	6.5	0.0	0.0	7.4	0.0	0.4	18.7	4.1	6.8	202.8	0.0	85.7	0.5	0.0	59.1	0.0	2.8	0.0	6.2	0.9	8.6	6.0	2.4	0.0	0.0	3.4
PDZD2	"KIAA0300, PDZK3"	ENSG00000133401	"PDZ domain containing 2"	O15018	5	31639410-32110931	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.8"	"Cell type enhanced"	"Detected in many"	13	"Cone photoreceptor cells: 92.3;Early spermatids: 193.7;Rod photoreceptor cells: 66.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 9.1;EFO-21: 5.1;SiHa: 12.7;SK-BR-3: 11.8;T-47d: 6.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB020784, HPA036503, HPA036504, HPA064387, HPA076072"	Uncertain		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Plasma membrane, Cytosol"		"CAB020784: , HPA036503: AB_2675161, HPA036504: , HPA064387: AB_2685252, HPA076072: "	"unprognostic (3.65e-2)"	"unprognostic (4.06e-2)"	"unprognostic (6.63e-2)"	"unprognostic (5.42e-5)"	"unprognostic (2.39e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.55e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.33e-3)"	"unprognostic (4.13e-2)"	"unprognostic (6.92e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.79e-1)"	16.3	1.3	7.8	1.0	28.8	0.3	5.6	3.6	18.1	2.9	1.9	5.1	2.4	0.8	3.0	7.4	6.1	2.8	1.2	19.6	6.6	4.8	9.5	0.4	10.0	0.5	5.4	8.8	16.7	1.5	0.8	2.6	11.9	11.5	2.0	1.1	4.3	2.3	2.5	2.6	11.1	1.1	2.9	3.2	0.5	2.0	6.2	6.1	0.3	1.3	0.7	2.0	1.1	2.9	0.4	0.7	0.7	0.6	0.2	1.0	0.0	0.1	0.0	3.5	0.1	0.0	0.0	9.1	0.0	0.0	0.6	0.6	0.0	0.0	0.0	5.1	0.0	1.3	4.7	1.8	1.0	0.0	0.0	0.4	0.0	2.8	0.0	0.0	0.0	2.7	0.3	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.8	0.0	0.0	0.0	4.0	0.1	0.1	0.8	12.7	11.8	0.0	3.1	6.1	0.0	0.0	0.0	2.5	0.0	0.5	0.0	0.0	3.0	0.0	0.0	1.2	0.4	0.5	0.4	0.5	0.1	1.0	0.1	0.3	0.1	0.1	0.4	0.1	0.1	0.7	0.2	0.6	0.7	0.0	0.0	7.8	28.8	3.6	18.1	6.6	4.8	5.4	8.8	11.5	6.1	41.7	30.5	0.0	3.4	14.9	5.2	41.8	0.0	1.4	5.7	5.2	92.3	19.5	0.0	0.1	193.7	6.8	0.0	0.0	0.2	2.5	5.6	1.0	1.1	0.0	1.9	14.3	0.0	6.2	0.3	37.2	6.9	1.7	6.8	0.0	0.0	5.2	2.1	0.0	9.9	8.7	66.0	45.3	2.0	10.1	2.7	16.2	17.6	0.0	0.0	1.3
PHLDB2	"FLJ21791, LL5b, LL5beta"	ENSG00000144824	"Pleckstrin homology like domain family B member 2"	Q86SQ0	3	111732497-111976517	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 104.0"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 138.6;Basal keratinocytes: 222.0;Smooth muscle cells: 129.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 32.4;HaCaT: 33.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA035146, HPA035147"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA035146: AB_10600927, HPA035147: AB_2674492"	"unprognostic (2.83e-2)"	"unprognostic (4.93e-3)"	"unprognostic (2.15e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (5.14e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.53e-1)"	"prognostic favorable (7.03e-8)"	"unprognostic (3.24e-3)"	"unprognostic (3.47e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.83e-1)"	15.5	3.8	1.3	13.2	1.9	0.4	9.9	1.6	2.9	13.9	22.8	1.4	8.4	2.8	17.4	10.1	10.7	10.7	9.1	21.7	1.3	1.2	36.6	24.6	14.4	2.2	2.1	1.9	8.5	6.4	0.9	5.3	104.0	7.1	16.7	4.4	6.9	7.0	14.3	6.0	5.8	6.5	49.3	2.4	7.9	11.4	4.3	0.4	1.7	5.9	6.8	2.3	33.8	17.8	1.0	1.0	0.4	0.1	1.7	5.6	1.3	32.4	3.6	20.4	0.0	6.6	10.9	8.4	18.8	9.2	12.5	14.8	10.2	2.4	0.0	19.8	7.2	12.6	33.8	0.3	12.1	22.8	0.5	0.4	0.0	8.7	3.3	7.2	0.0	0.1	12.8	7.2	8.6	16.0	14.1	20.0	0.3	0.0	0.1	3.7	0.0	1.3	0.0	8.2	0.3	6.3	2.8	26.3	0.0	7.4	7.8	0.5	1.5	18.5	0.3	1.9	11.7	0.6	0.1	17.4	3.4	28.6	9.0	4.5	1.7	0.0	0.0	3.4	0.0	6.4	0.2	0.0	0.0	5.2	0.0	3.7	0.4	3.6	5.6	0.1	1.0	0.0	2.3	0.4	1.7	0.1	1.0	0.8	1.3	1.3	1.9	1.6	2.9	1.3	1.2	2.1	1.9	7.1	0.4	74.5	9.8	2.4	138.6	222.0	0.1	94.0	25.5	5.3	12.5	31.4	2.0	21.1	19.9	56.7	10.2	32.4	0.0	0.0	17.6	42.7	33.9	48.7	6.9	28.4	3.0	0.0	10.4	43.6	3.2	3.9	13.3	3.2	21.9	1.8	3.4	0.0	37.0	0.0	21.2	28.0	0.3	12.9	129.6	0.3	2.1	100.2	55.8	7.0	1.4	85.9
PIK3CG		ENSG00000105851	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma"	P48736	7	106865278-106907145	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Angiogenesis, Chemotaxis, Endocytosis, Immunity, Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 24.5;bone marrow: 27.8;lymphoid tissue: 40.8"	"Cell type enhanced"	"Detected in some"	8	"B-cells: 17.3;Early spermatids: 26.6;granulocytes: 19.7;monocytes: 24.4;T-cells: 17.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 12.4;HL-60: 12.1;HMC-1: 15.5;Karpas-707: 12.9;MOLT-4: 23.5;U-266/70: 31.5;U-937: 22.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069976	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA069976: AB_2686224"	"unprognostic (8.34e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.82e-3)"	"unprognostic (3.02e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.38e-1)"	"unprognostic (5.24e-2)"	5.0	1.8	2.2	16.0	3.1	27.8	2.3	0.8	1.7	1.7	4.1	2.7	0.0	2.8	1.7	2.0	2.0	1.8	3.5	1.7	1.7	1.5	1.9	1.5	4.3	13.1	3.0	1.0	1.7	1.5	0.6	1.4	2.0	2.5	2.2	2.6	1.9	3.1	0.5	1.1	1.3	6.1	1.9	6.4	17.4	2.5	7.6	3.0	40.8	2.3	0.9	21.2	4.1	1.5	6.2	5.6	14.2	24.5	5.3	5.6	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.6	0.0	0.0	0.0	12.1	15.5	0.0	0.0	0.0	0.0	0.0	4.8	7.4	8.6	12.9	0.0	0.0	23.5	4.6	0.0	0.0	0.0	6.2	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	1.2	0.0	0.1	0.0	0.0	31.5	0.0	11.7	0.0	22.2	2.9	4.6	3.4	14.2	5.6	10.6	5.1	4.7	2.6	4.2	5.6	6.2	2.8	3.8	13.9	5.3	24.5	4.9	2.6	3.6	2.2	3.1	0.8	1.7	1.7	1.5	3.0	1.0	2.5	3.0	0.0	2.6	17.3	0.0	0.7	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	26.6	0.9	0.0	0.0	0.0	0.0	0.1	0.0	19.7	0.5	5.9	0.0	0.0	1.8	11.0	12.8	0.6	13.3	6.8	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	3.1	0.3	0.1	17.5	0.0	0.0
PIP4K2A	"PIP5K2A, PIP5KIIA, PIP5KIIalpha"	ENSG00000150867	"Phosphatidylinositol-5-phosphate 4-kinase type 2 alpha"	P48426	10	22534849-22714555	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 92.0"	"Cell type enhanced"	"Detected in all"	7	"Erythroid cells: 93.5;Melanocytes: 99.5;T-cells: 152.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065440, HPA068771"	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		8800000	"Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA065440: AB_2685490, HPA068771: AB_2686030"	"unprognostic (1.11e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.57e-3)"	"unprognostic (4.20e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.56e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (1.52e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.92e-3)"	13.0	7.3	43.8	20.3	63.8	17.3	6.9	6.6	41.4	13.2	7.8	75.5	1.0	5.9	9.9	5.6	9.2	7.2	15.1	5.9	56.0	31.7	7.6	8.3	11.5	33.4	65.7	22.9	4.3	4.9	29.5	4.2	10.5	36.5	4.4	9.0	5.7	3.9	6.3	2.6	4.0	8.1	14.4	92.0	26.6	8.4	5.4	59.8	10.1	5.9	1.0	38.5	11.5	5.8	14.7	12.0	26.3	16.6	38.4	46.7	39.3	8.9	8.8	10.3	3.3	16.5	22.5	7.8	16.6	17.7	9.0	11.1	8.2	14.3	18.7	6.0	33.3	19.8	3.1	8.9	4.6	9.1	41.4	9.3	35.2	6.4	18.1	29.3	6.7	27.6	11.2	4.2	12.2	11.9	13.9	13.3	25.3	19.5	36.6	16.6	3.7	26.9	6.0	4.2	4.3	6.3	10.9	14.7	25.4	13.3	1.7	1.8	4.3	5.3	2.7	26.4	12.2	2.3	11.7	16.0	7.0	10.2	12.8	10.1	23.3	13.1	13.6	18.9	20.5	5.3	16.1	8.8	26.3	34.5	15.6	46.7	14.7	27.5	40.0	11.6	8.6	18.6	34.9	10.9	38.4	16.6	12.0	19.6	39.3	43.8	63.8	6.6	30.3	56.0	31.7	65.7	22.9	36.5	59.8	3.0	7.9	43.2	3.6	15.7	4.1	6.8	15.3	1.4	7.9	17.4	2.0	6.7	10.0	8.7	15.7	24.8	2.6	93.5	9.3	4.0	17.1	5.4	22.0	6.4	27.8	12.7	4.7	68.2	77.2	23.8	15.5	49.0	99.5	85.6	2.8	4.0	16.5	3.5	9.6	9.8	8.1	19.4	21.1	4.1	2.3	14.8	10.4	152.2	2.3	5.5
PIP5K1A		ENSG00000143398	"Phosphatidylinositol-4-phosphate 5-kinase type 1 alpha"	Q99755	1	151197949-151249536	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029366	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA029366: AB_10602116"	"unprognostic (1.05e-1)"	"unprognostic (2.36e-2)"	"unprognostic (8.64e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.01e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (4.16e-7)"	"unprognostic (1.44e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.59e-1)"	18.1	19.5	15.7	15.4	21.0	9.6	20.2	22.6	27.6	19.8	18.0	20.3	14.7	16.4	24.8	22.6	20.7	19.4	20.7	18.9	17.3	13.4	17.8	18.3	21.7	17.1	12.7	17.5	20.4	16.6	21.8	25.3	44.6	14.6	17.3	15.6	29.5	17.8	15.2	26.1	20.4	20.4	27.2	16.1	20.1	16.8	42.1	14.0	19.3	20.1	13.9	22.3	16.2	17.7	9.1	8.7	11.7	6.2	4.7	5.9	6.3	17.7	13.8	21.4	24.7	14.1	15.0	21.1	23.5	33.0	43.9	39.4	25.1	17.2	16.2	25.0	25.0	19.8	15.1	27.7	16.1	38.5	24.3	19.8	12.8	18.3	12.0	26.7	22.9	16.2	19.9	15.0	27.3	34.6	19.4	17.8	25.8	12.5	13.8	22.0	24.9	22.8	11.4	31.7	13.6	21.5	22.1	18.7	12.0	22.5	10.3	14.4	19.0	31.7	24.4	20.6	37.4	25.6	21.7	17.1	17.5	24.4	16.1	28.2	19.3	32.1	36.5	17.0	6.7	20.8	0.1	5.5	7.3	5.3	6.2	4.1	9.1	5.0	5.9	8.4	4.6	5.4	4.2	11.7	4.7	4.8	8.7	3.9	6.3	15.7	21.0	22.6	27.6	17.3	13.4	12.7	17.5	14.6	14.0	29.8	13.5	19.0	21.3	58.7	33.2	17.3	12.7	12.0	11.4	29.6	92.3	21.0	8.3	11.8	2.8	13.2	15.9	0.0	7.5	24.0	19.1	15.9	11.5	11.6	11.1	25.4	5.8	17.8	10.1	3.6	12.4	11.5	11.8	10.0	8.4	13.8	13.3	8.4	10.3	7.9	43.5	12.9	19.6	46.5	22.4	43.7	53.1	8.7	9.5	32.5
PKP4	p0071	ENSG00000144283	"Plakophilin 4"	Q99569	2	158456964-158682879	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 111.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 5.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037334, HPA066647, HPA070648"	Approved		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA			"Cell Junctions"	"Plasma membrane"	"CAB037334: , HPA066647: AB_2685696, HPA070648: AB_2686291"	"unprognostic (2.76e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.48e-2)"	"prognostic favorable (5.80e-4)"	"unprognostic (2.34e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.82e-2)"	"unprognostic (9.69e-2)"	"prognostic favorable (3.29e-7)"	"unprognostic (2.23e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.28e-3)"	7.3	3.9	42.7	3.7	42.1	4.2	15.5	14.5	26.6	19.8	7.1	49.9	6.9	7.1	8.3	8.9	10.7	11.8	8.9	12.1	47.7	31.2	34.2	9.7	7.3	3.0	66.9	14.7	8.3	8.7	12.2	6.6	3.4	28.4	7.8	8.1	10.4	19.3	13.1	4.0	9.4	6.4	8.5	111.7	3.2	7.7	5.6	31.6	3.3	18.2	2.4	5.5	9.1	6.9	0.1	0.7	1.0	5.3	0.0	2.1	0.5	16.7	9.3	12.9	14.6	5.9	6.5	12.3	14.0	7.5	21.1	18.3	31.3	15.9	10.7	10.4	16.2	7.7	13.6	16.6	13.9	35.3	16.1	8.5	10.1	10.5	25.5	10.0	16.0	2.2	2.8	13.5	14.5	22.1	12.8	10.6	13.8	13.7	17.1	16.0	18.5	7.0	6.8	13.7	23.4	7.1	9.3	19.2	9.2	31.1	12.1	22.4	4.0	9.7	14.6	11.4	12.4	17.3	14.7	4.9	12.6	14.2	9.3	17.5	9.8	8.2	7.9	7.4	8.8	12.2	0.0	1.0	0.0	0.4	0.3	0.7	0.0	1.5	0.6	0.4	0.1	1.2	0.4	1.0	0.0	5.3	0.7	2.1	0.5	42.7	42.1	14.5	26.6	47.7	31.2	66.9	14.7	28.4	31.6	38.7	17.6	4.9	19.0	24.0	32.4	44.7	50.9	33.5	34.2	45.4	27.5	0.3	19.9	20.4	10.2	56.2	10.3	23.3	15.9	0.3	10.4	28.3	9.3	23.7	2.6	4.8	8.6	20.3	8.1	7.0	10.0	6.7	6.8	1.8	17.6	8.1	14.4	10.5	15.9	25.9	18.6	12.9	13.4	10.7	5.9	26.6	0.2	3.5	19.5	18.6
PLAA	"DOA1, FLJ11281, FLJ12699, PLA2P, PLAP"	ENSG00000137055	"Phospholipase A2 activating protein"	Q9Y263	9	26904083-26947463	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"Developmental protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005035, HPA020994, HPA020996"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		5300	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB005035: AB_562036, HPA020994: AB_1855444, HPA020996: AB_1855445"	"unprognostic (5.48e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.00e-3)"	"unprognostic (5.00e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.50e-3)"	"unprognostic (2.48e-1)"	"unprognostic (5.54e-2)"	"prognostic favorable (7.87e-4)"	"unprognostic (3.24e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.86e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.10e-1)"	13.6	20.1	9.4	12.4	13.1	29.6	11.9	12.9	18.0	13.4	12.3	11.1	13.5	10.5	15.6	12.8	16.2	10.8	13.6	26.2	10.1	10.2	15.0	19.6	14.4	16.4	9.6	10.9	12.3	12.9	15.0	10.0	17.4	13.4	12.1	13.1	9.5	13.4	11.6	52.6	13.5	12.3	16.1	10.0	16.1	12.0	15.7	7.9	27.0	13.0	18.2	14.6	14.9	12.7	13.2	12.2	19.2	17.9	13.5	16.5	8.6	27.8	16.5	20.9	21.1	14.2	18.1	15.8	26.2	15.0	20.1	19.7	5.8	13.4	25.2	21.9	20.0	14.0	11.2	20.7	20.7	22.2	33.1	8.7	15.6	27.2	11.1	14.5	12.5	21.4	16.1	12.5	24.5	17.9	15.2	20.0	18.9	9.5	25.6	21.6	11.6	24.2	12.2	30.3	14.4	14.4	17.3	13.1	14.9	15.6	16.7	13.4	23.0	14.0	16.6	8.2	21.4	11.5	9.7	24.2	0.0	24.9	13.0	21.2	8.4	18.3	26.2	14.2	17.9	10.4	19.2	11.9	18.7	11.2	16.8	12.5	13.2	11.6	11.3	12.2	11.5	10.7	12.2	11.2	13.5	17.9	6.3	16.5	8.6	9.4	13.1	12.9	18.0	10.1	10.2	9.6	10.9	13.4	7.9	14.9	9.1	11.2	9.4	9.7	8.3	21.0	2.5	12.0	13.6	8.7	0.0	21.0	8.3	14.9	21.7	15.3	9.5	0.0	14.0	21.7	10.4	9.6	40.3	9.0	18.5	4.8	9.2	12.9	13.3	3.6	8.1	9.9	1.7	10.8	7.3	8.5	12.8	8.7	7.8	7.9	6.1	19.4	17.8	24.7	22.0	8.3	41.2	13.8	11.4	10.2
PLAUR	"CD87, UPAR, URKR"	ENSG00000011422	"Plasminogen activator, urokinase receptor"	Q03405	19	43646095-43670547	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 118.0;bone marrow: 165.0"	"Cell type enhanced"	"Detected in many"	17	"Basal glandular cells: 664.4;Macrophages: 801.6;Urothelial cells: 2343.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 118.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 50.2;U-251 MG: 71.3;U-87 MG: 62.2;WM-115: 60.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA050843, CAB073533"	Uncertain		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		760000	"Plasma membrane"		"CAB073533: , HPA050843: AB_2681255"	"unprognostic (9.28e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.29e-3)"	"unprognostic (3.59e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.18e-3)"	"prognostic unfavorable (2.33e-5)"	"unprognostic (8.08e-3)"	"unprognostic (4.30e-2)"	"unprognostic (2.29e-3)"	"unprognostic (5.30e-2)"	"prognostic unfavorable (7.83e-9)"	"unprognostic (4.99e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.33e-2)"	25.2	3.6	3.0	23.6	4.8	165.0	6.3	2.2	6.1	10.7	7.5	4.4	1.8	3.3	9.5	6.0	8.6	10.6	23.0	11.5	4.5	3.2	5.1	6.1	39.4	8.1	6.0	1.1	11.9	4.3	2.5	4.4	12.2	6.9	6.1	6.0	4.6	11.0	3.7	7.9	3.5	7.3	7.2	7.1	12.6	12.0	6.3	6.3	2.5	4.4	7.7	7.0	22.7	14.9	0.2	21.3	118.0	50.5	0.6	0.9	21.0	14.3	5.0	4.5	0.3	4.1	14.6	2.8	30.0	30.5	19.0	23.8	0.4	16.9	0.5	7.6	18.5	11.0	6.1	1.2	7.4	21.2	0.9	0.9	2.7	7.5	0.6	5.2	3.2	34.9	15.0	1.5	50.2	7.5	27.8	20.9	3.3	2.7	0.6	18.2	1.0	3.4	8.6	1.5	25.7	10.8	4.0	3.0	1.0	5.9	0.7	0.2	3.9	13.4	3.1	3.9	2.3	0.6	10.0	21.4	41.9	21.5	19.1	71.3	0.6	1.4	0.1	62.2	5.8	60.6	7.2	48.9	72.4	0.7	41.5	0.8	0.2	0.9	0.6	21.3	0.1	0.3	0.4	118.0	0.6	50.5	6.8	0.3	21.0	3.0	4.8	2.2	6.1	4.5	3.2	6.0	1.1	6.9	6.3	68.5	114.1	4.7	664.4	93.4	0.4	3.5	15.3	20.1	44.3	19.2	0.0	4.1	1.7	219.5	0.8	49.2	68.8	0.0	94.2	28.2	110.9	445.0	294.8	1.3	440.8	9.5	14.3	18.4	142.0	0.9	6.4	801.6	69.2	13.6	15.1	1.2	350.1	4.9	3.9	2.4	0.6	6.5	151.4	0.9	3.2	55.2	11.0	9.6	5.0	2343.3
PLEKHG3	"ARHGEF43, KIAA0599"	ENSG00000126822	"Pleckstrin homology and RhoGEF domain containing G3"	A1L390	14	64704102-64750247	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Collecting duct cells: 45.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 16.7;NK-cells: 6.4;T-cells: 12.2"	"Cell line enhanced"	"Detected in many"		"A-431: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063455, HPA065323, HPA073702, HPA074734"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Centrosome,Cytosol"		Yes	No			"Plasma membrane, Cytosol"	"Nucleoplasm, Cytokinetic bridge, Centrosome"	"HPA063455: AB_2685015, HPA065323: AB_2685467, HPA073702: AB_2732238, HPA074734: AB_2732265"	"unprognostic (8.71e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.22e-2)"	"unprognostic (7.21e-2)"	"unprognostic (5.53e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.34e-3)"	"unprognostic (3.63e-1)"	"unprognostic (3.54e-2)"	"prognostic favorable (7.39e-8)"	"unprognostic (2.29e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.67e-3)"	12.8	2.9	17.2	7.8	36.9	11.4	19.8	7.3	29.4	15.2	15.9	67.3	9.3	10.2	31.6	9.9	26.4	19.8	17.5	12.5	24.2	12.8	19.5	16.5	8.4	4.0	40.7	21.6	16.8	22.7	17.9	3.7	22.3	19.5	12.3	12.1	13.6	19.6	31.6	5.9	19.6	10.0	20.7	24.5	16.0	11.5	5.1	40.9	1.2	14.5	6.4	5.3	16.6	17.1	0.0	0.7	16.7	1.9	6.4	12.2	2.9	29.0	13.5	11.3	17.1	1.2	0.0	19.7	3.3	3.9	5.2	4.2	14.2	12.9	0.0	5.9	3.1	1.8	28.1	7.6	25.9	1.8	0.0	6.6	12.9	16.7	3.4	1.5	0.4	6.2	1.5	15.0	1.1	9.4	8.7	3.4	0.1	0.0	0.1	1.7	13.7	0.0	11.8	3.8	7.7	14.5	0.1	5.6	2.0	14.3	21.3	3.9	6.9	6.7	10.1	9.7	10.9	11.0	2.9	6.5	2.3	23.4	0.1	4.5	0.0	0.0	0.0	0.2	1.3	4.0	4.5	1.9	11.7	12.2	1.1	8.6	0.0	3.7	5.2	0.7	0.0	0.4	2.7	16.7	6.4	0.7	0.0	1.1	2.9	17.2	36.9	7.3	29.4	24.2	12.8	40.7	21.6	19.5	40.9	3.0	3.8	0.8	15.7	17.2	3.6	6.9	17.8	2.7	3.4	45.4	0.0	6.9	10.0	25.0	0.7	3.0	14.7	0.0	17.7	8.6	8.4	13.8	1.1	9.6	4.4	0.0	33.4	1.8	6.0	0.9	6.9	3.3	5.0	0.0	22.8	11.7	28.1	20.1	24.1	7.0	0.8	25.8	16.5	0.0	1.1	18.7	2.2	5.7	15.0	33.4
PLPP1	"LPP1, PAP-2a, PPAP2A"	ENSG00000067113	"Phospholipid phosphatase 1"	O14494	5	55424854-55535050	"Enzymes, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Ito cells: 254.8;Leydig cells: 203.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 200.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 93.3;fHDF/TERT166: 28.4;HMC-1: 48.9;HSkMC: 35.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033331, HPA047815"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB033331: AB_2168044, HPA047815: AB_2680164"	"unprognostic (1.22e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (6.06e-4)"	"unprognostic (2.81e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.37e-3)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (3.94e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.11e-2)"	56.3	26.7	12.5	14.8	14.6	0.6	57.9	10.6	18.5	34.5	30.9	26.1	18.0	17.3	36.8	26.0	18.4	20.4	61.0	33.7	13.4	10.8	34.5	42.0	15.9	17.3	20.8	10.1	16.5	17.6	16.9	10.1	22.4	21.4	82.0	24.7	29.8	9.8	24.0	18.4	16.6	25.4	39.6	28.2	10.2	21.7	18.1	14.5	4.4	32.7	9.6	10.0	43.1	18.1	5.4	13.6	3.3	0.7	2.7	9.5	1.6	2.0	4.9	1.4	2.9	93.3	10.9	2.0	4.4	12.4	2.4	5.8	3.4	3.6	2.0	4.2	28.4	6.7	1.3	5.1	2.5	2.8	1.3	4.0	0.2	2.1	4.2	14.7	0.5	48.9	35.8	5.3	3.6	2.2	4.9	4.0	1.9	0.0	5.7	4.9	1.2	1.3	1.0	3.3	0.2	4.0	0.4	2.4	0.1	9.3	15.9	1.8	1.2	4.4	0.9	2.6	6.4	3.2	0.3	4.9	0.8	1.5	3.7	3.1	3.5	1.4	2.4	3.3	0.2	4.0	0.0	0.4	3.3	1.5	0.4	1.6	5.4	5.2	3.2	1.9	3.4	9.5	7.5	0.3	2.7	0.7	13.6	2.2	1.6	12.5	14.6	10.6	18.5	13.4	10.8	20.8	10.1	21.4	14.5	6.0	10.3	3.9	48.9	0.0	5.2	0.0	15.3	4.0	10.3	27.9	2.0	2.2	5.0	22.3	30.3	45.0	26.9	0.0	24.7	9.6	32.8	109.6	25.6	50.5	11.0	1.6	1.2	254.8	14.9	19.1	203.1	3.6	0.0	7.2	23.2	14.3	28.1	29.4	83.1	24.5	4.8	58.2	0.0	47.0	18.1	0.0	4.1	4.3	14.9	41.0
PLSCR1	MMTRA1B	ENSG00000188313	"Phospholipid scramblase 1"	O15162	3	146515180-146544864	"Predicted intracellular proteins, Transporters"	"Antiviral defense"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 55.1;BJ hTERT+ SV40 Large T+ RasG12V: 73.3;HHSteC: 50.5;SK-MEL-30: 91.2"									"HPA068923, CAB070421"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	Yes			"Nucleoplasm, Golgi apparatus, Plasma membrane"		"CAB070421: AB_11153452, HPA068923: AB_2686059"	"unprognostic (7.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.34e-2)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.35e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.73e-3)"	"unprognostic (9.19e-3)"	"unprognostic (6.93e-3)"	"unprognostic (3.07e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.63e-1)"	60.9	14.9	11.9	39.7	21.4	27.0	31.1	5.7	19.0	20.9	29.6	7.2	22.1	18.4	19.6	25.7	25.4	19.5	30.8	22.7	16.1	12.7	32.0	36.5	33.8	38.6	17.6	4.9	40.0	26.1	10.3	18.4	25.7	22.1	25.0	28.0	12.6	32.3	34.2	16.4	9.9	24.6	19.4	29.8	46.0	20.5	15.4	14.8	16.4	27.5	14.9	19.5	27.5	48.0	6.5	27.5	26.2	41.2	14.3	8.1	17.6	17.2	6.9	4.4	2.0	6.6	11.2	6.8	5.4	14.8	55.1	73.3	5.5	14.4	1.3	12.9	3.4	43.1	14.2	3.5	5.1	9.3	5.3	3.5	11.1	2.2	4.1	50.5	6.3	5.8	17.8	8.7	6.1	31.1	8.8	8.0	3.2	7.1	17.2	11.2	6.7	4.9	2.4	4.2	11.7	6.2	4.4	4.9	0.4	15.5	4.7	2.7	0.0	6.9	3.4	91.2	6.3	3.4	7.7	4.8	4.4	3.8	9.9	9.0	13.2	2.4	0.0	4.5	4.6	3.8	8.2	41.2	11.0	5.6	40.4	8.1	6.5	3.7	5.0	27.5	4.9	2.6	3.8	26.2	14.3	22.7	7.3	2.1	17.6	11.9	21.4	5.7	19.0	16.1	12.7	17.6	4.9	22.1	14.8	32.8	47.9	22.6	70.0	32.7	0.4	4.0	86.6	81.7	60.3	90.7	0.0	46.8	63.0	225.1	1.5	110.1	67.7	0.0	192.6	100.1	54.5	74.2	26.7	25.9	121.5	0.0	31.9	91.4	84.8	2.2	106.4	157.8	45.5	24.4	60.9	52.6	150.7	102.1	43.2	33.8	1.3	38.8	58.7	0.3	2.2	25.0	37.2	21.3	51.4	160.1
PODXL	"Gp200, PC, PCLP"	ENSG00000128567	"Podocalyxin like"	O00592	7	131500262-131558217	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	15	"Cone photoreceptor cells: 82.5;Endothelial cells: 112.3;Rod photoreceptor cells: 186.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 34.6;NTERA-2: 46.7;SuSa: 47.0;TIME: 52.2;U-251 MG: 20.8"									"HPA002110, CAB016169, HPA045507, CAB062558, CAB068219, CAB068220"	Enhanced		Supported	"Vesicles,Plasma membrane,Centriolar satellite"		NA	NA		43000000	"Plasma membrane, Centriolar satellite"	Vesicles	"CAB016169: AB_628165, CAB062558: AB_2665627, CAB068219: AB_2665618, CAB068220: AB_2665619, HPA002110: AB_1855512, HPA045507: AB_2679356"	"unprognostic (1.26e-1)"	"unprognostic (7.68e-2)"	"unprognostic (8.28e-3)"	"unprognostic (6.46e-3)"	"unprognostic (5.16e-3)"	"unprognostic (5.85e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.95e-3)"	"unprognostic (3.52e-1)"	"unprognostic (9.20e-3)"	"unprognostic (3.40e-1)"	"prognostic favorable (2.89e-4)"	"unprognostic (2.56e-1)"	"unprognostic (8.78e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.03e-1)"	8.8	4.9	8.2	3.8	8.9	0.8	7.6	4.8	13.5	11.7	5.0	4.6	16.0	2.8	14.5	2.7	4.4	22.1	7.9	19.3	6.7	6.7	30.6	3.0	14.7	2.6	7.2	5.9	6.1	20.4	7.5	4.0	12.5	15.2	4.5	3.7	15.5	9.1	27.8	5.7	3.8	4.8	12.8	8.1	2.9	4.6	3.5	6.6	0.0	14.0	5.2	2.5	6.1	8.3	1.1	0.3	2.2	0.3	0.4	0.8	0.3	4.8	2.3	4.0	1.8	0.1	0.0	0.3	0.6	0.5	1.8	0.7	11.8	7.6	0.0	11.3	34.6	5.2	3.5	3.9	0.0	1.2	0.6	1.9	0.0	14.4	0.1	0.0	0.4	0.3	0.0	0.0	6.2	0.0	0.7	13.9	0.1	1.2	0.2	1.4	1.4	0.0	0.0	46.7	0.6	4.7	2.0	7.0	1.5	0.2	2.1	3.6	0.8	4.2	0.5	0.0	47.0	0.4	0.1	52.2	0.7	2.8	7.1	20.8	0.3	0.4	0.1	2.6	1.9	4.1	0.7	0.3	2.2	0.6	0.2	0.5	0.3	0.5	0.8	0.0	1.1	0.4	0.4	1.1	0.4	0.2	0.3	0.4	0.3	8.2	8.9	4.8	13.5	6.7	6.7	7.2	5.9	15.2	6.6	6.0	13.5	1.9	0.8	4.6	8.2	18.5	0.0	4.0	9.1	26.2	82.5	0.5	0.0	4.1	0.6	112.3	0.7	0.0	15.7	0.3	3.0	2.6	2.3	0.4	0.3	4.8	2.4	44.2	0.8	0.9	4.4	3.2	5.0	1.0	11.0	8.5	29.1	0.0	0.4	0.6	186.1	0.0	4.7	0.2	0.7	2.8	0.6	1.0	1.8	2.0
PPIP5K1	"HISPPD2A, IPS1, KIAA0377, VIP1"	ENSG00000168781	"Diphosphoinositol pentakisphosphate kinase 1"	Q6PFW1	15	43533462-43590253	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.4"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 39.3;Rod photoreceptor cells: 42.3"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039380	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039380: AB_10673528"	"unprognostic (8.72e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.18e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.59e-3)"	"prognostic unfavorable (8.57e-4)"	"unprognostic (6.67e-2)"	"unprognostic (2.85e-3)"	"prognostic favorable (7.14e-8)"	"unprognostic (2.67e-2)"	"unprognostic (3.35e-2)"	"unprognostic (5.92e-3)"	"unprognostic (7.95e-3)"	1.7	5.2	3.4	1.8	6.4	1.1	3.4	28.4	7.0	2.8	6.1			9.1	2.2	5.6	3.7	3.1	2.5	2.1	3.6	5.0	2.5	1.4	1.4	2.0	3.3		3.0	2.9	13.4	7.6	0.9		3.4	6.5		4.7	2.7	6.3	7.2	8.8	2.3	2.8	2.3	5.3	4.5			5.0		3.0	3.3	2.7	5.3	3.2	4.3	2.8	3.5	3.8	3.0	8.4	5.6	4.9	9.1	3.0	1.9	8.4	4.2	5.4	6.1	9.0	6.4	8.1	7.9	6.4	5.8	9.1	23.1	9.5	18.4	6.2	7.8	7.5	11.9	16.9	3.4	6.8	13.6	12.4	3.4	16.2	7.4	11.4	8.3	6.4	18.6	8.6	11.8	4.5	6.6	4.5	7.7	2.4	15.9	6.0	9.7	5.0	4.0	6.6	15.3	14.8	4.6	10.9	10.4	4.1	7.3	19.2	11.4	2.8	5.3	6.4	6.7	10.2	2.6	3.2	9.8	10.0	15.6	5.1	4.3	1.4	0.0	2.7	2.8	3.8	5.3	3.3	3.6	3.2	3.6	2.7	2.5	1.0	3.5	2.1	2.4	0.8	3.0											0.0	2.1	0.0	1.5	3.5	15.3	4.0	5.1	0.0	2.3	7.0	39.3	2.7	0.0	2.1	1.7	2.4	8.8	0.0	1.3	0.8	0.8	1.3	0.0	1.1	1.6	9.5	2.4	4.3	2.7	1.6	1.7	1.6	0.0	1.0	5.0	4.3	1.8	3.5	6.7	1.4	42.3	6.5	1.0	6.6	1.3	2.9	1.8	2.1	7.6	3.2
PPL		ENSG00000118898	Periplakin	O60437	16	4882507-4960741	"Plasma proteins, Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 126.9;lymphoid tissue: 60.9;tongue: 57.8"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 68.5;Collecting duct cells: 54.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 27.2;HaCaT: 57.0;MCF7: 20.8;SiHa: 30.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA042550, HPA059859"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		310000	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA042550: AB_2678048, HPA059859: AB_2684145"	"unprognostic (2.12e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (2.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.86e-2)"	10.8	0.7	2.2	1.4	0.7	0.2	6.8	0.6	3.0	23.5	2.9	0.2	4.1	1.7	2.6	5.1	126.9	2.9	5.8	1.8	1.8	0.2	3.0	3.3	4.7	0.2	0.0	0.9	1.7	2.8	1.6	2.8	2.9	0.5	4.6	1.0	0.7	24.3	3.3	3.2	30.7	2.0	5.0	0.0	0.2	2.1	1.5	0.0	0.5	7.2	57.8	60.9	5.0	39.9	0.1	0.0	1.6	0.0	0.0	0.0	0.0	6.9	2.5	0.0	0.0	18.7	27.2	9.0	0.0	0.4	0.0	0.1	11.6	17.8	0.1	4.1	0.3	1.0	57.0	0.3	6.8	0.0	0.0	0.4	0.0	13.8	2.0	1.2	0.0	0.0	1.3	6.3	0.0	2.2	1.4	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.0	1.8	9.2	5.4	0.0	0.0	8.7	13.6	11.1	9.4	0.1	30.5	10.2	0.1	2.8	5.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.0	3.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	2.2	0.7	0.6	3.0	1.8	0.2	0.0	0.9	0.5	0.0	68.5	23.2	0.5	33.9	31.1	7.7	3.5	30.6	12.0	30.7	54.1	5.9	1.6	1.7	15.3	0.6	6.4	4.5	0.0	4.0	1.2	11.0	30.6	0.0	10.9	0.6	1.6	37.8	4.3	0.8	0.2	51.2	1.8	16.9	1.8	3.9	5.3	16.8	5.8	3.9	0.8	11.2	0.0	5.6	3.9	2.9	44.8	1.1	0.7	5.0	47.5
PPP1R16B	"ANKRD4, KIAA0823, TIMAP"	ENSG00000101445	"Protein phosphatase 1 regulatory subunit 16B"	Q96T49	20	38805705-38923024	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.4;lymphoid tissue: 35.0"	"Cell type enhanced"	"Detected in many"	9	"Horizontal cells: 35.0;Ito cells: 32.5;monocytes: 35.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 22.7;HMC-1: 24.5;HUVEC TERT2: 14.5;U-266/70: 39.9;U-266/84: 16.0;U-698: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049571, HPA079512"	Approved		Supported	"Nuclear speckles,Plasma membrane"		NA	NA			"Plasma membrane"	"Nuclear speckles"	"HPA049571: , HPA079512: "	"unprognostic (2.62e-2)"	"prognostic favorable (2.11e-4)"	"unprognostic (2.67e-3)"	"unprognostic (3.35e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (7.87e-5)"	"unprognostic (1.13e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.31e-2)"	"unprognostic (6.28e-2)"	"unprognostic (4.09e-3)"	"unprognostic (4.77e-2)"	"unprognostic (3.45e-2)"	"unprognostic (8.53e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.90e-2)"	11.2	3.2	26.3	15.9	44.4	13.0	4.4	19.7	35.1	3.6	4.5	25.6	0.0	3.6	3.5	1.9	3.3	5.8	5.3	4.9	25.5	9.1	24.4	2.6	7.3	30.1	15.0	18.8	1.6	1.5	1.2	1.8	3.7	10.9	2.1	5.1	1.6	2.3	2.3	3.4	1.8	9.2	6.8	18.6	14.4	4.9	1.2	15.1	5.1	3.2	0.5	35.0	7.5	3.7	8.4	4.9	3.5	1.3	3.9	5.2	1.6	0.0	0.3	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.7	0.3	0.0	0.3	0.0	0.4	0.0	0.0	0.5	0.1	1.7	0.0	0.0	0.0	0.1	24.5	0.0	0.0	0.0	0.0	0.0	14.5	3.1	0.3	4.8	0.0	0.0	2.8	3.8	3.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	7.3	8.1	0.0	0.0	0.0	0.3	0.0	1.2	2.2	0.0	0.3	0.0	0.0	39.9	16.0	15.6	0.0	0.0	0.0	0.0	0.3	3.5	5.2	0.7	2.8	8.4	3.7	5.1	1.1	5.4	2.2	3.0	0.0	3.9	1.3	4.9	3.7	1.6	26.3	44.4	19.7	35.1	25.5	9.1	15.0	18.8	10.9	15.1	3.0	4.8	8.3	0.0	0.9	1.2	15.2	0.0	4.0	2.3	0.0	0.0	0.0	0.0	0.0	1.0	14.6	0.0	0.0	0.0	0.0	0.5	0.0	3.5	0.0	0.1	35.0	0.0	32.5	3.0	0.6	0.0	2.4	8.5	35.1	0.0	0.2	0.0	0.0	0.0	10.8	0.2	0.0	0.3	0.0	0.2	1.1	0.0	15.0	0.0	0.1
PRAME	"CT130, MAPE"	ENSG00000185686	"Preferentially expressed antigen in melanoma"	P78395	22	22547701-22559361	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation, Growth regulation, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 54.3"	"Cell type enriched"	"Detected in some"	8	"Spermatogonia: 241.6"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 73.4;melanoma: 139.6;ovarian cancer: 29.4;testis cancer: 51.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"K-562: 143.2"					"Not detected"	"Not detected"			"HPA045153, HPA068562"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA045153: AB_10797259, HPA068562: "	"unprognostic (9.36e-3)"	"unprognostic (9.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.87e-2)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (3.41e-4)"	"unprognostic (3.43e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.52e-3)"	"unprognostic (9.68e-3)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (7.48e-9)"	"unprognostic (1.95e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.26e-1)"	0.1	1.7	0.1	0.3	0.3	0.0	0.1	0.3	0.1	0.2	0.3	0.1	0.5	0.0	2.8	10.9	0.1	0.2	0.1	0.3	0.2	0.0	0.7	0.1	0.1	0.1	0.1	0.1	2.2	0.1	0.0	0.1	0.4	0.4	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.8	0.2	0.0	54.3	0.1	0.3	0.1	0.1	0.4	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	9.4	0.0	19.8	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	14.2	0.0	0.0	0.0	0.6	0.0	0.0	8.6	2.1	5.0	3.7	0.1	0.0	0.4	27.3	0.0	0.0	0.0	0.0	0.0	0.0	2.2	143.2	2.3	0.0	1.2	0.0	0.0	0.0	4.2	0.6	0.8	0.0	0.0	0.0	0.0	0.1	29.4	0.0	0.0	0.0	0.0	4.3	3.5	0.7	0.0	25.8	0.0	0.0	0.4	2.0	0.1	0.0	0.1	3.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.1	0.2	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	9.5	0.0	0.0	0.0	30.6	5.2	0.0	0.0	5.4	0.0	0.2	0.1	0.0	3.2	0.8	0.3	6.5	0.0	29.8	241.6	0.0	0.0	0.0	0.0	0.0
PRKCE		ENSG00000171132	"Protein kinase C epsilon"	Q02156	2	45651345-46187990	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell adhesion, Cell cycle, Cell division, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 36.5"	"Group enriched"	"Detected in many"	5	"Early spermatids: 209.3;Late spermatids: 297.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 19.4;TIME: 19.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001948, HPA008236, HPA044496"	Enhanced	Supported	Supported	"Vesicles,Plasma membrane,Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments, Cytosol"	"Vesicles, Plasma membrane"	"CAB001948: , HPA008236: , HPA044496: AB_2678959"	"unprognostic (1.10e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (9.61e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (9.62e-4)"	"unprognostic (3.05e-1)"	"unprognostic (6.72e-2)"	"unprognostic (7.49e-3)"	"unprognostic (9.99e-2)"	"prognostic favorable (2.63e-7)"	"unprognostic (1.21e-1)"	"unprognostic (7.11e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.23e-2)"	5.5	7.4	15.3	7.2	14.2	9.3	8.1	28.8	36.5	6.6	5.5	3.8	5.9	3.6	5.6	4.6	4.7	7.6	4.7	7.7	22.5	10.0	12.8	15.5	17.5	6.9	6.0	15.0	4.1	4.2	16.3	6.0	10.4	9.1	3.6	4.7	3.7	3.6	8.6	7.2	3.0	3.7	6.2	4.4	4.9	4.4	7.2	3.7	1.5	6.5	1.2	5.4	5.0	6.5	5.5	2.2	1.7	1.4	0.9	1.3	0.6	5.4	2.0	2.9	2.9	4.4	5.2	2.3	3.8	7.0	3.2	3.5	0.5	5.4	8.2	3.6	4.0	4.6	1.3	1.8	2.0	4.6	4.9	3.5	0.0	1.4	1.1	5.0	0.6	2.9	4.6	2.3	4.8	3.5	2.7	11.8	1.8	1.1	2.0	3.7	2.8	2.6	0.3	1.0	3.0	1.0	19.4	13.8	8.8	2.9	3.7	2.0	4.4	1.7	5.8	12.5	1.1	4.7	1.9	19.5	6.3	6.6	4.6	3.8	0.0	0.0	6.9	5.2	4.6	6.3	0.0	1.2	1.7	1.0	0.4	1.1	3.6	0.7	0.7	2.2	5.5	1.3	0.4	0.4	0.9	1.4	0.9	0.0	0.6	15.3	14.2	28.8	33.2	22.5	10.0	6.0	15.0	9.1	3.7	6.0	8.6	20.1	6.3	4.4	47.5	9.3	12.7	22.7	27.3	10.4	13.7	0.3	3.3	3.0	209.3	9.9	4.5	0.0	3.3	6.9	8.0	5.7	6.9	7.3	2.6	11.1	7.5	12.3	17.0	297.3	4.9	11.1	13.5	7.2	5.3	7.0	3.0	3.5	5.6	21.3	6.7	12.9	6.6	2.7	2.2	4.3	2.4	4.3	6.2	7.1
PRKD1	"PKC-mu, PKCM, PKD, PRKCM"	ENSG00000184304	"Protein kinase D1"	Q15139	14	29576479-30191898	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Apoptosis, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 24.9;Early spermatids: 31.1;Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 18.2;fHDF/TERT166: 19.3;HSkMC: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018367, HPA029834"	Uncertain		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Plasma membrane"	Cytosol	"CAB018367: AB_2253119, HPA029834: AB_10602821"	"unprognostic (5.35e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.27e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.08e-3)"	"unprognostic (8.88e-2)"	"unprognostic (2.37e-2)"	"unprognostic (5.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (2.44e-5)"	"unprognostic (9.45e-4)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (3.89e-1)"	7.4	10.6	8.0	5.3	9.7	0.7	19.0	4.9	8.9	5.1	8.7	5.1	24.1	3.1	8.3	9.0	3.5	6.8	9.0	6.3	9.8	5.9	15.1	2.3	14.9	1.6	5.6	6.6	15.7	7.3	35.7	9.2	4.5	10.8	20.1	3.5	4.9	3.5	24.4	3.1	2.7	3.5	19.7	16.4	2.4	4.8	16.1	8.6	0.5	8.2	2.9	1.8	14.1	12.2	0.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.6	4.1	18.2	17.0	0.1	12.3	9.5	12.6	6.8	0.0	0.5	0.0	1.2	19.3	4.3	0.1	6.0	1.4	6.9	0.0	4.2	0.0	0.1	0.4	9.2	0.0	0.1	18.0	0.6	0.9	1.5	6.5	2.5	0.0	1.2	0.4	11.8	1.4	0.0	0.0	2.5	0.0	6.4	0.0	7.1	3.2	13.5	5.7	3.6	7.2	2.1	0.0	4.7	4.9	0.0	0.1	6.4	12.0	4.9	1.0	3.5	0.0	0.0	0.0	3.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	8.0	9.7	4.9	8.9	9.8	5.9	5.6	6.6	10.8	8.6	0.0	6.1	0.0	3.8	0.5	1.2	1.4	7.6	0.0	0.0	12.2	5.9	0.0	24.9	1.5	31.1	4.5	0.0	23.3	3.6	0.1	3.8	16.3	0.0	1.5	0.2	1.6	2.9	12.3	2.6	12.4	6.9	0.3	6.8	0.0	0.2	16.1	3.2	0.0	12.0	3.7	2.8	0.0	4.7	3.4	4.9	0.6	0.2	0.0	0.0	0.9
PRR7	MGC10772	ENSG00000131188	"Proline rich 7, synaptic"	Q8TB68	5	177446445-177456286	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.5"	"Cell type enhanced"	"Detected in many"	6	"Intestinal endocrine cells: 41.2;Suprabasal keratinocytes: 58.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"PC-3: 17.4;SK-MEL-30: 16.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA046636	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA046636: AB_2679730"	"unprognostic (3.69e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.48e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.94e-3)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.75e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (1.98e-4)"	"unprognostic (8.84e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.69e-1)"	1.9	2.4	12.5	3.2	22.0	15.1	1.7	4.1	28.5	1.1	2.9	9.8	0.0	2.9	1.7	1.3	1.9	3.2	1.9	1.1	14.1	7.6	1.5	2.2	2.0	3.6	4.8	8.4	1.2	4.0	2.6	6.2	1.3	6.2	2.0	1.4	4.7	5.2	1.5	1.7	8.8	2.6	1.2	4.4	4.9	4.6	3.2	4.6	1.2	1.2	0.8	2.3	1.5	0.9	3.2	3.0	10.8	0.6	2.0	7.3	1.5	7.2	2.8	0.8	5.7	0.0	0.4	2.5	3.4	0.6	1.0	1.3	0.6	3.9	7.0	9.0	0.5	2.9	6.1	0.4	3.1	0.4	6.1	9.0	2.1	2.7	2.1	0.6	4.2	5.1	0.6	1.3	0.4	0.2	0.9	0.4	2.7	1.1	5.0	0.9	9.7	3.5	10.7	1.4	1.1	17.4	9.9	2.6	7.0	1.2	0.6	14.1	10.1	1.3	3.4	16.1	0.0	3.0	0.6	2.6	5.7	9.7	5.1	8.2	2.7	1.5	3.4	5.6	6.8	4.1	2.4	0.1	10.8	3.0	0.5	7.3	2.1	3.4	5.1	0.1	3.2	3.2	4.1	4.8	2.0	0.6	3.0	2.5	1.5	12.5	22.0	4.1	28.5	14.1	7.6	4.8	8.4	6.2	4.6	3.0	0.0	13.7	25.0	38.5	12.6	1.2	10.2	0.0	1.2	7.0	0.0	0.9	8.3	10.1	10.8	4.5	7.1	0.0	9.4	0.7	3.9	23.6	27.5	2.8	1.4	6.4	41.2	1.8	2.2	9.7	0.9	2.9	27.0	1.0	9.4	15.2	9.0	7.8	2.1	9.8	13.1	0.0	9.8	3.3	11.7	58.5	1.1	25.5	9.1	15.4
PRRT2	"DKFZp547J199, DSPB3, DYT10, EKD1, FICCA, FLJ25513, ICCA, IFITMD1, PKC"	ENSG00000167371	"Proline rich transmembrane protein 2"	Q7Z6L0	16	29811382-29815892	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation, Dystonia, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 86.7"	"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 79.8;Cone photoreceptor cells: 29.5;Leydig cells: 33.4;Peritubular cells: 37.8;Rod photoreceptor cells: 40.1"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"NK-cell: 7.3"	"Lineage enriched"	"Detected in single"	11	"NK-cells: 7.3"	"Cell line enhanced"	"Detected in many"		"AF22: 19.8;hTERT-RPE1: 12.2;REH: 15.1;U-138 MG: 13.7"									"HPA014447, HPA019203, HPA048045"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA014447: AB_1855786, HPA019203: AB_2670097, HPA048045: "	"unprognostic (7.60e-3)"	"unprognostic (3.00e-1)"	"unprognostic (8.32e-3)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.45e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.43e-8)"	"unprognostic (1.22e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.44e-2)"	3.7	7.2	27.2	2.8	40.5	0.8	2.1	86.7	53.6	10.1	6.0	6.0	3.1	6.2	20.7	8.3	4.4	10.2	10.3	5.3	18.9	13.0	2.1	0.9	5.7	3.5	5.5	33.2	35.7	2.4	8.6	17.6	7.1	18.0	16.2	2.6	5.2	4.6	14.4	4.3	3.1	6.8	10.3	7.4	1.8	7.3	9.9	10.2	0.0	2.8	0.3	1.6	5.1	10.7	0.2	0.0	0.5	0.2	7.3	0.6	0.3	0.3	1.2	19.8	7.4	1.0	3.7	0.5	2.4	4.0	0.8	0.9	1.1	2.3	0.2	0.4	3.2	0.6	2.0	2.7	0.4	0.3	5.2	1.6	1.3	8.8	0.8	0.2	0.0	0.3	3.4	0.1	1.4	0.1	12.2	1.0	0.6	0.2	1.6	0.6	3.3	0.5	0.6	5.7	0.0	1.0	15.1	1.1	0.4	0.1	0.7	4.3	4.5	0.2	2.9	0.4	3.2	7.3	0.1	1.1	13.7	4.8	0.8	1.3	3.4	0.4	0.1	5.4	0.1	0.5	0.5	0.0	0.1	0.2	0.1	0.3	0.1	0.6	0.4	0.0	0.2	0.4	0.2	0.2	7.3	0.2	0.0	0.1	0.3	27.2	40.5	86.7	53.6	18.9	13.0	5.5	33.2	18.0	10.2	3.0	0.0	0.0	1.3	1.0	79.8	0.8	0.0	6.7	1.2	0.0	29.5	1.5	1.7	1.1	1.7	2.0	9.6	0.0	1.4	0.6	9.3	1.4	0.0	0.0	0.3	19.1	5.8	2.5	0.0	6.3	33.4	0.0	0.0	1.0	2.0	6.5	2.3	10.5	37.8	0.2	40.1	6.5	13.2	2.4	3.2	0.4	2.2	0.0	1.7	1.0
PSCA		ENSG00000167653	"Prostate stem cell antigen"	O43653	8	142670308-142682724	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 72.6;stomach 1: 230.2;urinary bladder: 112.0"	"Cell type enhanced"	"Detected in many"	19	"Cholangiocytes: 124.9;Glandular cells: 317.3;Intestinal endocrine cells: 265.2;Urothelial cells: 540.7"	"Cancer enriched"	"Detected in many"	6	"urothelial cancer: 785.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 11.6;HeLa: 22.6;OE19: 8.9;RT4: 32.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030783, HPA056418"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA030783: AB_2673611, HPA056418: AB_2683123"	"unprognostic (1.21e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.81e-3)"	"unprognostic (8.25e-3)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (5.60e-5)"	"unprognostic (6.82e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.93e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.06e-3)"	0.4	0.2	0.0	0.2	0.0	0.2	0.3	0.0	0.2	7.0	2.4	0.7	0.1	0.6	0.3	0.2	72.6	1.1	21.2	0.1	0.0	0.0	2.6	0.1	3.0	0.2	0.0	0.0	0.1	0.3	0.1	0.5	17.2	0.0	30.1	0.7	0.1	11.7	0.6	0.1	0.8	1.5	18.9	0.0	0.2	230.2	0.2	0.0	0.0	0.1	9.3	35.1	112.0	54.5	0.0	0.8	0.0	0.3	0.0	0.0	0.0	5.4	0.3	0.0	0.0	1.1	3.7	5.6	2.5	0.6	1.1	0.9	0.0	11.6	0.0	0.2	0.2	4.2	1.1	0.0	0.2	0.7	0.3	0.0	0.0	22.6	0.0	0.0	0.0	0.8	3.2	4.1	2.4	0.0	0.3	0.0	0.0	0.0	0.0	0.8	3.0	0.8	0.3	0.6	8.9	0.6	0.3	0.0	0.4	0.5	32.2	0.1	0.2	2.7	8.3	1.7	0.2	0.1	0.1	0.5	0.8	0.9	1.5	0.0	1.0	0.0	0.0	1.5	0.4	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.0	1.0	0.0	16.8	0.8	0.0	1.0	124.9	115.1	19.4	1.8	0.0	2.1	6.6	0.3	0.2	0.0	0.0	0.0	1.0	1.8	0.3	317.3	0.0	0.0	0.6	0.0	265.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.9	0.0	33.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.6	1.1	23.8	0.0	0.6	540.7
PSMC5	"p45, p45/SUG, S8, SUG-1, SUG1, TBP10, TRIP1"	ENSG00000087191	"Proteasome 26S subunit, ATPase 5"	P62195	17	63827152-63832026	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Late spermatids: 1134.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017871, HPA064293"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		100000	"Plasma membrane, Cytosol"		"HPA017871: AB_1857638, HPA064293: AB_2685234"	"unprognostic (9.65e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.44e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.29e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (3.13e-6)"	"unprognostic (9.54e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.32e-1)"	36.8	43.1	44.8	35.8	42.6	26.7	30.3	47.7	48.3	29.5	36.5	30.3	40.8	26.2	32.0	42.4	46.0	32.2	42.0	41.7	38.6	42.9	52.3	48.7	26.3	33.5	50.1	42.2	28.2	36.7	77.0	32.6	42.9	41.8	32.7	36.7	26.7	36.0	41.7	94.2	45.2	28.9	41.8	39.3	33.4	33.2	32.7	35.7	33.0	37.8	60.4	43.9	33.3	32.4	30.4	31.2	30.9	40.9	34.2	57.7	40.5	42.1	63.6	44.4	28.8	31.2	33.1	36.6	43.0	30.9	52.1	41.5	68.3	26.4	28.5	29.6	43.0	40.3	31.5	44.7	39.9	74.8	25.5	47.2	62.6	52.1	55.6	31.2	62.7	41.9	32.9	30.0	53.4	49.4	24.4	47.0	30.6	47.0	36.5	48.3	74.0	46.2	23.7	39.1	42.8	54.9	43.4	88.2	41.3	36.8	49.7	37.4	50.9	29.5	52.0	24.3	46.9	51.3	30.4	44.0	64.0	60.1	29.4	86.3	38.8	59.9	46.1	38.4	45.1	40.6	22.8	25.6	30.9	37.8	37.2	51.4	30.4	44.8	40.4	31.2	24.4	37.7	42.2	8.1	34.2	40.9	22.4	57.7	40.5	44.8	42.6	47.7	48.3	38.6	42.9	50.1	42.2	41.8	35.7	47.6	76.5	84.8	121.6	84.0	80.6	136.5	122.3	78.9	86.4	64.6	17.7	224.0	208.9	141.7	473.4	88.7	101.6	140.2	187.9	149.0	99.1	113.3	89.9	118.0	143.6	68.3	87.2	75.5	81.1	1134.0	123.1	93.9	94.5	174.1	65.9	151.7	136.7	83.4	144.2	267.3	72.5	109.9	142.6	128.6	136.3	89.8	308.6	95.8	77.1	118.0
PTAFR		ENSG00000169403	"Platelet activating factor receptor"	P25105	1	28147166-28193936	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 98.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 73.9;Hofbauer cells: 62.8;Kupffer cells: 70.6;Macrophages: 55.7;Pancreatic endocrine cells: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"classical monocyte: 28.2;eosinophil: 98.3;neutrophil: 85.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 98.3;monocytes: 28.2"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 14.7;HMC-1: 53.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA027543	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Nucleoplasm, Vesicles"	"Plasma membrane"	"HPA027543: AB_10610287"	"unprognostic (2.22e-2)"	"unprognostic (2.59e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.75e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.59e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.38e-2)"	5.6	2.3	2.4	16.2	1.9	20.3	2.4	0.6	2.0	6.9	3.4	1.6	3.5	1.8	2.8	1.4	16.8	2.8	7.5	3.5	2.1	2.3	6.4	1.8	9.2	6.1	4.1	1.0	1.5	2.7	0.9	0.7	3.5	1.8	2.6	3.4	0.6	3.4	2.6	1.1	2.8	5.0	3.8	5.1	15.4	2.3	2.2	1.1	2.3	1.4	22.2	21.7	5.9	3.6	1.5	13.2	98.3	28.2	0.0	0.1	10.1	7.7	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.1	2.2	0.5	0.0	0.0	0.1	5.3	0.2	14.7	0.3	0.1	0.2	2.9	0.0	0.3	0.0	0.7	53.6	0.0	2.4	0.2	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.5	0.0	7.2	0.2	0.2	0.1	0.1	0.0	0.0	3.6	0.8	0.1	0.0	0.0	7.3	0.0	0.2	0.1	2.0	0.0	0.1	0.3	0.0	0.0	0.5	0.4	2.1	0.0	0.9	0.2	5.9	28.2	98.3	0.0	8.9	0.1	1.5	0.0	0.0	13.2	0.7	0.0	0.0	85.7	0.0	3.5	0.1	0.1	10.1	2.4	1.9	0.6	2.0	2.1	2.3	4.1	1.0	1.8	1.1	6.0	7.9	4.3	1.5	5.8	1.2	2.0	2.5	6.7	2.3	1.8	2.0	0.5	0.0	8.8	0.0	5.9	0.2	0.0	4.6	0.4	2.2	0.4	73.9	0.8	62.8	0.0	0.0	1.8	70.6	0.0	0.6	55.7	0.0	4.6	0.0	0.2	55.1	0.0	0.0	0.0	0.8	0.0	0.9	2.1	0.5	2.5	1.3	1.0	0.0	8.6
PTK2B	"CADTK, CAKB, FAK2, PTK, PYK2, RAFTK"	ENSG00000120899	"Protein tyrosine kinase 2 beta"	Q14289	8	27311482-27459391	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 46.7;brain: 65.2"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 73.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 37.7;REH: 41.9"	"Group enriched"	"Detected in many"	4	"amygdala: 202.9;basal ganglia: 236.9;cerebral cortex: 189.7;hippocampal formation: 443.3;olfactory region: 185.5"	"Low region specificity"	"Detected in all"			"CAB003850, HPA026091, HPA026276"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		84000	"Plasma membrane, Cytosol"		"CAB003850: AB_562205, HPA026091: AB_10599739, HPA026276: AB_10601234"	"unprognostic (2.36e-2)"	"prognostic favorable (3.32e-4)"	"unprognostic (1.06e-1)"	"unprognostic (7.36e-3)"	"unprognostic (3.72e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (5.11e-4)"	"unprognostic (3.33e-3)"	7.2	4.7	20.4	24.3	30.0	46.7	4.9	65.2	48.3	5.4	14.5	7.8	5.0	16.6	4.3	4.7	7.9	6.8	6.4	4.7	30.5	7.0	6.8	5.0	11.5	35.6	4.3	25.4	2.4	5.4	5.2	5.3	4.1	3.9	10.1	11.9	8.3	12.6	6.7	2.2	15.1	18.4	5.5	4.8	32.0	10.8	4.3	3.7	37.8	5.6	2.9	35.4	13.0	6.0	26.9	18.7	24.0	25.8	14.7	19.0	21.5	11.1	3.1	0.8	0.9	24.0	1.7	6.5	0.9	0.6	0.6	0.8	2.9	6.5	37.7	1.2	1.7	0.9	10.3	0.3	9.4	0.3	2.5	0.2	7.8	3.0	0.6	4.9	8.3	14.0	13.0	14.0	0.8	5.4	4.0	0.3	10.9	9.1	26.3	0.6	1.1	14.3	16.8	0.6	9.7	0.8	41.9	0.2	25.8	2.6	8.8	6.0	1.1	4.0	2.8	1.5	2.1	3.3	21.6	5.3	0.4	0.8	0.7	0.3	21.1	9.1	20.4	1.6	18.1	0.7	22.3	23.7	18.0	19.0	22.4	12.5	25.5	9.6	13.3	18.7	26.9	12.1	14.2	24.0	14.7	25.8	6.2	9.5	21.5	20.4	30.0	65.2	48.3	30.5	7.0	4.3	25.4	3.9	3.7	3.0	30.9	54.0	32.1	33.5	4.1	3.1	12.7	13.4	13.6	14.0	0.0	2.4	0.0	6.4	1.1	7.5	48.3	0.0	7.0	23.9	3.8	16.5	27.7	21.8	20.9	7.9	7.5	3.1	73.4	0.8	1.4	42.5	8.5	34.3	18.6	3.4	9.4	35.1	0.7	14.7	4.0	0.0	1.6	4.2	5.5	26.3	1.6	39.9	14.9	14.8
PTPRK	R-PTP-kappa	ENSG00000152894	"Protein tyrosine phosphatase, receptor type K"	Q15262	6	127968779-128520674	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 2.3;naive B-cell: 4.8;naive CD8 T-cell: 1.6"	"Group enriched"	"Detected in many"	7	"B-cells: 4.8;T-cells: 1.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054056, HPA054822"	Uncertain		Supported	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		13000000	"Cell Junctions"	"Vesicles, Plasma membrane"	"HPA054056: AB_2682359, HPA054822: AB_2682614"	"unprognostic (3.15e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.79e-3)"	"unprognostic (4.95e-3)"	"unprognostic (1.89e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.27e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (1.46e-1)"	"prognostic favorable (9.33e-5)"	"unprognostic (2.10e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.32e-2)"	12.0	5.2	18.6	10.7	20.3	1.2	20.9	4.7	24.4	12.2	21.9	25.6	11.2	25.7	12.1	10.3	9.1	13.2	29.6	11.4	17.2	12.6	13.3	23.6	17.4	5.7	20.5	19.3	15.6	25.7	11.4	12.2	17.4	14.9	16.3	23.4	3.9	18.3	17.5	9.1	13.5	27.4	14.6	17.1	6.4	24.6	2.7	23.7	15.3	10.1	6.5	7.6	18.4	15.1	4.8	0.0	0.0	0.0	0.4	1.6	0.2	4.5	4.9	2.9	0.2	6.2	8.3	3.0	12.3	23.8	5.1	4.6	8.1	3.8	0.0	3.7	11.3	14.8	12.9	3.1	9.7	7.2	13.6	4.9	0.1	7.5	11.2	7.6	0.0	0.4	6.1	9.0	10.6	14.5	13.3	13.8	4.4	0.0	0.2	12.4	9.1	6.9	0.0	3.1	8.3	6.3	24.8	6.3	0.8	12.6	9.3	15.5	0.0	12.7	14.2	0.7	3.5	3.9	0.3	23.4	8.0	5.6	15.5	11.1	0.1	1.6	0.0	10.2	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.1	0.0	4.8	0.4	1.6	0.0	0.4	0.0	0.0	0.1	0.2	18.6	20.3	4.7	24.4	17.2	12.6	20.5	19.3	14.9	23.7	23.8	27.4	9.7	78.6	56.3	3.1	19.3	76.5	18.7	33.0	17.4	3.9	21.8	0.0	51.8	3.4	46.7	63.1	0.0	53.2	4.5	30.5	99.0	1.1	36.5	5.1	9.5	42.2	8.0	1.0	2.1	15.8	1.8	16.9	2.8	41.3	7.0	84.8	57.5	17.0	11.2	0.6	58.2	35.8	3.6	5.8	33.2	22.4	1.0	48.9	100.5
PTPRR	"EC-PTP, PCPTP1, PTP-SL, PTPBR7, PTPRQ"	ENSG00000153233	"Protein tyrosine phosphatase, receptor type R"	Q15256	12	70638073-70920843	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 56.1"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 11.2;Club cells: 5.7;Enterocytes: 7.3;Horizontal cells: 15.9;Paneth cells: 11.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 56.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HDLM-2: 14.3;RT4: 27.4"	"Region enriched"	"Detected in all"	5	"cerebellum: 100.5"	"Low region specificity"	"Detected in all"			"CAB011461, HPA011851, HPA071067"	Uncertain		Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Plasma membrane, Cell Junctions, Cytosol"		"CAB011461: AB_298890, HPA011851: AB_1855939, HPA071067: AB_2686340"	"unprognostic (4.98e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.48e-5)"	"unprognostic (5.44e-3)"	"unprognostic (1.77e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.37e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.92e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (1.40e-5)"	0.4	3.8	18.8	1.6	11.3	0.3	0.4	56.1	20.9	0.5	11.2	0.1	0.0	5.1	8.4	0.3	0.4	0.5	1.9	0.4	8.6	4.9	0.4	0.4	0.4	0.4	1.3	13.2	0.4	0.6	0.3	0.9	0.7	3.3	0.5	7.8	0.8	0.4	2.1	0.4	0.4	11.3	4.9	3.1	0.4	4.4	0.4	1.4	0.0	0.4	0.0	0.3	4.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	27.4	0.1	4.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	18.8	11.3	56.1	20.9	8.6	4.9	1.3	13.2	3.3	1.4	0.0	0.0	0.0	0.1	0.5	11.2	2.5	0.0	0.0	5.7	0.0	0.0	0.0	0.0	2.1	1.7	1.5	7.3	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	15.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	1.9	11.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.4	0.3
PTPRS		ENSG00000105426	"Protein tyrosine phosphatase, receptor type S"	Q13332	19	5158495-5340803	"Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Heparin-binding, Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 54.1;Melanocytes: 75.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	82	"plasmacytoid DC: 13.4"	"Lineage enriched"	"Detected in single"	82	"dendritic cells: 13.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 41.4;HaCaT: 42.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054747			Approved	"Plasma membrane,Cytosol"	"Secreted - unknown location"	NA	NA		92000000	"Plasma membrane, Cytosol"		"HPA054747: AB_2682591"	"unprognostic (8.14e-2)"	"unprognostic (4.59e-3)"	"unprognostic (2.57e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.96e-3)"	"unprognostic (6.85e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.86e-1)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (2.80e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.05e-1)"	"unprognostic (3.46e-2)"	59.1	17.3	14.4	9.4	14.8	3.1	32.0	27.6	53.3	28.7	11.4	29.6	14.4	4.6	21.4	15.4	13.3	24.0	22.2	18.6	15.9	15.1	10.7	6.9	13.9	8.6	20.5	12.1	29.2	38.4	10.5	16.6	4.3	12.0	23.1	3.6	28.9	21.5	20.1	11.9	23.8	6.5	17.5	13.8	8.3	12.7	10.8	18.7	4.4	21.1	7.2	7.5	19.1	22.7	0.0	13.4	0.0	0.0	0.0	0.1	0.0	3.7	21.3	19.2	41.4	8.8	7.2	2.5	6.4	7.7	7.8	6.4	0.2	2.0	0.0	15.3	10.8	6.2	42.1	5.1	0.0	3.5	0.4	8.2	0.0	8.7	13.2	4.0	0.0	4.8	7.6	1.8	1.6	0.3	10.2	0.2	2.6	5.9	0.0	3.1	15.7	1.6	4.0	10.8	0.1	9.1	0.0	4.2	0.0	1.6	7.5	14.8	20.3	6.1	1.1	11.7	3.9	7.4	1.6	0.9	7.0	12.1	16.0	7.8	2.1	0.0	12.2	3.6	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	14.4	14.8	27.6	17.6	15.9	15.1	20.5	12.1	12.0	18.7	6.0	0.6	3.2	32.4	54.1	33.8	10.9	12.7	1.4	2.3	12.2	2.0	0.5	8.3	1.4	2.3	10.2	0.0	0.0	0.8	23.7	30.9	35.7	0.0	18.3	1.5	11.1	2.9	28.3	0.3	2.9	43.1	1.4	75.9	0.0	0.0	37.3	0.5	0.0	33.9	2.4	7.7	12.9	39.2	7.2	5.3	32.0	0.8	0.0	0.0	21.1
PVR	"CD155, HVED, Necl-5, NECL5, PVS, Tage4"	ENSG00000073008	"Poliovirus receptor"	P15151	19	44643798-44663583	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 65.6"	"Cell type enhanced"	"Detected in many"	5	"Pancreatic endocrine cells: 48.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 6.4;intermediate monocyte: 6.6;myeloid DC: 5.6;non-classical monocyte: 8.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.6;monocytes: 8.1"	"Cell line enhanced"	"Detected in many"		"TIME: 53.4"									"HPA012568, HPA064739"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted - unknown location"	NA	NA		940000000	"Nucleoplasm, Vesicles, Plasma membrane"		"HPA012568: AB_1846248, HPA064739: "	"unprognostic (2.90e-3)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (3.36e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (9.30e-4)"	"unprognostic (9.05e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.69e-1)"	"unprognostic (4.97e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-3)"	"prognostic unfavorable (2.75e-4)"	10.0	13.9	7.4	7.5	8.1	4.7	9.2	11.0	11.0	6.5	10.6	6.5	4.1	13.7	11.3	5.7	6.6	8.8	9.2	23.5	5.8	10.0	10.6	65.6	14.8	2.4	6.0	6.5	10.4	15.9	9.9	20.7	15.5	9.7	10.4	7.7	6.6	8.5	6.9	19.8	5.5	13.0	11.1	7.0	4.8	12.3	6.0	7.2	2.3	8.5	10.8	3.7	8.3	6.7	0.0	5.6	1.2	8.1	0.6	0.4	2.2	21.8	15.3	1.5	6.1	1.9	2.3	2.6	36.9	10.3	12.1	13.9	8.9	9.3	0.0	21.2	10.7	21.2	14.4	5.2	14.0	8.1	2.6	10.1	3.9	9.6	6.0	12.9	1.5	8.4	2.9	6.9	10.7	21.0	12.1	13.1	2.3	1.8	0.0	5.6	1.9	1.3	1.3	3.4	7.4	11.3	0.0	7.0	2.0	26.0	6.7	6.6	7.7	23.4	14.7	5.2	1.7	8.3	3.7	53.4	14.7	18.1	10.8	28.8	0.0	2.1	0.0	11.7	7.5	8.3	0.0	6.4	0.0	0.2	6.6	0.0	0.0	0.0	0.4	5.6	0.0	0.2	0.1	1.2	0.6	8.1	0.5	0.0	2.2	7.4	8.1	11.0	11.0	5.8	10.0	6.0	6.5	9.7	7.2	14.9	28.0	4.5	12.8	3.2	6.9	11.2	20.4	2.7	18.2	1.8	2.0	2.4	3.3	43.0	8.5	13.5	11.9	0.0	30.3	30.1	5.4	11.3	1.1	36.5	7.4	1.6	12.6	7.4	9.2	10.2	5.2	7.8	1.7	25.2	9.7	1.3	48.8	14.4	14.9	2.8	3.3	0.0	17.8	3.4	1.5	4.8	0.8	0.0	10.6	6.5
PXK	"FLJ20335, Slob"	ENSG00000168297	"PX domain containing serine/threonine kinase like"	Q7Z7A4	3	58332880-58426126	"Enzymes, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 81.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 48.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024068	Approved		Supported	"Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Plasma membrane, Centriolar satellite"	"HPA024068: AB_1855967"	"unprognostic (2.98e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.62e-3)"	"unprognostic (5.03e-3)"	"prognostic favorable (5.68e-4)"	"unprognostic (3.90e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.86e-2)"	9.3	9.4	20.7	17.0	51.4	33.6	7.6	22.6	31.4	28.9	8.9	81.1	2.4	6.3	14.2	5.3	6.6	8.0	9.6	7.5	33.7	19.9	10.4	5.7	8.2	23.8	68.6	23.4	11.1	8.5	13.7	6.1	17.5	43.9	6.0	6.4	4.4	8.8	7.7	7.6	7.5	7.7	11.8	55.9	13.5	8.3	6.7	56.6	3.7	40.3	2.5	26.1	9.8	13.1	31.3	18.8	31.8	22.5	8.7	11.2	13.4	4.3	2.5	1.9	3.5	26.9	23.9	5.7	6.9	14.7	6.7	9.4	1.2	0.9	22.8	1.6	11.7	9.7	1.3	6.0	4.4	7.1	5.7	3.8	3.9	3.1	1.7	31.4	33.9	6.9	20.4	10.6	8.4	14.6	23.6	5.9	14.6	4.8	7.5	12.0	1.6	7.4	35.0	2.3	1.3	6.3	12.8	3.3	4.1	4.2	2.4	1.7	1.2	4.7	3.4	5.5	3.6	11.5	35.1	6.0	8.4	3.5	15.9	7.3	5.9	5.8	22.7	12.1	48.2	3.5	14.6	20.1	29.4	11.2	16.2	9.9	29.0	8.1	9.4	18.8	31.3	7.1	8.4	31.8	8.7	22.5	13.5	8.7	13.4	20.7	51.4	22.6	31.4	33.7	19.9	68.6	23.4	43.9	56.6	8.9	4.6	34.0	4.9	12.6	29.2	11.8	7.6	8.1	6.8	22.7	19.6	13.3	28.2	5.9	60.8	14.3	6.3	23.3	5.0	6.5	30.9	6.4	19.6	6.8	12.0	19.1	7.5	18.4	24.8	27.6	28.4	16.3	16.9	8.2	5.2	29.3	3.5	3.5	23.7	9.1	20.8	19.4	15.5	14.0	19.4	11.4	29.4	15.9	4.4	3.2
PYGL		ENSG00000100504	"Glycogen phosphorylase L"	P06737	14	50857891-50944736	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Extravillous trophoblasts: 117.8;Hofbauer cells: 137.9;Muller glia cells: 253.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 36.0;neutrophil: 41.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 57.0;HMC-1: 63.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000962, HPA004119"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		17000000	"Plasma membrane, Cytosol"		"HPA000962: AB_1079722, HPA004119: AB_1079723"	"unprognostic (2.70e-2)"	"unprognostic (8.64e-3)"	"unprognostic (1.46e-2)"	"unprognostic (8.55e-2)"	"unprognostic (9.41e-2)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (2.63e-4)"	"unprognostic (4.45e-3)"	"unprognostic (3.15e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.12e-3)"	47.6	9.9	4.9	9.7	6.8	40.0	28.1	1.3	3.9	17.2	10.1	3.0	23.7	1.7	10.9	7.3	24.8	7.8	5.5	15.0	3.9	3.4	6.8	58.8	19.6	25.6	6.5	1.6	15.4	4.1	12.5	3.7	23.3	5.3	11.4	10.3	17.8	11.8	55.2	7.1	15.3	3.5	11.2	8.7	38.8	4.5	6.8	5.4	2.4	7.1	9.1	7.3	18.4	24.3	0.0	7.3	41.4	13.8	0.1	0.0	5.5	28.7	8.1	2.1	13.4	10.0	12.0	23.4	5.8	4.9	16.0	24.4	21.4	3.7	0.0	11.3	34.4	19.0	57.0	21.7	29.2	27.8	0.1	9.2	5.5	13.0	16.6	17.9	20.9	63.0	25.5	11.9	21.6	9.1	15.9	14.1	0.1	2.2	0.1	11.3	28.7	0.0	28.9	8.1	2.6	30.2	0.5	7.5	1.1	22.1	19.3	0.9	0.9	26.3	9.1	0.3	8.5	4.3	41.1	0.6	6.2	10.4	11.5	18.6	0.2	0.0	0.0	5.7	21.7	3.3	11.3	13.8	36.0	0.0	6.3	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	41.4	0.1	3.9	0.3	0.0	5.5	4.9	6.8	1.3	3.9	3.9	3.4	6.5	1.6	5.3	5.4	20.8	7.5	2.7	8.9	27.2	4.1	2.0	7.6	10.7	15.9	7.0	0.0	29.4	3.3	9.4	0.4	6.0	3.4	0.0	1.8	117.8	14.4	8.6	5.8	53.3	137.9	1.6	1.2	6.7	43.8	0.7	13.3	29.1	18.6	15.4	6.9	253.1	7.2	0.0	20.5	3.4	9.1	6.5	7.1	0.7	0.6	19.4	17.6	2.9	11.5	7.4
RAB13		ENSG00000143545	"RAB13, member RAS oncogene family"	P51153	1	153981617-153986358	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 7.7;myeloid DC: 10.7;plasmacytoid DC: 12.0"	"Group enriched"	"Detected in many"	9	"dendritic cells: 12.0;monocytes: 7.7"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 116.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003996	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		4600000	"Plasma membrane, Cytosol"		"HPA003996: AB_1079728"	"unprognostic (4.39e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.51e-2)"	"unprognostic (4.11e-2)"	"unprognostic (4.28e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.80e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.10e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.06e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.51e-3)"	"unprognostic (1.28e-2)"	49.0	40.4	18.1	28.7	30.2	29.7	52.1	13.6	23.5	33.1	33.6	13.7	46.6	17.8	28.5	47.1	43.2	25.0	46.7	36.9	21.9	17.0	61.3	51.5	40.8	36.7	22.9	11.1	39.2	65.6	28.4	11.1	29.0	29.1	41.5	24.5	21.6	47.4	44.4	26.8	25.0	28.7	35.3	31.3	44.8	34.5	24.0	24.7	5.9	54.8	35.0	24.9	41.0	78.4	1.0	12.0	0.9	7.7	0.0	0.7	2.4	17.2	21.3	19.3	20.3	65.0	116.2	6.3	21.1	50.0	19.1	19.5	21.5	14.7	0.0	31.8	25.1	9.7	11.9	11.4	19.2	26.6	11.1	8.8	14.4	13.4	12.0	27.3	0.0	10.2	84.5	16.6	32.9	14.6	53.9	33.2	0.0	3.0	0.0	32.4	35.9	0.0	7.3	31.0	23.7	20.4	4.2	25.2	0.0	43.0	18.3	1.2	16.0	27.6	23.9	42.5	30.0	39.3	11.5	61.5	34.8	20.6	21.5	22.8	0.1	0.0	0.2	54.2	2.5	52.7	0.0	7.7	0.1	0.0	1.4	0.1	0.8	0.1	0.1	10.7	1.0	0.1	0.7	0.9	0.0	0.2	12.0	0.0	2.4	18.1	30.2	13.6	23.5	21.9	17.0	22.9	11.1	29.1	24.7	38.7	70.7	13.4	148.7	81.7	1.1	69.4	104.4	56.2	63.7	102.9	2.0	102.3	114.4	187.9	86.7	180.9	76.1	0.0	130.8	137.5	109.8	182.0	40.3	126.2	237.1	0.0	85.5	141.2	101.8	184.7	98.4	112.5	94.5	413.0	147.2	16.7	149.6	95.1	116.7	162.0	3.2	148.8	189.5	61.2	17.1	85.7	77.7	12.5	130.8	173.5
RAB8A	"MEL, RAB8"	ENSG00000167461	"RAB8A, member RAS oncogene family"	P61006	19	16111629-16134234	"Predicted intracellular proteins"	"Autophagy, Cilium biogenesis/degradation, Protein transport, Transport"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041945			Supported	"Nucleoplasm,Plasma membrane"		No	No		16000000	"Nucleoplasm, Plasma membrane"		"HPA041945: "	"unprognostic (1.10e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (6.56e-5)"	"unprognostic (6.60e-2)"	"unprognostic (7.25e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (9.99e-2)"	23.4	22.8	15.6	24.5	14.1	32.5	15.9	16.6	13.6	18.2	23.1	18.5	15.0	37.6	17.2	11.8	22.9	18.0	17.1	10.6	13.6	11.2	24.8	57.8	19.3	24.9	14.2	8.4	23.3	24.7	8.8	15.5	30.9	13.6	16.3	20.1	16.5	27.4	14.7	5.2	22.3	56.2	14.1	16.7	43.4	20.1	15.9	14.7	33.4	18.5	12.7	36.1	19.7	17.9	34.3	45.4	55.2	81.1	39.0	31.8	75.5	29.0	19.6	16.2	13.6	13.2	11.7	25.4	17.7	15.3	23.6	24.8	22.4	33.6	20.1	20.2	17.3	20.6	19.3	21.7	21.8	15.0	41.2	12.7	42.1	18.3	23.0	15.1	36.5	42.0	12.1	11.3	22.2	9.7	12.7	19.3	20.7	19.5	30.7	18.7	33.5	30.4	32.0	20.3	34.9	31.6	34.6	17.8	35.6	17.4	22.3	15.0	14.8	17.9	21.2	11.2	10.9	17.2	13.6	19.1	19.8	12.9	38.6	30.1	16.7	34.3	30.3	19.1	36.5	21.4	36.0	50.6	55.2	31.8	69.8	28.4	34.3	28.4	28.6	45.4	31.8	22.5	26.5	53.8	39.0	81.1	32.5	26.6	75.5	15.6	14.1	16.6	13.6	13.6	11.2	14.2	8.4	13.6	14.7	23.8	26.1	58.8	41.8	42.4	14.1	2.8	17.8	45.5	23.9	29.6	13.7	78.7	69.6	59.2	24.1	29.5	105.7	0.0	45.1	81.2	38.0	31.1	46.3	44.5	79.7	6.4	29.1	23.9	36.3	12.6	25.6	79.9	32.1	147.9	48.7	29.6	58.4	77.2	23.3	44.7	12.2	32.3	24.7	24.4	19.0	45.9	66.6	64.7	40.4	32.5
RALA	RAL	ENSG00000006451	"RAS like proto-oncogene A"	P11233	7	39623483-39708124	"Predicted intracellular proteins, RAS pathway related proteins"	"Cell cycle, Cell division, Exocytosis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Pancreatic endocrine cells: 277.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 78.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047037, HPA065232"	Approved		Supported	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane"	"Focal adhesion sites"	"HPA047037: , HPA065232: AB_2685440"	"unprognostic (1.20e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.91e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.98e-2)"	"unprognostic (9.14e-2)"	"prognostic unfavorable (5.32e-5)"	"unprognostic (7.71e-2)"	"unprognostic (2.17e-1)"	"prognostic favorable (7.46e-4)"	"prognostic unfavorable (6.30e-4)"	"unprognostic (3.32e-1)"	"unprognostic (4.95e-3)"	"unprognostic (5.38e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.95e-2)"	19.2	25.2	24.7	14.3	24.6	4.8	24.4	16.1	22.0	18.4	22.3	17.2	8.0	23.5	15.7	15.5	44.9	15.0	20.0	13.8	24.7	20.2	15.9	15.4	30.3	14.8	27.6	18.9	17.4	11.6	12.8	14.2	23.7	20.3	12.9	23.6	9.1	18.5	12.7	16.8	19.5	25.5	15.7	36.0	16.0	24.4	12.2	21.9	19.9	13.8	31.0	28.9	15.2	20.8	13.3	16.3	21.5	11.2	15.7	20.4	11.5	20.1	4.6	11.4	9.9	21.8	18.2	7.9	17.7	25.6	16.1	17.9	11.5	9.9	10.4	6.7	13.7	15.1	21.0	16.1	11.5	27.9	9.9	7.6	8.1	7.6	8.4	35.4	14.0	11.5	14.3	14.1	28.7	40.9	20.2	78.1	10.2	16.2	6.9	16.3	6.5	9.8	16.7	32.1	22.1	9.2	12.3	10.3	9.0	16.4	9.4	20.5	19.9	10.9	17.5	12.0	21.5	16.4	15.4	25.0	9.5	8.5	12.0	12.6	12.3	9.5	12.7	10.7	14.6	17.3	21.5	9.8	11.0	9.7	11.2	12.0	11.5	15.7	12.4	16.3	13.3	20.4	17.9	4.5	15.7	8.6	10.6	19.7	11.5	24.7	24.6	16.1	20.8	24.7	20.2	27.6	18.9	20.3	21.9	77.4	36.8	45.3	32.8	80.0	10.9	33.0	45.9	29.4	21.6	22.7	5.9	45.4	18.3	162.0	51.6	66.4	59.6	23.3	107.3	77.4	54.6	33.5	31.1	26.2	97.6	11.1	45.8	69.3	24.5	12.3	44.3	67.7	28.7	146.1	46.5	37.7	277.8	66.0	65.4	28.4	15.8	32.3	24.7	52.6	55.6	95.7	51.8	25.5	51.1	47.7
RAPGEF2	"DKFZP586O1422, KIAA0313, PDZ-GEF1, PDZGEF1, RA-GEF"	ENSG00000109756	"Rap guanine nucleotide exchange factor 2"	Q9Y4G8	4	159103013-159360174	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, GTPase activation, Guanine-nucleotide releasing factor"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 9.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 9.4;NK-cells: 5.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 40.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068798			Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA068798: "	"unprognostic (4.88e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.67e-2)"	"unprognostic (7.79e-3)"	"unprognostic (8.16e-2)"	"unprognostic (4.71e-3)"	"unprognostic (4.20e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.76e-7)"	"unprognostic (2.29e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.78e-1)"	16.7	8.0	28.4	8.8	23.8	51.0	16.3	21.5	34.1	12.6	14.5	11.3	10.4	10.9	12.7	7.3	9.9	10.2	14.1	14.9	23.4	15.3	16.4	20.9	18.1	8.5	14.1	29.6	10.2	13.4	20.7	13.8	26.1	16.9	9.3	14.8	10.0	18.7	9.4	15.7	12.7	11.9	14.0	13.9	19.2	13.7	6.7	14.3	9.3	27.5	8.9	7.8	11.9	13.8	0.4	1.4	9.4	1.4	5.2	1.5	0.3	3.3	4.5	21.5	6.6	8.5	9.6	33.1	6.5	8.2	5.9	4.3	13.9	7.4	19.0	2.4	6.4	8.6	3.0	7.3	8.3	7.1	3.2	5.1	29.5	9.5	8.0	6.2	3.5	40.9	5.6	4.7	14.2	5.0	12.6	16.9	7.9	6.5	17.8	7.3	5.9	8.8	0.5	9.1	3.9	4.5	7.3	5.4	0.7	5.3	7.6	6.1	8.2	9.5	4.6	7.9	10.8	2.3	2.4	17.8	9.4	9.9	11.9	5.3	19.9	11.7	0.3	11.1	1.5	5.7	2.7	1.4	1.0	0.8	0.8	1.0	0.4	0.7	0.5	0.8	0.3	0.9	0.4	9.4	5.2	0.9	1.4	1.5	0.3	28.4	23.8	21.5	34.1	23.4	15.3	14.1	29.6	16.9	14.3	53.6	26.7	7.5	10.9	18.1	16.3	32.9	12.7	16.0	17.0	7.0	39.3	9.4	0.0	8.1	4.0	30.0	12.3	46.7	10.8	8.1	15.0	16.7	48.7	25.6	10.1	31.8	13.8	31.9	25.1	3.8	7.2	14.1	32.1	7.2	10.8	29.8	16.9	17.5	8.1	6.4	23.4	51.8	17.8	3.6	6.5	17.6	4.9	7.5	6.4	12.8
RAPH1	"ALS2CR18, ALS2CR9, KIAA1681"	ENSG00000173166	"Ras association (RalGDS/AF-6) and pleckstrin homology domains 1"	Q70E73	2	203394345-203535410	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 51.1"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 68.3;Ito cells: 89.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.8;non-classical monocyte: 2.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA016744, HPA020027"	Approved		Approved	"Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Nuclear bodies, Plasma membrane"	Cytosol	"HPA016744: AB_1844781, HPA020027: AB_1844782"	"unprognostic (9.78e-2)"	"unprognostic (9.05e-2)"	"unprognostic (7.17e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.32e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.24e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.40e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.79e-1)"	11.0	6.1	7.3	6.3	7.6	2.7	17.6	8.4	12.7	9.8	7.9	3.7	6.8	6.9	6.8	8.4	9.2	6.3	12.5	8.3	5.2	5.0	8.2	51.1	17.2	6.8	4.2	8.4	3.6	5.8	4.0	9.9	11.1	6.0	7.2	6.7	8.5	11.2	4.4	8.3	10.2	10.2	7.1	4.8	26.7	7.8	7.9	3.1	1.7	25.8	7.9	5.6	9.6	8.7	0.0	1.1	0.0	2.8	1.1	0.6	0.3	5.5	3.8	8.1	4.6	6.4	8.3	7.2	7.7	5.7	8.0	10.2	17.7	5.9	0.0	1.9	11.7	5.9	2.7	4.2	6.6	16.8	1.1	2.4	0.0	9.2	3.1	16.0	0.0	0.1	11.5	5.6	14.7	15.5	8.8	12.5	0.8	0.4	4.3	16.0	3.1	0.0	0.0	4.8	2.8	4.9	0.1	11.5	3.1	5.8	17.9	2.8	3.8	5.3	5.1	6.4	11.2	2.8	0.2	14.8	19.8	6.4	9.4	8.1	2.0	3.4	0.0	16.3	0.1	4.4	0.0	0.8	0.0	0.2	2.8	0.6	0.0	0.5	0.1	1.1	0.0	0.4	0.1	0.0	1.1	2.6	0.1	0.5	0.3	7.3	7.6	8.4	12.7	5.2	5.0	4.2	8.4	6.0	3.1	14.9	6.7	2.2	16.6	43.6	9.3	0.8	15.3	5.3	10.3	14.0	13.7	7.1	6.6	5.8	10.1	18.9	21.2	0.0	8.0	5.9	19.4	17.6	1.1	68.3	15.3	9.5	2.4	89.0	14.9	3.2	4.4	15.9	11.8	2.8	7.2	20.0	14.3	14.0	4.6	2.4	4.6	19.4	16.1	15.7	10.4	35.8	9.2	1.8	11.2	19.1
RASAL3	FLJ21438	ENSG00000105122	"RAS protein activator like 3"	Q86YV0	19	15451624-15464571	"Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 29.9"	"Group enriched"	"Detected in many"	5	"B-cells: 38.9;granulocytes: 39.2;T-cells: 62.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 14.4;HEL: 11.9;HMC-1: 23.1;Karpas-707: 25.7;NB-4: 13.1;RPMI-8226: 10.9;TIME: 17.1;U-937: 16.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043417	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA043417: AB_2678473"	"unprognostic (2.72e-2)"	"prognostic favorable (8.75e-4)"	"unprognostic (3.27e-2)"	"prognostic favorable (3.58e-5)"	"unprognostic (2.31e-1)"	"prognostic favorable (3.07e-4)"	"unprognostic (1.82e-2)"	"unprognostic (6.21e-3)"	"unprognostic (7.40e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (2.98e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	2.8	2.1	3.1	19.2	3.8	16.7	1.7	0.5	1.9	1.4	3.4	4.6	0.7	3.6	1.7	1.1	3.0	1.9	4.5	1.1	4.1	1.8	3.3	2.8	8.0	23.5	4.5	1.3	0.9	1.3	0.3	1.4	0.8	3.7	2.3	1.9	1.5	7.5	1.1	0.7	1.2	14.5	0.9	5.1	29.9	4.0	0.6	4.6	27.3	3.1	1.6	28.9	4.5	2.0	2.9	3.2	8.8	9.3	8.9	16.4	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	11.9	0.0	0.0	0.2	9.5	23.1	0.0	0.0	0.0	0.0	0.0	0.1	3.9	0.0	25.7	0.0	0.1	5.0	13.1	0.0	0.0	0.0	1.4	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	17.1	0.0	0.0	0.0	0.0	0.2	4.6	7.0	0.0	16.1	0.0	4.3	1.7	8.8	14.9	3.4	8.9	2.2	9.5	16.4	2.6	2.9	8.0	9.6	2.5	8.9	9.3	3.2	6.4	3.5	3.1	3.8	0.5	1.9	4.1	1.8	4.5	1.3	3.7	4.6	3.0	9.3	38.9	0.0	0.2	0.0	2.2	0.0	8.1	2.3	0.0	0.0	0.1	0.0	0.1	0.4	2.9	0.0	0.0	0.5	0.2	0.9	0.1	39.2	3.9	9.8	0.0	0.0	4.3	9.2	0.6	0.0	7.4	0.0	2.8	0.0	0.1	0.3	0.0	1.1	0.8	0.0	0.0	0.5	0.4	0.3	0.5	0.3	62.3	0.0	0.1
RASGRP1	"CalDAG-GEFII, RASGRP"	ENSG00000172575	"RAS guanyl releasing protein 1"	O95267	15	38488103-38565575	"Disease related genes, Predicted intracellular proteins, RAS pathway related proteins"	Differentiation	"Guanine-nucleotide releasing factor"	"Disease mutation, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 33.1;lymphoid tissue: 55.8"	"Cell type enhanced"	"Detected in many"	14	"Collecting duct cells: 31.4;Muller glia cells: 101.6;T-cells: 55.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	4	"T-cells: 10.4"	"Group enriched"	"Detected in some"	4	"HDLM-2: 25.3;JURKAT: 33.6;MOLT-4: 23.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039389			Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA039389: AB_2732481"	"unprognostic (3.44e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-3)"	"unprognostic (9.63e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.50e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.40e-1)"	"unprognostic (9.30e-2)"	1.7	1.0	5.7	9.9	17.0	7.8	1.9	33.1	18.5	1.4	1.6	0.8	0.0	2.5	1.6	1.6	6.7	4.7	2.7	1.6	6.1	3.2	5.9	1.2	4.2	20.0	3.0	6.2	0.8	2.0	0.3	1.2	4.9	22.3	1.0	2.3	1.4	2.5	1.0	0.8	7.3	3.7	0.7	1.6	8.6	4.8	2.2	1.1	55.8	1.2	1.6	16.3	4.3	2.4	1.2	0.0	0.8	0.0	2.4	10.4	1.4	0.0	0.1	0.5	0.1	0.0	0.0	0.0	1.9	0.6	1.0	0.8	2.1	0.0	5.4	0.4	0.0	0.1	0.1	1.1	0.0	0.9	25.3	1.0	0.4	0.2	0.0	0.3	0.2	0.4	0.0	0.0	0.5	0.0	0.0	0.0	33.6	0.2	1.7	0.0	0.8	23.9	0.0	0.3	0.0	0.0	6.7	0.1	0.0	1.0	0.0	2.3	0.8	1.2	0.0	0.1	0.7	0.6	0.0	0.1	0.2	0.8	2.7	0.3	4.2	2.0	6.4	0.1	0.0	0.2	0.0	0.0	0.8	5.7	0.0	4.2	1.2	6.4	5.7	0.0	0.7	6.0	6.0	0.3	2.4	0.0	0.0	10.4	1.4	5.7	17.0	33.1	11.7	6.1	3.2	3.0	6.2	22.3	1.1	6.0	15.4	11.3	0.4	2.2	9.4	2.6	10.2	0.0	0.0	31.4	9.8	0.2	3.3	16.1	1.2	0.0	0.0	0.0	8.9	0.1	1.0	0.4	3.5	0.0	0.6	6.4	0.0	0.6	0.3	0.2	0.0	0.0	6.8	0.0	0.5	101.6	22.6	0.0	0.0	5.9	18.1	0.0	1.5	0.9	2.8	7.2	0.0	55.4	0.4	0.3
RASGRP2	CALDAG-GEFI	ENSG00000068831	"RAS guanyl releasing protein 2"	Q7LDG7	11	64726911-64745456	"Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.6;bone marrow: 63.9;lymphoid tissue: 47.6"	"Cell type enhanced"	"Detected in many"	9	"B-cells: 95.7;Kupffer cells: 67.8;Sertoli cells: 129.4;Smooth muscle cells: 71.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 23.1;HL-60: 41.7;NB-4: 79.1;REH: 23.6;THP-1: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015635, HPA015667"	Approved		Supported	"Plasma membrane"		NA	NA		1900000	"Plasma membrane"		"HPA015635: , HPA015667: AB_1856090"	"unprognostic (5.96e-2)"	"unprognostic (3.24e-3)"	"unprognostic (5.55e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.52e-2)"	"unprognostic (4.74e-5)"	"unprognostic (1.11e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.23e-1)"	7.6	4.2	4.6	26.8	26.4	63.9	4.5	4.3	8.2	5.6	9.9	3.2	4.5	3.6	8.8	4.9	4.5	8.9	4.7	13.7	5.5	4.7	5.5	3.1	8.5	47.6	4.7	5.7	2.7	1.2	0.7	1.5	8.1	4.1	6.9	3.2	5.3	7.4	10.4	5.8	1.5	25.6	8.1	2.7	43.9	5.4	3.1	8.2	9.7	2.9	2.5	30.1	7.0	4.8	51.6	29.1	24.5	32.2	16.7	32.8	22.2	0.0	0.0	0.7	0.0	0.0	0.0	2.0	0.3	0.0	0.3	0.2	0.3	0.0	14.3	0.6	0.0	0.2	0.1	1.2	0.2	0.0	0.0	0.4	23.1	0.0	0.0	0.0	41.7	8.5	0.0	0.0	0.1	0.0	0.0	0.0	5.9	0.9	0.2	0.0	0.3	9.8	79.1	0.6	0.1	0.0	23.6	0.0	1.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.5	0.1	24.8	0.1	0.0	0.5	0.3	0.0	0.1	0.0	13.2	0.0	13.2	0.0	16.5	11.8	19.1	24.4	28.6	13.2	51.6	25.3	19.3	11.6	32.0	32.8	29.0	24.5	16.7	32.2	29.1	29.9	22.2	4.6	26.4	4.3	8.2	5.5	4.7	4.7	5.7	4.1	8.2	3.0	2.6	95.7	0.1	2.1	0.8	46.4	2.5	1.4	0.0	0.0	0.0	1.5	0.0	0.0	5.2	6.8	0.0	0.0	0.0	1.3	4.5	0.1	3.5	0.9	5.7	0.0	0.0	31.3	67.8	11.9	16.7	22.0	0.0	26.2	0.0	0.7	0.0	0.0	44.9	1.0	2.3	129.4	71.9	10.1	28.3	1.1	9.8	47.3	0.2	0.1
RASGRP4		ENSG00000171777	"RAS guanyl releasing protein 4"	Q8TDF6	19	38409051-38426305	"Predicted intracellular proteins, RAS pathway related proteins"	Differentiation	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 22.4;bone marrow: 23.3;lymphoid tissue: 23.1"	"Group enriched"	"Detected in some"	8	"Cardiomyocytes: 10.9;granulocytes: 26.5;Hofbauer cells: 12.0;Kupffer cells: 34.4;Macrophages: 11.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 22.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"HEL: 19.4;HMC-1: 19.4;U-937: 5.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA041929			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA041929: AB_10961405"	"unprognostic (1.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.23e-4)"	"unprognostic (6.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.30e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.56e-1)"	"unprognostic (2.66e-2)"	4.5	1.8	2.4	8.0	3.3	23.3	5.4	0.7	1.8	1.8	1.7	2.8	0.1	1.4	1.6	2.9	1.6	2.6	3.4	6.2	2.0	1.3	1.5	1.8	11.8	23.1	3.4	0.2	1.1	1.6	0.5	0.9	3.0	1.8	1.7	1.2	1.7	1.6	0.8	1.5	1.4	2.4	2.7	4.2	19.2	1.9	0.8	2.4	0.5	1.0	0.2	1.0	2.6	3.1	0.1	5.2	22.4	9.5	0.0	0.7	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	19.4	0.0	0.0	0.0	0.1	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	6.0	7.1	10.6	0.0	8.5	0.0	0.0	0.2	0.0	5.2	0.1	0.0	0.0	22.4	0.0	9.5	0.4	0.7	2.1	2.4	3.3	0.7	1.8	2.0	1.3	3.4	0.2	1.8	2.4	0.0	1.1	0.0	0.0	0.7	0.0	10.9	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.2	0.0	26.5	0.0	12.0	0.0	0.0	1.8	34.4	0.0	0.0	11.0	1.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1
RC3H1	"KIAA2025, RNF198, roquin, RP5-1198E17.5"	ENSG00000135870	"Ring finger and CCCH-type domains 1"	Q5TC82	1	173931214-174022297	"Predicted intracellular proteins"		"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027428, HPA027434, HPA027448"	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Golgi apparatus, Plasma membrane"	"HPA027428: AB_10600324, HPA027434: AB_10601235, HPA027448: AB_10601683"	"unprognostic (6.91e-2)"	"unprognostic (7.76e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (5.25e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.43e-3)"	"unprognostic (6.83e-3)"	10.4	7.8	11.8	8.0	10.3	32.6	10.6	26.7	14.0	9.9	10.3	12.3	8.3	6.9	10.9	8.4	11.8	9.4	8.1	9.0	11.9	7.4	8.1	11.2	11.3	8.8	10.4	7.1	10.8	9.8	10.2	14.6	9.1	12.4	8.7	8.6	13.3	9.0	7.6	19.1	14.0	10.6	8.4	9.3	13.6	9.1	9.7	9.0	15.2	9.9	7.7	13.6	8.4	9.8	2.8	1.6	10.4	3.9	2.3	2.7	1.1	7.3	10.2	5.7	8.8	10.8	8.4	7.8	5.0	7.2	5.8	5.1	9.4	8.2	10.4	9.0	8.1	4.5	7.1	8.5	7.1	8.2	7.2	2.1	9.0	7.6	7.8	6.6	11.7	10.5	8.0	5.5	8.4	5.7	5.4	8.9	5.1	10.2	6.4	7.0	5.5	7.0	10.6	9.8	6.8	1.1	7.7	10.2	7.6	10.3	14.2	6.8	6.1	9.5	12.3	4.8	10.0	8.2	11.9	12.9	7.6	7.6	6.5	6.4	8.0	8.1	13.4	5.1	5.3	7.6	4.5	3.2	4.0	2.0	3.2	2.1	2.1	1.9	2.3	1.6	2.8	2.7	2.3	10.4	2.3	3.9	1.3	1.5	1.1	11.8	10.3	26.7	14.0	11.9	7.4	10.4	7.1	12.4	9.0	38.7	30.9	19.0	14.5	30.6	34.5	22.4	22.9	25.4	19.4	22.7	76.6	8.9	8.3	21.9	9.1	26.3	25.0	0.0	16.3	6.7	36.9	24.8	15.1	29.4	10.0	36.5	32.8	33.7	35.2	6.7	14.7	18.5	28.7	19.8	27.4	25.7	19.9	17.5	9.9	8.1	44.8	19.4	26.8	35.6	11.7	35.8	9.7	30.5	23.4	26.1
RDX	DFNB24	ENSG00000137710	Radixin	P35241	11	109864295-110296722	"Disease related genes, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 81.0"	"Cell type enhanced"	"Detected in all"	4	"Alveolar cells type 1: 449.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000263, HPA000763, CAB037312"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		77000000	"Plasma membrane"	Nucleoplasm	"CAB037312: AB_261933, HPA000263: AB_1856043, HPA000763: AB_1856042"	"unprognostic (2.23e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.74e-2)"	"unprognostic (6.93e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.91e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.32e-3)"	"unprognostic (6.47e-2)"	"unprognostic (4.14e-3)"	"unprognostic (5.43e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.08e-3)"	15.9	81.0	17.9	7.0	29.2	4.2	22.3	9.3	20.2	14.7	10.1	19.5	11.1	2.9	12.7	9.1	11.9	8.8	11.6	16.9	20.8	17.0	21.7	28.6	20.4	8.7	27.5	15.2	23.7	22.0	16.0	16.1	16.4	31.6	11.3	4.9	7.4	9.0	11.9	35.5	5.5	5.3	14.9	50.4	10.6	8.3	13.9	30.6	3.5	19.7	11.8	5.9	13.4	11.9	9.4	9.6	17.1	11.4	13.1	15.8	5.6	17.1	9.1	36.3	14.4	21.4	23.8	20.7	21.8	12.4	14.4	15.9	25.5	30.1	0.0	33.5	27.0	22.6	15.8	20.1	20.9	21.6	10.3	11.1	12.7	30.4	18.9	20.0	4.7	8.8	24.3	11.9	17.9	32.2	23.9	39.1	2.8	18.1	7.7	33.3	30.3	2.7	3.8	11.5	1.0	14.9	7.9	25.5	7.5	18.3	8.6	9.9	10.7	38.4	17.4	13.7	28.5	22.3	7.6	24.1	24.0	17.9	11.5	16.9	2.5	4.1	16.6	9.1	2.8	55.1	17.1	11.4	16.5	9.4	9.4	12.5	9.4	8.4	6.9	9.6	6.1	5.7	4.6	1.3	13.1	7.1	7.8	15.8	5.6	17.9	29.2	9.3	19.0	20.8	17.0	27.5	15.2	31.6	30.6	449.6	96.4	30.6	43.1	49.8	78.4	144.4	71.4	41.5	64.8	71.5	41.2	104.4	92.9	108.4	11.2	193.3	6.7	70.0	374.9	158.2	87.8	55.0	65.8	217.4	75.7	95.3	21.4	279.3	93.7	28.8	254.9	61.2	69.2	186.7	9.3	84.0	127.6	20.1	250.7	141.1	88.4	122.9	79.0	72.1	242.5	35.4	190.1	31.6	16.8	27.6
RECK	"hRECK, ST15"	ENSG00000122707	"Reversion inducing cysteine rich protein with kazal motifs"	O95980	9	36036433-36124451	"Plasma proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Protease inhibitor, Serine protease inhibitor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 55.3;ASC TERT1: 44.3;BJ: 17.2;BJ hTERT+: 24.7;fHDF/TERT166: 15.2;HSkMC: 19.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025109, HPA071729"	Supported		Supported	"Plasma membrane"		NA	NA		37000000	"Plasma membrane"		"CAB025109: , HPA071729: AB_2686438"	"unprognostic (3.42e-1)"	"unprognostic (4.01e-3)"	"unprognostic (5.50e-2)"	"unprognostic (5.05e-4)"	"unprognostic (8.87e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.51e-2)"	"unprognostic (9.06e-2)"	"unprognostic (8.48e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (7.31e-4)"	"unprognostic (2.68e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.60e-2)"	15.9	8.9	6.9	6.3	8.2	1.5	31.7	9.1	7.8	18.9	10.2	8.5	6.2	4.3	18.4	7.5	13.7	12.0	15.6	11.3	8.4	4.9	6.9	6.7	16.7	6.1	8.3	4.9	17.2	3.9	3.7	7.8	12.7	8.3	12.3	7.6	10.5	7.8	8.9	5.7	8.7	7.7	17.3	7.9	8.1	9.8	7.9	8.5	8.4	10.5	9.8	6.2	17.8	16.8	3.5	3.7	1.2	5.5	3.6	8.9	3.1	0.3	0.6	2.1	1.1	55.3	44.3	0.0	17.2	24.7	1.2	3.0	0.0	0.0	0.6	1.6	15.2	1.0	0.1	0.4	0.3	1.7	1.0	0.9	0.6	0.7	0.0	4.4	0.0	3.0	19.7	0.4	1.9	0.7	5.0	3.8	1.3	0.0	0.5	3.2	0.0	1.6	0.2	0.7	0.0	0.5	1.7	1.6	0.0	0.8	0.0	0.2	1.2	0.3	0.2	0.6	2.3	0.0	2.3	11.7	2.4	0.9	1.5	0.9	0.7	0.8	0.7	1.5	2.2	1.5	1.2	3.3	0.9	5.4	3.5	6.1	1.7	7.1	5.7	3.7	3.5	8.9	6.4	0.5	3.6	5.5	2.1	3.2	3.1	6.9	8.2	9.1	7.8	8.4	4.9	8.3	4.9	8.3	8.5	3.0	4.8	7.8	2.6	6.4	14.3	1.6	2.5	4.0	2.3	3.5	13.7	0.7	0.0	5.5	30.6	14.3	0.0	0.0	1.3	6.3	15.6	4.0	9.2	0.8	13.1	7.9	5.8	25.8	8.4	31.4	17.3	7.0	3.3	6.4	1.4	17.7	1.8	0.0	16.6	1.5	7.6	0.0	9.9	25.9	24.0	6.6	0.7	8.5	0.9	1.0
RELL1		ENSG00000181826	"RELT like 1"	Q8IUW5	4	37590800-37686376	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 16.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 16.1"	"Cell line enhanced"	"Detected in many"		"RH-30: 33.2;TIME: 21.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013377	Approved		Supported	"Plasma membrane,Microtubules"		NA	NA			"Plasma membrane, Microtubules"		"HPA013377: AB_1844403"	"unprognostic (1.70e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.78e-2)"	"unprognostic (5.30e-2)"	"unprognostic (6.80e-2)"	"unprognostic (7.28e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.71e-2)"	21.1	3.0	5.5	6.2	9.7	28.8	19.3	6.4	6.5	8.4	10.4	6.5	2.8	7.2	8.3	7.8	9.8	7.3	9.7	12.1	5.1	5.0	4.9	5.5	10.4	14.6	9.1	2.1	8.9	4.0	2.6	3.2	20.7	17.9	6.2	7.5	8.1	5.3	5.0	10.1	11.5	8.6	11.1	28.2	10.9	14.7	4.1	5.3	6.0	18.1	9.6	6.6	15.6	13.3	0.1	3.2	16.1	4.0	0.9	1.7	1.3	2.9	3.8	9.2	6.5	6.4	5.3	7.3	5.2	5.4	4.6	5.8	11.6	3.6	0.6	4.0	4.8	6.7	2.8	3.0	5.5	7.2	0.0	1.5	1.2	3.2	9.9	3.8	4.3	3.0	7.2	4.5	5.6	5.6	1.8	18.3	2.3	2.2	3.0	3.4	2.4	4.5	2.3	1.8	3.1	1.1	1.6	33.2	1.5	4.5	4.3	2.0	5.7	4.8	3.6	4.6	1.9	12.3	1.5	21.8	9.3	5.4	7.0	5.8	1.5	1.6	4.9	8.4	6.8	7.0	0.0	4.0	2.5	1.3	0.8	1.2	0.1	1.2	1.1	1.6	0.0	1.1	1.7	16.1	0.9	0.5	3.2	1.1	1.3	5.5	9.7	6.4	6.5	5.1	5.0	9.1	2.1	17.9	5.3	8.9	1.9	2.4	1.2	3.0	0.4	1.7	10.2	4.0	5.7	0.0	0.0	1.0	0.0	2.6	5.2	6.4	5.1	0.0	7.3	3.0	2.1	2.3	2.3	0.8	2.3	3.2	1.2	8.0	2.8	4.0	3.4	3.1	1.7	2.8	1.1	4.9	9.3	1.9	5.6	0.0	1.5	12.9	2.8	1.2	0.1	4.1	4.3	5.7	0.6	3.8
RET	"CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51"	ENSG00000165731	"Ret proto-oncogene"	P07949	10	43077027-43130351	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Hirschsprung disease, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 63.9"	"Cell type enriched"	"Detected in some"	44	"Horizontal cells: 74.7"	"Cancer enhanced"	"Detected in many"		"breast cancer: 11.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 6.7"	"Group enriched"	"Detected in many"	13	"dendritic cells: 2.1;monocytes: 6.7"	"Cell line enhanced"	"Detected in some"		"MCF7: 18.0;NB-4: 11.8;SH-SY5Y: 91.8;THP-1: 27.4"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"midbrain: 95.5"	"CAB002581, HPA008356, HPA008495"	Approved	Supported	Approved	"Golgi apparatus,Plasma membrane,Cytosol"		No	NA		260000	"Golgi apparatus, Cytosol"	"Plasma membrane"	"CAB002581: AB_563673, HPA008356: AB_1847232, HPA008495: "	"unprognostic (7.94e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.49e-1)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (1.15e-1)"	"unprognostic (9.13e-4)"	"unprognostic (1.27e-2)"	"unprognostic (3.62e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.54e-3)"	"unprognostic (4.43e-1)"	"unprognostic (9.35e-5)"	"unprognostic (1.64e-3)"	"unprognostic (8.28e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.02e-2)"	1.8	15.2	1.1	1.8	1.3	0.7	1.2	4.1	9.0	1.9	3.1	0.9	1.1	1.5	0.9	0.6	1.2	0.7	1.0	1.2	1.5	5.8	1.0	11.7	0.7	0.8	17.5	1.2	0.8	1.3	63.9	6.3	0.8	16.8	2.2	1.5	2.8	13.6	2.0	4.5	1.1	2.6	1.1	2.8	0.6	2.1	2.0	0.0	0.1	0.8	5.1	0.6	1.9	1.4	0.2	2.1	0.0	6.7	0.0	0.3	0.4	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	11.8	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	91.8	0.0	0.0	0.0	0.1	1.3	27.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	6.7	2.1	0.3	0.4	1.1	1.3	4.1	9.0	1.5	5.8	17.5	1.2	16.8	0.0	0.0	0.3	0.0	0.5	0.2	0.1	1.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.2	1.7	1.0	1.2	1.1	0.8	0.1	74.7	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.4	0.0	1.4	0.4	1.1	0.5	0.0	0.0	0.0	0.1
RGP1	KIAA0258	ENSG00000107185	"RGP1 homolog, RAB6A GEF complex partner 1"	Q92546	9	35749287-35758575	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020414, HPA021085"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA020414: AB_1852289, HPA021085: AB_1852291"	"unprognostic (2.10e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (2.22e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.81e-3)"	"unprognostic (9.77e-2)"	"prognostic favorable (8.55e-13)"	"unprognostic (2.46e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.18e-1)"	13.4	18.2	12.0	11.4	16.8	7.1	12.3	13.7	24.8	12.2	17.7	18.3	23.8	14.9	15.3	12.5	14.0	12.3	12.1	17.6	11.6	11.2	16.7	14.2	13.2	9.8	10.7	14.8	15.0	17.6	32.6	18.3	14.1	13.0	12.9	19.1	15.4	18.3	22.5	25.8	13.1	17.2	14.1	10.6	12.8	16.5	13.2	13.7	11.2	17.3	11.9	13.0	13.5	10.6	4.0	2.1	3.4	1.9	3.7	3.7	0.9	11.3	10.7	12.5	10.3	11.7	12.7	7.4	9.0	13.1	12.5	11.7	9.1	4.3	8.8	6.5	11.4	23.2	6.5	11.9	17.0	10.4	11.7	7.0	7.6	20.4	6.8	11.0	8.2	10.7	12.7	21.7	13.2	16.1	18.0	14.8	6.9	5.1	4.9	11.3	5.3	2.5	2.9	5.2	9.4	12.6	8.3	8.9	6.2	11.0	8.0	9.2	9.9	7.9	11.2	7.3	11.5	9.3	3.9	18.7	10.1	12.8	6.9	7.5	7.4	10.2	9.4	14.4	3.4	12.9	3.4	0.9	1.4	2.6	1.5	3.7	2.8	1.9	3.0	0.6	4.0	2.3	2.4	2.3	3.7	1.9	2.1	1.6	0.9	12.0	16.8	13.7	24.8	11.6	11.2	10.7	14.8	13.0	13.7	6.0	9.3	26.0	21.1	5.0	40.9	16.3	20.4	8.1	10.3	26.2	19.6	9.3	11.6	16.1	16.4	13.4	35.4	0.0	15.2	8.8	6.0	21.5	5.7	15.3	6.4	15.9	41.6	8.0	10.3	27.7	7.8	5.6	1.7	7.2	23.9	21.8	17.1	31.7	10.3	12.9	22.1	6.5	7.2	15.8	4.3	4.5	8.6	15.2	26.3	26.2
RGS10		ENSG00000148908	"Regulator of G protein signaling 10"	O43665	10	119499828-119542708	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 77.9;lymphoid tissue: 96.9"	"Cell type enhanced"	"Detected in many"	9	"Erythroid cells: 256.9;granulocytes: 281.0;Hofbauer cells: 444.1;Macrophages: 293.8;monocytes: 273.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 94.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004559, HPA021305, HPA058485"	Enhanced	Supported	Supported	"Nucleoplasm,Plasma membrane"		NA	NA		1400000	"Nucleoplasm, Plasma membrane"		"CAB004559: AB_628216, HPA021305: AB_1856225, HPA058485: AB_2683732"	"unprognostic (1.64e-2)"	"prognostic favorable (6.81e-4)"	"unprognostic (7.98e-2)"	"prognostic favorable (6.32e-4)"	"unprognostic (5.21e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.32e-3)"	"unprognostic (6.35e-2)"	"unprognostic (9.90e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (4.20e-10)"	"unprognostic (2.50e-1)"	"unprognostic (9.20e-2)"	"unprognostic (7.70e-2)"	"unprognostic (7.92e-3)"	9.6	7.7	11.9	28.2	12.1	23.6	15.4	2.8	12.4	25.8	44.0	17.0	5.3	12.5	15.3	13.1	21.9	10.8	18.8	11.7	12.0	10.5	8.3	3.9	13.5	47.6	17.4	6.7	10.3	3.9	0.8	6.6	16.9	10.5	17.8	18.9	6.4	18.1	8.2	13.2	9.3	23.1	19.1	28.5	18.7	12.8	3.7	11.1	96.9	14.7	11.1	34.3	17.9	20.0	6.9	40.2	20.5	26.3	7.6	77.9	63.0	30.1	5.6	0.4	53.0	7.6	49.0	5.0	14.1	21.4	8.5	13.7	1.7	7.2	12.9	7.5	10.9	8.3	6.7	7.9	8.5	22.6	6.3	9.1	34.6	1.6	4.1	12.3	7.0	94.1	19.0	11.4	16.5	15.4	29.1	16.1	12.7	8.8	10.5	9.8	13.7	40.9	24.5	2.4	3.7	15.3	8.0	0.0	4.8	4.3	7.1	2.1	1.7	2.7	34.7	49.6	6.8	6.6	12.5	21.3	4.9	4.2	7.0	12.0	0.5	8.1	4.7	1.5	30.7	2.1	20.5	21.5	0.2	15.0	26.3	15.7	6.9	32.5	25.8	40.2	3.6	77.9	58.5	9.9	7.6	21.6	23.9	35.0	63.0	11.9	12.1	2.8	12.4	12.0	10.5	17.4	6.7	10.5	11.1	0.0	19.1	64.8	23.8	32.6	0.0	1.2	0.0	2.7	11.4	1.8	0.0	10.7	51.4	0.7	1.8	5.3	4.2	256.9	5.6	30.7	57.9	75.3	281.0	0.4	444.1	0.0	18.0	14.7	196.4	3.9	46.3	293.8	89.4	273.3	63.2	1.4	8.0	5.8	8.9	3.8	0.8	12.9	31.9	0.2	1.7	24.6	8.5	117.2	14.2	34.9
RGS3	"C2PA, FLJ20370, PDZ-RGS3"	ENSG00000138835	"Regulator of G protein signaling 3"	P49796	9	113444731-113597743	"Plasma proteins, Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 149.4;Proximal tubular cells: 130.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 53.6;HDLM-2: 86.1"	"Low region specificity"	"Detected in all"							HPA044234			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA044234: "	"prognostic unfavorable (9.93e-4)"	"unprognostic (4.04e-2)"	"unprognostic (5.33e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (6.62e-4)"	"unprognostic (6.79e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.59e-3)"	"unprognostic (3.04e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.90e-1)"	25.2	17.8	7.6	10.7	18.3	4.7	34.0	4.2	13.8	9.8	13.0	27.9	5.1	9.9	11.4	8.0	11.3	8.4	25.0	52.2	9.7	10.1	31.9	20.1	24.9	12.5	18.4	8.5	7.2	17.5	6.3	8.1	18.9	18.1	14.5	9.6	12.9	5.6	6.6	24.6	7.0	10.8	17.9	16.8	16.2	12.3	14.8	17.1	4.0	13.2	10.7	8.3	18.3	8.1	1.4	3.8	10.6	4.1	22.4	15.0	7.8	0.9	3.5	8.7	8.0	2.7	4.0	0.6	8.8	53.6	7.2	6.1	8.6	3.2	3.7	6.5	7.1	7.2	2.3	0.1	3.4	4.2	86.1	0.0	0.3	2.9	5.2	5.5	0.0	1.2	7.2	3.6	19.9	2.9	16.0	27.0	0.2	0.0	3.7	13.0	3.9	0.2	0.4	2.2	6.0	2.9	0.2	4.3	0.6	14.8	1.7	6.8	0.9	0.8	6.9	5.2	4.4	4.7	0.8	13.0	24.2	2.6	1.1	16.5	1.8	0.3	0.5	27.9	0.8	11.1	3.4	3.5	2.1	15.0	4.1	10.1	1.4	3.5	12.1	3.8	1.2	1.4	6.6	10.6	22.4	3.1	0.1	2.0	7.8	7.6	18.3	4.2	13.8	9.7	10.1	18.4	8.5	18.1	17.1	14.9	11.5	1.9	9.8	10.6	0.6	39.3	61.1	6.7	6.8	21.0	5.9	4.1	69.6	58.9	34.8	43.8	18.6	0.0	27.0	3.4	35.7	4.0	48.3	27.3	12.9	149.4	0.0	71.8	13.6	11.9	4.4	7.1	52.3	7.2	7.0	2.7	26.2	14.2	13.1	130.2	6.1	6.5	49.5	6.6	1.5	9.9	2.5	20.3	9.0	11.6
RHEX	"C1orf186, FLJ16052"	ENSG00000263961	"Regulator of hemoglobinization and erythroid cell expansion"	Q6ZWK4	1	206052723-206102459	"Predicted membrane proteins"	"Differentiation, Erythrocyte maturation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"blood: 117.7"	"Cell type enriched"	"Detected in some"	14	"granulocytes: 308.1"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 42.8;ovarian cancer: 41.1"					"Cell type enriched"	"Detected in some"	51	"basophil: 117.7"	"Lineage enriched"	"Detected in many"	51	"granulocytes: 117.7"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 189.5"					"Low region specificity"	"Detected in all"			HPA037859			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA037859: AB_10697084"	"unprognostic (9.26e-3)"	"unprognostic (1.91e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.27e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.04e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.80e-3)"	4.3	0.0	0.0	3.9	0.0	0.0	1.8	0.0	0.0	13.1	3.1	0.0	12.1	0.9	6.2	8.2	3.4	1.6	16.2	0.4	0.0		6.8	1.8	5.2	4.0	0.0	0.0	0.8	0.0	0.0	0.0	1.2	0.0	9.4	3.3	2.9	0.0	16.9	1.5	0.2	4.0	7.0	0.0	0.4	2.4	1.1	0.0	0.6	0.0	1.7	2.5	4.3	10.0	0.3	2.2	117.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.1	0.0	8.6	189.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	38.1	0.0	0.0	0.0	0.0	0.0	0.2	2.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	117.7	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.2											0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	19.2	0.0	1.5	1.7	2.9	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	308.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
RHOA	"ARH12, ARHA, Rho12, RhoA, RHOH12"	ENSG00000067560	"Ras homolog family member A"	P61586	3	49359145-49412998	"Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins"	"Cell cycle, Cell division, Host-virus interaction"	Hydrolase	"Cancer-related genes, Disease mutation, Ectodermal dysplasia, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005052	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		65000000	"Plasma membrane, Cytosol"		"CAB005052: AB_562216"	"unprognostic (1.50e-1)"	"unprognostic (3.38e-1)"	"prognostic favorable (3.08e-4)"	"unprognostic (8.75e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.15e-4)"	"unprognostic (1.39e-1)"	"unprognostic (8.83e-2)"	"unprognostic (9.44e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.29e-2)"	"prognostic favorable (3.21e-6)"	"unprognostic (5.14e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.52e-2)"	141.1	89.5	63.0	79.8	60.6	91.4	93.1	34.3	77.3	80.3	79.1	100.4	48.9	63.6	84.4	66.4	116.7	67.8	74.2	72.5	57.6	54.8	104.0	80.7	104.6	102.4	74.0	43.8	102.7	64.9	45.8	48.2	105.3	68.8	76.0	80.3	81.6	66.5	72.0	86.0	73.9	90.8	88.9	97.3	116.0	73.4	57.3	60.3	127.1	108.1	80.1	99.8	103.4	75.7	42.6	78.4	124.2	125.7	38.3	50.5	151.5	55.7	43.0	54.0	57.9	62.0	94.0	42.2	121.4	77.8	84.9	78.3	36.4	58.5	81.8	34.9	145.8	49.3	31.8	59.3	66.2	87.2	63.1	35.3	78.1	57.9	42.7	66.5	77.0	58.6	73.4	47.1	69.4	55.9	85.8	108.6	43.5	41.6	51.5	100.6	26.6	83.8	75.1	51.6	56.0	54.8	38.8	54.3	64.3	73.4	63.7	19.8	45.1	72.9	52.8	54.7	55.8	34.2	86.8	117.2	68.2	61.8	89.9	87.2	51.2	103.7	93.9	66.4	75.8	77.8	52.5	99.7	106.8	49.1	125.7	41.6	42.6	41.4	47.6	78.4	37.5	32.2	40.1	124.2	38.3	120.4	58.7	50.5	151.5	63.0	60.6	34.3	77.3	57.6	54.8	74.0	43.8	68.8	60.3	360.3	233.2	266.1	228.8	240.6	42.2	113.5	155.4	182.0	182.0	171.0	5.9	328.4	288.5	303.4	30.3	372.7	339.7	93.5	302.0	572.5	345.6	260.3	251.7	153.0	691.2	77.9	225.0	312.5	712.8	42.2	310.4	490.6	310.4	582.5	261.8	172.7	313.0	270.7	383.3	255.4	33.0	271.7	354.1	227.5	221.8	244.4	439.3	304.1	267.8	270.4
RIPK1	RIP	ENSG00000137275	"Receptor interacting serine/threonine kinase 1"	Q13546	6	3063991-3115187	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Inflammatory response, Necrosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010302, HPA015257"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB010302: AB_2178118, HPA015257: AB_1856294"	"unprognostic (1.24e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.75e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.29e-1)"	"unprognostic (9.65e-3)"	"unprognostic (3.44e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.38e-2)"	"prognostic favorable (6.71e-4)"	24.5	12.0	6.9	15.7	12.4	10.5	28.0	11.9	11.0	16.4	18.9	9.6	22.9	14.5	16.8	17.7	17.1	13.5	17.9	12.3	7.5	6.8	18.5	36.7	16.7	19.8	11.8	6.6	13.2	19.9	14.4	17.9	24.4	10.2	17.8	16.6	10.9	21.1	18.7	11.4	18.9	24.8	21.3	6.9	19.4	15.8	9.0	9.4	18.6	18.5	15.2	19.2	15.0	20.4	4.1	3.2	6.6	3.9	6.6	7.6	2.1	9.5	6.8	10.3	10.6	22.0	14.1	5.7	15.0	20.4	15.9	18.3	9.2	6.6	8.9	14.5	21.5	16.7	11.0	12.8	12.3	17.4	18.4	6.9	11.5	4.5	6.7	12.4	9.9	14.7	19.0	11.0	14.7	10.7	13.0	13.7	5.5	12.9	5.1	15.3	12.3	6.8	10.8	6.5	11.5	8.5	8.3	7.6	10.0	14.2	19.1	8.9	8.8	9.9	6.2	16.6	21.9	11.4	7.1	16.6	17.4	9.3	6.6	11.1	7.9	10.2	9.5	7.3	5.5	19.2	1.1	3.0	6.4	6.1	3.7	4.9	2.0	4.9	7.6	3.2	4.1	4.1	5.4	6.6	6.6	3.9	2.9	5.7	2.1	6.9	12.4	11.9	11.0	7.5	6.8	11.8	6.6	10.2	9.4	6.0	8.1	8.8	8.6	9.7	3.4	6.9	12.7	21.4	20.5	8.7	11.8	7.3	5.0	8.1	1.6	15.8	13.6	0.0	11.3	5.6	9.8	8.2	10.4	12.3	10.1	4.8	6.3	11.6	5.1	0.4	6.4	11.1	3.3	17.2	15.4	7.2	10.3	10.1	5.6	8.2	21.0	19.4	15.1	0.9	2.5	8.7	10.0	12.5	9.3	12.2
RND1	"ARHS, Rho6, RHOS"	ENSG00000172602	"Rho family GTPase 1"	Q92730	12	48857145-48865898	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 21.8;liver: 50.6"	"Group enriched"	"Detected in many"	6	"Alveolar cells type 2: 240.1;Ductal cells: 153.1;Exocrine glandular cells: 130.1;Pancreatic endocrine cells: 223.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	5	"SK-BR-3: 39.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077800			Supported	"Vesicles,Plasma membrane,Actin filaments"		NA	NA			"Vesicles, Plasma membrane, Actin filaments"		"HPA077800: AB_2686854"	"unprognostic (5.60e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.59e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.89e-1)"	"unprognostic (8.38e-3)"	"unprognostic (6.18e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.35e-3)"	2.9	1.3	9.9	2.6	15.0	2.0	2.8	2.6	21.8	1.4	2.8	1.4	0.2	2.6	4.4	1.5	1.8	1.1	13.3	2.5	7.4	7.6	1.8	50.6	12.3	1.4	7.1	8.6	0.9	2.0	3.2	3.2	1.6	8.6	3.7	2.3	1.0	4.0	1.5	0.6	0.6	2.3	2.6	5.6	0.9	6.1	0.8	2.3	0.0	5.5	2.1	2.4	6.9	2.0	1.7	1.7	0.0	0.0	0.5	1.6	0.2	0.6	4.3	2.1	1.2	0.4	0.0	0.3	0.0	0.2	0.6	0.7	2.7	0.9	3.3	0.8	0.0	0.2	0.0	1.7	0.1	0.4	1.0	1.0	0.4	0.0	1.6	0.2	1.0	0.6	0.0	0.1	0.3	0.4	0.0	1.1	2.2	0.1	3.3	0.0	5.5	0.4	0.2	5.1	7.4	0.2	1.0	0.2	1.5	0.6	0.8	0.0	0.6	0.1	39.2	0.1	5.4	3.8	0.1	0.2	0.0	0.4	0.0	0.5	1.7	2.8	5.9	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	1.6	1.7	0.2	0.1	1.7	1.1	0.7	0.1	0.0	0.5	0.0	0.0	0.4	0.2	9.9	15.0	2.6	20.4	7.4	7.6	7.1	8.6	8.6	2.3	26.8	240.1	2.4	4.0	10.2	2.7	3.6	12.7	9.4	33.0	1.8	7.9	0.9	0.0	153.1	0.4	18.8	10.5	0.0	130.1	0.6	5.6	18.5	14.0	9.6	1.0	0.0	30.2	1.8	0.3	0.0	0.0	10.2	13.5	10.8	4.1	3.2	223.3	14.0	0.4	1.3	3.3	0.0	18.6	0.7	1.7	9.3	1.3	5.0	3.1	7.3
RNF146	"dactylidin, dJ351K20.1, DKFZp434O1427"	ENSG00000118518	"Ring finger protein 146"	Q9NTX7	6	127266610-127288567	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027158, HPA027209"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA027158: AB_10600772, HPA027209: AB_10602312"	"unprognostic (8.22e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.74e-2)"	"prognostic favorable (5.26e-5)"	"unprognostic (2.65e-2)"	"prognostic favorable (7.32e-4)"	"unprognostic (4.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.15e-2)"	27.3	20.9	28.5	16.6	29.1	5.1	23.9	63.7	34.5	22.7	18.6	29.2	10.5	11.8	32.0	35.2	14.2	17.9	21.3	25.2	26.3	21.7	20.9	16.8	21.0	17.3	30.0	27.7	28.5	12.6	26.5	27.4	27.8	31.3	18.6	17.6	17.5	16.7	20.3	55.9	16.0	15.2	26.1	28.7	24.6	15.5	16.3	27.7	9.2	26.7	15.5	17.6	19.2	18.7	11.7	14.2	22.8	22.8	11.5	10.3	9.1	5.5	7.0	26.7	23.5	24.8	24.9	9.7	18.9	30.3	10.1	14.6	9.1	8.4	10.0	13.4	15.4	15.9	7.1	7.9	8.9	14.8	11.5	6.9	12.7	8.4	12.7	24.6	7.5	9.1	21.7	18.7	11.4	22.8	23.4	17.7	10.0	13.7	9.9	22.3	10.6	7.4	13.6	9.7	3.4	7.3	9.4	6.9	5.0	14.4	6.1	16.0	16.2	7.4	10.5	11.6	16.5	7.1	26.1	20.8	17.9	5.9	18.5	13.3	14.3	8.8	6.6	13.7	13.2	16.8	16.8	18.9	16.1	9.3	20.0	9.7	11.1	8.0	10.3	14.2	11.7	7.3	10.2	22.8	11.5	22.8	7.1	8.6	9.1	28.5	29.1	63.7	34.5	26.3	21.7	30.0	27.7	31.3	27.7	32.8	24.8	20.8	11.4	15.8	34.0	33.0	38.2	20.1	7.9	8.7	3.9	25.1	34.9	24.3	40.1	34.9	12.8	0.0	14.1	22.7	38.1	21.4	21.9	25.2	22.8	28.6	19.7	28.3	67.8	33.7	64.5	25.0	43.9	24.4	11.5	36.1	15.1	13.9	62.6	42.1	18.1	32.3	33.5	44.7	12.2	17.6	32.2	28.7	10.9	14.1
RP2	"NM23-H10, NME10, TBCCD2"	ENSG00000102218	"RP2, ARL3 GTPase activating protein"	O75695	X	46836940-46882358	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Kupffer cells: 61.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000234, HPA000909"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA		77000	"Nucleoplasm, Plasma membrane"	"Nuclear bodies"	"HPA000234: AB_1079831, HPA000909: AB_2666140"	"unprognostic (2.26e-1)"	"unprognostic (6.01e-3)"	"unprognostic (2.79e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (7.97e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.76e-3)"	"unprognostic (3.10e-2)"	"unprognostic (3.79e-3)"	"unprognostic (9.75e-2)"	"unprognostic (6.15e-3)"	"unprognostic (2.96e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.28e-3)"	17.2	10.6	5.0	10.7	6.6	31.4	8.2	5.6	4.3	6.3	10.1	5.5	3.5	7.4	8.4	7.1	17.2	5.8	9.3	5.9	5.7	4.8	10.2	17.1	14.0	18.1	8.1	2.8	6.9	4.7	5.6	4.1	28.0	8.5	6.9	7.7	4.9	8.3	6.1	2.9	5.0	18.6	6.3	10.6	24.3	6.4	5.7	6.7	12.1	5.9	8.7	11.7	7.0	8.7	5.0	10.7	23.0	15.9	3.4	3.3	5.3	11.3	5.4	11.0	6.0	8.7	10.8	26.2	14.6	11.5	12.9	13.1	23.4	9.8	13.5	5.9	15.4	11.0	7.5	10.6	10.6	17.6	5.9	6.1	7.2	6.9	5.6	10.0	15.0	25.3	8.4	7.0	10.2	5.5	7.3	16.3	6.1	3.2	7.1	14.5	1.0	9.3	13.8	6.8	7.7	10.5	11.9	15.1	7.2	8.3	11.6	4.1	5.5	12.9	8.1	6.6	20.6	9.0	14.2	14.4	10.0	7.5	15.8	5.1	2.7	3.5	8.0	5.2	10.8	10.4	23.0	10.6	16.6	3.2	14.4	2.6	5.0	2.6	2.7	10.7	4.6	3.3	3.0	20.9	3.4	15.9	3.8	2.8	5.3	5.0	6.6	5.6	4.3	5.7	4.8	8.1	2.8	8.5	6.7	8.9	6.1	9.3	2.7	14.1	1.7	1.2	10.2	13.4	3.4	8.7	2.0	20.8	0.0	4.1	1.0	6.7	17.1	0.0	4.6	5.1	11.3	5.8	11.5	18.8	21.5	0.0	3.5	11.6	61.8	1.9	5.2	29.1	20.3	10.8	8.8	3.2	9.2	11.6	5.3	3.1	4.8	6.5	6.0	6.0	4.6	13.0	31.9	6.5	8.0	11.8
RPSA	"37LRP, LAMR1, LRP, p40, SA"	ENSG00000168028	"Ribosomal protein SA"	P08865	3	39406689-39412542	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor, Ribonucleoprotein, Ribosomal protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											CAB009561	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		710000	"Plasma membrane, Cytosol"		"CAB009561: AB_2182543"	"unprognostic (3.67e-3)"	"unprognostic (2.92e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.38e-2)"	"unprognostic (5.10e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.36e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.50e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.46e-1)"	47.5	42.9	48.8	88.4	56.9	107.0	76.7	26.3	56.2	50.9	63.6	29.1	65.6	48.4	73.5	50.1	93.4	82.4	52.2	67.3	43.2	33.7	44.1	63.8	67.5	300.2	41.7	37.7	145.1	264.7	35.7	42.2	45.0	43.5	58.9	71.5	31.4	148.1	50.2	60.4	70.5	53.0	73.9	48.1	76.8	58.4	60.2	26.8	83.5	72.8	105.2	112.4	53.8	80.4	92.4	64.0	6.9	24.8	61.5	101.2	114.8	94.0	86.2	75.0	123.6	66.0	150.6	117.9	67.2	109.0	153.3	89.8	94.2	82.0	213.0	41.3	132.2	40.9	37.6	162.1	155.2	132.2	76.8	84.8	96.4	81.9	91.4	127.9	135.4	90.9	167.2	258.7	117.8	189.1	111.8	157.7	127.2	100.1	103.3	110.7	65.8	157.2	101.3	250.8	146.3	148.3	74.3	107.5	156.3	107.1	43.5	54.3	110.8	36.6	283.1	116.5	106.9	82.6	188.5	62.1	47.1	86.9	78.3	163.4	79.9	121.4	127.0	75.6	131.9	62.2	6.9	20.6	4.8	53.8	24.8	93.5	92.4	89.8	71.4	58.1	89.5	101.2	88.4	3.0	61.5	20.4	64.0	66.1	114.8	48.8	56.9	26.3	56.2	43.2	33.7	41.7	37.7	43.5	26.8	482.4	691.4	2495.2	2051.4	1601.1	264.3	56.9	960.5	540.7	781.4	308.8	90.3	2456.3	840.6	1172.8	115.3	934.8	552.2	584.0	2956.9	3841.9	1034.7	1574.0	748.4	620.0	1468.8	163.7	993.6	761.1	1046.6	195.0	1148.6	961.8	700.1	1430.1	1771.7	254.3	1913.9	673.4	702.5	847.9	249.3	465.7	1029.7	293.8	1026.5	1675.1	2024.4	2012.8	2593.9	2441.2
RRP12	KIAA0690	ENSG00000052749	"Ribosomal RNA processing 12 homolog"	Q5JTH9	10	97356358-97426076	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 62.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 19.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049945, HPA074403"			Supported	"Nucleoli,Vesicles,Plasma membrane,Cytosol"		No	No			Nucleoli	"Vesicles, Plasma membrane, Cytosol"	"HPA049945: AB_2680965, HPA074403: "	"unprognostic (2.79e-1)"	"unprognostic (7.65e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.12e-8)"	"unprognostic (2.64e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (2.54e-5)"	"unprognostic (2.58e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.81e-2)"	"unprognostic (6.99e-3)"	7.1	8.4	5.9	7.4	11.9	62.6	4.6	3.8	15.7	4.1	4.0	5.4	2.9	5.2	6.4	3.9	7.1	6.4	6.4	8.4	4.4	7.2	4.4	9.3	5.6	6.0	5.9	6.1	6.0	16.4	9.6	10.6	3.9	9.6	5.5	3.6	4.1	6.6	3.9	31.7	8.2	3.8	5.3	3.2	7.1	5.3	13.9	6.1	4.6	4.9	7.2	5.4	4.2	4.3	3.4	4.3	19.3	11.1	1.2	2.4	3.7	15.9	21.4	5.7	12.3	4.4	5.2	12.5	10.1	6.1	10.5	8.2	23.2	14.8	17.6	13.2	6.4	9.4	20.6	15.6	11.7	7.1	9.6	18.7	13.6	8.0	18.0	7.3	21.1	17.9	5.4	16.6	25.8	23.9	11.9	5.9	9.9	19.4	11.8	5.9	20.8	14.3	13.6	24.5	8.5	14.5	15.7	7.8	17.4	7.3	8.9	7.7	16.4	8.1	7.8	10.1	4.6	18.8	11.0	7.7	7.1	12.2	15.8	31.9	24.2	21.0	20.7	10.1	27.2	7.5	0.2	7.3	4.6	2.0	9.3	2.4	2.9	1.2	1.6	4.3	3.4	1.9	2.1	19.3	1.2	11.1	3.6	0.8	3.7	5.9	11.9	3.8	15.7	4.4	7.2	5.9	6.1	9.6	6.1	32.8	39.8	13.7	10.9	20.8	6.2	9.5	7.6	25.4	34.2	14.0	39.3	4.4	0.0	9.1	5.6	6.7	3.9	0.0	7.4	5.9	7.6	10.1	39.4	6.8	10.4	4.8	20.6	4.9	10.8	3.6	3.4	8.4	6.8	1.0	7.2	2.2	7.8	5.1	2.5	6.8	12.3	0.0	6.1	9.9	18.4	17.1	7.7	4.4	7.8	12.4
RTN4R	NOGOR	ENSG00000040608	"Reticulon 4 receptor"	Q9BZR6	22	20241415-20283246	"Disease related genes, Predicted membrane proteins"		Receptor	"Disease mutation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 12.0;brain: 33.2"	"Cell type enhanced"	"Detected in many"	6	"Muller glia cells: 9.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 12.0"	"Lineage enriched"	"Detected in many"	9	"T-cells: 12.0"	"Cell line enhanced"	"Detected in many"		"NB-4: 20.5;REH: 28.8;SCLC-21H: 17.6;SK-MEL-30: 13.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB012443			Supported	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA		1300000	"Plasma membrane, Focal adhesion sites"	"Actin filaments"	"CAB012443: "	"unprognostic (1.28e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.29e-2)"	"unprognostic (6.58e-2)"	"unprognostic (3.49e-1)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.90e-3)"	"unprognostic (1.21e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.07e-1)"	0.8	1.1	10.9	1.2	7.0	1.3	0.7	33.2	24.6	0.8	1.7	1.2	0.3	3.9	4.9	0.5	0.9	1.3	0.6	1.4	8.8	3.1	0.9	4.0	1.7	1.1	1.4	6.8	1.1	2.7	0.6	1.6	1.1	4.9	1.2	0.6	0.7	1.3	1.2	0.8	5.2	1.8	0.7	2.8	5.9	2.3	1.1	0.5	0.1	1.1	0.4	0.7	0.7	0.7	0.1	1.3	0.0	0.0	0.7	12.0	1.7	4.2	2.0	1.3	3.0	0.0	0.0	0.7	0.4	0.0	0.3	0.1	3.2	1.2	0.2	1.4	0.0	2.1	6.9	0.8	1.8	0.0	0.1	7.4	0.1	1.8	0.4	0.7	0.1	0.2	0.0	2.3	0.0	0.2	0.0	0.0	2.0	0.2	0.2	0.0	5.9	2.2	20.5	4.8	1.2	3.7	28.8	0.0	0.2	0.2	1.8	17.6	2.8	2.0	1.5	13.7	0.3	1.7	0.6	0.0	0.2	8.2	0.0	0.1	0.0	0.5	0.5	0.2	4.2	0.0	0.0	0.0	0.0	5.1	0.0	12.0	0.0	4.5	5.1	0.2	0.1	2.7	5.7	0.0	0.7	0.0	1.3	3.1	1.7	10.9	7.0	33.2	20.1	8.8	3.1	1.4	6.8	4.9	0.5	3.0	0.0	0.0	3.6	4.5	5.3	1.7	0.0	0.0	0.0	0.0	3.9	0.0	0.0	2.4	2.0	1.4	1.3	0.0	3.7	4.3	0.5	3.1	0.0	0.9	1.3	6.4	0.0	0.6	0.0	0.0	0.3	0.0	1.7	1.0	1.4	9.8	2.4	0.0	0.0	0.0	4.8	0.0	0.6	0.0	1.3	4.8	0.0	1.0	1.6	2.6
RTN4RL1	"DKFZp547J144, NgR3, NGRH2"	ENSG00000185924	"Reticulon 4 receptor like 1"	Q86UN2	17	1934677-2025345	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.3"	"Cell type enhanced"	"Detected in many"	14	"Bipolar cells: 17.9;Cone photoreceptor cells: 35.3;Horizontal cells: 31.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 10.8;HaCaT: 10.8;hTCEpi: 10.3;T-47d: 13.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044428	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Midbody"	"Intracellular and membrane"	NA	NA			"Actin filaments"	"Nucleoplasm, Plasma membrane, Midbody"	"HPA044428: AB_10963229"	"unprognostic (5.23e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.93e-2)"	"unprognostic (7.25e-2)"	"unprognostic (2.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (8.97e-3)"	"unprognostic (6.21e-2)"	"unprognostic (2.55e-3)"	"unprognostic (6.32e-3)"	"prognostic unfavorable (7.69e-4)"	"unprognostic (3.86e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.01e-2)"	"unprognostic (3.15e-2)"	8.3	5.0	6.8	1.2	8.0	0.6	7.0	4.6	19.3	3.4	1.3	0.6	7.2	0.8	1.9	1.0	1.4	3.6	2.9	2.7	9.6	2.7	2.6	3.2	3.9	0.8	1.3	7.9	1.6	3.8	2.0	6.5	1.3	0.7	6.1	0.8	8.4	9.8	5.3	3.9	11.3	1.2	1.2	1.0	2.7	1.2	1.3	0.1	0.0	1.5	0.8	0.9	1.4	3.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	1.4	1.6	1.8	2.5	2.1	0.3	0.0	0.1	1.1	0.3	0.0	0.0	0.0	0.0	0.1	10.8	0.2	10.8	4.7	0.1	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	10.3	0.0	3.7	0.0	0.0	2.6	0.1	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.3	0.8	0.3	1.2	0.0	0.0	2.3	0.1	0.3	0.8	1.8	0.3	13.5	0.1	0.0	0.0	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	8.0	4.6	19.3	9.6	2.7	1.3	7.9	0.7	0.1	0.0	2.1	0.0	0.2	2.4	17.9	2.6	0.0	2.7	2.3	3.5	35.3	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.1	0.0	2.1	1.4	31.8	0.0	6.7	0.0	0.9	0.0	0.0	3.3	0.0	0.0	1.5	0.1	0.0	0.0	0.0	10.0	0.0	0.5	0.0	0.1	2.5	0.0	0.0	0.0	0.2
SCEL	"FLJ21667, MGC22531"	ENSG00000136155	Sciellin	O95171	13	77535674-77645263	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 145.6;skin 1: 70.8;tongue: 62.2"	"Cell type enriched"	"Detected in many"	13	"Alveolar cells type 1: 631.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.4;HaCaT: 23.3;HBEC3-KT: 11.1;OE19: 31.1;RPTEC TERT1: 45.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA039737, HPA040154"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA039737: AB_10805485, HPA040154: AB_10795359"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (4.07e-4)"	"unprognostic (5.91e-2)"	"unprognostic (4.54e-2)"		"unprognostic (6.62e-2)"	"unprognostic (3.51e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (4.57e-2)"	"prognostic favorable (6.87e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.75e-3)"	"prognostic unfavorable (1.73e-5)"	0.4	0.0	0.1	0.2	0.4	0.0	4.9	0.1	0.2	15.2	0.2	0.2	0.1	0.0	0.8	0.2	145.6	0.0	0.3	0.1	0.1	0.0	0.4	0.1	27.8	0.1	0.1	0.1	0.2	0.1	0.0	0.1	3.7	0.2	0.1	0.4	0.1	11.8	0.1	0.3	70.8	0.2	0.1	0.2	0.1	0.0	0.5	0.1	0.4	0.5	62.2	35.1	0.4	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.7	0.0	0.0	23.3	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.1	6.3	0.0	0.0	0.0	45.3	0.0	1.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1	631.3	30.6	0.0	0.0	9.5	0.0	0.2	0.0	6.7	42.1	0.0	0.0	0.3	0.0	4.1	5.8	0.0	0.0	0.0	0.2	0.0	0.3	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.6	1.7	0.0	4.3	1.5	26.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.7	48.8	0.1	0.0	0.0	2.6
SCN1A	"FEB3, GEFSP2, HBSCI, NAC1, Nav1.1, SCN1, SMEI"	ENSG00000144285	"Sodium voltage-gated channel alpha subunit 1"	P35498	2	165984641-166149214	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 33.9"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 2: 26.9;Bipolar cells: 33.9"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC TERT1: 11.6;Hep G2: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078664			Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"	"Nuclear bodies"	"HPA078664: AB_2686888"	"unprognostic (9.25e-2)"	"unprognostic (3.97e-2)"		"unprognostic (6.88e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.03e-9)"	"unprognostic (6.92e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.06e-3)"	"unprognostic (6.93e-1)"	1.1	1.3	5.2	1.1	13.6	1.0	1.1	10.3	26.6	1.1	1.1	2.3	0.0	1.0	1.1	1.1	1.0	6.8	1.0	1.1	6.9	8.3	1.1	1.1	5.6	1.0	5.7	9.7	1.0	1.0	1.1	2.9	1.2	33.9	1.1	1.1	0.3	1.0	1.0	1.2	1.1	1.1	1.1	3.6	1.1	1.1	1.4	4.2	0.0	1.1	0.0	1.0	1.1	0.1	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	11.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	6.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	5.2	13.6	10.3	26.6	6.9	8.3	5.7	9.7	33.9	4.2	6.0	26.9	0.0	0.0	0.0	33.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
SCN5A	"CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1"	ENSG00000183873	"Sodium voltage-gated channel alpha subunit 5"	Q14524	3	38548057-38649673	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Calmodulin-binding, Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Cardiomyopathy, Disease mutation, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"heart muscle: 67.3"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 66.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"LHCN-M2: 22.0;RH-30: 18.3"	"Group enriched"	"Detected in some"	5	"amygdala: 3.2;basal ganglia: 10.5;hypothalamus: 7.0"	"Low region specificity"	"Detected in many"			HPA063346			Supported	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Plasma membrane"	"Nucleoplasm, Nucleoli"	"HPA063346: "	"unprognostic (9.29e-4)"	"unprognostic (4.05e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (8.48e-2)"	"unprognostic (7.12e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.16e-4)"	"unprognostic (4.85e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.95e-3)"	0.3	0.2	1.3	0.2	0.3	0.4	0.6	0.1	2.3	2.0	0.4	0.0	0.4	0.3	0.9	0.8	0.2	0.4	0.3	67.3	0.5	0.7	0.1	0.1	0.2	0.1	0.1	0.3	0.6	0.2	0.1	0.8	0.3	0.0	1.3	0.2	1.2	0.3	1.6	5.5	0.2	0.3	0.4	0.1	0.2	0.2	0.5	0.0	0.0	0.3	0.1	0.1	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.1	0.8	0.4	0.0	0.1	0.3	2.7	0.0	0.0	0.0	0.9	0.9	2.7	0.0	0.4	0.0	1.2	0.7	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.5	0.0	1.7	3.6	0.4	0.0	0.0	22.0	1.1	0.0	0.0	2.0	0.0	0.0	0.0	18.3	0.0	0.0	2.4	0.3	2.4	0.0	0.0	0.0	0.7	0.0	0.0	4.4	0.0	4.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.1	2.3	0.5	0.7	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.2	3.1	66.1	0.0	0.0	0.0	0.0	13.7	0.1	0.0	0.1	1.0	0.4	0.0	0.0	0.0	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.7	0.0	0.4	0.3	0.9	0.0	0.0	0.0	0.0	1.0
SCN8A	"CerIII, CIAT, MED, NaCh6, Nav1.6, PN4"	ENSG00000196876	"Sodium voltage-gated channel alpha subunit 8"	Q9UQD0	12	51590266-51812864	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 27.6;pituitary gland: 9.7"	"Cell type enhanced"	"Detected in some"	9	"Bipolar cells: 13.7;Cone photoreceptor cells: 9.8;Intestinal endocrine cells: 10.9;Rod photoreceptor cells: 10.5;Spermatogonia: 10.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 12.0;ASC TERT1: 12.7;BJ hTERT+: 11.2;WM-115: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022169, HPA043937, HPA073590"			Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Vesicles, Cell Junctions"	"CAB022169: , HPA043937: , HPA073590: "	"unprognostic (2.96e-2)"	"unprognostic (8.49e-2)"	"unprognostic (6.93e-2)"	"unprognostic (3.52e-6)"	"unprognostic (8.13e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.77e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.73e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.29e-5)"	"unprognostic (4.38e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.75e-2)"	1.1	3.0	9.1	1.5	18.1	1.9	1.9	16.7	27.6	1.0	2.0	1.6	0.0	1.1	1.5	2.0	0.9	1.1	2.5	0.9	12.6	4.5	1.9	4.3	1.0	1.3	3.2	13.7	1.8	3.2	1.5	9.7	0.9	14.8	1.8	2.5	0.9	1.7	1.2	1.0	1.1	1.2	1.0	2.2	1.7	2.7	3.8	1.6	0.0	1.7	0.0	1.2	1.0	0.6	0.4	0.2	0.0	0.0	0.0	1.0	0.0	1.4	1.0	12.0	0.1	1.6	12.7	0.2	6.8	11.2	7.9	7.3	2.0	1.4	0.3	1.6	8.9	3.5	0.0	1.9	0.0	9.3	1.2	0.6	0.1	0.1	0.2	0.1	0.2	0.9	1.7	0.0	5.2	1.1	3.1	8.4	2.8	0.1	0.1	4.9	0.8	2.0	0.1	4.1	0.7	3.8	0.0	0.6	0.0	0.0	0.4	4.8	2.0	3.5	1.8	0.2	1.8	0.3	0.1	2.2	7.7	5.1	2.8	4.3	0.1	0.1	0.0	1.5	1.6	11.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.7	1.0	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	9.1	18.1	16.7	25.0	12.6	4.5	3.2	13.7	14.8	1.6	0.0	0.0	0.0	0.4	0.0	13.7	1.2	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.2	0.4	0.4	0.0	0.0	0.5	0.0	0.0	0.2	0.0	3.4	0.0	4.8	10.9	1.3	0.0	0.2	0.0	0.0	0.0	0.0	1.3	5.3	0.5	0.0	0.7	0.5	10.5	0.0	0.3	1.9	10.0	0.0	0.0	0.0	0.6	0.1
SCNN1D	"dNaCh, ENaCdelta"	ENSG00000162572	"Sodium channel epithelial 1 delta subunit"	P51172	1	1280436-1292029	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 9.6"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-266/70: 11.4"									HPA026884	Enhanced		Supported	"Plasma membrane,Actin filaments"		NA	NA			"Plasma membrane, Actin filaments"		"HPA026884: AB_10601501"	"unprognostic (2.08e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.39e-4)"	"unprognostic (1.06e-2)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.60e-4)"	"unprognostic (1.44e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (5.27e-2)"	"prognostic unfavorable (6.67e-5)"	"unprognostic (3.13e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.06e-2)"	3.2	3.8	4.0	1.9	5.1	3.6	1.2	12.8	6.3	1.7	2.0			7.0	3.2	1.1	1.1	3.9	1.5	1.5	4.1	3.3	1.4	3.2	1.5	2.5	3.1		4.6	3.0	0.8	5.9	1.3		2.3	0.2		8.6	2.4	3.9	4.6	5.1	1.0	3.2	3.8	2.4	10.2			1.3		0.7	0.7	1.8	0.5	0.9	0.0	0.2	0.0	0.8	0.2	0.6	5.0	2.0	5.2	1.4	0.8	0.9	3.3	1.0	1.7	1.9	0.9	2.8	3.6	1.8	1.5	2.5	0.8	0.9	0.8	0.3	6.7	3.1	0.4	6.0	1.3	1.4	0.1	3.6	2.3	1.1	2.6	0.0	2.2	0.5	6.5	2.4	8.5	0.4	1.8	1.4	2.4	1.0	0.6	3.7	9.3	0.4	0.8	0.8	0.2	2.7	3.8	1.4	1.5	2.2	0.8	6.6	1.8	1.4	3.2	2.7	5.0	1.1	11.4	0.7	2.9	2.9	6.1	3.6	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.0	0.9	0.0	0.2											3.0	2.9	0.0	0.2	0.7	3.2	4.0	0.0	2.7	2.3	0.0	3.9	0.1	0.0	0.4	9.6	0.0	1.7	0.0	0.4	0.2	1.0	0.1	2.3	2.1	0.3	4.8	1.2	0.6	0.6	3.2	0.9	0.9	0.0	0.0	0.2	2.0	1.2	3.5	1.8	0.6	2.5	0.0	0.9	1.8	2.1	1.4	0.0	0.0	0.6	0.3
SCNN1G	"ENaCgamma, SCNEG"	ENSG00000166828	"Sodium channel epithelial 1 gamma subunit"	P51170	16	23182715-23216883	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 42.9;salivary gland: 26.8"	"Cell type enhanced"	"Detected in some"	29	"Alveolar cells type 1: 17.9;Club cells: 21.6;Collecting duct cells: 85.5"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 15.6"	"Region enriched"	"Detected in some"	6	"cerebellum: 9.7"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.8"	"Group enriched"	"Detected in some"	7	"hTCEpi: 31.4;RT4: 14.2"	"Region enriched"	"Detected in single"	13	"cerebellum: 2.8"	"Low region specificity"	"Detected in all"			HPA071194			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA071194: AB_2686359"	"unprognostic (2.90e-1)"	"unprognostic (5.21e-3)"	"unprognostic (5.79e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.71e-3)"		"unprognostic (1.97e-1)"	"unprognostic (4.85e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (3.20e-7)"	"unprognostic (2.80e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.17e-3)"	1.1	0.3	0.6	0.2	0.0	0.4	2.5	9.7	0.4	14.0	5.5	0.0	4.8	0.2	3.2	1.7	10.3	0.5	0.2	0.2	1.5	0.0	42.9	0.2	15.6	0.2	0.0	0.3	0.2	3.8	0.2	6.5	0.7	0.7	10.2	1.1	0.0	26.8	12.8	2.2	6.6	0.2	0.3	0.3	0.2	6.9	0.3	0.0	1.5	25.5	3.3	3.9	1.7	11.3	0.3	0.3	1.8	0.2	0.2	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	14.2	1.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.3	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.2	0.1	1.8	0.2	0.1	0.3	0.1	0.0	0.6	0.0	9.7	0.4	1.5	0.0	0.0	0.3	0.7	0.0	17.9	3.4	0.0	4.0	0.3	0.0	0.8	0.0	2.7	21.6	85.5	0.0	0.1	0.0	1.3	0.0	0.0	0.3	0.0	1.5	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	1.4
SDE2	"C1orf55, FLJ35382"	ENSG00000143751	"SDE2 telomere maintenance homolog"	Q6IQ49	1	225982702-225999331	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028467, HPA031255, HPA031256"	Approved		Supported	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Nuclear speckles"	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA028467: AB_10599192, HPA031255: AB_10601462, HPA031256: AB_10603568"	"unprognostic (9.69e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.90e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.84e-2)"	25.6	11.2	10.7	13.3	12.8	33.6	21.6	10.8	11.5	12.3	10.6	17.9	9.0	11.0	15.1	11.5	14.3	12.8	13.4	12.2	10.8	11.0	11.9	17.9	16.2	13.9	14.1	9.8	16.2	14.2	15.6	13.9	14.5	12.5	12.9	11.6	11.1	12.0	11.2	20.9	18.0	12.9	12.7	13.5	14.4	11.5	14.1	14.4	33.9	15.8	11.0	14.1	15.6	16.9	8.2	7.8	17.9	7.2	12.5	11.2	6.3	8.5	6.2	10.1	10.7	7.1	7.9	12.6	9.1	8.7	12.5	9.6	9.0	9.8	12.5	14.3	7.7	4.9	11.0	12.6	7.9	15.3	9.5	10.3	13.8	5.3	8.2	13.0	13.5	16.8	8.7	11.5	13.3	16.9	7.1	8.6	15.1	25.1	15.2	9.2	2.5	18.8	10.8	14.0	13.2	6.6	15.9	13.0	16.2	7.5	6.0	9.1	15.1	10.4	11.4	17.1	8.5	11.2	16.7	8.4	10.7	7.6	13.8	19.9	9.1	6.5	15.5	11.0	8.4	21.1	16.3	6.0	5.5	8.2	6.2	11.2	8.2	8.3	7.9	6.7	7.1	8.6	8.0	17.9	12.5	7.2	7.8	6.4	6.3	10.7	12.8	10.8	11.5	10.8	11.0	14.1	9.8	12.5	14.4	26.8	23.5	17.7	14.0	38.7	5.2	7.3	2.5	13.4	25.0	8.7	0.0	7.6	13.3	5.8	47.5	16.2	11.3	23.3	6.1	8.4	15.4	11.4	34.6	17.9	9.7	14.3	16.7	12.9	16.1	12.7	9.2	13.9	18.6	5.4	10.7	11.4	8.2	10.7	6.0	9.0	7.7	6.5	17.3	15.1	13.9	51.7	11.9	15.0	9.8	16.6
SEMA6C	KIAA1869	ENSG00000143434	"Semaphorin 6C"	Q9H3T2	1	151131685-151146664	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 124.1;tongue: 43.4"	"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 15.3;Cone photoreceptor cells: 19.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 11.9;HUVEC TERT2: 20.9;TIME: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA076150, HPA077625"			Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		290000	"Nucleoplasm, Plasma membrane"	"Nucleoli fibrillar center, Cytosol"	"HPA076150: , HPA077625: "	"unprognostic (6.97e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.56e-3)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (2.79e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.25e-2)"	"prognostic favorable (3.06e-5)"	"unprognostic (3.72e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.12e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-1)"	3.2	1.9	2.3	1.5	3.0	1.3	3.4	16.8	5.8	4.2	2.6	1.5	0.8	6.7	4.1	3.5	3.2	2.9	3.9	12.7	2.3	3.5	3.0	3.3	1.9	3.4	1.7	3.3	4.8	1.7	1.7	4.3	1.6	2.7	2.8	1.6	3.4	3.1	1.9	124.1	3.4	5.2	3.6	1.1	1.3	1.6	15.0	0.6	0.5	1.3	43.4	2.9	2.2	3.6	0.9	0.6	0.7	0.0	0.1	1.4	0.2	0.8	0.8	11.9	4.6	5.1	1.7	1.1	0.8	0.4	0.8	1.1	0.2	0.5	0.5	3.4	2.7	1.7	1.2	1.1	0.4	0.7	1.0	3.5	6.2	0.5	1.0	0.7	0.1	2.3	2.9	1.4	1.0	0.5	2.4	20.9	3.4	0.5	0.6	2.0	0.4	1.0	0.8	5.4	0.1	1.4	7.4	2.6	0.3	0.4	0.3	6.1	7.9	1.1	0.5	1.0	3.1	1.3	1.0	9.7	2.0	2.9	3.0	0.4	5.0	0.9	5.1	0.5	0.2	0.7	0.0	0.0	0.7	0.1	0.0	1.4	0.0	0.2	0.0	0.0	0.9	0.5	0.0	0.5	0.1	0.0	0.6	0.3	0.2	2.3	3.0	16.8	5.8	2.3	3.5	1.7	3.3	2.7	0.6	0.0	3.2	1.7	0.8	1.4	4.2	15.3	2.5	0.0	1.2	0.0	19.6	0.2	0.0	0.3	0.5	3.1	0.3	0.0	0.4	0.4	2.1	0.5	0.0	2.4	0.3	6.4	0.0	4.9	1.6	2.1	5.2	0.0	1.7	0.0	0.0	1.7	0.4	0.0	2.5	2.7	6.9	0.0	2.0	2.8	1.1	0.9	0.1	0.0	0.2	0.5
SERINC5	"C5orf12, TPO1"	ENSG00000164300	"Serine incorporator 5"	Q86VE9	5	80111651-80256079	"Predicted membrane proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Glandular cells: 145.8;Urothelial cells: 161.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037898, HPA037899"	Supported		Supported	"Vesicles,Plasma membrane,Centrosome,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Vesicles, Centrosome"	"HPA037898: AB_10673649, HPA037899: AB_2675727"	"unprognostic (2.95e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.08e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.80e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.68e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.81e-2)"	"unprognostic (8.09e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.17e-2)"	6.9	21.1	9.0	7.8	11.2	3.0	6.7	5.3	15.6	10.2	16.3	28.8	11.2	5.1	6.9	12.9	9.7	9.6	8.4	4.1	9.5	7.3	5.3	26.3	8.0	9.3	13.4	7.0	9.8	7.8	4.2	5.3	24.7	12.1	20.3	17.5	3.6	9.8	8.4	3.1	10.9	9.5	4.4	9.7	8.3	9.7	18.9	15.0	7.8	5.2	6.7	12.3	9.3	7.7	0.8	4.0	6.2	6.9	0.4	17.5	4.7	4.9	8.9	3.0	1.9	4.2	4.4	9.1	4.1	2.7	1.8	1.9	18.0	25.9	0.8	4.2	5.2	4.2	14.5	4.1	10.8	2.6	0.7	2.2	0.6	1.1	9.6	1.5	0.6	1.9	5.1	6.0	4.7	12.3	5.1	3.3	24.6	1.6	4.3	4.8	8.6	10.0	2.4	4.2	7.0	3.1	12.0	2.7	1.3	5.3	24.7	0.2	2.9	3.6	8.5	15.9	16.2	3.7	3.1	3.6	5.3	1.5	5.3	5.0	5.6	1.5	13.0	9.9	1.7	21.5	6.2	6.9	4.4	1.6	3.4	1.2	0.5	13.9	4.2	4.0	0.8	17.5	10.5	3.6	0.4	1.0	0.9	4.5	4.7	9.0	11.2	5.3	10.9	9.5	7.3	13.4	7.0	12.1	15.0	56.6	23.8	3.7	42.8	5.7	3.7	7.5	22.9	2.7	23.9	15.7	0.0	14.2	8.3	21.5	1.4	17.5	72.2	0.0	16.8	20.9	20.6	145.8	8.1	74.0	19.5	3.2	57.7	43.0	25.4	4.2	17.0	27.0	5.0	36.1	63.6	60.6	25.3	57.5	37.4	4.6	4.8	32.3	3.8	1.2	7.9	8.5	108.0	16.7	74.3	161.9
SH3D21	"C1orf113, FLJ22938"	ENSG00000214193	"SH3 domain containing 21"	A4FU49	1	36306387-36324886	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 26.2"	"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 13.1;Late spermatids: 38.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.0;NK-cell: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 13.5;hTERT-RPE1: 22.0;SuSa: 11.2"									"HPA042212, HPA042456, HPA066168"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA042212: AB_10961180, HPA042456: AB_10959746, HPA066168: AB_2685627"	"prognostic favorable (2.60e-4)"	"unprognostic (8.35e-3)"	"unprognostic (3.86e-3)"	"unprognostic (9.01e-2)"	"unprognostic (2.07e-3)"	"unprognostic (7.32e-3)"	"unprognostic (2.04e-4)"	"unprognostic (7.47e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.38e-3)"	"prognostic unfavorable (1.76e-6)"	"unprognostic (8.88e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.99e-2)"	"unprognostic (8.59e-2)"	1.6	1.1	11.6	3.4	9.5	1.9	10.1	12.2	11.3	4.4	5.3	1.1	1.4	16.6	2.8	2.7	7.1	1.9	3.0	2.2	5.2	2.2	8.6	1.4	4.5	2.8	1.9	7.0	4.0	1.0	1.3	2.2	19.4	7.4	7.0	6.0	12.4	12.7	2.6	1.0	16.2	24.3	2.0	2.4	1.6	2.3	6.6	1.9	0.0	26.2	4.1	4.5	3.7	6.7	0.1	0.3	2.0	0.5	2.7	0.6	0.0	8.3	0.2	1.6	1.9	0.5	1.0	9.1	4.0	0.8	3.0	1.3	4.7	3.4	1.5	4.4	1.7	0.3	13.5	1.4	3.0	2.5	0.4	0.6	1.3	2.9	3.7	1.3	0.7	2.0	0.5	2.5	2.0	1.5	22.0	1.1	4.1	0.2	2.6	1.4	4.9	1.4	0.7	1.0	2.2	1.6	2.0	0.1	1.0	3.4	1.0	3.4	1.7	0.9	10.1	3.1	11.2	0.3	0.3	2.3	1.2	0.7	4.0	0.4	3.0	0.9	1.7	3.4	0.7	0.3	0.0	0.5	0.0	0.4	0.0	0.0	0.1	0.6	0.0	0.3	0.0	0.0	0.0	2.0	2.7	0.0	0.0	0.0	0.0	11.6	9.5	12.2	11.3	5.2	2.2	1.9	7.0	7.4	1.9	0.0	1.3	0.8	1.5	2.7	5.2	0.9	0.0	0.0	0.0	5.2	0.0	2.5	1.7	0.5	13.1	0.9	11.8	0.0	0.3	2.1	1.4	2.0	1.1	0.0	7.0	11.1	0.0	0.6	3.2	38.8	1.1	4.7	3.3	3.6	2.0	1.0	2.7	0.8	2.5	0.8	1.1	0.0	1.7	2.1	1.5	2.8	4.8	0.0	1.6	1.1
SHANK1	"SPANK-1, SSTRIP, synamon"	ENSG00000161681	"SH3 and multiple ankyrin repeat domains 1"	Q9Y566	19	50661827-50719450	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"brain: 35.7"	"Cell type enhanced"	"Detected in some"	20	"Bipolar cells: 5.3;Cardiomyocytes: 3.0;Cone photoreceptor cells: 2.0;Horizontal cells: 7.9"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 7.5;SH-SY5Y: 3.6;U-138 MG: 4.2;U-2 OS: 10.6;U-87 MG: 4.0;U-937: 4.4"	"Low region specificity"	"Detected in all"							"HPA032129, HPA032130"	Uncertain		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA032129: AB_10602796, HPA032130: AB_2674169"	"unprognostic (1.62e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.83e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.14e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.29e-3)"	0.9	2.6	27.9	0.9	10.0	1.2	0.9	13.6	35.7	1.3	0.9	1.1	0.0	0.9	1.3	1.0	0.9	2.2	1.1	0.9	25.6	12.3	0.9	0.8	0.8	0.9	6.0	11.1	0.9	0.9	2.1	2.8	1.0	4.1	1.0	0.8	0.2	0.9	1.0	1.0	1.2	0.9	1.1	2.2	0.9	0.8	1.4	3.5	0.4	0.9	0.0	0.9	0.9	0.0	0.0	0.7	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.0	0.2	0.5	0.0	1.3	1.2	0.1	0.1	0.0	0.0	0.0	2.0	0.7	0.1	0.0	0.2	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.1	0.0	0.4	0.4	0.0	0.0	0.1	0.0	0.6	0.9	0.0	0.0	0.7	0.1	0.1	0.8	1.2	0.0	0.1	7.5	0.0	0.8	0.0	0.0	0.0	3.6	0.0	0.0	1.1	0.0	0.0	3.2	2.3	4.2	10.6	0.0	0.0	0.0	0.0	0.0	4.0	4.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.0	0.0	27.9	10.0	13.6	23.0	25.6	12.3	6.0	11.1	4.1	3.5	0.0	0.0	0.0	0.0	0.0	5.3	3.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
SIGLEC10	"MGC126774, PRO940, SIGLEC-10, SLG2"	ENSG00000142512	"Sialic acid binding Ig like lectin 10"	Q96LC7	19	51410021-51417803	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"blood: 99.9;lymphoid tissue: 74.6"	"Group enriched"	"Detected in some"	5	"B-cells: 17.9;granulocytes: 39.2;Kupffer cells: 67.4;Macrophages: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"eosinophil: 99.9;intermediate monocyte: 33.9;non-classical monocyte: 66.7"	"Group enriched"	"Detected in many"	14	"granulocytes: 99.9;monocytes: 66.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 21.3;HDLM-2: 6.5;HEL: 10.9;HMC-1: 8.7;NB-4: 6.7;U-698: 15.7;U-937: 9.0"									"CAB025807, HPA027093"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"	NA	NA			Cytosol	"Plasma membrane, Actin filaments"	"CAB025807: , HPA027093: AB_1856858"	"unprognostic (7.18e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.67e-2)"	"unprognostic (3.95e-2)"	"unprognostic (9.41e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.12e-1)"	"prognostic unfavorable (4.74e-5)"	"unprognostic (2.73e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.05e-2)"	2.6	6.2	4.5	24.6	9.8	9.1	1.4	0.7	4.9	2.7	3.7	5.7	0.0	5.3	1.3	0.7	2.2	2.7	2.7	1.6	3.3	3.0	2.6	7.2	7.7	74.6	6.6	1.8	1.2	2.4	0.2	2.5	1.1	7.7	2.6	3.3	0.7	2.3	0.7	0.6	0.9	9.6	3.2	7.4	37.0	3.1	0.9	4.8	2.0	1.2	0.2	13.2	4.8	1.3	5.8	5.1	99.9	66.7	0.0	0.1	4.4	0.1	0.0	0.4	0.4	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	1.0	21.3	0.6	0.0	0.3	0.4	0.0	0.1	0.0	6.5	1.6	10.9	0.2	0.1	0.0	4.9	8.7	0.0	0.0	0.1	0.0	0.1	0.0	1.3	0.5	1.1	0.0	0.4	0.1	6.7	0.6	0.5	0.3	1.4	0.1	0.4	0.0	0.2	0.3	0.3	0.3	0.1	0.2	0.4	0.1	4.0	0.5	0.6	1.0	0.4	0.2	1.0	0.2	15.7	0.4	9.0	0.3	1.5	5.6	99.9	0.1	33.9	0.0	5.8	0.0	0.0	5.1	3.6	0.0	0.0	11.5	0.0	66.7	0.2	0.1	4.4	4.5	9.8	0.7	4.9	3.3	3.0	6.6	1.8	7.7	4.8	3.0	2.2	17.9	0.9	0.1	1.4	0.3	0.0	0.0	0.0	1.8	2.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.1	0.3	1.0	39.2	0.5	7.8	0.0	0.0	0.6	67.4	0.0	0.0	34.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.2	0.3	1.1	0.1	2.2	0.0	0.8
SIGLEC14		ENSG00000254415	"Sialic acid binding Ig like lectin 14"	Q08ET2	19	51642553-51646801	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 48.7;bone marrow: 13.3;lymphoid tissue: 21.6"	"Cell type enhanced"	"Detected in some"	22	"Hofbauer cells: 16.1;Kupffer cells: 31.5;Macrophages: 9.8"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in many"	6	"classical monocyte: 25.8;intermediate monocyte: 29.7;myeloid DC: 15.9;neutrophil: 48.7;non-classical monocyte: 21.3"	"Group enriched"	"Detected in many"	6	"dendritic cells: 15.9;granulocytes: 48.7;monocytes: 29.7"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 47.5"									"HPA014377, HPA014428"	Uncertain		Uncertain	"Vesicles,Plasma membrane"		NA	NA		18000000	Vesicles	"Plasma membrane"	"HPA014377: AB_2189277, HPA014428: "	"unprognostic (3.05e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.77e-3)"	"unprognostic (9.28e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.28e-3)"	"unprognostic (8.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.89e-1)"	1.6	1.6	0.6	13.0	0.5	13.3	0.5	0.0	0.3	0.6	0.6			0.0	0.4	0.0	0.2	1.7	1.0	0.8	0.6	0.6	0.4	1.4	5.1	6.2	1.3		0.1	0.3	0.0	0.1	0.9		0.4	0.4		0.7	0.1	0.0	0.0	4.0	0.9	1.9	21.6	0.7	1.3			0.2		7.0	2.2	0.2	4.9	15.9	48.7	29.7	0.1	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.7	47.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	3.6	25.8	0.4	0.0	29.7	0.0	4.9	0.0	0.0	15.9	4.8	0.0	0.0	48.7	0.1	21.3	2.9	0.0	7.6											0.0	1.4	0.9	0.0	0.0	0.0	0.1	2.5	1.4	0.0	0.0	0.0	0.3	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	16.1	0.0	0.0	0.0	31.5	0.0	0.3	9.8	0.0	1.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0
SIPA1L3	KIAA0545	ENSG00000105738	"Signal induced proliferation associated 1 like 3"	O60292	19	37907228-38208372	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 68.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A549: 29.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042072, HPA045480, HPA074988"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA042072: AB_2677832, HPA045480: AB_2679342, HPA074988: "	"unprognostic (4.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.56e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.43e-2)"	"unprognostic (9.26e-3)"	"unprognostic (6.45e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.96e-2)"	6.2	6.2	10.8	15.3	11.9	5.4	10.0	18.1	13.2	9.8	18.3	13.0	13.9	31.1	6.7	6.4	9.0	9.3	7.6	11.1	15.8	7.7	12.4	6.9	10.5	11.4	10.5	7.8	6.0	17.1	7.4	7.8	3.4	8.5	9.7	12.8	11.2	14.1	9.1	11.4	19.0	29.7	6.2	8.7	12.2	16.4	8.1	12.4	11.7	18.2	6.7	20.2	10.0	11.8	4.6	0.9	1.1	3.5	0.9	1.4	0.3	16.8	29.9	3.7	4.7	2.2	2.2	2.5	7.3	6.2	4.8	4.6	10.2	9.8	9.6	6.3	6.2	4.1	3.8	3.4	13.7	5.4	3.2	1.6	2.6	2.8	3.2	4.3	1.8	2.8	1.7	7.2	9.0	19.3	7.2	5.5	2.8	1.9	2.1	8.4	5.2	2.4	2.5	3.0	13.4	8.0	5.3	3.0	1.4	10.7	14.5	8.9	4.8	8.0	13.8	1.1	2.1	9.2	1.7	11.6	8.1	2.8	24.8	11.2	2.8	4.7	3.3	10.4	2.4	10.4	0.2	0.4	1.1	0.5	0.7	0.2	3.0	0.4	0.5	0.2	4.6	0.4	1.4	0.3	0.9	3.5	0.9	0.3	0.3	10.8	11.9	18.1	13.2	15.8	7.7	10.5	7.8	8.5	12.4	6.0	8.5	13.9	4.5	10.6	18.9	5.1	22.9	10.7	10.3	22.7	13.7	1.6	3.3	6.9	4.1	4.5	68.3	0.0	13.1	1.1	2.2	6.5	2.3	20.2	2.9	31.8	24.2	6.2	4.9	6.4	2.0	5.3	5.0	5.4	41.5	2.3	12.5	30.2	1.8	17.1	5.9	6.5	2.8	1.4	4.7	14.1	0.7	3.2	27.0	4.6
SLC13A3	"NADC3, SDCT2"	ENSG00000158296	"Solute carrier family 13 member 3"	Q8WWT9	20	46557823-46684467	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"kidney: 128.6"	"Cell type enhanced"	"Detected in many"	25	"Cytotrophoblasts: 97.7;Proximal tubular cells: 272.5;Syncytiotrophoblasts: 66.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 10.0;EFO-21: 11.4;Hep G2: 32.6;HHSteC: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014333, HPA014353, HPA014736"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA014333: AB_2732407, HPA014353: AB_1856968, HPA014736: AB_1856970"	"unprognostic (1.07e-2)"	"unprognostic (7.40e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.05e-2)"	0.7	0.9	2.6	0.5	6.2	0.4	0.9	2.5	3.6	0.9	0.5	15.1	0.0	0.4	0.9	0.7	0.6	1.1	0.9	0.6	3.4	3.1	128.6	7.0	0.8	0.5	9.3	2.1	1.8	3.0	0.4	0.6	12.9	6.5	2.3	0.5	8.1	1.7	0.6	0.6	1.0	0.4	0.9	7.8	0.5	1.7	2.7	5.6	0.0	0.8	0.0	0.6	1.0	0.4	0.6	2.4	2.7	0.4	0.7	0.9	0.0	0.0	0.0	0.9	3.3	5.1	4.8	10.0	2.1	1.2	1.1	0.9	0.0	0.0	0.1	11.4	0.1	0.0	1.2	0.0	1.5	2.7	0.0	0.3	3.9	0.2	32.6	11.4	0.0	2.9	6.5	4.5	6.6	3.3	3.2	0.0	0.0	8.7	0.2	0.0	0.3	0.0	0.4	6.1	0.2	0.0	0.1	0.0	0.0	0.7	0.2	0.4	0.1	0.0	2.4	0.5	0.6	1.7	0.1	0.1	0.1	2.4	5.2	0.0	0.3	0.6	0.0	0.4	0.0	0.2	2.7	0.4	0.3	0.9	0.2	0.2	0.4	0.3	0.3	0.1	0.6	0.6	0.6	1.3	0.7	0.3	2.4	0.3	0.0	2.6	6.2	2.5	3.6	3.4	3.1	9.3	2.1	6.5	5.6	0.0	2.1	0.0	1.1	1.1	0.7	0.5	0.0	5.3	0.0	7.0	0.0	97.7	13.3	0.1	17.2	0.2	0.0	0.0	0.8	4.5	1.1	3.2	0.0	11.6	8.1	0.0	0.0	0.0	0.8	22.8	2.8	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.4	272.5	0.2	0.0	0.3	1.1	0.9	0.5	66.4	0.0	0.0	0.5
SLC13A5	"INDY, NACT"	ENSG00000141485	"Solute carrier family 13 member 5"	Q86YT5	17	6684713-6713567	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Amelogenesis imperfecta, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	65	"liver: 150.4;salivary gland: 153.9"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 374.3"	"Cancer enriched"	"Detected in some"	15	"liver cancer: 27.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	61	"Hep G2: 35.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044343	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA044343: AB_10961771"	"unprognostic (8.46e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.79e-2)"	"unprognostic (8.79e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.30e-3)"	"unprognostic (3.78e-11)"	"unprognostic (2.42e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.04e-1)"	0.2	0.8	1.0	0.1	1.9	0.1	0.2	0.6	2.3	0.2	0.1	0.0	0.0	0.1	0.3	0.1	0.3	0.9	0.1	0.1	0.9	0.7	0.4	150.4	0.1	0.2	0.8	1.2	0.3	0.2	0.1	0.2	0.1	0.6	0.1	0.1	0.0	153.9	0.1	0.1	0.1	0.1	0.1	0.2	0.9	0.1	0.8	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	1.9	0.6	2.3	0.9	0.7	0.8	1.2	0.6	0.0	0.0	0.0	7.0	0.6	0.5	0.2	0.6	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	23.3	0.4	0.1	0.0	0.3	0.0	374.3	0.0	0.0	0.0	15.4	21.0	0.0	0.6	0.3	0.0	0.0	0.0	7.4	9.8	0.0	0.0	0.0	1.4	0.0	0.0	0.9	1.5	0.4	0.1	0.0	0.0	0.2
SLC14A1	"HsT1341, JK, RACH1, RACH2"	ENSG00000141469	"Solute carrier family 14 member 1 (Kidd blood group)"	Q13336	18	45687025-45752520	"Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 44.5;prostate: 64.7;urinary bladder: 29.6"	"Group enriched"	"Detected in some"	10	"Basal glandular cells: 246.2;Erythroid cells: 93.5;Glandular cells: 129.8;Urothelial cells: 212.7"	"Group enriched"	"Detected in many"	5	"glioma: 5.3;prostate cancer: 8.6;urothelial cancer: 16.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 2.4;gdT-cell: 2.0;memory CD4 T-cell: 2.0;memory CD8 T-cell: 2.4;naive CD8 T-cell: 3.4;NK-cell: 1.8;T-reg: 7.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.4;NK-cells: 1.8;T-cells: 7.2"	"Group enriched"	"Detected in some"	5	"GAMG: 79.4;RT4: 30.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059570, HPA077233"	Supported		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA059570: AB_2684066, HPA077233: "	"unprognostic (2.04e-1)"	"unprognostic (2.56e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.70e-2)"	"unprognostic (7.97e-2)"	"unprognostic (8.17e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.09e-2)"	"unprognostic (6.93e-2)"	2.2	2.1	15.6	1.5	21.5	10.3	2.4	4.6	24.2	2.9	1.6	33.7	0.0	1.9	1.1	1.4	1.1	1.0	8.7	8.2	33.7	11.7	10.1	1.5	4.1	2.4	28.0	23.4	1.0	1.5	1.2	0.4	2.0	44.5	64.7	1.8	0.0	2.6	3.2	3.4	1.7	2.1	3.9	34.9	2.6	2.0	1.0	44.0	0.0	3.6	0.0	2.6	29.6	3.0	0.7	0.3	2.4	0.1	1.8	7.2	1.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	79.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.0	1.1	0.0	0.0	0.7	0.3	0.3	0.1	0.1	2.4	2.0	0.0	0.1	0.6	2.0	2.4	0.0	0.7	0.5	3.4	0.4	1.8	0.0	0.3	7.2	1.1	15.6	21.5	4.6	24.2	33.7	11.7	28.0	23.4	44.5	44.0	0.0	1.1	1.3	246.2	0.2	0.3	6.7	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.7	0.0	93.5	0.2	0.0	0.1	129.8	0.0	0.0	0.1	0.0	0.0	17.8	1.2	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	5.7	0.0	212.7
SLC16A3	"MCT3, MCT4"	ENSG00000141526	"Solute carrier family 16 member 3"	O15427	17	82228397-82261129	"Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.2"	"Cell type enhanced"	"Detected in many"	18	"Extravillous trophoblasts: 1393.3;Syncytiotrophoblasts: 626.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB017490, HPA021451"	Approved		Supported	"Nuclear membrane,Plasma membrane"		NA	NA			"Plasma membrane"	"Nuclear membrane"	"CAB017490: AB_2189333, HPA021451: AB_1853663"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.07e-4)"	"unprognostic (4.31e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.47e-3)"	"unprognostic (4.26e-3)"	"prognostic unfavorable (1.19e-7)"	"prognostic unfavorable (2.02e-5)"	"unprognostic (2.52e-1)"	"unprognostic (2.09e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.71e-7)"	"unprognostic (2.27e-1)"	"unprognostic (4.00e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.36e-2)"	10.4	4.8	3.9	16.9	5.2	11.2	8.8	1.0	5.2	8.0	10.5	3.8	1.7	8.0	4.8	4.7	12.4	5.0	10.4	7.4	4.1	3.8	10.9	3.7	19.0	14.2	9.6	0.6	8.3	3.9	1.4	3.6	36.7	8.4	6.9	4.3	42.9	8.1	4.8	81.2	2.1	8.0	4.5	8.0	17.3	13.9	12.7	6.9	3.9	8.7	7.3	11.0	13.0	7.4	3.7	10.3	40.4	12.4	9.9	6.2	5.4	11.5	5.8	0.1	0.1	2.6	8.3	11.5	48.2	29.7	34.3	38.9	2.7	30.2	0.1	38.0	34.0	29.7	4.1	4.1	69.9	14.4	20.7	0.2	22.0	42.9	50.4	44.2	32.3	27.2	17.1	10.3	23.0	10.6	45.1	18.6	0.4	0.1	6.8	29.7	3.1	0.3	31.8	0.4	4.8	47.0	0.1	0.5	7.6	18.1	0.5	0.7	0.3	46.4	41.3	0.6	4.8	6.0	27.2	32.2	68.4	1.1	1.0	50.3	22.1	0.3	1.0	33.5	20.4	0.6	17.5	12.4	34.6	4.1	11.7	6.2	3.7	3.5	4.6	10.3	2.8	1.8	2.2	40.4	9.9	11.8	6.1	3.0	5.4	3.9	5.2	1.0	5.2	4.1	3.8	9.6	0.6	8.4	6.9	8.9	12.7	14.3	34.8	5.8	9.7	4.8	7.6	14.7	14.8	54.1	3.9	56.0	0.0	116.4	3.0	22.8	93.3	0.0	16.0	1393.3	24.4	12.4	75.9	0.8	262.7	120.8	20.1	17.2	103.7	2.7	2.8	101.0	13.5	232.6	23.8	21.4	199.4	84.2	3.5	3.8	7.4	0.0	14.7	1.6	7.1	5.8	626.2	40.6	16.6	118.3
SLC16A7	MCT2	ENSG00000118596	"Solute carrier family 16 member 7"	O60669	12	59596067-59789855	"Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 34.7"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 116.7;Cholangiocytes: 104.4;Early spermatids: 85.1;Late spermatids: 90.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 64.5"	HPA005911	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA005911: AB_1853659"	"unprognostic (1.52e-2)"	"unprognostic (9.47e-3)"	"unprognostic (9.48e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.39e-2)"	"unprognostic (9.79e-2)"	"prognostic favorable (8.85e-5)"	"unprognostic (2.19e-3)"	"unprognostic (3.11e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.45e-2)"	20.1	10.0	2.2	9.2	4.3	4.5	9.2	6.4	8.3	5.4	4.8	1.1	1.1	2.2	8.6	2.7	12.3	4.4	8.9	34.7	2.0	1.9	16.4	5.7	9.4	12.1	3.2	3.3	4.7	13.7	2.2	9.5	2.1	5.5	3.8	3.7	2.7	6.2	2.6	4.2	9.4	4.6	10.5	3.7	16.8	12.8	6.2	2.3	12.8	4.0	8.6	9.4	9.7	8.5	5.8	2.8	0.3	9.1	3.0	7.2	2.4	0.1	2.3	0.5	0.3	10.7	16.3	0.1	9.9	6.4	3.4	3.1	0.2	5.9	5.1	2.3	16.7	3.2	0.5	0.6	1.2	5.2	1.4	0.3	9.2	10.4	0.3	5.6	14.9	0.1	8.4	3.2	0.9	9.8	6.1	1.2	6.2	0.1	11.2	5.5	2.1	4.3	2.2	0.6	1.0	3.1	0.3	0.0	2.4	7.6	14.4	2.6	0.6	0.0	0.2	4.7	0.6	0.3	1.8	0.0	8.1	2.7	14.8	0.3	10.8	0.1	8.6	9.3	0.0	1.3	0.3	2.0	0.0	5.4	3.7	7.2	2.4	4.3	4.8	2.1	5.8	4.9	6.9	0.2	3.0	9.1	2.8	4.8	2.4	2.2	4.3	6.4	8.3	2.0	1.9	3.2	3.3	5.5	2.3	26.8	21.3	14.7	5.7	9.0	23.7	116.7	104.4	24.1	15.9	43.6	9.8	0.2	19.9	46.2	85.1	7.1	0.7	0.0	57.0	0.2	12.5	1.9	9.3	10.5	3.0	7.9	0.0	11.1	27.7	90.6	6.4	8.4	3.3	1.8	24.4	1.3	30.7	0.0	9.6	1.0	5.3	6.5	16.0	4.1	3.0	11.0	0.6	20.8	0.9	2.8
SLC17A5	"AST, ISSD, NSD, SD, SIALIN, SIASD, SLD"	ENSG00000119899	"Solute carrier family 17 member 5"	Q9NRA2	6	73593379-73654155	"Disease related genes, Predicted membrane proteins"	"Amino-acid transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"parathyroid gland: 155.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 41.7;ASC TERT1: 31.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044479			Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA044479: "	"unprognostic (6.48e-3)"	"unprognostic (7.95e-3)"	"unprognostic (9.23e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.59e-3)"	"unprognostic (4.44e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.29e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (3.52e-4)"	"unprognostic (1.09e-1)"	7.2	5.8	6.4	2.9	6.8	2.9	9.6	6.3	6.8	4.9	7.8	4.7	12.5	6.5	5.1	17.2	5.0	3.4	6.2	6.2	4.5	6.7	24.3	13.2	7.6	4.9	5.0	4.5	3.4	8.7	155.6	9.3	12.6	6.7	6.9	8.6	6.6	15.5	8.6	3.5	4.8	12.9	4.6	5.9	4.3	6.0	4.1	4.7	3.0	30.5	2.6	7.1	5.9	4.3	5.2	9.9	12.4	10.6	12.0	9.4	6.0	2.8	3.8	3.9	6.2	41.7	31.1	5.2	9.3	23.5	2.5	8.9	2.5	6.9	2.6	4.5	13.1	5.9	5.0	5.4	2.3	4.5	1.8	6.3	1.1	2.1	5.9	8.4	2.1	4.4	14.2	3.5	5.7	4.0	10.7	6.4	3.5	2.7	2.9	8.8	1.9	0.8	1.2	2.8	11.9	2.3	1.9	4.8	11.1	6.6	7.9	1.5	2.7	1.9	5.6	5.4	6.0	2.5	13.2	9.3	1.2	1.1	5.0	2.2	8.2	11.4	0.7	4.2	4.6	3.7	12.4	10.6	4.2	8.5	9.7	8.3	5.2	9.4	8.1	9.9	3.7	7.8	8.6	7.4	12.0	6.0	7.4	8.2	6.0	6.4	6.8	6.3	6.8	4.5	6.7	5.0	4.5	6.7	4.7	20.8	20.2	7.8	12.1	8.5	7.8	5.3	15.3	14.7	9.1	48.8	27.5	14.4	3.3	12.2	27.9	15.0	21.9	0.0	11.9	12.0	22.1	30.0	13.9	31.0	53.7	0.0	11.6	25.8	26.5	32.1	6.9	22.4	10.1	7.2	42.3	7.3	16.7	17.5	10.6	30.8	24.7	0.0	8.0	11.1	2.3	9.8	19.1	7.9	15.0	18.6
SLC1A6	EAAT4	ENSG00000105143	"Solute carrier family 1 member 6"	P48664	19	14950034-15022990	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 52.1;testis: 23.3"	"Cell type enhanced"	"Detected in some"	11	"Bipolar cells: 12.3;Early spermatids: 29.3;Horizontal cells: 22.3;Late spermatids: 27.3;Syncytiotrophoblasts: 33.4"	"Cancer enriched"	"Detected in some"	7	"urothelial cancer: 5.2"	"Region enriched"	"Detected in many"	5	"cerebellum: 52.1"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HAP1: 6.6;NTERA-2: 5.4;U-698: 24.6"	"Region enriched"	"Detected in many"	6	"cerebellum: 152.9"	"Low region specificity"	"Detected in all"			"HPA041505, HPA044066"	Enhanced	Supported	Supported	"Plasma membrane,Intermediate filaments"		NA	NA			"Plasma membrane"	"Intermediate filaments"	"HPA041505: AB_2677520, HPA044066: AB_2678796"	"unprognostic (3.62e-2)"	"unprognostic (1.35e-1)"		"unprognostic (4.41e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"		"unprognostic (5.94e-3)"	"unprognostic (8.90e-2)"	"unprognostic (6.52e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.11e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.57e-2)"	"prognostic unfavorable (6.88e-6)"	0.4	0.5	3.2	0.5	9.6	1.2	0.8	52.1	12.8	0.4	0.5	0.6	0.0	0.6	0.8	4.2	0.4	0.5	0.5	0.4	4.8	4.0	0.4	0.5	0.5	0.5	1.6	3.4	0.6	0.9	0.6	0.0	4.3	3.0	0.9	0.6	0.1	0.7	0.9	0.5	9.2	0.5	0.5	1.4	0.7	0.5	23.3	0.9	0.0	0.6	0.0	0.6	0.4	0.0	2.0	0.7	2.2	0.7	0.5	0.6	0.1	0.1	0.1	0.3	0.3	0.2	0.2	0.8	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.1	1.2	6.6	0.1	0.1	0.2	0.1	0.2	0.3	0.2	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.6	0.1	0.5	0.0	0.3	5.4	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.4	0.2	0.2	2.6	0.0	1.1	0.3	0.1	0.0	0.3	1.0	0.2	0.1	0.4	0.1	24.6	0.1	0.3	0.1	1.6	0.7	0.5	0.6	0.4	0.4	1.0	0.5	0.3	0.3	2.0	0.6	0.6	2.2	0.5	0.4	0.7	0.3	0.1	3.2	9.6	52.1	6.5	4.8	4.0	1.6	3.4	3.0	0.9	0.0	0.0	0.0	0.6	2.9	12.3	1.6	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.0	29.3	0.0	0.0	0.0	0.3	8.5	1.0	0.2	0.0	0.0	0.4	22.3	0.0	0.0	0.0	27.3	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.7	0.0	0.3	1.7	1.5	5.9	33.4	0.0	0.0	0.1
SLC28A1	CNT1	ENSG00000156222	"Solute carrier family 28 member 1"	O00337	15	84884654-84945796	"Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	25	"intestine: 32.7;kidney: 35.6;liver: 43.8"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 34.1;Hofbauer cells: 40.6;Proximal tubular cells: 88.5"	"Group enriched"	"Detected in some"	63	"liver cancer: 10.9;renal cancer: 33.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"A-431: 3.5;BEWO: 2.0;Karpas-707: 1.1;RPMI-8226: 1.6;SK-BR-3: 1.8;SuSa: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019551, HPA056247"	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nuclear speckles, Cytosol"	"HPA019551: AB_2670187, HPA056247: "	"unprognostic (3.81e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.49e-2)"	"unprognostic (5.08e-2)"	"unprognostic (7.08e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.42e-2)"	"unprognostic (7.72e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.55e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	5.0	0.1	0.1	17.3	0.1	1.5	0.1	0.1	0.1	0.5	0.1	0.1	35.6	43.8	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.0	32.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	3.5	0.3	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.5	0.0	0.9	0.1	0.0	0.0	0.0	0.5	1.6	0.0	0.0	0.1	0.4	0.1	1.8	0.1	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	7.6	1.4	0.0	7.0	0.0	0.4	10.0	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	34.1	40.6	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	88.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1
SLC2A2	GLUT2	ENSG00000163581	"Solute carrier family 2 member 2"	P11168	3	170996348-171026750	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 77.4;liver: 172.8"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 433.3"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 105.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	68	"CACO-2: 7.3;Hep G2: 24.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB010444, HPA028997"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB010444: AB_641068, HPA028997: AB_2672860"			"unprognostic (9.56e-2)"		"unprognostic (1.24e-1)"		"prognostic favorable (2.63e-5)"				"unprognostic (3.10e-1)"		"unprognostic (1.02e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.31e-2)"			0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	27.9	0.0	0.0	10.8	0.1	0.2	0.1	0.1	3.8	0.1	0.1	0.1	15.3	172.8	0.1	0.0	0.1	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	77.4	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	24.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86.6	0.0	0.0	0.0	0.0	0.0	1.7	0.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	433.3	0.0	0.0	0.0	6.7	8.9	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	49.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0
SLC30A1	"ZNT1, ZRC1"	ENSG00000170385	"Solute carrier family 30 member 1"	Q9Y6M5	1	211571568-211578742	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 53.3"	"Cell type enhanced"	"Detected in all"	5	"Hepatocytes: 83.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015275, HPA049000"	Uncertain		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA015275: AB_1857083, HPA049000: AB_2680593"	"unprognostic (1.13e-1)"	"unprognostic (2.67e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.81e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.82e-3)"	"unprognostic (4.72e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.42e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.53e-2)"	11.4	16.6	9.3	7.5	11.4	15.5	17.3	5.2	13.6	13.0	15.3	6.9	4.9	17.2	7.1	7.6	9.0	9.2	12.9	6.1	9.7	7.9	13.4	53.3	12.0	3.5	9.5	8.0	9.5	8.9	8.8	4.8	9.3	8.7	7.3	8.9	7.7	5.9	9.2	3.6	13.9	28.1	7.5	8.3	10.7	6.4	12.5	5.5	3.1	11.0	5.2	4.4	7.7	8.4	0.5	2.5	3.9	4.2	1.3	1.7	1.0	4.7	6.9	3.8	4.9	16.6	7.7	33.7	13.0	9.6	6.9	6.9	3.0	22.6	2.6	11.4	11.9	9.6	8.1	5.7	7.5	8.3	6.7	4.3	2.1	14.1	6.9	9.3	7.4	4.8	11.5	19.0	8.8	14.4	10.4	4.2	1.6	8.4	12.5	8.5	4.3	1.4	4.6	11.7	5.1	5.5	4.5	1.8	9.6	21.5	12.7	3.8	6.7	12.7	6.7	29.0	7.5	3.4	9.7	6.8	5.2	12.1	17.3	10.3	5.5	8.4	2.2	4.8	7.5	4.5	3.9	3.9	1.3	1.2	4.2	1.7	0.5	0.9	0.8	2.5	0.3	0.9	1.2	0.4	1.3	3.2	1.7	0.8	1.0	9.3	11.4	5.2	13.6	9.7	7.9	9.5	8.0	8.7	5.5	8.9	9.8	5.1	7.2	25.3	10.9	17.9	17.8	6.7	2.3	34.9	5.9	9.8	1.7	5.4	21.7	18.0	37.9	46.7	10.7	27.0	15.0	12.6	4.7	83.9	29.4	6.4	9.1	15.4	33.3	2.8	9.2	15.1	20.3	5.4	23.6	26.5	7.9	31.7	7.1	29.5	8.5	6.5	11.6	33.0	9.4	40.4	20.5	10.2	20.5	11.4
SLC34A1	"NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2"	ENSG00000131183	"Solute carrier family 34 member 1"	Q06495	5	177379235-177398848	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	79	"kidney: 94.5"	"Cell type enriched"	"Detected in some"	16	"Proximal tubular cells: 128.7"	"Cancer enriched"	"Detected in single"	12	"renal cancer: 1.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Group enriched"	"Detected in some"	12	"HEL: 6.7;U-937: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051255, HPA077175"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol"		Yes	NA			"Nuclear speckles, Plasma membrane"	"Nucleoplasm, Mitotic spindle, Cytosol"	"HPA051255: AB_2681409, HPA077175: "	"unprognostic (1.17e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.49e-2)"		"unprognostic (1.56e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.66e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.2	0.0	6.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	7.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	128.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0
SLC34A2	NAPI-3B	ENSG00000157765	"Solute carrier family 34 member 2"	O95436	4	25648011-25678748	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lung: 259.9;seminal vesicle: 69.1"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 443.7;Alveolar cells type 2: 1050.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 585.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	81	"BEWO: 12.6;EFO-21: 47.7;RPTEC TERT1: 34.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA037989, HPA066474"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA037989: AB_10670536, HPA066474: "	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.25e-2)"	"unprognostic (7.33e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.60e-3)"	"unprognostic (6.27e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.08e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.93e-1)"	0.1	0.1	0.1	0.0	0.1	0.0	3.2	0.2	0.1	13.0	0.1	0.0	24.7	2.9	6.9	2.1	0.5	13.0	3.4	0.1	0.1	0.1	10.8	0.5	259.9	0.0	0.1	0.0	2.9	4.4	0.0	0.6	2.6	0.8	0.3	0.0	1.6	27.4	69.1	0.1	0.7	2.1	0.0	0.1	0.1	0.4	0.5	0.0	0.4	27.9	0.1	1.9	0.0	0.1	0.4	0.2	1.9	0.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	47.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	34.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	1.9	0.5	0.2	0.3	0.3	0.1	0.2	0.1	0.1	0.0	0.4	0.3	0.2	1.5	0.4	0.1	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.8	0.0	443.7	1050.6	0.0	0.1	0.0	0.0	0.6	40.8	125.8	178.6	19.2	0.0	1.6	5.0	57.7	3.5	0.0	0.0	0.0	7.1	0.0	0.0	3.5	26.7	0.0	0.2	0.0	0.0	0.0	0.0	14.0	1.1	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	2.9	0.0	0.0	0.1	0.5	0.1	0.0	0.2	0.0	0.0	0.1
SLC35G2	"DKFZp564K2464, MGC3295, TMEM22"	ENSG00000168917	"Solute carrier family 35 member G2"	Q8TBE7	3	136818647-136855892	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 36.2;Endothelial cells: 26.0;Ito cells: 26.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"gdT-cell: 1.6;memory CD8 T-cell: 3.5;naive CD8 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	16	"T-cells: 3.5"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 34.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052054, HPA064728"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA052054: AB_2681709, HPA064728: AB_2685336"	"unprognostic (1.04e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.91e-4)"	"unprognostic (2.56e-4)"	"unprognostic (5.34e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.16e-5)"	"unprognostic (1.83e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (1.16e-7)"	"unprognostic (1.00e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.30e-2)"	20.2	24.6	10.6	3.7	12.0	1.3	18.3	16.6	17.4	8.1	3.6	6.4	6.6	2.2	6.7	8.1	4.1	5.0	8.7	7.6	11.6	15.2	4.3	7.1	6.0	3.3	10.9	10.5	5.3	13.3	6.7	15.9	11.7	11.3	4.8	3.8	3.2	2.7	4.8	2.8	3.0	2.4	8.5	12.4	3.1	3.1	17.2	4.9	0.9	8.8	2.1	2.5	8.2	9.3	0.2	0.0	0.0	0.1	0.0	3.5	0.3	1.7	4.9	5.0	2.2	10.1	8.2	0.0	7.8	34.1	11.7	17.7	4.6	2.6	0.0	6.0	8.0	18.7	0.6	5.9	0.3	10.9	0.0	1.6	1.4	6.0	2.8	12.9	0.0	0.0	11.6	0.9	10.2	2.8	8.6	8.7	3.1	0.8	0.0	14.9	0.0	2.1	1.5	1.1	0.0	3.7	1.8	3.3	0.0	10.0	0.4	8.3	5.5	6.3	0.0	10.7	1.8	0.0	0.8	5.9	8.7	2.2	3.8	8.4	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.5	0.0	0.1	3.5	0.0	0.2	0.1	2.4	0.0	0.0	0.0	0.0	0.0	0.3	10.6	12.0	16.6	17.0	11.6	15.2	10.9	10.5	11.3	4.9	11.9	6.5	2.7	3.7	3.0	5.4	2.0	0.0	1.4	10.3	1.8	11.8	1.0	1.7	2.7	36.2	26.0	0.5	0.0	9.3	1.1	11.0	3.3	2.3	1.8	0.6	6.4	4.1	26.4	1.0	19.8	9.2	3.5	3.3	3.6	0.6	6.8	9.1	0.0	2.8	0.4	4.7	6.5	7.2	22.7	9.4	2.6	1.8	4.8	0.6	1.8
SLC39A6	LIV-1	ENSG00000141424	"Solute carrier family 39 member 6"	Q13433	18	36108532-36129385	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Glandular cells: 212.3"	"Cancer enhanced"	"Detected in all"		"breast cancer: 361.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042377	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA042377: AB_2677968"	"unprognostic (7.60e-2)"	"unprognostic (2.27e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.58e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.87e-3)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.50e-2)"	"unprognostic (7.63e-3)"	"unprognostic (2.16e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.30e-1)"	11.1	12.6	14.3	8.6	13.4	4.3	63.5	19.4	14.7	15.7	8.7	16.0	68.7	4.1	24.7	24.5	9.8	27.7	10.3	8.2	14.2	17.5	12.3	7.7	7.9	8.2	18.3	8.7	30.5	15.5	32.1	23.9	52.5	16.0	55.2	5.9	25.1	15.5	51.5	7.7	22.6	5.7	12.7	21.7	11.2	8.1	9.9	13.5	8.0	15.7	10.7	11.3	23.8	20.2	12.6	25.2	22.2	14.6	12.9	15.6	9.7	10.4	13.2	31.7	18.6	33.5	24.8	8.3	28.5	33.8	19.1	22.5	7.3	11.6	11.3	14.4	27.4	13.3	25.5	27.6	26.7	29.1	25.1	10.0	4.9	18.6	10.6	21.3	16.5	12.4	22.6	59.1	29.0	25.3	17.6	2.8	9.4	2.5	22.8	26.8	16.0	16.2	3.7	7.6	5.7	7.5	16.8	18.1	14.8	21.3	35.2	33.4	29.4	35.1	10.3	48.1	13.6	14.0	7.8	4.6	46.7	7.8	8.8	14.3	21.5	20.8	8.6	16.1	11.7	24.5	19.5	9.8	22.2	13.0	14.6	15.6	12.6	11.1	11.5	12.2	12.3	9.8	14.2	7.5	12.9	13.7	25.2	12.2	9.7	14.3	13.4	19.4	12.4	14.2	17.5	18.3	8.7	16.0	13.5	35.7	16.0	13.7	44.4	40.8	40.2	16.6	10.2	42.8	60.3	40.1	31.4	5.4	1.7	46.8	16.8	10.8	2.8	0.0	32.7	50.5	40.3	212.3	23.1	7.9	18.4	22.3	24.5	7.4	15.6	14.6	34.5	25.1	64.1	24.4	6.7	35.8	34.0	0.0	44.9	13.9	25.8	38.8	37.6	43.4	22.9	65.1	19.9	16.0	4.1	55.4
SLC3A2	"4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE"	ENSG00000168003	"Solute carrier family 3 member 2"	P08195	11	62856102-62888875	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Syncytiotrophoblasts: 652.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 132.2;SiHa: 134.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010455, HPA017980"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		210000000	"Plasma membrane"	Nucleoplasm	"CAB010455: AB_638288, HPA017980: AB_2669723"	"unprognostic (1.79e-1)"	"unprognostic (9.61e-3)"	"unprognostic (3.59e-1)"	"unprognostic (7.87e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (2.09e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.71e-1)"	"prognostic favorable (8.22e-4)"	"unprognostic (2.92e-2)"	"unprognostic (5.52e-3)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (1.48e-4)"	28.5	30.8	34.6	23.0	36.8	62.4	30.8	18.7	34.8	26.0	26.8	25.3	30.4	34.3	29.2	41.2	31.2	23.8	19.9	14.7	31.3	27.1	71.4	31.8	33.5	17.8	37.8	24.1	29.9	39.2	138.6	19.3	75.5	32.9	28.3	13.9	52.5	39.0	27.5	32.5	32.1	33.8	19.6	38.0	21.9	28.2	33.4	30.8	13.6	33.7	33.4	22.2	20.6	56.6	16.6	73.9	11.6	36.2	20.3	39.8	37.3	16.4	69.3	7.1	22.0	8.6	6.9	65.6	28.6	11.0	15.0	13.3	66.2	31.2	18.1	31.8	16.8	28.7	57.0	12.9	56.2	8.0	32.9	12.2	13.0	50.5	29.2	79.9	15.2	19.0	15.1	132.2	18.3	56.1	5.5	8.7	39.4	25.0	40.1	9.2	79.2	15.6	19.4	11.8	20.5	23.5	16.2	10.7	35.4	10.5	9.2	12.1	5.8	134.7	50.5	97.2	12.0	18.1	19.9	16.0	15.3	22.8	22.4	20.1	49.9	55.3	57.4	15.0	23.9	43.6	8.5	36.2	11.6	30.1	34.8	39.8	14.4	27.7	30.8	22.1	16.6	23.5	25.2	7.5	20.3	27.6	73.9	26.2	37.3	34.6	36.8	18.7	34.7	31.3	27.1	37.8	24.1	32.9	30.8	44.7	40.7	54.9	229.6	193.7	59.3	10.9	20.4	36.1	40.9	47.1	62.8	187.9	28.2	148.4	23.7	94.0	85.3	93.5	129.2	134.7	88.4	145.6	82.0	22.5	178.6	50.9	80.9	70.6	47.5	19.5	28.1	97.7	212.6	153.3	33.1	212.1	128.6	31.6	28.7	161.8	52.2	6.5	137.2	12.6	29.8	131.6	652.9	75.6	40.7	193.5
SLC40A1	"FPN1, HFE4, IREG1, MTP1, SLC11A3"	ENSG00000138449	"Solute carrier family 40 member 1"	Q9NP59	2	189560579-189583758	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 126.4;lymphoid tissue: 170.2"	"Group enriched"	"Detected in many"	5	"Kupffer cells: 1044.2;Syncytiotrophoblasts: 2060.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 64.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 93.2;CACO-2: 21.3;HEL: 75.5;HMC-1: 19.9;T-47d: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065634	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA065634: AB_2685524"	"unprognostic (1.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.22e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.43e-2)"	"unprognostic (6.44e-2)"	"prognostic favorable (8.55e-5)"	"unprognostic (4.66e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.96e-2)"	"unprognostic (4.11e-2)"	18.2	126.4	3.9	10.1	5.5	3.9	47.4	1.8	3.5	20.0	25.7	3.7	13.9	34.4	24.7	24.3	6.3	25.9	25.2	37.1	4.1	4.3	14.4	42.1	45.9	170.2	5.1	1.9	50.9	24.0	4.6	9.8	51.3	6.4	18.4	15.8	11.6	10.2	16.6	12.3	4.9	44.7	13.6	5.8	76.4	11.3	16.2	3.5	17.0	20.8	6.4	8.8	11.1	20.4	0.1	22.7	64.7	20.8	0.8	17.3	20.1	0.0	1.3	0.1	0.0	93.2	0.6	4.5	0.0	1.1	0.3	0.5	21.3	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.0	0.2	0.0	0.3	75.5	0.3	7.8	0.3	0.2	19.9	6.5	0.0	0.2	0.0	2.1	2.2	2.9	7.7	0.2	1.1	0.0	3.1	4.9	0.2	16.0	0.3	0.0	0.8	0.4	0.9	3.1	0.1	0.9	0.1	6.2	0.0	7.4	36.8	1.1	0.0	0.1	2.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	20.3	20.8	32.9	0.4	4.7	0.6	0.0	11.3	1.0	22.7	0.1	17.3	3.7	64.7	0.8	0.4	3.7	1.0	20.1	3.9	5.5	1.8	3.5	4.1	4.3	5.1	1.9	6.4	3.5	116.1	32.3	28.1	45.3	8.1	3.7	37.5	142.7	53.5	39.8	31.4	3.9	335.3	41.4	23.9	6.9	30.8	119.4	70.0	64.9	10.7	46.3	32.2	9.2	223.5	72.3	6.4	17.9	211.8	1044.2	4.7	112.2	26.2	8.5	1.8	50.3	9.6	51.2	77.2	55.2	100.1	43.2	64.7	18.1	5.0	0.9	7.0	2060.1	8.4	30.8	19.7
SLC41A3	FLJ20473	ENSG00000114544	"Solute carrier family 41 member 3"	Q96GZ6	3	126006355-126101561	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045847	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA045847: AB_2679472"	"unprognostic (1.77e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.37e-2)"	"unprognostic (7.68e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (1.36e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.82e-3)"	"unprognostic (5.74e-2)"	"unprognostic (3.57e-1)"	"prognostic favorable (6.04e-7)"	"unprognostic (1.26e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.54e-2)"	11.2	20.2	21.3	10.7	20.7	5.3	22.2	29.8	43.4	18.6	10.6	12.6	12.1	10.1	21.1	32.9	10.8	24.0	16.3	17.1	17.9	20.6	14.0	8.5	9.5	14.3	17.1	16.5	31.2	17.6	19.7	16.9	10.9	21.4	12.5	10.9	18.6	16.7	14.5	25.5	10.7	8.9	17.1	11.7	8.8	10.7	30.5	6.0	27.7	18.0	11.5	10.4	12.3	11.9	9.0	8.6	9.3	8.2	13.0	18.8	5.6	17.7	7.3	12.1	10.2	34.5	20.3	18.3	10.2	17.7	14.2	16.8	9.7	16.2	13.0	19.3	20.1	15.4	14.0	4.4	17.7	12.4	12.6	13.9	7.1	13.8	14.0	28.6	12.8	7.9	19.7	21.7	8.5	17.6	20.9	19.5	16.1	5.9	10.9	18.6	9.5	14.1	10.5	9.2	23.6	11.5	7.5	12.5	17.6	16.9	13.2	9.4	10.2	15.7	5.1	43.1	11.9	5.1	17.3	13.4	13.2	10.2	20.1	11.4	8.3	6.7	6.3	12.0	5.7	12.1	9.3	5.7	3.9	11.2	8.2	9.1	9.0	10.6	11.5	8.6	8.4	9.2	8.7	1.2	13.0	5.1	8.4	18.8	5.6	21.3	20.7	29.8	43.4	17.9	20.6	17.1	16.5	21.4	6.0	14.9	10.4	8.0	20.1	12.2	12.9	12.9	25.5	6.7	14.8	21.0	3.9	30.6	3.3	30.8	27.0	24.2	6.8	0.0	21.8	27.8	22.2	13.0	5.7	5.8	14.0	27.0	20.3	27.0	8.9	12.0	34.8	9.4	13.5	14.4	12.7	23.0	21.6	3.5	51.6	10.9	10.8	25.8	19.6	12.6	38.4	13.4	21.2	17.5	16.6	16.8
SLC46A1	"HCP1, MGC9564, PCFT"	ENSG00000076351	"Solute carrier family 46 member 1"	Q96NT5	17	28394756-28407197	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 52.7"	"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 25.6;Hepatocytes: 24.9;Hofbauer cells: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"CACO-2: 67.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011614	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB011614: AB_2270597"	"unprognostic (1.10e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.59e-2)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (9.11e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.04e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.10e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.04e-1)"	3.1	17.8	4.6	2.5	7.0	1.3	5.1	13.2	5.2	2.9	43.8	5.2	9.4	45.4	2.2	4.5	1.8	6.7	3.0	2.2	4.4	6.0	3.8	17.9	3.2	4.9	4.0	4.0	4.4	5.0	8.1	7.8	5.0	5.0	3.7	2.7	6.1	5.7	5.8	2.0	2.0	52.7	2.6	4.6	4.9	2.3	2.2	4.2	2.2	4.0	0.4	1.2	2.4	2.4	2.7	2.6	7.1	5.9	2.9	1.7	0.8	1.7	7.4	2.5	4.1	2.0	0.4	7.8	2.1	1.5	1.7	2.0	67.6	2.1	0.2	1.2	1.1	5.0	5.8	2.8	4.7	1.5	4.3	6.6	0.0	4.6	5.7	0.7	0.0	3.4	1.0	8.7	1.8	5.4	2.4	0.1	0.6	2.8	0.4	0.3	2.3	0.0	0.2	1.5	1.7	1.0	0.1	2.0	0.8	1.3	3.9	6.6	3.5	14.5	6.8	0.9	3.6	5.3	1.1	0.2	0.2	3.0	0.4	2.2	3.1	3.5	0.1	0.4	0.4	1.6	7.1	1.6	1.1	0.8	5.9	1.4	2.7	0.9	0.7	2.6	1.7	1.0	1.7	2.3	2.9	4.3	1.1	1.6	0.8	4.6	7.0	13.2	5.2	4.4	6.0	4.0	4.0	5.0	4.2	11.9	4.0	3.2	1.9	0.3	25.6	1.8	15.3	4.0	1.2	7.0	3.9	16.6	0.0	2.8	3.4	1.0	1.3	0.0	3.9	7.3	3.1	2.2	1.1	24.9	21.1	19.1	1.2	2.5	13.0	13.5	3.7	3.9	0.0	1.0	2.1	1.6	3.5	0.9	3.2	4.1	5.6	6.5	1.0	0.0	0.2	0.3	3.7	0.0	1.2	1.4
SLC4A7	"NBC3, SBC2, SLC4A6"	ENSG00000033867	"Solute carrier family 4 member 7"	Q9Y6M7	3	27372721-27484420	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 48.5"	"Group enriched"	"Detected in many"	10	"Cone photoreceptor cells: 691.1;Rod photoreceptor cells: 667.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 38.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB022494, HPA035857"	Enhanced		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA			"Plasma membrane"	"Focal adhesion sites, Cytosol"	"CAB022494: , HPA035857: AB_10795135"	"unprognostic (2.94e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.91e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.68e-1)"	"unprognostic (6.79e-4)"	"unprognostic (4.13e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.58e-3)"	"prognostic unfavorable (7.91e-6)"	"unprognostic (1.09e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.26e-2)"	14.5	5.0	3.2	10.5	4.6	3.3	17.0	4.0	4.8	10.8	38.2	5.0	8.8	48.5	8.1	12.6	8.4	6.5	12.5	9.3	5.0	3.8	15.3	3.7	9.3	10.3	4.8	1.9	9.0	3.3	2.4	4.4	5.6	4.5	10.3	6.9	20.0	8.3	8.4	5.6	5.6	43.4	18.2	5.8	9.7	7.8	6.1	5.5	6.8	6.3	14.7	15.5	15.0	14.9	1.8	2.0	0.1	0.9	2.4	3.9	0.7	5.9	11.1	10.0	4.6	4.7	8.4	7.1	20.2	9.4	7.8	6.1	3.0	3.1	13.5	1.7	7.8	7.5	2.6	9.5	9.8	12.4	11.4	3.1	6.2	7.6	3.2	8.1	14.0	5.4	6.7	4.3	11.8	38.2	16.5	12.8	8.9	4.1	4.8	16.0	2.1	13.9	3.2	6.6	0.7	11.0	9.5	7.9	2.7	18.3	4.2	2.5	6.3	9.2	6.8	3.1	8.9	15.5	5.4	8.9	18.4	5.1	12.7	15.6	1.8	1.9	7.7	16.1	9.9	8.4	0.0	0.5	0.0	3.0	0.6	2.0	1.2	3.8	3.9	1.4	1.8	1.5	2.7	0.1	2.4	0.9	2.0	3.2	0.7	3.2	4.6	4.0	4.8	5.0	3.8	4.8	1.9	4.5	5.5	0.0	12.8	13.2	28.2	26.1	65.7	18.7	15.3	5.3	25.0	59.3	691.1	4.5	8.3	13.6	6.7	25.3	5.8	0.0	6.2	23.0	30.2	41.3	23.1	5.9	16.9	6.4	36.7	14.7	33.1	5.9	8.3	36.7	33.7	20.8	50.6	45.2	13.6	12.7	9.2	10.5	667.4	38.8	32.8	32.4	21.7	26.8	6.8	33.0	12.2	33.6
SLC5A12	"MGC52019, SMCT2"	ENSG00000148942	"Solute carrier family 5 member 12"	Q1EHB4	11	26667019-26723427	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 60.8;kidney: 90.3"	"Cell type enriched"	"Detected in some"	18	"Proximal tubular cells: 145.9"	"Cancer enriched"	"Detected in single"	26	"renal cancer: 9.0"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.2"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.2;NTERA-2: 3.8;SuSa: 7.8;T-47d: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060904	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA060904: AB_2684385"	"unprognostic (3.69e-3)"	"unprognostic (6.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.01e-2)"	"unprognostic (9.35e-3)"	"unprognostic (4.21e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.91e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.40e-3)"	0.0	0.0	0.1	0.0	1.2	0.2	0.0	0.0	0.1	0.0	11.3	0.0	0.2	1.7	0.0	18.5	0.0	0.0	0.0	3.4	0.1	0.1	90.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.8	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.8	1.0	0.7	0.9	0.7	0.1	0.4	0.1	0.2	0.6	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.6	0.2	0.6	0.8	0.2	0.1	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.7	0.1	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.1	0.3	0.4	5.2	0.1	0.3	0.2	0.5	3.8	0.7	0.1	0.1	0.0	0.6	0.1	1.1	2.0	0.3	1.7	0.2	0.0	7.8	2.8	0.5	0.6	0.4	0.2	0.4	0.2	2.3	0.7	0.2	0.2	0.0	0.0	1.0	0.5	0.1	0.6	0.7	0.4	1.1	0.4	0.4	0.5	1.5	0.7	0.6	0.4	0.9	0.6	0.8	0.1	0.1	0.1	1.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	3.5	0.0	0.1	8.3	0.0	0.7	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.3	0.0	145.9	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.4	0.0
SLC5A3	"SMIT, SMIT1"	ENSG00000198743	"Solute carrier family 5 member 3"	P53794	21	34073570-34106262	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 46.0"	"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 130.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029791			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA029791: AB_10601892"	"unprognostic (9.70e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.54e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (1.98e-5)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.60e-2)"	10.1	9.5	10.5	7.3	11.0	3.6	26.6	8.0	10.1	6.5	7.6	4.6	9.4	5.0	11.3	9.1	7.5	8.5	4.9	6.8	11.6	6.8	46.0	9.5	8.5	7.6	11.7	4.7	9.0	5.8	6.3	6.6	15.8	13.6	7.0	8.8	11.3	6.4	6.9	7.8	10.1	7.4	5.9	14.7	4.9	7.8	10.6	9.0	5.9	42.7	4.4	8.0	6.5	22.1	0.8	2.3	0.7	1.0	1.0	2.6	0.7	6.3	5.7	11.9	8.4	10.0	8.2	5.7	7.2	22.1	4.5	6.9	9.4	13.9	10.2	5.9	14.6	8.5	3.3	14.4	4.1	7.7	10.6	3.7	10.6	5.3	3.1	2.6	4.5	4.5	3.9	10.7	12.3	4.9	13.9	2.7	8.5	10.4	2.4	11.6	4.3	4.8	3.7	6.0	2.4	5.6	4.9	2.1	4.6	17.8	8.9	6.2	2.9	15.0	4.0	3.4	7.4	2.4	4.8	2.6	8.9	6.9	16.9	2.9	12.7	10.9	7.7	17.9	6.6	5.9	0.0	1.0	0.2	2.6	0.9	2.1	0.8	1.4	1.7	0.9	0.8	1.9	2.6	0.7	1.0	0.4	2.3	0.4	0.7	10.5	11.0	8.0	10.1	11.6	6.8	11.7	4.7	13.6	9.0	14.9	12.2	8.0	40.9	0.0	28.5	7.6	12.7	16.0	23.9	130.9	19.6	21.2	18.3	3.4	8.6	4.5	28.0	0.0	4.5	15.7	10.7	71.1	41.4	15.3	12.8	35.0	47.1	6.7	12.1	5.2	6.1	9.8	0.0	24.4	48.3	6.0	5.8	46.0	19.4	6.5	20.8	12.9	2.2	12.1	18.9	0.0	23.6	17.3	26.6	32.3
SLC7A2	"ATRC2, CAT-2, HCAT2"	ENSG00000003989	"Solute carrier family 7 member 2"	P52569	8	17497088-17570573	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 68.1;parathyroid gland: 78.2;skeletal muscle: 57.8"	"Cell type enhanced"	"Detected in many"	11	"Hepatocytes: 230.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 67.7;RT4: 17.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009277			Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Cell Junctions"	"HPA009277: AB_2668229"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.20e-2)"	"unprognostic (7.24e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (2.65e-7)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.46e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.79e-1)"	10.6	3.8	8.6	1.4	3.4	0.1	18.0	2.5	8.3	11.5	2.5	2.4	2.9	0.8	6.4	11.8	3.7	13.6	5.1	9.7	6.8	0.9	3.8	68.1	3.3	2.8	4.4	3.5	35.1	32.2	78.2	3.0	29.0	9.1	4.9	1.5	13.0	2.4	3.3	57.8	3.3	2.0	4.3	10.9	1.8	3.3	7.7	3.5	0.0	14.3	10.4	1.2	3.4	6.4	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.9	0.3	10.4	0.0	0.1	11.3	0.0	7.0	0.5	0.6	3.3	0.0	0.0	2.4	0.0	1.5	0.0	7.5	1.7	2.4	0.0	3.9	0.0	8.1	7.2	67.7	3.1	0.0	9.1	1.4	8.8	8.4	0.0	3.2	0.0	0.0	0.0	7.9	11.0	0.4	3.6	3.8	2.3	0.9	0.0	5.2	5.4	0.8	17.4	0.1	1.4	0.5	0.2	3.1	8.0	0.0	0.3	7.2	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.6	3.4	2.5	8.3	6.8	0.9	4.4	3.5	9.1	3.5	11.9	63.8	0.0	6.1	7.3	1.8	14.3	33.1	84.3	27.3	7.0	33.4	17.0	0.0	4.5	10.8	5.2	0.1	0.0	79.6	13.8	18.2	28.5	2.3	230.6	4.7	0.0	84.5	6.7	6.9	17.4	35.1	1.5	3.3	1.0	2.2	15.0	29.6	0.0	26.2	1.8	38.5	58.2	52.8	0.4	0.4	3.3	21.7	2.5	2.6	1.8
SLC7A5	"CD98, D16S469E, E16, LAT1, MPE16"	ENSG00000103257	"Solute carrier family 7 member 5"	Q01650	16	87830023-87869488	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 71.2"	"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 70.0;granulocytes: 68.9;Intestinal endocrine cells: 82.6;Smooth muscle cells: 85.8;Syncytiotrophoblasts: 89.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"plasmacytoid DC: 15.9"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 15.9"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 108.7;hTCEpi: 186.8;MCF7: 101.2;SiHa: 153.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052673, HPA056077"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Vesicles	"HPA052673: AB_2681909, HPA056077: AB_2683031"	"unprognostic (2.71e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (6.86e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.93e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.64e-2)"	"unprognostic (7.19e-3)"	8.2	3.2	18.3	14.7	24.5	71.2	4.3	15.9	45.8	7.9	4.6	16.7	8.9	6.2	5.3	30.4	38.7	3.3	6.4	8.2	19.8	22.1	3.6	9.7	3.8	11.1	23.9	9.6	5.1	12.1	1.5	9.0	28.4	23.4	4.3	3.4	34.9	11.5	15.4	11.2	10.7	5.7	4.8	17.7	6.4	12.7	34.9	19.8	3.7	4.2	16.7	15.0	11.5	7.7	0.5	15.9	0.6	0.0	0.2	1.4	0.4	14.9	56.6	1.1	15.9	0.4	0.9	40.8	12.0	4.3	7.3	4.7	36.9	21.4	13.7	10.6	15.2	2.5	67.4	11.7	108.7	5.1	14.3	5.9	11.2	53.1	26.4	17.1	10.4	20.7	3.0	186.8	9.0	66.8	2.4	1.4	48.5	16.7	15.3	5.8	101.2	12.5	15.3	5.2	9.4	13.8	12.2	4.3	20.9	8.1	1.2	9.1	3.6	153.4	30.7	32.9	10.8	14.1	13.8	1.1	2.6	17.1	10.6	9.3	20.0	16.3	59.1	10.1	25.9	24.4	0.6	0.0	0.0	1.0	0.0	1.2	0.5	0.5	0.8	0.3	0.0	0.1	0.4	0.1	0.2	0.0	15.9	1.4	0.4	18.3	24.5	15.9	28.1	19.8	22.1	23.9	9.6	23.4	19.8	0.0	1.1	16.4	11.1	65.1	12.7	2.8	2.5	0.0	0.0	1.8	15.7	12.4	0.0	16.8	0.8	4.3	1.7	70.0	8.0	28.4	10.4	13.9	68.9	14.5	8.2	9.5	82.6	2.5	3.5	4.0	1.7	6.6	37.1	2.8	2.8	13.3	19.5	0.2	1.4	0.5	50.1	0.0	85.8	1.7	2.5	32.9	89.8	8.6	1.6	26.1
SLC8A1	NCX1	ENSG00000183023	"Solute carrier family 8 member A1"	P32418	2	40097270-40611053	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sodium transport, Transport"	Calmodulin-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 67.7"	"Cell type enriched"	"Detected in many"	11	"Cardiomyocytes: 601.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 25.2"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 25.2"	"Cell line enhanced"	"Detected in many"		"BJ: 15.4;fHDF/TERT166: 37.3;hTERT-HME1: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022694, HPA070007"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Plasma membrane"		"CAB022694: , HPA070007: AB_2686227"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.57e-6)"	"unprognostic (1.56e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.66e-2)"	"unprognostic (7.04e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.46e-2)"	"unprognostic (6.77e-2)"	3.9	2.9	7.7	4.4	14.3	1.4	2.0	3.5	15.3	5.5	7.3	1.8	7.1	3.3	12.2	3.9	4.0	3.9	5.3	67.7	7.7	6.6	11.0	2.2	3.7	2.5	5.2	8.2	2.1	1.5	1.1	1.9	6.8	7.6	12.2	3.4	1.0	1.5	17.2	1.5	2.1	3.6	20.5	2.8	4.4	2.5	1.4	2.5	0.1	1.6	0.0	1.3	9.8	2.8	0.0	2.4	25.2	6.0	0.0	0.0	0.5	1.5	1.2	1.1	0.1	1.7	3.6	0.0	15.4	6.0	5.1	3.3	0.0	2.5	0.0	1.2	37.3	5.5	0.6	0.3	2.5	5.3	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	5.9	10.9	2.3	0.4	0.0	0.0	0.2	6.5	0.0	0.4	0.0	0.8	0.1	2.1	4.1	8.1	0.0	1.8	0.2	1.7	0.3	0.0	0.0	0.0	5.6	0.0	0.3	5.2	4.8	0.1	0.0	1.6	0.8	0.0	0.0	0.8	0.9	0.7	0.0	4.9	0.0	0.0	5.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	25.2	0.0	6.0	0.1	0.0	0.5	7.7	14.3	3.5	15.3	7.7	6.6	5.2	8.2	7.6	2.5	3.0	3.2	2.9	0.0	1.1	50.8	601.5	2.5	0.0	1.2	33.2	3.9	0.4	0.0	0.0	0.8	3.3	0.0	0.0	0.0	1.4	4.8	0.1	0.0	0.0	28.3	0.0	0.0	20.3	56.6	0.7	0.0	46.7	1.7	1.0	0.6	35.9	0.1	0.0	7.8	0.1	6.9	12.9	19.6	0.2	0.4	2.8	0.9	0.0	0.0	0.0
SLC9A1	"APNH, NHE1, PPP1R143"	ENSG00000090020	"Solute carrier family 9 member A1"	P19634	1	27098815-27166981	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"	Calmodulin-binding	"Deafness, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 60.7"	"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022371, HPA048532, HPA052891"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB022371: , HPA048532: AB_2680431, HPA052891: AB_2681981"	"unprognostic (6.18e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (7.47e-4)"	"unprognostic (2.70e-2)"	"unprognostic (4.33e-3)"	"unprognostic (3.18e-2)"	"unprognostic (9.74e-2)"	"prognostic unfavorable (7.10e-4)"	"unprognostic (3.44e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.16e-2)"	7.1	11.3	7.5	9.9	10.1	7.3	8.4	11.7	18.9	8.7	14.0	5.0	26.9	20.7	10.6	6.8	10.3	7.1	24.4	13.4	4.6	5.3	7.3	2.4	11.2	5.8	5.0	6.7	6.9	6.4	13.4	8.0	42.5	14.8	8.5	10.2	10.1	60.7	55.4	3.8	9.2	24.7	8.1	3.9	10.5	45.6	8.3	4.9	6.0	8.0	6.5	9.0	18.8	8.4	0.9	0.6	5.5	1.5	0.4	4.2	1.8	13.7	4.7	4.5	4.5	10.2	7.4	27.6	11.3	17.3	9.9	10.8	5.7	9.0	6.2	9.7	14.7	4.8	17.2	4.4	28.0	6.2	7.4	4.1	9.5	3.1	2.4	31.1	5.5	7.2	9.2	13.6	16.7	23.3	7.2	16.4	4.4	2.6	6.1	14.5	8.2	2.8	2.9	6.2	17.0	9.8	5.1	4.0	2.9	5.2	20.8	5.2	1.6	9.5	13.0	5.7	4.8	6.0	3.5	17.6	10.6	4.2	9.8	6.2	5.5	3.5	1.8	11.3	6.2	6.1	0.1	1.5	1.5	1.9	0.9	4.2	0.2	2.2	2.0	0.6	0.9	1.4	1.7	5.5	0.4	1.5	0.1	0.8	1.8	7.5	10.1	11.7	18.9	4.6	5.3	5.0	6.7	14.8	4.9	6.0	17.9	5.2	16.2	27.7	6.3	11.3	10.2	0.0	3.4	10.4	0.0	30.0	0.0	8.5	26.9	7.1	52.0	0.0	10.9	16.2	11.0	8.8	26.5	1.0	11.5	19.1	12.0	8.0	4.9	9.7	8.6	6.6	6.8	1.8	12.3	10.8	19.4	22.0	12.4	1.3	3.6	6.5	8.7	1.4	3.4	22.0	44.3	6.7	14.3	16.3
SLC9A3	NHE3	ENSG00000066230	"Solute carrier family 9 member A3"	P48764	5	470458-524332	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 65.8;intestine: 85.1;kidney: 43.6"	"Cell type enhanced"	"Detected in some"	15	"Alveolar cells type 1: 14.9;Club cells: 10.3;Collecting duct cells: 15.7;Proximal tubular cells: 38.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 28.2"	"Region enriched"	"Detected in single"	14	"cerebellum: 4.6"	"Not detected"	"Not detected"			"HPA036493, HPA036669"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA036493: AB_10673353, HPA036669: AB_10670843"	"unprognostic (1.27e-1)"	"unprognostic (4.88e-1)"	"unprognostic (9.35e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.51e-1)"	"unprognostic (9.40e-2)"	"prognostic unfavorable (8.49e-4)"	"unprognostic (5.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.32e-1)"	0.6	0.6	0.5	16.2	1.0	0.0	0.6	4.2	0.9	0.9	27.5	0.7	1.1	12.7	0.9	3.4	2.4	0.8	65.8	0.6	0.6	0.6	43.6	0.5	0.5	0.9	0.9	0.7	0.8	1.1	0.6	0.9	0.5	1.2	1.4	2.3	1.2	2.1	0.8	0.7	4.2	85.1	1.1	0.6	0.5	22.7	1.1	0.5	0.6	0.7	2.4	2.7	0.8	2.0	1.9	2.0	0.2	1.2	3.5	6.8	2.9	4.2	3.8	7.0	7.4	1.7	2.0	5.5	4.2	2.5	5.2	3.3	9.3	4.9	10.2	5.5	1.9	3.8	7.0	3.9	2.5	2.5	28.2	7.3	4.6	16.5	3.4	2.6	3.4	5.9	2.7	5.2	2.3	3.5	2.6	1.5	4.2	6.1	5.4	1.8	6.6	3.7	16.7	2.6	12.2	6.3	5.6	6.6	5.3	1.8	3.6	7.9	3.3	12.6	3.5	2.6	3.2	8.0	2.7	1.9	6.0	5.3	4.1	2.7	9.1	3.6	5.8	3.8	15.3	3.8	0.0	1.2	0.1	4.3	0.5	3.8	1.6	5.6	4.1	1.4	1.9	6.8	5.2	0.2	3.5	0.4	2.0	4.2	2.9	0.5	1.0	4.2	0.9	0.6	0.6	0.9	0.7	1.2	0.5	14.9	4.3	0.0	0.0	0.0	0.0	0.6	0.0	5.3	10.3	15.7	0.0	0.0	5.0	7.5	0.0	0.0	1.0	0.0	7.7	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	8.2	0.0	0.0	6.5	0.0	0.0	38.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC9A3R2	"E3KARP, NHERF-2, SIP-1, TKA-1"	ENSG00000065054	"SLC9A3 regulator 2"	Q15599	16	2025356-2039026	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Endothelial cells: 275.4;Hepatocytes: 196.4;Ito cells: 306.3;Pancreatic endocrine cells: 190.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 3.6;intermediate monocyte: 2.7;myeloid DC: 6.8;plasmacytoid DC: 5.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 6.8;monocytes: 3.6"	"Cell line enhanced"	"Detected in many"		"A549: 38.1;MCF7: 60.8;PC-3: 57.3;SK-BR-3: 38.5;U-251 MG: 38.3;WM-115: 41.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001672, HPA066520"	Enhanced		Supported	"Plasma membrane"		NA	NA		120000	"Plasma membrane"		"HPA001672: AB_1080017, HPA066520: AB_2732748"	"unprognostic (6.99e-2)"	"unprognostic (4.56e-2)"	"unprognostic (2.06e-2)"	"prognostic favorable (1.03e-4)"	"unprognostic (1.41e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.94e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.20e-2)"	"unprognostic (6.20e-3)"	"unprognostic (9.10e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.80e-2)"	51.5	19.4	20.0	10.0	25.4	1.1	41.0	15.5	26.6	29.7	13.1	15.2	13.5	13.5	28.7	10.3	16.1	20.9	30.4	65.1	18.4	15.7	40.7	80.9	51.2	11.1	21.0	15.9	18.3	14.0	5.3	17.4	25.1	17.8	25.5	6.5	37.5	76.3	22.9	60.9	7.1	15.7	9.9	12.2	39.0	35.0	8.8	13.5	2.5	32.7	21.5	12.3	13.3	25.0	0.1	6.8	0.0	3.6	0.1	0.9	1.0	6.3	38.1	1.0	7.9	1.3	1.8	1.1	27.8	16.8	14.0	4.6	5.0	8.5	0.0	13.2	11.9	1.8	6.2	3.0	2.7	1.5	0.0	9.1	0.6	16.4	12.1	9.3	0.1	2.8	1.9	2.8	4.1	1.2	6.6	13.9	2.9	4.6	0.5	0.9	60.8	0.1	7.0	1.5	15.2	57.3	5.4	1.6	10.0	3.1	0.6	7.3	6.8	1.9	38.5	2.5	1.0	31.2	3.3	35.5	4.4	6.4	0.4	38.3	1.0	0.8	0.1	0.5	0.7	41.1	0.0	3.6	0.0	0.9	2.7	0.3	0.0	0.2	0.2	6.8	0.1	0.9	0.9	0.0	0.1	0.9	5.0	0.2	1.0	20.0	25.4	15.5	26.6	18.4	15.7	21.0	15.9	17.8	13.5	3.0	13.8	20.1	19.8	13.5	1.5	21.0	66.2	6.7	5.7	12.2	0.0	0.8	5.0	30.7	12.9	275.4	5.7	0.0	7.5	0.7	37.7	42.0	0.0	196.4	2.2	3.2	20.6	306.3	28.2	22.9	75.9	9.5	32.1	1.8	66.3	11.2	190.9	5.8	41.8	12.2	4.4	25.8	53.1	1.7	7.7	9.9	0.8	6.9	14.3	41.9
SLC9A5	NHE5	ENSG00000135740	"Solute carrier family 9 member A5"	Q14940	16	67237683-67272190	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 13.5;lymphoid tissue: 14.5"	"Cell type enriched"	"Detected in some"	5	"Horizontal cells: 15.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041004, HPA041329"	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA041004: AB_10794433, HPA041329: AB_10794373"	"unprognostic (8.90e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.84e-2)"	"unprognostic (9.85e-11)"	"unprognostic (9.21e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.12e-3)"	"unprognostic (9.07e-2)"	1.7	1.7	2.9	1.1	8.8	0.5	1.1	13.5	8.6	0.9	1.4	0.5	3.6	1.3	1.1	3.2	0.6	0.6	1.9	2.3	2.9	3.6	1.1	0.6	2.9	2.1	2.1	2.3	1.4	1.5	0.5	0.6	1.7	4.3	1.0	1.1	0.5	1.0	2.5	1.7	4.2	0.9	0.6	2.7	14.5	0.8	3.3	1.2	0.0	1.0	0.0	1.3	1.6	0.4	1.5	0.8	1.0	0.5	0.6	0.9	0.1	0.5	4.1	3.7	1.2	6.8	4.7	0.4	1.3	5.8	3.4	3.1	0.2	2.9	0.0	0.8	1.6	1.7	0.2	1.0	0.7	1.3	1.2	1.2	3.2	0.3	0.9	0.8	1.4	6.7	5.3	1.4	1.9	0.4	6.3	0.7	1.2	0.7	1.9	2.2	2.3	0.1	0.3	2.5	0.2	0.4	0.0	0.8	0.9	0.6	0.7	2.1	0.9	3.5	0.2	1.8	0.9	1.4	0.3	1.0	8.8	1.4	1.6	0.6	3.6	0.9	1.8	6.3	0.7	2.2	0.0	0.4	0.0	0.0	0.0	0.6	1.5	0.4	0.9	0.1	0.0	0.4	0.4	1.0	0.6	0.5	0.8	0.0	0.1	2.9	8.8	13.5	8.6	2.9	3.6	2.1	2.3	4.3	1.2	3.0	3.2	0.0	0.1	0.6	1.9	1.2	2.5	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.6	0.7	0.0	0.0	0.2	0.1	0.6	0.4	0.0	0.0	0.1	15.9	1.2	2.5	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.3	0.4	0.0	2.1	0.0	0.6	0.0	0.7	1.7	1.1	0.6	0.0	0.0	0.2	0.1
SLCO1A2	"OATP, OATP-A, OATP1A2, SLC21A3"	ENSG00000084453	"Solute carrier organic anion transporter family member 1A2"	P46721	12	21264600-21419594	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.9;liver: 11.2;retina: 14.2;salivary gland: 14.5"	"Cell type enriched"	"Detected in some"	9	"Alveolar cells type 1: 32.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 13.3;RPMI-8226: 9.2;SuSa: 14.2;U-266/70: 19.8;U-266/84: 8.0"					"Low region specificity"	"Detected in all"			HPA071152			Supported	"Plasma membrane"		No	No			"Plasma membrane"		"HPA071152: AB_2686350"	"unprognostic (5.43e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.66e-4)"	"unprognostic (2.52e-2)"	"unprognostic (3.20e-1)"		"unprognostic (1.24e-1)"	0.2	0.1	3.3	0.0	3.4	0.0	3.6	3.4	17.9	0.1	0.1	1.9	0.0	0.0	0.1	0.1	0.2	0.3	0.1	0.9	4.1	2.5	1.1	11.2	2.7	0.6	3.0	4.0	0.2	2.3	0.5	0.5	1.2	9.7	0.7	0.0	14.2	14.5	0.0	0.4	0.4	0.2	0.0	2.9	0.4	0.4	1.6	1.4	0.0	0.3	0.0	0.3	0.4	0.1	1.3	0.7	4.3	0.4	1.1	2.3	0.2	2.0	0.5	0.8	0.2	0.0	0.0	2.7	0.0	0.0	0.0	0.0	2.9	1.7	0.1	2.1	0.1	0.0	0.2	0.2	0.1	0.4	0.5	0.7	0.0	0.4	1.1	0.0	0.3	0.2	0.0	1.3	0.1	0.1	1.2	0.1	0.4	3.4	1.4	0.0	2.0	0.3	0.1	13.3	1.5	0.1	0.1	0.2	9.2	0.0	2.0	1.8	2.3	0.0	0.2	0.2	14.2	2.6	0.7	0.0	0.0	1.4	0.6	0.3	19.8	8.0	0.1	0.2	0.2	0.1	0.6	0.4	0.3	1.4	0.3	2.3	1.3	2.2	1.5	0.1	1.0	2.1	1.6	4.3	1.1	0.1	0.7	1.8	0.2	3.3	3.4	3.4	5.0	4.1	2.5	3.0	4.0	9.7	1.4	32.8	1.9	0.0	0.0	0.0	0.0	0.4	0.0	2.7	0.0	1.8	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.1	0.0	0.0	0.0
SLCO1B3	"OATP1B3, OATP8, SLC21A8"	ENSG00000111700	"Solute carrier organic anion transporter family member 1B3"	Q9NPD5	12	20810702-20916911	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"liver: 88.1"	"Cell type enriched"	"Detected in some"	20	"Hepatocytes: 91.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 35.8;A549: 9.8;CAPAN-2: 7.1;GAMG: 7.8;HeLa: 8.1;PC-3: 9.8;U-2 OS: 8.5"									"HPA004943, HPA050892"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA004943: AB_1854758, HPA050892: AB_2681265"		"unprognostic (5.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.95e-2)"		"unprognostic (1.63e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.09e-2)"		"unprognostic (3.08e-2)"	"unprognostic (1.54e-2)"	"unprognostic (7.37e-2)"		"unprognostic (1.50e-1)"	"unprognostic (6.61e-3)"		"unprognostic (2.36e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	4.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	88.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.8	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	7.1	0.0	2.5	0.0	7.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	8.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	91.8	0.0	0.0	0.0	0.6	1.9	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1
SLCO5A1	"OATP-J, OATP5A1, OATPRP4, SLC21A15"	ENSG00000137571	"Solute carrier organic anion transporter family member 5A1"	Q9H2Y9	8	69667047-69835064	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 21.4;lymphoid tissue: 9.5;skeletal muscle: 13.9;tongue: 16.2"	"Group enriched"	"Detected in many"	6	"Bipolar cells: 12.4;Cardiomyocytes: 13.6;Glandular cells: 10.0;Intestinal endocrine cells: 15.0;monocytes: 36.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HAP1: 9.0;NTERA-2: 6.0;RPMI-8226: 5.7;SCLC-21H: 6.5;U-266/70: 3.5"	"Group enriched"	"Detected in some"	7	"basal ganglia: 2.3;olfactory region: 8.2"					HPA025062	Uncertain		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA025062: AB_1857220"	"unprognostic (1.30e-3)"	"unprognostic (7.35e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.37e-4)"	"unprognostic (1.75e-1)"	"unprognostic (4.48e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.92e-6)"	"unprognostic (2.20e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.50e-2)"	0.7	0.2	0.5	1.5	0.7	1.5	0.2	0.1	0.8	0.3	0.4	0.1	0.0	0.4	0.5	1.5	1.0	0.5	0.4	21.4	0.7	0.7	0.2	0.4	0.3	4.1	0.3	0.3	0.2	0.7	0.0	4.7	0.0	0.5	4.2	0.7	0.6	0.9	0.0	13.9	0.3	0.7	0.2	0.2	0.8	0.3	0.4	0.0	9.5	0.5	16.2	1.7	0.9	0.2	1.7	0.1	0.7	0.0	0.2	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.0	0.0	0.0	2.4	2.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.1	6.0	0.0	0.9	1.0	0.9	5.7	0.1	0.0	6.5	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.6	0.1	1.2	3.5	0.6	0.0	0.3	0.0	1.7	0.7	0.0	0.1	0.3	0.0	0.0	0.5	0.1	0.2	0.0	1.7	0.1	0.2	0.3	0.2	0.0	0.1	0.1	0.0	0.5	0.7	0.1	0.7	0.7	0.7	0.3	0.3	0.5	0.0	3.0	0.0	1.9	1.1	0.2	12.4	13.6	0.0	0.0	1.2	0.0	2.0	0.0	0.0	1.5	0.4	0.7	0.0	0.0	1.2	0.0	0.6	10.0	0.0	0.0	0.1	1.6	15.0	0.0	0.0	0.4	0.0	0.3	0.0	36.9	1.6	0.3	2.4	0.0	0.0	0.0	0.2	0.0	1.0	0.9	1.7	0.4	0.0	0.0	0.9	0.7
SLITRK6	FLJ22774	ENSG00000184564	"SLIT and NTRK like family member 6"	Q9H5Y7	13	85792787-85806683	"Disease related genes, Predicted membrane proteins"	"Hearing, Sensory transduction, Vision"		Deafness	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 24.2;salivary gland: 22.8;smooth muscle: 22.4;urinary bladder: 27.8"	"Cell type enhanced"	"Detected in some"	25	"Bipolar cells: 14.0;Ciliated cells: 69.6;Club cells: 25.0"	"Cancer enhanced"	"Detected in many"		"breast cancer: 21.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 11.1;cerebellum: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 13.5;OE19: 10.9;RT4: 46.2;WM-115: 10.9"	"Region enhanced"	"Detected in many"		"thalamus: 24.7"	"Low region specificity"	"Detected in many"			"HPA014491, HPA014513"	Uncertain		Supported	"Plasma membrane"		NA	NA		9500	"Plasma membrane"		"HPA014491: AB_10601603, HPA014513: AB_2669026"	"unprognostic (6.14e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (8.52e-4)"	"unprognostic (6.10e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.82e-2)"	"unprognostic (7.60e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.31e-5)"	"unprognostic (5.60e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.51e-2)"	0.4	0.3	0.3	2.7	11.1	0.0	2.9	4.9	0.3	1.0	4.5	0.0	0.2	2.8	0.7	3.4	3.6	0.3	1.1	1.9	0.3	1.3	0.3	1.1	3.1	0.0	0.6	0.0	0.3	0.4	0.0	0.4	4.1	0.8	24.2	5.8	1.7	22.8	1.8	0.3	4.5	7.2	22.4	0.4	0.2	1.2	0.5	1.8	0.0	0.6	3.4	0.7	27.8	5.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.2	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	13.5	0.0	1.6	1.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	10.9	0.9	0.1	0.0	0.0	0.0	46.2	0.4	0.5	0.2	0.0	0.0	0.8	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	10.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	11.1	4.9	0.3	0.3	1.3	0.6	0.0	0.8	1.8	0.0	2.6	0.0	4.8	3.4	14.0	0.3	0.0	69.6	25.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.0	0.0	0.2	0.0	0.0	3.7	0.0	0.0	8.9	0.0	0.0	0.0	0.4	1.1	1.1	0.0	0.4	0.0	1.4	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.0	3.1
SMAGP	"hSMAGP, MGC149453, MGC149454"	ENSG00000170545	"Small cell adhesion glycoprotein"	Q0VAQ4	12	51244558-51270890	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 53.4"	"Group enriched"	"Detected in many"	9	"Cytotrophoblasts: 1087.3;Syncytiotrophoblasts: 704.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 39.4;OE19: 47.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039711	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA039711: AB_10674985"	"unprognostic (2.55e-3)"	"unprognostic (2.63e-1)"	"unprognostic (3.96e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (3.01e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.11e-2)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (1.46e-1)"	"prognostic favorable (2.24e-4)"	"unprognostic (4.32e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.52e-1)"	7.5	6.9	0.9	11.3	1.7	0.9	26.3	1.1	1.3	13.1	22.6	0.9	5.3	6.9	8.0	13.6	53.4	3.2	21.8	6.0	1.0	1.0	10.9	4.3	17.6	14.2	1.5	0.4	5.2	14.9	4.6	1.9	50.0	3.0	4.8	24.3	2.6	10.2	6.9	3.6	12.6	8.5	3.4	4.3	11.5	14.1	4.8	0.7	1.2	4.2	28.7	33.1	7.9	24.6	22.5	2.6	8.6	3.7	12.3	9.5	3.5	23.3	7.2	0.8	0.8	3.2	12.7	39.4	18.0	18.1	9.2	5.7	14.2	24.6	0.2	3.2	11.1	3.4	8.3	5.1	6.9	12.9	1.1	4.1	3.1	0.9	4.7	8.9	0.7	3.0	8.2	5.3	19.9	18.0	21.1	22.1	6.0	2.4	1.3	14.8	20.6	3.8	2.8	3.6	47.5	27.9	0.2	0.3	0.8	13.3	5.4	0.9	1.1	3.9	15.8	2.8	9.9	13.6	1.2	7.7	10.3	9.8	0.5	10.9	0.4	0.6	0.4	15.1	7.7	5.5	1.9	3.7	6.4	9.5	2.4	6.1	22.5	4.2	6.9	2.6	17.6	3.9	7.0	8.6	12.3	2.6	1.5	2.7	3.5	0.9	1.7	1.1	1.3	1.0	1.0	1.5	0.4	3.0	0.7	0.0	18.8	28.2	46.4	19.3	1.2	1.1	53.5	8.1	12.5	15.7	0.0	1087.3	41.4	27.1	6.5	53.4	61.6	0.0	95.9	65.5	13.8	46.6	12.7	5.8	83.3	1.6	19.7	38.1	5.4	2.1	12.0	6.7	13.5	5.4	100.2	2.5	97.3	73.7	9.2	15.3	1.2	25.8	8.1	5.2	28.8	26.0	704.6	15.2	97.4	72.3
SNAP23	"HsT17016, SNAP23A, SNAP23B"	ENSG00000092531	"Synaptosome associated protein 23"	O00161	15	42491233-42545356	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 273.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 102.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001214, CAB037083, CAB037317"	Approved		Supported	"Plasma membrane"		NA	NA		12000000	"Plasma membrane"		"CAB037083: AB_477494, CAB037317: AB_261925, HPA001214: AB_1080037"	"unprognostic (1.77e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.76e-3)"	"unprognostic (2.42e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.67e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.93e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.93e-2)"	29.9	24.0	15.2	28.4	20.5	14.3	28.6	11.1	17.5	20.8	30.8	21.6	27.7	23.0	38.9	18.6	20.3	21.3	18.7	24.6	16.6	11.7	22.8	23.0	28.0	35.4	27.3	10.5	24.6	19.8	10.4	17.7	81.6	18.9	24.1	24.5	16.3	37.0	25.8	32.8	15.3	40.8	22.8	23.4	41.6	22.1	25.1	21.3	20.1	20.3	18.1	35.1	25.5	53.7	17.2	22.9	102.0	36.3	10.3	11.5	23.0	17.5	7.9	15.0	14.6	24.7	19.5	23.1	22.1	16.7	13.1	15.9	25.7	6.9	8.5	29.2	13.6	14.4	15.0	16.6	12.9	18.6	14.4	9.6	40.6	8.6	24.1	17.9	16.3	39.1	15.5	10.2	11.7	20.1	18.7	50.2	19.6	30.4	8.8	17.8	6.0	19.4	16.9	12.7	25.3	6.1	35.7	8.9	14.0	18.4	15.9	2.4	9.6	15.9	14.6	14.0	23.9	21.0	23.5	39.4	13.3	18.1	15.9	21.8	19.1	33.8	45.5	16.0	33.2	17.1	30.2	24.7	102.0	8.4	36.3	9.8	17.2	8.9	8.2	22.9	15.4	11.5	8.8	56.2	10.3	34.4	9.5	9.8	23.0	15.2	20.5	11.1	17.5	16.6	11.7	27.3	10.5	18.9	21.3	104.2	26.2	49.8	68.2	45.1	7.4	14.3	22.9	41.5	19.4	19.2	19.6	58.5	48.0	63.9	163.9	67.1	52.1	0.0	45.9	88.6	49.1	68.2	79.9	24.3	76.0	4.8	14.3	67.5	97.9	273.8	36.2	83.7	42.2	120.8	68.8	14.6	83.4	48.0	57.0	61.4	19.1	51.8	45.7	15.6	6.5	33.6	119.1	47.7	32.9	54.8
SNTB2	"D16S2531E, EST25263, SNT2B2, SNT3, SNTL"	ENSG00000168807	"Syntrophin beta 2"	Q13425	16	69187129-69309052	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Muller glia cells: 187.1;Rod photoreceptor cells: 126.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001394			Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Golgi apparatus, Plasma membrane"	Nucleoplasm	"HPA001394: AB_1080170"	"unprognostic (4.86e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.77e-2)"	"unprognostic (8.07e-3)"	"unprognostic (6.46e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.64e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.71e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.88e-1)"	20.7	8.4	5.8	10.2	7.9	3.8	13.4	5.3	9.4	22.9	12.2	4.5	13.3	5.5	17.8	10.9	16.1	13.0	10.4	8.6	4.8	3.2	14.1	5.8	12.7	7.2	4.8	4.8	13.9	6.6	31.9	7.2	7.4	5.3	16.7	7.8	26.0	8.3	8.4	8.8	12.7	9.6	15.7	5.0	8.6	9.3	10.5	4.0	6.4	22.8	6.8	7.5	18.3	20.2	1.0	0.6	3.0	1.0	2.6	3.7	0.9	4.0	6.2	4.3	3.4	16.0	21.6	5.3	8.0	11.2	6.3	7.0	6.1	3.7	5.1	4.9	9.3	3.3	7.4	5.8	3.9	8.2	2.2	3.2	2.2	6.1	5.2	5.3	0.1	3.4	15.4	2.9	10.3	4.2	6.6	18.8	1.4	1.3	8.0	7.6	4.6	1.7	0.7	2.9	2.4	5.0	10.1	3.8	9.5	3.3	6.2	1.6	3.6	24.5	3.5	2.5	3.4	4.1	0.3	14.6	11.9	5.7	8.3	7.4	1.8	2.8	5.8	7.6	0.8	5.4	1.1	1.0	1.0	3.2	1.0	3.3	1.0	1.6	1.8	0.6	0.8	1.0	3.7	3.0	2.6	1.0	0.4	1.6	0.9	5.8	7.9	5.3	9.4	4.8	3.2	4.8	4.8	5.3	4.0	17.9	9.4	7.8	23.9	33.8	22.9	6.5	2.5	5.3	7.9	26.2	39.3	8.1	3.3	9.2	20.9	65.9	17.4	0.0	21.0	7.0	31.2	42.1	1.1	9.7	6.1	4.8	9.9	84.7	22.9	21.8	54.7	10.1	28.7	1.8	17.0	187.1	14.1	24.6	61.2	27.4	126.8	6.5	39.2	22.7	8.3	33.9	3.1	21.0	16.8	25.9
SNTG2	"G2SYN, SYN5"	ENSG00000172554	"Syntrophin gamma 2"	Q9NY99	2	950868-1367613	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	21	"Early spermatids: 58.0;Horizontal cells: 85.8;Late spermatids: 26.8;Spermatocytes: 17.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 3.7;HAP1: 4.1;JURKAT: 3.8;MOLT-4: 2.4;NTERA-2: 5.0;SCLC-21H: 4.9"	"Low region specificity"	"Detected in single"							"HPA065258, HPA077904"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA065258: , HPA077904: "	"unprognostic (7.52e-3)"	"unprognostic (7.52e-4)"	"unprognostic (4.15e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.39e-3)"		"unprognostic (2.46e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.87e-3)"	"unprognostic (3.58e-3)"	"unprognostic (3.64e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.05e-2)"	8.8	2.2	0.9	1.2	1.7	0.7	7.5	1.7	1.4	5.6	1.8	0.4	1.0	1.3	10.2	8.1	4.3	2.5	4.9	1.0	2.6	1.4	0.8	0.6	1.3	0.9	1.1	0.3	1.2	6.7	0.9	9.2	0.7	5.1	1.6	1.6	3.5	1.4	0.8	6.4	3.5	1.4	5.2	2.9	7.7	1.4	5.7	0.9	2.2	2.0	3.1	2.0	2.8	2.6	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.3	0.0	0.0	3.7	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	2.4	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.7	1.7	1.4	2.6	1.4	1.1	0.3	5.1	0.9	0.0	0.0	0.0	0.1	0.8	0.7	0.6	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	58.0	5.2	0.0	0.0	0.2	0.4	0.4	0.3	0.0	0.0	0.1	85.8	0.0	0.0	0.0	26.8	0.3	0.0	1.7	0.0	0.0	0.5	0.0	0.0	3.9	0.2	4.0	0.0	0.4	17.7	3.1	0.1	0.0	0.0	0.0	0.1
SORBS1	"CAP, FLJ12406, KIAA1296, ponsin, SH3D5, sh3p12"	ENSG00000095637	"Sorbin and SH3 domain containing 1"	Q9BX66	10	95311771-95561414	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 126.5"	"Cell type enriched"	"Detected in many"	7	"Cardiomyocytes: 479.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 7.6;eosinophil: 2.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 15.2;HMC-1: 26.6;SK-MEL-30: 22.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027559, CAB032850, HPA043084"	Enhanced		Supported	"Plasma membrane,Focal adhesion sites,Centrosome"		NA	NA			"Focal adhesion sites"	"Plasma membrane, Centrosome"	"CAB032850: AB_2286335, HPA027559: AB_10600812, HPA043084: AB_2678307"	"prognostic favorable (2.84e-4)"	"unprognostic (3.53e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.01e-3)"	95.0	6.4	23.0	16.4	21.6	1.8	23.5	16.8	22.5	14.9	70.2	18.7	22.1	8.1	41.8	12.5	45.0	25.1	28.9	83.7	20.9	8.3	5.9	14.7	8.7	1.4	13.4	14.1	9.8	7.3	17.5	3.5	9.9	19.2	42.0	20.0	6.4	7.2	65.7	46.4	6.3	15.5	126.5	20.6	2.9	40.0	5.5	19.3	0.0	4.0	12.7	1.2	63.9	31.4	0.1	0.0	7.6	1.2	0.6	1.0	0.2	0.7	0.7	6.4	1.6	2.4	0.1	0.9	0.2	0.1	0.2	0.0	15.2	5.7	0.0	1.2	0.1	2.4	0.3	1.2	0.3	0.1	1.8	2.3	3.7	0.2	9.1	0.8	0.0	26.6	0.4	0.2	0.3	0.1	0.1	2.6	0.9	6.0	1.2	0.6	0.4	0.0	0.3	3.0	2.8	1.4	0.5	2.2	0.2	7.2	10.0	2.8	2.0	0.9	0.3	22.8	4.6	1.2	0.2	0.2	0.0	2.3	0.1	1.2	0.8	0.2	0.1	2.8	0.2	6.4	7.6	0.2	2.2	0.7	1.2	1.0	0.1	0.3	0.4	0.0	0.1	0.3	0.1	0.2	0.6	0.2	0.0	0.5	0.2	23.0	21.6	16.8	20.7	20.9	8.3	13.4	14.1	19.2	19.3	20.8	18.1	0.5	5.1	10.3	5.9	479.0	12.7	0.0	2.3	1.8	2.0	17.9	3.3	4.4	61.7	19.0	1.0	0.0	2.6	1.9	15.3	5.3	15.1	42.9	2.7	6.4	5.8	38.6	4.9	26.4	6.9	1.1	13.5	1.0	14.0	18.2	2.8	3.5	72.2	4.3	5.4	0.0	64.3	2.8	4.7	10.9	24.7	0.0	5.2	3.3
SORT1	"Gp95, NT3"	ENSG00000134243	"Sortilin 1"	Q99523	1	109309568-109397951	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Endocytosis, Osteogenesis, Transport"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 71.1;epididymis: 75.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 9.0;non-classical monocyte: 10.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006889, CAB011498"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA	7170000		"Golgi apparatus, Cytosol"	"Plasma membrane"	"CAB011498: AB_2192606, HPA006889: AB_1080056"	"unprognostic (2.10e-2)"	"unprognostic (7.46e-2)"	"prognostic favorable (7.74e-6)"	"unprognostic (4.12e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (3.34e-3)"	"unprognostic (4.27e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.95e-1)"	"unprognostic (4.46e-3)"	22.9	6.5	24.0	6.2	35.5	10.1	15.5	6.4	40.6	10.1	15.2	50.3	18.1	11.5	11.9	75.2	22.0	14.8	9.5	31.8	45.2	19.8	21.1	3.7	19.2	3.6	57.9	22.8	3.6	9.3	24.2	5.7	22.9	27.1	10.3	14.4	12.2	11.8	24.8	36.4	8.3	11.3	14.6	71.1	5.4	9.5	21.6	42.2	1.1	22.5	5.1	5.4	8.7	8.2	0.0	4.5	2.3	10.0	0.4	0.0	1.7	11.8	4.7	11.9	14.5	34.8	6.9	34.3	8.8	14.1	8.7	9.3	12.2	4.4	0.1	11.3	3.7	6.4	2.9	14.0	6.9	12.5	0.3	6.6	3.2	7.7	13.1	13.6	0.0	10.7	17.3	1.1	10.6	2.3	23.3	1.3	9.9	24.4	1.2	12.1	12.5	8.3	0.2	4.4	5.3	2.0	9.3	28.1	5.7	16.6	8.6	12.2	7.0	5.2	34.5	37.0	17.7	14.5	2.0	0.3	1.8	7.1	0.3	14.7	11.8	9.6	0.0	3.1	0.0	7.6	0.0	7.1	2.3	0.0	9.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	1.9	0.4	10.0	1.6	0.0	1.7	24.0	35.5	6.4	33.9	45.2	19.8	57.9	22.8	27.1	42.2	35.7	42.8	0.0	4.2	1.1	14.6	83.1	33.1	22.7	18.2	71.5	33.4	26.8	5.0	23.3	53.4	7.3	49.9	0.0	20.8	26.7	6.1	10.7	7.0	22.5	27.9	12.7	16.1	4.3	36.7	56.4	8.1	24.8	20.3	20.8	30.9	20.4	21.0	17.5	46.7	9.9	42.2	32.3	31.1	51.1	20.4	1.6	30.8	1.8	19.9	10.8
SPG11	"FLJ21439, KIAA1840"	ENSG00000104133	"SPG11, spatacsin vesicle trafficking associated"	Q96JI7	15	44562696-44663678	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040412, HPA040947"	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoli	"HPA040412: AB_10795418, HPA040947: AB_10796232"	"unprognostic (1.10e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.99e-1)"	"unprognostic (9.31e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.26e-3)"	"unprognostic (2.58e-2)"	"unprognostic (9.19e-2)"	"prognostic favorable (6.28e-5)"	"unprognostic (8.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.72e-1)"	"unprognostic (6.06e-2)"	23.8	24.6	16.6	26.4	22.2	25.8	23.4	21.2	21.2	20.8	26.0	31.7	25.8	17.9	18.6	28.1	22.9	19.0	20.2	19.3	16.1	15.2	22.0	25.1	22.6	26.9	26.3	15.6	20.5	25.5	33.4	25.9	15.7	22.1	22.3	21.6	18.7	22.7	26.6	19.0	31.8	26.2	21.5	22.1	39.2	22.8	22.1	23.1	35.8	30.9	12.6	26.0	23.0	19.4	12.8	7.1	13.6	13.0	6.7	8.3	3.8	8.0	5.5	14.1	13.7	22.0	21.7	10.1	8.5	10.9	8.3	10.7	6.6	7.9	5.9	10.6	11.3	14.4	18.5	9.7	13.0	8.2	17.8	5.9	13.6	13.0	10.0	15.5	13.6	12.6	16.5	14.9	6.8	19.7	13.1	11.7	10.5	17.3	15.4	11.7	7.0	6.0	12.5	7.4	24.9	7.5	8.0	11.8	6.5	17.7	21.1	9.2	10.8	9.3	14.8	7.9	12.1	14.1	18.6	12.8	11.1	5.5	13.7	10.2	15.3	13.5	11.9	11.4	18.0	11.3	6.0	8.8	12.3	7.8	10.2	8.3	10.9	6.5	5.8	6.9	12.8	5.4	6.4	13.6	6.7	13.0	7.1	6.6	3.8	16.6	22.2	21.2	21.2	16.1	15.2	26.3	15.6	22.1	23.1	41.7	17.4	28.3	13.4	8.2	22.1	15.9	17.8	44.2	29.6	26.2	45.2	13.6	5.0	16.4	24.2	10.8	26.7	0.0	14.7	8.5	12.9	17.8	26.5	19.5	17.6	15.9	19.3	23.9	45.3	24.1	16.4	30.5	13.5	84.8	28.1	15.6	16.1	17.3	13.1	14.6	21.7	6.5	8.9	40.8	24.7	9.7	7.8	23.0	25.1	17.9
SPHK1	SPHK	ENSG00000176170	"Sphingosine kinase 1"	Q9NYA1	17	76376584-76387860	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Ductal cells: 89.4;monocytes: 99.2;Muller glia cells: 144.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 34.4;hTEC/SVTERT24-B: 30.0;TIME: 30.0;U-138 MG: 30.2;U-251 MG: 38.5"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"olfactory region: 11.7"	"HPA022829, HPA028761"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA022829: AB_1857438, HPA028761: AB_10600814"	"unprognostic (1.04e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.68e-2)"	"unprognostic (9.32e-3)"	"unprognostic (3.13e-1)"	"unprognostic (7.43e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (5.14e-6)"	"unprognostic (1.39e-1)"	"unprognostic (4.82e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.10e-3)"	9.3	2.2	4.7	10.5	3.5	15.0	20.4	0.4	3.2	5.5	5.0	4.0	0.4	1.9	6.3	8.3	13.8	5.3	12.7	10.5	5.3	2.1	4.1	2.4	12.9	10.1	4.4	1.5	5.5	15.1	3.1	2.7	7.4	4.7	4.3	1.1	11.0	11.5	1.7	6.8	8.7	6.3	5.2	4.0	2.7	3.8	3.7	6.3	3.0	9.4	16.2	12.1	5.6	7.0	0.2	8.0	2.4	3.4	0.1	1.4	1.3	9.8	1.0	4.3	0.2	2.2	2.0	4.4	22.8	15.1	19.2	11.6	5.3	1.0	0.4	2.1	16.8	8.2	2.1	3.2	29.2	4.7	0.4	1.7	0.1	7.3	34.4	4.8	0.3	0.8	3.9	0.6	30.0	11.8	8.2	18.5	1.0	4.6	0.0	3.7	12.6	0.9	0.1	0.2	2.2	8.3	0.6	1.1	0.7	1.0	0.1	0.5	1.0	2.3	0.2	19.7	2.7	0.8	1.4	30.0	30.2	5.8	23.1	38.5	0.4	0.1	0.4	22.9	1.7	4.5	2.4	3.4	0.0	1.4	1.7	0.4	0.0	0.2	0.4	1.0	0.2	0.0	0.3	0.4	0.1	0.3	8.0	0.0	1.3	4.7	3.5	0.4	3.2	5.3	2.1	4.4	1.5	4.7	6.3	0.0	0.0	0.5	42.7	11.2	1.3	3.9	33.1	0.0	3.4	1.8	0.0	0.6	0.0	89.4	0.2	35.0	0.7	0.0	10.7	14.8	17.3	28.4	6.9	0.0	31.0	31.8	0.0	4.3	5.7	0.9	3.4	17.1	11.8	99.2	1.1	144.5	62.5	0.3	18.7	1.1	1.8	0.0	39.2	0.0	7.7	9.4	1.1	5.7	0.2	22.4
SPINT1	"HAI, MANSC2"	ENSG00000166145	"Serine peptidase inhibitor, Kunitz type 1"	O43278	15	40844018-40858207	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 121.0"	"Cell type enhanced"	"Detected in many"	13	"Cytotrophoblasts: 913.5;Syncytiotrophoblasts: 1399.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 52.1;HaCaT: 59.5;hTCEpi: 42.4;RT4: 48.2;SK-BR-3: 89.3;T-47d: 42.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA006903, HPA031178"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		3400000	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA006903: AB_1079038, HPA031178: AB_2732463"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.00e-3)"	"unprognostic (3.00e-3)"	"unprognostic (5.03e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (6.04e-2)"	"unprognostic (8.24e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.37e-7)"	"unprognostic (5.37e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.17e-2)"	2.2	0.5	0.9	11.6	1.2	0.0	12.6	2.9	0.8	12.9	64.4	1.2	38.6	31.9	3.6	25.5	71.1	6.4	30.7	0.8	0.8	0.7	27.9	1.5	18.5	3.7	0.9	0.6	3.4	25.0	28.8	9.7	85.5	1.3	17.5	17.9	3.2	50.8	24.0	0.6	39.1	121.0	2.3	1.0	3.1	17.6	1.9	0.7	4.8	15.4	26.9	44.3	12.8	21.5	5.1	19.0	15.3	10.9	3.6	1.8	3.8	19.0	0.1	0.0	0.1	0.0	0.0	52.1	0.3	0.4	0.6	0.3	30.4	32.0	0.0	22.8	0.0	0.5	59.5	4.9	28.6	0.4	0.1	1.6	0.8	0.5	1.6	0.3	3.3	15.1	0.0	42.4	0.6	2.7	0.5	2.3	1.9	0.4	0.1	0.0	14.8	0.1	2.5	5.9	32.2	2.8	1.9	0.0	3.7	28.8	48.2	12.8	0.6	1.4	89.3	2.3	9.6	42.7	2.5	0.0	0.0	0.3	0.1	0.0	0.1	3.6	0.1	0.1	2.5	0.1	0.0	10.9	7.9	0.3	9.3	0.5	5.1	1.8	0.8	19.0	3.9	0.7	0.2	15.3	3.6	9.6	2.3	0.2	3.8	0.9	1.2	2.9	0.8	0.8	0.7	0.9	0.6	1.3	0.7	53.6	17.1	2.7	86.0	67.5	0.0	0.4	109.5	4.0	18.2	127.4	0.0	913.5	21.6	354.0	0.5	0.7	428.8	0.0	224.2	67.1	7.5	132.0	10.3	0.4	125.6	0.0	141.5	0.0	13.6	0.8	3.4	17.8	13.5	101.8	147.7	0.0	241.9	199.9	0.0	40.0	0.1	0.0	5.2	0.6	5.2	76.9	1399.8	2.2	145.0	168.6
SPPL2B	"IMP4, KIAA1532, PSL1"	ENSG00000005206	"Signal peptide peptidase like 2B"	Q8TCT7	19	2328615-2354806	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 82.4"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005592, HPA039292"	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome"		NA	NA			"Nucleoplasm, Plasma membrane"	Centrosome	"CAB005592: AB_325074, HPA039292: AB_2676429"	"unprognostic (4.16e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.48e-2)"	"prognostic favorable (5.00e-5)"	"unprognostic (2.34e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.93e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.72e-1)"	"prognostic favorable (1.33e-4)"	"unprognostic (3.29e-3)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (2.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.40e-2)"	5.4	4.6	5.0	11.7	5.4	11.7	4.0	6.9	6.9	3.4	9.0	7.9	9.6	19.3	4.7	10.0	3.2	5.2	9.8	3.3	5.6		4.2	3.9	3.5	10.3	7.1	4.7	3.4	13.8	6.3	11.0	6.8	7.1	4.7	3.9	6.0	10.5	8.7	7.5	8.7	16.2	5.0	7.0	8.1	13.8	20.1	6.4	9.3	3.0	3.7	5.7	2.3	2.0	14.4	17.4	9.3	7.7	6.2	8.2	5.9	8.3	13.4	5.8	10.2	4.8	4.9	14.8	11.0	3.2	4.0	4.3	9.4	9.6	8.0	10.4	5.1	3.8	11.3	1.9	3.8	1.2	9.3	8.4	5.3	21.0	12.5	9.0	9.3	7.0	7.1	4.3	3.8	2.7	6.3	5.6	16.8	8.6	20.5	2.4	9.3	10.1	11.9	10.8	7.5	5.5	16.9	3.0	22.1	4.4	21.1	10.3	9.8	11.0	6.7	8.4	3.9	11.2	15.7	12.5	7.4	5.3	18.6	8.6	27.1	9.7	8.4	9.2	10.9	12.8	9.3	7.7	7.0	6.6	7.5	4.8	9.0	6.0	6.5	9.4	14.4	7.8	8.2	3.4	6.2	5.1	17.4	5.9	5.9											3.0	15.0	22.0	6.2	0.0	23.4	5.1	28.1	20.1	9.1	24.4	45.2	44.0	1.7	13.7	36.9	9.0	59.3	0.0	10.0	18.3	4.6	7.2	6.9	10.6	10.4	30.2	39.1	14.7	9.5	82.4	13.8	5.3	0.0	5.4	51.1	13.7	10.1	30.8	14.9	6.2	39.6	0.0	8.1	41.9	12.4	0.0	35.8	4.5	38.9	4.3
SPPL3	"DKFZP586C1324, IMP2, MGC126674, MGC126676, MGC90402, PSL4"	ENSG00000157837	"Signal peptide peptidase like 3"	Q8TCT6	12	120762510-120904371	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004194, HPA059958"	Uncertain		Supported	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA004194: AB_2667171, HPA059958: AB_2684179"	"unprognostic (3.29e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.06e-1)"	"unprognostic (7.96e-3)"	"prognostic unfavorable (1.29e-5)"	"unprognostic (3.17e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.66e-1)"	"unprognostic (9.34e-2)"	"unprognostic (9.92e-2)"	"unprognostic (7.54e-2)"	"unprognostic (9.40e-2)"	17.8	15.3	18.9	12.8	23.1	13.9	19.4	21.8	31.4	25.2	20.4	25.6	18.4	14.0	23.1	13.3	39.5	23.3	18.2	13.9	17.4	18.3	18.3	14.9	20.8	21.5	19.2	20.6	25.9	19.6	42.4	14.3	21.9	16.5	16.9	21.7	19.1	19.2	22.7	13.8	48.3	18.5	23.5	17.1	19.0	14.2	34.7	20.8	25.2	24.7	22.2	20.6	19.8	29.3	4.1	6.3	7.3	2.9	2.8	4.4	1.5	12.4	12.5	18.9	11.8	25.0	16.9	13.3	9.6	28.6	20.7	16.7	12.9	12.8	11.5	0.1	16.7	18.4	15.3	19.2	20.7	21.5	9.1	11.8	9.8	7.4	9.8	26.5	11.3	12.8	17.0	33.2	17.7	16.7	24.6	20.3	17.8	10.8	5.8	17.8	11.0	15.1	9.1	12.6	11.7	8.8	9.0	15.9	8.2	16.2	35.5	13.0	14.0	18.3	8.4	14.4	21.1	25.5	7.9	15.1	9.6	13.2	5.9	7.1	13.5	24.2	11.2	14.3	9.4	15.9	7.3	2.9	2.6	3.2	2.8	4.4	3.2	4.0	4.0	4.9	4.1	3.9	4.3	5.5	2.8	2.4	6.3	3.1	1.5	18.9	23.1	21.8	31.4	17.4	18.3	19.2	20.6	16.5	20.8	17.9	17.3	21.4	28.0	48.9	33.5	17.7	17.8	8.1	13.6	38.4	25.5	32.4	1.7	16.9	6.4	28.1	32.5	0.0	21.2	21.9	34.3	27.4	4.6	27.7	32.0	35.0	26.0	32.5	31.3	6.2	26.4	27.5	25.3	13.6	36.3	27.5	19.2	31.7	32.9	18.7	22.1	12.9	21.7	48.8	40.1	74.0	54.0	16.0	33.6	30.8
SRC	"ASV, c-src, SRC1"	ENSG00000197122	"SRC proto-oncogene, non-receptor tyrosine kinase"	P12931	20	37344685-37406050	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell adhesion, Cell cycle, Host-virus interaction, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 5.3;non-classical monocyte: 4.4"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.0;monocytes: 5.3"	"Cell line enhanced"	"Detected in many"		"A549: 35.9;HBEC3-KT: 33.4;RT4: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004023, HPA030875"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		NA	NA		20000000	"Plasma membrane, Cell Junctions"	"Nucleoplasm, Cytosol"	"CAB004023: AB_2106059, HPA030875: AB_2673640"	"unprognostic (5.58e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.56e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (4.90e-5)"	"unprognostic (3.89e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (1.63e-4)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.33e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (5.22e-5)"	6.9	17.5	12.8	11.1	12.0	5.4	9.9	6.4	16.0	16.0	16.4	3.5	15.1	29.5	20.3	9.7	16.2	14.2	42.1	5.8	11.3	6.6	13.4	2.9	10.4	7.0	3.3	9.9	15.8	19.1	6.6	11.3	6.3	5.1	19.9	13.1	13.1	7.5	22.5	3.4	7.7	28.1	27.2	3.6	12.2	29.8	27.3	4.8	4.0	6.6	10.5	10.4	26.4	20.0	0.3	3.0	0.1	5.3	0.6	0.1	1.6	7.7	35.9	8.3	7.4	3.1	5.0	17.2	7.2	6.2	8.8	5.6	13.5	7.0	0.2	4.5	13.0	10.0	14.2	4.9	33.4	3.4	0.0	4.5	2.0	1.3	20.9	7.5	0.1	3.1	5.3	11.4	5.7	7.7	9.8	8.0	4.6	0.2	0.0	1.4	5.3	1.9	0.2	3.9	21.5	32.6	8.4	2.2	0.2	3.7	34.4	7.7	27.9	8.1	11.4	8.9	6.6	10.2	2.8	11.6	10.5	7.1	3.8	6.4	0.1	0.2	0.1	7.4	0.0	7.8	0.0	2.6	0.0	0.0	5.3	0.0	0.3	0.0	0.1	1.1	0.3	0.0	0.0	0.1	0.6	4.4	3.0	0.1	1.6	12.8	12.0	6.4	16.0	11.3	6.6	3.3	9.9	5.1	4.8	3.0	1.7	4.4	10.8	7.2	5.4	1.6	15.3	1.4	0.0	12.2	2.0	1.6	1.7	9.7	1.3	1.4	30.0	0.0	16.2	7.0	8.2	11.2	0.0	0.9	5.8	3.2	16.1	1.3	6.9	1.5	10.0	12.1	1.7	7.2	25.9	4.1	29.0	18.1	16.3	9.5	4.7	12.9	6.4	0.2	0.7	8.0	1.9	0.0	14.9	27.7
SSTR1		ENSG00000139874	"Somatostatin receptor 1"	P30872	14	38207999-38213067	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 15.0;intestine: 14.3;stomach 1: 22.8"	"Group enriched"	"Detected in some"	5	"Cholangiocytes: 5.1;Enterocytes: 9.0;Hepatocytes: 6.4;Intestinal endocrine cells: 17.4;Ito cells: 9.8;Mucus-secreting cells: 8.0;Paneth cells: 8.7;Undifferentiated cells: 6.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 47.9;BJ hTERT+: 13.3;BJ hTERT+ SV40 Large T+: 8.8;fHDF/TERT166: 28.3;HeLa: 10.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA003207, HPA031506"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA003207: , HPA031506: AB_2673913"	"unprognostic (1.40e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.34e-2)"	"unprognostic (9.90e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.16e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.19e-2)"	"prognostic favorable (4.28e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.28e-2)"	0.7	0.4	6.8	0.6	6.9	0.0	0.6	0.5	15.0	0.9	3.7	0.6	0.1	14.3	1.0	0.6	0.4	0.7	0.5	0.8	4.3	10.4	2.2	6.7	5.5	0.1	6.8	4.0	0.6	3.8	0.1	1.4	2.8	2.8	1.2	2.5	0.2	0.2	0.5	0.7	0.4	8.2	0.6	1.3	0.7	22.8	0.1	0.7	0.1	0.3	0.1	0.1	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	47.9	13.3	8.8	0.7	0.5	0.0	0.0	0.0	28.3	0.0	0.1	0.0	0.0	6.4	0.0	0.0	0.0	10.9	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	3.8	0.1	0.0	0.0	0.0	1.9	0.0	1.4	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	6.9	0.5	15.0	4.3	10.4	6.8	4.0	2.8	0.7	0.0	0.0	0.0	0.0	0.2	0.6	0.6	5.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.8	9.0	0.0	0.7	0.0	0.6	0.1	0.0	6.4	0.0	0.0	17.4	9.8	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.3	8.7	0.0	1.3	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	6.0	0.0
SSTR5		ENSG00000162009	"Somatostatin receptor 5"	P35346	16	1078781-1080142	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 8.2;lymphoid tissue: 5.2;pituitary gland: 9.0"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"Hep G2: 9.4;PC-3: 35.0"	"Group enriched"	"Detected in some"	5	"basal ganglia: 4.2;hypothalamus: 2.7"	"Low region specificity"	"Detected in all"			HPA066503			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA066503: AB_2685679"		"unprognostic (2.16e-2)"	"unprognostic (7.31e-2)"		"unprognostic (3.69e-2)"	"unprognostic (2.39e-2)"		"unprognostic (2.14e-1)"			"unprognostic (9.89e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-1)"		"unprognostic (4.09e-2)"	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.4	0.4	0.0	0.7	0.6	0.9	0.5	0.0	8.2	2.9	0.0	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	9.0	0.0	0.0	1.1	0.0	0.0	1.1	0.9	0.1	0.1	0.8	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	5.2	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	35.0	0.0	1.3	0.3	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
STAMBP	AMSH	ENSG00000124356	"STAM binding protein"	O95630	2	73828916-73873659	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	12	"LHCN-M2: 162.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035800, HPA035801"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		11000	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA035800: AB_10670591, HPA035801: AB_2732470"	"unprognostic (1.86e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (4.70e-5)"	"unprognostic (6.13e-2)"	"unprognostic (2.08e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.89e-1)"	12.9	12.8	22.1	13.9	23.0	10.5	17.8	20.1	21.8	18.1	18.4	35.0	13.6	17.8	23.1	15.4	22.7	16.5	14.7	19.0	23.3	21.2	19.6	16.9	13.4	15.3	33.0	14.3	16.3	15.1	20.9	17.8	20.6	26.3	20.2	20.7	14.6	18.3	15.7	30.1	14.4	25.2	19.0	54.7	13.8	15.6	13.3	22.3	18.4	20.1	15.9	19.0	16.8	16.4	17.6	16.9	27.8	17.8	16.7	20.7	12.3	5.4	6.3	5.0	4.6	4.7	5.7	5.8	3.3	4.6	6.2	6.0	10.5	5.2	4.6	5.3	2.8	8.3	4.3	5.3	11.8	7.1	8.0	6.0	6.1	4.4	8.2	6.5	5.0	7.4	4.5	8.5	7.3	10.6	7.9	3.6	6.3	6.6	7.0	162.7	6.6	7.7	4.5	8.0	7.8	3.4	5.4	13.2	6.5	6.6	6.2	9.2	6.8	4.1	5.0	7.1	5.6	4.7	3.0	3.1	5.6	6.7	3.3	5.9	6.6	6.4	3.5	6.9	5.4	6.5	22.6	16.2	27.8	14.4	17.8	15.4	17.6	16.7	14.0	16.9	16.2	17.5	13.2	24.1	16.7	15.7	16.4	20.7	12.3	22.1	23.0	20.1	21.2	23.3	21.2	33.0	14.3	26.3	22.3	17.9	15.3	14.1	25.1	14.4	19.9	35.5	35.7	25.4	27.3	24.4	11.8	35.2	41.4	32.4	59.2	21.7	40.9	46.7	31.9	28.3	22.6	34.8	51.9	34.7	29.0	25.4	9.9	20.3	24.7	104.7	30.2	29.2	6.8	36.9	31.9	21.5	36.9	38.6	32.5	47.1	19.2	38.8	20.6	32.3	49.5	18.9	37.2	19.5	31.2	23.0
STEAP4	"FLJ23153, SchLAH, STAMP2, TIARP, TNFAIP9"	ENSG00000127954	"STEAP4 metalloreductase"	Q687X5	7	88270892-88306891	"Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 122.8"	"Cell type enhanced"	"Detected in many"	15	"Alveolar cells type 2: 320.5;Club cells: 178.6;Sertoli cells: 452.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 45.9"	"Group enriched"	"Detected in some"	5	"midbrain: 1.7;pons and medulla: 6.4"	"Cell type enriched"	"Detected in some"	13	"neutrophil: 48.9"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 48.9"	"Group enriched"	"Detected in some"	6	"HSkMC: 39.3;SiHa: 36.9;U-2197: 52.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA065201			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA065201: "	"unprognostic (3.76e-2)"	"unprognostic (2.16e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.96e-2)"	"prognostic favorable (2.97e-4)"	"unprognostic (7.40e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.66e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.51e-3)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.53e-2)"	122.8	29.3	0.3	12.7	0.8	2.4	55.6	0.6	0.7	15.9	14.0	1.1	5.3	1.4	10.7	22.3	23.7	17.1	9.3	18.7	0.5	0.3	10.8	71.7	27.5	49.4	1.7	0.2	17.8	13.3	12.0	35.1	45.0	6.4	25.8	3.9	4.9	14.6	4.6	22.1	10.5	5.2	13.9	1.8	5.3	5.7	27.3	0.4	0.4	40.9	8.4	5.2	28.4	26.3	0.0	0.3	48.9	3.8	0.0	0.0	0.7	1.4	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.1	5.8	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	39.3	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	36.9	3.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	52.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.8	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	48.9	0.0	0.0	0.0	0.0	0.7	0.3	0.8	0.6	0.7	0.5	0.3	1.7	0.2	6.4	0.4	50.6	320.5	0.0	6.3	8.4	1.1	4.0	0.0	97.7	178.6	0.0	2.0	0.3	0.0	11.7	12.9	8.9	0.0	0.0	8.2	9.0	11.1	62.8	15.1	0.4	2.1	0.0	0.0	19.0	5.1	1.9	106.4	7.7	5.0	0.0	0.0	2.4	16.5	0.0	8.5	0.0	0.2	452.7	115.4	0.9	0.2	16.4	9.2	0.0	0.0	12.2
STOML2	"HSPC108, SLP-2"	ENSG00000165283	"Stomatin like 2"	Q9UJZ1	9	35099776-35103195	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015944, HPA062016"	Supported		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		98000	"Plasma membrane, Cytosol"		"CAB015944: , HPA062016: AB_2684659"	"unprognostic (2.49e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.20e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (4.77e-4)"	"unprognostic (5.14e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (3.00e-5)"	"unprognostic (2.74e-2)"	"unprognostic (5.26e-1)"	"unprognostic (2.67e-1)"	"unprognostic (5.47e-2)"	23.2	38.6	20.5	24.8	20.7	26.9	25.3	20.9	30.3	22.1	30.8	19.9	17.4	26.6	26.6	25.5	32.9	28.2	35.4	49.6	18.6	19.1	38.6	67.1	17.1	31.7	18.8	18.8	30.9	48.3	20.4	17.4	28.5	20.7	25.6	33.6	25.0	32.1	25.5	59.2	26.3	39.0	26.7	13.8	23.1	28.7	23.2	14.3	32.4	34.8	46.3	33.8	24.8	21.1	34.7	44.4	20.5	27.1	33.8	40.3	37.7	47.0	54.7	29.4	43.8	21.6	26.0	31.5	23.3	34.4	66.6	48.7	61.6	22.2	39.9	16.5	29.8	47.7	20.2	44.8	52.4	44.6	34.0	41.0	24.4	46.4	58.2	63.3	46.1	28.0	32.9	40.9	54.0	64.9	21.0	43.4	40.7	39.6	24.5	32.5	38.1	41.0	81.8	46.0	35.3	34.6	35.9	24.8	42.6	36.0	28.4	27.3	33.2	13.1	35.5	30.1	21.9	24.6	29.8	23.4	22.8	32.2	18.8	41.1	17.2	29.4	37.6	30.3	29.3	30.5	20.5	27.1	14.8	25.5	23.1	30.0	34.7	28.8	28.7	35.8	30.2	27.8	25.3	4.7	33.8	16.6	44.4	40.3	37.7	20.5	20.7	20.9	30.3	18.6	19.1	18.8	18.8	20.7	14.3	38.7	30.7	67.8	97.0	85.6	32.1	74.2	99.3	64.3	54.6	47.1	7.9	204.6	212.2	112.4	62.9	62.9	121.7	46.7	133.0	205.2	74.7	89.1	82.0	100.2	114.0	17.5	94.8	54.6	32.3	17.5	69.6	50.8	94.5	110.0	124.3	59.7	118.2	126.3	65.4	214.3	28.6	51.8	82.4	68.9	106.7	100.1	139.1	53.3	180.1	119.6
STOML3	"Epb7.2l, SRO"	ENSG00000133115	"Stomatin like 3"	Q8TAV4	13	38965925-38991066	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.7;epididymis: 8.1;fallopian tube: 31.7;lung: 9.2"	"Cell type enriched"	"Detected in some"	24	"Ciliated cells: 133.8"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	39	"AF22: 19.0"	"Region enriched"	"Detected in some"	6	"olfactory region: 29.0"	"Low region specificity"	"Detected in all"			"HPA012892, HPA071011"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA012892: AB_1857610, HPA071011: AB_2732169"		"unprognostic (2.64e-1)"	"unprognostic (1.91e-2)"	"prognostic favorable (1.49e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-1)"		"unprognostic (4.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.74e-1)"		"unprognostic (1.22e-1)"	0.1	0.1	2.9	0.1	3.8	0.1	0.2	0.0	0.2	1.7	0.2	6.6	0.0	0.2	1.1	8.1	0.1	31.7	0.1	0.1	4.4	4.1	0.1	0.1	9.2	0.1	0.0	0.0	7.6	0.1	0.1	0.0	0.3	9.7	0.2	0.2	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.6	2.1	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.8	0.0	0.2	4.4	4.1	0.0	0.0	9.7	2.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	133.8	5.7	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0
SVIL		ENSG00000197321	Supervillin	O95425	10	29457338-29736781	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 235.1;tongue: 93.5"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 411.9;Peritubular cells: 245.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.2"	"Group enriched"	"Detected in many"	6	"granulocytes: 15.2;monocytes: 4.2"	"Cell line enhanced"	"Detected in many"		"HaCaT: 40.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010878, HPA020095, HPA020138"	Approved		Supported	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane"	"Actin filaments, Cytosol"	"CAB010878: AB_476685, HPA020095: AB_1857680, HPA020138: AB_1857681"	"unprognostic (1.11e-1)"	"unprognostic (2.94e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.26e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.28e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.38e-3)"	"unprognostic (7.11e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (5.70e-5)"	11.9	2.1	0.7	10.5	1.1	3.7	4.5	0.6	0.9	18.7	42.3	0.6	10.7	1.7	34.3	13.3	18.2	8.9	15.5	25.5	0.5	0.6	2.8	2.0	3.8	2.3	0.8	0.7	13.9	2.4	5.1	4.1	2.9	1.7	12.6	5.3	10.0	10.6	15.3	235.1	4.7	9.1	36.4	1.3	1.5	14.2	5.5	0.5	4.6	6.9	93.5	11.6	28.6	9.9	0.1	0.7	15.2	4.2	1.2	1.7	0.6	17.4	7.5	3.4	1.2	10.0	26.8	5.6	2.8	6.8	1.1	1.1	8.9	17.3	0.0	12.4	1.1	10.9	40.4	1.9	6.6	1.1	0.2	3.7	0.0	9.6	5.7	6.0	1.5	0.3	24.6	6.5	12.5	4.5	22.5	20.0	2.5	0.0	0.1	1.7	5.4	1.4	0.8	1.7	7.8	2.7	3.2	10.2	0.1	11.9	5.8	4.2	3.4	2.5	0.3	8.9	11.7	3.1	1.9	12.9	5.7	5.9	28.3	8.4	0.1	0.0	0.0	22.2	3.4	19.7	2.9	1.1	5.2	1.2	1.9	1.5	0.0	1.1	0.6	0.7	0.1	1.7	1.1	15.2	1.2	4.2	0.2	0.1	0.6	0.7	1.1	0.6	0.9	0.5	0.6	0.8	0.7	1.7	0.5	44.7	29.1	9.7	91.1	62.4	7.4	411.9	15.3	60.2	75.1	36.6	23.6	24.9	6.6	80.7	2.3	48.5	22.2	0.0	36.6	17.5	59.3	70.6	9.3	10.2	8.5	4.8	23.0	21.5	9.7	2.7	101.5	25.2	27.0	1.8	26.4	30.4	47.2	34.5	245.1	9.7	16.1	45.3	155.7	6.3	7.7	52.4	20.7	4.4	38.0	78.2
SWAP70	"KIAA0640, SWAP-70"	ENSG00000133789	"Switching B cell complex subunit SWAP70"	Q9UH65	11	9664077-9752991	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 29.5;naive B-cell: 29.6"	"Group enriched"	"Detected in all"	6	"B-cells: 29.6;granulocytes: 16.4;monocytes: 9.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006810, HPA006929"	Supported		Supported	"Plasma membrane,Actin filaments"		NA	NA		7100	"Plasma membrane"	"Actin filaments"	"HPA006810: AB_1857683, HPA006929: "	"unprognostic (4.16e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.79e-3)"	"unprognostic (5.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.44e-1)"	30.8	7.3	10.6	24.0	12.0	10.6	25.8	4.2	13.7	14.5	12.9	10.5	10.4	9.0	19.0	10.8	14.5	11.5	13.2	12.5	12.7	8.2	11.4	5.8	20.6	36.0	12.3	7.9	9.2	8.8	17.5	8.4	25.4	11.9	15.9	7.8	13.1	15.8	11.3	9.7	21.2	16.2	14.0	14.7	32.6	9.9	5.2	12.0	7.5	16.4	10.2	42.2	20.6	26.5	29.6	2.9	16.4	9.7	2.8	1.4	1.7	11.6	6.5	9.2	0.0	19.3	16.9	16.2	12.8	15.6	12.1	13.4	7.2	9.3	46.6	12.6	24.4	17.5	14.1	11.2	7.1	15.7	4.2	4.5	12.3	7.8	3.5	10.8	9.5	23.0	11.8	8.9	8.8	15.9	9.9	36.8	6.0	1.1	0.1	12.6	1.8	2.8	4.6	8.5	3.1	3.3	6.8	8.6	1.3	10.1	31.1	0.4	4.7	12.1	15.7	10.2	13.5	6.2	7.3	42.2	21.4	7.6	17.8	11.9	1.3	3.5	32.9	8.5	10.7	8.7	5.7	2.0	16.4	0.4	4.8	0.2	29.5	0.5	0.4	2.9	29.6	0.4	0.5	0.4	2.8	9.7	0.8	1.4	1.7	10.6	12.0	4.2	13.7	12.7	8.2	12.3	7.9	11.9	12.0	62.5	50.8	86.5	57.8	31.6	1.9	16.2	22.9	54.9	62.6	19.2	0.0	67.5	11.6	42.4	1.3	127.6	12.3	0.0	18.6	99.2	29.6	58.5	130.9	6.2	56.8	25.4	12.5	49.1	49.2	1.5	27.6	47.7	27.0	129.8	7.6	8.6	27.5	14.0	32.5	10.2	2.0	19.4	36.3	3.8	8.2	27.4	117.2	11.7	7.7	47.9
SYMPK	"SPK, SYM"	ENSG00000125755	Symplekin	Q92797	19	45815410-45863290	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 114.2;Late spermatids: 108.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041756, HPA042449"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA041756: AB_10963544, HPA042449: AB_2678003"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.33e-3)"	"unprognostic (9.93e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.16e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.38e-2)"	14.7	15.9	15.3	23.7	24.2	20.7	15.2	25.1	32.2	17.1	18.2	25.3	20.3	18.6	22.6	18.9	17.4	19.3	17.6	14.6	17.3	18.0	15.0	21.6	15.6	27.2	19.3	16.8	21.6	16.3	20.5	24.0	34.8	19.9	17.4	12.2	16.1	21.5	17.5	33.4	21.1	18.0	13.9	18.7	23.0	19.4	38.0	22.0	28.5	20.5	11.6	23.4	16.8	16.7	7.9	9.2	6.5	7.1	4.2	5.2	2.7	19.5	34.6	14.2	10.7	13.9	17.8	23.9	15.6	11.0	16.0	18.3	15.3	18.0	34.5	10.7	17.6	9.1	16.1	19.0	17.0	14.4	26.7	21.3	19.9	23.7	16.1	16.0	21.8	23.4	12.9	10.4	17.2	19.6	11.0	16.5	18.3	26.2	22.6	13.9	18.3	20.2	23.1	12.1	17.1	8.0	21.7	16.5	21.4	11.4	35.4	16.2	20.5	19.1	12.5	12.6	14.9	17.1	30.2	18.2	13.3	21.3	10.2	22.7	29.9	56.5	28.0	15.2	14.7	21.8	2.1	5.1	2.2	3.4	3.8	3.2	4.7	3.0	5.2	4.2	7.9	2.6	2.4	6.5	4.2	7.1	9.2	2.3	2.7	15.3	24.2	25.1	32.2	17.3	18.0	19.3	16.8	19.9	22.0	0.0	7.7	30.4	14.0	18.5	20.9	5.9	22.9	5.3	5.7	24.4	33.4	28.3	46.4	19.9	114.2	15.7	30.0	0.0	14.8	27.8	19.9	17.1	12.7	31.6	15.8	20.6	34.9	31.3	25.6	108.4	17.8	20.1	13.5	41.5	31.6	9.8	17.3	23.0	19.8	10.3	28.0	19.4	14.2	22.9	39.6	18.6	47.9	13.8	27.0	18.6
SYTL2	"CHR11SYT, exophilin-4, FLJ20163, FLJ21219, KIAA1597, MGC102768, PPP1R151, SGA72M, SLP2"	ENSG00000137501	"Synaptotagmin like 2"	Q9HCH5	11	85694224-85811159	"Plasma proteins, Predicted intracellular proteins, Transporters"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 65.2"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 139.2;granulocytes: 122.9;Mucus-secreting cells: 160.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 10.5;MAIT T-cell: 17.9"	"Lineage enriched"	"Detected in many"	6	"T-cells: 17.9"	"Cell line enhanced"	"Detected in many"		"MCF7: 25.3;OE19: 41.5;RH-30: 51.1;RPTEC TERT1: 36.5"	"Low region specificity"	"Detected in many"							HPA039651	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Nucleoplasm, Golgi apparatus"	"Plasma membrane"	"HPA039651: AB_10795153"	"unprognostic (8.07e-3)"	"unprognostic (6.72e-3)"	"prognostic favorable (2.67e-4)"	"unprognostic (9.34e-4)"	"unprognostic (6.60e-3)"	"unprognostic (2.19e-4)"	"unprognostic (2.24e-2)"	"unprognostic (5.37e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.72e-2)"	"prognostic favorable (9.07e-4)"	12.8	5.5	27.6	11.8	13.9	1.8	9.7	6.8	32.0	6.5	26.3	6.8	2.1	11.4	7.6	11.8	9.6	6.3	15.0	5.7	13.8	9.0	14.5	3.9	8.1	5.7	8.4	21.5	3.7	2.5	7.2	5.5	9.8	12.4	9.9	39.8	5.7	8.4	5.8	3.7	4.6	17.7	7.8	12.8	5.4	65.2	3.2	5.1	5.8	4.2	5.0	3.8	17.2	11.3	0.1	0.7	0.0	0.0	3.0	17.9	1.7	0.9	2.2	3.5	0.3	0.8	4.6	0.0	8.6	11.3	7.6	17.4	9.7	1.3	0.2	3.2	6.0	11.1	6.3	0.2	0.7	10.1	0.6	0.0	0.0	0.0	0.1	0.5	0.7	0.1	5.8	1.1	16.5	0.2	1.8	0.0	0.2	0.1	0.1	9.6	25.3	0.0	0.2	5.9	41.5	3.9	0.3	51.1	0.0	36.5	13.2	0.1	0.1	1.9	1.5	0.8	3.1	0.1	0.1	0.0	12.0	4.6	7.5	0.4	0.0	0.0	4.5	12.3	0.1	7.3	0.0	0.0	0.0	10.5	0.0	17.9	0.0	2.1	6.3	0.0	0.1	1.7	3.1	0.0	3.0	0.0	0.7	0.8	1.7	27.6	13.9	6.8	32.0	13.8	9.0	8.4	21.5	12.4	5.1	20.8	30.4	1.4	10.2	3.2	8.3	1.6	10.2	139.2	38.7	64.6	7.9	0.7	0.0	8.4	1.1	3.6	40.7	0.0	14.7	0.2	9.3	37.7	122.9	0.4	0.5	1.6	18.5	7.4	4.7	0.4	1.7	3.9	10.1	1.0	160.5	13.4	13.2	34.8	28.3	7.7	8.1	32.3	29.7	3.3	2.1	5.0	0.3	30.0	35.7	46.4
SYVN1	"DER3, HRD1"	ENSG00000162298	"Synoviolin 1"	Q86TM6	11	65121780-65134533	"Enzymes, Predicted membrane proteins"	"Stress response, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Hepatocytes: 60.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 56.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005480, HPA024300, CAB037030"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane"		NA	NA			Nucleoplasm	"Endoplasmic reticulum, Plasma membrane"	"CAB037030: AB_1840939, HPA005480: AB_1079084, HPA024300: AB_1851073"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.85e-2)"	"prognostic favorable (6.88e-4)"	"unprognostic (7.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.89e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.16e-1)"	13.8	20.8	11.0	33.0	15.3	13.8	14.9	13.3	19.3	15.1	14.2	21.0	20.2	13.2	16.0	21.1	14.4	16.1	15.3	12.9	11.3	10.0	16.4	78.0	14.2	28.9	18.2	8.7	17.1	68.1	24.4	21.0	20.9	14.4	15.0	15.4	13.3	48.9	22.6	16.7	14.4	19.6	13.6	12.8	27.1	18.3	14.4	14.9	10.3	23.5	8.0	42.2	13.3	12.6	17.5	13.0	11.6	5.4	2.2	5.5	3.8	8.6	11.1	6.7	9.0	17.1	9.8	6.7	9.0	9.3	11.5	8.2	6.0	15.2	49.0	12.3	11.5	15.2	13.5	7.3	9.1	9.5	7.6	5.5	7.7	12.9	13.4	20.8	11.5	14.0	12.4	16.5	10.1	23.0	10.3	7.4	5.2	9.6	25.1	6.7	12.9	5.0	8.3	7.2	9.1	7.7	8.5	5.7	19.7	7.2	8.6	4.4	9.0	8.3	20.7	14.5	6.2	15.4	7.6	7.1	8.0	5.3	14.3	6.0	50.2	34.7	56.6	10.8	5.9	8.9	11.6	5.4	9.3	5.5	3.3	5.0	15.4	3.9	5.1	3.1	17.5	2.9	3.0	5.2	2.2	3.2	13.0	3.6	3.8	11.0	15.3	13.3	19.3	11.3	10.0	18.2	8.7	14.4	14.9	14.9	21.3	22.2	6.0	15.7	10.2	3.4	33.1	9.4	20.5	10.4	31.4	11.5	1.7	10.5	4.3	8.3	15.8	23.3	16.3	12.6	12.1	13.4	1.1	60.4	13.6	12.7	8.1	14.1	14.8	3.5	19.0	11.6	11.8	6.4	25.0	10.8	17.1	12.4	12.4	7.2	17.1	12.9	7.5	21.0	10.9	14.1	35.8	10.2	14.5	11.6
TACSTD2	"EGP-1, GA733-1, M1S1, TROP2"	ENSG00000184292	"Tumor associated calcium signal transducer 2"	P09758	1	58575423-58577773	"Disease related genes, Predicted membrane proteins"	"Sensory transduction, Vision"	"Tumor antigen"	"Amyloidosis, Corneal dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.9;salivary gland: 56.4"	"Cell type enhanced"	"Detected in many"	15	"Basal glandular cells: 5162.0;Glandular cells: 2977.4;Urothelial cells: 7434.9"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"eosinophil: 12.4"	"Group enriched"	"Detected in many"	65	"dendritic cells: 3.7;granulocytes: 12.4;monocytes: 3.2"	"Cell line enhanced"	"Detected in some"		"A-431: 75.7;CAPAN-2: 102.7;HaCaT: 102.9;RT4: 35.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043104, HPA055067, CAB072852"	Enhanced		Supported	"Nucleoli,Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	"Nucleoli, Vesicles"	"CAB072852: , HPA043104: AB_10960710, HPA055067: AB_2682687"	"unprognostic (1.80e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.67e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-2)"	"unprognostic (7.91e-2)"	"prognostic favorable (3.99e-4)"	"unprognostic (7.10e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.91e-3)"	"unprognostic (2.50e-1)"	0.0	0.0	0.0	0.0	0.0	0.7	17.1	0.0	0.0	23.1	0.0			0.0	1.7	2.6	103.9	2.7	0.9	0.0	0.0	0.0	10.4	0.0	8.0	0.0	0.0		0.0	9.0	0.0	0.0	1.5		15.7	0.0		56.4	12.6	0.0	42.1	0.0	0.0	0.0	0.0	7.3	0.0			0.1		20.6	17.7	36.1	0.0	3.7	12.4	3.2	0.0	0.0	1.8	75.7	0.0	0.0	0.1	0.0	0.0	29.0	0.0	0.0	0.0	0.0	0.0	102.7	0.0	9.9	6.4	0.0	102.9	0.0	18.8	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	1.1	0.0	4.3	0.0	0.0	0.1	0.0	16.3	0.0	0.1	0.0	16.7	0.1	0.0	0.0	0.0	13.8	35.5	0.0	0.0	3.3	27.4	0.1	0.3	17.9	0.1	4.6	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	12.4	0.0	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.8											321.6	110.2	1.3	5162.0	1324.0	0.0	0.3	287.9	277.1	312.8	1212.6	0.0	74.9	36.5	1546.3	0.0	14.3	0.4	0.0	1122.5	4.7	23.0	2977.4	8.1	0.6	7.6	0.0	0.0	0.6	0.3	0.0	0.0	32.3	108.0	54.1	2.9	0.0	1294.2	4.0	0.0	3.3	0.0	0.0	47.2	0.5	0.9	1339.0	65.6	0.0	0.9	7434.9
TBC1D24	"DFNA65, DFNB86, KIAA1171, TLDC6"	ENSG00000162065	"TBC1 domain family member 24"	Q9ULP9	16	2475051-2509560	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"	"Deafness, Disease mutation, Epilepsy, Mental retardation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 33.4"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SCLC-21H: 26.8"									"HPA044712, HPA068080"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"		"HPA044712: AB_10795619, HPA068080: AB_2685948"	"prognostic unfavorable (3.22e-4)"	"unprognostic (5.23e-2)"	"unprognostic (4.02e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.37e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.66e-3)"	"unprognostic (2.02e-2)"	"unprognostic (8.19e-2)"	"unprognostic (7.78e-3)"	"unprognostic (1.61e-1)"	6.0	5.8	11.0	2.9	9.6	3.7	4.9	15.8	17.7	4.2	3.5	2.8	6.7	3.8	3.3	5.0	2.2	4.3	3.5	4.9	9.0	5.4	7.6	6.6	6.4	3.0	3.8	12.2	2.1	16.6	5.2	5.6	3.6	7.5	4.5	1.9	5.4	33.4	6.4	6.1	3.5	2.8	3.1	3.7	3.4	3.8	2.4	4.5	0.8	5.5	1.0	2.3	4.0	2.9	0.2	1.3	0.0	0.9	0.2	2.2	1.0	2.6	5.0	3.4	6.9	4.0	4.0	2.9	4.7	2.5	3.1	2.7	4.7	2.2	6.6	4.3	3.6	1.5	4.7	5.3	1.5	2.3	7.1	6.3	5.9	6.6	4.0	2.4	4.3	2.6	1.5	2.1	2.7	1.1	2.1	3.9	2.4	7.2	3.7	2.9	4.6	2.9	8.6	3.0	2.3	3.3	15.3	6.5	4.6	2.2	1.7	26.8	6.5	3.2	11.8	1.9	1.3	3.8	3.9	4.0	6.1	6.7	6.0	4.6	2.4	2.2	8.2	2.6	6.3	5.5	0.0	0.7	0.0	2.2	0.8	0.7	0.2	0.5	0.7	1.3	0.1	0.5	0.3	0.0	0.2	0.9	0.6	0.0	1.0	11.0	9.6	15.8	12.4	9.0	5.4	3.8	12.2	7.5	4.5	26.8	22.4	2.7	2.7	0.5	15.4	4.7	15.3	4.0	10.3	5.2	41.2	1.3	28.2	4.8	0.2	3.6	1.7	23.3	5.3	0.7	8.4	3.5	3.5	15.1	3.0	25.4	10.9	12.3	5.4	0.7	8.3	2.3	1.7	1.8	2.6	11.1	4.8	3.5	5.6	3.3	25.0	0.0	3.7	2.7	3.8	1.3	0.2	2.6	4.4	1.4
TBC1D30	KIAA0984	ENSG00000111490	"TBC1 domain family member 30"	Q9Y2I9	12	64781193-64881032	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 19.8"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 13.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.4"	"Group enriched"	"Detected in many"	17	"granulocytes: 2.4;monocytes: 1.1;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"MCF7: 23.0;OE19: 15.2;RPMI-8226: 13.6;RT4: 17.6;SCLC-21H: 16.5;SK-BR-3: 17.0;T-47d: 12.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039772, HPA040043"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA039772: AB_10795409, HPA040043: AB_10795411"	"unprognostic (1.85e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.66e-1)"	"prognostic favorable (3.61e-5)"	"unprognostic (9.35e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.65e-5)"	"prognostic favorable (5.08e-4)"	"unprognostic (1.75e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.72e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.62e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.67e-3)"	"unprognostic (7.80e-3)"	1.8	1.6	4.7	2.3	11.4	0.5	5.3	13.4	15.8	7.6	3.3	1.5	12.4	5.0	3.1	2.5	1.2	2.1	4.8	1.1	7.1	5.5	3.9	1.7	3.9	0.9	4.7	7.0	1.5	19.8	8.9	6.5	1.4	16.5	3.7	3.5	2.0	14.4	11.6	0.9	1.3	3.5	2.4	3.0	2.5	6.9	3.2	2.8	0.0	3.3	0.2	0.7	4.9	1.9	0.0	0.0	2.4	1.1	0.0	1.3	0.3	6.9	1.4	0.4	0.4	0.0	0.5	0.6	0.0	0.0	0.0	0.1	6.5	2.2	0.3	1.1	0.0	0.3	0.1	6.8	0.1	0.0	0.0	6.7	0.3	1.2	0.3	0.1	2.3	1.4	0.4	0.0	0.0	0.2	0.6	5.6	1.0	0.0	2.4	0.2	23.0	0.0	0.4	0.9	15.2	6.8	0.1	0.1	13.6	0.8	17.6	16.5	1.3	1.4	17.0	0.2	0.7	12.4	1.1	5.3	0.0	1.0	0.5	3.4	0.0	0.0	0.2	0.1	0.7	0.3	0.0	1.1	0.0	0.4	1.1	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	2.4	0.0	0.7	0.0	0.0	0.3	4.7	11.4	13.4	15.8	7.1	5.5	4.7	7.0	16.5	2.8	0.0	4.6	0.5	2.1	0.8	9.4	0.4	5.1	2.7	5.7	3.5	7.9	0.4	8.3	3.1	13.6	4.2	2.6	0.0	4.3	0.3	0.5	7.1	9.2	0.0	1.5	0.0	0.0	2.5	2.5	1.0	0.3	2.8	5.0	1.0	6.3	2.5	3.6	3.5	0.0	1.7	0.5	0.0	0.3	3.3	1.5	1.3	0.1	0.9	3.3	8.4
TBXA2R		ENSG00000006638	"Thromboxane A2 receptor"	P21731	19	3594506-3606840	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"Ito cells: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 12.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 11.9;U-2197: 8.6;U-937: 7.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA077366			Supported	"Nuclear speckles,Plasma membrane"		NA	NA			"Plasma membrane"	"Nuclear speckles"	"HPA077366: AB_2686836"	"unprognostic (1.59e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.97e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.17e-3)"	"unprognostic (8.41e-2)"	"unprognostic (6.25e-2)"	"prognostic favorable (7.17e-4)"	"unprognostic (3.89e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (4.32e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.02e-1)"	8.7	11.8	1.4	3.9	1.6	2.1	3.9	0.5	1.6	13.5	3.8	1.7	3.9	2.6	7.4	4.8	8.0	4.7	6.0	6.8	2.4	1.5	10.1	18.4	6.7	7.3	1.4	1.9	8.3	2.2	2.5	1.7	10.6	2.7	3.6	1.4	5.0	1.7	4.2	3.1	1.8	4.4	6.5	2.1	14.9	3.7	3.4	1.9	2.2	3.9	3.2	1.8	6.8	9.6	12.6	0.3	3.2	0.4	3.1	9.6	3.9	0.1	0.2	0.2	4.1	0.9	2.2	0.7	3.0	0.8	2.3	1.8	0.1	0.3	0.1	4.4	1.2	2.3	0.1	0.9	0.0	0.9	0.2	1.0	2.9	11.9	0.3	1.2	0.0	5.3	1.1	0.0	3.0	0.0	1.7	0.9	0.0	4.5	0.4	0.4	0.2	0.2	1.5	0.1	0.1	2.6	0.1	0.0	0.2	0.0	0.1	0.2	1.7	0.2	0.4	0.1	0.3	1.8	5.1	2.6	4.8	1.1	8.6	2.8	0.2	0.3	0.2	4.0	7.4	1.1	2.9	0.4	0.2	2.6	0.2	0.3	1.8	0.8	2.3	0.0	12.6	4.6	9.6	3.2	3.1	0.2	0.3	0.2	3.9	1.4	1.6	0.5	1.6	2.4	1.5	1.4	1.9	2.7	1.9	0.0	0.0	1.3	0.1	0.5	0.4	0.8	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.1	2.3	0.1	0.0	0.0	0.7	0.0	0.0	35.0	1.2	0.0	0.3	0.0	1.7	0.0	0.0	0.3	0.1	0.0	0.7	0.0	0.1	0.0	3.1	0.1	1.3	0.5	0.1	0.0	0.0	0.0
TCAF2	"FAM115C, FAM139A, FLJ40722, GATD9"	ENSG00000170379	"TRPM8 channel associated factor 2"	A6NFQ2	7	143620952-143730409	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 12.2;Hepatocytes: 10.9;Syncytiotrophoblasts: 13.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 9.2;HUVEC TERT2: 9.8;TIME: 15.5;U-87 MG: 13.4"									"HPA038756, HPA038758"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"		"HPA038756: AB_10960427, HPA038758: AB_10960353"	"unprognostic (6.59e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.86e-3)"	"prognostic unfavorable (9.53e-5)"	"unprognostic (1.89e-1)"	"unprognostic (3.11e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (4.17e-6)"	"unprognostic (7.19e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.85e-2)"	3.1	2.7	1.5	5.8	2.7	5.8	8.4	2.0	4.0	5.2	1.8	0.6	2.0	1.8	6.1	2.1	13.1	2.2	3.5	3.5	2.3	1.9	3.1	6.4	7.1	12.4	1.6	1.2	4.2	3.2	2.1	3.8	8.1	2.8	5.5	1.6	1.7	5.7	9.2	2.1	6.7	3.5	5.0	4.7	4.0	3.1	2.2	2.0	7.3	2.3	7.6	7.0	8.0	12.1	2.6	1.0	7.0	0.4	3.5	6.5	1.3	4.8	0.3	0.3	0.3	1.0	1.0	1.9	1.5	2.6	0.7	1.9	0.2	0.5	0.3	2.1	1.2	0.6	0.9	0.1	2.5	2.2	9.2	0.5	0.8	0.7	0.3	1.1	0.3	0.6	2.6	1.1	0.3	0.9	2.0	9.8	0.7	2.7	4.8	4.1	0.9	0.7	0.9	0.4	4.7	2.4	0.4	2.0	2.2	0.0	1.9	0.3	0.2	0.5	3.5	0.3	0.9	1.8	0.3	15.5	1.4	1.0	5.2	0.4	7.7	2.4	0.2	13.4	0.5	2.8	7.0	0.4	0.4	4.0	0.4	4.2	2.6	6.5	4.1	0.3	2.5	5.8	4.6	1.6	3.5	0.3	1.0	6.2	1.3	1.5	2.7	2.0	4.0	2.3	1.9	1.6	1.2	2.8	2.0	0.0	2.6	0.0	1.1	0.0	0.2	0.4	0.0	0.0	3.4	0.0	0.0	12.2	0.0	0.4	0.9	2.1	0.0	0.0	0.3	4.3	0.5	2.7	2.3	10.9	1.8	0.0	0.0	0.6	1.6	0.4	1.7	0.7	0.0	0.0	0.1	1.7	1.3	0.0	0.7	0.3	0.0	0.0	0.6	3.2	0.2	0.0	13.2	2.9	0.0	1.0
TCAF2C		ENSG00000283528	"TRPM8 channel associated factor 2C"		7	143639230-143647646	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in some"	4	"blood: 2.2;parathyroid gland: 1.9;placenta: 1.3"	"Not detected"	"Not detected"											"Cell type enhanced"	"Detected in some"		"basophil: 2.2;T-reg: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 1.1;OE19: 1.5;U-266/70: 3.9;U-266/84: 1.8"									"HPA038756, HPA038758"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"		"HPA038756: AB_10960427, HPA038758: AB_10960353"																		0.0	0.0		0.2		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.4	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	1.9		1.3		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.1		0.0	0.1	0.0			0.0		0.0	0.0		0.6	0.0	2.2	0.0	0.0	1.8	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.9	1.8	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	1.8	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TCHP	"MGC10854, TpMs"	ENSG00000139437	"Trichoplein keratin filament binding"	Q9BT92	12	109900264-109983841	"Predicted intracellular proteins"	"Apoptosis, Cilium biogenesis/degradation"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038638, HPA061543"	Supported		Supported	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Plasma membrane, Centrosome, Cytosol"		"HPA038638: AB_10670785, HPA061543: AB_2684556"	"unprognostic (2.21e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.15e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (5.52e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.92e-2)"	8.6	10.4	16.0	11.3	29.3	8.3	9.3	22.9	25.0	10.2	11.2	19.0	7.5	9.9	13.0	10.9	18.3	8.7	8.3	10.3	15.9	11.0	8.5	7.0	10.0	14.5	23.8	13.9	11.3	12.7	12.1	12.1	10.4	18.6	10.7	9.6	11.0	13.4	11.6	10.8	36.1	10.2	15.0	15.9	15.0	10.2	12.5	24.2	10.9	12.0	7.7	15.1	11.4	15.4	3.2	3.3	4.5	5.2	9.2	7.4	4.4	16.2	14.6	7.9	9.4	7.0	7.6	10.6	15.5	8.2	13.6	7.6	9.1	5.7	22.9	4.5	9.0	7.4	13.7	8.6	9.7	12.3	12.2	8.4	16.6	9.0	8.9	8.5	22.4	12.7	6.2	12.0	14.2	10.8	8.6	12.1	14.5	17.8	4.6	11.2	11.2	20.4	22.8	9.5	4.0	14.8	18.8	15.5	19.3	6.1	14.7	11.7	12.4	11.3	12.2	10.9	5.9	11.0	16.3	13.3	13.9	9.7	8.9	19.7	13.4	16.9	16.4	14.8	18.6	14.5	0.0	4.2	3.4	6.2	2.7	4.3	3.2	5.4	7.4	3.3	2.3	5.4	4.2	4.5	9.2	5.2	2.4	7.2	4.4	16.0	29.3	22.9	25.0	15.9	11.0	23.8	13.9	18.6	24.2	17.9	18.4	6.7	7.8	8.8	25.8	12.2	15.3	36.1	11.4	7.0	17.7	9.1	8.3	17.1	25.7	12.1	10.7	23.3	13.3	7.9	7.2	6.6	12.7	6.6	10.1	23.8	14.3	6.2	12.9	33.9	10.3	9.7	6.8	12.6	9.2	14.6	13.8	10.5	26.2	4.3	23.5	12.9	10.0	18.4	34.3	21.7	5.8	14.9	9.8	34.8
TEC	PSCTK4	ENSG00000135605	"Tec protein tyrosine kinase"	P42680	4	48135783-48269864	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 12.7;granulocytes: 18.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 13.3;eosinophil: 11.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 13.3"	"Cell line enhanced"	"Detected in many"		"HEL: 10.6;HMC-1: 16.7;U-266/70: 16.7;U-266/84: 11.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA005733, HPA024657"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA005733: AB_1857878, HPA024657: AB_2671637"	"unprognostic (7.19e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.07e-3)"	"unprognostic (4.21e-2)"	"unprognostic (8.57e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.36e-2)"	"prognostic favorable (7.12e-4)"	"unprognostic (7.46e-3)"	"unprognostic (7.83e-2)"	"unprognostic (1.01e-4)"	"unprognostic (4.24e-2)"	"unprognostic (2.16e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.96e-3)"	3.9	4.5	0.8	7.2	1.1	9.8	5.1	0.6	2.0	3.4	4.8	0.5	8.4	2.8	3.0	21.6	9.5	3.6	2.1	3.3	0.9	0.9	4.0	5.7	6.4	7.0	1.5	0.3	2.9	2.9	2.6	6.4	2.0	3.2	2.0	2.5	3.0	6.8	4.7	2.1	8.1	6.5	3.0	1.2	6.7	2.2	5.5	0.6	4.4	4.4	5.8	11.1	3.2	6.5	0.9	1.3	13.3	0.6	2.9	0.4	0.3	2.3	0.6	0.0	0.0	0.0	0.0	0.1	0.4	1.8	1.1	2.3	0.0	1.8	1.5	1.7	0.0	0.0	0.5	0.9	0.0	1.5	0.1	0.7	10.6	0.8	0.1	0.0	1.7	16.7	0.0	0.2	1.4	0.0	1.1	0.0	0.5	5.8	0.4	3.3	0.8	1.0	3.8	0.3	1.1	0.7	2.4	2.2	0.0	2.8	0.7	0.0	0.2	0.5	0.3	0.4	0.9	0.6	3.4	0.0	0.0	0.0	2.3	0.0	16.7	11.9	2.1	0.0	2.4	0.1	13.3	0.5	11.0	0.1	0.6	0.3	0.9	0.1	0.4	1.3	0.6	0.4	0.4	0.4	2.9	0.1	0.1	0.0	0.3	0.8	1.1	0.6	2.0	0.9	0.9	1.5	0.3	3.2	0.6	6.0	5.0	0.8	1.5	2.3	0.5	1.6	12.7	0.0	4.5	0.0	0.0	1.3	0.0	1.3	3.9	0.6	2.2	0.0	0.9	0.1	0.9	1.1	18.5	3.2	4.0	0.0	2.9	0.0	4.5	1.7	0.0	2.8	1.7	0.0	1.4	5.0	0.9	0.0	0.4	1.8	2.4	6.5	0.7	0.7	1.1	2.6	0.7	2.5	2.0	1.3
TEK	"CD202b, TIE-2, TIE2, VMCM, VMCM1"	ENSG00000120156	"TEK receptor tyrosine kinase"	Q02763	9	27109141-27230175	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"Endothelial cells: 58.3;Ito cells: 110.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.2"	"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 36.5;NTERA-2: 18.2;TIME: 39.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010359, HPA073265"	Approved		Supported	"Plasma membrane,Centriolar satellite"	"Secreted to blood"	NA	NA	7750000	8300000	"Plasma membrane"	"Centriolar satellite"	"CAB010359: AB_2203226, HPA073265: AB_2686592"	"unprognostic (2.24e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.26e-3)"	"prognostic favorable (2.31e-5)"	"unprognostic (7.48e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (7.81e-4)"	"unprognostic (7.50e-3)"	"unprognostic (6.87e-3)"	"unprognostic (1.83e-1)"	"unprognostic (5.24e-3)"	28.6	7.8	8.1	4.6	5.9	0.4	17.9	3.4	5.4	10.8	4.7	4.6	3.4	3.2	14.5	5.3	6.7	5.9	9.1	13.0	7.1	6.1	25.4	8.7	27.8	2.9	6.9	3.4	6.1	4.5	3.5	4.0	36.3	6.9	5.4	4.7	12.4	3.4	5.5	7.8	3.0	5.3	10.6	5.3	23.4	4.0	3.7	3.5	0.3	9.7	8.4	2.4	6.4	12.4	0.0	0.1	2.2	0.6	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.2	2.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.0	0.0	0.7	0.0	0.0	0.7	0.0	0.9	0.3	0.0	36.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.8	0.0	0.0	39.6	0.0	0.2	3.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	8.1	5.9	3.4	5.4	7.1	6.1	6.9	3.4	6.9	3.5	3.0	2.2	0.0	0.0	1.3	0.0	7.8	0.0	0.0	1.2	1.8	0.0	0.4	0.0	0.0	0.6	58.3	0.0	0.0	0.0	1.5	2.4	0.2	0.0	0.8	0.2	0.0	0.0	110.5	10.4	0.4	0.6	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.2	0.0	0.4	0.0	0.2	1.1	1.1	0.0	0.0	0.0
TGFBR1	"ACVRLK4, ALK-5, ALK5, ESS1, MSSE, TBR-i, TBRI"	ENSG00000106799	"Transforming growth factor beta receptor 1"	P36897	9	99104038-99154192	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation, Growth regulation"	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 114.1;Late spermatids: 74.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 68.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002441, CAB031481, HPA056473"	Uncertain		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"CAB002441: AB_564029, CAB031481: AB_2202455, HPA056473: AB_2683144"	"unprognostic (2.58e-3)"	"unprognostic (1.20e-2)"	"unprognostic (3.64e-3)"	"unprognostic (2.80e-1)"	"unprognostic (8.63e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.14e-2)"	11.1	6.9	10.3	11.5	14.6	20.0	15.4	12.6	11.3	14.4	20.0	11.0	5.5	7.4	18.8	8.0	13.2	10.9	14.9	9.7	7.8	7.5	16.0	9.8	19.2	18.9	15.8	4.3	13.3	8.8	6.5	13.5	50.9	14.1	12.3	9.2	10.4	10.2	12.2	8.4	6.6	11.0	28.6	17.9	13.9	25.5	11.4	12.4	10.8	7.7	8.1	11.5	13.0	10.2	1.6	2.0	13.1	2.4	4.0	8.3	1.9	3.4	5.2	31.4	9.7	7.3	5.4	4.7	11.7	12.9	11.0	12.3	5.2	2.5	7.6	3.6	9.1	8.7	8.1	10.6	9.1	14.8	19.9	3.3	11.4	5.7	4.6	12.1	7.0	27.9	11.2	9.8	17.1	8.1	6.9	1.9	2.9	15.8	3.2	15.0	5.3	1.0	8.0	6.7	3.2	3.1	2.8	68.5	3.2	2.7	0.8	8.5	9.9	9.1	40.7	12.2	13.5	7.5	9.6	3.6	8.2	7.1	35.0	7.1	3.3	3.3	5.2	17.2	12.1	7.0	13.1	2.4	9.1	8.3	1.6	7.2	1.6	3.6	6.1	2.0	1.3	3.5	6.7	4.9	4.0	1.9	1.4	2.2	1.9	10.3	14.6	12.6	11.3	7.8	7.5	15.8	4.3	14.1	12.4	6.0	9.1	9.3	6.5	20.9	7.2	6.3	5.1	1.4	10.3	57.6	0.0	17.0	0.0	14.1	114.1	14.5	3.3	23.3	27.1	5.9	46.2	13.4	29.9	11.5	43.1	0.0	9.2	8.0	20.9	74.1	8.9	36.3	33.7	19.0	6.6	2.9	25.9	3.5	12.7	12.2	1.6	32.3	22.2	8.0	10.5	14.2	16.2	11.5	7.2	8.4
TGFBR2	"MFS2, TBR-ii, TBRII"	ENSG00000163513	"Transforming growth factor beta receptor 2"	P37173	3	30606502-30694142	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Apoptosis, Differentiation, Growth regulation"	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Cancer-related genes, Craniosynostosis, Disease mutation, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Endothelial cells: 188.8;Ito cells: 564.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 54.5;ASC TERT1: 82.2;HSkMC: 70.9;LHCN-M2: 67.2;TIME: 61.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB073537			Supported	"Plasma membrane"		NA	NA		560000	"Plasma membrane"		"CAB073537: "	"unprognostic (1.74e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.81e-2)"	"unprognostic (8.02e-2)"	91.8	24.6	6.7	24.6	10.3	7.3	88.3	3.6	7.3	36.5	42.6	9.8	18.6	13.2	42.6	23.3	36.2	28.4	42.6	73.5	6.9	5.2	32.6	21.9	52.6	75.7	12.6	3.7	22.2	26.0	17.4	10.3	24.2	9.9	35.2	17.5	27.9	22.5	19.5	34.9	17.0	31.3	37.2	12.0	68.7	26.8	15.4	8.2	19.3	40.9	16.8	26.9	48.0	82.0	5.3	6.8	20.0	6.6	1.4	19.7	3.9	2.5	14.7	0.9	0.0	54.5	82.2	2.5	12.8	18.0	4.4	4.4	3.3	13.6	0.3	46.2	17.1	5.2	5.1	0.6	18.7	7.3	1.0	1.3	1.4	1.7	16.5	23.3	2.3	12.1	70.9	16.6	19.0	18.4	20.2	47.6	1.7	0.3	0.0	67.2	0.2	2.3	1.7	0.4	12.8	5.9	2.1	5.9	0.3	23.6	6.0	0.0	0.9	3.8	1.0	3.6	1.2	0.0	2.5	61.6	21.7	5.4	9.8	4.8	0.5	0.0	2.0	13.0	2.5	8.7	6.9	2.9	20.0	3.5	3.0	3.2	4.0	5.4	4.2	2.6	5.3	19.7	9.1	12.6	1.4	6.6	6.8	1.2	3.9	6.7	10.3	3.6	7.3	6.9	5.2	12.6	3.7	9.9	8.2	134.0	83.8	41.5	14.2	33.2	1.9	64.1	48.4	12.0	53.4	26.2	0.0	5.3	3.3	11.4	2.0	188.8	9.7	0.0	13.8	4.3	48.1	7.3	28.9	45.3	27.1	0.0	8.1	564.1	139.2	2.0	30.5	46.1	28.7	1.8	11.9	0.2	25.3	10.8	44.6	5.6	0.9	32.3	36.0	0.3	1.1	26.7	3.1	39.4	13.0	9.0
TIGD7	Sancho	ENSG00000140993	"Tigger transposable element derived 7"	Q6NT04	16	3298832-3305729	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA041357, HPA041474"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA041357: AB_10794992, HPA041474: AB_10795696"	"unprognostic (7.69e-2)"	"unprognostic (3.04e-4)"	"unprognostic (6.56e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.50e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.81e-2)"	"unprognostic (8.56e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.04e-1)"	"unprognostic (5.90e-3)"	"unprognostic (3.12e-2)"	3.7	5.6	7.7	8.2	7.6	1.3	11.7	8.6	6.8	8.5	5.9	5.3	5.8	3.1	9.3	8.2	5.2	8.8	4.7	7.7	7.1	8.3	6.8	3.9	4.6	4.8	7.1	3.7	17.4	4.4	16.9	17.6	5.3	7.5	8.4	3.6	3.8	4.1	8.9	5.5	3.5	4.0	6.9	6.7	6.5	3.7	12.5	7.3	8.5	11.0	2.8	5.0	11.0	6.1	4.9	1.1	6.3	2.8	3.8	5.7	1.5	0.9	2.1	5.5	3.0	2.9	4.2	4.5	2.9	1.8	4.5	4.2	0.3	1.7	2.0	4.7	2.1	3.3	0.5	2.0	0.8	5.7	0.2	2.8	5.8	1.7	0.1	3.3	1.0	7.7	4.4	1.5	4.2	1.3	4.7	3.4	1.5	2.8	3.7	3.8	1.2	1.9	8.8	6.3	0.5	5.0	10.3	1.3	8.4	2.4	0.5	7.6	2.8	6.8	0.9	2.5	5.0	3.2	3.3	1.1	2.7	6.5	2.8	1.6	7.7	7.8	6.4	1.6	3.4	3.0	1.0	1.4	6.3	3.3	1.0	5.7	1.6	2.8	4.8	1.0	4.9	5.5	3.6	3.5	3.8	2.8	1.1	2.9	1.5	7.7	7.6	8.6	6.8	7.1	8.3	7.1	3.7	7.5	7.3	8.9	5.0	0.5	3.2	0.7	7.4	8.4	5.1	2.7	5.7	0.0	3.9	1.2	3.3	2.3	2.6	1.7	0.5	0.0	1.2	0.9	0.9	2.7	1.1	0.5	0.8	4.8	1.2	0.6	1.6	1.6	2.6	1.1	5.0	0.0	0.8	3.2	0.8	0.0	4.2	0.8	1.8	6.5	1.7	10.5	10.4	0.5	1.1	2.6	0.4	1.4
TLN1	"ILWEQ, TLN"	ENSG00000137076	"Talin 1"	Q9Y490	9	35696948-35732395	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002006, HPA004748"	Supported		Supported	"Plasma membrane,Focal adhesion sites,Centriolar satellite,Cytosol"		NA	NA		3600000000	"Focal adhesion sites, Cytosol"	"Plasma membrane, Centriolar satellite"	"CAB002006: , HPA004748: AB_1857760"	"unprognostic (9.71e-2)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (1.96e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.18e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (7.21e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.71e-2)"	"unprognostic (7.83e-2)"	"unprognostic (8.83e-3)"	47.4	23.7	10.9	29.3	16.6	25.1	38.1	9.6	11.8	34.7	64.0	18.8	22.8	13.0	57.4	20.6	41.2	38.3	48.4	30.3	11.1	7.1	30.5	36.1	33.0	26.0	17.9	7.3	39.0	12.8	19.6	14.6	30.4	14.4	39.5	15.5	22.8	14.9	43.6	24.5	16.5	27.6	87.0	12.4	54.1	38.2	17.3	14.1	33.4	20.7	12.5	20.7	72.5	49.6	3.3	6.8	12.7	9.2	4.8	7.1	7.1	11.4	19.2	11.9	16.3	40.9	31.1	13.6	32.0	35.1	31.1	28.2	15.8	5.1	13.9	10.6	59.0	19.7	6.2	13.9	19.9	22.8	31.3	9.0	31.6	24.9	14.0	25.4	19.1	52.8	37.6	9.5	45.7	21.7	42.9	47.6	12.1	10.8	14.3	41.0	5.0	12.8	5.0	9.7	5.2	14.8	17.3	6.9	8.1	15.5	9.2	2.7	11.3	15.6	8.7	10.2	11.3	7.4	13.2	57.3	49.6	19.3	15.1	25.7	5.0	4.9	9.7	38.4	10.3	44.7	6.7	7.0	8.4	7.1	7.8	5.9	3.3	4.2	5.4	5.3	3.2	2.0	4.2	12.7	4.8	9.2	6.8	2.8	7.1	10.9	16.6	9.6	11.8	11.1	7.1	17.9	7.3	14.4	14.1	101.3	67.1	67.7	36.3	35.6	10.9	115.6	40.8	50.9	78.5	50.6	9.8	34.4	19.9	88.6	37.6	106.8	42.8	46.7	54.0	72.5	71.0	43.2	194.8	46.5	103.3	14.3	32.7	76.1	163.8	17.2	92.0	155.9	21.9	147.9	23.2	33.9	81.9	24.6	120.9	45.4	17.3	200.5	199.7	26.8	25.9	23.2	49.2	86.7	23.2	31.2
TLR4	"ARMD10, CD284, hToll, TLR-4"	ENSG00000136869	"Toll like receptor 4"	O00206	9	117704175-117724730	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"	"Age-related macular degeneration, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	15	"Hofbauer cells: 31.7;Ito cells: 59.5;Kupffer cells: 88.0;Macrophages: 33.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 30.1"	"Group enriched"	"Detected in many"	30	"dendritic cells: 7.5;granulocytes: 30.1;monocytes: 21.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 29.6;TIME: 21.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004025, HPA049174"	Approved		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"	"Golgi apparatus"	"CAB004025: , HPA049174: AB_2680662"	"unprognostic (1.60e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.22e-2)"	"prognostic favorable (6.29e-4)"	"unprognostic (3.39e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.38e-1)"	"unprognostic (5.18e-2)"	"unprognostic (8.00e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.63e-2)"	"prognostic unfavorable (3.79e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.96e-2)"	29.2	12.1	15.5	23.5	12.5	17.8	21.9	9.4	10.3	6.9	6.8	10.6	3.0	4.4	5.8	7.7	5.0	6.8	10.6	10.9	19.9	7.5	9.0	16.5	16.0	30.9	12.4	11.4	6.7	3.0	2.9	3.8	22.8	10.5	5.7	7.4	7.2	9.0	3.6	7.4	5.2	6.6	10.4	11.1	41.4	4.5	2.4	13.0	1.1	8.3	5.6	7.5	12.1	16.1	0.6	7.5	30.1	21.4	0.0	0.0	6.9	0.0	0.0	12.7	0.0	5.9	12.0	0.1	5.0	8.8	1.3	0.7	0.0	1.2	1.7	0.2	13.0	3.9	0.0	0.0	1.1	1.9	0.0	0.0	2.7	2.7	0.1	4.4	9.1	0.0	7.4	0.0	2.8	0.3	11.4	15.5	0.0	0.0	29.6	15.4	0.0	0.0	1.8	1.5	1.2	0.6	0.0	14.3	9.3	0.5	14.8	0.0	0.0	3.2	0.0	0.5	1.2	0.0	5.0	21.4	0.7	9.6	0.0	2.4	0.0	0.0	0.0	0.4	9.6	7.6	17.6	21.4	7.2	0.0	19.6	0.0	0.6	0.0	0.0	7.5	0.2	0.0	0.0	30.1	0.0	20.2	0.3	0.0	6.9	15.5	12.5	9.4	10.3	19.9	7.5	12.4	11.4	10.5	13.0	0.0	5.3	1.5	0.1	0.7	0.2	2.5	5.1	2.7	4.5	0.0	0.0	0.2	0.0	0.0	0.0	19.7	0.3	0.0	0.2	0.2	1.9	0.2	15.1	1.8	31.7	0.0	0.0	59.5	88.0	0.0	0.0	33.1	1.7	0.0	0.6	13.8	0.3	1.7	0.0	0.4	0.8	6.5	0.9	0.0	0.2	0.0	0.7	0.0	0.1	2.2
TM4SF20	"FLJ22800, TCCE518"	ENSG00000168955	"Transmembrane 4 L six family member 20"	Q53R12	2	227362156-227381995	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	86	"intestine: 147.8"	"Cell type enhanced"	"Detected in some"	23	"Early spermatids: 33.2;Enterocytes: 27.7;Late spermatids: 61.3;Paneth cells: 11.5"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 5.0;liver cancer: 4.7;pancreatic cancer: 5.5;stomach cancer: 11.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 7.2;RPMI-8226: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051838, HPA063184, HPA065531"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane, Focal adhesion sites"		"HPA051838: AB_2681631, HPA063184: AB_2684958, HPA065531: AB_2685506"	"unprognostic (4.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.75e-2)"		"unprognostic (4.96e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.44e-3)"	"unprognostic (7.76e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.04e-3)"		0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	46.5	0.0	0.0	73.5	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.9	0.0	0.1	0.0	0.1	0.1	147.8	0.2	0.1	0.1	0.1	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.1	1.2	1.1	0.5	1.7	0.7	0.0	0.1	7.2	0.2	0.1	0.0	0.0	1.3	0.9	0.1	0.0	0.0	1.4	0.5	0.2	0.1	0.4	0.2	0.2	0.0	0.0	0.1	0.1	0.4	0.0	1.3	0.2	0.0	0.5	0.3	0.0	0.1	0.0	0.0	0.4	0.0	0.4	0.4	0.8	0.3	0.0	0.1	1.6	0.3	0.1	0.1	0.5	0.1	4.5	0.1	0.3	0.6	1.7	1.1	0.1	0.0	0.1	0.3	0.1	0.3	0.6	0.3	2.0	0.2	0.5	0.3	0.4	0.2	0.2	0.2	0.8	0.5	0.1	0.7	0.3	0.3	0.7	0.4	0.4	0.0	1.1	0.7	0.5	1.1	1.7	0.1	1.2	0.4	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.2	0.0	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.3	0.0	0.0	0.0	0.0	0.6	0.2	0.0	11.5	0.7	0.0	0.2	0.0	0.0	0.5	0.2	0.0	0.0	0.0	1.2	0.0
TMEM107	MGC10744	ENSG00000179029	"Transmembrane protein 107"	Q6UX40	17	8173237-8176399	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cilium biogenesis/degradation"	"Developmental protein"	"Ciliopathy, Disease mutation, Meckel syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 171.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052555, HPA059653"	Approved		Approved	"Nucleoplasm,Plasma membrane,Midbody ring"		Yes	No			"Nucleoplasm, Plasma membrane"	"Midbody ring"	"HPA052555: AB_2681870, HPA059653: AB_2684096"	"unprognostic (2.87e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.85e-2)"	"prognostic favorable (9.39e-5)"	"unprognostic (1.94e-2)"	"unprognostic (8.83e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.02e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.99e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.49e-1)"	8.6	11.8	13.7	7.1	19.6	17.5	13.0	7.3	23.2	11.7	8.3	9.9	10.7	4.2	10.0	30.1	8.8	38.7	9.4	8.8	11.0	13.4	12.1	4.0	12.8	17.7	10.9	17.1	7.5	9.6	17.8	20.8	10.0	15.6	5.9	7.8	12.6	8.7	10.1	1.7	12.7	6.0	10.1	10.5	11.9	7.1	15.9	8.2	7.8	19.1	4.3	9.6	9.5	7.8	33.1	18.7	28.4	29.9	14.5	20.8	12.7	31.6	10.0	15.5	7.1	9.4	14.2	3.1	7.4	7.0	6.5	8.6	1.2	18.2	8.7	9.5	7.4	4.6	22.1	6.3	14.5	10.3	10.7	7.4	4.7	17.4	3.4	3.8	1.8	5.2	6.9	9.2	17.1	8.3	13.7	10.8	10.8	4.0	17.1	15.3	9.4	4.3	5.0	1.6	3.9	4.6	7.9	4.2	12.5	12.0	2.4	4.5	7.1	8.6	1.8	6.3	3.7	5.4	6.4	6.8	3.3	6.3	5.2	3.9	6.7	3.7	3.4	19.0	7.1	5.3	10.5	13.3	28.4	18.8	15.8	16.3	26.7	18.1	20.0	11.8	33.1	20.0	20.8	10.9	14.5	29.9	18.7	14.3	12.7	13.7	19.6	7.3	23.2	11.0	13.4	10.9	17.1	15.6	8.2	8.9	9.8	33.9	18.2	17.1	17.7	6.2	40.8	171.3	25.0	31.4	43.2	15.0	11.6	14.4	7.1	20.4	10.3	0.0	9.6	17.4	16.6	14.7	34.8	17.8	39.4	11.1	8.7	23.9	38.4	6.3	11.8	29.7	32.1	21.6	12.1	32.1	11.5	14.4	14.2	15.3	60.3	0.0	11.3	47.4	49.2	25.0	11.1	34.5	15.3	9.7
TMEM2		ENSG00000135048	"Transmembrane protein 2"	Q9UHN6	9	71683366-71816690	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Developmental protein, Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 67.6"	"Cell type enhanced"	"Detected in many"	5	"Ito cells: 115.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 36.6;BEWO: 34.0;OE19: 36.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044889	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA		130000	"Plasma membrane"	Vesicles	"HPA044889: AB_10962641"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.15e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (1.13e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.16e-1)"	23.3	3.9	6.0	10.5	4.4	12.4	13.6	8.9	6.0	3.0	18.6	1.9	10.1	12.2	4.5	5.2	4.4	4.9	19.2	9.5	8.6	3.6	9.3	24.9	35.7	14.0	4.0	4.1	3.1	9.2	24.0	9.5	67.6	4.3	5.5	13.1	7.9	9.5	10.2	5.5	6.4	20.0	5.5	5.1	15.6	14.5	3.7	2.4	6.4	8.0	4.6	8.8	11.4	6.8	6.3	0.9	5.5	2.1	0.5	4.1	1.4	5.8	28.0	36.6	1.7	3.8	6.9	34.0	19.7	12.6	13.7	10.1	7.8	8.0	0.1	5.9	5.0	3.0	8.7	11.8	2.7	18.6	0.7	3.6	10.0	5.9	20.8	5.9	0.0	2.7	7.1	3.0	10.6	2.4	3.6	18.0	0.8	1.4	3.0	7.4	4.9	1.1	0.1	7.6	36.1	2.7	0.9	10.9	0.7	8.6	18.9	1.8	0.2	5.1	3.6	5.3	11.8	2.5	0.3	7.8	9.3	10.5	5.1	9.8	0.6	8.4	0.3	1.8	0.9	11.7	0.2	2.1	5.5	2.7	1.9	0.8	0.7	2.9	2.6	0.9	6.3	4.1	2.0	4.5	0.5	1.8	0.2	3.9	1.4	6.0	4.4	8.9	6.0	8.6	3.6	4.0	4.1	4.3	2.4	32.8	30.4	9.4	38.3	26.8	5.5	0.0	33.1	4.0	17.0	0.0	9.8	36.3	0.0	0.0	10.6	37.9	75.4	0.0	0.0	12.0	19.0	42.5	4.6	27.6	35.9	0.0	9.7	115.4	56.5	2.9	2.8	14.9	16.9	0.0	32.3	73.6	0.0	26.4	1.1	0.0	35.2	6.5	20.8	1.0	0.6	19.2	75.1	62.3	28.3	40.3
TMEM266	"C15orf27, FLJ38190"	ENSG00000169758	"Transmembrane protein 266"	Q2M3C6	15	76059837-76229121	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 50.7"	"Cell type enhanced"	"Detected in some"	8	"Cone photoreceptor cells: 9.8;Cytotrophoblasts: 12.8;Late spermatids: 11.1;Rod photoreceptor cells: 7.6;Sertoli cells: 6.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.3"	"Region enriched"	"Detected in many"	12	"cerebellum: 50.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.0;HEK 293: 3.6;NTERA-2: 3.7;U-937: 3.3"	"Region enriched"	"Detected in all"	6	"cerebellum: 65.8"	"Region enriched"	"Detected in all"	6	"cerebellum: 66.4"	"HPA041921, HPA049425"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA041921: AB_10796789, HPA049425: AB_2732552"	"unprognostic (8.63e-3)"	"unprognostic (6.11e-3)"	"unprognostic (3.44e-3)"	"unprognostic (9.17e-5)"	"unprognostic (4.67e-1)"	"unprognostic (2.61e-2)"	"unprognostic (9.34e-3)"	"unprognostic (5.61e-2)"	"unprognostic (8.48e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.86e-2)"	0.1	1.9	1.1	0.2	1.9	0.2	0.4	50.7	4.2	0.2	0.2	0.6	0.0	0.3	0.2	0.1	0.3	0.3	0.1	0.1	0.9	1.3	0.9	0.1	1.1	0.3	0.7	0.3	0.1	2.4	0.2	5.1	2.4	1.9	0.4	0.2	1.1	0.2	0.1	10.6	1.5	0.1	0.1	0.4	0.6	0.3	1.4	0.0	0.0	0.2	0.7	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.9	0.1	0.8	0.8	0.0	2.0	3.6	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.9	50.7	4.2	0.9	1.3	0.7	0.3	1.9	0.0	0.0	0.0	0.0	0.9	0.0	2.6	0.0	0.0	2.7	0.0	1.8	9.8	12.8	1.7	0.0	5.9	0.0	0.0	0.0	0.2	1.7	0.7	0.8	0.0	0.0	4.2	1.6	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.7	0.5	7.6	6.5	0.0	0.5	2.1	0.0	4.9	0.0	0.0	0.4
TMPRSS2	PRSS10	ENSG00000184012	"Transmembrane serine protease 2"	O15393	21	41464551-41531116	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 75.6;pancreas: 64.5;prostate: 68.2"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 190.3;Glandular cells: 290.4;Paneth cells: 127.7;Urothelial cells: 115.9"	"Cancer enriched"	"Detected in many"	7	"prostate cancer: 250.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 14.1;MCF7: 6.1;OE19: 20.6;RT4: 33.9;SK-BR-3: 6.9"	"Not detected"	"Not detected"							"HPA034493, HPA035787"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"	Nucleoplasm	"HPA034493: , HPA035787: AB_2674782"	"unprognostic (4.80e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.16e-1)"	"prognostic favorable (2.56e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.51e-3)"	"unprognostic (9.43e-2)"	"unprognostic (9.02e-3)"	"unprognostic (6.24e-2)"	"unprognostic (6.43e-2)"	"prognostic favorable (7.86e-6)"	"unprognostic (2.00e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.15e-2)"	0.2	0.1	0.2	15.5	0.4	0.0	6.1	0.2	0.5	1.3	38.7	0.4	24.4	17.5	0.5	0.9	10.7	2.2	17.3	0.2	0.3	0.1	19.4	18.4	20.7	0.2	0.2	0.2	0.7	64.5	0.0	1.3	1.0	0.4	68.2	18.5	0.3	52.3	35.7	0.2	2.1	75.6	0.9	0.2	0.3	36.7	0.8	0.3	0.5	19.9	3.9	10.2	5.9	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	14.1	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.1	0.5	1.2	20.6	0.0	0.0	0.0	1.3	0.5	33.9	0.0	0.4	0.0	6.9	0.1	0.2	5.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.4	0.2	0.5	0.3	0.1	0.2	0.2	0.4	0.3	47.6	88.6	0.0	31.0	0.2	0.0	0.6	25.5	14.7	38.7	45.4	0.0	0.5	19.9	30.0	19.4	0.0	190.3	0.0	52.6	0.1	0.6	290.4	6.9	28.7	0.1	0.0	17.3	0.0	0.8	3.5	0.0	1.5	10.1	1.0	79.6	0.0	53.4	127.7	0.0	3.7	0.0	0.0	1.0	0.2	0.0	0.1	0.2	0.0	73.2	115.9
TNFRSF11A	"CD265, FEO, LOH18CR1, PDB2, RANK"	ENSG00000141655	"TNF receptor superfamily member 11a"	Q9Y6Q6	18	62325287-62391292	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Deafness, Disease mutation, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 28.7;intestine: 23.9;salivary gland: 34.3"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 21.1;monocytes: 34.3;Mucus-secreting cells: 23.6;Paneth cells: 28.1;Undifferentiated cells: 33.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"NK-cell: 8.9"	"Lineage enriched"	"Detected in many"	8	"NK-cells: 8.9"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 52.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB010391, HPA047976"	Approved		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Plasma membrane"	Cytosol	"CAB010391: AB_2205352, HPA047976: AB_2680227"	"unprognostic (4.08e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.73e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.96e-4)"	"unprognostic (4.24e-3)"	"unprognostic (7.79e-4)"	"unprognostic (1.52e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.69e-5)"	"unprognostic (1.56e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.02e-2)"	"unprognostic (7.07e-2)"	6.5	1.7	1.7	4.8	1.2	0.2	4.3	0.4	2.3	1.5	18.4	0.8	7.6	23.1	0.9	1.9	3.8	1.3	28.7	1.1	1.3	0.7	0.9	0.8	2.3	7.4	1.0	1.0	0.7	2.9	0.1	10.1	2.8	0.7	2.1	13.9	1.3	34.3	12.9	0.6	3.3	23.9	1.3	2.9	1.2	4.3	1.2	0.8	0.7	2.0	1.8	2.3	2.3	2.3	0.0	0.6	0.2	0.0	8.9	1.0	0.0	1.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.2	0.0	1.5	0.1	0.6	0.9	3.5	0.3	0.1	52.5	2.3	0.0	0.5	0.7	0.0	0.2	0.5	0.1	0.1	0.3	1.3	1.8	1.3	0.1	0.0	0.0	0.0	0.4	0.0	0.0	2.5	2.9	8.3	0.1	0.0	0.2	0.6	0.6	8.9	0.3	0.2	1.3	0.0	0.3	0.5	0.1	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	8.9	0.0	0.6	1.0	0.0	1.7	1.2	0.4	2.3	1.3	0.7	1.0	1.0	0.7	0.8	0.0	2.1	0.0	2.9	1.1	0.4	1.1	10.2	0.0	0.0	0.0	0.0	0.1	0.0	7.3	0.2	2.2	21.1	0.0	6.5	0.6	0.3	2.6	0.0	0.0	12.8	3.2	10.4	3.7	15.0	0.0	0.6	2.5	1.7	34.3	23.6	0.0	9.6	28.1	0.0	0.0	0.0	0.0	0.3	0.7	1.4	1.9	0.1	0.0	33.6	3.8
TNFRSF21	"CD358, DR6"	ENSG00000146072	"TNF receptor superfamily member 21"	O75509	6	47231532-47309905	"CD markers, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Apoptosis, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 63.4"	"Cell type enhanced"	"Detected in many"	11	"Basal glandular cells: 142.4;Glandular cells: 135.6;Syncytiotrophoblasts: 149.4;Urothelial cells: 360.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	35	"plasmacytoid DC: 31.6"	"Lineage enriched"	"Detected in single"	309	"dendritic cells: 31.6"	"Cell line enhanced"	"Detected in many"		"OE19: 39.2;RT4: 99.8;SuSa: 43.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006746, CAB009805"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		1300000	"Plasma membrane, Cytosol"		"CAB009805: AB_2206956, HPA006746: AB_1078701"	"unprognostic (1.19e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.26e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.41e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.74e-1)"	"prognostic favorable (7.23e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.45e-2)"	25.9	3.7	9.7	8.7	13.6	5.9	7.8	7.4	20.8	9.6	19.3	26.9	1.0	6.4	9.1	3.0	21.8	9.9	18.7	4.1	13.8	16.0	26.2	4.6	9.5	11.5	26.8	7.9	5.0	17.9	35.6	4.4	17.0	29.5	10.2	18.5	3.0	15.2	2.4	3.5	2.7	10.2	8.2	63.4	11.6	30.4	5.8	10.1	11.5	2.9	19.2	16.5	41.2	11.6	0.0	31.6	0.1	0.0	0.0	0.0	0.2	29.2	9.5	9.3	2.9	25.5	7.5	10.5	3.4	6.7	1.0	0.4	16.4	20.7	2.1	13.8	2.4	20.0	17.7	1.3	12.6	0.6	0.0	2.9	0.0	1.2	16.5	14.9	0.4	0.1	13.4	15.1	0.6	11.5	0.8	4.9	1.9	0.7	0.0	0.3	5.7	2.5	0.2	7.3	39.2	9.8	5.4	2.8	3.1	17.7	99.8	6.7	1.4	2.9	2.8	2.4	43.8	2.1	2.0	1.0	2.8	2.5	0.1	3.1	0.0	0.0	3.0	4.5	2.1	7.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	31.6	0.0	0.2	9.7	13.6	7.4	20.8	13.8	16.0	26.8	7.9	29.5	10.1	0.0	12.7	0.0	142.4	21.1	0.6	7.6	35.7	10.7	25.0	1.8	0.0	24.6	13.3	69.3	45.6	5.6	30.3	0.0	25.8	16.8	14.1	135.6	19.6	0.0	20.6	0.0	11.5	1.8	36.8	29.9	2.6	5.8	11.8	0.0	40.2	4.4	63.5	46.7	1.1	48.5	1.3	77.6	16.2	0.6	1.4	8.7	149.4	1.3	14.0	360.8
TNFRSF8	"CD30, D1S166E, KI-1"	ENSG00000120949	"TNF receptor superfamily member 8"	P28908	1	12063377-12144207	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.3"	"Cell type enhanced"	"Detected in some"	14	"Early spermatids: 2.8;Kupffer cells: 6.0;Late spermatids: 7.2"	"Cancer enriched"	"Detected in some"	12	"testis cancer: 9.3"	"Region enriched"	"Detected in single"	14	"basal ganglia: 13.1"	"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 21.7;non-classical monocyte: 33.3"	"Lineage enriched"	"Detected in many"	5	"monocytes: 33.3"	"Cell line enriched"	"Detected in some"	21	"HDLM-2: 112.6"					"Low region specificity"	"Detected in many"			"CAB000016, HPA014823, HPA032081, HPA032082"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB000016: AB_563546, HPA014823: , HPA032081: AB_2674141, HPA032082: AB_2674142"	"unprognostic (1.07e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.17e-8)"	"unprognostic (3.31e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.31e-2)"	10.7	0.2	0.1	7.2	13.1	1.4	5.8	0.2	0.4	1.1	0.8	0.0	1.5	0.2	1.7	1.3	0.9	2.1	1.4	3.8	0.1	0.2	0.9	0.2	3.9	2.9	0.5	0.5	1.2	0.4	0.0	0.1	6.2	0.5	1.0	0.5	0.0	0.7	0.3	3.1	1.6	1.3	1.3	1.4	2.9	6.4	2.5	0.9	3.0	0.7	2.7	5.3	2.6	3.8	0.0	3.2	6.8	33.3	0.0	0.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	112.6	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	5.2	0.3	0.0	0.0	0.3	0.0	4.5	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.3	0.0	21.7	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	6.8	0.0	33.3	0.8	0.3	2.7	0.1	13.1	0.2	0.4	0.1	0.2	0.5	0.5	0.5	0.9	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	1.4	0.0	0.0	1.3	6.0	7.2	0.3	1.9	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.1	0.2	0.0	0.0	0.0
TNFSF13B	"BAFF, BLYS, CD257, TALL-1, TALL1, THANK, TNFSF20"	ENSG00000102524	"TNF superfamily member 13b"	Q9Y275	13	108251240-108308484	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 76.5;lymphoid tissue: 39.6"	"Cell type enhanced"	"Detected in many"	23	"Hofbauer cells: 88.9;Kupffer cells: 144.9;Macrophages: 141.3;monocytes: 457.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 76.5"	"Group enriched"	"Detected in many"	10	"dendritic cells: 31.0;granulocytes: 76.5;monocytes: 53.7"	"Cell line enriched"	"Detected in some"	7	"U-937: 61.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009188, HPA030526"	Enhanced		Supported	"Vesicles,Plasma membrane,Focal adhesion sites"	"Secreted to blood"	NA	NA	393000	530000	"Plasma membrane"	"Vesicles, Focal adhesion sites"	"CAB009188: , HPA030526: "	"unprognostic (6.48e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (2.53e-11)"	"unprognostic (1.23e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.25e-1)"	7.2	8.2	3.0	18.5	8.2	13.2	3.4	1.4	5.2	1.6	4.2	2.1	1.0	7.8	1.2	6.5	3.5	2.9	9.4	9.4	5.7	2.9	3.1	5.0	13.2	39.6	7.2	2.6	2.9	2.7	0.5	2.1	6.4	5.7	3.7	6.4	2.6	5.4	1.8	1.6	1.6	6.8	3.5	11.6	23.5	3.4	1.0	4.9	7.2	5.1	1.7	12.7	8.5	3.8	1.0	31.0	76.5	53.7	0.6	5.3	20.8	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.1	0.3	0.2	0.8	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.3	0.1	0.0	0.1	3.6	0.1	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	1.9	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.1	0.0	0.0	0.1	0.1	0.0	8.1	0.0	0.1	0.0	0.0	0.1	3.8	0.1	0.0	3.9	61.0	0.6	1.2	53.7	14.4	0.8	39.8	5.3	0.6	3.5	0.7	31.0	1.0	1.7	0.5	76.5	0.6	31.7	11.5	2.8	20.8	3.0	8.2	1.4	5.2	5.7	2.9	7.2	2.6	5.7	4.9	14.9	17.5	3.7	0.7	6.4	0.3	0.5	12.7	2.7	5.7	5.2	0.0	0.5	1.7	2.0	1.0	1.3	0.5	0.0	29.2	0.9	13.3	1.6	4.7	1.5	88.9	0.0	1.2	4.9	144.9	0.2	4.9	141.3	8.5	457.1	0.2	0.4	1.9	0.0	1.8	1.0	0.0	6.5	5.0	0.1	0.1	4.1	0.9	6.2	1.2	1.3
TNKS1BP1	"FLJ45975, KIAA1741, TAB182"	ENSG00000149115	"Tankyrase 1 binding protein 1"	Q9C0C2	11	57299638-57324952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Basal keratinocytes: 74.2;Suprabasal keratinocytes: 77.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037929, HPA037930"	Enhanced		Supported	"Plasma membrane,Actin filaments"		NA	NA		50000	"Plasma membrane"	"Actin filaments"	"HPA037929: AB_10672613, HPA037930: AB_2675745"	"unprognostic (7.31e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.38e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.13e-1)"	"unprognostic (9.17e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.90e-2)"	"unprognostic (4.27e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.22e-3)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (2.11e-8)"	"unprognostic (2.46e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.07e-1)"	35.1	15.5	8.4	10.6	9.1	1.2	37.8	4.2	8.3	33.0	18.3	5.9	32.0	13.6	22.8	31.7	35.8	19.0	29.0	12.8	6.6	4.4	12.6	35.8	22.0	4.8	5.3	5.9	25.7	17.5	10.8	11.0	34.4	5.7	22.2	7.8	11.8	24.0	33.4	33.1	39.6	18.2	23.4	4.5	8.0	24.6	13.8	5.2	7.8	17.6	28.6	18.1	29.3	33.5	0.1	0.9	0.0	0.0	0.0	2.0	0.1	22.5	15.2	10.9	8.8	34.6	26.5	8.2	15.9	29.9	12.3	11.4	6.7	15.5	0.5	10.2	26.1	13.2	39.4	8.2	27.4	8.0	8.6	2.6	2.9	9.4	3.1	23.6	3.6	1.1	26.3	32.9	18.8	14.6	15.4	15.7	3.2	3.3	2.4	17.1	11.5	2.7	3.7	12.0	11.9	12.0	4.2	15.2	6.4	14.4	30.1	3.8	6.0	21.1	32.0	11.4	8.0	48.0	3.0	29.8	12.7	12.3	14.9	8.9	4.0	0.9	2.8	28.7	1.0	6.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.3	0.9	0.1	0.2	0.3	0.0	0.0	0.0	0.0	2.0	0.1	8.4	9.1	4.2	8.3	6.6	4.4	5.3	5.9	5.7	5.2	11.9	34.4	0.8	26.4	74.2	5.2	3.9	33.1	1.4	20.5	41.8	2.0	12.3	0.0	28.2	1.5	23.2	20.0	0.0	19.3	2.7	23.3	28.6	2.3	38.5	3.5	7.9	17.3	17.2	1.2	2.3	44.5	3.9	16.9	0.0	23.7	3.8	29.7	14.2	46.3	1.1	1.3	32.3	19.9	1.2	3.4	77.0	20.5	0.7	12.1	30.4
TRAIP	"RNF206, TRIP"	ENSG00000183763	"TRAF interacting protein"	Q9BWF2	3	49828599-49856574	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 25.0"	"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 11.8;Spermatogonia: 9.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036261, HPA036262"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA036261: AB_10673348, HPA036262: AB_2675029"	"unprognostic (5.30e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.50e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.68e-3)"	"prognostic unfavorable (8.77e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.24e-2)"	"unprognostic (7.97e-2)"	"unprognostic (9.01e-5)"	"unprognostic (5.84e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-1)"	4.8	1.6	3.4	6.0	10.7	9.5	3.0	7.4	3.0	3.5	3.7	2.0	3.2	2.3	3.8	2.4	4.5	3.0	2.9	1.5	2.7	2.7	1.6	1.2	1.3	8.1	2.0	2.8	3.4	1.6	1.6	2.0	2.5	3.0	2.9	4.8	2.7	3.1	1.7	2.8	6.7	3.4	3.4	5.1	3.7	1.9	25.0	3.4	11.5	2.2	3.1	6.8	1.9	3.0	5.1	1.6	0.6	3.0	2.7	4.9	1.6	6.4	7.9	11.3	11.4	1.0	1.6	9.4	7.8	3.8	16.6	15.9	9.6	7.5	16.0	5.6	4.5	11.6	8.6	11.9	9.0	12.4	9.2	7.9	12.0	9.6	8.5	0.4	9.8	10.1	1.1	1.3	13.3	7.1	2.0	4.3	14.3	8.6	11.6	7.3	9.4	16.2	12.5	9.1	7.7	13.1	9.0	7.7	9.3	3.0	9.1	5.5	9.4	8.7	7.3	5.5	8.5	6.6	13.9	3.3	10.6	12.7	14.6	15.3	8.5	20.3	17.1	5.3	13.3	9.5	0.0	1.5	0.6	2.3	0.8	2.0	5.1	1.3	4.9	1.3	3.8	1.7	2.6	0.3	2.7	3.0	1.6	0.8	1.6	3.4	10.7	7.4	3.0	2.7	2.7	2.0	2.8	3.0	3.4	3.0	1.1	2.2	0.6	1.0	3.1	2.0	0.0	0.0	0.0	3.5	0.0	2.1	0.0	1.3	3.3	0.7	0.5	0.0	0.8	6.7	1.4	0.5	0.0	0.8	3.0	0.0	0.0	0.6	0.3	4.0	2.3	0.5	1.7	2.8	1.3	1.9	0.9	0.0	1.1	0.3	3.6	0.0	1.0	11.8	9.5	0.3	0.8	2.9	2.3	0.1
TREML1	"dJ238O23.3, TLT1"	ENSG00000161911	"Triggering receptor expressed on myeloid cells like 1"	Q86YW5	6	41149342-41154337	"Plasma proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 37.9;bone marrow: 10.5;heart muscle: 10.0;lymphoid tissue: 26.7"	"Cell type enriched"	"Detected in some"	11	"monocytes: 44.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"basophil: 19.2"	"Lineage enriched"	"Detected in single"	31	"granulocytes: 19.2"	"Cell line enriched"	"Detected in single"	167	"HEL: 38.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016700, HPA017860"	Enhanced		Approved	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		94000000	"Nuclear speckles, Cytosol"	"Golgi apparatus, Plasma membrane"	"HPA016700: AB_1858262, HPA017860: AB_1858261"	"unprognostic (6.70e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.15e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.48e-2)"	"unprognostic (4.53e-5)"	"unprognostic (1.10e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.34e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.11e-4)"	"unprognostic (1.36e-1)"	"unprognostic (8.38e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.41e-2)"	1.2	1.2	2.1	3.7	1.2	10.5	0.6	0.5	1.3	0.4	0.3	0.3	0.3	0.0	0.3	0.6	0.3	0.6	1.3	10.0	2.1	1.6	0.3	0.3	2.9	7.7	3.3	0.3	1.9	0.5	0.2	0.6	1.7	1.2	0.3	1.3	0.6	1.3	0.3	0.8	0.3	0.4	0.3	4.3	26.7	0.2	0.8	0.3	1.4	0.6	0.3	7.1	1.1	0.3	0.1	0.3	19.2	0.6	0.0	0.2	37.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	38.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.6	0.8	0.0	0.5	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	3.9	0.0	0.1	0.3	0.0	37.9	2.1	1.2	0.5	0.7	2.1	1.6	3.3	0.3	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	1.0	0.0	0.0	1.7	0.0	44.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
TRPM4	FLJ20041	ENSG00000130529	"Transient receptor potential cation channel subfamily M member 4"	Q8TD43	19	49157741-49211836	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Immunity, Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 120.1;Mucus-secreting cells: 88.2;Paneth cells: 80.4;Undifferentiated cells: 78.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 85.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 5.4;granulocytes: 4.9;monocytes: 6.8"	"Cell line enhanced"	"Detected in many"		"OE19: 15.6;RT4: 32.4;SK-BR-3: 21.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA041169	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		6500	"Nucleoplasm, Plasma membrane"		"HPA041169: AB_2677343"	"unprognostic (8.20e-3)"	"unprognostic (1.41e-1)"	"unprognostic (7.86e-2)"	"prognostic favorable (2.88e-7)"	"unprognostic (1.62e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (2.53e-7)"	"unprognostic (8.46e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.00e-2)"	6.7	3.8	3.5	13.7	3.7	4.3	8.5	3.0	6.8	8.2	25.2	4.5	8.6	20.6	7.9	9.1	7.7	5.4	24.8	9.3	2.7	2.2	14.2	23.6	9.4	3.5	2.6	5.7	2.7	17.4	3.4	3.3	5.0	6.9	20.2	11.4	10.6	16.2	13.2	16.4	16.1	26.8	9.4	2.5	3.4	18.3	4.2	2.2	0.4	10.1	11.5	6.8	9.9	8.6	1.1	5.4	4.9	6.8	1.0	0.7	2.1	6.0	4.5	1.1	5.0	3.8	3.6	3.6	5.1	3.0	1.4	1.9	3.3	9.5	0.2	1.3	3.4	1.9	7.9	0.7	1.5	0.6	0.1	1.6	1.0	1.9	2.0	3.4	0.1	6.6	4.3	7.0	2.6	1.2	1.7	2.4	0.5	2.4	1.2	3.5	9.0	0.4	0.5	0.6	15.6	6.9	2.2	1.0	0.3	2.4	32.4	0.4	1.1	2.1	21.3	1.1	0.4	11.6	2.0	6.1	7.6	4.2	4.2	0.1	2.2	2.2	0.2	4.3	3.9	2.8	2.7	6.8	1.1	0.6	4.0	0.5	0.8	0.5	0.4	5.4	1.1	0.6	0.7	4.9	1.0	1.5	4.9	0.3	2.1	3.5	3.7	3.0	6.8	2.7	2.2	2.6	5.7	6.9	2.2	29.8	1.6	11.7	13.4	11.1	2.1	14.9	22.9	2.7	3.4	14.0	0.0	5.3	16.6	7.6	2.1	9.2	120.1	0.0	16.1	5.7	6.6	47.1	5.7	64.7	16.1	0.0	20.8	15.4	9.7	3.1	6.4	7.9	37.1	14.4	88.2	6.3	25.2	80.4	6.7	3.8	2.4	32.3	9.1	6.6	11.9	10.0	2.9	0.0	78.1	25.3
TRPV2	"VRL, VRL-1, VRL1"	ENSG00000187688	"Transient receptor potential cation channel subfamily V member 2"	Q9Y5S1	17	16415542-16437003	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"granulocytes: 48.5;Hofbauer cells: 48.6;monocytes: 52.3"	"Cancer enriched"	"Detected in all"	8	"melanoma: 59.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 27.1;fHDF/TERT166: 35.4;HMC-1: 29.8;SK-MEL-30: 30.7;TIME: 27.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044993	Uncertain		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA044993: AB_10960889"	"unprognostic (1.57e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.85e-2)"	"unprognostic (6.16e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.40e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.19e-6)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (5.53e-4)"	"unprognostic (8.07e-2)"	"unprognostic (1.23e-1)"	25.4	17.6	5.9	14.3	4.9	15.6	11.3	1.9	7.6	6.7	6.0	4.2	0.5	5.4	8.2	6.1	5.7	6.8	6.7	8.9	5.0	8.1	4.4	4.5	25.8	24.9	6.0	4.2	8.9	8.4	7.7	1.8	15.6	8.1	6.3	5.0	4.9	4.4	2.1	3.8	5.0	8.8	9.2	4.1	23.4	5.3	2.8	2.5	23.4	5.7	4.2	18.0	8.1	6.7	9.0	25.9	20.4	22.3	26.5	29.8	17.4	0.1	0.5	0.0	0.0	8.7	27.1	1.6	2.7	3.1	3.0	3.0	0.1	0.1	3.1	0.7	35.4	2.6	0.0	0.0	0.0	1.7	13.7	0.2	3.4	0.0	8.4	10.4	4.7	29.8	12.0	0.0	18.2	0.2	1.4	1.2	4.2	11.6	8.6	14.4	0.1	6.0	6.5	0.0	0.0	0.0	3.6	0.1	1.3	13.5	0.3	0.4	0.0	0.0	0.0	30.7	14.5	0.0	4.1	27.6	0.0	0.1	0.1	0.3	0.0	0.1	1.6	2.8	6.9	4.1	20.4	12.2	15.2	29.8	22.3	25.9	9.0	21.9	27.6	25.9	8.7	12.5	21.7	3.0	26.5	19.8	22.7	21.2	17.4	5.9	4.9	1.9	7.6	5.0	8.1	6.0	4.2	8.1	2.5	0.0	7.7	9.3	0.1	2.5	0.5	1.0	2.5	1.4	1.2	0.0	0.0	1.9	0.0	0.2	0.3	8.7	0.0	0.0	3.1	1.3	8.9	0.0	48.5	0.5	48.6	0.0	0.0	11.1	17.4	0.0	1.7	26.8	27.0	52.3	0.0	0.0	4.0	0.0	4.2	0.0	0.4	25.8	17.3	0.5	0.9	1.5	13.5	29.9	0.0	0.1
TSPAN15	"NET-7, TM4SF15"	ENSG00000099282	"Tetraspanin 15"	O95858	10	69451473-69507669	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Ductal cells: 106.8;Exocrine glandular cells: 167.5;Mucus-secreting cells: 103.1;Pancreatic endocrine cells: 141.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"MAIT T-cell: 17.4"	"Lineage enriched"	"Detected in many"	6	"T-cells: 17.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 34.9;EFO-21: 48.7;MCF7: 36.8;OE19: 33.8;PC-3: 60.5;SK-BR-3: 30.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044657, HPA071160"	Approved		Approved	"Nuclear bodies,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Nuclear bodies, Plasma membrane"	"Vesicles, Cytosol"	"HPA044657: AB_10967927, HPA071160: "	"unprognostic (2.03e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.44e-3)"	"unprognostic (6.81e-3)"	"prognostic unfavorable (8.00e-4)"	"unprognostic (2.23e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.76e-1)"	"unprognostic (8.22e-3)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (8.49e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.78e-3)"	34.2	3.1	11.5	9.7	22.7	0.9	24.9	40.4	17.0	8.9	30.4	49.2	12.5	24.0	15.1	8.4	7.1	16.2	17.1	8.3	18.0	9.2	10.2	3.0	20.4	4.9	33.1	11.2	3.0	10.8	1.4	3.3	17.7	16.8	17.6	24.9	5.4	16.8	17.0	9.9	4.6	21.5	23.0	43.0	13.5	46.4	4.0	28.3	0.8	6.7	2.7	4.8	22.6	6.8	0.0	2.7	0.0	0.0	0.1	17.4	0.5	11.1	23.2	0.4	0.0	0.5	0.0	2.7	0.0	0.4	0.6	1.5	10.0	34.9	0.0	48.7	0.5	2.1	22.8	1.6	2.5	0.7	9.2	4.6	0.6	0.7	2.2	0.2	0.0	0.4	0.5	0.7	0.3	0.3	1.7	8.9	4.6	0.2	0.0	0.2	36.8	0.1	0.2	0.6	33.8	60.5	0.8	0.4	0.4	6.8	20.7	7.9	3.0	0.1	30.7	3.8	4.1	13.4	0.5	7.7	0.0	0.1	0.0	3.8	0.2	1.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	17.4	0.0	2.7	2.5	2.7	0.0	0.9	0.2	0.0	0.1	0.0	0.2	0.9	0.5	11.5	22.7	40.4	17.0	18.0	9.2	33.1	11.2	16.8	28.3	29.8	5.8	2.7	9.7	3.2	3.0	0.8	25.5	14.7	6.8	27.9	5.9	1.5	3.3	106.8	26.3	18.7	73.5	0.0	167.5	9.1	4.7	50.7	1.1	0.0	20.5	1.6	38.6	11.1	5.6	4.9	0.6	10.5	27.0	27.1	103.1	36.7	141.3	88.3	0.0	1.3	1.4	12.9	7.6	0.9	17.7	2.8	2.5	2.5	61.6	27.1
TTC17	FLJ10890	ENSG00000052841	"Tetratricopeptide repeat domain 17"	Q96AE7	11	43358932-43494933	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038508	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA038508: AB_10671744"	"unprognostic (2.71e-1)"	"unprognostic (4.04e-3)"	"unprognostic (6.48e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.03e-2)"	"unprognostic (5.01e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (4.75e-6)"	"unprognostic (1.04e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.54e-2)"	12.7	13.6	16.3	15.8	18.4	6.8	21.2	21.1	17.0	12.7	10.7	9.1	21.1	10.9	15.0	13.9	11.5	17.7	11.5	10.5	12.8	7.4	12.0	19.9	20.4	19.8	21.7	11.3	26.6	47.7	20.5	20.8	15.0	15.4	13.8	12.0	10.6	20.7	11.7	12.1	10.9	14.0	17.7	12.9	11.9	16.4	12.3	17.3	11.1	19.5	9.1	11.1	12.8	12.5	22.4	23.3	24.5	29.0	20.4	23.1	21.1	5.8	12.0	12.6	19.8	32.0	26.6	8.9	14.1	19.0	11.9	14.4	8.3	8.7	12.3	14.2	14.1	13.8	12.4	8.9	9.3	14.4	9.5	11.7	9.4	7.8	8.1	39.6	14.1	12.2	24.6	28.7	8.6	28.0	27.1	11.8	9.0	13.5	10.5	11.9	7.0	10.3	8.1	18.9	22.7	10.4	9.7	13.5	14.2	15.1	8.6	6.8	16.2	11.0	29.4	17.6	13.4	27.6	16.0	15.7	17.1	7.6	19.1	20.3	20.8	16.7	11.8	11.0	8.5	18.1	22.3	28.3	23.8	21.0	29.0	21.9	22.4	22.6	19.7	21.9	20.7	23.1	21.0	24.5	20.4	24.7	23.3	20.3	21.1	16.3	18.4	21.1	17.0	12.8	7.4	21.7	11.3	15.4	17.3	59.6	54.2	28.4	28.8	37.4	41.5	17.6	28.1	49.5	54.6	21.0	56.9	25.8	3.3	19.2	29.2	34.4	26.8	0.0	37.4	25.1	35.1	39.2	33.7	51.6	22.7	44.5	21.5	41.1	45.4	12.2	52.9	30.9	27.0	27.9	41.3	25.2	28.5	31.7	34.3	11.1	49.2	51.8	28.6	40.9	34.8	37.8	25.7	35.4	34.6	32.8
TTLL5	KIAA0998	ENSG00000119685	"Tubulin tyrosine ligase like 5"	Q6EMB2	14	75633625-75955078	"Disease related genes, Predicted intracellular proteins"	Transcription	Ligase	"Cone-rod dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 51.1"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 119.8;Early spermatids: 86.9;Late spermatids: 71.0;Rod photoreceptor cells: 81.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032128	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA032128: AB_10600835"	"unprognostic (7.35e-2)"	"unprognostic (7.29e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.96e-2)"	"unprognostic (7.21e-5)"	"unprognostic (1.26e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.97e-2)"	"unprognostic (2.15e-2)"	5.9	6.5	7.6	5.9	11.1	10.1	7.4	12.0	10.4	8.0	6.5	18.0	6.4	4.9	11.8	7.7	8.1	11.8	6.7	6.8	7.9	7.1	6.6	4.4	6.6	5.0	10.1	6.9	8.1	5.8	13.2	9.5	7.6	13.9	7.4	7.6	8.2	7.7	7.5	5.2	7.2	4.8	8.9	15.8	4.2	6.0	51.1	10.5	10.1	8.1	5.5	7.3	7.1	7.1	3.8	5.7	12.4	3.8	3.4	5.1	2.3	14.3	10.5	9.3	9.5	7.3	11.4	8.5	8.5	10.3	10.2	13.1	6.5	13.5	4.0	4.7	8.9	7.5	13.7	7.9	14.0	19.4	4.8	4.8	7.9	11.0	7.1	6.2	5.7	7.7	8.7	7.0	12.8	14.3	11.1	21.9	11.4	4.5	6.9	10.1	20.1	9.7	7.9	6.6	11.3	10.8	6.0	13.0	5.5	9.8	14.2	12.2	7.8	17.9	13.1	4.4	7.5	18.0	6.3	24.7	13.6	12.1	12.0	7.8	5.8	8.3	9.4	13.8	6.6	9.0	12.4	3.5	2.7	4.6	3.3	4.0	3.8	4.2	4.5	5.1	3.5	5.1	4.7	3.8	3.4	3.8	5.7	3.4	2.3	7.6	11.1	12.0	10.4	7.9	7.1	10.1	6.9	13.9	10.5	3.0	8.5	2.4	5.1	4.4	8.9	7.6	20.4	34.8	13.6	10.4	119.8	6.8	3.3	6.0	86.9	9.0	6.3	0.0	4.6	11.2	7.8	7.7	11.6	5.8	5.0	0.0	7.5	24.5	7.0	71.0	11.5	6.4	5.0	9.0	6.1	8.1	4.3	9.9	11.0	1.4	81.7	12.9	4.4	28.7	15.8	5.5	5.0	6.9	6.8	4.1
TULP3	TUBL3	ENSG00000078246	"Tubby like protein 3"	O75386	12	2877223-2941140	"Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015285, HPA018496"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Plasma membrane"	"Secreted - unknown location"	NA	NA			"Nucleoplasm, Nucleoli"	"Plasma membrane"	"HPA015285: AB_1858460, HPA018496: AB_2669889"	"unprognostic (5.33e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.80e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (2.45e-1)"	"unprognostic (1.78e-2)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (2.44e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (7.18e-4)"	"unprognostic (7.52e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.19e-2)"	14.0	12.0	8.1	6.9	12.9	2.4	13.0	21.2	11.1	22.7	13.6	19.6	12.6	5.3	27.7	11.7	14.1	20.9	11.5	12.7	12.1	5.3	12.1	6.5	9.5	7.2	11.0	7.7	37.1	6.8	13.5	15.4	12.7	10.9	12.5	8.1	17.2	9.8	14.0	9.9	19.8	7.0	17.5	9.7	7.3	11.7	13.2	13.8	4.4	13.3	6.3	9.2	11.6	28.4	3.5	2.8	0.6	1.5	4.8	6.3	1.7	9.1	7.8	14.9	12.3	15.0	22.4	14.1	14.4	24.2	15.6	17.3	9.9	8.5	6.8	2.2	21.2	13.3	7.7	8.8	9.3	18.1	8.8	6.5	4.1	9.7	6.3	19.4	4.3	4.7	13.1	11.0	23.6	32.3	19.2	12.0	8.7	3.8	6.4	13.0	8.2	6.4	3.8	20.1	7.3	5.8	6.9	14.6	2.5	9.8	7.7	3.8	10.0	12.6	7.5	8.2	28.4	9.4	4.3	9.6	11.5	13.9	23.3	13.9	2.0	2.4	5.9	11.6	2.4	17.5	0.0	1.5	0.5	4.0	1.5	6.3	2.9	3.1	4.0	1.3	3.5	3.8	5.2	0.6	4.8	0.8	2.8	5.5	1.7	8.1	12.9	21.2	11.1	12.1	5.3	11.0	7.7	10.9	13.8	6.0	8.0	4.2	14.7	18.0	5.6	5.0	12.7	52.2	17.0	1.8	2.0	7.8	19.9	14.2	2.5	13.6	3.2	0.0	6.4	8.8	23.1	19.1	0.0	3.8	4.6	38.1	3.5	19.0	2.2	2.4	37.7	4.7	18.6	9.0	5.0	46.7	9.7	0.0	23.3	13.5	9.5	38.8	23.7	30.7	52.5	17.7	9.7	5.3	5.6	11.1
TXNDC11	EFP1	ENSG00000153066	"Thioredoxin domain containing 11"	Q6PKC3	16	11679080-11742878	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 48.2;U-266/70: 39.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041174, HPA041390"	Supported		Supported	"Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"		"HPA041174: AB_10794191, HPA041390: AB_10796670"	"unprognostic (1.96e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.82e-3)"	"prognostic favorable (2.12e-5)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (2.43e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.68e-3)"	"unprognostic (4.90e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.35e-2)"	"unprognostic (9.96e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.34e-2)"	12.5	12.5	6.1	10.9	8.1	24.1	12.3	12.8	9.9	12.7	20.8	8.3	13.2	19.2	12.9	16.0	12.6	12.7	17.5	11.4	7.3	4.4	21.2	47.2	22.4	21.3	7.4	4.4	13.9	22.9	28.6	11.4	15.0	7.1	13.2	15.4	18.6	24.1	14.3	23.2	9.9	27.4	7.8	5.0	23.6	17.6	5.6	6.7	15.9	28.6	11.6	33.2	15.0	10.2	5.7	3.6	9.6	3.3	7.8	9.2	3.5	8.8	6.2	2.9	4.0	7.9	6.6	5.1	8.9	12.2	8.1	10.5	3.0	14.2	22.5	15.0	11.1	11.1	8.0	3.6	7.4	6.7	10.0	4.7	4.7	7.1	14.9	11.6	7.0	9.7	5.0	8.5	9.1	14.4	6.3	10.2	5.1	7.2	29.0	7.1	8.1	5.4	2.7	3.8	6.4	3.2	7.0	5.9	48.2	9.3	4.8	4.1	3.9	17.3	13.5	9.4	3.4	8.3	9.7	10.5	3.8	4.4	17.7	5.0	39.6	21.6	13.6	8.0	8.9	6.3	4.9	3.3	9.6	2.7	2.5	6.6	5.7	4.9	6.0	3.6	4.9	4.8	3.1	1.0	7.8	2.8	2.8	9.2	3.5	6.1	8.1	12.8	9.9	7.3	4.4	7.4	4.4	7.1	6.7	41.7	44.0	21.5	22.2	13.1	15.1	7.6	20.4	10.7	26.1	17.4	47.1	17.5	13.3	17.8	2.3	13.1	35.1	0.0	34.6	26.3	14.1	29.3	15.0	32.5	27.0	22.3	23.5	16.0	15.1	1.1	18.7	21.9	21.9	24.4	36.5	14.5	23.5	21.0	12.4	11.8	22.2	6.5	18.1	11.2	9.5	10.3	20.9	18.7	22.7	27.1
TYROBP	"DAP12, KARAP, PLO-SL, PLOSL"	ENSG00000011600	"TYRO protein tyrosine kinase binding protein"	O43914	19	35904401-35908295	"Disease related genes, Predicted membrane proteins"	Immunity			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 267.2;bone marrow: 125.7;lymphoid tissue: 123.6"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 3494.1;Kupffer cells: 3415.8;Macrophages: 2767.6;monocytes: 2409.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 267.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"HMC-1: 118.8;THP-1: 65.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009493, HPA041899"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB009493: AB_638987, HPA041899: AB_10795266"	"unprognostic (7.09e-2)"	"unprognostic (8.38e-3)"	"unprognostic (7.87e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.04e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (4.47e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.39e-2)"	76.0	21.4	13.3	54.9	20.7	125.7	16.4	2.8	11.3	11.9	14.3	24.0	2.3	17.1	8.1	19.3	7.2	14.0	25.7	17.5	12.9	14.2	17.6	29.8	75.3	80.0	20.8	5.6	11.7	8.7	1.8	9.0	32.0	17.2	14.9	12.3	15.0	12.4	7.2	7.3	6.7	18.9	16.0	36.3	123.6	10.4	7.3	18.6	8.5	6.7	6.6	10.3	22.3	8.4	0.7	79.3	267.2	190.6	62.8	20.3	162.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.1	5.4	118.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	8.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	65.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.8	0.0	32.8	190.6	100.9	20.3	134.4	10.6	0.7	0.4	2.8	79.3	0.3	0.5	2.3	267.2	62.8	130.3	68.5	0.3	162.3	13.3	20.7	2.8	11.3	12.9	14.2	20.8	5.6	17.2	18.6	53.6	239.1	119.8	2.3	49.0	0.0	5.3	56.0	37.5	79.6	19.2	0.0	18.6	1.7	0.8	2.5	35.9	0.7	0.0	4.8	19.4	38.6	1.2	723.1	19.1	3494.1	0.0	0.0	89.6	3415.8	4.7	8.6	2767.6	54.0	2409.4	0.0	0.5	1.2	0.2	1.1	6.8	1.1	77.6	17.2	0.7	2.8	39.0	32.5	348.1	0.1	1.0
UBE2A	"HHR6A, RAD6A, UBC2"	ENSG00000077721	"Ubiquitin conjugating enzyme E2 A"	P49459	X	119574467-119591083	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Chromatin regulator, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Syncytiotrophoblasts: 425.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003875, HPA051765, HPA065898"			Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"HPA003875: AB_2667061, HPA051765: AB_2681597, HPA065898: AB_2685577"	"unprognostic (2.27e-3)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.12e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (9.07e-4)"	"unprognostic (1.66e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.54e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (2.20e-6)"	"unprognostic (9.54e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.92e-2)"	24.8	20.6	26.7	23.1	24.6	16.8	32.5	20.2	24.2	23.7	32.8	23.9	20.2	21.7	23.8	26.7	37.2	20.3	21.2	42.2	23.6	22.1	32.2	26.6	22.8	26.3	26.8	19.7	18.7	17.2	24.3	18.2	112.4	24.7	20.4	30.2	20.0	21.0	22.6	46.8	23.6	29.2	27.9	29.1	25.1	20.4	17.0	19.5	36.3	23.2	32.8	31.5	26.7	24.0	21.0	29.0	34.1	36.3	12.8	21.2	17.4	31.1	26.3	16.6	14.0	29.0	35.8	15.5	32.4	28.9	38.5	36.6	13.6	21.5	24.7	32.9	35.6	64.7	22.5	23.6	17.1	37.2	34.2	14.0	10.9	21.0	12.1	26.6	27.2	18.8	24.4	24.5	37.0	16.1	27.2	26.7	22.1	13.4	22.1	43.6	33.0	42.0	25.8	27.6	32.9	29.8	21.5	17.6	23.0	31.1	20.5	12.7	13.1	43.0	19.8	23.5	21.6	17.3	23.9	26.0	24.8	11.1	48.9	36.5	21.4	34.8	24.3	26.4	34.6	19.3	16.5	22.7	34.1	18.1	35.4	14.3	21.0	15.7	15.8	29.0	18.8	10.0	14.3	30.1	12.8	36.3	23.0	21.2	17.4	26.7	24.6	20.2	24.2	23.6	22.1	26.8	19.7	24.7	19.5	95.3	39.2	51.3	71.2	110.8	14.0	62.9	48.4	83.0	53.4	38.4	29.5	150.4	86.2	88.0	32.0	62.8	76.2	46.7	89.2	129.6	86.9	77.3	55.4	31.6	116.0	7.9	43.7	44.2	59.6	10.6	34.2	89.3	79.2	168.7	43.9	37.6	102.2	80.7	38.2	92.2	34.3	45.3	103.2	39.1	30.0	111.8	425.3	58.0	43.9	88.5
UBE2B	"HHR6B, RAD6B, UBC2"	ENSG00000119048	"Ubiquitin conjugating enzyme E2 B"	P63146	5	134371179-134391992	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 83.3"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 83.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003875, HPA051765, HPA065898"			Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"HPA003875: AB_2667061, HPA051765: AB_2681597, HPA065898: AB_2685577"	"unprognostic (1.98e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.39e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.64e-3)"	"unprognostic (6.30e-3)"	"unprognostic (3.42e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.52e-2)"	17.7	27.7	20.4	17.0	16.6	25.9	22.8	16.2	28.3	13.8	18.0	7.9	11.6	14.4	19.4	17.0	25.6	13.6	18.3	59.2	20.3	16.4	17.8	19.8	21.8	18.7	13.8	18.7	16.7	26.4	7.8	16.2	27.8	17.6	15.4	15.1	10.2	16.1	18.5	106.5	15.9	16.2	21.6	15.1	16.6	14.1	21.7	12.7	13.2	18.2	34.0	16.3	19.2	22.8	9.6	8.8	83.3	14.1	9.6	14.6	10.5	35.5	9.3	19.6	18.6	17.1	18.5	31.6	26.7	14.1	17.2	20.5	28.3	23.9	19.4	32.3	17.0	47.0	14.2	14.8	19.7	18.8	30.7	16.0	10.6	25.9	30.3	20.0	12.6	21.9	15.9	27.0	15.6	13.2	23.2	14.7	16.2	19.5	35.3	15.5	20.7	20.0	33.4	8.4	10.6	8.9	20.2	21.6	27.0	15.4	27.5	26.5	20.6	21.0	9.9	46.4	22.2	21.3	34.8	29.1	20.0	14.0	26.9	29.2	29.5	40.3	27.4	22.6	23.9	19.9	34.7	11.5	31.2	9.4	12.5	8.6	9.6	12.0	9.5	7.9	9.6	14.6	12.3	83.3	9.6	14.1	8.8	14.1	10.5	20.4	16.6	16.2	28.3	20.3	16.4	13.8	18.7	17.6	12.7	68.5	53.6	80.6	311.1	324.0	73.3	287.9	109.5	50.9	37.5	71.5	76.6	127.7	145.9	138.0	194.0	119.9	104.0	210.2	148.2	103.0	162.4	304.2	116.3	90.1	106.8	82.6	126.4	82.3	121.3	244.2	143.5	139.6	215.9	189.4	109.5	124.2	180.7	129.8	106.4	130.7	89.5	148.8	178.2	201.6	171.6	323.2	605.1	89.5	82.7	405.3
UBE2C	UBCH10	ENSG00000175063	"Ubiquitin conjugating enzyme E2 C"	O00762	20	45812576-45816957	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 130.8"	"Group enriched"	"Detected in many"	5	"Erythroid cells: 397.1;Extravillous trophoblasts: 368.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"CAB011464, HPA034569, CAB035990, HPA054975"	Approved		Supported	"Plasma membrane,Cytosol"		Yes	Yes			"Plasma membrane, Cytosol"		"CAB011464: AB_442965, CAB035990: , HPA034569: AB_2674226, HPA054975: AB_2682658"	"unprognostic (1.45e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (6.24e-6)"	"unprognostic (2.27e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.09e-1)"	"unprognostic (3.61e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.68e-1)"	3.1	2.3	0.4	24.0	0.9	25.1	4.3	0.4	0.7	3.8	9.5	0.4	0.8	7.8	2.0	2.6	25.6	0.6	3.2	2.8	0.5	0.4	2.1	2.1	4.6	15.6	0.6	0.5	1.2	1.3	0.0	0.6	12.6	0.9	1.3	11.7	0.7	3.7	0.6	1.0	8.3	10.0	3.5	1.2	11.6	7.0	15.3	0.5	130.8	0.8	17.6	26.3	2.8	7.8	1.2	0.9	2.7	0.6	2.4	10.0	4.2	39.3	28.9	52.2	25.0	1.4	3.2	30.0	31.3	15.9	51.6	37.1	94.9	45.6	41.8	30.7	14.9	64.3	38.9	0.2	33.5	52.7	17.8	27.5	12.9	22.2	24.9	0.4	18.4	32.3	1.0	3.6	34.9	34.2	7.8	25.1	26.7	0.2	35.6	42.4	64.9	30.3	5.2	31.3	44.8	69.3	32.2	47.3	0.2	17.4	13.7	30.1	25.1	49.3	36.1	19.8	27.4	36.5	27.1	9.1	46.3	40.5	31.4	60.5	11.3	0.3	46.5	28.1	13.1	43.8	0.0	0.1	0.0	0.2	0.0	0.0	1.2	1.2	2.3	0.9	0.2	0.2	0.1	2.7	2.4	0.6	0.5	10.0	4.2	0.4	0.9	0.4	0.7	0.5	0.4	0.6	0.5	0.9	0.5	0.0	5.9	29.5	3.6	15.3	0.0	0.0	2.5	0.0	7.9	0.0	0.0	15.5	0.0	0.8	5.8	0.2	5.5	397.1	0.4	368.9	5.1	2.7	5.7	3.9	75.1	0.0	1.2	22.7	19.9	5.4	0.9	9.3	0.0	1.8	12.8	0.0	1.0	6.2	0.0	0.0	0.0	0.0	1.9	6.1	18.0	10.2	26.1	10.1	15.1	8.2
UBE2D3	UbcH5C	ENSG00000109332	"Ubiquitin conjugating enzyme E2 D3"	P61077	4	102794383-102868896	"Enzymes, Predicted intracellular proteins"	"Apoptosis, DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003920	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (7.43e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.78e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.31e-2)"	"prognostic favorable (4.51e-4)"	"unprognostic (5.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.34e-2)"	67.2	70.6	39.1	52.7	44.6	132.7	70.4	36.9	50.9	45.5	51.8	37.5	38.4	49.3	46.3	39.1	63.2	45.7	47.5	72.5	37.3	39.5	63.0	91.9	67.5	68.1	43.4	36.9	60.6	53.4	42.8	49.1	66.5	45.2	49.6	48.5	38.4	46.7	43.3	91.1	53.2	58.9	48.4	44.4	68.2	49.5	40.0	42.2	88.8	66.3	55.4	61.4	74.6	81.4	24.7	31.2	118.0	36.2	29.7	33.2	50.9	53.5	30.7	51.2	41.3	54.7	79.0	44.0	54.5	72.7	48.7	46.0	46.0	76.5	57.4	35.7	55.3	63.2	30.7	54.6	73.2	67.1	53.2	27.5	52.2	31.6	37.5	57.4	73.4	45.0	59.9	46.4	53.7	75.3	63.0	63.1	47.3	65.6	58.7	64.8	43.2	107.7	41.8	37.1	61.3	30.7	56.8	50.3	41.4	49.1	51.2	51.8	43.6	33.5	86.1	61.5	63.1	35.7	43.4	57.9	51.0	43.6	33.3	49.5	52.0	67.0	87.8	54.3	40.9	54.7	71.1	35.9	54.6	25.1	36.1	33.2	24.7	31.8	29.6	31.2	20.1	32.6	29.7	118.0	29.7	36.2	21.5	32.6	50.9	39.1	44.6	36.9	50.9	37.3	39.5	43.4	36.9	45.2	42.2	154.9	181.2	227.9	605.7	749.7	127.0	210.7	150.3	190.1	129.7	132.6	117.8	279.1	464.2	286.3	668.3	228.0	265.9	93.5	333.2	474.9	260.0	477.5	219.4	203.4	354.6	116.0	231.0	159.0	357.1	423.2	152.5	359.3	339.1	356.1	198.5	111.8	351.4	245.4	140.0	328.0	157.1	103.5	376.3	128.5	151.0	711.0	533.9	297.5	192.3	680.6
ULBP1	RAET1I	ENSG00000111981	"UL16 binding protein 1"	Q9BZM6	6	149964007-149973710	"Predicted membrane proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.9;lung: 9.7;testis: 10.5"	"Cell type enhanced"	"Detected in some"	16	"Alveolar cells type 1: 6.0;Alveolar cells type 2: 2.1;Ciliated cells: 4.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"cerebellum: 13.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 23.1;JURKAT: 17.8"									"HPA007547, HPA071005"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA007547: AB_1079430, HPA071005: AB_2686332"	"unprognostic (8.94e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.28e-4)"	"unprognostic (6.69e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.47e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.57e-12)"	"unprognostic (1.95e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.16e-2)"	0.7	0.6	2.0	0.4	0.6	0.5	0.5	13.9	1.5	0.4	0.7	0.2	0.0	0.4	0.5	0.5	0.8	0.9	0.5	1.2	1.5	0.3	1.2	0.9	9.7	0.2	0.3	0.0	1.2	0.4	0.6	0.6	1.3	1.0	0.8	0.4	0.5	1.0	0.2	1.6	0.6	0.3	0.3	1.2	0.3	0.9	10.5	0.2	0.2	3.8	0.6	0.5	0.7	4.9	0.7	0.1	0.9	1.8	0.3	3.5	0.3	2.7	1.3	2.6	1.4	2.6	7.7	2.7	3.6	1.1	1.6	2.8	1.8	3.1	2.7	2.9	12.4	6.6	2.6	23.1	4.5	4.3	12.0	3.8	0.2	0.9	0.0	13.6	0.1	1.0	8.4	5.6	11.4	3.0	1.3	2.3	17.8	2.2	0.0	4.0	3.2	2.8	0.0	0.9	1.7	4.2	1.2	2.4	0.3	4.9	2.0	0.9	0.3	5.3	3.3	0.8	1.6	2.6	5.3	1.9	1.3	2.3	5.1	3.2	0.4	0.4	2.5	7.9	4.0	3.3	0.1	0.2	0.1	2.4	1.3	3.5	0.7	1.2	2.8	0.1	0.2	0.7	1.2	0.9	0.3	1.8	0.0	1.9	0.3	2.0	0.6	13.9	1.5	1.5	0.3	0.3	0.0	1.0	0.2	6.0	2.1	0.0	0.4	0.1	0.0	0.4	0.0	4.0	1.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.5	0.0	0.0	0.0	0.1
ULBP2	RAET1H	ENSG00000131015	"UL16 binding protein 2"	Q9BZM5	6	149942000-149949235	"Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 10.8"	"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 6.9;Exocrine glandular cells: 7.4;Ito cells: 9.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"gdT-cell: 5.5;memory CD4 T-cell: 1.8;memory CD8 T-cell: 3.2;naive CD8 T-cell: 3.9;T-reg: 3.0"	"Lineage enriched"	"Detected in single"	7	"T-cells: 5.5"	"Cell line enhanced"	"Detected in many"		"SiHa: 32.0;U-2197: 23.1"									CAB018974	Approved		Supported	"Vesicles,Plasma membrane"	"Secreted in other tissues"	NA	NA			"Vesicles, Plasma membrane"		"CAB018974: "	"unprognostic (2.09e-5)"	"prognostic unfavorable (8.07e-4)"	"unprognostic (2.38e-3)"	"unprognostic (3.90e-1)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (1.26e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.42e-4)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.86e-1)"	3.3	1.7	4.5	1.9	2.3	4.3	5.9	5.3	6.5	1.6	0.6	0.0	0.0	0.9	0.6	0.5	10.8	0.5	1.6	4.1	4.4	1.0	1.9	1.7	6.2	1.1	1.0	2.1	0.2	1.6	0.3	1.1	4.4	3.9	0.6	0.7	0.3	1.5	0.4	0.6	1.0	0.4	2.0	0.6	0.5	0.7	3.6	0.1	0.5	3.5	4.6	2.4	4.1	5.2	0.0	0.0	0.0	0.0	0.8	5.5	0.9	9.2	0.8	0.2	2.9	0.5	2.8	1.6	9.6	5.6	10.1	8.3	3.5	5.3	0.0	14.7	10.9	14.5	6.6	3.6	8.8	5.8	4.2	1.9	0.5	1.4	0.0	3.6	0.0	0.7	1.3	6.8	8.9	3.9	8.2	5.7	8.0	1.1	0.0	7.4	6.4	0.8	0.0	0.0	1.7	4.9	1.4	2.2	0.0	14.3	2.7	0.3	0.0	32.0	0.7	0.9	1.6	0.9	4.0	8.9	6.6	8.3	23.1	11.0	0.0	0.0	0.4	9.5	5.1	4.7	0.0	0.0	0.0	5.5	0.0	0.6	0.0	1.8	3.2	0.0	0.0	0.6	3.9	0.0	0.8	0.0	0.0	3.0	0.9	4.5	2.3	5.3	6.5	4.4	1.0	1.0	2.1	3.9	0.1	0.0	2.2	0.0	5.4	3.3	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	6.9	6.3	3.8	0.0	0.0	7.4	0.2	0.9	0.9	0.0	0.0	1.8	0.0	0.0	9.2	1.2	6.4	0.0	1.7	1.7	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	0.0	1.0	2.3	3.2	2.5	0.0	2.9	0.0	3.2
USP14	TGT	ENSG00000101557	"Ubiquitin specific peptidase 14"	P54578	18	158383-214629	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001308	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		1400000	"Plasma membrane, Cytosol"		"HPA001308: AB_1080499"	"unprognostic (2.21e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.59e-3)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (7.81e-5)"	"prognostic unfavorable (4.30e-5)"	"unprognostic (5.14e-2)"	"unprognostic (5.00e-2)"	"prognostic favorable (7.91e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.76e-2)"	24.8	24.2	25.9	20.7	32.1	19.4	21.7	21.7	28.4	16.5	17.1	17.9	19.1	13.4	19.4	24.3	25.3	14.7	14.4	23.3	22.1	27.6	23.2	24.4	15.8	21.9	22.6	28.8	16.2	16.2	22.3	18.0	25.1	29.2	29.9	19.4	14.5	16.7	20.5	53.3	15.7	12.9	23.9	22.1	15.4	15.6	17.2	16.5	19.5	20.1	25.4	28.6	17.8	17.8	13.1	15.2	7.7	15.2	23.0	21.2	11.0	27.1	22.3	19.0	19.3	18.8	18.8	34.0	35.7	19.5	36.3	34.0	29.0	14.5	40.3	27.3	29.2	34.9	15.3	37.4	27.2	41.4	11.4	18.5	22.7	15.0	22.7	18.9	55.7	21.8	15.0	21.1	37.1	21.3	16.8	27.9	19.9	31.2	29.9	35.8	22.0	31.1	15.2	18.5	16.3	26.2	25.9	24.9	29.3	26.8	23.6	22.2	18.6	37.0	17.9	15.2	21.6	17.5	15.1	31.5	42.7	32.3	39.2	50.5	19.8	35.9	40.0	24.6	23.3	26.5	5.0	10.7	7.7	17.8	15.2	21.2	13.1	17.7	18.4	15.2	10.1	17.5	16.9	0.8	23.0	11.4	11.1	16.7	11.0	25.9	32.1	21.7	27.1	22.1	27.6	22.6	28.8	29.2	16.5	20.8	33.1	28.2	36.7	52.1	52.7	40.0	22.9	42.8	51.2	41.8	29.5	80.1	38.1	58.5	41.3	39.3	15.4	23.3	46.8	58.4	42.1	56.1	33.5	39.4	45.0	109.7	21.2	28.3	30.4	14.7	29.4	39.1	33.7	54.1	19.4	35.6	58.1	19.5	43.2	43.1	50.1	0.0	45.7	26.2	61.2	45.8	113.4	38.8	27.3	39.1
UTRN	"DMDL, DRP, DRP1"	ENSG00000152818	Utrophin	P46939	6	144285701-144853034	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 381.2;Early spermatids: 418.2;Late spermatids: 250.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HAP1: 58.4;HUVEC TERT2: 41.7;TIME: 53.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016348, HPA018894"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		6000000	"Nucleoplasm, Plasma membrane"		"CAB016348: AB_628424, HPA018894: AB_10600839"	"unprognostic (3.47e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.44e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.10e-2)"	"prognostic favorable (7.61e-5)"	"unprognostic (6.32e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-2)"	34.5	14.1	11.6	34.5	23.5	22.9	25.4	3.1	11.3	32.6	15.3	6.8	21.9	7.7	28.8	21.5	17.7	21.4	15.8	13.8	9.2	12.8	15.5	11.8	35.2	30.9	12.7	8.8	22.7	23.8	53.1	13.0	21.1	16.0	23.4	15.2	17.3	18.4	24.8	11.7	16.7	14.8	19.8	16.6	45.8	13.3	45.0	8.5	27.4	32.4	20.0	25.7	20.7	23.4	11.7	15.0	10.6	48.0	10.3	12.6	3.7	6.9	5.9	10.5	13.6	18.3	16.8	6.3	10.3	10.1	8.4	12.3	22.5	2.6	2.2	9.1	23.1	9.9	4.1	58.4	8.7	12.1	23.3	6.7	8.3	6.4	13.3	7.2	9.2	0.1	9.7	1.8	12.4	6.5	7.9	41.7	6.6	0.5	6.1	11.8	4.6	7.3	4.0	4.2	4.3	6.3	6.6	19.0	0.2	9.7	0.2	13.4	0.2	16.1	2.2	6.4	16.8	8.9	12.5	53.6	8.1	10.1	4.1	9.8	4.7	6.3	0.3	4.9	5.6	13.2	9.8	12.3	6.6	12.6	36.3	9.0	7.4	8.0	10.2	5.1	11.7	7.0	7.3	10.6	10.3	48.0	15.0	6.4	3.7	11.6	23.5	3.1	11.3	9.2	12.8	12.7	8.8	16.0	8.5	381.2	100.6	59.6	24.2	26.2	6.0	51.2	35.7	125.8	185.4	29.6	0.0	73.5	0.0	20.7	418.2	142.7	5.3	0.0	27.6	3.8	38.2	40.0	27.8	12.1	19.7	57.2	30.0	68.2	90.1	250.3	22.2	56.1	37.1	8.2	14.2	29.3	24.9	10.5	31.5	4.9	3.4	142.3	109.3	5.7	4.6	39.6	108.1	64.0	20.4	18.4
VASP		ENSG00000125753	"Vasodilator stimulated phosphoprotein"	P50552	19	45506579-45526983	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 388.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 23.6"	"Group enriched"	"Detected in all"	6	"granulocytes: 23.6;monocytes: 10.4"	"Cell line enhanced"	"Detected in all"		"HMC-1: 65.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004612, HPA005724"	Enhanced		Supported	"Plasma membrane,Cell Junctions,Focal adhesion sites"		NA	NA		110000000	"Plasma membrane, Cell Junctions, Focal adhesion sites"		"CAB004612: AB_2213431, HPA005724: AB_1858721"	"unprognostic (3.07e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.70e-2)"	"unprognostic (7.85e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (3.49e-5)"	"unprognostic (1.66e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.64e-3)"	"unprognostic (4.39e-1)"	"prognostic unfavorable (5.91e-7)"	"unprognostic (1.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.08e-2)"	29.1	10.3	4.9	33.3	5.9	40.3	19.0	3.9	4.7	22.6	38.2	5.3	15.4	28.8	37.5	13.3	34.3	23.8	32.2	21.1	5.2	4.3	17.9	21.1	30.5	44.5	7.7	2.2	22.5	10.5	2.9	7.5	31.5	6.2	26.8	9.8	8.9	12.9	20.3	10.4	13.0	43.7	36.7	4.8	69.2	33.4	14.4	6.6	28.3	11.7	12.8	33.2	39.2	17.5	1.8	2.6	23.6	10.4	2.0	2.1	2.2	15.5	16.4	4.8	8.2	2.4	4.2	12.3	16.1	12.4	11.1	9.7	7.4	32.8	7.2	13.7	12.8	7.4	14.5	1.4	15.9	3.7	21.2	3.7	41.4	8.1	12.5	13.6	15.1	65.0	6.4	9.0	10.4	6.7	9.0	16.5	6.1	24.7	15.7	6.8	13.0	6.9	13.1	8.4	14.6	11.3	5.2	3.0	2.7	9.5	50.0	5.7	4.0	19.1	9.8	11.3	3.2	10.6	26.0	24.6	17.8	18.0	5.7	25.3	8.4	10.1	12.4	12.4	18.5	21.3	5.6	4.0	23.6	2.1	6.5	1.5	1.8	1.7	2.0	2.6	1.7	1.1	1.3	17.1	2.0	10.4	1.0	1.2	2.2	4.9	5.9	3.9	4.7	5.2	4.3	7.7	2.2	6.2	6.6	14.9	24.5	57.0	75.3	87.2	7.9	14.6	30.6	10.7	34.2	31.4	25.5	54.0	14.9	140.2	2.8	53.3	134.7	0.0	86.8	388.2	29.9	56.5	81.9	13.5	148.4	6.4	110.1	45.4	113.3	3.6	24.2	183.9	47.2	67.7	118.7	13.1	143.6	173.9	46.3	13.6	13.6	129.4	84.5	7.5	10.0	68.0	117.9	82.0	102.2	112.6
VPS36	"C13orf9, CGI-145, Eap45"	ENSG00000136100	"Vacuolar protein sorting 36 homolog"	Q86VN1	13	52412602-52450628	"Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 249.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039734, HPA043947"	Approved		Supported	"Vesicles,Lysosomes,Plasma membrane,Cell Junctions"		NA	NA			"Vesicles, Lysosomes"	"Plasma membrane, Cell Junctions"	"HPA039734: AB_2676652, HPA043947: AB_2678744"	"unprognostic (2.43e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.57e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.96e-3)"	"unprognostic (1.19e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.57e-2)"	"prognostic favorable (9.91e-6)"	"unprognostic (6.47e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.83e-2)"	16.4	14.5	16.5	15.9	22.3	7.0	23.5	36.8	27.7	17.1	21.1	13.6	12.8	23.8	22.4	12.9	24.6	16.6	18.0	20.3	15.4	13.0	22.6	20.2	17.5	15.6	16.2	18.5	20.0	19.0	14.4	20.1	21.7	25.9	20.1	24.7	18.2	21.6	18.3	23.4	44.6	27.9	23.7	13.8	22.3	15.7	4.2	13.8	18.1	20.0	16.8	18.1	20.3	21.7	14.4	14.9	13.9	19.2	19.4	19.3	11.8	3.8	6.4	11.3	7.4	11.8	16.5	9.7	8.8	6.8	8.9	5.4	7.5	12.7	13.5	4.7	12.6	5.7	10.8	8.9	10.6	10.0	10.0	8.6	15.8	10.1	6.7	14.0	21.2	17.2	11.5	20.9	6.1	10.0	10.0	9.0	17.6	11.6	11.9	17.2	4.9	15.4	21.3	10.7	15.1	3.3	16.2	6.4	8.2	15.7	10.0	5.8	12.2	6.2	14.9	13.4	13.8	8.7	35.4	14.0	5.8	6.9	5.7	9.9	8.9	11.1	14.3	5.9	15.0	13.3	13.9	13.5	10.9	12.1	14.8	19.3	14.4	13.3	15.1	14.3	12.3	12.4	13.2	3.7	19.4	19.2	14.9	14.3	11.8	16.5	22.3	36.8	27.7	15.4	13.0	16.2	18.5	25.9	13.8	77.4	38.5	35.3	43.5	38.0	114.4	71.9	38.2	33.5	47.8	31.4	113.9	51.3	58.0	31.0	1.2	57.1	58.8	0.0	25.7	34.0	26.8	47.9	42.8	49.9	37.6	49.3	47.8	33.7	36.4	1.9	46.1	34.1	27.0	27.9	56.5	33.0	27.4	59.4	49.1	58.0	249.2	45.3	28.3	8.4	18.5	50.8	31.9	37.6	49.4	40.0
VTCN1	"B7-H4, B7H4, B7S1, B7X, FLJ22418"	ENSG00000134258	"V-set domain containing T cell activation inhibitor 1"	Q7Z7D3	1	117143587-117210960	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 46.4;epididymis: 29.9;kidney: 27.0;pancreas: 35.9"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 52.4;Ductal cells: 73.6;Exocrine glandular cells: 31.1"	"Group enriched"	"Detected in many"	6	"breast cancer: 55.8;endometrial cancer: 45.2;ovarian cancer: 49.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SK-BR-3: 74.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054200	Approved		Approved	"Plasma membrane,Cell Junctions,Focal adhesion sites"		No	NA			"Plasma membrane"	"Cell Junctions, Focal adhesion sites"	"HPA054200: AB_2682415"	"unprognostic (4.13e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.56e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.45e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	46.4	0.1	0.1	6.7	0.1	0.1	7.0	0.0	2.6	29.9	0.4	14.2	1.9	0.2	0.1	0.1	27.0	0.9	0.3	0.1	0.1	0.1	4.5	35.9	0.0	1.4	3.0	0.1	1.5	0.0	0.1	17.5	3.6	0.2	2.2	0.1	0.8	0.1	0.1	1.5	2.5	0.1	0.2	0.1	0.5	1.5	2.1	0.7	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.0	0.0	74.4	0.0	9.6	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	2.4	0.0	0.0	1.2	0.0	4.0	10.3	52.4	0.0	1.7	0.0	73.6	1.6	0.0	0.0	0.0	31.1	1.1	0.0	1.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	3.9
WDR1		ENSG00000071127	"WD repeat domain 1"	O75083	4	10074339-10116949	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 926.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020804, HPA036434, HPA070293"	Approved		Supported	"Plasma membrane,Cell Junctions"		NA	NA		280000000	"Plasma membrane, Cell Junctions"		"CAB020804: , HPA036434: AB_2675121, HPA070293: AB_2732152"	"unprognostic (1.35e-1)"	"unprognostic (6.64e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.63e-3)"	"unprognostic (6.83e-3)"	"unprognostic (1.69e-1)"	"unprognostic (9.00e-3)"	"unprognostic (2.52e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (1.73e-5)"	"unprognostic (1.11e-1)"	"unprognostic (3.56e-1)"	"unprognostic (3.46e-2)"	"unprognostic (4.83e-3)"	40.2	23.7	19.0	49.4	18.1	33.5	35.0	8.1	22.6	53.5	53.3	25.8	38.4	39.2	80.9	54.2	59.6	54.9	57.6	49.5	19.6	20.5	55.4	41.3	41.7	57.4	22.1	17.1	51.5	22.2	19.5	18.6	40.4	26.8	47.1	38.3	37.6	38.5	49.1	32.1	31.6	54.5	88.0	19.5	46.9	41.1	38.0	16.0	74.5	49.9	36.4	50.2	69.6	41.5	22.9	40.2	54.2	61.2	32.5	55.6	64.1	30.5	30.7	27.5	23.1	20.9	34.7	43.4	77.3	71.4	69.9	55.0	36.7	38.7	21.3	25.2	92.2	76.0	20.0	29.9	56.5	74.8	33.2	10.2	60.7	31.4	26.0	48.9	19.2	70.4	33.3	29.0	70.9	35.5	53.5	75.1	38.0	18.1	35.4	67.7	17.5	84.8	27.1	32.6	24.6	30.8	40.0	25.2	18.0	43.6	48.8	9.3	10.2	33.0	18.3	31.8	37.7	15.3	20.9	112.9	53.9	22.6	44.6	67.6	22.4	35.8	27.9	57.0	29.3	66.8	37.1	29.0	54.2	48.3	51.7	37.4	22.9	40.6	48.2	37.8	16.9	41.7	44.4	54.1	32.5	61.2	40.2	55.6	64.1	19.0	18.1	8.1	22.6	19.6	20.5	22.1	17.1	26.8	16.0	32.8	48.2	70.0	155.9	129.0	22.1	55.6	73.9	62.9	60.3	99.5	39.3	147.9	72.9	294.0	462.5	69.7	206.5	0.0	185.6	249.1	66.7	101.7	80.8	62.3	224.0	31.8	104.6	84.7	141.3	926.6	43.4	122.8	75.9	402.2	113.7	74.5	238.9	137.2	86.7	88.0	24.9	97.0	170.5	94.8	67.2	119.7	193.7	125.0	117.8	177.3
XRN1	SEP1	ENSG00000114127	"5'-3' exoribonuclease 1"	Q8IZH2	3	142306607-142448062	"Predicted intracellular proteins"		"DNA-binding, Exonuclease, Hydrolase, Nuclease, RNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"RH-30: 58.4"	"Low region specificity"	"Detected in all"							"HPA035005, HPA035006"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA035005: AB_10670695, HPA035006: AB_10672750"	"unprognostic (3.52e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (9.43e-4)"	"unprognostic (7.68e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.43e-2)"	"unprognostic (6.32e-2)"	16.5	12.4	9.9	16.2	15.5	24.4	15.9	23.8	15.7	15.7	17.5	7.5	12.4	14.7	15.2	14.2	13.4	11.5	11.0	10.1	8.4	6.8	9.6	21.7	15.9	16.1	11.7	9.0	17.4	13.2	17.4	26.5	23.6	10.7	12.5	13.0	8.2	14.4	13.3	21.2	17.2	25.0	14.4	15.2	16.2	11.7	11.8	10.9	30.8	12.9	10.8	15.3	15.0	15.2	7.4	6.1	18.3	4.7	4.3	8.4	2.5	10.0	1.9	4.6	3.9	5.2	8.6	2.8	4.7	6.3	6.1	7.6	1.7	3.0	4.0	4.9	6.2	4.9	3.9	4.1	2.4	9.4	10.2	3.1	5.9	3.3	1.6	4.5	5.9	6.0	6.7	2.7	4.4	5.8	5.7	5.5	4.5	3.9	9.6	5.5	1.9	5.1	3.1	1.4	1.4	2.1	4.2	58.4	5.0	2.9	5.1	2.7	3.4	8.4	4.6	3.6	2.9	5.6	4.6	7.4	4.3	2.4	4.9	4.0	13.8	7.0	6.4	4.0	3.1	3.7	18.3	4.7	12.2	8.3	4.2	5.8	7.4	6.4	7.4	2.3	6.0	8.4	5.8	17.2	4.3	4.0	6.1	4.6	2.5	9.9	15.5	23.8	15.7	8.4	6.8	11.7	9.0	10.7	10.9	50.6	26.6	34.1	28.0	22.8	31.5	23.0	17.8	26.8	33.0	43.6	47.1	17.6	10.0	12.9	37.7	26.6	30.0	23.3	11.0	6.0	21.8	33.7	19.8	42.4	14.1	25.4	27.1	36.8	30.0	15.1	23.0	23.1	13.5	26.2	18.5	23.2	15.6	24.6	27.3	12.0	57.0	6.5	17.9	55.7	14.9	24.7	44.7	35.5	13.6	42.3
YES1	"c-yes, HsT441, Yes"	ENSG00000176105	"YES proto-oncogene 1, Src family tyrosine kinase"	P07947	18	721588-812546	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 14.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 14.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004370, HPA026480"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		4300000	"Plasma membrane, Cytosol"		"CAB004370: AB_627370, HPA026480: AB_1858921"	"unprognostic (3.28e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.24e-2)"	"unprognostic (4.24e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.85e-3)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (2.14e-1)"	"unprognostic (8.12e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.11e-1)"	26.2	13.1	17.0	9.4	15.6	2.6	47.2	6.7	12.8	15.8	23.8	8.9	13.7	18.2	13.1	17.4	22.0	10.7	14.9	17.9	14.8	12.4	22.6	43.2	23.6	13.7	15.8	6.6	13.2	21.4	16.7	10.7	31.3	16.8	12.2	17.3	6.5	23.7	21.0	10.6	12.3	24.8	18.8	16.8	34.5	15.5	13.6	12.0	8.1	16.8	15.6	7.1	21.9	17.5	0.1	0.1	14.7	0.0	1.0	2.5	0.6	14.4	7.2	22.8	17.8	13.7	17.0	26.8	9.6	19.7	11.4	15.7	17.1	10.7	0.0	10.3	16.3	14.6	8.5	21.3	17.1	22.4	0.0	7.2	4.3	7.1	11.9	11.1	3.3	7.7	13.0	18.4	17.2	19.2	14.2	38.4	2.4	18.7	6.4	16.2	9.9	2.0	4.3	14.4	8.8	9.2	2.5	17.9	1.2	16.6	17.2	4.6	5.4	19.9	15.1	12.6	15.7	10.4	6.9	33.0	28.1	31.2	21.2	25.9	5.6	2.7	0.8	10.6	4.7	16.6	14.7	0.0	0.9	2.5	0.0	1.6	0.1	0.5	1.4	0.0	0.0	1.2	1.9	0.0	1.0	0.0	0.1	0.1	0.6	17.0	15.6	6.7	12.8	14.8	12.4	15.8	6.6	16.8	12.0	23.8	30.8	1.5	33.5	53.3	6.2	16.5	20.4	26.8	34.2	27.9	5.9	28.2	3.3	25.6	20.2	77.6	27.4	0.0	34.0	20.3	31.2	52.1	12.8	33.4	4.3	3.2	21.9	41.1	5.6	7.9	17.0	5.3	23.6	1.0	35.7	16.3	40.3	21.0	12.0	38.5	8.0	19.4	20.6	12.8	11.7	43.4	38.1	15.2	31.0	58.7
YOD1	"DKFZp451J1719, DUBA8, OTUD2"	ENSG00000180667	"YOD1 deubiquitinase"	Q5VVQ6	1	207043849-207052980	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway, Unfolded protein response"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 44.7"	"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 69.8;Urothelial cells: 62.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 40.3;K-562: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028400, HPA028439"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		40000	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA028400: AB_10599854, HPA028439: AB_10600994"	"unprognostic (3.69e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.28e-2)"	"unprognostic (9.87e-3)"	"unprognostic (9.38e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.03e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.62e-1)"	4.5	4.6	4.0	4.0	5.3	44.7	6.6	4.8	7.5	6.1	3.9	7.6	2.6	4.1	4.0	3.1	24.5	3.7	3.5	5.0	4.0	2.2	4.5	5.2	9.4	4.2	7.1	4.4	3.5	3.6	2.5	5.1	6.3	5.1	3.4	4.0	3.4	9.7	3.0	6.5	14.9	4.8	2.7	8.5	5.2	8.4	5.6	6.9	14.3	5.8	10.0	8.2	5.8	12.3	0.5	1.3	3.9	1.5	1.2	1.8	0.9	5.4	2.9	4.6	2.7	1.6	2.1	9.0	3.6	2.8	2.7	2.8	5.5	5.6	2.8	1.5	2.2	1.3	6.0	0.0	4.4	3.1	2.3	4.9	40.3	11.9	2.6	1.5	5.2	14.2	1.5	3.4	2.2	8.6	3.2	2.4	5.9	28.0	0.0	2.3	0.0	4.6	2.9	4.4	2.2	6.5	2.3	0.2	2.1	2.7	6.1	2.4	5.3	5.9	6.9	7.7	4.2	2.4	3.7	1.1	2.4	6.2	1.9	4.7	4.6	0.2	4.2	2.8	0.0	1.6	3.9	1.2	2.0	1.1	1.5	1.5	0.4	1.7	0.9	1.3	0.5	1.4	1.8	2.9	1.2	1.0	0.7	0.8	0.9	4.0	5.3	4.8	7.5	4.0	2.2	7.1	4.4	5.1	6.9	38.7	9.8	0.8	21.4	28.0	7.8	5.3	5.1	13.4	5.7	1.8	3.9	2.3	1.7	3.8	28.6	3.5	9.8	46.7	9.3	2.7	5.7	29.8	8.1	5.4	2.4	11.1	8.5	3.7	8.5	69.8	1.4	6.4	13.5	1.8	3.5	4.2	15.5	4.9	2.1	5.4	16.2	6.5	3.1	8.8	4.1	35.1	1.5	7.5	5.4	62.9
ZDHHC20	"DHHC20, FLJ25952"	ENSG00000180776	"Zinc finger DHHC-type containing 20"	Q5W0Z9	13	21372573-21459370	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.4"	"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 77.2;Kupffer cells: 86.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014483, HPA014702"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA014483: AB_1859000, HPA014702: AB_1859001"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-3)"	"unprognostic (7.31e-3)"	"unprognostic (8.89e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (6.55e-4)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (3.76e-2)"	"unprognostic (7.65e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.13e-2)"	7.5	7.0	8.3	9.4	33.6	14.9	11.3	6.4	15.3	10.3	10.9	21.0	7.6	10.8	9.3	5.6	18.4	7.1	10.0	5.4	12.7	11.8	3.8	7.6	10.6	12.3	47.4	4.9	6.5	6.1	4.0	5.3	10.8	26.1	9.2	9.6	3.1	10.4	9.9	5.5	12.2	15.4	8.9	45.0	8.6	23.1	22.0	35.8	10.4	10.0	5.1	10.9	16.2	9.6	4.6	7.8	8.8	15.2	10.1	10.2	11.1	13.2	7.7	11.2	7.1	10.5	11.1	27.5	14.6	14.7	9.8	8.7	13.9	40.9	14.2	7.9	17.8	10.3	21.7	12.9	11.2	18.5	15.4	8.2	24.9	4.8	7.7	5.9	16.8	10.8	10.0	7.9	9.6	6.8	12.4	15.1	18.4	6.9	6.0	14.4	11.2	23.5	6.4	9.1	35.2	7.6	18.9	20.2	4.9	11.6	24.9	10.7	4.9	19.1	12.0	7.8	12.0	11.0	8.6	26.2	10.3	9.9	17.3	10.8	6.2	7.6	14.7	7.4	9.7	29.1	8.8	15.2	3.4	10.2	14.2	9.4	4.6	8.8	8.7	7.8	3.7	8.3	8.5	2.7	10.1	12.0	3.9	9.3	11.1	8.3	33.6	6.4	15.3	12.7	11.8	47.4	4.9	26.1	35.8	47.6	26.9	15.8	6.9	0.9	8.3	6.4	17.8	20.1	36.4	10.4	7.9	18.2	0.0	8.6	77.2	15.0	29.0	0.0	10.5	16.6	10.3	19.1	13.9	17.4	19.9	17.5	23.1	19.6	86.8	67.8	14.4	35.8	1.7	7.2	29.0	4.4	18.7	23.0	10.3	6.2	9.6	19.4	6.9	9.7	12.3	1.4	37.3	20.8	23.4	16.9
ZNF185	SCELL	ENSG00000147394	"Zinc finger protein 185 with LIM domain"	O15231	X	152914442-152973480	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 93.5;esophagus: 67.6"	"Cell type enhanced"	"Detected in many"	10	"Pancreatic endocrine cells: 42.4;Suprabasal keratinocytes: 18.4;Urothelial cells: 17.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 21.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 21.6;monocytes: 13.9"	"Cell line enhanced"	"Detected in many"		"A-431: 31.7;EFO-21: 37.7;HBEC3-KT: 26.2;PC-3: 23.2;TIME: 61.8"					"Low region specificity"	"Detected in all"			"HPA000400, HPA016438"	Enhanced		Supported	"Plasma membrane,Actin filaments,Focal adhesion sites,Cytosol"		NA	NA		5400	"Plasma membrane, Cytosol"	"Actin filaments, Focal adhesion sites"	"HPA000400: AB_1080685, HPA016438: AB_1859109"	"unprognostic (1.34e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.75e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (7.94e-2)"	"unprognostic (6.28e-2)"	"prognostic unfavorable (3.30e-5)"	"unprognostic (5.18e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.60e-1)"	3.9	1.7	1.8	2.0	3.2	0.8	1.8	2.7	2.0	14.3	1.8	1.4	10.7	0.0	3.8	93.5	67.6	3.1	2.0	1.9	1.7	0.8	2.0	1.1	3.3	3.1	2.1	1.1	1.2	0.9	0.1	2.3	4.0	1.7	4.2	0.3	1.3	10.1	28.1	1.5	9.9	1.2	1.4	1.2	3.7	0.8	1.9	2.0	1.2	3.9	1.4	6.6	2.1	22.8	0.4	3.8	21.6	13.9	0.2	0.6	10.2	31.7	6.7	0.6	0.4	0.8	1.1	1.5	1.5	0.1	3.9	0.5	0.2	9.6	0.4	37.7	2.3	0.4	4.5	0.9	26.2	16.3	0.3	0.6	2.0	2.7	1.0	1.9	0.1	0.1	0.8	18.8	0.4	15.4	3.9	20.2	0.4	0.1	0.3	0.1	7.5	0.1	0.1	0.5	8.1	23.2	0.1	0.1	0.2	2.0	3.0	0.2	2.2	0.0	6.0	0.9	6.5	6.2	0.7	61.8	0.2	13.7	0.8	1.1	0.3	0.2	0.2	0.4	2.3	0.4	21.6	13.9	5.7	0.5	12.9	0.3	0.4	0.4	0.6	3.8	0.3	0.6	0.3	9.5	0.2	10.2	2.5	0.5	10.2	1.8	3.2	2.7	2.0	1.7	0.8	2.1	1.1	1.7	2.0	11.9	1.6	0.5	4.9	8.1	0.5	1.0	2.5	2.7	4.5	8.7	2.0	3.2	0.0	8.6	0.2	0.5	0.0	0.0	2.6	4.3	2.8	5.1	1.1	0.0	8.6	0.0	0.0	0.6	8.8	0.0	1.1	4.6	3.3	4.6	2.1	3.0	42.4	0.0	1.1	0.9	0.0	0.0	0.5	2.3	5.3	18.4	0.6	0.0	3.3	17.6
ZNF655	"VIK, VIK-1"	ENSG00000197343	"Zinc finger protein 655"	Q8N720	7	99558406-99576453	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029534, HPA050750"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA029534: AB_10603008, HPA050750: AB_2681225"	"prognostic favorable (7.12e-4)"	"unprognostic (3.03e-2)"	"unprognostic (9.62e-2)"	"unprognostic (5.00e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.31e-2)"	"unprognostic (3.93e-3)"	"prognostic unfavorable (7.24e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.12e-1)"	14.6	19.0	17.4	24.1	20.7	10.3	16.9	31.1	20.3	18.8	20.2	19.7	18.0	22.2	15.3	19.0	39.2	15.6	15.1	11.3	14.7	14.4	19.1	21.2	19.9	23.8	21.3	16.1	19.4	30.8	13.9	25.0	21.1	20.4	16.9	16.8	14.1	25.5	19.0	18.2	25.5	19.7	19.8	21.3	22.2	24.1	11.1	19.4	27.8	16.0	14.3	23.1	21.4	20.7	15.0	17.5	44.7	22.2	14.7	25.7	21.4	16.2	15.8	5.8	8.6	6.6	9.9	5.0	9.8	18.5	17.0	16.3	8.7	16.0	11.4	0.1	13.7	22.6	10.3	6.8	11.9	17.2	13.7	9.9	7.9	6.7	11.0	10.1	14.4	15.3	8.5	14.5	15.7	22.2	8.2	7.4	9.7	21.0	15.8	10.6	0.0	20.1	13.2	6.8	0.0	0.0	7.2	5.4	22.4	11.2	17.9	6.7	12.4	9.3	0.3	9.8	9.6	5.3	8.6	5.2	9.5	25.1	15.6	17.6	18.6	27.1	24.8	9.7	7.3	15.3	44.7	18.8	31.2	22.3	19.9	20.5	15.0	20.5	25.6	17.5	13.3	16.5	20.7	21.9	14.7	22.2	10.1	25.7	21.4	17.4	20.7	31.1	20.3	14.7	14.4	21.3	16.1	20.4	19.4	89.3	73.3	45.4	33.6	39.8	46.9	31.5	33.1	26.8	48.9	22.7	39.3	24.8	28.2	24.8	7.8	13.4	38.0	0.0	31.4	35.4	23.7	39.5	17.4	20.8	32.5	47.7	39.9	19.0	58.3	7.1	23.6	52.1	21.9	33.3	34.0	23.0	36.8	49.1	23.7	33.4	45.2	12.9	24.1	30.2	25.1	42.8	61.6	48.4	25.9	52.5
